data_1f7x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f7x _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -142.89 149.9 39.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.66 170.98 16.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.601 -1.312 . . . . 0.0 110.605 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.04 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 11' ' ' ILE . 22.4 mm -91.95 128.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.65 140.84 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.844 0.83 . . . . 0.0 110.63 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -136.88 127.32 26.68 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.848 -1.158 . . . . 0.0 111.335 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.7 114.45 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.06 153.03 41.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.91 -165.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -69.89 155.71 40.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.065 -1.022 . . . . 0.0 109.178 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.89 140.51 55.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 109.64 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.76 6.12 73.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -129.76 143.1 50.65 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.607 -0.937 . . . . 0.0 108.856 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.2 mt-10 -123.07 150.94 42.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.409 -0.807 . . . . 0.0 109.324 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -87.5 142.44 27.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.222 -0.924 . . . . 0.0 109.864 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -67.9 140.32 56.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -0.923 . . . . 0.0 108.736 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.14 97.68 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.768 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.68 -46.58 87.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.961 -1.317 . . . . 0.0 109.783 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.02 -30.64 67.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.314 -0.866 . . . . 0.0 108.919 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.9 tt -72.19 -56.8 4.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.627 -0.671 . . . . 0.0 109.352 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.04 -42.86 95.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.35 -40.98 92.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.503 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -64.82 -41.98 95.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.929 -1.107 . . . . 0.0 110.033 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.53 -46.67 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.328 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.56 -40.13 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 0.0 110.022 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.99 -17.77 64.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.56 5.43 24.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.911 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.33 72.14 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 121.05 -1.031 . . . . 0.0 110.697 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.68 150.36 30.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.355 . . . . 0.0 109.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 38' ' ' ILE . 97.6 mt -119.05 133.05 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 109.67 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.773 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.92 171.29 23.54 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.79 -163.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -1.116 . . . . 0.0 109.725 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 92.4 mmm 58.2 20.35 7.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.71 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m120 50.08 39.11 18.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.559 -0.713 . . . . 0.0 111.396 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.94 161.56 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.098 -1.001 . . . . 0.0 108.558 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 120.62 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.05 -1.031 . . . . 0.0 110.352 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 38.6 m80 -105.12 127.9 53.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.5 ttt180 -102.67 129.23 49.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.052 -1.03 . . . . 0.0 108.893 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 13.4 m-70 -93.27 168.77 10.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.422 -0.799 . . . . 0.0 109.052 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.3 tp -52.71 -52.59 55.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.6 m -93.58 149.99 38.09 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.22 -2.14 10.01 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.57 0.846 . . . . 0.0 111.713 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -95.94 0.03 51.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.02 14.07 82.12 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 55' ' ' GLY . 83.8 p -68.41 -38.59 81.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.155 -1.203 . . . . 0.0 109.532 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -90.44 171.43 36.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 27.6 Cg_endo -74.55 178.67 6.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 120.944 1.096 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.57 118.83 22.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.129 -0.982 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.8 mp -97.81 -26.55 14.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -159.25 160.61 35.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.067 -1.02 . . . . 0.0 108.927 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.1 m -134.32 -178.56 5.1 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.915 -1.115 . . . . 0.0 112.094 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.3 tt -137.9 134.06 34.57 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.322 0.582 . . . . 0.0 109.476 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -134.15 162.22 32.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -75.32 160.81 29.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 109.849 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -69.93 -22.98 63.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 110.92 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 71.8 t -86.76 121.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.822 -1.174 . . . . 0.0 109.719 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -58.57 147.31 70.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.054 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -76.33 15.98 6.95 Favored 'Cis proline' 0 N--CA 1.492 1.435 0 C-N-CA 123.402 -1.499 . . . . 0.0 111.76 -0.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 70.05 18.66 74.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.2 p -90.76 171.47 9.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -114.6 151.94 32.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 77.8 m-20 -131.2 148.42 70.12 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -46.08 -13.96 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.562 0.842 . . . . 0.0 111.668 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.4 mt-10 -85.46 16.12 4.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 21.8 ptt? -81.94 -2.82 52.7 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 58.9 mttm -86.24 -0.76 56.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.029 -1.044 . . . . 0.0 108.773 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.5 m-20 -152.15 69.34 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.559 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -155.32 169.94 23.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.909 -1.119 . . . . 0.0 109.53 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 80.4 p -130.41 154.49 47.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.69 149.88 20.75 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.872 -1.142 . . . . 0.0 109.57 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.24 -36.43 99.02 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.508 0.805 . . . . 0.0 112.185 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.68 -157.78 19.94 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.159 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.0 160.3 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.594 -0.945 . . . . 0.0 109.116 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' ALA . 54.5 m -116.62 124.36 49.6 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.549 0.69 . . . . 0.0 109.867 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.05 129.48 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.24 163.61 34.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 110.282 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -140.02 128.56 22.89 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -88.97 118.67 28.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 108.735 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.14 152.52 39.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.45 138.13 53.87 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.275 -1.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.7 m -105.46 160.94 14.76 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.799 0.809 . . . . 0.0 110.736 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.17 143.73 52.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.709 -0.62 . . . . 0.0 109.953 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.74 -152.96 24.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -93.72 110.15 21.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -1.115 . . . . 0.0 109.068 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -56.21 -31.05 63.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.678 -0.639 . . . . 0.0 109.713 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 -37.02 75.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.99 -38.98 76.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 108.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -60.16 -41.16 92.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CG ' ' NE2' ' A' ' 133' ' ' GLN . 70.7 t80 -59.79 -46.09 90.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -61.24 -46.59 89.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.11 -40.05 88.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.099 -1.001 . . . . 0.0 110.248 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.3 mtp -59.02 -49.14 79.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.0 110.124 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.09 -40.04 90.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.4 mt-30 -60.02 -42.59 94.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 108.92 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 p -70.11 -39.9 75.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.454 -0.779 . . . . 0.0 109.19 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.41 -57.8 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 110.275 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -60.12 -39.69 87.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.999 -1.063 . . . . 0.0 109.764 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 13.6 m-70 -59.99 -48.3 82.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.913 -1.117 . . . . 0.0 108.636 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.14 -49.9 82.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.63 -50.13 66.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.504 -0.747 . . . . 0.0 109.327 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.81 -40.0 91.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 110.275 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.94 -40.18 75.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.1 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.12 1.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.163 -0.961 . . . . 0.0 109.609 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.45 23.07 77.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.87 -176.58 49.6 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.146 -1.208 . . . . 0.0 110.349 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.06 130.37 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.696 -0.884 . . . . 0.0 108.791 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.54 130.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -130.34 159.61 36.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.369 -0.832 . . . . 0.0 109.411 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -88.34 -173.31 4.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.4 m-20 -60.74 -38.51 85.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -76.4 14.6 0.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 121' ' ' ARG . 18.7 mtt-85 57.56 36.8 27.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 52.4 mtt-85 -112.0 149.28 32.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.2 mtp -52.27 130.3 30.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.3 mmm -60.52 138.98 57.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 p -134.87 150.94 74.67 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.7 -46.49 10.33 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 120.813 1.008 . . . . 0.0 112.708 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.27 -41.34 93.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.0 -39.88 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.927 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.0 -40.02 79.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.199 -0.938 . . . . 0.0 108.476 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.12 -36.68 82.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.621 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.58 -46.57 86.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.005 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -60.01 -40.15 88.29 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 108.741 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.576 ' NE2' ' CG ' ' A' ' 98' ' ' PHE . 85.6 mm-40 -60.94 -40.05 91.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 0.0 109.009 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.31 -40.05 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.953 . . . . 0.0 108.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.86 -42.8 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.343 -0.848 . . . . 0.0 108.754 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.07 -40.49 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 32.2 mmt180 -61.33 -37.31 82.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.38 -0.825 . . . . 0.0 109.706 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.0 mt-10 -59.88 -40.2 87.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.18 -32.97 27.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 111.008 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.9 mttt -59.79 -41.85 92.08 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.877 -1.139 . . . . 0.0 110.903 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.2 -29.48 68.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.83 -1.169 . . . . 0.0 109.811 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.43 91.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -104.62 -1.07 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.814 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -154.76 131.37 10.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.06 -170.2 1.87 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.576 -1.327 . . . . 0.0 110.88 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.06 132.3 65.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 11' ' ' ILE . 22.7 mm -86.87 130.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -126.94 144.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.091 0.948 . . . . 0.0 110.964 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.2 mtt -145.12 151.28 38.23 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.485 HD21 ' HG1' ' A' ' 83' ' ' THR . 35.0 m120 -131.24 130.13 42.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.142 . . . . 0.0 111.153 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.0 t -109.31 118.43 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 154.75 39.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.978 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.02 -165.8 0.13 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.67 155.49 35.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.934 -1.104 . . . . 0.0 108.826 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -58.73 139.45 56.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.102 -0.999 . . . . 0.0 109.589 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.22 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -128.49 143.3 50.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.575 -0.956 . . . . 0.0 108.936 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -120.39 140.46 51.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.437 -0.789 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.64 142.12 28.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 109.944 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.99 137.78 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.44 -0.787 . . . . 0.0 109.347 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.26 96.82 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.581 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.05 -46.32 89.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.772 -1.428 . . . . 0.0 109.512 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.41 -24.69 63.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -72.6 -56.54 5.18 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.11 -45.06 94.23 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.955 -1.09 . . . . 0.0 110.301 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.03 -45.99 90.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 111.518 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.4 p -63.47 -43.17 98.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.88 -1.138 . . . . 0.0 110.192 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.15 -47.14 93.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 110.202 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.0 -40.07 94.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -68.13 -19.56 64.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.536 -0.728 . . . . 0.0 109.833 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.54 7.85 11.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 109.693 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.85 9.39 84.54 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -79.76 147.6 31.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.386 . . . . 0.0 109.266 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 88.9 mt -122.91 134.37 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.98 102.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.253 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.44 168.09 29.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.53 -162.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.195 -1.179 . . . . 0.0 109.186 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.7 mtt 59.92 20.15 9.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.81 -0.557 . . . . 0.0 110.609 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.6 m120 52.35 33.19 12.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.129 -0.982 . . . . 0.0 111.362 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 12.2 pt -139.61 155.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.008 -1.058 . . . . 0.0 108.483 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -88.02 120.19 29.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.883 -1.136 . . . . 0.0 110.019 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 52.7 m-70 -105.41 127.14 52.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.638 -0.664 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 47' ' ' ARG . 15.4 ttt-85 -101.82 128.87 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.526 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 29.0 m-70 -93.84 175.74 6.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.44 -49.97 68.75 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.167 -0.958 . . . . 0.0 108.53 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 55.2 m -92.65 149.24 37.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -71.34 -2.19 10.84 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.695 0.93 . . . . 0.0 111.644 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.01 -2.78 52.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.933 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.68 85.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.8 p -69.95 -40.0 75.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -1.184 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.58 171.51 54.05 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.526 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.2 Cg_endo -71.49 177.23 7.0 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.04 1.16 . . . . 0.0 111.306 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.58 122.25 26.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 108.925 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 mp -101.06 -47.58 4.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 163.08 33.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.123 -0.986 . . . . 0.0 108.526 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.489 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.2 m -136.15 -177.01 4.51 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.125 -0.984 . . . . 0.0 111.842 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.3 tt -136.79 130.37 31.81 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.47 0.652 . . . . 0.0 109.43 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.48 160.54 33.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 93.8 m-20 -75.06 157.89 34.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.317 -0.865 . . . . 0.0 110.674 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.6 mtp -69.94 -22.19 63.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -87.04 120.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.88 151.3 64.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 110.07 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.38 15.7 7.25 Favored 'Cis proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.042 -1.232 . . . . 0.0 112.344 -1.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.94 18.61 80.17 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.9 p -87.88 175.61 7.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -1.158 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 40.4 m-85 -125.31 156.4 38.72 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 73' ' ' GLU . 39.4 m-20 -140.02 147.24 49.96 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 121.175 -0.953 . . . . 0.0 110.676 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -47.56 -11.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.36 0.807 . . . . 0.0 110.806 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 71' ' ' ASP . 44.5 mp0 -85.56 22.37 1.59 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.1 mtm -73.57 -0.1 14.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.0 mttm -88.13 -1.45 58.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.005 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.2 m-20 -151.23 74.78 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.725 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -160.05 164.61 33.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.01 -1.056 . . . . 0.0 109.544 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.5 p -139.11 155.88 47.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.62 149.02 16.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.826 -1.172 . . . . 0.0 109.353 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.85 -36.42 95.43 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.412 0.741 . . . . 0.0 111.812 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.43 -157.1 15.06 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.02 158.8 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.697 -0.884 . . . . 0.0 109.114 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.485 ' HG1' HD21 ' A' ' 14' ' ' ASN . 76.8 m -110.03 118.3 36.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 109.842 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 94.5 mt -100.56 130.04 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.98 168.97 20.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.898 -1.126 . . . . 0.0 111.021 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 ttp -141.28 135.24 30.41 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -88.32 108.62 19.42 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.41 141.36 22.9 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.53 135.25 34.39 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.498 0.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.525 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.0 m -105.32 168.52 9.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.394 -0.816 . . . . 0.0 109.289 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -69.98 149.96 47.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.97 -157.63 32.37 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.71 117.84 31.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -1.079 . . . . 0.0 109.575 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 90' ' ' SER . 57.8 mm-40 -57.6 -28.38 63.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.3 mt -69.91 -38.14 76.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 109.247 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.86 -40.0 76.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -61.39 -40.55 94.77 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.21 -48.38 81.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.27 -46.45 89.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 108.94 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.29 -40.1 95.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.98 -46.68 88.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.023 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.54 -45.04 84.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.519 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 29.3 mm100 -60.03 -40.23 88.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.164 -0.96 . . . . 0.0 108.448 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 p -70.02 -40.52 75.14 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.67 7.62 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.456 -0.777 . . . . 0.0 109.561 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -61.02 -40.89 95.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -60.63 -50.38 73.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.054 -1.029 . . . . 0.0 108.912 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.9 -50.09 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.71 -49.0 63.34 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.95 -40.02 87.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 110.227 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.89 -40.01 75.91 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.148 -0.97 . . . . 0.0 110.958 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.34 0.79 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.06 -1.025 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.04 21.52 76.94 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.52 50.39 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.01 136.43 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.602 -0.94 . . . . 0.0 108.916 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.03 135.05 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 109.938 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -134.85 160.21 38.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.356 -0.84 . . . . 0.0 109.425 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -86.41 -174.85 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.38 -0.825 . . . . 0.0 109.115 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.5 m-20 -60.04 -36.02 76.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.357 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -77.25 12.76 1.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 109.103 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.443 ' H ' ' C ' ' A' ' 119' ' ' ASP . 40.8 mtm-85 55.91 39.54 30.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.741 -0.6 . . . . 0.0 109.853 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -117.69 153.22 33.72 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.6 mmm -50.46 130.03 23.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 75.4 mmm -60.08 139.81 57.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.518 -0.739 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -134.45 151.21 75.74 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -43.98 -46.84 10.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.873 1.049 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -60.08 -39.99 88.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.1 -39.97 82.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 110.287 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.43 -40.04 85.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.949 -1.094 . . . . 0.0 108.603 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -63.64 -39.59 94.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.591 -0.693 . . . . 0.0 109.431 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.62 -46.97 87.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.435 ' HH ' ' CG ' ' A' ' 119' ' ' ASP . 60.0 m-85 -59.86 -41.55 91.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -62.6 -40.13 95.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.83 -41.0 94.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.08 -43.3 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 108.891 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.97 -47.46 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.538 -0.727 . . . . 0.0 109.361 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.3 mtt180 -61.06 -39.9 91.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.11 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.441 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 51.5 mt-10 -60.48 -40.06 89.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.213 -0.93 . . . . 0.0 110.971 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.52 -34.04 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.062 -1.024 . . . . 0.0 110.794 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 98.1 mttt -60.01 -44.45 94.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.538 -1.352 . . . . 0.0 110.571 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.17 -31.08 69.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.924 -1.11 . . . . 0.0 109.566 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.96 95.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 109.671 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -104.76 -3.86 23.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.764 . . . . 0.0 109.679 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -150.86 149.25 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -163.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 109.675 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.54 130.45 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 HD12 HG23 ' A' ' 11' ' ' ILE . 30.6 mm -93.33 122.87 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.429 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.7 mt -119.18 151.34 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.26 1.029 . . . . 0.0 111.77 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.2 mtt -148.25 158.66 44.22 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -141.46 127.33 19.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.747 -1.221 . . . . 0.0 111.066 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.97 118.72 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 157.93 43.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.955 -1.091 . . . . 0.0 110.484 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -175.32 1.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.507 -0.745 . . . . 0.0 109.346 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -65.55 158.38 27.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -59.29 143.35 49.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.145 -0.972 . . . . 0.0 109.42 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.53 77.26 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -129.98 140.23 50.93 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.973 . . . . 0.0 109.355 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -127.69 148.6 50.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.494 -0.754 . . . . 0.0 109.21 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.4 mt -87.64 142.73 27.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.927 . . . . 0.0 110.151 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.76 145.58 54.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.19 98.23 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.728 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -61.71 -46.8 88.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.318 . . . . 0.0 109.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.87 -28.81 65.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.9 tt -73.08 -58.75 3.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.358 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.27 -44.28 95.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.36 -44.13 97.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 110.802 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 m -60.54 -40.2 90.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.813 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.96 -47.63 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.38 -40.11 95.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.263 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -66.63 -20.58 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.0 111.022 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.505 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -82.12 -9.47 59.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.731 -1.231 . . . . 0.0 110.506 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.519 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 110.0 7.06 27.56 Favored Glycine 0 N--CA 1.503 3.126 0 O-C-N 121.125 -0.984 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.689 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 35.7 m-85 -78.04 150.89 33.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.775 -1.427 . . . . 0.0 110.105 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.3 mt -126.39 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.84 110.63 1.6 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 110.191 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -100.09 171.89 23.93 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -63.78 -163.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 109.033 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.7 mtp 57.19 19.81 5.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.0 109.816 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 m120 50.71 39.06 20.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.69 -0.631 . . . . 0.0 111.485 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.05 167.02 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.013 -1.054 . . . . 0.0 108.176 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.07 121.47 35.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.976 -1.077 . . . . 0.0 111.035 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.53 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 50.8 m80 -110.2 130.27 55.57 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.625 -0.672 . . . . 0.0 109.207 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.689 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 37.6 ttm180 -103.8 132.87 49.65 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.78 -1.2 . . . . 0.0 108.643 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.55 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 84.1 m-70 -95.74 169.8 9.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 109.684 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.8 tp -55.98 -51.15 68.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 108.938 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -92.93 145.94 31.11 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.48 -2.29 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.715 0.943 . . . . 0.0 111.839 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.65 -2.56 51.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.86 86.61 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.024 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -70.01 -40.57 75.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.001 -1.293 . . . . 0.0 109.311 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.55 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -82.56 168.03 47.37 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.548 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.7 Cg_endo -70.28 174.86 9.33 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.433 1.422 . . . . 0.0 112.019 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.12 126.3 30.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 108.854 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.82 -39.92 7.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.106 -0.996 . . . . 0.0 109.532 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -149.39 165.45 32.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 108.617 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 45.2 m -133.32 -179.91 5.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.201 -0.937 . . . . 0.0 111.333 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tt -136.95 134.58 36.87 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -135.14 163.6 29.55 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.732 -0.605 . . . . 0.0 109.74 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 89.5 m-20 -77.02 164.77 25.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.527 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.6 mmm -69.94 -28.0 65.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.94 121.53 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.102 -0.999 . . . . 0.0 110.493 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -60.95 152.82 68.71 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.687 -0.633 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.93 5.02 19.43 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.377 -0.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.88 19.2 70.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.395 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.0 p -86.36 165.12 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -1.21 . . . . 0.0 109.671 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 82.5 m-85 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.627 -0.67 . . . . 0.0 109.638 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' H ' ' CG ' ' A' ' 74' ' ' MET . 90.7 m-20 -120.83 151.19 54.32 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -50.59 -12.55 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 CA-C-N 119.553 0.876 . . . . 0.0 112.178 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -88.9 4.36 48.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.428 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 72.5 mmm -81.71 16.86 1.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 44.7 mmtm -88.23 -4.72 58.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.004 -1.06 . . . . 0.0 108.584 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 78.2 m-20 -148.57 79.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.26 171.02 20.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.0 109.218 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.7 p -135.34 150.3 49.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.375 -0.828 . . . . 0.0 109.043 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.27 150.86 23.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.34 -44.08 20.77 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 120.529 0.82 . . . . 0.0 111.861 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.97 -154.56 12.1 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.97 160.51 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.688 -0.889 . . . . 0.0 109.502 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.2 m -112.81 127.96 56.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.677 0.751 . . . . 0.0 110.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -111.34 130.06 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.27 169.71 19.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.701 -1.249 . . . . 0.0 110.245 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.2 ttp -137.52 132.39 33.15 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.442 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.6 mt-30 -91.1 118.76 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.023 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.26 150.37 37.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.37 136.17 43.24 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 123.724 -1.365 . . . . 0.0 111.964 0.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 35.3 m -106.6 159.45 16.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.515 -0.74 . . . . 0.0 110.601 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -73.53 146.56 44.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 0.0 109.294 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.74 -160.9 29.18 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.93 111.55 23.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.173 . . . . 0.0 109.422 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.48 -25.0 22.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.364 -0.835 . . . . 0.0 108.777 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.51 -40.14 73.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.095 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -70.88 -40.0 72.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -60.62 -40.01 90.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.64 -43.54 89.78 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.614 -0.679 . . . . 0.0 109.283 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.48 -41.7 96.31 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.366 -0.833 . . . . 0.0 109.66 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.94 -41.07 95.54 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 109.097 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.3 mtp -58.54 -48.61 80.29 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.45 -0.781 . . . . 0.0 108.989 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.34 -47.66 78.5 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.482 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.52 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.0 mt-30 -60.5 -40.79 92.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 108.978 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.8 p -70.04 -40.82 74.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.02 -59.48 5.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.805 -0.559 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.97 -38.07 84.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 110.01 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 11.9 m-70 -60.06 -46.54 89.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.825 -1.172 . . . . 0.0 109.049 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.15 -48.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 108.592 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.27 -50.01 40.92 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.47 -39.92 89.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.676 -0.64 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.02 -40.82 74.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.166 -0.959 . . . . 0.0 111.453 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.87 3.39 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.083 -1.011 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.01 29.53 75.18 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.22 46.51 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.9 138.54 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.694 -0.886 . . . . 0.0 108.843 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.05 135.66 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.963 -1.086 . . . . 0.0 109.58 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.0 mt -133.51 155.24 49.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.309 -0.87 . . . . 0.0 109.6 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -84.23 -170.2 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.454 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.3 m-20 -61.94 -33.28 73.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 109.89 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -78.07 10.43 2.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.202 -0.936 . . . . 0.0 108.62 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.539 HH11 ' HG2' ' A' ' 121' ' ' ARG . 10.7 mtt-85 59.67 40.44 19.94 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.494 0.664 . . . . 0.0 109.292 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -124.64 153.8 41.71 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.4 mtp -50.86 126.46 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.1 mtp -60.04 140.07 57.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -127.66 150.38 72.9 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -40.75 -47.42 4.69 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.83 1.02 . . . . 0.0 112.604 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.05 -39.84 87.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.391 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -65.71 -42.13 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.153 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.02 -40.44 89.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 108.833 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -63.65 -38.66 91.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.457 -0.777 . . . . 0.0 109.399 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -60.05 -46.64 88.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -59.99 -40.07 87.91 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.553 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.64 -40.01 93.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.95 -40.84 97.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.85 -40.52 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.39 -45.09 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.691 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -62.48 -36.74 83.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.173 . . . . 0.0 110.124 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.426 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.02 -44.29 94.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.166 -0.959 . . . . 0.0 110.94 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.8 -30.81 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.969 -1.082 . . . . 0.0 110.92 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 144' ' ' ALA . 25.5 mtpp -59.69 -39.86 85.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.956 -1.09 . . . . 0.0 111.003 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.03 -29.72 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.559 -1.338 . . . . 0.0 109.002 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.72 95.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.714 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -101.03 -27.83 13.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.204 -0.935 . . . . 0.0 109.817 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.594 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.9 mttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.9 145.99 28.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.33 169.09 21.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.74 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -115.8 130.35 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mm -92.16 129.07 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.3 mt -124.22 143.95 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.832 0.825 . . . . 0.0 110.461 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.0 mtt -142.96 149.46 38.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -132.26 128.59 38.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.977 -1.077 . . . . 0.0 111.187 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.97 119.73 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.16 157.93 43.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.56 -176.04 2.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -63.15 147.34 51.14 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.092 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 4.5 p80 -51.57 147.22 6.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.01 78.38 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -131.54 149.99 52.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.586 -0.95 . . . . 0.0 109.595 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.6 mt-10 -127.59 150.0 49.91 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.2 mt -84.26 141.97 30.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -0.975 . . . . 0.0 109.673 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -66.27 140.04 58.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.256 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.49 95.88 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.771 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.07 -47.72 83.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.967 -1.313 . . . . 0.0 110.246 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.71 -29.96 67.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 108.991 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.51 -59.74 2.6 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.9 -45.88 91.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -60.09 -42.25 94.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 109.998 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 t -64.08 -40.3 95.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 0.0 109.494 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.11 -45.33 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.089 -1.007 . . . . 0.0 109.221 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.68 -39.96 95.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.279 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -65.91 -21.95 66.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.17 7.89 10.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.358 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.11 15.46 78.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.048 -1.072 . . . . 0.0 110.894 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -81.63 150.08 28.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.896 -1.355 . . . . 0.0 109.504 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 38' ' ' ILE . 86.9 mt -119.98 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.9 103.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -0.924 . . . . 0.0 109.595 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.0 170.78 34.94 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -163.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 59.4 22.97 11.46 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.431 0.634 . . . . 0.0 110.202 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 50.96 36.15 14.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.751 . . . . 0.0 111.153 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 44' ' ' ILE . 14.0 pt -139.96 161.33 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.127 -0.983 . . . . 0.0 109.297 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -90.88 134.2 34.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.51 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 39.8 m-70 -123.02 127.86 49.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.803 -0.561 . . . . 0.0 109.505 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.4 ttt180 -100.0 123.92 44.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 25.9 m-70 -93.36 170.09 9.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.742 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.95 -51.74 66.63 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.369 -0.832 . . . . 0.0 108.92 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -97.59 148.89 35.09 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.0 108.855 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.69 -4.22 11.76 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.546 0.831 . . . . 0.0 111.611 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.14 -1.6 57.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.68 14.17 82.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -68.61 -44.21 74.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -1.198 . . . . 0.0 109.332 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.17 162.35 44.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -69.61 -176.68 1.52 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.587 1.194 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.22 127.45 33.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 109.438 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.4 mp -99.16 -39.33 8.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.203 -0.936 . . . . 0.0 108.696 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -149.38 154.37 38.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 29.9 m -129.97 170.48 13.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.263 -0.898 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.5 tt -126.36 134.52 51.05 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.574 0.702 . . . . 0.0 109.493 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -133.64 161.81 33.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.543 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.0 m-20 -73.91 160.82 30.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.008 -1.057 . . . . 0.0 110.189 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.8 mmm -69.23 -22.03 63.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.0 110.013 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.29 120.59 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.208 -0.932 . . . . 0.0 110.048 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -60.67 150.91 73.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.53 8.26 11.87 Favored 'Cis proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.317 -0.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.55 79.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.7 p -87.74 171.06 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.249 -1.147 . . . . 0.0 109.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 88.4 m-85 -120.73 161.53 21.28 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.288 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t70 -136.65 137.63 24.24 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -45.19 -12.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 120.12 1.079 . . . . 0.0 111.802 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.8 mt-10 -85.19 12.88 7.09 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.2 ptt? -80.89 9.87 5.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.295 0.569 . . . . 0.0 109.578 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -84.39 -6.72 59.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.41 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 74.1 m-20 -150.16 75.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -0.847 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -155.78 169.99 23.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 108.849 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 67.1 p -133.88 153.63 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.325 -0.859 . . . . 0.0 109.136 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 148.62 19.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 109.182 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -47.43 -53.64 6.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 120.524 0.816 . . . . 0.0 111.646 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.24 -154.0 8.04 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.685 -0.891 . . . . 0.0 109.03 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 62' ' ' ALA . 44.0 m -112.0 120.13 40.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.824 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.8 mt -105.03 130.05 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.8 170.0 17.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 34.8 ttm -138.94 129.8 26.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' OG ' ' A' ' 90' ' ' SER . 94.7 mt-30 -90.09 112.63 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.4 142.33 24.39 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.49 138.92 57.18 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 124.022 -1.241 . . . . 0.0 112.927 0.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 6.9 m -114.05 164.72 13.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.337 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -71.12 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.52 -165.71 39.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -94.9 117.77 30.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -1.115 . . . . 0.0 108.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -55.71 -29.48 59.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.432 -0.792 . . . . 0.0 109.621 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.43 -39.97 77.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.236 -0.915 . . . . 0.0 108.947 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -70.19 -39.99 74.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.917 -1.115 . . . . 0.0 108.557 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.38 -40.07 92.97 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -58.2 -42.95 87.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.93 -44.84 95.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 108.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.53 -39.99 93.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.8 mmm -57.56 -50.05 74.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.83 -44.27 81.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.975 . . . . 0.0 109.421 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.469 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -59.99 -40.52 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.948 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 p -70.18 -41.84 73.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.64 7.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.819 . . . . 0.0 110.146 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.8 m-70 -60.08 -50.03 75.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.082 . . . . 0.0 109.235 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.98 -50.02 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.176 -0.953 . . . . 0.0 109.561 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.05 -50.58 58.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 110.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.98 -39.97 75.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.956 . . . . 0.0 111.076 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 m -98.86 -0.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.044 . . . . 0.0 109.509 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.47 23.9 77.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.48 -170.7 47.41 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.4 t -134.5 139.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -1.027 . . . . 0.0 109.337 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.5 133.57 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.44 154.8 49.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 25.6 p-10 -84.86 -174.86 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.8 m-20 -59.93 -36.96 78.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 109.252 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.497 ' OE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 mt-30 -77.4 16.87 0.56 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.396 -0.815 . . . . 0.0 109.31 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.2 mtt180 60.07 20.81 10.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.967 -0.458 . . . . 0.0 111.0 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.542 ' NH2' ' NZ ' ' A' ' 128' ' ' LYS . 34.4 mtm-85 -106.18 147.63 28.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.209 -0.932 . . . . 0.0 108.518 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.96 137.14 21.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.161 -0.962 . . . . 0.0 110.542 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.9 mtt -59.93 144.22 49.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.623 -0.673 . . . . 0.0 110.327 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.6 p -132.94 152.23 79.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -42.09 -47.69 6.7 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 120.639 0.893 . . . . 0.0 112.074 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -60.85 -43.22 98.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.542 ' NZ ' ' NH2' ' A' ' 122' ' ' ARG . 98.4 mttt -67.29 -39.97 86.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 110.218 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.93 -39.93 87.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.997 -1.064 . . . . 0.0 108.275 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -67.8 -38.59 83.5 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.684 -0.635 . . . . 0.0 109.909 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -59.75 -46.07 90.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.73 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -60.06 -41.08 91.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.044 . . . . 0.0 108.239 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.5 -39.99 95.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.558 -0.714 . . . . 0.0 109.125 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.04 -40.03 92.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.511 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -43.45 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 108.769 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.98 -42.08 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 137' ' ' ARG . 49.3 mtt-85 -62.23 -39.85 94.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 74.9 mm-40 -60.02 -39.97 87.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.107 -0.995 . . . . 0.0 109.35 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.19 -27.96 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 mmtt -60.04 -45.3 93.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.0 110.173 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.95 -31.06 70.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.309 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.63 96.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 46.4 p-10 -105.31 -3.3 22.93 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.29 -0.881 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.8 mttt . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.6 149.55 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.579 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.46 162.59 27.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 109.69 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.32 130.67 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 0.0 109.145 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mm -90.82 132.49 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.9 mt -129.93 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 122.279 1.038 . . . . 0.0 111.344 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.3 mtt -142.87 151.66 41.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -131.55 121.71 24.89 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.833 -1.167 . . . . 0.0 111.113 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.1 t -99.71 110.01 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.54 159.79 42.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -166.3 0.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.11 159.96 32.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -58.38 145.14 39.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.45 10.26 82.22 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -130.06 147.52 51.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -1.043 . . . . 0.0 109.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.71 145.75 50.8 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.7 mt -85.19 147.68 26.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.777 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.14 142.98 55.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.024 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.31 99.36 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.918 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.33 -43.74 98.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.374 . . . . 0.0 109.835 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.94 -28.51 65.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.1 tt -71.04 -59.58 2.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.16 -39.95 88.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.6 p -66.45 -39.82 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 109.968 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.409 HG21 HD11 ' A' ' 32' ' ' ILE . 94.8 mt -59.87 -49.94 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -62.16 -40.0 94.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.956 -1.09 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.81 -22.88 66.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.99 7.72 12.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.029 -1.045 . . . . 0.0 110.266 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.58 75.98 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.138 -0.976 . . . . 0.0 111.118 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.78 150.01 26.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.323 . . . . 0.0 110.051 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.78 132.39 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.62 100.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.908 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.34 171.72 32.56 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.76 -161.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -1.156 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 98.0 mtp 60.0 20.55 9.65 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.51 0.671 . . . . 0.0 109.914 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 m120 51.93 33.56 11.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.567 -0.708 . . . . 0.0 111.565 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 pt -141.65 168.13 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.0 109.189 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.06 121.5 33.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.459 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 63.3 m-70 -106.51 130.03 54.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.784 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 47' ' ' ARG . 7.2 ttt-85 -102.8 126.89 50.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.274 -0.892 . . . . 0.0 109.184 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 28.5 m-70 -97.35 170.92 8.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.0 -49.99 74.08 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -91.36 145.72 31.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 -2.72 9.4 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.668 0.912 . . . . 0.0 111.833 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.54 -3.68 52.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 109.85 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.0 9.78 86.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -70.9 -42.61 69.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.294 . . . . 0.0 110.229 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.01 164.99 54.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -68.4 175.12 7.28 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.997 1.131 . . . . 0.0 111.374 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.8 121.84 26.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.004 . . . . 0.0 109.323 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.1 mp -97.68 -38.1 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.207 -0.933 . . . . 0.0 108.741 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.57 167.52 29.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 67.5 m -137.33 -179.08 5.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 111.173 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -136.51 131.65 34.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.1 160.29 34.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 109.543 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.59 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 94.0 m-20 -74.5 159.45 32.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.03 -21.32 63.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 110.177 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.15 121.24 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.056 -1.028 . . . . 0.0 109.901 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -60.69 150.66 74.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 109.189 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.34 12.21 20.22 Favored 'Cis proline' 0 N--CA 1.494 1.526 0 C-N-CA 123.584 -1.423 . . . . 0.0 111.723 -0.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 19.03 67.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.6 167.18 14.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.285 -1.127 . . . . 0.0 110.443 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 88.7 m-85 -122.39 141.87 51.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.573 -0.705 . . . . 0.0 109.484 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 73' ' ' GLU . 47.8 m-20 -128.79 150.0 73.76 Favored Pre-proline 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.68 -6.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.548 0.874 . . . . 0.0 111.778 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 71' ' ' ASP . 97.2 mt-10 -89.32 0.22 56.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.404 ' CE ' ' ND2' ' A' ' 63' ' ' ASN . 65.8 mmm -85.33 13.68 6.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.46 -0.775 . . . . 0.0 109.585 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -85.42 -8.6 58.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.164 . . . . 0.0 108.75 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -150.76 79.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -155.8 174.14 15.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.1 p -129.84 150.28 51.21 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.28 150.22 19.5 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.156 -0.965 . . . . 0.0 109.095 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -44.76 -43.61 14.69 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 120.415 0.743 . . . . 0.0 111.619 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -149.54 10.9 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 159.95 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.985 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -113.22 120.88 42.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 109.537 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.0 mt -103.03 130.5 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -145.85 170.6 16.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.936 -1.102 . . . . 0.0 110.496 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -138.45 130.68 28.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.35 123.91 33.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.579 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 4.4 m -102.26 148.81 35.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.857 . . . . 0.0 109.016 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.42 141.93 72.76 Favored 'Cis proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.94 -1.275 . . . . 0.0 111.87 -1.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -107.0 155.72 19.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.971 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 92' ' ' GLY . 64.7 t80 -72.33 155.3 40.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 109.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CD2' ' A' ' 91' ' ' TYR . . . 80.75 -157.85 40.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -97.49 118.05 33.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -1.095 . . . . 0.0 109.076 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.38 -32.9 70.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.583 -0.698 . . . . 0.0 110.432 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.1 mt -69.9 -40.07 75.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.931 -1.106 . . . . 0.0 109.973 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -71.64 -40.02 70.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.923 -1.111 . . . . 0.0 108.361 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.9 -39.83 93.34 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.891 0.853 . . . . 0.0 108.811 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 64.8 t80 -59.51 -50.0 75.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -62.42 -39.94 94.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.01 -41.92 93.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.27 -46.06 89.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.375 -0.828 . . . . 0.0 109.473 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.17 -41.4 98.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.015 -1.053 . . . . 0.0 108.764 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.483 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.1 mt-30 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.349 -0.844 . . . . 0.0 108.803 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 p -71.76 -40.25 69.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.9 67.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.58 -35.64 80.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 109.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.2 m-70 -60.09 -45.84 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.074 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 108' ' ' ILE . 96.7 mt -60.27 -49.9 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 108.948 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.61 -49.7 55.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.51 -0.744 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.55 -39.98 89.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.18 -40.08 78.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.319 -0.863 . . . . 0.0 110.909 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.3 m -103.14 0.02 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.99 22.93 77.29 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.66 -171.24 47.89 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.06 141.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.988 . . . . 0.0 109.561 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.76 130.04 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 108.985 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' ' SD ' ' A' ' 124' ' ' MET . 76.0 mt -132.0 159.97 37.2 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' N ' ' SD ' ' A' ' 124' ' ' MET . 35.7 p-10 -85.31 -172.59 4.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.6 m-20 -59.97 -37.94 81.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.986 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -76.95 14.02 0.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 108.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.7 mtt180 55.91 32.81 20.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.732 -0.605 . . . . 0.0 109.526 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.54 156.58 19.34 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.9 mmm -50.92 133.97 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 117' ' ' LEU . 96.5 mmm -58.27 139.91 54.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.742 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.519 ' HG1' ' H ' ' A' ' 128' ' ' LYS . 27.9 p -129.4 148.71 70.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -49.96 -43.76 40.2 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 119.43 0.832 . . . . 0.0 111.947 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.42 -40.1 89.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.519 ' H ' ' HG1' ' A' ' 125' ' ' THR . 63.6 mmtt -65.76 -39.95 91.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.049 -1.032 . . . . 0.0 109.878 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.98 -40.05 87.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 108.675 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.63 -39.22 91.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.06 -46.37 88.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -59.98 -46.31 89.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.564 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 37.4 mm-40 -60.01 -39.98 87.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.396 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.95 -41.64 92.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.69 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.6 mt -63.36 -43.64 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.741 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.08 -44.96 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.803 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.474 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.1 mmt180 -60.03 -39.93 87.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 96.2 mt-10 -60.17 -38.63 83.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.529 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -66.42 -39.73 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 110.537 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.8 mttt -59.88 -50.08 75.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.887 -1.133 . . . . 0.0 110.889 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 2.1 p-10 -62.38 -36.99 84.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.822 -1.174 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.42 99.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.305 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -102.27 -0.76 32.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.22 -0.925 . . . . 0.0 109.783 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 109.526 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -148.89 142.02 24.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.87 171.91 17.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 109.607 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.63 129.92 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.07 129.94 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.3 mt -128.72 146.12 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.083 0.944 . . . . 0.0 110.775 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -145.76 151.09 37.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.405 ' OD1' ' SD ' ' A' ' 64' ' ' MET . 67.3 m-80 -136.86 130.28 31.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.647 -1.283 . . . . 0.0 111.244 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.25 129.96 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.74 159.9 41.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 110.577 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.39 -172.47 1.46 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -65.96 155.99 34.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.839 -1.163 . . . . 0.0 108.298 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -55.53 133.1 50.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.128 . . . . 0.0 109.636 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.29 5.8 75.49 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.5 m -127.04 153.69 45.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.478 -1.013 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.98 153.67 45.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.533 -0.73 . . . . 0.0 109.083 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.87 138.37 32.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.989 . . . . 0.0 109.693 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -69.75 145.19 52.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.14 -42.97 98.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.1 -46.66 89.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -1.191 . . . . 0.0 109.906 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' O ' ' OG ' ' A' ' 31' ' ' SER . 93.0 mt -69.73 -28.48 65.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.7 -57.31 4.48 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.593 -0.692 . . . . 0.0 109.549 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.97 -46.12 90.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.045 . . . . 0.0 110.824 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -64.79 -41.36 95.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.002 -1.062 . . . . 0.0 111.067 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 27' ' ' LEU . 52.2 m -63.03 -39.99 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.027 -1.046 . . . . 0.0 110.098 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.12 -49.82 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 110.695 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -63.26 -40.06 96.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.926 -1.109 . . . . 0.0 109.806 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -61.65 -23.62 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 110.761 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.597 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.32 -8.69 59.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.831 -1.168 . . . . 0.0 110.614 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 109.37 9.96 24.55 Favored Glycine 0 N--CA 1.503 3.105 0 O-C-N 121.01 -1.056 . . . . 0.0 110.845 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.748 ' N ' HH21 ' A' ' 47' ' ' ARG . 30.0 m-85 -79.89 148.95 31.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.683 -1.481 . . . . 0.0 109.972 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.6 133.56 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.24 105.69 0.53 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 110.265 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -94.59 171.38 30.48 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.45 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.125 -1.221 . . . . 0.0 110.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.9 mtt 59.96 22.68 11.77 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.406 0.622 . . . . 0.0 110.198 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.1 m120 52.57 36.21 19.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 111.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 44' ' ' ILE . 19.8 pt -140.08 161.6 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.995 -1.066 . . . . 0.0 108.572 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.08 120.94 33.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.064 -1.022 . . . . 0.0 110.677 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 54.3 m80 -106.79 131.5 53.83 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.748 HH21 ' N ' ' A' ' 37' ' ' PHE . 32.6 ttm180 -104.5 130.22 52.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.006 -1.059 . . . . 0.0 108.497 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.443 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 69.6 m-70 -100.15 169.42 9.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.844 . . . . 0.0 109.979 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.1 tp -57.06 -50.0 74.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -89.91 148.32 39.41 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.49 -4.45 15.02 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.597 0.865 . . . . 0.0 111.83 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -94.96 -0.17 54.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.187 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 9.05 87.2 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -69.91 -40.4 75.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -1.187 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.49 166.01 52.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.443 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.5 Cg_endo -68.63 175.03 7.63 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 120.916 1.078 . . . . 0.0 111.737 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.35 123.36 29.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.1 mp -99.84 -37.14 9.18 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.09 161.93 41.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 108.672 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 49.2 m -134.44 -177.97 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.859 0.838 . . . . 0.0 110.844 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -136.66 130.85 32.8 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.82 162.67 30.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.5 m120 -78.49 164.9 24.34 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.045 -1.034 . . . . 0.0 110.547 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 14' ' ' ASN . 89.8 mmm -70.03 -22.61 63.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 0.0 110.461 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 94.2 t -86.95 119.24 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.978 -1.076 . . . . 0.0 110.115 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.91 147.72 78.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.151 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.64 14.56 6.93 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.552 -1.437 . . . . 0.0 111.842 -0.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 72.13 17.75 77.47 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 p -87.29 175.92 7.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -1.229 . . . . 0.0 109.728 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 80.1 m-85 -119.59 147.9 43.95 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 0.0 109.52 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 27.0 m-20 -134.0 150.2 73.72 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -46.66 -8.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.641 0.894 . . . . 0.0 112.306 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.7 mt-10 -85.66 10.36 13.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.74 -1.29 53.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.766 -0.584 . . . . 0.0 109.87 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.7 mttp -84.3 -6.78 59.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.5 m-20 -150.1 78.01 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -162.31 171.39 17.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.842 -1.161 . . . . 0.0 109.814 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.8 p -131.86 156.99 45.1 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.04 18.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.024 -1.048 . . . . 0.0 109.141 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 -24.36 54.05 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 120.515 0.81 . . . . 0.0 111.89 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.4 -164.02 36.27 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.731 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.11 166.52 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.751 -0.852 . . . . 0.0 108.735 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -119.89 129.97 54.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.532 -0.73 . . . . 0.0 110.387 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.52 128.96 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.72 164.08 32.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.001 -1.062 . . . . 0.0 110.827 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.7 ttm -132.19 130.22 40.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.73 105.35 17.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.3 m -97.38 148.72 34.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.82 134.43 35.74 Favored 'Cis proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.364 0.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -105.56 159.89 15.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.07 145.49 49.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.339 -0.851 . . . . 0.0 109.214 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.31 -161.55 23.29 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 89.6 m-20 -96.25 108.96 21.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.013 -1.286 . . . . 0.0 109.05 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.29 -31.34 65.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.46 -0.775 . . . . 0.0 110.065 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.05 -40.63 74.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.014 . . . . 0.0 110.338 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -77.09 -40.61 45.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.619 -1.3 . . . . 0.0 108.925 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 81.0 m-20 -60.05 -38.09 81.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -58.45 -40.96 84.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -63.68 -40.08 95.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.941 -1.099 . . . . 0.0 108.604 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.56 -39.96 89.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.93 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.8 mtp -58.13 -49.88 75.44 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.537 -0.727 . . . . 0.0 109.36 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.53 -45.53 86.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 109.294 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.5 mt-30 -60.25 -40.17 89.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 108.445 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.564 ' HG ' ' H ' ' A' ' 105' ' ' ALA . 93.7 p -70.39 -44.0 68.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -59.89 -54.57 44.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.517 -0.739 . . . . 0.0 110.197 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.096 -1.002 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.6 m-70 -59.98 -43.66 94.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.0 108.506 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.24 -49.99 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.71 -49.41 68.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.09 -39.97 91.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.9 -40.0 75.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.895 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.17 2.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.018 -1.052 . . . . 0.0 109.532 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 67.13 25.36 73.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -162.67 38.52 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.417 -1.049 . . . . 0.0 110.487 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.59 154.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.646 -0.914 . . . . 0.0 109.203 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.2 t -94.93 129.82 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.426 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.1 mt -122.05 160.08 25.71 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.563 -0.711 . . . . 0.0 110.102 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.11 -171.29 3.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.7 m-20 -60.09 -40.04 88.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 109.697 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -76.23 17.76 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 119' ' ' ASP . 87.1 mtm180 56.2 35.02 25.01 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.468 0.651 . . . . 0.0 109.756 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -110.24 144.2 39.29 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.7 mtp -51.3 129.56 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 108.943 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.2 mtt -59.08 141.19 54.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 110.106 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 p -129.56 150.4 75.58 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -42.5 -45.17 8.26 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.469 0.78 . . . . 0.0 112.237 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -61.34 -40.01 92.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.188 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.054 -1.029 . . . . 0.0 110.544 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.92 -40.11 83.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.872 . . . . 0.0 108.765 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -65.95 -39.88 90.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.462 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.83 -43.57 94.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 109.839 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.462 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 58.1 m-85 -60.14 -44.03 95.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.019 -1.051 . . . . 0.0 108.394 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.72 -40.07 96.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.58 -40.04 93.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.615 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.53 -40.95 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.145 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.67 -38.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 108.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 137' ' ' ARG . 27.2 mtt-85 -59.86 -38.91 83.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.045 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.6 -39.99 90.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.117 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.58 -28.77 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 111.025 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 144' ' ' ALA . 68.5 mttm -60.03 -45.24 93.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.663 -1.273 . . . . 0.0 110.179 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.07 -30.13 69.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.906 -1.121 . . . . 0.0 109.192 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.52 93.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.963 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -100.48 -25.62 14.13 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.354 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -147.5 130.85 16.6 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.3 -166.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.699 -1.251 . . . . 0.0 110.272 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.2 t -140.02 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 11' ' ' ILE . 23.2 mm -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 95.5 mt -120.0 147.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.281 1.039 . . . . 0.0 111.652 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.0 mtt -146.2 158.82 43.9 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' CG ' ' NH1' ' A' ' 121' ' ' ARG . 34.6 m120 -141.15 121.77 14.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.658 -1.277 . . . . 0.0 111.457 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.49 113.48 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.42 44.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.82 -169.91 0.51 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.88 157.34 37.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.03 -1.044 . . . . 0.0 109.1 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -60.06 140.13 57.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.709 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.81 2.08 63.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.1 m -127.19 149.7 49.86 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.577 -0.955 . . . . 0.0 109.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -131.18 145.07 51.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.553 -0.717 . . . . 0.0 109.218 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.6 146.78 25.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.02 146.42 51.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 108.948 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.45 97.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mm-40 -61.19 -44.1 97.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.338 . . . . 0.0 109.857 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 89.5 mt -69.95 -27.85 65.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tt -76.07 -59.62 2.68 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.71 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -47.93 83.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.288 -0.883 . . . . 0.0 111.579 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.3 p-10 -61.27 -39.99 92.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.894 -1.129 . . . . 0.0 110.342 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 56.5 m -62.21 -40.25 95.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.871 -1.143 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 32' ' ' ILE . 89.3 mt -60.59 -45.92 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.225 -0.922 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -60.7 -40.03 90.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.31 -19.87 65.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.911 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.56 8.7 9.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.945 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.89 81.76 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -81.51 151.78 27.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.297 . . . . 0.0 110.113 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.98 139.95 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.62 107.41 0.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 109.572 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.83 171.49 34.52 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.43 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.235 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 72.1 mtm 56.73 26.1 10.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 110.09 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.9 m120 50.03 39.44 19.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 111.293 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 pt -141.67 161.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.5 130.76 37.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HD1' ' CB ' ' A' ' 60' ' ' SER . 12.9 m-70 -117.79 127.97 54.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -99.99 127.08 46.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.158 -0.964 . . . . 0.0 108.545 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.7 m-70 -95.8 170.05 9.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.492 -0.755 . . . . 0.0 109.701 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -49.99 -53.93 23.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.089 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -90.82 149.23 39.98 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.305 -0.872 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.66 -5.18 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.814 1.009 . . . . 0.0 112.452 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -93.04 0.04 57.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.135 -0.978 . . . . 0.0 110.041 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.1 81.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.4 p -70.0 -40.0 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -1.173 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -85.8 173.52 47.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.533 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.0 Cg_endo -73.96 178.4 6.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.37 1.38 . . . . 0.0 111.658 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.64 123.08 27.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.884 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.6 mp -97.38 -47.05 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.157 -0.965 . . . . 0.0 109.03 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -138.08 160.11 40.25 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.546 ' CB ' ' HD1' ' A' ' 46' ' ' HIS . 2.9 m -127.66 178.2 6.29 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.196 0.998 . . . . 0.0 111.694 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 tt -138.6 130.07 27.44 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.599 0.714 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 160.11 34.33 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.62 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.5 m-20 -73.73 161.79 29.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.991 -1.068 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mtp -69.66 -29.96 67.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 110.906 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 p -86.35 131.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.804 -1.185 . . . . 0.0 110.126 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -59.97 150.04 71.17 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -76.91 5.93 18.49 Favored 'Cis proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.552 -0.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.82 83.08 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -88.55 169.97 11.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.101 -1.235 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.62 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 75.3 m-85 -120.05 143.49 48.07 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -119.82 149.99 49.66 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.439 -0.788 . . . . 0.0 108.889 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.3 -20.15 61.23 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 120.498 0.798 . . . . 0.0 112.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.95 -2.71 58.21 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -0.927 . . . . 0.0 109.121 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.594 ' CE ' ' ND2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -89.24 25.24 1.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.526 -0.734 . . . . 0.0 110.652 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 29.4 mmtm -80.96 0.88 33.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.885 -1.134 . . . . 0.0 109.351 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 91.6 m-20 -142.0 86.77 2.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.96 177.97 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 109.724 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 p -131.73 150.12 52.26 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.56 149.48 19.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 0.0 109.219 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -45.28 -41.44 17.12 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 120.366 0.711 . . . . 0.0 111.393 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.59 -150.79 10.28 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.11 159.98 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.607 -0.937 . . . . 0.0 109.726 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 m -114.72 124.88 52.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.87 129.94 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -146.65 149.45 33.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.919 -1.113 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.2 ttm -102.31 133.33 47.4 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.464 -0.772 . . . . 0.0 109.526 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.7 mt-30 -91.07 105.36 17.76 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 16.0 m -97.46 147.21 32.65 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.185 -0.947 . . . . 0.0 108.537 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -74.23 133.64 31.97 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.377 0.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.6 m -105.29 158.85 16.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -72.73 149.9 43.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.732 . . . . 0.0 109.94 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.1 -160.36 34.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.1 116.15 28.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -1.159 . . . . 0.0 108.952 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.55 -31.81 69.76 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 110.219 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.07 -41.47 74.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.155 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -74.29 -39.98 62.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.63 -39.81 89.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 133' ' ' GLN . 55.9 t80 -53.09 -40.06 63.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -59.99 -40.0 87.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.198 -0.939 . . . . 0.0 108.713 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.82 -39.97 93.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 109.177 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mtp -56.61 -50.01 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.156 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.32 -44.7 90.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.91 . . . . 0.0 109.608 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.525 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 84.3 mt-30 -60.02 -40.84 90.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 108.826 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 p -70.17 -40.04 74.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.418 -0.801 . . . . 0.0 109.711 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.85 52.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.162 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -62.09 -37.2 84.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 0.0 109.971 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 10.9 m-70 -60.12 -47.63 85.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.987 -1.071 . . . . 0.0 109.126 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 108' ' ' ILE . 96.7 mt -60.11 -49.95 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.78 -47.72 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.69 -40.32 91.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 110.096 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -71.14 -39.99 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 0.0 111.158 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.33 2.33 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.76 23.1 68.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.08 -173.24 45.54 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 134.83 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.606 -0.938 . . . . 0.0 109.136 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -70.69 135.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.62 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 mt -132.4 156.19 47.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.459 -0.776 . . . . 0.0 109.732 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -87.89 -173.62 4.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.6 m-20 -60.03 -34.47 73.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.021 . . . . 0.0 108.996 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.34 14.98 0.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 108.961 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 119' ' ' ASP . 20.2 mmt180 60.11 24.12 13.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.656 -0.652 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -110.96 150.85 28.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.44 -0.788 . . . . 0.0 109.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.9 mtm -50.52 129.39 22.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.081 -1.012 . . . . 0.0 109.597 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 mtp -59.93 139.7 57.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.778 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -125.6 151.01 69.86 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -40.34 -46.43 4.31 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 120.911 1.074 . . . . 0.0 112.532 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -60.14 -39.99 88.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.616 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.82 -39.73 83.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.188 -0.945 . . . . 0.0 110.341 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.65 -40.53 75.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.973 -1.079 . . . . 0.0 108.128 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.406 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 34.3 ttm-85 -65.29 -39.33 92.42 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.84 -46.85 87.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.68 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 62.0 m-85 -60.13 -42.7 95.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.053 -1.029 . . . . 0.0 108.258 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 98' ' ' PHE . 23.6 mm100 -62.97 -40.1 96.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 95.6 m-20 -61.65 -40.97 96.83 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.419 -0.801 . . . . 0.0 109.838 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -40.05 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.906 -1.121 . . . . 0.0 109.432 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.25 -39.23 81.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 99.1 mtt180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.886 -1.134 . . . . 0.0 111.303 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 15.2 mp0 -60.09 -39.09 84.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.794 -1.191 . . . . 0.0 110.164 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.07 -39.33 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.916 -1.115 . . . . 0.0 110.391 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.96 -50.08 75.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.779 -1.2 . . . . 0.0 110.929 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -60.91 -32.54 72.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.684 -1.26 . . . . 0.0 109.253 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.34 -23.78 67.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 108.826 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -98.74 -2.2 38.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.064 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.465 -179.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -99.79 139.16 35.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.07 -175.93 5.55 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.738 -1.226 . . . . 0.0 110.231 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.04 133.32 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 11' ' ' ILE . 19.4 mm -88.93 135.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.468 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.1 mt -130.73 143.16 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.992 0.901 . . . . 0.0 110.701 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.512 ' C ' HD21 ' A' ' 14' ' ' ASN . 58.5 mtm -149.31 152.09 35.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.512 HD21 ' C ' ' A' ' 13' ' ' MET . 5.7 m120 -129.13 130.36 46.34 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.099 -1.0 . . . . 0.0 111.013 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.97 113.8 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.09 153.32 38.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.175 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.24 -175.94 1.34 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -60.07 150.52 29.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 108.99 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -59.9 148.27 35.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.04 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.54 -5.57 77.27 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -128.98 142.1 51.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.941 . . . . 0.0 108.894 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -121.93 150.15 42.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.746 . . . . 0.0 109.305 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.27 142.46 29.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.343 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -67.69 141.03 56.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.0 108.795 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.1 96.47 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -62.59 -46.52 87.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.217 . . . . 0.0 109.573 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.1 -29.16 66.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 109.031 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.2 tt -73.65 -58.92 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.07 -44.11 94.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.64 -40.7 95.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.501 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -64.82 -40.08 94.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.86 -50.26 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.353 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -63.97 -40.07 95.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.05 -20.39 66.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.416 -0.802 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.53 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.47 1.07 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 109.657 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.86 16.84 43.36 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 121.156 -0.965 . . . . 0.0 111.166 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -82.35 152.46 26.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.403 . . . . 0.0 110.242 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.86 134.81 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.12 104.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.067 -1.021 . . . . 0.0 109.996 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -93.63 171.31 31.77 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -65.56 -163.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.249 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.6 mmm 58.7 19.96 7.33 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.643 0.735 . . . . 0.0 109.688 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 51.76 38.19 22.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.526 -0.734 . . . . 0.0 111.898 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 pt -140.56 166.29 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.875 -1.14 . . . . 0.0 108.505 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -92.63 122.58 35.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.829 -1.169 . . . . 0.0 110.201 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.9 m80 -106.45 127.33 53.21 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.457 -0.777 . . . . 0.0 109.092 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 37.5 ttt180 -103.88 128.71 51.36 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.06 -1.025 . . . . 0.0 109.05 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 64.4 m-70 -98.66 171.41 8.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.33 -0.856 . . . . 0.0 109.733 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.9 -49.68 72.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.8 m -91.15 147.79 36.41 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 109.015 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.45 -7.97 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.747 0.964 . . . . 0.0 111.905 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -91.44 -0.25 57.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 109.974 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.79 12.01 84.9 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.197 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.2 p -70.59 -40.59 73.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.008 -1.289 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.3 167.83 51.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.512 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 15.0 Cg_endo -69.67 170.42 16.51 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 120.934 1.089 . . . . 0.0 111.427 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.71 126.2 30.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.0 mp -99.39 -30.72 12.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 109.098 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CB ' ' SD ' ' A' ' 101' ' ' MET . 28.2 p90 -159.15 159.98 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 108.615 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 17.6 m -129.88 175.88 8.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 110.564 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.4 tt -133.24 132.45 41.47 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.506 0.669 . . . . 0.0 109.604 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -130.1 162.39 28.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.571 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 89.2 m-20 -75.28 160.92 29.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.974 -1.078 . . . . 0.0 110.782 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.6 mmm -69.51 -35.27 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.716 -0.615 . . . . 0.0 111.047 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.57 136.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.879 -1.138 . . . . 0.0 110.303 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -58.98 151.94 52.93 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -78.48 4.08 27.88 Favored 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.232 -0.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.31 86.0 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.6 p -85.91 170.32 12.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -1.133 . . . . 0.0 109.633 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.571 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 91.3 m-85 -113.99 155.99 24.88 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' GLU . 32.9 m-20 -135.52 148.75 67.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 74' ' ' MET . 21.7 Cg_exo -44.05 -14.37 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.64 0.893 . . . . 0.0 112.498 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mp0 -86.17 16.3 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.5 ptt? -83.78 -4.96 59.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.33 0.586 . . . . 0.0 110.005 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 97.1 mttt -83.34 -4.61 58.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.785 -1.197 . . . . 0.0 109.429 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.4 m-20 -150.03 78.31 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 109.326 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.61 170.48 20.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.984 -1.072 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -131.49 150.74 52.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.443 ' HG1' ' N ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -154.65 149.68 20.47 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 0.0 109.19 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' N ' ' HG1' ' A' ' 79' ' ' THR . 2.8 Cg_exo -48.84 -47.15 22.17 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 120.554 0.836 . . . . 0.0 111.916 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.14 -150.38 7.61 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.02 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.823 . . . . 0.0 109.886 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.3 m -113.2 122.81 48.61 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.99 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -145.09 150.21 36.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.0 ttm -110.15 135.7 50.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.675 -0.641 . . . . 0.0 109.404 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -91.83 104.02 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 m -98.32 149.04 35.33 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -74.46 137.59 51.05 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.263 0.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 74.3 m -103.35 168.0 9.45 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 0.0 110.541 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 65.3 t80 -72.32 154.6 40.86 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.377 0.608 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 72.85 -146.87 39.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.13 114.87 26.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.298 -1.119 . . . . 0.0 109.057 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -57.77 -31.04 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.928 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.06 -39.8 75.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.67 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.29 -36.0 74.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.895 -1.128 . . . . 0.0 108.251 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 97' ' ' ASN . 3.0 m120 -59.95 -40.03 87.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.91 -44.36 94.34 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -63.05 -40.13 96.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.258 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.77 -45.2 94.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.471 ' SD ' ' CB ' ' A' ' 59' ' ' PHE . 20.5 mtm -59.92 -43.57 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.884 -1.135 . . . . 0.0 109.787 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.88 -40.2 95.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.454 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 88.7 mm-40 -60.08 -40.93 91.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.0 109.791 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.1 p -70.48 -40.05 73.87 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 109.429 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.3 70.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.3 -40.44 94.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.872 -1.143 . . . . 0.0 109.206 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 26.4 m-70 -60.17 -49.36 77.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 108' ' ' ILE . 81.9 mt -60.29 -49.85 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.253 -0.905 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.2 -48.98 64.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.673 . . . . 0.0 109.441 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.14 -40.02 88.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.93 -40.07 75.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 m -99.98 -0.93 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.99 -1.069 . . . . 0.0 109.838 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.48 20.79 75.76 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.57 -178.35 52.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.2 t -130.37 139.8 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.592 -0.946 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.72 130.78 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.311 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.06 155.79 45.57 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.375 -0.828 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -84.73 -174.91 5.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.465 -0.772 . . . . 0.0 109.963 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.588 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 98.5 m-20 -60.07 -35.12 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -78.53 11.53 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 108.82 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 119' ' ' ASP . 57.7 mtp180 56.41 38.45 29.71 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -116.08 145.82 42.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.7 mtt -51.16 126.7 17.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.7 mtt -61.26 151.28 32.19 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.845 0.831 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.6 p -133.74 149.24 71.39 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -42.43 -50.12 5.84 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 CA-C-N 119.574 0.884 . . . . 0.0 112.628 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.29 -40.0 88.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -65.14 -40.87 94.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.155 . . . . 0.0 110.461 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.84 -40.32 88.13 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 108.485 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 130' ' ' ARG . 19.9 ttt-85 -63.93 -38.54 91.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.686 -0.634 . . . . 0.0 109.664 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.42 -44.85 89.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.989 -1.07 . . . . 0.0 109.815 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.588 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 60.5 m-85 -59.93 -40.13 87.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -59.87 -39.92 86.9 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -38.39 84.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.466 -0.771 . . . . 0.0 109.301 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.7 mm -56.52 -46.42 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.01 -43.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 137' ' ' ARG . 30.8 mtt-85 -60.08 -40.05 88.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 95.9 mt-10 -62.92 -38.68 91.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.44 -24.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 110.883 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.3 mttm -60.03 -40.03 87.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.793 -1.192 . . . . 0.0 109.748 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 2.3 p30 -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.88 -1.137 . . . . 0.0 109.206 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.09 99.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 47.1 p-10 -102.87 -0.11 31.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.351 -0.843 . . . . 0.0 109.607 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -146.18 136.15 23.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.592 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -161.82 166.36 26.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.56 -1.338 . . . . 0.0 110.492 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.98 129.32 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.428 HD12 HG23 ' A' ' 11' ' ' ILE . 26.3 mm -91.38 123.06 43.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.62 148.86 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 122.469 1.128 . . . . 0.0 111.59 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mtt -145.71 154.25 41.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -137.09 122.8 19.88 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.735 -1.228 . . . . 0.0 111.076 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.05 116.75 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.04 153.18 39.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.939 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.09 -177.0 1.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -59.96 146.58 41.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 108.845 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.97 141.78 13.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 -3.88 74.29 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -117.74 152.63 34.88 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.591 -0.946 . . . . 0.0 109.5 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.78 147.69 50.81 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.472 -0.767 . . . . 0.0 109.149 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.66 143.65 27.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.225 -0.922 . . . . 0.0 109.831 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -70.58 141.36 51.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 108.875 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.95 98.24 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 97.2 mt-10 -61.41 -46.07 91.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.958 -1.319 . . . . 0.0 109.636 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.94 -27.08 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tt -72.97 -60.23 2.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.54 -0.725 . . . . 0.0 109.171 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.48 -39.99 89.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 26' ' ' GLU . 96.2 m-20 -61.11 -40.98 95.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.7 p -67.69 -40.2 84.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.129 -0.982 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 32' ' ' ILE . 81.7 mt -60.11 -48.18 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.334 -0.853 . . . . 0.0 109.534 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.56 -40.14 96.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 109.697 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.48 -20.39 63.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.564 -0.71 . . . . 0.0 110.552 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.85 2.76 32.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 110.296 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.95 15.05 65.91 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.845 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -80.05 153.9 28.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.849 -1.383 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 ' CD1' ' CA ' ' A' ' 53' ' ' GLY . 96.6 mt -124.7 136.75 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -62.75 106.32 0.78 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.678 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.78 171.52 28.93 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -62.59 -164.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -1.093 . . . . 0.0 109.344 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.0 mtt 57.76 21.26 7.23 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.573 0.702 . . . . 0.0 109.827 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.2 m120 50.02 39.39 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.594 -0.691 . . . . 0.0 111.723 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 44' ' ' ILE . 24.5 pt -140.01 165.86 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.809 -1.182 . . . . 0.0 108.983 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -91.52 118.44 30.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 110.417 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.542 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 42.1 m80 -105.15 128.46 53.39 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.419 -0.801 . . . . 0.0 109.085 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -100.15 129.23 46.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.993 -1.067 . . . . 0.0 108.7 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.405 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 52.1 m-70 -97.38 170.14 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.99 -49.99 74.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.167 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 m -91.25 144.23 29.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.28 -0.887 . . . . 0.0 109.102 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -67.23 -5.47 13.87 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.574 0.849 . . . . 0.0 111.738 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.45 -0.53 54.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.93 . . . . 0.0 110.157 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' CA ' ' CD1' ' A' ' 38' ' ' ILE . . . 77.67 10.03 86.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -68.23 -39.99 82.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -1.104 . . . . 0.0 109.854 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.79 165.67 46.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.405 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.9 Cg_endo -67.38 175.98 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.194 1.262 . . . . 0.0 112.087 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.94 29.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.1 mp -101.0 -46.81 4.97 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.274 -0.892 . . . . 0.0 109.764 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -143.84 167.4 22.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.004 -1.06 . . . . 0.0 108.501 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.542 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 1.9 m -137.51 -177.04 4.61 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.869 -1.144 . . . . 0.0 112.04 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 tt -139.97 132.09 28.01 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.514 0.673 . . . . 0.0 109.992 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.66 166.66 22.71 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.3 m-20 -77.69 170.19 17.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.842 -1.161 . . . . 0.0 110.472 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mtp -68.97 -29.57 67.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.498 -0.752 . . . . 0.0 111.818 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' GLY . 34.0 m -86.2 118.82 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.51 -1.369 . . . . 0.0 109.749 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -61.5 147.81 87.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.538 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.91 2.87 17.87 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.175 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 69.99 33.32 69.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.3 p -84.34 169.95 14.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.042 -1.269 . . . . 0.0 109.887 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 70.8 m-85 -119.7 150.73 39.88 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 73' ' ' GLU . 53.9 m-20 -139.16 150.26 64.02 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 74' ' ' MET . 16.6 Cg_exo -42.89 -15.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.901 1.067 . . . . 0.0 112.316 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.5 mt-10 -85.09 16.21 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.2 ptt? -83.53 -0.0 48.42 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.024 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -85.02 -4.39 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.66 -1.275 . . . . 0.0 109.694 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -147.83 77.42 1.42 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.53 169.71 24.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 109.498 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -135.51 156.94 48.08 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.62 19.35 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.083 . . . . 0.0 109.37 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.77 -30.67 77.22 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 120.418 0.745 . . . . 0.0 111.744 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.86 -160.85 27.57 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.09 159.94 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.488 -1.007 . . . . 0.0 109.47 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -115.45 119.66 36.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.0 109.745 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -104.75 129.93 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -147.08 170.05 17.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.92 -1.113 . . . . 0.0 110.491 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.0 ttp -133.19 130.96 39.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.729 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.56 123.16 35.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.592 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 3.7 m -98.43 150.07 36.36 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.262 -0.899 . . . . 0.0 108.62 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -76.06 142.72 74.48 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.386 -0.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 m -109.99 157.81 18.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.513 -0.742 . . . . 0.0 109.73 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 64.2 t80 -75.88 154.61 35.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.16 -159.39 45.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -93.78 114.95 27.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -1.107 . . . . 0.0 108.848 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.09 -27.22 43.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.936 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.99 -38.22 75.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.546 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.05 -39.32 75.78 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.87 -41.06 86.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.13 -43.05 99.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 108.673 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.0 -39.87 93.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.026 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.0 mmm -56.79 -49.99 73.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.036 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.6 mm-40 -60.28 -41.4 93.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.153 -0.967 . . . . 0.0 109.0 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.8 p -71.93 -39.94 69.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -56.04 26.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.911 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.48 -40.69 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.608 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.7 m-70 -60.06 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.422 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.06 -49.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 108.856 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.69 -51.69 53.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.624 -0.673 . . . . 0.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 110.814 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.36 -39.9 77.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.409 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.87 0.06 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.27 20.53 76.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.4 -178.35 51.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.95 131.55 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.538 -0.978 . . . . 0.0 108.939 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.8 130.68 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.949 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.7 mt -132.7 159.91 38.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 37.8 p-10 -86.59 -172.2 3.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.611 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 91.5 m-20 -60.06 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.0 . . . . 0.0 109.735 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -76.31 13.91 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 108.653 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.5 mtt180 59.87 34.6 21.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.135 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -110.03 151.27 27.38 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.7 mtp -52.96 129.99 32.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.089 . . . . 0.0 109.319 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 39.5 mtt -59.6 140.86 56.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.98 . . . . 0.0 109.932 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.6 p -133.63 151.1 76.58 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -43.57 -47.74 9.18 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.486 0.791 . . . . 0.0 111.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.99 -41.58 92.37 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 27.4 mmtp -69.99 -39.98 75.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.2 mt -60.0 -39.96 87.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 108.501 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -62.43 -39.9 94.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.46 -46.97 85.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.085 -1.009 . . . . 0.0 109.549 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.611 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 67.9 m-85 -60.01 -45.43 92.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.943 -1.098 . . . . 0.0 108.587 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.02 -39.57 86.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -45.73 91.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.82 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 135' ' ' ILE . 86.1 mt -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.84 -1.162 . . . . 0.0 108.698 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.05 -45.25 95.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.066 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -61.97 -38.18 87.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.84 . . . . 0.0 109.603 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.4 mt-10 -59.97 -39.7 86.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.421 -0.799 . . . . 0.0 110.715 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 -33.63 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.428 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.4 mttm -59.91 -45.5 92.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.82 -1.175 . . . . 0.0 110.545 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.23 -33.31 72.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.665 -1.272 . . . . 0.0 109.681 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.34 -39.96 93.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 110.936 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 41.3 p-10 -98.54 3.01 48.05 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.061 -1.024 . . . . 0.0 109.592 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.389 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 7.7 mtpm? . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -146.51 146.97 30.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.17 -166.22 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.436 -1.415 . . . . 0.0 111.393 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -131.5 134.89 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.433 HD13 HG23 ' A' ' 11' ' ' ILE . 24.9 mm -90.27 127.81 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -119.98 148.03 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.385 1.088 . . . . 0.0 111.684 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.528 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.9 mtt -145.36 159.05 43.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.39 119.71 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.835 -1.166 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -101.96 110.02 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.58 159.34 44.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.98 179.0 3.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.02 156.26 15.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.108 -0.995 . . . . 0.0 108.773 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -59.95 145.49 45.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.071 -1.018 . . . . 0.0 109.336 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 1.52 68.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.2 m -131.26 147.54 52.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.973 . . . . 0.0 109.276 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.94 145.31 51.42 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.378 -0.826 . . . . 0.0 109.433 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.61 145.81 26.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.718 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.04 146.83 50.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.46 97.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 62.0 mm-40 -61.87 -45.69 92.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.004 -1.292 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 84.4 mt -70.01 -29.14 66.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 108.627 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.5 tt -74.1 -57.14 4.16 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.391 0.615 . . . . 0.0 110.022 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.0 -49.99 75.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 111.63 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.9 p-10 -62.13 -40.07 94.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.841 -1.162 . . . . 0.0 110.315 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.458 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -60.42 -43.17 97.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 32' ' ' ILE . 96.6 mt -59.94 -46.57 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.428 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.14 -41.13 99.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 110.054 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.79 -18.96 64.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.2 3.96 21.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 5.41 65.9 Favored Glycine 0 N--CA 1.497 2.759 0 O-C-N 120.821 -1.174 . . . . 0.0 111.041 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.46 149.61 33.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.708 -1.466 . . . . 0.0 109.185 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.14 139.71 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.99 116.18 3.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.774 -1.204 . . . . 0.0 108.755 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -91.99 172.12 34.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.36 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.767 -0.843 . . . . 0.0 110.431 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mmm 58.18 -99.71 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 42' ' ' MET . 56.6 m-80 -164.81 28.47 0.06 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.74 168.21 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.355 -0.84 . . . . 0.0 110.556 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.58 119.96 32.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.327 -0.858 . . . . 0.0 109.95 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.526 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 47.4 m80 -103.2 141.19 36.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.299 -0.876 . . . . 0.0 109.04 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 45.8 ttt180 -120.49 131.29 54.66 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.476 -0.765 . . . . 0.0 109.047 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.558 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.3 m-70 -94.69 174.55 7.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.2 tp -53.56 -49.97 66.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 108.469 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -92.26 146.03 31.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.84 -3.01 10.52 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 120.593 0.862 . . . . 0.0 111.985 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.75 1.35 57.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.209 -0.932 . . . . 0.0 109.831 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.6 10.01 75.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.83 -41.89 70.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.015 -1.285 . . . . 0.0 110.167 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.558 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.37 173.41 54.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.538 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.8 Cg_endo -73.75 173.0 14.68 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.085 1.19 . . . . 0.0 111.431 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 122.05 26.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.065 -1.022 . . . . 0.0 109.213 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' CD2' HD22 ' A' ' 97' ' ' ASN . 9.0 mp -103.17 -33.76 9.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.372 -0.83 . . . . 0.0 109.844 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.08 169.12 24.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.056 . . . . 0.0 108.685 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 8.2 m -139.13 -176.46 4.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 0.0 111.232 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -137.32 132.91 34.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.387 0.613 . . . . 0.0 109.397 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.06 162.32 31.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.0 m-20 -76.26 169.02 19.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.885 -1.134 . . . . 0.0 109.682 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.3 mmm -69.47 -28.75 66.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 110.648 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.32 118.08 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.767 -1.208 . . . . 0.0 110.234 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -62.54 152.02 81.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.477 -0.765 . . . . 0.0 108.944 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -78.12 1.95 28.08 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.711 -1.37 . . . . 0.0 111.964 -0.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.0 38.35 19.48 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.93 157.63 19.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -1.195 . . . . 0.0 109.744 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -120.0 139.97 51.67 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.53 -0.731 . . . . 0.0 109.373 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.19 149.98 67.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.86 -13.37 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 120.651 0.901 . . . . 0.0 112.561 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.35 -10.1 57.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 92.9 mtp -89.04 22.07 2.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.87 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -85.31 -7.8 58.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 108.558 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 89.3 m-20 -144.7 83.57 1.71 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.64 174.35 15.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.256 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -128.64 148.14 50.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 109.152 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.74 150.58 20.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 108.926 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -45.77 -50.6 9.36 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 CA-C-N 119.299 0.785 . . . . 0.0 111.763 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.6 -150.17 8.34 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.01 160.07 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.488 -1.007 . . . . 0.0 110.067 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 62' ' ' ALA . 24.6 m -107.89 119.96 40.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.0 109.458 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.35 129.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -146.94 168.01 22.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 110.916 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.7 ttp -136.75 129.97 31.29 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -91.39 114.64 27.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.39 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.4 151.98 37.63 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -78.51 134.19 32.38 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.394 -0.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.3 m -108.53 162.04 14.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.489 -0.757 . . . . 0.0 109.856 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.06 146.72 50.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -0.802 . . . . 0.0 109.938 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.24 -159.52 27.53 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -97.31 112.65 24.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.99 -29.14 65.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.822 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.29 -39.97 78.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -71.15 -40.13 71.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.012 -1.055 . . . . 0.0 108.868 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.518 HD22 ' CD2' ' A' ' 58' ' ' LEU . 28.1 m120 -60.97 -39.9 91.38 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 109.098 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 87.1 t80 -59.24 -49.96 75.83 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.82 -40.05 96.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.6 -47.46 86.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 110.68 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.8 mtm -59.96 -39.97 87.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.893 -1.129 . . . . 0.0 109.319 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.47 -41.5 98.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 109.103 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.13 -41.2 92.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 109.002 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 p -72.18 -40.03 68.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 108.941 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.0 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.552 -0.718 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -62.13 -39.2 91.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.94 -1.1 . . . . 0.0 109.689 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 14.9 m-70 -59.97 -44.14 94.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.674 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.01 -49.45 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.35 -50.16 51.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.589 -0.695 . . . . 0.0 109.607 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.99 -40.19 92.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.792 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -39.92 75.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.805 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.0 m -97.76 -1.44 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.0 109.704 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.73 19.89 75.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.58 -174.68 48.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.8 t -131.12 138.14 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.517 -0.99 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 t -70.44 133.2 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.658 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.5 159.99 35.44 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.556 -0.715 . . . . 0.0 109.759 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -87.76 -171.62 3.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 109.419 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.5 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -76.88 15.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.049 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.3 mtt180 55.6 38.96 30.86 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.4 0.619 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 122' ' ' ARG . 29.7 mtt-85 -112.07 151.9 28.85 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -51.5 130.65 28.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.0 mmm -59.16 139.97 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -137.6 150.31 67.81 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -47.9 -44.06 28.2 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.844 1.029 . . . . 0.0 112.401 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -39.91 87.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -67.89 -40.03 83.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 110.123 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.1 -39.88 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -61.96 -40.14 94.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.556 -0.715 . . . . 0.0 109.078 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -59.94 -48.2 82.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.862 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.414 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 55.8 m-85 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.584 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 94.5 mm-40 -59.97 -40.12 87.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.72 -40.39 97.03 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.81 -45.16 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 108.859 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.09 -49.38 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -60.05 -39.98 87.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 54.2 mm-40 -60.26 -41.66 93.71 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 109.821 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -40.79 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 144' ' ' ALA . 26.4 mtpp -59.98 -48.06 83.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.963 -1.086 . . . . 0.0 111.266 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 4.2 p30 -60.08 -32.34 70.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.999 -1.063 . . . . 0.0 110.357 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -62.26 -39.95 94.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -104.04 -1.64 27.16 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.169 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.407 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -145.17 133.71 22.01 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -159.93 170.47 21.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.85 -1.156 . . . . 0.0 110.355 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.82 131.4 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.364 -0.835 . . . . 0.0 109.069 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.58 130.92 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.2 mt -125.46 146.02 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.184 0.993 . . . . 0.0 111.937 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.5 mtt -145.96 157.36 43.89 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -141.28 129.94 22.8 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.628 -1.295 . . . . 0.0 111.169 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.29 116.45 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.03 38.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -170.69 0.85 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -68.02 158.09 33.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.99 -1.069 . . . . 0.0 108.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -59.96 145.58 45.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.382 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.23 82.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 m -118.0 148.47 42.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.512 -0.993 . . . . 0.0 108.801 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 63.6 mm-40 -129.31 143.06 50.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.5 mt -86.35 139.21 31.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 109.458 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.6 145.16 52.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.343 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.91 97.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.91 -41.55 98.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.095 -1.238 . . . . 0.0 109.7 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.03 -27.1 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -71.31 -59.03 2.99 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.418 -0.801 . . . . 0.0 109.383 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.989 -1.069 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.96 -42.85 94.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 109.958 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -69.97 -46.92 64.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 110.52 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.8 mt -60.06 -44.23 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 0.0 110.102 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.24 -43.12 98.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 109.724 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -68.72 -16.39 63.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.513 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.25 3.91 25.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.875 . . . . 0.0 110.056 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.0 9.91 83.66 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -80.22 154.39 27.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.283 . . . . 0.0 109.398 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.17 141.69 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -59.64 111.7 1.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.973 -1.079 . . . . 0.0 109.083 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.72 171.85 33.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.34 -169.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.567 -0.961 . . . . 0.0 109.171 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.1 mtm 56.19 29.42 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.809 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 m120 49.94 38.66 16.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.558 -0.714 . . . . 0.0 111.493 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 pt -140.22 159.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.877 -1.14 . . . . 0.0 109.182 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.34 129.99 35.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.089 -1.007 . . . . 0.0 109.872 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.596 ' HD1' ' CB ' ' A' ' 60' ' ' SER . 12.3 m-70 -118.44 127.87 54.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 59.2 ttt180 -100.02 124.98 45.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.0 108.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 19.8 m-70 -95.05 169.68 9.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.8 tp -55.54 -50.06 70.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.7 m -92.34 144.55 29.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 108.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.44 -3.14 10.41 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.518 0.863 . . . . 0.0 111.975 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.25 0.06 57.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.1 11.36 84.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 m -70.06 -45.43 67.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -1.197 . . . . 0.0 109.878 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.49 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.59 166.35 54.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.74 177.92 4.43 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.081 1.187 . . . . 0.0 111.456 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.49 124.6 30.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.96 . . . . 0.0 109.053 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.9 mp -100.73 -39.76 7.68 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.099 -1.0 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -148.19 159.86 43.53 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' HD1' ' A' ' 46' ' ' HIS . 2.5 m -130.21 -179.85 5.48 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.204 1.002 . . . . 0.0 112.342 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.94 129.95 24.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.215 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.75 160.97 35.29 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 17.0 m120 -75.32 159.09 31.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.098 -1.002 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -69.98 -25.22 63.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.64 -0.662 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.7 t -85.21 126.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.733 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -59.73 149.99 69.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.102 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.29 9.87 15.94 Favored 'Cis proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.727 -0.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 14.5 80.98 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 69' ' ' THR . 16.9 p -88.99 170.14 10.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 110.877 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 39.3 m-85 -119.27 158.78 25.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.6 m-20 -143.07 150.65 53.41 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.197 -0.94 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -48.98 -8.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.125 0 CA-C-N 119.171 0.74 . . . . 0.0 110.94 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.3 mt-10 -86.77 18.18 3.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.417 ' SD ' ' CD1' ' A' ' 70' ' ' PHE . 47.5 mtm -73.89 1.24 11.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.9 mmtp -88.75 -0.07 56.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 109.943 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 60.7 m-20 -154.8 77.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.012 -1.055 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -167.76 170.66 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.7 p -137.11 159.17 42.67 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.97 148.3 18.43 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.932 -1.105 . . . . 0.0 109.251 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 3.5 Cg_endo -57.8 -35.58 98.72 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.577 0.851 . . . . 0.0 112.0 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.23 -161.09 25.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.99 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.51 -0.994 . . . . 0.0 108.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -114.7 128.08 56.11 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.488 -0.758 . . . . 0.0 110.454 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.6 mt -111.56 129.19 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 24.9 p90 -149.09 159.96 43.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.877 -1.139 . . . . 0.0 110.976 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.6 ttm -113.64 130.55 56.37 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.44 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.1 mt-30 -91.94 115.18 27.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 1.2 m -98.58 150.4 36.68 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 120.978 -1.076 . . . . 0.0 109.379 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.24 134.72 36.92 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.902 -1.291 . . . . 0.0 111.561 -1.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.9 m -104.56 154.2 20.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.409 -0.807 . . . . 0.0 110.097 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -71.31 148.59 46.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 109.509 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.61 -164.61 39.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.63 114.39 26.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -1.179 . . . . 0.0 109.322 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -52.99 -18.56 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.04 -40.02 75.39 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -75.98 -41.45 51.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 108.962 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.61 -41.27 80.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.34 -40.11 89.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.074 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.09 -40.11 94.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.3 mtp -59.47 -49.91 75.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.99 -45.9 92.93 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.062 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.2 mt-30 -60.28 -40.46 90.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 p -73.15 -40.03 65.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.76 -54.01 51.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.447 -0.783 . . . . 0.0 109.907 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -63.23 -40.0 96.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 109.638 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 3.9 m-70 -60.15 -45.94 91.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.366 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.95 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.15 -49.96 59.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -0.824 . . . . 0.0 109.291 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.36 -40.05 89.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.39 -40.15 77.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 110.796 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 m -98.41 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.01 20.02 74.3 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.28 -170.24 46.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 132.92 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.934 . . . . 0.0 109.098 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.47 132.88 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.513 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 mt -132.13 159.96 37.4 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.481 -0.762 . . . . 0.0 109.795 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 44.7 p-10 -88.55 -169.34 2.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 121' ' ' ARG . 94.1 m-20 -59.97 -39.61 86.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.181 -0.95 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -76.44 16.61 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.244 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 119' ' ' ASP . 49.6 mtm-85 57.75 28.88 16.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.584 . . . . 0.0 109.953 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 51.0 mtt-85 -110.32 155.66 21.8 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.514 -0.741 . . . . 0.0 109.441 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.1 mtm -53.76 132.23 40.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.3 mtt -60.0 140.75 56.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -129.78 150.29 75.42 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -43.58 -41.07 10.95 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 CA-C-N 119.354 0.805 . . . . 0.0 111.744 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.3 -40.01 88.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.946 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -69.37 -39.31 78.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 109.791 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.74 -40.49 79.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 108.781 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -65.88 -38.95 90.12 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.93 -47.79 84.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.943 . . . . 0.0 109.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -59.95 -42.77 94.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 108.486 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.72 -40.02 95.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.539 -0.726 . . . . 0.0 109.047 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -40.02 87.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.447 -0.783 . . . . 0.0 109.692 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 135' ' ' ILE . 96.9 mt -62.51 -40.03 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.953 -1.092 . . . . 0.0 109.259 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.406 ' CG2' ' HZ2' ' A' ' 140' ' ' LYS . 82.0 mt -59.93 -42.95 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.946 -1.096 . . . . 0.0 109.391 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 0.8 OUTLIER -60.08 -37.14 79.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.198 -0.939 . . . . 0.0 109.751 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.73 -33.88 45.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 144' ' ' ALA . 39.3 mmtm -59.63 -45.96 90.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 109.958 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -62.44 -36.44 82.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.647 -1.283 . . . . 0.0 108.807 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 110.197 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -97.81 0.36 46.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 108.803 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.497 -0.752 . . . . 0.0 109.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mttt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -148.46 145.02 27.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.486 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -164.66 160.1 19.62 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.328 -1.482 . . . . 0.0 110.743 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.53 129.92 59.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -88.43 129.95 38.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.8 mt -122.0 147.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.303 1.049 . . . . 0.0 111.49 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -145.79 154.14 41.7 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -133.21 120.91 21.76 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.898 -1.126 . . . . 0.0 111.088 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.01 112.48 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.93 158.67 43.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 110.124 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.7 -170.55 0.7 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.555 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -59.93 154.3 19.14 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 108.762 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -59.83 141.56 55.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.071 -1.018 . . . . 0.0 109.606 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.19 -8.59 79.26 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 m -112.2 151.93 28.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.473 -1.016 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.97 150.54 49.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.425 -0.797 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.31 145.82 27.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.903 . . . . 0.0 109.908 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.42 140.62 57.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 109.016 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.22 -40.48 97.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.56 -47.74 82.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.2 mt -68.2 -24.5 64.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.53 -58.28 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.956 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.89 -49.93 75.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.214 -0.928 . . . . 0.0 111.084 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.4 p-10 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 110.023 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 53.7 m -61.99 -40.66 96.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.971 -1.081 . . . . 0.0 109.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.29 -48.45 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 108.886 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -60.22 -40.01 88.64 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.91 -21.56 64.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 9.87 7.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.956 -1.09 . . . . 0.0 110.376 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.21 9.67 86.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -80.4 155.47 27.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.296 . . . . 0.0 109.583 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 140.65 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 108.24 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 171.82 33.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.27 -167.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -1.107 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.8 mmm 57.22 26.87 12.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.475 -0.766 . . . . 0.0 109.654 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 51.11 39.91 24.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.446 -0.784 . . . . 0.0 111.514 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.6 pt -141.65 160.88 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.014 -1.054 . . . . 0.0 109.402 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.38 136.56 32.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 18.6 m-70 -125.72 128.13 47.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.0 ttt-85 -101.09 126.2 47.76 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.388 -0.82 . . . . 0.0 109.083 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.532 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 58.6 m-70 -96.51 170.08 9.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.729 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.3 tp -55.83 -49.83 72.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -92.04 149.06 38.12 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.295 -0.878 . . . . 0.0 109.333 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.16 -5.89 17.52 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 120.926 1.084 . . . . 0.0 112.234 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 49.8 p-10 -94.18 -0.04 55.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.074 -1.016 . . . . 0.0 110.299 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.4 85.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.433 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 27.0 m -70.03 -41.71 73.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.749 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.61 165.35 52.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.532 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.6 Cg_endo -69.14 174.25 9.24 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.03 1.153 . . . . 0.0 111.602 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.56 125.88 30.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 109.134 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.1 mp -99.06 -39.63 8.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.18 158.59 44.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.499 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 29.0 m -129.68 179.46 5.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.244 1.021 . . . . 0.0 112.159 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 tt -139.51 132.94 30.15 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.1 167.17 22.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.7 m120 -74.9 160.23 30.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.002 -1.061 . . . . 0.0 109.773 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.88 -20.51 63.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.862 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.95 113.57 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.002 -1.061 . . . . 0.0 109.114 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -62.74 151.73 83.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.501 -0.749 . . . . 0.0 109.563 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -76.67 10.97 12.62 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.6 -1.416 . . . . 0.0 112.34 -0.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.39 30.82 57.95 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.374 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -85.85 163.83 17.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -1.19 . . . . 0.0 109.836 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.1 m-85 -120.82 143.13 49.03 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.3 m-20 -129.12 149.93 73.99 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.1 -9.07 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.138 0.728 . . . . 0.0 111.569 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 71' ' ' ASP . 98.0 mt-10 -89.77 3.92 51.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.548 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 67.6 mmm -88.1 16.46 6.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 62.6 mttp -85.34 -6.32 59.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.962 -1.086 . . . . 0.0 109.182 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 68.6 m-20 -151.91 79.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.75 171.69 19.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.1 p -128.64 151.75 49.14 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.95 149.04 19.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.07 -1.019 . . . . 0.0 109.308 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -43.58 -49.98 7.35 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.666 0.911 . . . . 0.0 111.896 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.09 -154.75 13.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.97 160.02 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.395 -1.062 . . . . 0.0 109.82 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.5 m -109.08 120.93 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.719 -0.613 . . . . 0.0 110.146 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mt -103.71 130.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 31.8 p90 -147.17 169.98 18.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 111.215 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.8 ttm -128.26 130.07 47.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.417 ' O ' ' OG ' ' A' ' 90' ' ' SER . 92.0 mm-40 -91.51 115.62 28.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.486 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 1.7 m -98.8 149.92 36.2 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.18 -0.95 . . . . 0.0 109.093 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.61 137.02 46.73 Favored 'Cis proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.867 -1.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.1 m -107.74 154.15 21.92 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.487 -0.758 . . . . 0.0 109.397 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.11 145.49 51.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 110.043 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.51 -165.61 33.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -96.39 112.29 24.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.34 -1.094 . . . . 0.0 109.114 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -55.3 -25.53 34.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.81 -40.14 76.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 109.591 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.28 -41.63 66.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.785 -1.197 . . . . 0.0 108.065 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.69 -39.79 95.09 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -51.34 -40.65 59.55 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.5 -40.02 94.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.86 -40.04 96.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 0.0 109.287 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mtp -58.66 -50.03 75.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.079 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.95 -47.32 75.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.353 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 77.1 mt-30 -59.95 -40.81 90.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 108.977 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.5 p -70.4 -40.16 74.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.14 -56.42 22.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.823 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -61.21 -37.82 84.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.462 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.9 m-70 -59.94 -50.13 74.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.06 -1.025 . . . . 0.0 108.746 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.99 -49.01 86.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.73 -49.23 65.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -70.03 -40.15 75.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.72 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.6 m -97.44 -0.03 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 0.0 109.873 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.03 26.01 74.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.77 -176.54 50.21 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -130.21 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.702 -0.881 . . . . 0.0 109.202 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -74.96 130.26 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.132 -0.98 . . . . 0.0 109.352 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -130.56 159.88 35.82 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 40.3 p-10 -85.7 -170.69 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 0.0 108.989 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.6 m-20 -60.13 -39.49 86.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.78 16.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.328 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 58.46 29.37 18.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 110.395 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.516 ' NE ' ' HZ3' ' A' ' 128' ' ' LYS . 84.5 mtm180 -107.91 154.33 21.76 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.336 -0.852 . . . . 0.0 108.969 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.2 mtt -52.42 125.17 15.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 109.722 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 mtp -60.14 140.49 56.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.522 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.2 p -127.18 150.53 72.53 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -43.64 -43.23 11.44 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.185 0.745 . . . . 0.0 112.018 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.431 ' O ' ' CD ' ' A' ' 131' ' ' GLU . 27.3 mt-30 -60.08 -44.74 94.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.516 ' HZ3' ' NE ' ' A' ' 122' ' ' ARG . 97.9 mttt -62.59 -39.76 94.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 109.772 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.64 -39.01 76.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -65.83 -39.99 91.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -59.43 -48.6 81.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.701 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -60.08 -45.99 91.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 108.548 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.0 -40.02 96.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.491 -0.756 . . . . 0.0 108.961 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.4 -42.11 98.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.2 -42.8 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.003 -1.06 . . . . 0.0 109.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.07 -41.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 31.2 mmt180 -60.05 -40.91 91.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 108.962 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -61.11 -37.46 82.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 0.0 108.98 178.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.93 -39.86 78.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 110.27 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.02 -48.6 81.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 111.379 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 2.8 p-10 -59.91 -32.86 71.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.558 -1.339 . . . . 0.0 109.221 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.12 82.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 110.148 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -98.6 -11.35 22.22 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 109.506 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -147.89 150.4 34.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.1 -175.1 3.84 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.562 -1.336 . . . . 0.0 110.811 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.98 136.3 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 11' ' ' ILE . 22.7 mm -93.59 124.64 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.9 mt -121.36 151.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.043 0.925 . . . . 0.0 111.091 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 84' ' ' ILE . 67.5 mtt -148.88 159.02 44.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -140.17 121.29 14.75 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.973 -1.08 . . . . 0.0 110.603 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.28 117.27 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.42 155.0 40.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.14 -174.21 1.49 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.447 -0.783 . . . . 0.0 108.901 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -64.26 149.03 48.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.073 -1.017 . . . . 0.0 108.763 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 30.1 p-80 -55.81 149.85 13.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 109.756 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.57 -7.18 82.43 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -121.06 154.69 35.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.564 -0.962 . . . . 0.0 109.477 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -129.16 147.34 50.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.07 137.68 33.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 55.3 t-20 -67.95 142.05 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.05 -41.42 97.99 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.795 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.73 -47.24 86.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.309 . . . . 0.0 110.095 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.01 -30.26 67.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.4 -57.48 4.77 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.551 -0.718 . . . . 0.0 109.252 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.99 -44.23 94.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.385 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' OD1' ' OE1' ' A' ' 34' ' ' GLN . 60.3 t-20 -60.45 -40.27 90.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 110.192 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 p -65.82 -39.82 91.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 32' ' ' ILE . 92.5 mt -59.87 -48.82 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -62.35 -39.97 94.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.902 -1.124 . . . . 0.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' OD1' ' A' ' 30' ' ' ASN . 27.5 mt-30 -67.84 -22.41 65.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.377 -0.827 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.98 6.09 14.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.953 -1.092 . . . . 0.0 109.997 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.83 76.19 Favored Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.947 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -78.6 150.35 32.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.76 -1.435 . . . . 0.0 109.726 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 38' ' ' ILE . 96.6 mt -127.34 139.57 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -60.69 105.34 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.03 172.14 29.19 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.51 -165.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -1.035 . . . . 0.0 109.598 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mmm 58.36 20.12 7.02 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.689 . . . . 0.0 109.81 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 49.99 39.63 19.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.086 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.2 pt -140.51 166.98 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -91.91 127.02 37.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.917 -1.114 . . . . 0.0 110.487 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 36.5 m-70 -116.07 128.82 56.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.528 -0.732 . . . . 0.0 109.75 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 47' ' ' ARG . 17.6 ttt-85 -102.97 126.95 50.35 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 70.9 m-70 -94.76 171.22 8.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.963 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.54 -50.14 70.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.9 . . . . 0.0 108.739 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -93.34 143.73 27.16 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -66.97 -2.65 8.24 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 119.552 0.876 . . . . 0.0 111.952 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -94.25 0.19 55.5 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 0.0 110.109 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.92 86.61 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.452 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 91.3 p -70.1 -40.0 75.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.914 -1.345 . . . . 0.0 109.762 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.77 162.82 52.18 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 12.3 Cg_endo -67.26 176.93 4.2 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.994 1.129 . . . . 0.0 111.247 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.23 118.67 22.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.017 -1.052 . . . . 0.0 109.319 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 6.6 mp -96.72 -47.97 5.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -142.95 159.99 41.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.993 . . . . 0.0 109.395 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.546 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.0 m -136.55 159.92 40.33 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.82 0.819 . . . . 0.0 111.208 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.5 tt -113.11 131.69 55.73 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.361 0.601 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -137.57 162.78 32.84 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.9 m-20 -77.69 153.55 32.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.884 -1.135 . . . . 0.0 109.886 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.05 -29.86 66.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.094 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.43 134.94 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.972 -1.08 . . . . 0.0 109.774 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -56.87 154.02 20.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -79.77 2.06 36.52 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 123.753 -1.353 . . . . 0.0 112.464 -0.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.85 -4.73 73.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.5 p -89.6 169.89 10.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -1.051 . . . . 0.0 110.078 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 79.6 m-85 -121.76 152.47 39.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.5 m-20 -135.17 149.74 70.91 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -49.04 -11.11 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 120.47 0.78 . . . . 0.0 111.792 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.4 mm-40 -89.95 4.46 50.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.401 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 73.9 mmm -87.92 20.24 3.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.0 110.155 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.0 mttp -88.23 -1.69 58.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 81.7 m-20 -146.73 81.55 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -160.33 172.49 17.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 p -130.67 151.58 50.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.31 150.02 21.48 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.263 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.48 -38.37 95.49 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 CA-C-N 119.092 0.712 . . . . 0.0 111.566 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.08 -156.47 15.17 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.51 160.08 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.768 -0.843 . . . . 0.0 109.066 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.5 m -114.14 120.26 39.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.473 -0.767 . . . . 0.0 110.432 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 13' ' ' MET . 97.5 mt -105.95 128.19 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -145.27 152.34 39.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.176 -0.953 . . . . 0.0 110.136 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttp -121.2 130.04 53.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.444 ' O ' ' OG ' ' A' ' 90' ' ' SER . 97.3 mt-30 -86.33 110.88 19.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 108.96 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.19 147.44 33.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.403 ' CG ' HD21 ' A' ' 143' ' ' ASN . 4.1 Cg_endo -75.8 131.49 24.43 Favored 'Cis proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.605 0.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 43.5 m -100.36 166.73 10.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.736 0.779 . . . . 0.0 110.186 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.13 146.02 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.771 -0.581 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.4 -156.46 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -93.77 119.09 32.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -1.209 . . . . 0.0 108.537 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -57.44 -32.64 67.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.838 -0.539 . . . . 0.0 110.511 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.96 -40.11 75.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.85 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.11 -40.62 68.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.004 -1.06 . . . . 0.0 109.157 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.253 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -58.83 -45.03 90.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -61.11 -39.73 91.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.448 -0.783 . . . . 0.0 109.43 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.11 -43.78 95.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 109.678 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.15 -44.92 94.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.49 -46.2 91.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.5 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 78.3 mt-30 -60.05 -43.93 95.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -70.42 -40.01 74.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.23 -55.58 33.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.041 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -60.28 -35.93 76.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.925 -1.11 . . . . 0.0 108.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 9.0 m-70 -60.08 -45.88 91.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.11 -0.994 . . . . 0.0 108.839 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -60.01 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.048 -1.032 . . . . 0.0 108.568 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.2 -48.99 61.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.487 0.66 . . . . 0.0 109.286 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.09 -40.01 88.1 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.926 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.9 -40.04 75.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 111.349 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.75 -0.39 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.075 -1.015 . . . . 0.0 109.566 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.83 25.96 74.89 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.06 -169.3 44.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.51 134.04 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -1.016 . . . . 0.0 109.238 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.14 130.89 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.054 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.0 mt -126.74 159.02 34.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 108.907 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -86.49 -171.51 3.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 109.069 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.476 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 97.2 m-20 -60.07 -35.01 74.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.323 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.84 16.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 119' ' ' ASP . 45.1 mtm-85 58.16 26.28 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.641 . . . . 0.0 109.914 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 54.0 mtp180 -109.18 151.49 26.4 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.593 -0.692 . . . . 0.0 109.331 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -52.51 134.69 34.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.886 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.4 mmm -59.9 133.61 56.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.0 p -132.72 151.15 77.58 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -41.36 -45.99 5.78 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 120.926 1.084 . . . . 0.0 113.04 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -60.09 -39.97 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.95 -1.094 . . . . 0.0 109.409 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.36 -40.11 85.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.32 -39.97 84.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 108.828 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -62.58 -39.54 94.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.474 -0.766 . . . . 0.0 109.143 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.59 -48.59 81.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.123 -0.986 . . . . 0.0 109.75 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.476 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 65.3 m-85 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.041 -1.037 . . . . 0.0 109.398 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.87 87.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.316 -0.865 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.21 -44.42 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 108.702 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.07 -45.78 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.383 -0.823 . . . . 0.0 109.379 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 99.0 mtt180 -60.31 -37.41 80.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 110.161 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.6 mt-10 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.866 . . . . 0.0 110.29 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.6 t -73.35 -35.56 46.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 110.8 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 144' ' ' ALA . 49.4 mtpt -60.15 -46.61 89.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 111.464 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.7 p-10 -61.17 -29.15 69.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.606 -1.309 . . . . 0.0 110.125 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.07 99.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.403 HD21 ' CG ' ' A' ' 89' ' ' PRO . 98.6 m-20 -112.44 -11.55 13.63 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.382 -0.824 . . . . 0.0 110.192 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -150.02 133.56 16.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.63 8.36 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.67 -1.269 . . . . 0.0 110.477 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -125.03 132.29 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.94 134.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.1 mt -131.2 141.84 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.947 0.88 . . . . 0.0 111.196 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.43 148.01 29.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -128.01 130.54 48.5 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.054 -1.029 . . . . 0.0 110.901 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.73 117.94 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.01 159.82 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 110.383 -178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.12 -164.96 0.2 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.704 -0.622 . . . . 0.0 109.645 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -70.0 155.97 39.82 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -57.57 135.78 56.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 5.18 65.0 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -126.31 144.41 50.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -1.019 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.4 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.5 mt-10 -124.52 147.69 48.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.51 137.04 33.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.167 -0.958 . . . . 0.0 110.233 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.43 143.07 57.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 108.862 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.49 -41.85 97.34 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.084 -1.01 . . . . 0.0 111.061 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.98 -43.15 95.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.889 -1.359 . . . . 0.0 108.877 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 95.5 mt -69.95 -27.12 64.48 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -76.57 -56.3 4.74 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 110.463 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.98 -49.0 79.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.03 -1.044 . . . . 0.0 111.312 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 31' ' ' SER . 42.8 p-10 -61.85 -39.15 90.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 110.866 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 93.4 p -62.62 -40.43 96.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.789 -1.194 . . . . 0.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.29 -49.71 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -65.66 -39.93 91.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 109.817 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -63.72 -22.42 66.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.03 -1.24 52.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.0 . . . . 0.0 109.602 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.08 19.08 44.03 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.041 -1.037 . . . . 0.0 111.418 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -81.23 160.61 24.25 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.356 . . . . 0.0 110.281 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.22 137.01 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.96 102.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.061 . . . . 0.0 109.841 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 171.02 41.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.4 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.443 -1.034 . . . . 0.0 109.242 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 95.4 mtp 56.66 23.52 7.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.664 -0.647 . . . . 0.0 110.222 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.71 40.26 23.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 111.259 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.552 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.9 pt -139.84 163.82 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.024 -1.047 . . . . 0.0 109.179 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -90.51 131.77 36.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.043 -1.035 . . . . 0.0 110.167 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 17.5 m-70 -123.68 132.07 53.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.687 -0.633 . . . . 0.0 109.869 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 30.9 ttt180 -104.86 121.71 44.26 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 48.1 m-70 -95.4 171.0 8.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.393 -0.817 . . . . 0.0 109.562 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.63 -50.05 71.2 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.8 m -92.37 144.23 28.59 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.33 -6.0 17.3 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.7 0.933 . . . . 0.0 112.104 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -93.15 0.89 57.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.154 -0.967 . . . . 0.0 109.407 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.48 14.25 82.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 55' ' ' GLY . 50.1 p -70.43 -40.45 73.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.081 -1.246 . . . . 0.0 109.237 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.46 166.86 48.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.459 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 20.8 Cg_endo -70.86 -179.49 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.195 1.263 . . . . 0.0 111.751 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.25 121.69 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.137 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.0 mp -95.96 -20.54 18.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.995 -1.066 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -169.63 158.15 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.937 . . . . 0.0 108.948 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.473 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.6 m -127.26 171.86 11.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.935 0.874 . . . . 0.0 111.822 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.08 130.2 25.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.543 0.687 . . . . 0.0 109.189 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.17 163.89 28.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.522 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 12.4 m120 -74.11 158.03 34.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.062 . . . . 0.0 110.127 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.02 -23.8 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.62 -0.675 . . . . 0.0 110.537 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 p -87.17 129.88 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.978 -1.076 . . . . 0.0 109.775 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -60.45 149.86 75.83 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.481 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.31 4.72 26.34 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.546 -0.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.88 85.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -85.48 170.98 12.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -1.202 . . . . 0.0 109.473 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 82.7 m-85 -116.46 150.58 37.62 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 7.5 m-20 -139.06 152.31 69.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.89 -15.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.045 1.163 . . . . 0.0 112.65 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.1 mt-10 -85.24 13.33 6.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' ASP . 24.3 ptt? -82.7 -7.3 59.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.77 -0.581 . . . . 0.0 110.243 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.8 mttt -85.25 -4.03 59.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.08 -1.013 . . . . 0.0 110.222 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 71.1 m-20 -150.29 73.23 1.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.933 -1.104 . . . . 0.0 109.885 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -158.1 169.86 23.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.4 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 49.9 p -131.96 150.11 52.25 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.218 -0.926 . . . . 0.0 109.093 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.75 147.78 19.66 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.972 -1.08 . . . . 0.0 108.77 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.99 -33.53 5.52 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.62 0.88 . . . . 0.0 111.866 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.44 -146.42 9.8 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.481 -1.343 . . . . 0.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.03 159.11 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.602 -0.94 . . . . 0.0 109.655 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 m -114.23 121.12 42.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.592 -0.692 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -102.55 125.72 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -149.86 161.96 41.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.953 -1.092 . . . . 0.0 110.65 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 4.9 tpt -146.31 147.46 31.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.72 . . . . 0.0 109.238 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' N ' ' SD ' ' A' ' 86' ' ' MET . 92.9 mt-30 -94.07 121.88 36.01 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.44 151.59 37.74 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.89 172.5 56.33 Favored 'Cis proline' 0 N--CA 1.503 2.033 0 C-N-CA 124.057 -1.226 . . . . 0.0 113.055 0.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.562 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 15.9 m -130.32 167.11 19.03 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.841 0.829 . . . . 0.0 111.031 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -72.8 144.47 47.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.05 -151.01 34.64 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -97.31 123.22 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.359 -1.083 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' N ' ' A' ' 90' ' ' SER . 53.5 mm-40 -56.21 -30.05 61.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 0.0 109.532 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.95 -40.02 79.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.258 -0.901 . . . . 0.0 109.077 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -73.05 -40.37 65.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.928 -1.108 . . . . 0.0 108.093 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.65 -40.01 94.69 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.14 -46.02 91.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.739 -0.601 . . . . 0.0 109.97 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.5 -39.87 89.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.417 ' O ' ' OG ' ' A' ' 104' ' ' SER . 64.9 mtp -60.03 -49.65 76.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.161 -0.962 . . . . 0.0 108.793 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.98 -45.98 83.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.427 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.1 mt-30 -59.98 -39.93 87.37 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 101' ' ' MET . 16.4 p -69.91 -41.49 74.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.369 -0.832 . . . . 0.0 109.035 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.01 -57.71 11.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.415 -0.803 . . . . 0.0 110.085 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.61 -39.62 88.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.693 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.5 m-70 -59.82 -49.8 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 108.775 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 108' ' ' ILE . 96.5 mt -60.17 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.19 -48.87 61.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.98 -39.84 93.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 110.281 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.66 -40.11 84.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.22 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.8 m -100.65 -0.68 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.267 -0.896 . . . . 0.0 109.903 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 20.89 74.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.44 -173.76 49.35 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.47 132.96 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -1.049 . . . . 0.0 109.851 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.17 131.96 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.7 158.23 39.16 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.615 0.721 . . . . 0.0 109.645 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -86.23 -174.31 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.517 -0.74 . . . . 0.0 109.564 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.9 m-20 -59.97 -36.09 76.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.011 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 120' ' ' GLN . 27.4 mp0 -78.73 16.32 0.88 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 119' ' ' ASP . 51.4 mtm-85 56.19 39.52 30.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.521 -0.737 . . . . 0.0 110.582 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.84 155.59 33.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.463 -0.773 . . . . 0.0 109.202 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.5 mtm -54.14 132.75 43.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.373 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 79.4 mmm -60.35 140.04 57.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.257 -0.902 . . . . 0.0 110.193 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.7 p -130.81 150.56 76.85 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -48.43 -39.44 36.11 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 CA-C-N 119.36 0.807 . . . . 0.0 111.974 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.32 -40.77 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.439 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.84 -39.42 76.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.49 -0.756 . . . . 0.0 110.087 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.39 -40.08 77.46 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 130' ' ' ARG . 26.4 ttm-85 -62.91 -40.01 96.27 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.358 -0.839 . . . . 0.0 109.1 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.83 -47.9 83.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.958 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.07 -41.93 93.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.986 -1.071 . . . . 0.0 108.182 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -62.29 -38.25 88.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 96.0 m-20 -60.35 -40.78 91.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.329 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.421 HG22 HD13 ' A' ' 135' ' ' ILE . 88.3 mt -64.8 -39.84 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.988 . . . . 0.0 108.994 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.06 -49.2 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.3 mtm180 -61.59 -39.58 91.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.019 -1.051 . . . . 0.0 110.396 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.9 mt-10 -60.23 -39.99 88.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.972 -1.08 . . . . 0.0 110.769 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.88 -36.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 144' ' ' ALA . 60.5 mttm -59.94 -45.5 92.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.97 -1.081 . . . . 0.0 111.702 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 1.1 p-10 -60.85 -34.27 74.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.713 -1.242 . . . . 0.0 110.036 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.65 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.769 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.76 -2.23 30.61 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.087 -1.008 . . . . 0.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 mttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.11 141.17 35.37 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.538 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -157.84 159.97 37.23 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.697 -1.252 . . . . 0.0 110.469 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.86 132.34 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.628 -0.67 . . . . 0.0 109.98 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.05 139.23 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 93.8 mt -127.85 143.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 122.203 1.002 . . . . 0.0 111.558 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -144.32 151.05 38.81 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.459 HD21 ' HG1' ' A' ' 83' ' ' THR . 31.7 m120 -134.56 126.14 28.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.712 -1.242 . . . . 0.0 110.951 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.71 114.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.53 152.83 38.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.862 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.26 -164.49 0.11 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.391 -0.818 . . . . 0.0 109.274 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -62.55 153.03 33.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.99 140.78 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.05 -1.031 . . . . 0.0 109.14 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.12 -1.97 80.83 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.2 m -118.67 151.4 38.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.566 -0.961 . . . . 0.0 109.185 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 96.2 mt-10 -128.15 148.9 50.61 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.49 -0.756 . . . . 0.0 108.999 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.16 144.46 28.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.511 HD21 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.92 141.99 56.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.094 -1.004 . . . . 0.0 108.929 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' H ' HD21 ' A' ' 24' ' ' ASN . . . -59.92 -42.33 98.19 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.576 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.27 -47.64 85.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.044 -1.268 . . . . 0.0 110.153 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.74 -28.26 66.65 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.44 -59.8 2.54 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.115 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.07 -41.43 92.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 109.264 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.529 ' CG ' HE21 ' A' ' 34' ' ' GLN . 42.7 t30 -62.91 -43.3 99.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 110.02 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.1 p -65.55 -38.59 90.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.417 HG23 HD12 ' A' ' 32' ' ' ILE . 89.1 mt -60.03 -46.21 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.998 -1.064 . . . . 0.0 109.358 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.5 -40.85 98.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.734 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.529 HE21 ' CG ' ' A' ' 30' ' ' ASN . 74.7 mt-30 -67.8 -22.3 65.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 110.036 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.06 8.09 9.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.434 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 82.28 12.64 80.37 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.36 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -81.19 153.74 27.05 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.741 -1.446 . . . . 0.0 109.856 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.4 mt -124.38 133.89 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -60.89 98.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.908 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.91 171.1 44.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.99 -163.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -1.219 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.3 mtt 58.46 20.0 7.04 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 49.95 39.95 19.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.671 -0.643 . . . . 0.0 111.248 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 pt -141.08 167.25 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.052 -1.03 . . . . 0.0 108.817 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -93.49 123.33 36.72 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.971 -1.08 . . . . 0.0 110.552 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.446 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 39.9 m80 -106.53 136.45 46.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.686 -0.634 . . . . 0.0 109.367 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 47' ' ' ARG . 0.0 OUTLIER -99.89 128.43 45.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 108.598 178.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.41 165.18 11.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.534 -0.729 . . . . 0.0 109.14 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 tp -59.73 -49.32 78.21 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.2 m -90.54 145.0 31.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.855 . . . . 0.0 109.142 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -67.2 -10.72 29.59 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 120.679 0.919 . . . . 0.0 111.712 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 44.8 t0 -92.91 -1.33 56.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 109.815 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.4 t -70.03 -40.06 75.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.942 -1.328 . . . . 0.0 109.391 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.61 160.99 45.93 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.46 170.97 10.09 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.397 1.099 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.34 129.94 35.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.277 -0.89 . . . . 0.0 109.638 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.3 mp -101.76 -39.58 7.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.188 -0.945 . . . . 0.0 109.679 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -150.0 162.88 39.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.09 -1.006 . . . . 0.0 108.692 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 14.1 m -129.61 173.06 10.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.961 0.886 . . . . 0.0 111.273 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.7 tt -131.79 129.96 41.2 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.37 162.94 29.82 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 93.8 m-20 -74.25 157.22 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 109.651 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -69.92 -28.21 65.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.747 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.68 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -60.06 152.25 62.09 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.95 1.9 48.71 Favored 'Cis proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.58 0.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.62 -0.11 79.74 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.9 p -87.81 169.55 11.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -1.111 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 94.0 m-85 -121.3 140.8 51.6 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 73' ' ' GLU . 75.9 m-20 -121.7 150.21 54.81 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -50.45 -9.17 0.17 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 119.267 0.774 . . . . 0.0 111.63 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 71' ' ' ASP . 80.1 mm-40 -90.12 6.84 40.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.856 . . . . 0.0 109.498 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 68.9 mmm -86.39 21.84 1.99 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 26.7 mtpp -86.0 -6.9 58.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.901 -1.124 . . . . 0.0 109.07 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.2 m-20 -149.94 80.12 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.2 170.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.834 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 77.7 p -133.98 152.28 51.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.16 148.43 18.38 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.077 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -46.66 -44.17 22.0 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 CA-C-N 119.094 0.712 . . . . 0.0 111.232 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.16 -152.98 11.05 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.98 160.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.994 . . . . 0.0 109.4 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.459 ' HG1' HD21 ' A' ' 14' ' ' ASN . 76.5 m -114.42 120.52 40.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.2 129.98 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -145.7 152.97 40.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.022 -1.048 . . . . 0.0 110.592 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.5 ttm -109.2 129.92 55.49 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.702 -0.624 . . . . 0.0 109.376 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 108.758 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.538 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 2.1 m -98.16 151.14 37.38 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.207 -0.933 . . . . 0.0 108.569 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.91 138.19 53.8 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.043 -1.232 . . . . 0.0 112.57 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.9 m -113.24 149.41 33.83 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.488 0.661 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -70.95 149.2 46.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -0.772 . . . . 0.0 110.023 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.04 -164.16 32.2 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -98.38 114.66 27.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -1.145 . . . . 0.0 109.359 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.89 -27.95 63.76 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.0 -41.68 61.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 108.133 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.14 -34.55 77.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.13 -50.02 74.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.53 -39.97 89.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -61.17 -40.0 92.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.95 -45.02 93.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 108.997 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.24 -42.53 99.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.328 -0.858 . . . . 0.0 108.866 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.7 mm-40 -60.18 -40.13 88.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 109.135 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.3 p -70.48 -40.0 73.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.515 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.73 43.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 110.044 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.83 -37.68 85.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 5.7 m-70 -59.94 -49.36 77.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.074 -1.016 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.06 -46.44 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.303 -0.873 . . . . 0.0 108.729 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.66 -46.81 63.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.443 -0.785 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.49 -40.08 90.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 110.547 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.89 -40.1 75.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -0.965 . . . . 0.0 110.931 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 m -100.18 0.75 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.187 -0.946 . . . . 0.0 110.018 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.58 25.32 70.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.07 -173.04 49.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -129.9 132.76 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.691 -0.887 . . . . 0.0 109.285 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.52 134.68 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.302 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.9 mt -135.05 159.95 39.87 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -86.47 -169.2 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.506 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 96.8 m-20 -60.06 -38.95 84.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -75.4 12.42 0.98 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.28 37.58 28.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.803 -0.56 . . . . 0.0 109.764 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -117.11 158.72 23.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.713 -0.617 . . . . 0.0 109.747 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.1 mmm -51.17 120.67 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.297 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 mtp -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.195 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -130.18 152.12 79.58 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -43.96 -42.97 12.49 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 120.582 0.855 . . . . 0.0 111.976 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.88 -39.93 91.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.83 -40.02 83.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.854 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.1 mt -57.54 -40.04 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.95 -39.96 93.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.592 -0.692 . . . . 0.0 109.265 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.42 -47.25 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.125 -0.985 . . . . 0.0 109.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 55.7 m-85 -60.06 -41.98 93.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 108.983 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.36 -40.09 89.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.3 m-20 -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.63 -43.82 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.118 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 78.6 mt -60.18 -39.95 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.964 . . . . 0.0 109.798 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.0 -39.98 87.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.961 -1.087 . . . . 0.0 109.104 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.15 -30.72 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.0 mmtt -59.98 -45.0 94.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.023 -1.048 . . . . 0.0 110.446 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -59.92 -36.2 76.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.845 -1.16 . . . . 0.0 109.805 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.29 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -103.7 -0.56 29.29 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.328 -0.858 . . . . 0.0 110.353 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -150.56 135.45 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.01 177.99 10.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.208 -1.557 . . . . 0.0 112.011 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.54 138.88 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -91.28 126.37 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -125.78 145.05 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 121.961 0.886 . . . . 0.0 110.806 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.5 mtm -148.33 154.37 39.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 117' ' ' LEU . 15.1 m120 -132.15 131.84 42.64 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.963 -1.086 . . . . 0.0 111.383 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -109.17 118.81 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 156.79 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.21 175.63 5.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.473 -0.767 . . . . 0.0 109.059 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -56.08 160.14 3.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.228 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -60.07 141.72 55.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.389 -0.82 . . . . 0.0 109.832 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.28 2.02 74.47 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.1 m -125.52 148.52 48.86 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.422 -1.046 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.0 151.37 50.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.452 -0.78 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.17 139.54 30.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.323 -0.86 . . . . 0.0 110.331 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.63 141.42 56.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.813 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.23 96.43 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.39 -47.46 85.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.324 . . . . 0.0 109.56 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.34 -25.81 64.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 108.817 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.13 -55.61 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.566 -0.709 . . . . 0.0 109.869 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.86 -49.03 79.29 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 0.0 110.315 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 39.9 t30 -60.07 -44.52 94.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 111.591 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.7 m -61.83 -42.92 99.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.866 -1.146 . . . . 0.0 110.369 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.79 -44.86 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.964 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.22 -40.0 95.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.71 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 50.9 mt-30 -69.48 -19.72 63.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.19 -0.944 . . . . 0.0 111.431 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.502 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -81.47 -9.89 59.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.626 -1.296 . . . . 0.0 110.83 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.532 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.72 8.75 22.17 Favored Glycine 0 N--CA 1.502 3.086 0 O-C-N 121.029 -1.044 . . . . 0.0 110.817 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.677 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 38.1 m-85 -81.59 144.6 31.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.827 -1.396 . . . . 0.0 110.094 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.47 132.23 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.07 106.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 110.131 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.6 171.9 29.54 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.78 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -1.109 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.2 mtt 58.12 20.09 6.67 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.687 0.756 . . . . 0.0 109.777 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 52.94 33.7 15.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 111.613 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.97 163.28 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -89.75 129.2 36.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.981 -1.075 . . . . 0.0 110.689 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.6 m80 -115.72 130.02 56.69 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.677 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 39.9 ttm180 -104.64 124.31 49.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 24.9 m-70 -92.89 170.01 10.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 0.0 109.562 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.8 tp -55.66 -49.3 73.3 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -89.17 148.42 40.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -71.2 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.739 0.96 . . . . 0.0 112.372 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.69 0.23 54.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.01 -1.056 . . . . 0.0 110.383 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.82 86.3 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -72.25 -44.62 62.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.155 -1.203 . . . . 0.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -70.49 168.15 49.15 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.32 175.65 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.18 1.253 . . . . 0.0 111.837 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.85 121.25 26.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.5 mp -98.06 -55.21 2.85 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.068 -1.02 . . . . 0.0 109.715 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -142.97 160.54 40.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.07 . . . . 0.0 108.702 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 19.7 m -129.36 -179.05 4.93 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.231 1.015 . . . . 0.0 111.35 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 tt -139.77 130.23 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -133.25 168.46 18.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.47 -0.769 . . . . 0.0 109.61 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.8 m120 -77.85 166.37 22.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.753 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 80.2 mmm -69.97 -22.2 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.89 -0.506 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' GLY . 14.3 t -87.66 118.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -62.27 149.31 87.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.206 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.47 10.73 15.5 Favored 'Cis proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.91 -1.287 . . . . 0.0 111.484 -1.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 79.04 29.12 52.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.7 p -86.03 169.04 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -1.108 . . . . 0.0 110.676 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.3 m-85 -126.06 156.38 40.06 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.1 p-10 -135.6 148.49 65.88 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.01 -16.82 6.76 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.503 0.858 . . . . 0.0 111.665 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -89.91 6.98 39.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.083 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.546 ' SD ' ' O ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.51 21.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.82 . . . . 0.0 109.808 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -86.05 -8.58 57.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.997 . . . . 0.0 109.911 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 83.7 m-20 -144.57 82.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.256 -0.903 . . . . 0.0 108.912 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.03 172.31 18.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 109.065 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.4 p -131.18 152.32 50.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.368 -0.833 . . . . 0.0 108.76 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.28 149.44 19.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -43.91 -49.73 8.02 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 120.495 0.796 . . . . 0.0 111.719 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.39 -152.26 8.7 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.99 160.89 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.6 -0.941 . . . . 0.0 109.573 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 62' ' ' ALA . 52.8 m -112.15 128.03 56.1 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.558 -0.714 . . . . 0.0 110.103 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.98 130.0 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -149.64 167.08 27.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.565 -1.335 . . . . 0.0 110.879 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 ttp -132.94 130.8 40.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' O ' ' OG ' ' A' ' 90' ' ' SER . 91.8 mt-30 -87.59 108.52 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 108.953 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.54 144.05 27.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.04 134.91 37.73 Favored 'Cis proline' 0 N--CA 1.498 1.761 0 C-N-CA 124.341 -1.108 . . . . 0.0 113.371 0.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.3 m -110.41 159.91 17.06 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.54 0.686 . . . . 0.0 109.828 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -70.75 142.18 51.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.174 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.33 -159.71 26.41 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.59 123.55 39.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.16 -1.2 . . . . 0.0 109.562 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 39.5 mp0 -59.93 -36.61 77.41 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 110.402 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.69 -38.81 80.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.958 . . . . 0.0 109.955 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -69.97 -39.96 75.66 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.892 -1.13 . . . . 0.0 108.123 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -61.34 -39.99 92.6 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.85 -41.37 97.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.087 -1.008 . . . . 0.0 109.007 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.24 -39.98 94.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.897 . . . . 0.0 109.041 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.1 mtp -58.13 -48.36 80.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.429 -0.794 . . . . 0.0 109.312 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.66 -42.68 98.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.922 -1.111 . . . . 0.0 109.184 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -41.72 92.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.711 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -69.94 -39.98 75.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.39 58.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -62.2 -40.63 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.001 -1.062 . . . . 0.0 110.084 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -60.47 -47.45 86.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.174 . . . . 0.0 108.749 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.92 -50.02 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.03 -49.97 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.661 -0.649 . . . . 0.0 109.844 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.18 -40.19 89.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.282 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.9 -40.01 75.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.937 . . . . 0.0 111.151 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 m -100.69 -1.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.084 -1.01 . . . . 0.0 109.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 24.63 75.38 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.9 -176.42 51.14 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.46 133.03 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.636 -0.92 . . . . 0.0 108.905 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 t -70.24 130.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.013 -1.054 . . . . 0.0 109.096 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 14' ' ' ASN . 77.4 mt -129.23 155.99 44.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.587 -0.695 . . . . 0.0 109.286 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.515 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 30.4 p-10 -85.42 -172.64 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 109.481 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.1 m-20 -60.01 -38.71 83.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.65 16.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.377 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.0 mtm180 56.1 33.55 22.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -109.87 149.1 30.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 0.0 109.144 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 65.5 mtt -50.75 135.73 23.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.977 . . . . 0.0 109.265 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.67 137.15 57.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -134.47 150.35 73.56 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.02 -42.37 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 119.162 0.736 . . . . 0.0 111.879 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -60.6 -39.98 90.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 51.0 mmtt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.058 -1.026 . . . . 0.0 110.051 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.9 -43.15 94.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -69.3 -32.9 72.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.799 -1.188 . . . . 0.0 109.747 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -59.98 -45.31 93.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.005 -1.06 . . . . 0.0 108.876 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -60.78 -41.07 94.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.69 -39.96 93.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 0.0 109.085 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.54 -40.2 96.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.65 -42.06 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 136' ' ' ILE . 81.7 mt -60.03 -41.93 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.208 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.5 mtt180 -61.92 -37.65 85.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.7 mt-10 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.778 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.35 -32.16 30.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.9 mmmm -60.07 -45.92 91.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.075 -1.016 . . . . 0.0 110.17 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.79 -31.83 71.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.754 -1.216 . . . . 0.0 108.892 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.01 94.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 110.385 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 55.6 p30 -97.91 0.37 46.41 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 0.0 110.104 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.545 -179.88 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -145.0 151.86 39.24 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.29 160.34 32.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 109.932 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.16 129.99 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 11' ' ' ILE . 12.0 mm -92.27 117.16 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 84.2 mt -121.58 142.16 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 121.946 0.879 . . . . 0.0 111.191 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.0 mtm -146.1 150.18 35.45 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -129.71 128.67 42.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.972 -1.08 . . . . 0.0 111.291 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.45 116.4 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' VAL . . . -147.34 157.24 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 109.97 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.89 -174.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 109.063 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -61.02 156.65 17.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 108.88 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -60.02 140.12 57.01 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.51 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.18 70.23 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -121.11 147.3 45.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.551 -0.97 . . . . 0.0 109.699 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -125.87 145.5 50.22 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.42 149.18 25.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 110.564 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -70.84 145.27 50.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.129 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.56 -42.05 99.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.51 -43.75 98.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.301 . . . . 0.0 110.166 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.79 -27.02 64.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -75.12 -57.86 3.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.541 -0.724 . . . . 0.0 109.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.32 -42.33 95.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.0 110.532 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -64.04 -40.06 95.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.2 m -65.19 -41.38 94.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 110.419 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.02 -46.88 93.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.009 -1.057 . . . . 0.0 109.4 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -65.38 -43.25 91.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 0.0 109.401 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -17.24 64.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.432 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.35 1.57 36.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.023 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.71 9.55 66.2 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 121.071 -1.018 . . . . 0.0 111.016 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -80.75 151.07 29.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.822 -1.399 . . . . 0.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.9 mt -120.0 130.67 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.88 101.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.995 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.05 171.22 38.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.3 -163.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.469 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.7 mtm 58.03 23.25 9.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.428 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.36 39.41 20.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 111.231 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.0 pt -142.0 164.84 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.026 -1.047 . . . . 0.0 109.429 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -91.89 136.28 33.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.072 -1.017 . . . . 0.0 109.886 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.672 ' CG ' ' HG ' ' A' ' 60' ' ' SER . 43.8 m-70 -125.16 125.11 43.18 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.726 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.7 ttt180 -105.09 125.53 51.08 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.475 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 34.2 m-70 -94.73 173.99 7.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.442 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.64 -50.76 65.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.261 -0.899 . . . . 0.0 108.832 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -93.83 144.06 27.52 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 0.0 108.784 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.36 -4.42 11.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 120.57 0.847 . . . . 0.0 112.149 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -91.48 -0.94 57.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.383 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.28 86.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 t -69.95 -41.01 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -1.198 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.37 169.13 54.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.475 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.1 Cg_endo -69.55 173.47 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.2 1.266 . . . . 0.0 111.427 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 120.8 25.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.034 . . . . 0.0 108.649 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD2' HD22 ' A' ' 97' ' ' ASN . 9.7 mp -100.81 -35.08 9.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.234 -0.916 . . . . 0.0 109.75 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -153.47 165.45 35.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.924 -1.11 . . . . 0.0 108.762 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.672 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 5.4 m -138.48 161.97 35.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.037 -1.039 . . . . 0.0 111.229 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 tt -114.75 135.07 54.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.41 162.08 32.01 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.587 -0.696 . . . . 0.0 109.29 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.606 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 76.6 m-20 -78.64 166.85 22.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.015 -1.053 . . . . 0.0 110.053 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.4 mmm -69.92 -23.09 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.465 -0.772 . . . . 0.0 110.205 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -88.14 112.5 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 110.521 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -60.3 150.42 72.41 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -77.87 8.55 19.93 Favored 'Cis proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.114 -1.202 . . . . 0.0 111.982 -0.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.43 35.83 25.16 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.6 p -85.94 160.47 19.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.256 -1.143 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 32.7 m-85 -128.52 139.02 52.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 t70 -127.77 137.82 31.57 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -48.13 -4.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.591 1.247 . . . . 0.0 112.888 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -90.83 3.96 53.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.054 -1.028 . . . . 0.0 111.345 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 mtm -79.72 26.14 0.32 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.567 -1.333 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.0 mmtp -81.91 2.39 30.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.581 -1.325 . . . . 0.0 109.261 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 70.1 m-20 -153.79 81.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 108.76 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -158.84 171.41 20.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.11 -0.994 . . . . 0.0 109.964 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.7 p -137.88 154.68 49.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.23 149.12 17.35 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 109.19 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -46.93 -45.22 21.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 120.786 0.991 . . . . 0.0 112.027 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.23 -152.84 10.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.94 159.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -1.05 . . . . 0.0 109.396 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' ALA . 51.9 m -111.53 124.94 53.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.226 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.11 130.61 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.77 160.41 41.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 110.85 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.9 ttp -141.46 131.73 25.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.658 -0.651 . . . . 0.0 109.622 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.18 115.21 27.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.048 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.24 152.38 38.65 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.357 -0.839 . . . . 0.0 109.065 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.603 ' CG ' HD21 ' A' ' 143' ' ' ASN . 6.5 Cg_endo -77.63 136.77 44.29 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.655 -1.394 . . . . 0.0 112.149 -0.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.9 m -104.59 166.52 10.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.574 -0.704 . . . . 0.0 109.721 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -68.93 141.5 54.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.446 -0.784 . . . . 0.0 109.045 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.78 28.4 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -94.19 115.33 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.966 -1.314 . . . . 0.0 109.703 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 50.5 mp0 -58.05 -28.0 64.11 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.696 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.8 mt -69.73 -40.04 76.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.196 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -73.05 -40.51 65.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.901 -1.124 . . . . 0.0 108.948 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.43 HD22 ' CD2' ' A' ' 58' ' ' LEU . 26.9 m120 -61.86 -41.96 98.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.86 -49.92 75.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.75 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.13 -39.96 94.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -43.39 95.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.0 mtp -57.78 -44.57 86.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 108.746 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -41.21 97.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 108.726 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.2 mt-30 -60.15 -41.54 92.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.086 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -70.28 -39.89 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 109.147 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.82 68.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 110.435 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -60.76 -37.83 83.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.87 -1.144 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 19.3 m-70 -60.06 -50.05 75.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.048 -1.033 . . . . 0.0 109.151 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.9 -50.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.539 -0.725 . . . . 0.0 109.652 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.46 -49.36 55.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.58 -39.78 89.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 110.338 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.11 -40.06 75.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.675 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.84 0.4 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.055 -1.028 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.22 21.87 75.9 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.94 -176.8 49.96 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 16' ' ' ALA . 58.4 t -135.33 140.74 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.6 -0.941 . . . . 0.0 108.952 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -73.3 127.95 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.978 . . . . 0.0 109.945 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 mt -128.8 153.62 47.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.76 -178.04 6.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' NH1' ' A' ' 121' ' ' ARG . 97.9 m-20 -59.39 -28.89 67.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.049 -1.032 . . . . 0.0 109.082 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -82.13 12.36 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 108.972 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 119' ' ' ASP . 14.6 mmt-85 61.48 27.59 17.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.7 -0.625 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -107.88 147.8 30.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 0.0 109.328 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 92.2 mmm -50.41 121.6 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 35.2 mtp -59.79 139.93 56.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.839 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -130.29 151.0 77.74 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -41.94 -41.64 6.54 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 120.503 0.802 . . . . 0.0 111.622 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.07 -42.19 94.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.445 -0.784 . . . . 0.0 109.235 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.49 -39.88 77.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.862 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.5 mt -56.61 -40.09 74.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.814 -1.179 . . . . 0.0 108.373 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -64.63 -38.23 90.29 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.017 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.98 -45.56 92.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.971 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.23 -41.96 94.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.862 -1.149 . . . . 0.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.62 -39.78 92.49 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 97.6 m-20 -60.06 -39.63 86.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.513 -0.742 . . . . 0.0 109.183 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.1 mt -59.93 -41.73 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 108.65 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.21 -39.87 81.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.36 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 137' ' ' ARG . 16.3 mtt-85 -59.99 -40.14 88.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.576 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -60.39 -39.8 88.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.925 -1.109 . . . . 0.0 109.035 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.6 -32.03 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.6 mttt -60.0 -42.68 94.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.841 -1.162 . . . . 0.0 110.923 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.985 -1.072 . . . . 0.0 109.854 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.89 -59.13 3.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.924 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.603 HD21 ' CG ' ' A' ' 89' ' ' PRO . 80.9 m-20 -103.9 -14.57 15.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.296 -0.878 . . . . 0.0 110.478 -178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.4 148.11 29.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.47 175.97 8.6 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.67 -1.269 . . . . 0.0 110.359 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.08 131.44 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 11' ' ' ILE . 21.0 mm -91.25 125.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.12 144.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.896 0.855 . . . . 0.0 110.867 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.5 mtt -144.6 156.16 43.99 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.5 126.72 24.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.959 -1.088 . . . . 0.0 111.022 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.01 119.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.3 158.63 44.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.775 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.65 -164.49 0.09 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -69.26 159.42 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 108.815 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -60.07 140.79 56.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.09 80.39 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.8 m -110.04 152.4 25.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.391 -1.064 . . . . 0.0 109.216 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -130.25 149.03 52.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.8 140.36 29.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.02 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.82 143.42 54.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.12 96.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.03 -44.83 96.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -1.209 . . . . 0.0 109.545 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.02 -29.48 66.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -0.812 . . . . 0.0 108.931 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.419 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.3 tt -71.14 -57.3 4.64 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.6 -0.687 . . . . 0.0 109.456 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.99 -43.41 95.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.187 -0.946 . . . . 0.0 110.476 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.93 -40.02 94.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 110.056 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 32' ' ' ILE . 79.4 p -65.51 -40.16 92.68 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.928 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.538 ' N ' ' HG ' ' A' ' 31' ' ' SER . 96.6 mt -60.07 -48.34 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -62.23 -43.32 99.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.982 . . . . 0.0 110.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.87 -20.01 66.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.5 5.62 17.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.35 85.14 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -81.22 154.37 26.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.038 -1.272 . . . . 0.0 109.619 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.9 mt -128.63 142.81 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -59.04 99.92 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.113 -0.992 . . . . 0.0 109.542 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.22 168.85 45.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -62.99 -163.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.496 -1.003 . . . . 0.0 108.923 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt 56.5 22.2 6.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -0.819 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.6 m120 51.89 40.09 27.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 111.146 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.08 170.03 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 109.327 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.22 135.08 34.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.978 -1.076 . . . . 0.0 109.836 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.571 ' HD1' ' HG ' ' A' ' 60' ' ' SER . 6.2 m-70 -119.53 133.91 55.46 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 7.5 tpt180 -102.38 120.97 41.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.385 -0.822 . . . . 0.0 108.972 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 68.7 m-70 -98.26 170.06 9.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 109.723 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.26 -49.98 74.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 108.988 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.8 m -91.93 147.78 35.61 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.95 -6.18 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.671 0.914 . . . . 0.0 112.794 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -93.23 -0.89 56.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.917 -1.115 . . . . 0.0 110.158 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.43 12.09 84.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.466 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.9 p -70.2 -39.9 74.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.53 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.88 167.1 51.05 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.451 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 16.0 Cg_endo -69.03 171.31 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.228 1.285 . . . . 0.0 112.113 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.35 122.82 28.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.209 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.4 mp -98.91 -36.87 9.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.228 -0.92 . . . . 0.0 109.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.8 162.31 40.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 108.589 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.571 ' HG ' ' HD1' ' A' ' 46' ' ' HIS . 4.4 m -131.06 175.99 8.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.081 -1.012 . . . . 0.0 111.859 -177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -136.65 131.69 33.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.44 162.17 35.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.4 m120 -77.2 162.92 27.01 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.212 -0.93 . . . . 0.0 110.751 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mtt -69.96 -23.72 63.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.598 -0.689 . . . . 0.0 110.396 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -85.85 119.99 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.971 -1.081 . . . . 0.0 109.632 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -59.89 149.71 71.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.52 -0.738 . . . . 0.0 109.064 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -77.12 8.94 16.4 Favored 'Cis proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.758 -0.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 16.69 76.52 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.1 p -87.99 173.56 8.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.079 -1.247 . . . . 0.0 109.924 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.04 140.12 51.49 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLU . 5.6 m-20 -126.52 150.08 69.66 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 74' ' ' MET . 21.3 Cg_exo -45.39 -12.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.6 0.867 . . . . 0.0 111.93 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -83.54 13.22 4.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.4 ptt? -83.82 -1.39 54.25 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.513 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 98.9 mttt -85.94 -3.78 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.798 -1.189 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.0 m-20 -150.45 75.75 1.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.686 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -159.06 168.98 25.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.118 -0.989 . . . . 0.0 109.414 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.8 p -136.53 155.56 49.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.44 150.43 20.7 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 109.449 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -47.22 -46.72 18.86 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 120.366 0.711 . . . . 0.0 111.24 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.38 -151.04 8.06 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.98 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.529 -0.983 . . . . 0.0 109.322 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.5 m -113.02 120.18 40.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 0.0 109.489 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.21 129.97 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -143.71 163.69 32.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.125 -0.984 . . . . 0.0 110.496 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.0 ttp -138.97 129.74 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.713 -0.617 . . . . 0.0 109.563 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -92.28 119.71 32.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 0.0 109.117 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -102.75 150.31 37.6 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.24 133.76 32.69 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.568 0.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.8 m -102.18 170.23 8.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.95 139.95 55.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.377 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.82 -154.38 24.65 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -99.58 122.02 42.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.299 -1.118 . . . . 0.0 109.652 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 56.6 mp0 -55.87 -28.61 57.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.5 -39.93 77.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.037 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -40.34 70.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.095 -1.003 . . . . 0.0 109.102 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.59 -40.04 90.3 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -57.02 -41.43 78.54 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.41 -42.03 99.14 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.137 -0.977 . . . . 0.0 108.733 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.01 -39.99 95.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 108.71 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mmm -57.23 -50.12 73.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.832 . . . . 0.0 109.497 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -47.75 78.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.24 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.529 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -60.0 -40.84 90.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.782 . . . . 0.0 109.217 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 p -71.96 -42.93 65.99 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.167 -0.958 . . . . 0.0 109.298 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.12 -54.53 44.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -62.78 -35.09 78.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.585 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.8 m-70 -60.05 -49.94 75.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 108' ' ' ILE . 81.5 mt -59.97 -49.91 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.889 -1.132 . . . . 0.0 108.011 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.95 -49.22 66.49 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.04 -40.01 91.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.558 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.94 77.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.8 m -96.12 0.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.975 -1.078 . . . . 0.0 108.873 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 21.67 76.91 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . -84.07 -169.68 45.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -131.97 138.11 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.602 -0.94 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 t -73.69 138.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.284 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.28 160.0 37.5 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.436 -0.79 . . . . 0.0 109.649 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -84.13 -171.67 3.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.402 -0.811 . . . . 0.0 109.672 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.438 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 94.7 m-20 -60.01 -39.86 87.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.217 -0.927 . . . . 0.0 110.083 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.43 14.47 0.97 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -0.909 . . . . 0.0 109.396 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 57.4 37.63 28.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.745 -0.597 . . . . 0.0 109.744 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -112.13 151.48 29.42 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 19.5 mmt -50.2 126.37 14.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.957 -1.09 . . . . 0.0 109.284 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.9 mtt -58.9 139.97 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.788 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -129.12 151.36 77.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -41.47 -45.0 6.1 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 120.762 0.975 . . . . 0.0 112.184 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -60.8 -39.9 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.768 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -63.74 -40.05 95.79 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.243 -0.91 . . . . 0.0 109.717 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.57 -40.05 86.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.706 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -66.26 -37.94 86.64 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.615 -0.678 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.13 -49.99 75.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.528 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.438 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 73.1 m-85 -59.97 -49.37 77.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 108.738 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.17 -38.05 82.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.08 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.1 -40.96 91.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.149 -0.969 . . . . 0.0 109.67 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.65 -40.06 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.639 -1.288 . . . . 0.0 108.467 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.97 -47.57 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.15 -39.89 87.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.863 . . . . 0.0 108.915 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 89.6 mt-10 -60.98 -41.1 95.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.85 -39.95 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -60.01 -44.92 94.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.349 -0.844 . . . . 0.0 111.592 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.6 p30 -59.97 -34.15 72.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.574 -1.329 . . . . 0.0 109.112 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.39 -35.92 82.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.027 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -97.31 -0.23 46.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.741 . . . . 0.0 109.382 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.39 144.11 27.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.17 9.83 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.584 -1.322 . . . . 0.0 110.148 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.81 130.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 11' ' ' ILE . 26.3 mm -93.17 122.67 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.2 mt -120.06 147.63 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.23 1.014 . . . . 0.0 111.372 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -143.81 147.37 34.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.43 120.96 25.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.5 117.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.54 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.452 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.53 -164.49 0.12 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.9 155.03 39.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.925 -1.109 . . . . 0.0 108.482 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -59.93 139.99 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.076 . . . . 0.0 109.349 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.57 3.5 66.6 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -124.42 149.43 46.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.501 -1.0 . . . . 0.0 109.248 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.4 mt-10 -126.73 145.81 50.46 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.21 146.34 27.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -68.67 143.62 54.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 109.156 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.55 -43.43 98.88 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.28 -45.67 92.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -1.214 . . . . 0.0 110.152 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.79 -29.83 67.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.32 -58.79 3.2 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.583 -0.698 . . . . 0.0 109.347 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.7 mt -60.09 -41.63 92.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.62 -39.89 94.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -64.26 -40.81 96.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.695 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 32' ' ' ILE . 93.8 mt -60.19 -44.64 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.333 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.34 -40.37 95.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.029 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' OE1' ' OE2' ' A' ' 111' ' ' GLU . 78.0 mt-30 -68.27 -20.04 64.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.279 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.71 7.29 15.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.196 -0.94 . . . . 0.0 110.292 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.63 83.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.988 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -80.63 152.53 28.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.434 . . . . 0.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.39 145.26 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.82 118.86 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.0 108.966 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.67 171.57 41.59 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.6 -162.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.569 -0.96 . . . . 0.0 109.711 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 89.8 mmm 54.78 -101.34 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' MET . 26.7 m120 -163.27 31.85 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 pt -134.69 163.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.494 -0.754 . . . . 0.0 110.115 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -88.07 134.41 33.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.296 -0.878 . . . . 0.0 110.143 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.528 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 8.0 m-70 -118.34 129.79 55.64 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 15.9 ttt180 -106.11 125.42 50.97 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-70 -95.13 174.12 7.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.824 . . . . 0.0 110.222 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.33 -49.97 74.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.8 m -92.7 147.89 35.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.28 -0.887 . . . . 0.0 108.693 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.12 -5.95 17.07 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.68 0.92 . . . . 0.0 112.06 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -92.65 1.28 57.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.179 -0.95 . . . . 0.0 110.204 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.74 11.45 84.53 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -70.15 -40.07 74.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.241 . . . . 0.0 110.091 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.547 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.0 169.82 53.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.537 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.4 Cg_endo -72.78 -179.96 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.133 1.222 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.43 123.4 29.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 108.729 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -101.02 -28.3 12.8 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -159.94 165.31 32.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.599 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.528 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 17.2 m -132.48 170.11 15.6 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.129 -0.982 . . . . 0.0 111.53 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.7 tt -132.63 130.96 40.88 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 169.68 17.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.417 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 91.7 m-20 -75.14 163.49 27.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 109.617 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -70.02 -21.68 63.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.44 -0.788 . . . . 0.0 110.464 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.17 114.85 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.109 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -60.13 149.75 73.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.417 -0.802 . . . . 0.0 109.422 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -76.49 6.8 16.3 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.858 -1.309 . . . . 0.0 111.374 -1.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.89 31.23 49.5 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 p -86.09 165.85 16.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.286 . . . . 0.0 109.944 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.548 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.24 148.65 43.42 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' MET . 1.8 p30 -133.96 151.4 76.7 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 74' ' ' MET . 2.9 Cg_exo -50.34 -11.86 0.41 Allowed 'Trans proline' 0 N--CA 1.486 1.072 0 CA-C-N 119.429 0.832 . . . . 0.0 110.362 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 71' ' ' ASP . 75.3 mm-40 -82.17 6.48 16.42 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 23.3 ptt? -79.61 1.65 25.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -85.02 -2.15 57.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.82 -1.175 . . . . 0.0 108.267 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -154.09 78.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -159.3 167.61 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.221 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.414 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 42.6 p -140.72 154.58 46.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.235 -0.916 . . . . 0.0 108.936 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.83 150.16 21.02 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.075 -1.015 . . . . 0.0 109.248 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -41.93 -36.87 3.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 120.724 0.95 . . . . 0.0 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.41 -150.63 12.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.97 159.97 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 109.58 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -113.17 125.9 54.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.675 . . . . 0.0 109.632 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.12 129.97 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -146.79 166.26 27.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.972 -1.08 . . . . 0.0 110.274 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 50.3 ttp -137.33 131.32 32.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 90' ' ' SER . 90.4 mm-40 -88.15 117.73 27.25 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -105.5 148.2 35.94 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 137.5 50.24 Favored 'Cis proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.695 -1.377 . . . . 0.0 112.262 -0.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 51.2 m -103.73 166.94 10.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.502 -0.749 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -72.19 146.22 47.51 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.587 -0.696 . . . . 0.0 109.352 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 -156.35 31.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.14 111.95 23.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -1.135 . . . . 0.0 109.019 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.8 mp0 -54.18 -26.46 28.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.467 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.9 mt -70.02 -39.95 75.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.0 108.68 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -71.61 -40.02 70.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 97' ' ' ASN . 1.7 m120 -59.99 -40.41 89.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.91 -45.45 92.52 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.44 -40.59 97.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.98 -40.04 91.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 108.842 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp -59.41 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.26 -43.46 91.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.176 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 77.8 mt-30 -60.1 -39.98 88.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 p -70.47 -40.06 73.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.413 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.13 -53.78 54.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 110.239 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -61.88 -41.09 97.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.876 -1.14 . . . . 0.0 109.244 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 28.0 m-70 -60.34 -50.01 75.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.14 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.5 mt -60.8 -49.99 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.101 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.49 -49.47 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.503 -0.748 . . . . 0.0 109.135 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.07 -40.1 88.32 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.428 -0.795 . . . . 0.0 110.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.406 ' OE2' ' OE1' ' A' ' 34' ' ' GLN . 41.4 mt-10 -69.57 -39.92 77.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.975 -1.078 . . . . 0.0 110.721 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.6 m -99.65 -2.24 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.059 -1.026 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.06 23.76 76.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.07 -176.15 51.07 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.289 -1.124 . . . . 0.0 110.57 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.03 136.32 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.945 . . . . 0.0 109.692 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.64 133.13 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -133.15 161.81 33.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.802 . . . . 0.0 109.168 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -84.23 -170.57 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.915 . . . . 0.0 109.702 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 89.4 m-20 -60.09 -39.94 87.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.85 . . . . 0.0 110.046 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.539 ' CB ' HH12 ' A' ' 122' ' ' ARG . 96.6 mt-30 -80.33 14.18 2.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 59.68 34.52 22.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.983 -0.448 . . . . 0.0 111.702 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.539 HH12 ' CB ' ' A' ' 120' ' ' GLN . 50.9 mtm-85 -107.19 158.0 17.44 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.042 -1.036 . . . . 0.0 108.821 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.9 mtm -52.59 130.52 32.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.942 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mmm -59.94 141.57 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 110.066 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.0 p -132.25 150.04 74.88 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -47.3 -42.37 27.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.513 0.862 . . . . 0.0 112.082 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.09 -39.87 87.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.312 -0.868 . . . . 0.0 109.579 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -66.72 -40.02 88.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.94 -40.25 88.29 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.835 -1.166 . . . . 0.0 109.412 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.9 -37.66 86.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.349 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.87 -48.89 79.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.951 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.02 -45.36 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.986 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.8 -39.99 93.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.21 -40.02 88.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.28 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.07 -40.7 84.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.922 -1.112 . . . . 0.0 108.711 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.447 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.6 mmt180 -63.55 -36.15 82.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.18 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.02 -39.93 87.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.515 -0.741 . . . . 0.0 109.856 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.33 -35.15 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -59.77 -47.19 86.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 0.0 110.109 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -60.59 -31.96 71.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.871 -1.143 . . . . 0.0 109.3 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.99 92.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.563 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.79 0.26 44.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 108.904 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -144.36 142.59 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.73 -175.65 4.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.724 -1.235 . . . . 0.0 110.602 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -133.39 139.06 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 11' ' ' ILE . 36.7 mm -91.62 131.12 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.0 mt -121.11 147.29 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.989 0.9 . . . . 0.0 110.979 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.3 mtt -147.39 156.49 42.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -136.97 118.37 14.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.879 -1.138 . . . . 0.0 110.632 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.9 t -101.24 111.19 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.72 43.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.67 -164.11 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -68.39 161.47 27.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 108.624 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -61.93 140.04 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.047 -1.033 . . . . 0.0 109.895 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.35 2.13 85.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -116.94 146.33 43.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.446 -1.032 . . . . 0.0 109.054 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.7 144.98 50.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.92 147.94 26.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.43 138.25 55.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.44 97.07 Favored Glycine 0 N--CA 1.493 2.433 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.287 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.1 -45.49 94.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.284 . . . . 0.0 109.338 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.84 -27.02 64.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.41 -59.61 2.65 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.558 -0.714 . . . . 0.0 109.593 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.99 -43.52 95.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.291 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.01 -41.85 97.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -64.3 -40.99 97.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.165 -0.96 . . . . 0.0 109.676 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 32' ' ' ILE . 96.5 mt -60.08 -48.22 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.89 -40.99 95.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 109.667 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.68 -19.79 63.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.489 -0.757 . . . . 0.0 110.468 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.86 6.16 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 0.0 110.136 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.34 78.37 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -1.2 . . . . 0.0 109.995 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.74 138.82 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.46 98.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.082 . . . . 0.0 109.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 171.46 53.9 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.14 -170.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.464 -1.021 . . . . 0.0 109.578 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 70.8 mtm 56.74 30.11 17.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.484 -0.76 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 48.78 40.05 15.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 111.642 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.24 162.33 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.03 -1.044 . . . . 0.0 109.541 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.1 121.55 32.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.565 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 7.2 m-70 -103.92 130.5 51.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.296 -0.878 . . . . 0.0 109.818 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 7.5 tpt180 -101.75 120.62 40.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 59.1 m-70 -98.19 169.43 9.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -0.896 . . . . 0.0 109.735 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.67 -49.48 76.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -90.65 138.82 26.41 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.335 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.56 -7.29 14.04 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 CA-C-N 119.69 0.925 . . . . 0.0 111.616 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -92.61 -0.17 57.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.85 86.58 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.19 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -68.63 -41.38 79.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.499 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.42 163.39 50.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 15.3 Cg_endo -67.77 171.38 12.25 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.002 1.134 . . . . 0.0 112.05 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.65 120.61 24.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 108.723 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.1 mp -97.04 -31.28 12.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.181 -0.949 . . . . 0.0 108.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -156.84 164.52 37.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.565 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 1.7 m -135.72 -179.09 5.44 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.104 -0.997 . . . . 0.0 111.223 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -136.68 132.54 35.08 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.04 160.78 33.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.2 m-20 -73.66 159.27 33.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 109.266 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.02 -21.28 63.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.867 . . . . 0.0 110.573 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 68' ' ' GLY . 5.1 m -88.16 126.21 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.844 -1.16 . . . . 0.0 109.526 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -62.29 148.82 88.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 108.529 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.92 14.91 8.8 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.609 -1.413 . . . . 0.0 112.057 -0.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 71.26 20.42 78.11 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 p -88.01 167.97 13.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -1.138 . . . . 0.0 110.494 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 51.6 m-85 -120.28 143.46 48.32 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.683 -0.635 . . . . 0.0 109.476 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -126.87 136.66 29.13 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -49.1 -11.96 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 119.852 0.983 . . . . 0.0 113.17 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -87.46 -0.69 57.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.898 -1.126 . . . . 0.0 108.714 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 93.1 mtp -88.93 24.69 2.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.1 mttm -82.69 -3.96 57.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.841 -1.162 . . . . 0.0 109.282 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 84.0 m-20 -145.14 82.8 1.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.849 . . . . 0.0 108.734 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.42 176.43 11.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.7 p -130.24 153.44 48.6 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.57 150.42 19.42 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.801 -1.187 . . . . 0.0 110.506 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -46.4 -40.23 22.49 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 120.794 0.996 . . . . 0.0 111.912 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.89 -151.71 17.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.14 159.99 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.444 -1.033 . . . . 0.0 109.411 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.5 m -114.82 119.34 36.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.7 mt -102.6 134.48 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.44 163.21 35.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 110.025 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.5 ttp -137.74 129.55 28.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.713 . . . . 0.0 109.496 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.01 117.7 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 108.673 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.37 153.25 39.2 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.45 137.72 51.6 Favored 'Cis proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.789 -1.338 . . . . 0.0 112.132 0.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.0 m -106.15 165.71 11.04 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.55 -0.718 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -70.29 142.69 52.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 0.0 110.421 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.45 -152.97 22.36 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -97.37 116.97 30.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.328 -1.101 . . . . 0.0 108.951 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 32.5 mp0 -59.55 -34.11 72.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 110.165 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.09 -39.96 78.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.032 -1.042 . . . . 0.0 109.838 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -73.0 -39.5 66.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.791 -1.193 . . . . 0.0 108.368 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.1 -40.04 88.29 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 84.7 t80 -60.0 -46.48 89.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.08 -40.06 95.41 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.99 -44.28 94.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 90.9 mtp -57.47 -44.82 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 108.915 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.33 -43.71 98.18 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 108.765 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.534 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 91.7 mt-30 -59.87 -41.13 90.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.377 -0.827 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -71.31 -41.45 69.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.25 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.08 71.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.435 -0.79 . . . . 0.0 110.255 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -61.62 -37.02 82.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.794 -1.191 . . . . 0.0 109.157 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.0 m-70 -59.97 -47.6 85.17 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.07 -1.019 . . . . 0.0 109.128 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 108' ' ' ILE . 96.9 mt -60.04 -49.94 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 108.927 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -54.13 -50.31 67.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.93 -40.19 88.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 110.052 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -70.05 -40.44 75.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 111.341 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 m -99.35 -0.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.949 -1.094 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.28 19.61 72.51 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.77 -172.34 43.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -127.83 133.61 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.483 -1.01 . . . . 0.0 109.221 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.95 131.52 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.702 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.61 159.52 36.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.454 -0.779 . . . . 0.0 109.448 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 42.9 p-10 -88.58 -170.26 2.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.4 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 109.881 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -76.13 14.61 0.69 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 108.645 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.2 mtm180 57.4 27.87 14.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.861 -0.525 . . . . 0.0 110.432 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.643 ' NH2' ' HZ3' ' A' ' 128' ' ' LYS . 84.8 mtm180 -105.25 157.07 17.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.83 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 99.2 mtp -51.93 134.17 31.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.7 mmm -58.08 140.25 53.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -131.08 151.25 78.6 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.73 -42.96 62.04 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 120.524 0.816 . . . . 0.0 111.829 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.95 -39.95 87.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.643 ' HZ3' ' NH2' ' A' ' 122' ' ' ARG . 27.5 mmtp -64.74 -40.0 94.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 110.166 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.19 -40.11 84.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 108.616 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -64.11 -39.99 95.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.476 -0.765 . . . . 0.0 109.261 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -46.64 88.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 110.228 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 59.9 m-85 -60.01 -38.59 83.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.134 -0.979 . . . . 0.0 109.628 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -59.92 -38.81 83.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 108.536 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.75 -37.32 81.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 108.739 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.02 -43.38 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.75 -39.98 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -60.23 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.526 -0.733 . . . . 0.0 109.581 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.03 -37.56 80.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.32 -28.62 20.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.638 -0.664 . . . . 0.0 111.568 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.576 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 33.1 mttm -60.11 -40.07 88.38 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 111.535 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 50.7 p-10 -59.97 -29.48 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.444 -1.41 . . . . 0.0 109.627 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.59 -40.54 92.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 111.089 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -100.51 -11.44 20.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.156 -0.965 . . . . 0.0 110.264 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.07 . . . . 0.0 109.382 179.362 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -147.41 134.76 20.68 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.6 -174.44 3.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.292 -1.505 . . . . 0.0 111.066 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.8 134.72 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.94 122.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -119.89 147.76 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 122.148 0.975 . . . . 0.0 111.407 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -146.68 156.37 43.13 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -137.11 127.74 26.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.961 -1.087 . . . . 0.0 110.599 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.9 t -109.93 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.48 156.76 42.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.0 -177.23 1.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.66 159.93 17.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.265 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -60.1 141.16 56.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.135 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.1 71.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -127.79 147.27 50.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.955 . . . . 0.0 109.105 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -130.19 148.37 52.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.8 137.4 32.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.585 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -68.23 145.93 53.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.052 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.31 -42.6 98.86 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.208 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 77.2 mm-40 -61.04 -44.28 97.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.952 -1.322 . . . . 0.0 109.416 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.0 mt -69.58 -27.19 64.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 108.819 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.71 -58.28 3.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 110.027 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.2 -48.33 82.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 111.043 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 31' ' ' SER . 35.7 p-10 -62.73 -39.93 95.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.781 -1.199 . . . . 0.0 109.957 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -61.47 -45.75 92.94 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.023 -1.048 . . . . 0.0 109.21 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.05 -44.88 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.158 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.77 -40.05 91.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.25 -20.39 64.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 110.253 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.86 5.36 21.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.988 -1.07 . . . . 0.0 110.174 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.35 15.19 62.62 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 121.049 -1.032 . . . . 0.0 111.711 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -80.3 153.85 28.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.617 -1.52 . . . . 0.0 109.151 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.68 139.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -58.68 101.64 0.09 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.29 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.07 49.72 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.45 -167.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -1.064 . . . . 0.0 108.774 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.6 mtm 57.67 22.43 8.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.144 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 m120 51.93 40.12 27.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.754 -0.591 . . . . 0.0 111.598 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 pt -140.0 166.94 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.123 -0.986 . . . . 0.0 108.689 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.39 129.61 38.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 60' ' ' SER . 12.6 m-70 -119.57 126.45 51.26 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 55.0 ttt180 -100.45 127.12 46.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.095 -1.003 . . . . 0.0 109.299 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 23.5 m-70 -97.83 169.92 9.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.501 -0.75 . . . . 0.0 110.109 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.1 tp -56.94 -49.93 74.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -91.48 145.94 32.31 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 109.036 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.31 -6.61 17.86 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.57 0.847 . . . . 0.0 112.082 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 39.4 p-10 -94.11 -1.78 53.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.023 -1.048 . . . . 0.0 110.274 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 10.3 85.78 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.3 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 8.3 m -69.95 -39.96 75.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.333 . . . . 0.0 109.401 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.73 166.44 50.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -71.54 173.68 12.13 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.074 1.182 . . . . 0.0 111.732 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.93 125.06 29.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 108.977 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.8 mp -97.4 -25.71 15.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 109.303 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -159.66 159.84 33.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 109.136 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 4.0 m -126.53 172.75 9.97 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.021 0.915 . . . . 0.0 111.427 -177.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -139.64 128.66 23.63 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.533 0.682 . . . . 0.0 109.298 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -138.62 163.21 32.67 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.476 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -77.53 156.07 31.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.885 -1.135 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' NH1' ' A' ' 121' ' ' ARG . 77.6 mtm -69.89 -19.75 63.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.256 -0.902 . . . . 0.0 110.076 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -87.06 123.65 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 109.502 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -60.03 149.97 71.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 109.672 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -78.32 4.46 26.66 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.823 -1.324 . . . . 0.0 112.239 -0.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.58 9.32 85.85 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p -89.2 170.14 10.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.134 -1.215 . . . . 0.0 109.711 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 96.9 m-85 -120.33 150.26 41.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.572 -0.705 . . . . 0.0 109.533 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 74' ' ' MET . 84.9 m-20 -128.81 151.48 77.34 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.98 -11.13 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 120.503 0.802 . . . . 0.0 111.628 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 71' ' ' ASP . 77.1 mm-40 -90.94 5.52 48.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.635 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.506 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 70.8 mmm -85.56 14.1 6.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.9 mttm -85.99 -4.03 59.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.011 -1.055 . . . . 0.0 108.595 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 80.8 m-20 -148.27 80.74 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -159.67 171.11 20.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.9 p -126.01 149.35 48.89 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.418 -0.801 . . . . 0.0 109.045 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.0 149.91 20.42 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.048 -1.033 . . . . 0.0 109.21 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.83 -47.07 27.01 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 CA-C-N 119.16 0.736 . . . . 0.0 111.665 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.63 -152.5 7.94 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.484 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.16 160.05 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.865 . . . . 0.0 109.184 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ALA . 6.6 m -109.54 120.82 43.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.558 -0.714 . . . . 0.0 110.246 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.5 mt -108.99 127.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -147.68 170.53 17.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.505 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -142.24 129.99 21.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.6 -0.688 . . . . 0.0 109.158 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.602 ' N ' ' SD ' ' A' ' 86' ' ' MET . 96.4 mt-30 -93.5 121.73 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.32 153.7 38.32 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.091 -1.006 . . . . 0.0 108.714 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.12 147.62 87.83 Favored 'Cis proline' 0 N--CA 1.505 2.17 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.211 -0.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.535 ' OG ' ' SD ' ' A' ' 86' ' ' MET . 1.8 m -107.0 167.96 9.53 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.633 0.73 . . . . 0.0 110.7 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.64 149.33 42.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 110.167 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.5 -138.35 33.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -99.2 120.74 40.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -1.06 . . . . 0.0 109.777 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.21 -31.12 67.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.779 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.04 -39.66 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.915 . . . . 0.0 109.357 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -69.89 -40.06 75.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 108.173 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 97' ' ' ASN . 2.1 m120 -59.93 -40.06 87.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -59.61 -41.55 90.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.706 -0.621 . . . . 0.0 109.545 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.72 -42.0 96.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.63 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 109.753 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 97.5 mtp -57.62 -49.96 74.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.98 -43.66 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 109.191 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.6 mm-40 -60.03 -41.83 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.912 . . . . 0.0 109.006 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p -70.94 -40.42 72.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.782 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.39 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.291 -0.88 . . . . 0.0 110.014 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -62.01 -37.77 86.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 109.789 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.93 -49.18 78.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 0.0 109.296 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 108' ' ' ILE . 94.8 mt -60.2 -49.89 82.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.88 -48.06 64.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.703 -0.623 . . . . 0.0 109.794 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.18 -40.37 89.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -69.92 -40.11 75.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 111.053 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.91 2.32 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 109.935 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.51 24.45 72.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.31 -176.95 51.38 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.91 133.89 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.973 . . . . 0.0 109.089 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.61 132.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.237 -0.914 . . . . 0.0 109.425 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.7 mt -130.54 160.02 35.39 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.415 -0.803 . . . . 0.0 109.803 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -86.63 -170.25 2.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 109.163 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.508 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 96.3 m-20 -60.13 -39.87 87.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 109.739 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.68 18.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 121' ' ' ARG . 24.3 mtt-85 59.84 22.58 11.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.1 mtt180 -102.44 145.25 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.449 -0.782 . . . . 0.0 109.478 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.2 mtp -50.08 126.14 13.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.4 mtp -60.04 140.0 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.811 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p -131.55 153.17 81.48 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.83 -44.87 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 120.848 1.032 . . . . 0.0 112.081 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.12 -41.2 92.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.222 -0.924 . . . . 0.0 109.166 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.06 -40.06 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 110.197 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.57 -40.1 82.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.387 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 130' ' ' ARG . 0.1 OUTLIER -63.14 -40.06 96.49 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.417 -0.802 . . . . 0.0 109.189 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.835 . . . . 0.0 109.662 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.508 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 71.0 m-85 -60.02 -43.35 95.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 108.445 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -63.01 -40.09 96.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.353 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.06 -39.97 94.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.682 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.95 -44.72 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 108.709 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -41.3 85.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.804 . . . . 0.0 109.069 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 137' ' ' ARG . 51.3 mtt-85 -60.5 -39.96 89.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.224 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 73.9 mm-40 -62.4 -39.94 94.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 109.571 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -32.19 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 111.021 -177.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -59.98 -40.24 88.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.927 -1.108 . . . . 0.0 109.871 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.3 p30 -61.56 -30.61 70.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.0 108.717 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.65 -22.34 66.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -95.72 -1.81 49.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.812 . . . . 0.0 110.001 179.626 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -143.08 150.01 38.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.27 164.5 27.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.835 -1.166 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -120.0 131.4 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 11' ' ' ILE . 25.0 mm -90.62 133.38 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.456 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -129.26 143.32 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 122.092 0.949 . . . . 0.0 110.811 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -142.76 149.86 39.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -131.04 126.57 36.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.73 -1.231 . . . . 0.0 110.951 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.14 119.99 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.23 160.25 43.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.068 . . . . 0.0 110.025 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -168.38 0.35 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -61.54 157.82 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.815 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -59.97 139.97 57.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.55 74.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.8 m -129.31 144.27 51.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.474 -1.016 . . . . 0.0 109.309 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 42.3 mp0 -120.28 147.51 44.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.729 . . . . 0.0 109.311 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.17 143.99 30.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -68.99 144.51 54.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.136 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -42.16 98.3 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.1 -45.52 93.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -1.234 . . . . 0.0 109.773 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -69.97 -30.19 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 108.889 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tt -72.15 -55.76 6.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.666 -0.647 . . . . 0.0 109.605 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.01 -48.64 80.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.844 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -64.62 -40.08 94.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.235 -0.916 . . . . 0.0 111.683 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.1 p -64.81 -41.0 96.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 110.235 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.63 -44.07 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 109.824 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.47 -40.0 85.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.0 110.455 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.01 -19.66 64.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 111.024 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.54 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.57 -11.47 58.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.175 . . . . 0.0 110.87 -178.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.518 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.4 11.12 18.47 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.015 -1.053 . . . . 0.0 111.14 178.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' N ' HH21 ' A' ' 47' ' ' ARG . 36.3 m-85 -80.87 152.87 27.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.669 -1.489 . . . . 0.0 109.712 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 38' ' ' ILE . 95.3 mt -127.4 139.35 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.52 104.7 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -0.999 . . . . 0.0 110.055 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.2 171.58 34.08 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -67.12 -166.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -1.073 . . . . 0.0 109.315 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.7 mtm 57.42 25.58 11.53 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.603 0.716 . . . . 0.0 109.887 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 50.02 39.37 18.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.644 -0.66 . . . . 0.0 111.601 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.6 pt -140.85 167.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.021 -1.05 . . . . 0.0 109.005 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -92.42 136.77 32.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.037 -1.039 . . . . 0.0 110.333 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 19.4 m-70 -126.3 126.82 44.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.706 HH21 ' N ' ' A' ' 37' ' ' PHE . 28.9 ttm180 -99.21 124.28 44.15 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.517 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 56.9 m-70 -95.6 171.84 8.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 109.717 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -56.89 -50.01 73.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.762 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -91.67 141.99 26.28 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 109.071 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.53 -10.23 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.555 0.877 . . . . 0.0 112.08 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -91.87 -0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 109.947 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.42 83.51 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.0 p -69.9 -40.05 75.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.83 -1.394 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.28 168.24 50.1 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.517 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.5 Cg_endo -70.91 174.88 9.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.286 1.324 . . . . 0.0 112.223 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.22 122.4 27.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.9 mp -97.97 -43.81 6.92 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' SD ' ' A' ' 101' ' ' MET . 20.9 p90 -144.91 160.01 42.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.934 -1.104 . . . . 0.0 109.51 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.61 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 9.0 m -132.74 165.51 24.37 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.031 0.92 . . . . 0.0 111.44 -177.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.3 tt -119.96 134.79 55.14 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.02 159.95 39.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.599 . . . . 0.0 109.413 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -76.45 160.71 29.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.432 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.7 mtp -70.03 -25.56 63.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 110.254 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -86.8 121.51 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.963 -1.086 . . . . 0.0 109.738 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -59.43 151.03 62.12 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -77.57 5.02 22.42 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.686 -1.381 . . . . 0.0 112.479 -0.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.43 55.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.8 p -91.26 169.55 10.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.223 -1.163 . . . . 0.0 110.69 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -124.1 140.68 52.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.691 -0.63 . . . . 0.0 109.376 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -130.37 150.76 77.11 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.0 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -50.72 -7.0 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.42 0.829 . . . . 0.0 112.001 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' ASP . 49.3 mt-10 -89.45 2.53 54.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.431 -0.793 . . . . 0.0 109.556 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.3 mmm -86.83 16.32 4.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.2 mttm -87.42 -3.16 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 108.805 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -149.68 77.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.06 169.41 24.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.994 -1.066 . . . . 0.0 109.251 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -130.04 150.19 51.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.68 150.21 21.31 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.08 -52.83 5.94 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 120.438 0.759 . . . . 0.0 111.726 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.25 -151.82 8.12 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.05 160.0 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.963 . . . . 0.0 109.545 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.4 m -112.07 123.78 51.01 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.115 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.87 132.02 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.08 164.43 33.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.828 -1.17 . . . . 0.0 110.89 -178.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.2 ttp -138.15 128.63 26.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -92.96 112.57 24.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 109.236 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.41 154.3 37.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -75.72 134.36 35.44 Favored 'Cis proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.679 0.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.7 m -107.39 160.2 15.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.529 0.68 . . . . 0.0 109.624 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -70.51 150.43 46.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.928 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -158.96 26.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.16 117.11 30.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -1.146 . . . . 0.0 109.292 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.03 -37.56 80.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.635 . . . . 0.0 110.851 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.81 -39.88 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.99 -39.98 75.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.047 -1.033 . . . . 0.0 108.894 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -60.01 -50.03 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.59 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.8 -41.52 97.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.4 tp -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 59' ' ' PHE . 23.4 mmm -56.11 -46.81 78.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.416 -0.803 . . . . 0.0 109.255 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.85 -40.76 97.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.103 -0.998 . . . . 0.0 109.061 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.533 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 0.0 109.881 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.6 p -69.38 -41.0 77.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.02 -1.05 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.92 52.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 110.272 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -62.33 -34.93 77.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 15.0 m-70 -60.02 -46.54 89.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 108.767 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 108' ' ' ILE . 93.4 mt -60.1 -49.97 81.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.4 -0.813 . . . . 0.0 108.988 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.55 -47.7 63.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.541 -0.724 . . . . 0.0 109.97 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.73 -179.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.22 -40.01 74.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.047 -1.033 . . . . 0.0 111.165 -178.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.92 1.99 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.68 27.22 71.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.85 -172.0 45.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.19 139.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.608 -0.937 . . . . 0.0 108.881 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.56 134.94 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 109.736 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.11 160.01 37.23 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 -179.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -87.25 -168.86 2.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 94.9 m-20 -60.01 -39.57 86.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 109.849 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.17 21.75 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 119' ' ' ASP . 58.9 mtp180 55.85 31.33 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.41 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 98.4 mtt180 -109.16 150.9 27.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.438 -0.789 . . . . 0.0 109.297 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mmm -52.08 125.66 16.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 109.152 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.1 mtp -60.0 139.94 57.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.8 p -130.06 150.65 76.59 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -42.58 -43.49 8.47 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.849 1.032 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.389 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.72 -39.97 80.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.4 mt -55.69 -42.29 74.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 0.0 108.937 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.71 -38.87 90.4 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -59.97 -44.61 94.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.993 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -60.01 -42.18 93.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.52 179.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.78 -39.72 89.9 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 98.3 m-20 -60.03 -40.03 87.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.354 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.0 -41.13 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.048 -1.033 . . . . 0.0 108.833 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.11 -44.93 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 108.996 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 79.9 mtm180 -62.22 -35.25 78.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -0.969 . . . . 0.0 110.424 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 66.4 mm-40 -59.94 -38.86 83.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.736 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.1 t -73.31 -30.07 29.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 110.674 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.8 mttm -60.04 -41.1 91.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.759 -1.213 . . . . 0.0 110.987 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -59.94 -29.02 68.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.756 -1.215 . . . . 0.0 109.176 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.852 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 43.4 p-10 -104.57 -3.71 23.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.34 -0.85 . . . . 0.0 109.495 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.899 . . . . 0.0 109.524 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -102.24 143.68 31.72 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -160.96 179.54 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.49 -1.381 . . . . 0.0 110.633 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -125.65 130.0 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 11' ' ' ILE . 26.6 mm -92.26 127.95 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.8 mt -120.21 147.47 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.33 1.062 . . . . 0.0 111.712 -177.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -145.8 159.03 43.78 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -139.26 125.26 19.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.715 -1.241 . . . . 0.0 111.34 -179.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.51 124.97 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.61 164.59 30.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.046 -1.034 . . . . 0.0 111.979 -177.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.71 -164.51 0.36 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -71.37 160.05 33.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -58.79 130.01 44.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.746 -1.221 . . . . 0.0 109.356 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.47 -2.23 84.68 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 m -110.92 155.55 22.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.365 -1.079 . . . . 0.0 109.757 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -129.98 150.09 51.42 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.27 140.48 29.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -65.62 141.16 58.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' PHE . . . -60.06 -39.99 96.49 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.107 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.51 -46.69 88.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 109.662 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -30.01 68.17 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.41 -58.78 3.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.03 -40.05 88.0 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.349 -0.844 . . . . 0.0 109.708 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -64.28 -40.73 96.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -65.73 -39.64 91.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.304 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.02 -48.4 88.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.074 -1.017 . . . . 0.0 109.859 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -63.37 -39.96 95.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.138 . . . . 0.0 109.704 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.358 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.02 8.3 10.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . 80.09 10.47 85.49 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.39 148.61 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.722 -1.458 . . . . 0.0 108.972 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.6 mt -122.14 134.52 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -58.3 102.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.108 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.74 170.6 38.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.28 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.322 -1.105 . . . . 0.0 109.006 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.1 mtt 58.09 21.38 7.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 51.79 40.06 26.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.797 . . . . 0.0 111.48 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.26 159.29 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.881 -1.137 . . . . 0.0 109.187 178.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -90.49 119.55 30.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.058 -1.026 . . . . 0.0 109.118 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.525 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 13.9 m-70 -104.12 134.94 46.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.481 -0.762 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' NH1' ' O ' ' A' ' 36' ' ' GLY . 21.6 tpt180 -100.03 115.62 30.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 72.5 m-70 -95.25 169.31 10.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.225 -0.922 . . . . 0.0 109.907 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.12 -49.96 75.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.855 . . . . 0.0 109.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -96.1 150.0 36.67 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -70.6 -7.1 20.52 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.869 1.046 . . . . 0.0 112.455 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.85 0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.046 -1.034 . . . . 0.0 110.095 -179.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.34 7.66 86.97 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.317 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.07 -40.05 75.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.249 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.72 160.42 50.49 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.445 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 12.9 Cg_endo -68.02 175.09 6.95 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.068 1.179 . . . . 0.0 112.218 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.19 127.06 33.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.37 -0.831 . . . . 0.0 109.209 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 6.2 mp -100.56 -35.38 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.135 -0.978 . . . . 0.0 108.8 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 2.5 p90 -151.01 166.53 30.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.1 m -134.73 179.44 6.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.08 -1.013 . . . . 0.0 111.525 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.5 tt -139.95 131.65 27.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.94 159.74 35.72 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.526 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -76.93 161.53 28.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.05 -22.99 63.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 110.373 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.89 119.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.757 -1.215 . . . . 0.0 109.879 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -61.24 151.37 76.34 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.38 8.89 17.51 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.486 -0.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.1 63.23 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.9 p -83.92 167.89 16.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -1.2 . . . . 0.0 109.344 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.4 m-85 -120.29 143.8 48.15 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.638 -0.664 . . . . 0.0 109.784 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 73' ' ' GLU . 20.5 t70 -126.41 134.32 25.88 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -49.5 -9.34 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 119.959 1.021 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -88.38 1.0 55.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.42 ' CE ' ' CZ ' ' A' ' 77' ' ' PHE . 90.6 mtp -86.99 22.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 109.996 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 94.9 mttt -83.65 -4.81 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.021 -1.049 . . . . 0.0 108.955 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.0 m-20 -148.12 83.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' ' CE ' ' A' ' 74' ' ' MET . 7.1 p90 -158.85 177.65 10.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.551 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.0 p -134.03 149.98 51.2 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.12 150.3 23.64 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.063 -1.023 . . . . 0.0 109.35 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.93 -26.06 30.12 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.46 0.773 . . . . 0.0 111.657 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.33 33.96 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.036 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.886 . . . . 0.0 108.952 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.7 m -109.76 125.2 52.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.659 -0.651 . . . . 0.0 109.686 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.79 128.41 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -146.74 149.78 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.968 -1.082 . . . . 0.0 110.952 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.1 ttm -104.91 129.91 53.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.836 -0.54 . . . . 0.0 109.581 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -92.84 108.38 19.95 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.7 m -97.2 151.04 37.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 109.133 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.0 139.24 60.44 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.914 -1.286 . . . . 0.0 112.839 -0.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.2 m -105.22 159.51 15.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.627 -0.671 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -71.1 150.62 45.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.98 -152.38 38.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -98.96 121.09 40.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.414 -1.05 . . . . 0.0 109.29 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.94 -32.24 69.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.589 -0.694 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.03 -39.91 75.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.663 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.04 -42.2 73.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.953 -1.092 . . . . 0.0 108.088 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.94 -39.88 95.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.14 -40.1 73.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.19 -40.03 94.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.16 -39.9 91.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.132 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.2 mtp -57.84 -50.33 73.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.84 -42.91 89.92 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.986 -1.071 . . . . 0.0 108.961 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.8 mt-30 -61.99 -39.99 94.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 108.796 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.428 ' HG ' ' N ' ' A' ' 105' ' ' ALA . 25.9 p -73.14 -43.74 61.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' N ' ' HG ' ' A' ' 104' ' ' SER . . . -60.05 -53.04 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 0.0 110.014 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -60.31 -39.82 88.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.052 -1.03 . . . . 0.0 109.358 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 4.1 m-70 -59.9 -43.37 94.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.985 . . . . 0.0 108.891 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.0 -50.11 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.26 -48.33 68.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.607 -0.683 . . . . 0.0 109.263 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.64 -40.13 90.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 109.899 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -40.0 75.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.36 -0.838 . . . . 0.0 111.346 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -101.03 -0.81 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.116 -0.99 . . . . 0.0 109.678 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.37 23.39 76.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.33 -167.56 41.01 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.211 -1.17 . . . . 0.0 110.249 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.0 159.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.596 -0.944 . . . . 0.0 109.372 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 t -96.93 129.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.234 -0.916 . . . . 0.0 108.712 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.1 mt -124.49 163.63 21.45 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.82 0.819 . . . . 0.0 110.639 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -86.27 -170.92 3.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.752 -0.593 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.492 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 85.4 m-20 -60.12 -39.99 88.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.872 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.99 15.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.068 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 119' ' ' ASP . 86.4 mtm180 57.25 37.16 28.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.837 -0.539 . . . . 0.0 109.769 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 122' ' ' ARG . 20.0 mtt-85 -112.23 151.97 28.97 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.9 mtp -50.92 122.1 6.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.929 -1.107 . . . . 0.0 109.133 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.96 140.01 57.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.5 p -122.25 152.17 60.19 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -43.49 -43.61 10.92 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 120.61 0.873 . . . . 0.0 112.017 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -60.11 -40.5 89.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.277 -0.89 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.7 -40.01 84.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.794 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.82 -39.95 78.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 108.409 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.49 -39.97 89.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.457 -0.777 . . . . 0.0 109.397 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.46 77.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.492 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 67.3 m-85 -59.93 -46.05 90.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.956 -1.09 . . . . 0.0 108.779 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.98 -39.93 93.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.36 -0.838 . . . . 0.0 109.124 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.72 -46.15 90.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.521 -0.737 . . . . 0.0 110.57 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.19 -37.59 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 108.997 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.05 -42.54 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.052 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 81.7 mtm180 -60.02 -38.69 83.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.853 -1.154 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 40.4 mm-40 -59.98 -39.96 87.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.46 -0.775 . . . . 0.0 109.867 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.5 -33.64 63.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.596 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 144' ' ' ALA . 87.8 mttt -59.95 -50.0 75.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.817 -1.177 . . . . 0.0 110.027 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -61.19 -37.57 83.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.982 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.93 95.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.447 -0.783 . . . . 0.0 110.17 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 50.5 p30 -98.85 -2.98 36.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.309 -0.869 . . . . 0.0 109.406 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -144.64 132.56 21.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.85 -172.14 3.17 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.015 -1.053 . . . . 0.0 110.536 -178.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.92 140.59 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.49 130.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.0 mt -118.45 144.13 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 122.245 1.021 . . . . 0.0 111.681 -177.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -142.0 150.02 40.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' ND2' ' HG1' ' A' ' 83' ' ' THR . 35.0 m120 -128.02 119.62 25.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.019 -1.051 . . . . 0.0 111.037 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.62 110.86 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.99 160.79 42.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -165.25 0.25 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.56 142.42 55.42 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 108.826 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -51.47 137.15 24.59 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.039 -1.038 . . . . 0.0 109.237 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.27 1.22 66.93 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.1 m -121.02 149.95 41.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.516 -0.991 . . . . 0.0 108.697 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -125.41 146.87 49.42 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.764 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 148.62 25.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -68.93 142.48 54.71 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.42 96.99 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.31 -46.85 86.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 0.0 109.83 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.81 -30.17 67.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.197 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.5 tt -71.15 -58.67 3.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.23 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -59.99 -46.02 90.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.659 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.81 -42.26 97.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.698 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 t -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.479 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.94 -47.0 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -63.83 -41.57 97.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.69 -21.89 66.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.6 11.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.47 75.73 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.15 -0.969 . . . . 0.0 111.338 178.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -81.65 147.51 29.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.661 -1.494 . . . . 0.0 109.584 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -120.03 132.33 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.74 101.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -89.72 170.82 37.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.34 -162.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -1.044 . . . . 0.0 109.265 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 91.0 mmm 59.78 20.61 9.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.683 -0.635 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 51.21 34.97 12.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 111.362 178.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.2 165.83 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.006 -1.058 . . . . 0.0 108.999 178.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -89.72 141.51 28.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.947 -1.096 . . . . 0.0 110.464 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.526 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 29.0 m80 -130.19 130.07 44.22 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 47' ' ' ARG . 4.0 ttt-85 -103.0 127.29 50.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 17.9 m-70 -91.45 169.84 10.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.664 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.69 -49.96 73.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -92.65 144.81 29.26 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.58 -6.37 16.45 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.798 0.999 . . . . 0.0 112.213 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -92.71 1.92 57.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.949 . . . . 0.0 110.031 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.14 10.67 85.27 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.4 p -70.14 -40.8 74.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -1.184 . . . . 0.0 110.0 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.48 164.0 50.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -66.68 179.74 2.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.473 1.136 . . . . 0.0 111.852 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.56 29.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.65 -70.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.355 -0.841 . . . . 0.0 109.691 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 1.7 p90 -114.41 160.0 19.66 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.97 -1.081 . . . . 0.0 109.909 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 15.1 m -121.88 161.47 22.73 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.573 0.701 . . . . 0.0 109.927 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.5 tt -132.26 130.59 41.11 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.43 165.3 26.13 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.489 -0.757 . . . . 0.0 110.073 -178.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 88.7 m-20 -75.05 156.92 35.62 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.4 mtt -69.88 -23.88 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 p -87.5 121.12 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.068 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -58.06 151.78 43.79 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -80.43 -0.2 41.15 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.979 0.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.62 18.83 61.12 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.4 p -85.92 167.3 15.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.991 -1.299 . . . . 0.0 109.618 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.4 m-85 -124.33 141.85 51.75 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.519 -0.738 . . . . 0.0 109.808 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -129.8 151.09 77.57 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.58 -12.5 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 120.497 0.798 . . . . 0.0 112.409 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.91 -3.01 58.86 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.072 -1.017 . . . . 0.0 109.322 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.2 mtp -88.65 22.68 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.4 mttp -83.06 -4.84 58.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 94.0 m-20 -143.75 84.63 1.8 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.376 -0.828 . . . . 0.0 108.776 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.7 177.24 11.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 110.362 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.5 p -129.67 146.8 51.43 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.19 148.22 18.19 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 108.862 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -45.16 -31.65 6.17 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 120.611 0.874 . . . . 0.0 111.768 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.65 -147.71 16.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.49 159.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.457 -1.025 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.424 ' HG1' ' ND2' ' A' ' 14' ' ' ASN . 54.7 m -108.74 122.48 47.23 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -105.77 130.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.323 -0.861 . . . . 0.0 108.727 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.47 148.03 32.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.12 -0.988 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.9 tpp -104.02 130.28 51.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' OG ' ' A' ' 90' ' ' SER . 95.0 mt-30 -90.54 108.6 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.67 150.03 36.31 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.211 -0.93 . . . . 0.0 109.238 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.65 135.07 38.67 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.859 -1.309 . . . . 0.0 112.564 -0.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.5 m -108.05 162.58 13.91 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.632 0.73 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 59.6 t80 -73.78 158.14 35.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 110.041 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.72 -160.28 44.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -98.15 111.96 24.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.38 -1.07 . . . . 0.0 108.971 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.62 -30.33 68.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.768 . . . . 0.0 110.602 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.33 -40.06 77.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 109.363 -179.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.81 -40.35 63.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.743 -1.223 . . . . 0.0 108.242 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -61.2 -37.5 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.093 0.949 . . . . 0.0 108.606 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -56.33 -50.09 72.46 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.25 -39.19 92.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.12 -46.02 91.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.608 -0.683 . . . . 0.0 110.219 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.8 mtm -58.91 -42.67 90.21 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.667 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.61 -46.61 87.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.913 . . . . 0.0 108.937 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.4 mm-40 -60.17 -42.63 95.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 108.928 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.428 ' HG ' ' H ' ' A' ' 105' ' ' ALA . 67.6 p -71.55 -41.07 69.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 109.375 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -58.56 -55.41 35.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.601 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -61.25 -35.7 77.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.148 -0.97 . . . . 0.0 109.103 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.89 -47.08 87.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.98 -49.95 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.9 -47.7 60.63 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.77 -39.96 93.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.43 -40.02 77.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.05 -1.031 . . . . 0.0 110.703 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 m -98.44 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 109.275 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.85 24.88 76.15 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.34 -169.83 46.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.8 138.0 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.128 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 t -77.57 132.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 109.475 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.17 160.33 35.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.415 -0.803 . . . . 0.0 110.022 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -84.58 -173.12 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.477 -0.764 . . . . 0.0 108.976 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.588 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 93.3 m-20 -60.02 -36.07 76.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.088 -1.007 . . . . 0.0 109.994 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -79.61 15.3 1.37 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.916 . . . . 0.0 110.219 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.401 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 19.8 mmm-85 58.19 30.84 19.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -106.43 151.93 24.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 81.0 mmm -51.72 133.37 31.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.026 -1.046 . . . . 0.0 109.45 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.2 mmm -56.08 138.66 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.096 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.3 p -136.81 151.28 72.12 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.426 -0.797 . . . . 0.0 109.034 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -44.58 -45.72 12.85 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 120.449 0.766 . . . . 0.0 111.73 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.08 -40.01 88.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -68.48 -39.92 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.02 -40.13 88.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.995 -1.065 . . . . 0.0 109.011 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -65.28 -39.67 92.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.445 -0.785 . . . . 0.0 109.405 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.75 -47.6 85.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.195 -0.941 . . . . 0.0 110.348 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.588 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 71.3 m-85 -60.07 -46.59 89.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.928 -1.107 . . . . 0.0 108.526 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.2 -40.35 93.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.194 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.416 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.7 m-20 -62.35 -40.09 95.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.32 -40.68 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.052 -1.03 . . . . 0.0 108.596 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.56 -40.03 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.504 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 137' ' ' ARG . 7.4 mmt-85 -60.04 -39.96 87.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.066 -1.021 . . . . 0.0 110.554 -179.12 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.99 -40.07 92.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.725 -1.235 . . . . 0.0 109.524 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.15 -29.74 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' ALA . 47.4 mmtt -60.07 -39.47 86.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.835 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 2.2 p30 -60.07 -30.01 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.659 -1.276 . . . . 0.0 108.566 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.888 . . . . 0.0 109.218 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -101.22 -13.38 18.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.372 -0.83 . . . . 0.0 110.409 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.891 -1.13 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.32 147.11 31.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.61 -177.64 6.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.322 -1.486 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.99 131.46 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 mm -92.87 125.31 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 90.8 mt -123.66 143.71 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-O 122.166 0.984 . . . . 0.0 111.248 -177.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.402 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.4 mtt -142.88 138.18 30.07 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -120.85 127.46 51.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.992 -1.068 . . . . 0.0 111.251 -178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.38 114.67 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.71 152.27 38.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.288 -0.882 . . . . 0.0 109.647 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.91 -166.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.64 152.89 44.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.161 -0.962 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.06 141.23 56.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.609 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.09 1.91 64.7 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.4 m -129.01 150.01 50.6 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.438 -1.036 . . . . 0.0 109.137 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.11 148.16 49.44 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.45 146.67 26.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.721 HD21 ' H ' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -71.0 142.15 50.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 109.115 179.065 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.9 99.83 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.871 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.721 ' H ' HD21 ' A' ' 24' ' ' ASN . 99.0 mt-10 -61.62 -44.65 96.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.964 -1.315 . . . . 0.0 109.669 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.87 -26.58 64.26 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.409 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.0 tt -74.71 -59.88 2.53 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.652 -0.655 . . . . 0.0 109.76 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.86 -40.9 94.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 110.581 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.09 94.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 109.911 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 t -66.05 -41.05 91.33 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.16 -0.962 . . . . 0.0 109.806 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.13 -46.28 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 110.027 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.59 -40.2 96.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.974 -1.079 . . . . 0.0 109.395 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.56 -19.61 64.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.601 -0.687 . . . . 0.0 109.975 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.53 8.18 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.915 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.5 10.68 85.0 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.584 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -80.8 151.55 28.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.993 -1.299 . . . . 0.0 109.735 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.06 148.11 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.13 112.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.06 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.65 30.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.2 -170.18 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.596 -0.943 . . . . 0.0 108.626 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mtp 55.27 24.95 6.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.861 . . . . 0.0 109.726 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.04 42.1 24.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.745 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.7 pt -138.31 167.02 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.099 -1.0 . . . . 0.0 108.303 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -93.34 120.42 33.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.821 -1.174 . . . . 0.0 110.427 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.429 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 16.4 m170 -108.53 128.11 54.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.421 -0.8 . . . . 0.0 109.611 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 47' ' ' ARG . 9.3 ttt-85 -100.08 123.77 44.7 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.214 -0.928 . . . . 0.0 108.775 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 26.0 m-70 -92.46 171.59 8.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.57 -50.01 66.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 109.031 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -93.07 147.29 33.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 0.0 109.158 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -69.15 -4.2 13.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.65 0.9 . . . . 0.0 112.092 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -93.67 -1.07 55.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 0.0 109.746 -179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 13.42 83.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -68.93 -43.22 75.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -1.201 . . . . 0.0 109.533 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.435 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.33 171.62 54.26 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.67 176.36 8.28 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.018 1.145 . . . . 0.0 111.463 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.16 126.63 32.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 108.906 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.4 mp -101.16 -35.88 9.15 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.078 -1.014 . . . . 0.0 109.74 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -146.68 160.78 41.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.029 -1.044 . . . . 0.0 109.006 178.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 63.2 m -129.99 160.29 34.08 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.002 0.906 . . . . 0.0 111.437 -177.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.97 129.48 53.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 161.73 36.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.521 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 81.9 m-20 -77.66 159.93 28.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 48.7 mtm -67.83 -18.84 64.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 12.7 p -88.16 121.28 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.818 -1.176 . . . . 0.0 109.844 -179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -61.11 147.76 85.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.35 -0.843 . . . . 0.0 109.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.6 -0.53 19.46 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.763 -1.349 . . . . 0.0 111.741 -0.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.99 17.43 74.68 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 p -88.79 169.05 11.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.196 -1.179 . . . . 0.0 110.601 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.4 m-85 -119.91 143.8 47.77 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.27 150.01 72.91 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.349 -0.844 . . . . 0.0 109.146 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.23 -19.32 2.62 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.689 0.926 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -89.94 -4.36 57.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.95 -1.093 . . . . 0.0 109.131 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 85.6 mtp -93.51 23.51 4.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 110.372 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -85.49 -8.99 58.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.911 -1.118 . . . . 0.0 108.476 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -136.96 87.27 2.27 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 7.7 p90 -157.96 179.65 8.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.387 -0.821 . . . . 0.0 109.522 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.5 p -128.76 149.96 50.49 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.73 149.17 19.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.051 -1.03 . . . . 0.0 109.221 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.95 -40.64 80.14 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.669 0.913 . . . . 0.0 111.907 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.39 -156.54 17.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -130.38 159.96 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.617 -0.931 . . . . 0.0 109.506 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 m -114.21 120.68 41.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.526 -0.733 . . . . 0.0 109.476 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.64 128.49 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -149.28 159.92 43.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.699 -1.251 . . . . 0.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 44.2 ttm -120.25 129.95 54.28 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.31 102.08 14.5 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' CG1' ' OE1' ' A' ' 94' ' ' GLU . 15.9 m -96.04 148.31 34.34 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.308 -0.87 . . . . 0.0 108.894 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.67 130.24 19.96 Favored 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.796 -1.335 . . . . 0.0 112.957 0.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 m -105.42 161.36 14.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.64 -0.662 . . . . 0.0 109.644 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.04 150.02 47.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.694 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -164.65 31.29 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 96.0 m-20 -96.09 116.74 29.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.198 -1.178 . . . . 0.0 108.921 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE1' ' CG1' ' A' ' 88' ' ' VAL . 41.9 mt-10 -59.95 -34.86 73.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.649 . . . . 0.0 110.799 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.06 -39.99 75.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.535 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.22 -42.21 55.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.717 -1.239 . . . . 0.0 108.701 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 31.3 m120 -61.53 -39.89 92.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 73.0 t80 -52.44 -40.01 61.72 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.607 -0.683 . . . . 0.0 109.207 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -60.96 -40.01 91.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.112 -0.992 . . . . 0.0 109.1 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.37 -40.08 89.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 109.177 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.6 mtp -57.09 -50.33 73.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.17 -45.28 81.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.15 -39.99 88.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 108.822 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 p -70.14 -41.07 74.37 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.199 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.6 -55.62 31.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.319 -0.863 . . . . 0.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -60.73 -39.95 90.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 109.704 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 8.1 m-70 -59.83 -46.32 89.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 108' ' ' ILE . 82.3 mt -60.76 -47.45 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 108.977 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.86 -47.01 64.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.92 -40.67 94.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.851 . . . . 0.0 110.949 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.03 -40.08 75.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.708 -178.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.59 0.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.224 -0.923 . . . . 0.0 109.877 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.31 21.76 74.28 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.62 -176.8 51.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.49 132.02 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.604 -0.939 . . . . 0.0 109.272 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.96 131.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.188 -0.945 . . . . 0.0 108.898 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.6 mt -131.49 158.62 40.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.411 -0.806 . . . . 0.0 109.377 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 34.1 p-10 -84.03 -170.77 3.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.253 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.0 m-20 -60.06 -36.37 77.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.834 . . . . 0.0 109.623 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.59 14.91 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.6 mtt180 56.35 38.64 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 109.765 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.431 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.2 mtt180 -122.18 152.2 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.2 mtp -50.72 129.24 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.07 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.95 139.81 57.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -120.66 151.33 54.13 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -43.02 -43.92 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 120.8 1.0 . . . . 0.0 112.603 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.06 -40.0 87.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.31 -39.83 92.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 110.124 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.03 -40.05 83.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.954 -1.091 . . . . 0.0 108.543 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -65.07 -39.5 93.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.597 -0.689 . . . . 0.0 109.86 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.12 -47.65 85.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.304 -0.873 . . . . 0.0 110.565 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -59.98 -43.86 94.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 0.0 109.322 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.38 -39.94 89.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.704 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.58 -40.17 90.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 135' ' ' ILE . 96.6 mt -65.13 -39.94 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 108.904 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.9 -44.63 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.2 mtm180 -60.1 -38.0 81.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.46 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.4 mt-10 -60.09 -37.33 79.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 0.0 109.52 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.88 -38.17 74.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.369 -0.832 . . . . 0.0 110.38 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -60.06 -46.56 89.16 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.077 -1.015 . . . . 0.0 111.558 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -60.08 -35.06 74.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.697 -1.252 . . . . 0.0 109.588 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.49 -19.51 65.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.781 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -99.52 -8.7 24.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 109.832 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 0.0 109.524 179.894 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -152.21 140.58 20.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.75 164.56 26.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.426 -1.421 . . . . 0.0 110.734 -178.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.99 129.47 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.31 122.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -122.29 144.27 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 122.039 0.923 . . . . 0.0 110.835 -177.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.8 mtt -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -130.81 119.5 22.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.978 -1.076 . . . . 0.0 110.392 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.27 112.89 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.79 44.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.65 -164.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.175 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -67.25 155.03 39.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.962 . . . . 0.0 108.716 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -59.56 140.01 56.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.33 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -6.19 77.11 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 m -115.26 148.44 39.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.448 -1.031 . . . . 0.0 109.042 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -126.8 146.49 50.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.461 -0.774 . . . . 0.0 109.606 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.34 141.91 28.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -69.95 146.12 51.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.243 -0.911 . . . . 0.0 108.876 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.0 98.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.0 -45.73 93.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.061 -1.258 . . . . 0.0 109.755 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.1 mt -69.85 -24.48 63.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.8 -57.49 3.63 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 110.46 -179.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.94 -45.21 93.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 0.0 111.585 -178.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 31' ' ' SER . 39.4 p-10 -61.62 -39.8 92.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.0 110.28 -178.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.532 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 9.3 p -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 0.0 110.316 -179.406 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.04 -50.04 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 0.0 110.335 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.72 -39.96 95.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 0.0 110.127 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.26 -20.09 66.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.59 1.02 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.94 -1.1 . . . . 0.0 110.022 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 13.58 56.87 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.011 -1.056 . . . . 0.0 110.921 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.93 150.81 28.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.973 -1.31 . . . . 0.0 109.692 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.62 138.84 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.58 106.75 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.687 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.83 171.51 26.19 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.41 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 109.481 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 56.9 19.98 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.502 -0.749 . . . . 0.0 110.014 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.4 m120 49.86 40.04 19.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 111.379 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.16 167.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.973 -1.079 . . . . 0.0 108.574 178.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -93.18 120.91 33.99 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.787 -1.196 . . . . 0.0 110.68 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.53 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 47.1 m-70 -109.18 124.58 51.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 47' ' ' ARG . 13.9 ttt-85 -100.02 127.25 46.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.257 -0.902 . . . . 0.0 108.661 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 18.5 m-70 -95.67 171.55 8.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.37 -0.831 . . . . 0.0 110.399 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.97 -50.08 71.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 108.848 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.2 m -94.09 146.91 32.48 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 179.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.2 -6.37 18.16 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 CA-C-N 119.436 0.834 . . . . 0.0 112.368 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -92.54 -2.24 56.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 109.773 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.05 86.02 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -67.64 -40.43 84.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.011 -1.288 . . . . 0.0 109.189 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.507 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.54 162.66 49.4 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.89 179.25 2.84 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 118.448 1.124 . . . . 0.0 111.716 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.69 119.83 23.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.156 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 10.3 mp -96.56 -47.52 5.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CG ' ' SD ' ' A' ' 101' ' ' MET . 40.2 p90 -145.33 159.16 43.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.904 -1.122 . . . . 0.0 109.01 178.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.2 m -132.02 169.74 15.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.856 0.836 . . . . 0.0 111.526 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.6 tt -123.48 133.0 54.09 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.512 0.672 . . . . 0.0 109.211 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -135.77 159.08 42.76 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.3 m-20 -76.27 152.48 36.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 0.0 108.732 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.7 mtm -70.02 -20.26 63.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.996 -1.065 . . . . 0.0 109.663 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.66 131.94 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 109.555 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -59.5 150.95 63.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.068 -1.02 . . . . 0.0 108.485 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -80.25 5.3 36.31 Favored 'Cis proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.243 -0.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.69 3.51 90.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.3 p -92.4 174.89 7.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.268 -1.137 . . . . 0.0 110.818 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.5 m-85 -126.24 146.76 49.86 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 73' ' ' GLU . 51.3 m-20 -129.99 149.82 74.22 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -49.13 -7.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.567 0.881 . . . . 0.0 111.85 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 71' ' ' ASP . 99.0 mt-10 -90.0 3.26 53.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 65.1 mmm -86.16 21.0 2.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -0.852 . . . . 0.0 109.866 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -85.93 -5.82 59.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 108.882 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -149.85 80.0 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.424 -0.797 . . . . 0.0 109.159 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -157.45 170.54 22.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.195 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.0 p -129.4 150.25 50.84 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.03 149.27 20.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.024 -1.047 . . . . 0.0 109.213 -179.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -48.05 -45.11 26.26 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.509 0.806 . . . . 0.0 111.639 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.16 -149.11 7.83 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.45 162.13 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.539 -0.977 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 62' ' ' ALA . 5.6 m -114.87 116.6 28.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.53 126.79 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -146.5 160.23 42.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.003 -1.061 . . . . 0.0 111.221 -178.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.0 ttm -124.15 131.08 53.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -90.15 120.0 30.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 108.545 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m -98.38 150.02 36.31 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.26 -0.9 . . . . 0.0 109.375 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.69 137.05 48.0 Favored 'Cis proline' 0 N--CA 1.498 1.784 0 C-N-CA 124.084 -1.215 . . . . 0.0 111.94 -2.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.3 m -105.26 150.31 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.394 -0.816 . . . . 0.0 110.047 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.7 152.06 41.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.587 -0.696 . . . . 0.0 109.83 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -163.02 31.94 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 95.8 m-20 -95.25 113.06 24.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.144 -1.209 . . . . 0.0 109.254 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 57.1 mp0 -58.99 -29.5 67.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.0 -42.9 72.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.99 -42.28 60.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.053 -1.03 . . . . 0.0 108.613 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 80.9 m-20 -62.2 -40.63 96.73 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.601 -0.687 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.498 -0.751 . . . . 0.0 109.02 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.5 -39.79 94.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tt -60.01 -42.41 94.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.743 -0.598 . . . . 0.0 109.541 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' CG ' ' A' ' 59' ' ' PHE . 21.7 mtm -59.92 -41.64 92.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.82 -1.175 . . . . 0.0 108.576 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.26 -43.14 98.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 108.676 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.2 mt-30 -60.07 -41.32 92.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.098 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 p -70.95 -40.03 72.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.57 -53.83 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 -179.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.102 . . . . 0.0 109.127 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.3 m-70 -60.02 -49.57 77.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.077 -1.014 . . . . 0.0 108.608 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.1 -50.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.87 -51.09 42.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.667 -0.646 . . . . 0.0 109.828 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.04 -40.07 88.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 110.617 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.09 -39.92 78.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 -178.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.73 0.34 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 20.25 76.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.78 -173.04 46.61 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.33 139.29 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.504 -0.998 . . . . 0.0 108.872 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 t -76.62 129.96 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.081 -1.012 . . . . 0.0 108.824 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' C ' ' SD ' ' A' ' 124' ' ' MET . 52.5 mt -131.4 159.85 36.8 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -0.767 . . . . 0.0 109.72 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' ' SD ' ' A' ' 124' ' ' MET . 43.6 p-10 -84.78 -173.97 5.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 109.173 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.7 m-20 -60.04 -36.45 77.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.472 ' CB ' ' NH1' ' A' ' 122' ' ' ARG . 96.5 mm-40 -77.17 13.24 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.7 mtm180 55.42 33.78 21.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.87 -0.518 . . . . 0.0 110.422 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 120' ' ' GLN . 25.1 mtm-85 -109.67 156.67 19.96 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.5 mtm -51.9 133.24 32.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 118' ' ' ASP . 97.6 mmm -60.68 139.95 57.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.653 ' N ' ' HZ1' ' A' ' 128' ' ' LYS . 74.6 p -130.43 149.87 74.63 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -48.63 -43.9 32.42 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 119.38 0.814 . . . . 0.0 111.963 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -60.3 -42.99 96.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.653 ' HZ1' ' N ' ' A' ' 125' ' ' THR . 9.8 mtmp? -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.105 . . . . 0.0 110.288 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.44 -39.99 81.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.738 -1.226 . . . . 0.0 108.409 179.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.08 -36.87 85.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.391 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.07 -49.44 77.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -60.05 -43.75 95.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.45 -39.83 94.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.0 -40.99 91.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.268 -0.895 . . . . 0.0 109.294 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.93 -41.03 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.885 -1.134 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.03 -46.28 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.493 ' HG2' HH11 ' A' ' 137' ' ' ARG . 1.6 mmt-85 -60.27 -40.02 88.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.098 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.5 mt-10 -60.93 -38.84 87.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.52 0.676 . . . . 0.0 109.63 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.81 -39.61 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 110.673 -179.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' ALA . 56.6 mttm -58.23 -46.9 85.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.927 -1.108 . . . . 0.0 110.572 -178.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.11 -33.02 71.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.704 -1.248 . . . . 0.0 108.622 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.26 93.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.56 -0.713 . . . . 0.0 110.289 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -99.96 -18.58 17.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -146.4 141.78 27.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -165.8 166.82 17.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 109.799 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.3 129.97 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 11' ' ' ILE . 24.8 mm -92.57 131.83 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.0 mt -131.13 142.09 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 122.165 0.983 . . . . 0.0 110.971 -178.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.85 135.06 32.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -116.24 122.68 45.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.048 -1.033 . . . . 0.0 111.342 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.46 111.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.27 155.69 40.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.111 -0.993 . . . . 0.0 110.55 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.48 -164.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.559 -0.713 . . . . 0.0 109.096 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -74.51 157.44 35.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.096 -1.003 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.24 143.56 52.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.73 0.24 72.55 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.7 m -130.01 141.78 50.7 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.587 -0.949 . . . . 0.0 109.341 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.72 149.11 44.52 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.451 -0.78 . . . . 0.0 108.936 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.4 145.34 26.9 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 62.6 t-20 -68.07 138.82 56.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.527 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.8 -40.42 98.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.351 . . . . 0.0 109.489 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -29.73 67.81 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.37 -57.93 4.29 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.2 -40.89 91.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.0 109.926 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -64.0 -40.37 96.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.4 t -65.77 -39.06 90.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 111.105 -179.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.82 -42.24 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.197 . . . . 0.0 109.972 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -64.88 -39.94 94.34 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.153 -0.967 . . . . 0.0 108.549 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -64.71 -20.62 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.492 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.62 2.01 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.779 . . . . 0.0 110.114 -178.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.68 13.49 82.35 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.425 179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -79.99 153.17 29.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.049 -1.266 . . . . 0.0 110.059 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 83.0 mt -120.21 133.84 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 110.182 -178.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.95 169.07 27.93 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -59.95 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -1.115 . . . . 0.0 109.189 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.9 mtt 58.89 19.86 7.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.5 m120 51.32 37.62 19.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.222 -0.924 . . . . 0.0 111.336 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.58 164.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.945 -1.097 . . . . 0.0 108.717 178.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -91.72 123.14 34.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.115 -0.991 . . . . 0.0 110.47 -178.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 44.8 m-70 -114.67 131.3 56.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.609 -0.682 . . . . 0.0 109.654 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 17.4 ttp180 -107.32 126.76 52.86 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.567 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 44.9 m-70 -92.75 171.47 8.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.378 -0.826 . . . . 0.0 110.676 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.41 -49.98 72.93 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.2 m -90.49 148.05 37.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.239 -0.913 . . . . 0.0 108.948 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.97 -12.0 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 120.748 0.966 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 56.3 p-10 -90.24 0.78 57.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 0.0 109.901 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.15 10.67 85.87 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 53.5 m -66.88 -40.06 87.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.848 -1.383 . . . . 0.0 109.726 -179.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.521 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.98 166.21 51.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.567 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.4 Cg_endo -71.16 175.78 8.75 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.493 1.462 . . . . 0.0 112.125 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.29 124.04 27.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.037 . . . . 0.0 109.25 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 86' ' ' MET . 10.2 mp -102.94 -57.25 2.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.405 -0.809 . . . . 0.0 110.026 -179.216 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -130.5 159.49 36.96 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.77 -1.207 . . . . 0.0 108.518 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.8 m -137.3 162.26 34.01 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.017 -1.052 . . . . 0.0 111.731 -177.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -113.58 136.16 53.12 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -136.36 160.53 38.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -75.92 161.5 28.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.095 -1.003 . . . . 0.0 109.904 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.1 mtp -69.83 -19.41 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 110.492 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 68' ' ' GLY . 7.9 p -89.49 117.44 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.741 -1.224 . . . . 0.0 109.747 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -62.04 148.86 87.71 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -75.43 9.29 10.7 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.828 -1.322 . . . . 0.0 112.234 0.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 73.86 21.76 78.88 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.926 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.2 p -86.08 171.85 11.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.1 -1.235 . . . . 0.0 109.789 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 84.0 m-85 -121.43 144.81 48.47 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.562 -0.711 . . . . 0.0 109.943 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 73' ' ' GLU . 11.9 m-20 -129.98 150.44 75.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.59 -8.79 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 120.512 0.808 . . . . 0.0 112.123 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 71' ' ' ASP . 48.7 mt-10 -89.94 2.61 54.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.6 mmm -86.23 17.28 3.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -87.41 -7.84 57.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 108.939 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.1 m-20 -150.3 79.99 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -156.25 172.44 18.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.2 p -129.81 150.97 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.177 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.12 148.15 18.18 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.912 . . . . 0.0 109.341 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -45.34 -43.1 17.35 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 120.594 0.863 . . . . 0.0 111.547 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.9 10.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.6 m -129.98 160.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.325 -1.103 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 62' ' ' ALA . 97.9 m -116.47 129.99 56.51 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.617 0.722 . . . . 0.0 110.517 -179.298 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.9 131.96 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 22.3 p90 -147.03 170.65 16.68 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.916 -1.115 . . . . 0.0 111.172 -178.068 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 4.9 tpp -139.61 122.63 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.3 mt-30 -88.94 114.98 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 0.0 108.66 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.4 m -101.43 152.08 37.93 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.411 -0.805 . . . . 0.0 109.103 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.27 140.51 61.11 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 C-N-CA 123.7 -1.375 . . . . 0.0 112.214 -0.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 20.4 m -119.47 154.38 33.85 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.471 -0.768 . . . . 0.0 109.788 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -71.04 152.61 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.323 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.47 -163.53 26.3 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 92.7 m-20 -95.82 110.41 22.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.276 -1.132 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -59.89 -32.53 70.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.565 -0.709 . . . . 0.0 110.228 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.75 -40.08 76.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.961 -1.087 . . . . 0.0 109.875 -178.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -72.06 -40.26 68.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.636 -1.29 . . . . 0.0 108.627 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 35.7 m120 -60.49 -40.07 90.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.4 ' CE2' ' NE2' ' A' ' 133' ' ' GLN . 63.3 t80 -58.18 -43.12 87.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.83 -41.23 95.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.98 -40.18 94.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 108.872 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.92 -49.06 79.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.008 179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.27 -41.47 89.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.96 . . . . 0.0 110.046 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.536 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 32.5 mt-30 -59.95 -41.83 92.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.966 -1.084 . . . . 0.0 108.873 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -71.13 -40.28 71.5 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.433 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.28 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.069 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.71 -42.21 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 20.0 m-70 -60.1 -46.73 88.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.894 179.387 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.04 -50.0 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.353 -0.842 . . . . 0.0 109.076 179.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.73 -49.57 62.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.77 -40.22 91.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 110.578 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.41 -39.87 77.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.931 -1.105 . . . . 0.0 110.568 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 m -98.78 -0.0 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.95 -1.094 . . . . 0.0 109.741 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.17 22.88 77.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.03 -170.17 46.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.29 137.12 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.578 -0.954 . . . . 0.0 108.93 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -72.01 133.19 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 0.0 108.953 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.01 159.32 39.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 36.7 p-10 -87.47 -172.0 3.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.078 179.315 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 121' ' ' ARG . 73.6 m-20 -60.02 -39.84 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.809 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.465 ' OE1' ' NH2' ' A' ' 122' ' ' ARG . 79.0 mt-30 -76.38 17.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.34 -0.85 . . . . 0.0 109.388 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.478 HH11 ' HG2' ' A' ' 121' ' ' ARG . 22.3 mtt-85 58.24 25.49 12.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.688 -0.633 . . . . 0.0 110.185 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 85.7 mtm180 -105.12 151.87 23.48 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.325 -0.86 . . . . 0.0 109.267 179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 98.2 mtp -51.93 136.55 28.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.2 mmm -58.81 139.95 55.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.588 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.1 p -132.2 150.65 76.62 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -41.45 -49.92 4.85 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.804 1.003 . . . . 0.0 112.878 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 110.039 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -66.56 -39.94 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.928 -1.108 . . . . 0.0 110.329 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.82 -40.15 87.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 0.0 108.044 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.22 -38.79 85.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.16 -48.94 79.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.876 -1.14 . . . . 0.0 109.721 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -59.94 -46.32 89.79 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.4 ' NE2' ' CE2' ' A' ' 98' ' ' PHE . 98.1 mt-30 -61.89 -39.48 92.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.607 -0.683 . . . . 0.0 109.187 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.24 -40.97 96.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 135' ' ' ILE . 86.2 mt -62.47 -41.78 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.875 -1.141 . . . . 0.0 109.133 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.21 -46.25 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 59.6 mtp180 -60.21 -40.16 89.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.703 . . . . 0.0 109.83 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.85 -40.45 88.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.04 -1.038 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.67 -38.05 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' ALA . 24.6 mtpp -59.83 -42.87 94.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.718 -1.239 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.08 -34.07 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.432 -1.417 . . . . 0.0 109.072 179.685 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.68 92.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.159 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.14 0.44 45.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.48 -0.763 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.153 -0.967 . . . . 0.0 109.313 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -149.65 145.2 26.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.79 -172.66 3.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.886 -1.134 . . . . 0.0 110.394 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.08 133.47 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mm -88.46 132.71 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.458 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 91.0 mt -131.42 140.63 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 122.346 1.07 . . . . 0.0 111.514 -177.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.9 mtm -147.21 138.39 23.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -118.82 132.56 56.13 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.196 -0.94 . . . . 0.0 111.908 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.56 118.94 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.23 38.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.62 -173.24 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 108.672 178.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -68.76 160.06 31.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.989 -1.07 . . . . 0.0 109.255 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -59.46 142.5 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.95 -6.22 79.16 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -121.9 148.9 44.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.2 mp0 -130.71 149.36 52.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 109.091 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.3 mt -84.91 136.23 33.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.25 146.32 53.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.156 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.87 98.56 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.79 -47.14 87.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.248 . . . . 0.0 109.581 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.07 -32.68 73.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.99 -56.93 4.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.638 -0.664 . . . . 0.0 109.842 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.97 -46.91 87.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -61.8 -40.78 96.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.23 -0.919 . . . . 0.0 110.586 -179.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 t -63.89 -40.04 95.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 110.139 -179.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -40.96 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 108.993 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.53 -40.27 95.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.352 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -68.81 -18.09 64.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.459 -0.776 . . . . 0.0 109.804 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -80.76 5.41 15.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.09 11.94 83.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -80.17 156.7 26.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.245 . . . . 0.0 110.031 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.84 137.19 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -62.13 105.89 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.955 -1.091 . . . . 0.0 109.77 -179.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.69 172.6 31.46 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.31 -164.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -1.03 . . . . 0.0 109.85 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 68.2 mtt 58.84 20.06 7.62 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.828 0.823 . . . . 0.0 109.092 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 53.14 40.06 30.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.727 -0.608 . . . . 0.0 111.691 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.13 169.7 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.8 -1.188 . . . . 0.0 109.052 178.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -94.53 115.51 27.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.0 110.629 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 52.2 m80 -101.06 127.93 47.36 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.356 -0.84 . . . . 0.0 109.437 178.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 61.9 ttt180 -106.05 127.55 53.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.099 -1.001 . . . . 0.0 108.514 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 48' ' ' HIS . 15.2 m-70 -97.44 177.1 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 109.648 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -56.51 -49.66 74.06 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 108.833 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -90.28 149.16 40.71 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.362 -0.836 . . . . 0.0 109.224 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.96 -12.22 33.83 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 120.967 1.112 . . . . 0.0 112.95 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -93.03 0.01 57.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.894 -1.129 . . . . 0.0 110.34 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 13.41 82.23 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.705 179.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -69.86 -39.99 76.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.835 -1.391 . . . . 0.0 109.523 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.64 170.57 54.23 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -68.76 169.22 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.355 1.37 . . . . 0.0 111.891 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.94 121.71 26.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.918 . . . . 0.0 109.089 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.7 mp -101.34 -37.36 8.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.273 -0.892 . . . . 0.0 109.533 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -151.38 159.86 44.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.418 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.0 m -133.69 -179.56 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.841 0.829 . . . . 0.0 110.723 -177.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 5.9 tt -134.02 134.08 42.02 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.77 160.0 36.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.733 -0.605 . . . . 0.0 109.74 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 70' ' ' PHE . 9.0 m120 -73.36 160.74 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.99 -1.069 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mmm -68.88 -29.84 68.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 110.673 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -86.79 121.78 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.398 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -59.59 152.58 55.7 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -79.14 3.94 31.36 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.799 -1.334 . . . . 0.0 112.86 0.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.41 21.61 61.98 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.9 p -85.3 160.45 19.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.112 -1.228 . . . . 0.0 109.883 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 63' ' ' ASN . 28.3 m-85 -125.13 139.95 53.31 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.624 -0.672 . . . . 0.0 109.426 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' N ' ' SD ' ' A' ' 74' ' ' MET . 41.9 m-20 -120.25 149.51 49.63 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.04 -14.49 41.87 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 119.345 0.802 . . . . 0.0 111.936 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.71 -0.0 57.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.279 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 71' ' ' ASP . 10.9 ptm -84.59 25.75 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.336 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 56.5 mtpt -79.08 2.44 20.66 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.546 -1.346 . . . . 0.0 109.282 -179.07 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 90.8 m-20 -142.76 84.25 1.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -161.29 174.13 14.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.977 -1.077 . . . . 0.0 109.977 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -130.09 152.54 49.43 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.72 149.03 18.51 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.14 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -49.33 -49.51 15.33 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-N 119.058 0.699 . . . . 0.0 111.732 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.93 18.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.99 159.91 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.492 -1.005 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.6 m -108.82 122.43 47.17 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.356 0.598 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.2 mt -104.07 129.72 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -148.73 157.28 43.34 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.803 -1.186 . . . . 0.0 111.655 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.4 ttm -121.62 134.58 55.0 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.464 ' O ' ' OG ' ' A' ' 90' ' ' SER . 98.4 mm-40 -90.64 104.01 16.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 m -97.75 149.18 35.45 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.192 -0.943 . . . . 0.0 109.471 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.65 131.81 25.46 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.636 -1.402 . . . . 0.0 112.205 -0.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 60.8 m -103.82 166.68 10.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.75 148.54 47.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.641 -0.662 . . . . 0.0 109.398 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.75 -160.02 33.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.45 113.27 24.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.105 . . . . 0.0 109.443 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.99 -33.01 71.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.619 -0.675 . . . . 0.0 109.916 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.01 -41.49 74.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 110.597 -178.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.32 -42.1 62.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.834 -1.167 . . . . 0.0 108.681 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -62.6 -33.84 75.8 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.07 -48.69 80.67 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -59.96 -39.97 87.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.77 -40.16 91.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.7 mtp -59.89 -42.81 94.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 108.763 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.39 -40.04 96.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.28 -0.887 . . . . 0.0 109.211 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 27.7 mt-30 -60.15 -40.04 88.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 p -71.62 -40.06 70.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.92 71.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.98 -40.06 96.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.246 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.4 m-70 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.997 . . . . 0.0 108.961 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 108' ' ' ILE . 83.3 mt -59.91 -49.22 84.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.4 -49.61 66.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.831 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.88 -39.97 75.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.256 -0.903 . . . . 0.0 111.046 -178.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -102.0 -1.02 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.04 -1.037 . . . . 0.0 110.388 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.09 20.76 73.21 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.93 -172.58 48.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.36 139.23 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.588 -0.948 . . . . 0.0 109.077 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 t -77.18 133.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.155 -0.966 . . . . 0.0 108.894 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.0 mt -130.08 156.87 43.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.359 -0.838 . . . . 0.0 109.213 -179.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -86.29 -173.36 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 0.0 109.358 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 87.5 m-20 -60.08 -38.26 82.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.92 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -77.59 15.29 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.5 mtm180 56.37 39.58 30.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.702 . . . . 0.0 109.776 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 122' ' ' ARG . 43.4 mtt-85 -116.23 151.16 36.32 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.682 . . . . 0.0 109.292 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.3 mtt -50.56 134.79 23.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.8 mmm -58.39 138.63 56.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.396 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -140.0 152.85 68.67 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -48.0 -43.56 29.95 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 CA-C-N 119.018 0.685 . . . . 0.0 111.391 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.18 -40.81 91.27 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -69.92 -41.04 75.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.052 . . . . 0.0 108.974 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.166 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -62.53 -40.03 95.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.95 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.77 . . . . 0.0 110.277 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' O ' ' A' ' 12' ' ' ILE . 65.0 m-85 -60.04 -42.56 94.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.065 . . . . 0.0 108.692 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -62.56 -39.96 95.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 92.8 m-20 -62.01 -43.07 99.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 0.0 110.236 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.37 -40.64 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.828 -1.17 . . . . 0.0 109.673 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 136' ' ' ILE . 85.2 mt -60.21 -43.45 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 110.169 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 85.5 mtm180 -60.04 -40.18 88.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.043 . . . . 0.0 110.385 -179.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -61.51 -39.9 92.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.005 -1.059 . . . . 0.0 110.172 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.09 -26.19 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 111.987 -178.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -59.86 -39.65 85.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.581 -1.324 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 57.0 p-10 -59.99 -30.03 68.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.697 -1.252 . . . . 0.0 109.54 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.595 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -63.54 -37.43 87.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -96.99 -13.27 22.43 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.237 -0.915 . . . . 0.0 109.481 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.707 179.869 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.79 104.37 3.32 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.431 ' H ' ' CG2' ' A' ' 139' ' ' VAL . . . -99.34 175.23 5.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 110.443 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.42 130.16 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mm -95.8 123.83 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.17 144.21 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 121.777 0.799 . . . . 0.0 109.979 -178.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.6 mtt -143.81 151.32 39.78 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -133.52 125.06 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 110.59 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.87 117.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 159.43 44.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.117 -0.989 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.64 174.05 8.12 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -59.34 151.96 22.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 108.567 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -53.21 148.51 8.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.178 -0.951 . . . . 0.0 108.936 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.13 -1.3 79.92 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -130.04 148.47 51.9 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.426 -1.044 . . . . 0.0 109.026 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 55.8 mm-40 -127.53 148.7 50.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.426 -0.796 . . . . 0.0 108.942 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.5 mt -87.92 139.02 30.94 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.117 -0.989 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -70.85 145.57 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.78 -40.85 98.73 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.44 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -48.49 81.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.94 -1.33 . . . . 0.0 109.715 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.45 -27.43 65.24 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -59.31 2.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.589 -179.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.71 -45.44 92.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 -179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 14.1 t-20 -61.29 -40.4 93.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.407 ' OG ' ' OE1' ' A' ' 111' ' ' GLU . 35.0 t -64.45 -39.74 94.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 32' ' ' ILE . 96.6 mt -60.04 -49.16 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.973 -1.079 . . . . 0.0 110.051 -178.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.13 -40.26 97.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.995 -1.066 . . . . 0.0 109.296 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 34.9 mt-30 -68.1 -16.5 64.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 110.117 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -84.79 -0.63 54.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.994 -1.066 . . . . 0.0 109.96 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.33 13.2 57.63 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.907 -1.12 . . . . 0.0 110.49 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -82.94 149.92 26.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -1.226 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.9 mt -120.4 133.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.04 104.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 -178.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.86 171.34 32.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.72 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -1.169 . . . . 0.0 109.27 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.0 mmm 57.9 20.28 6.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.461 -0.775 . . . . 0.0 109.851 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 50.61 39.45 21.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 111.59 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.2 pt -140.04 160.69 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -91.03 118.57 30.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.005 -1.059 . . . . 0.0 110.409 -179.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.445 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 29.4 m-70 -103.49 127.08 50.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 58.5 ttt180 -102.22 124.27 47.52 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.555 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 57.9 m-70 -94.06 171.14 9.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.64 -47.94 78.62 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -91.45 147.1 34.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.758 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.85 -8.85 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.622 0.881 . . . . 0.0 111.941 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -94.67 -0.33 54.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.08 -1.013 . . . . 0.0 110.742 -179.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.76 86.43 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.9 p -70.22 -40.13 74.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.048 -1.266 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.35 162.8 51.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.537 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.3 Cg_endo -66.53 176.25 4.35 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.067 1.178 . . . . 0.0 112.103 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 118.95 23.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 108.771 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.5 mp -97.6 -42.08 7.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.79 159.54 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.988 -1.07 . . . . 0.0 108.549 178.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.4 m -132.32 175.21 9.47 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.326 -0.858 . . . . 0.0 111.078 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -128.37 131.78 48.55 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.597 0.713 . . . . 0.0 109.138 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -129.31 160.21 33.73 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.611 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 84.2 m-20 -74.6 158.24 34.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.92 -1.112 . . . . 0.0 110.334 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -70.11 -27.57 64.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.633 -0.667 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.69 135.51 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.951 -1.093 . . . . 0.0 109.592 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -62.88 149.81 89.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.525 -0.734 . . . . 0.0 110.114 -179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.13 5.35 24.78 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.962 -0.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.16 4.97 80.83 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -88.81 170.48 10.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.611 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.6 m-85 -118.61 140.09 50.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.574 -0.703 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' H ' ' HG3' ' A' ' 74' ' ' MET . 58.2 m-20 -124.33 150.02 62.83 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.79 -10.99 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.441 0.836 . . . . 0.0 112.551 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' ASP . 31.0 mp0 -88.9 2.37 53.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.001 . . . . 0.0 109.344 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.443 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 63.5 mmm -86.51 18.42 3.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.605 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.7 mttm -85.92 -4.66 59.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.082 -1.011 . . . . 0.0 108.941 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.9 m-20 -149.92 80.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 108.914 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.66 173.11 17.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 109.898 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.4 p -130.24 149.85 51.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.57 149.41 20.11 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.016 -1.053 . . . . 0.0 109.286 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.533 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 18.1 Cg_exo -44.71 -53.59 4.93 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.312 0.675 . . . . 0.0 111.39 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.09 -147.34 5.48 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.97 160.0 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.84 -0.8 . . . . 0.0 109.51 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 62' ' ' ALA . 88.2 m -113.42 118.59 34.96 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.9 mt -105.04 129.1 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.77 165.53 27.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.256 -179.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.0 ttp -140.08 127.78 21.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -90.33 117.58 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.998 . . . . 0.0 108.573 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.7 150.72 36.98 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 108.704 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -74.87 139.08 59.7 Favored 'Cis proline' 0 N--CA 1.496 1.645 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.639 -0.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.6 m -104.86 167.12 9.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -70.24 141.93 52.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.02 -155.74 27.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -95.34 119.39 33.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 108.724 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 56.7 mp0 -57.54 -31.55 66.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.534 -0.729 . . . . 0.0 110.442 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.51 -40.4 77.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.394 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.48 -40.18 70.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.24 -40.02 94.77 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -59.89 -50.11 75.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 108.699 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -60.01 -40.11 88.14 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 tp -60.52 -41.49 94.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.433 ' O ' ' OG ' ' A' ' 104' ' ' SER . 86.5 mtp -59.61 -45.4 92.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.116 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.12 -42.9 95.77 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.045 -1.034 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.03 -40.84 90.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.265 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 101' ' ' MET . 15.8 p -70.33 -40.12 74.35 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.339 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.96 -55.54 32.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.537 -0.727 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.37 -37.25 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.008 -179.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -60.07 -44.6 94.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.042 -1.036 . . . . 0.0 108.963 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 108' ' ' ILE . 84.5 mt -60.39 -49.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.27 -47.69 65.7 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.33 -40.02 89.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.149 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.407 ' OE1' ' OG ' ' A' ' 31' ' ' SER . 98.9 mt-10 -68.8 -40.38 79.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.1 -1.0 . . . . 0.0 110.938 -178.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.7 1.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.083 -1.011 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.44 25.58 72.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.68 -167.84 43.92 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.2 t -137.43 140.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.412 -1.052 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.66 130.65 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.163 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -127.01 157.51 39.37 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.0 109.297 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -84.62 -173.41 4.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.312 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.9 m-20 -60.65 -38.65 85.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.268 -0.895 . . . . 0.0 108.69 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.63 17.74 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.49 -0.756 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.15 32.44 20.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.606 -0.684 . . . . 0.0 110.709 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -111.7 147.65 35.12 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.4 mtt -52.14 125.55 16.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.609 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -60.88 136.24 58.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.904 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 128' ' ' LYS . 30.7 p -122.93 149.99 57.94 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -41.19 -44.07 5.35 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 120.662 0.908 . . . . 0.0 112.185 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.67 -39.89 90.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.291 -0.881 . . . . 0.0 109.056 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' THR . 68.6 mttm -67.89 -39.61 83.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.42 -40.18 74.3 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 130' ' ' ARG . 48.6 mtt-85 -63.37 -39.48 94.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -59.96 -44.19 94.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.121 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -62.58 -40.11 95.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 108.676 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -60.91 -39.03 87.78 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.297 -0.877 . . . . 0.0 108.841 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.58 -39.99 93.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.33 -40.89 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.007 -1.058 . . . . 0.0 108.852 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.29 -41.97 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.1 mtt180 -61.82 -28.87 69.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.916 -0.49 . . . . 0.0 110.725 -179.415 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 97.3 mt-10 -60.12 -40.1 88.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.831 -1.168 . . . . 0.0 109.645 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.431 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 64.1 t -71.97 -34.03 49.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.466 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 144' ' ' ALA . 62.9 mttm -59.88 -43.15 94.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.929 -1.107 . . . . 0.0 110.902 -179.025 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.89 -26.62 68.27 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.172 179.736 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.51 -59.7 3.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -112.21 -28.01 8.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.488 -0.757 . . . . 0.0 110.133 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.329 -0.857 . . . . 0.0 109.809 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.83 142.71 30.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.7 -174.27 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.566 -1.334 . . . . 0.0 110.5 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.8 t -131.46 136.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.2 mm -91.27 129.43 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.486 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 81.4 mt -131.64 142.72 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.056 0.931 . . . . 0.0 110.912 -177.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.8 mtm -147.85 152.17 37.18 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -129.92 129.3 43.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.921 -1.112 . . . . 0.0 111.434 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.03 112.19 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.11 154.85 39.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.119 -0.988 . . . . 0.0 110.848 -178.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.77 168.45 17.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -56.08 160.18 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.073 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.71 150.14 33.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.77 -4.41 78.9 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 m -130.14 147.48 51.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.523 -0.986 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.53 150.2 50.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.502 -0.749 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.95 145.04 27.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.109 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -70.77 141.13 51.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 108.841 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.23 97.98 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.379 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.06 -45.03 96.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.294 . . . . 0.0 109.425 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mt -69.95 -24.1 63.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.102 179.261 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tt -77.1 -55.43 5.45 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.956 -179.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.97 -48.7 80.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.127 -0.983 . . . . 0.0 111.104 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 31' ' ' SER . 43.2 p-10 -64.19 -40.02 95.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.858 -1.151 . . . . 0.0 110.66 -178.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 75.5 m -60.9 -40.55 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.888 -1.133 . . . . 0.0 109.797 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 32' ' ' ILE . 96.8 mt -60.05 -48.27 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -61.63 -40.06 93.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.26 -20.03 65.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 0.0 110.245 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.552 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.74 1.05 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.663 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.5 61.66 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -80.0 154.68 28.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.264 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.12 136.94 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.12 106.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.051 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.41 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -94.66 172.83 31.71 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.54 -168.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 110.061 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 77.1 mtm 59.24 25.4 13.99 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.613 0.721 . . . . 0.0 109.844 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 50.64 36.35 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.641 -0.662 . . . . 0.0 111.823 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -140.09 167.52 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.004 -1.06 . . . . 0.0 108.594 177.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 111.083 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 56.4 m80 -103.85 131.05 51.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.425 -0.797 . . . . 0.0 109.392 178.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.0 ttt180 -105.96 127.29 53.05 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.223 -0.923 . . . . 0.0 108.702 178.085 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.532 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 60.7 m-70 -97.37 171.71 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.0 110.173 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.28 -49.95 68.41 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -90.36 148.15 38.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.828 . . . . 0.0 109.014 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -70.27 -7.39 21.09 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.844 1.029 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.86 -0.27 55.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.116 -0.99 . . . . 0.0 110.283 -179.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.07 86.1 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -69.99 -41.26 74.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -1.145 . . . . 0.0 110.243 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.83 166.98 52.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.532 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.5 Cg_endo -65.62 168.54 14.65 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.068 1.179 . . . . 0.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.996 -1.065 . . . . 0.0 109.231 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mp -101.66 -40.12 7.14 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.891 . . . . 0.0 109.563 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -150.12 163.14 38.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 109.316 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 74.8 m -134.1 178.71 6.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.881 0.848 . . . . 0.0 111.137 -177.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.0 tt -132.5 131.43 41.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.44 162.57 31.86 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.704 -0.623 . . . . 0.0 109.48 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.48 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 11.6 m120 -74.93 159.68 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 110.53 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.0 -23.52 63.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.593 -0.692 . . . . 0.0 110.119 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -85.36 121.73 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.922 -1.111 . . . . 0.0 109.55 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -59.59 149.92 68.6 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.314 -0.866 . . . . 0.0 108.929 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -77.28 12.12 13.02 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.16 -0.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.19 85.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -87.14 170.58 11.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -1.088 . . . . 0.0 110.062 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -116.89 144.8 44.1 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' GLU . 78.1 m-20 -129.21 150.6 75.9 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 74' ' ' MET . 22.8 Cg_exo -44.81 -12.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.697 0.931 . . . . 0.0 112.16 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -85.13 15.23 4.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 71' ' ' ASP . 7.8 ptp -81.79 -5.12 57.9 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.376 -179.14 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.9 mttm -88.11 -4.63 58.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.88 -1.137 . . . . 0.0 110.468 -179.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.0 m-20 -150.96 69.7 0.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.885 -1.134 . . . . 0.0 109.822 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -154.44 170.0 22.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.6 p -129.68 154.03 47.55 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.6 148.87 17.67 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.95 -1.094 . . . . 0.0 109.329 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.69 -51.17 9.45 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 120.416 0.744 . . . . 0.0 111.62 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.98 -149.52 7.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.03 163.07 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.608 -0.936 . . . . 0.0 110.068 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.6 m -115.04 126.54 54.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 84' ' ' ILE . 85.8 mt -109.88 130.02 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.98 155.15 40.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.785 -1.197 . . . . 0.0 111.556 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.6 ttm -119.51 131.18 55.52 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.5 mm-40 -90.38 112.33 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.8 m -97.93 150.36 36.68 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.73 132.3 26.48 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.47 0.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 49.6 m -106.4 158.37 16.94 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.595 -0.691 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -73.01 153.07 41.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.61 -164.47 33.02 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 71.5 m-20 -95.29 107.92 20.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -1.067 . . . . 0.0 108.918 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.88 -30.26 68.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.667 -0.646 . . . . 0.0 110.529 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.71 -39.99 76.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.274 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.88 -40.6 60.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.042 -1.036 . . . . 0.0 108.815 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 72.3 m-80 -62.47 -35.83 80.56 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -59.6 -49.98 75.66 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -60.79 -40.08 91.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.96 -43.22 95.2 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.0 mtp -58.5 -41.17 84.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 0.0 109.1 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.15 -40.76 86.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.601 179.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.8 mt-30 -60.04 -40.13 88.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 0.0 109.526 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.405 ' HG ' ' N ' ' A' ' 105' ' ' ALA . 53.6 p -72.53 -40.01 67.11 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 109.458 179.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.405 ' N ' ' HG ' ' A' ' 104' ' ' SER . . . -59.54 -53.51 57.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 110.102 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.62 -37.74 82.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.975 -1.078 . . . . 0.0 109.314 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 12.5 m-70 -59.98 -47.48 85.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.048 179.546 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 108' ' ' ILE . 92.7 mt -60.03 -49.95 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.401 -0.812 . . . . 0.0 109.208 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.16 -50.39 49.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.571 -0.705 . . . . 0.0 109.513 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.07 -39.99 87.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.327 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.64 -39.95 80.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 110.591 -178.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -100.2 -0.16 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.58 24.33 76.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.29 -173.53 49.21 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.76 134.38 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.631 -0.923 . . . . 0.0 108.956 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.71 128.25 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 108.94 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.06 159.99 35.96 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.395 -0.816 . . . . 0.0 109.824 -179.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -85.95 -170.07 2.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.757 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.2 m-20 -60.12 -39.85 87.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.295 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.88 14.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 108.962 -179.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.4 mtt180 56.23 35.13 25.24 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.382 0.61 . . . . 0.0 109.371 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 122' ' ' ARG . 13.0 mtt-85 -109.7 153.33 24.42 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.619 -0.676 . . . . 0.0 109.315 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.2 mtm -50.27 124.37 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.3 mtp -60.03 140.0 57.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.866 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 p -131.65 150.83 77.39 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -43.64 -42.75 11.47 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.706 0.937 . . . . 0.0 112.411 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.01 -39.92 87.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.59 -39.61 88.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 109.528 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.9 -39.96 83.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 108.071 179.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.73 -40.06 96.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.01 -47.87 84.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 109.688 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -60.08 -42.58 94.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.862 -1.149 . . . . 0.0 108.585 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -60.79 -40.01 91.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.69 -38.93 86.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.631 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.0 -43.34 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.031 . . . . 0.0 108.608 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.35 85.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 108.684 179.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 57.0 mtp180 -59.89 -39.97 87.16 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.443 -0.786 . . . . 0.0 109.431 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.443 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 80.8 mm-40 -60.01 -41.36 91.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 109.805 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.92 -32.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.845 -179.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -60.04 -40.28 88.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.953 -1.092 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -59.98 -30.96 69.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.266 179.878 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.57 94.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 109.953 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -96.84 -2.67 43.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.0 109.433 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.47 6.43 43.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.114 . . . . 0.0 109.699 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.89 72.85 79.25 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 6' ' ' ARG . 11.5 Cg_exo -58.18 129.37 32.63 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.047 1.165 . . . . 0.0 112.583 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -78.77 32.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 108.563 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 4' ' ' PRO . 97.7 mtt180 -75.38 156.66 35.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.645 -0.659 . . . . 0.0 110.791 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -83.78 -6.88 59.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -142.89 149.9 39.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.66 170.98 16.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.601 -1.312 . . . . 0.0 110.605 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.04 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 11' ' ' ILE . 22.4 mm -91.95 128.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.65 140.84 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.844 0.83 . . . . 0.0 110.63 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -136.88 127.32 26.68 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.848 -1.158 . . . . 0.0 111.335 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.7 114.45 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.06 153.03 41.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.91 -165.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -69.89 155.71 40.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.065 -1.022 . . . . 0.0 109.178 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.89 140.51 55.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 109.64 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.76 6.12 73.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -129.76 143.1 50.65 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.607 -0.937 . . . . 0.0 108.856 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.2 mt-10 -123.07 150.94 42.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.409 -0.807 . . . . 0.0 109.324 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -87.5 142.44 27.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.222 -0.924 . . . . 0.0 109.864 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -67.9 140.32 56.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -0.923 . . . . 0.0 108.736 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.14 97.68 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.768 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.68 -46.58 87.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.961 -1.317 . . . . 0.0 109.783 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.02 -30.64 67.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.314 -0.866 . . . . 0.0 108.919 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.9 tt -72.19 -56.8 4.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.627 -0.671 . . . . 0.0 109.352 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.04 -42.86 95.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.35 -40.98 92.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.503 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -64.82 -41.98 95.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.929 -1.107 . . . . 0.0 110.033 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.53 -46.67 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.328 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.56 -40.13 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 0.0 110.022 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.99 -17.77 64.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.56 5.43 24.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.911 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.33 72.14 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 121.05 -1.031 . . . . 0.0 110.697 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.68 150.36 30.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.355 . . . . 0.0 109.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 38' ' ' ILE . 97.6 mt -119.05 133.05 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 109.67 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.773 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.92 171.29 23.54 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.79 -163.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -1.116 . . . . 0.0 109.725 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 92.4 mmm 58.2 20.35 7.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.71 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m120 50.08 39.11 18.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.559 -0.713 . . . . 0.0 111.396 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.94 161.56 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.098 -1.001 . . . . 0.0 108.558 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 120.62 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.05 -1.031 . . . . 0.0 110.352 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 38.6 m80 -105.12 127.9 53.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.5 ttt180 -102.67 129.23 49.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.052 -1.03 . . . . 0.0 108.893 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 13.4 m-70 -93.27 168.77 10.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.422 -0.799 . . . . 0.0 109.052 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.3 tp -52.71 -52.59 55.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.6 m -93.58 149.99 38.09 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.22 -2.14 10.01 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.57 0.846 . . . . 0.0 111.713 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -95.94 0.03 51.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.02 14.07 82.12 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.442 ' HG ' ' N ' ' A' ' 55' ' ' GLY . 83.8 p -68.41 -38.59 81.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.155 -1.203 . . . . 0.0 109.532 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -90.44 171.43 36.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 27.6 Cg_endo -74.55 178.67 6.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 120.944 1.096 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.57 118.83 22.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.129 -0.982 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.8 mp -97.81 -26.55 14.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -159.25 160.61 35.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.067 -1.02 . . . . 0.0 108.927 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.1 m -134.32 -178.56 5.1 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.915 -1.115 . . . . 0.0 112.094 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.3 tt -137.9 134.06 34.57 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.322 0.582 . . . . 0.0 109.476 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -134.15 162.22 32.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -75.32 160.81 29.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 109.849 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -69.93 -22.98 63.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 110.92 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 71.8 t -86.76 121.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.822 -1.174 . . . . 0.0 109.719 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -58.57 147.31 70.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.054 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -76.33 15.98 6.95 Favored 'Cis proline' 0 N--CA 1.492 1.435 0 C-N-CA 123.402 -1.499 . . . . 0.0 111.76 -0.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 70.05 18.66 74.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.2 p -90.76 171.47 9.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -114.6 151.94 32.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 77.8 m-20 -131.2 148.42 70.12 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -46.08 -13.96 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.562 0.842 . . . . 0.0 111.668 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.4 mt-10 -85.46 16.12 4.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 21.8 ptt? -81.94 -2.82 52.7 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 58.9 mttm -86.24 -0.76 56.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.029 -1.044 . . . . 0.0 108.773 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.5 m-20 -152.15 69.34 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.559 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -155.32 169.94 23.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.909 -1.119 . . . . 0.0 109.53 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 80.4 p -130.41 154.49 47.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.69 149.88 20.75 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.872 -1.142 . . . . 0.0 109.57 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.24 -36.43 99.02 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.508 0.805 . . . . 0.0 112.185 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.68 -157.78 19.94 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.159 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.0 160.3 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.594 -0.945 . . . . 0.0 109.116 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' ALA . 54.5 m -116.62 124.36 49.6 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.549 0.69 . . . . 0.0 109.867 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.05 129.48 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.24 163.61 34.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 110.282 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -140.02 128.56 22.89 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -88.97 118.67 28.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 108.735 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.14 152.52 39.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.45 138.13 53.87 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.275 -1.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.7 m -105.46 160.94 14.76 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.799 0.809 . . . . 0.0 110.736 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.17 143.73 52.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.709 -0.62 . . . . 0.0 109.953 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.74 -152.96 24.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -93.72 110.15 21.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -1.115 . . . . 0.0 109.068 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -56.21 -31.05 63.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.678 -0.639 . . . . 0.0 109.713 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 -37.02 75.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.99 -38.98 76.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 108.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -60.16 -41.16 92.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CG ' ' NE2' ' A' ' 133' ' ' GLN . 70.7 t80 -59.79 -46.09 90.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -61.24 -46.59 89.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.11 -40.05 88.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.099 -1.001 . . . . 0.0 110.248 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.3 mtp -59.02 -49.14 79.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.0 110.124 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.09 -40.04 90.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 109.782 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.4 mt-30 -60.02 -42.59 94.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 108.92 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 p -70.11 -39.9 75.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.454 -0.779 . . . . 0.0 109.19 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.41 -57.8 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 110.275 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -60.12 -39.69 87.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.999 -1.063 . . . . 0.0 109.764 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 13.6 m-70 -59.99 -48.3 82.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.913 -1.117 . . . . 0.0 108.636 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.14 -49.9 82.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.63 -50.13 66.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.504 -0.747 . . . . 0.0 109.327 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.81 -40.0 91.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 110.275 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.94 -40.18 75.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.1 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.12 1.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.163 -0.961 . . . . 0.0 109.609 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.45 23.07 77.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.87 -176.58 49.6 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.146 -1.208 . . . . 0.0 110.349 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.06 130.37 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.696 -0.884 . . . . 0.0 108.791 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.54 130.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -130.34 159.61 36.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.369 -0.832 . . . . 0.0 109.411 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -88.34 -173.31 4.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.4 m-20 -60.74 -38.51 85.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -76.4 14.6 0.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 121' ' ' ARG . 18.7 mtt-85 57.56 36.8 27.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 52.4 mtt-85 -112.0 149.28 32.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.2 mtp -52.27 130.3 30.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.3 mmm -60.52 138.98 57.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 p -134.87 150.94 74.67 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.7 -46.49 10.33 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 120.813 1.008 . . . . 0.0 112.708 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.27 -41.34 93.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.0 -39.88 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.927 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.0 -40.02 79.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.199 -0.938 . . . . 0.0 108.476 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.12 -36.68 82.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.621 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.58 -46.57 86.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.005 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -60.01 -40.15 88.29 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 108.741 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.576 ' NE2' ' CG ' ' A' ' 98' ' ' PHE . 85.6 mm-40 -60.94 -40.05 91.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 0.0 109.009 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.31 -40.05 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.953 . . . . 0.0 108.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.86 -42.8 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.343 -0.848 . . . . 0.0 108.754 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.07 -40.49 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 32.2 mmt180 -61.33 -37.31 82.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.38 -0.825 . . . . 0.0 109.706 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 94.0 mt-10 -59.88 -40.2 87.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.18 -32.97 27.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 111.008 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.9 mttt -59.79 -41.85 92.08 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.877 -1.139 . . . . 0.0 110.903 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.2 -29.48 68.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.83 -1.169 . . . . 0.0 109.811 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.43 91.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -104.62 -1.07 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.814 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG3' ' H ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.429 ' H ' ' HG3' ' A' ' 1' ' ' MET . 94.8 m-20 -87.07 -9.73 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.116 . . . . 0.0 108.849 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -91.07 149.94 40.84 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 52.3 Cg_exo -35.71 158.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.4 1.4 . . . . 0.0 113.271 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.18 29.89 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -78.28 92.34 4.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.085 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -85.98 -16.15 39.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -154.76 131.37 10.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.06 -170.2 1.87 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.576 -1.327 . . . . 0.0 110.88 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.06 132.3 65.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 11' ' ' ILE . 22.7 mm -86.87 130.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -126.94 144.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.091 0.948 . . . . 0.0 110.964 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.2 mtt -145.12 151.28 38.23 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.485 HD21 ' HG1' ' A' ' 83' ' ' THR . 35.0 m120 -131.24 130.13 42.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.142 . . . . 0.0 111.153 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.0 t -109.31 118.43 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 154.75 39.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.978 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.02 -165.8 0.13 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.67 155.49 35.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.934 -1.104 . . . . 0.0 108.826 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -58.73 139.45 56.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.102 -0.999 . . . . 0.0 109.589 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.22 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -128.49 143.3 50.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.575 -0.956 . . . . 0.0 108.936 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -120.39 140.46 51.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.437 -0.789 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.64 142.12 28.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 109.944 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.99 137.78 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.44 -0.787 . . . . 0.0 109.347 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.26 96.82 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.581 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.05 -46.32 89.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.772 -1.428 . . . . 0.0 109.512 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.41 -24.69 63.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -72.6 -56.54 5.18 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.11 -45.06 94.23 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.955 -1.09 . . . . 0.0 110.301 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.03 -45.99 90.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 111.518 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.4 p -63.47 -43.17 98.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.88 -1.138 . . . . 0.0 110.192 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.15 -47.14 93.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 110.202 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.0 -40.07 94.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -68.13 -19.56 64.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.536 -0.728 . . . . 0.0 109.833 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.54 7.85 11.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 109.693 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.85 9.39 84.54 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -79.76 147.6 31.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.386 . . . . 0.0 109.266 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 88.9 mt -122.91 134.37 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.98 102.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.253 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.44 168.09 29.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.53 -162.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.195 -1.179 . . . . 0.0 109.186 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.7 mtt 59.92 20.15 9.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.81 -0.557 . . . . 0.0 110.609 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.6 m120 52.35 33.19 12.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.129 -0.982 . . . . 0.0 111.362 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 12.2 pt -139.61 155.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.008 -1.058 . . . . 0.0 108.483 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -88.02 120.19 29.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.883 -1.136 . . . . 0.0 110.019 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 52.7 m-70 -105.41 127.14 52.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.638 -0.664 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 47' ' ' ARG . 15.4 ttt-85 -101.82 128.87 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.526 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 29.0 m-70 -93.84 175.74 6.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.44 -49.97 68.75 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.167 -0.958 . . . . 0.0 108.53 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 55.2 m -92.65 149.24 37.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -71.34 -2.19 10.84 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.695 0.93 . . . . 0.0 111.644 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.01 -2.78 52.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.933 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.68 85.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.8 p -69.95 -40.0 75.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -1.184 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.58 171.51 54.05 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.526 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.2 Cg_endo -71.49 177.23 7.0 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.04 1.16 . . . . 0.0 111.306 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.58 122.25 26.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 108.925 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 mp -101.06 -47.58 4.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 163.08 33.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.123 -0.986 . . . . 0.0 108.526 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.489 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.2 m -136.15 -177.01 4.51 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.125 -0.984 . . . . 0.0 111.842 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.3 tt -136.79 130.37 31.81 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.47 0.652 . . . . 0.0 109.43 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.48 160.54 33.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 93.8 m-20 -75.06 157.89 34.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.317 -0.865 . . . . 0.0 110.674 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.6 mtp -69.94 -22.19 63.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -87.04 120.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.88 151.3 64.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 110.07 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.38 15.7 7.25 Favored 'Cis proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.042 -1.232 . . . . 0.0 112.344 -1.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.94 18.61 80.17 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.9 p -87.88 175.61 7.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -1.158 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 40.4 m-85 -125.31 156.4 38.72 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 73' ' ' GLU . 39.4 m-20 -140.02 147.24 49.96 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 121.175 -0.953 . . . . 0.0 110.676 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -47.56 -11.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.36 0.807 . . . . 0.0 110.806 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 71' ' ' ASP . 44.5 mp0 -85.56 22.37 1.59 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.1 mtm -73.57 -0.1 14.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.0 mttm -88.13 -1.45 58.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.005 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.2 m-20 -151.23 74.78 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.725 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -160.05 164.61 33.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.01 -1.056 . . . . 0.0 109.544 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.5 p -139.11 155.88 47.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.62 149.02 16.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.826 -1.172 . . . . 0.0 109.353 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.85 -36.42 95.43 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.412 0.741 . . . . 0.0 111.812 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.43 -157.1 15.06 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.02 158.8 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.697 -0.884 . . . . 0.0 109.114 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.485 ' HG1' HD21 ' A' ' 14' ' ' ASN . 76.8 m -110.03 118.3 36.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 109.842 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 94.5 mt -100.56 130.04 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.98 168.97 20.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.898 -1.126 . . . . 0.0 111.021 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 ttp -141.28 135.24 30.41 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -88.32 108.62 19.42 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.41 141.36 22.9 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.53 135.25 34.39 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.498 0.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.525 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.0 m -105.32 168.52 9.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.394 -0.816 . . . . 0.0 109.289 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -69.98 149.96 47.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.97 -157.63 32.37 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.71 117.84 31.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -1.079 . . . . 0.0 109.575 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 90' ' ' SER . 57.8 mm-40 -57.6 -28.38 63.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.3 mt -69.91 -38.14 76.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 109.247 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.86 -40.0 76.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -61.39 -40.55 94.77 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -59.21 -48.38 81.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.27 -46.45 89.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 108.94 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.29 -40.1 95.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.98 -46.68 88.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.023 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.54 -45.04 84.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.519 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 29.3 mm100 -60.03 -40.23 88.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.164 -0.96 . . . . 0.0 108.448 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 p -70.02 -40.52 75.14 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.67 7.62 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.456 -0.777 . . . . 0.0 109.561 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -61.02 -40.89 95.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -60.63 -50.38 73.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.054 -1.029 . . . . 0.0 108.912 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.9 -50.09 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.71 -49.0 63.34 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.95 -40.02 87.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 110.227 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.89 -40.01 75.91 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.148 -0.97 . . . . 0.0 110.958 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.34 0.79 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.06 -1.025 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.04 21.52 76.94 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.52 50.39 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.01 136.43 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.602 -0.94 . . . . 0.0 108.916 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.03 135.05 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 109.938 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -134.85 160.21 38.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.356 -0.84 . . . . 0.0 109.425 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -86.41 -174.85 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.38 -0.825 . . . . 0.0 109.115 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.5 m-20 -60.04 -36.02 76.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.357 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -77.25 12.76 1.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 109.103 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.443 ' H ' ' C ' ' A' ' 119' ' ' ASP . 40.8 mtm-85 55.91 39.54 30.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.741 -0.6 . . . . 0.0 109.853 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -117.69 153.22 33.72 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.6 mmm -50.46 130.03 23.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 75.4 mmm -60.08 139.81 57.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.518 -0.739 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -134.45 151.21 75.74 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -43.98 -46.84 10.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.873 1.049 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -60.08 -39.99 88.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.1 -39.97 82.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 110.287 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.43 -40.04 85.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.949 -1.094 . . . . 0.0 108.603 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -63.64 -39.59 94.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.591 -0.693 . . . . 0.0 109.431 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.62 -46.97 87.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.435 ' HH ' ' CG ' ' A' ' 119' ' ' ASP . 60.0 m-85 -59.86 -41.55 91.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -62.6 -40.13 95.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.83 -41.0 94.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.08 -43.3 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 108.891 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.97 -47.46 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.538 -0.727 . . . . 0.0 109.361 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.3 mtt180 -61.06 -39.9 91.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.11 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 51.5 mt-10 -60.48 -40.06 89.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.213 -0.93 . . . . 0.0 110.971 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.52 -34.04 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.062 -1.024 . . . . 0.0 110.794 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 98.1 mttt -60.01 -44.45 94.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.538 -1.352 . . . . 0.0 110.571 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.17 -31.08 69.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.924 -1.11 . . . . 0.0 109.566 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.96 95.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 109.671 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -104.76 -3.86 23.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.764 . . . . 0.0 109.679 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.368 0.604 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.9 10.05 25.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 109.572 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 5' ' ' LYS . 5.1 mptt -129.73 79.99 72.43 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.514 -0.741 . . . . 0.0 109.448 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -72.94 10.02 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.027 1.152 . . . . 0.0 111.473 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 3' ' ' LYS . 44.4 mtmt -88.15 5.43 41.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -75.73 143.93 41.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.705 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -85.83 -17.42 35.74 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -150.86 149.25 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -163.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 109.675 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.54 130.45 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 HD12 HG23 ' A' ' 11' ' ' ILE . 30.6 mm -93.33 122.87 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.429 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.7 mt -119.18 151.34 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.26 1.029 . . . . 0.0 111.77 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.2 mtt -148.25 158.66 44.22 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -141.46 127.33 19.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.747 -1.221 . . . . 0.0 111.066 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.97 118.72 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 157.93 43.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.955 -1.091 . . . . 0.0 110.484 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -175.32 1.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.507 -0.745 . . . . 0.0 109.346 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -65.55 158.38 27.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -59.29 143.35 49.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.145 -0.972 . . . . 0.0 109.42 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.53 77.26 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -129.98 140.23 50.93 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.973 . . . . 0.0 109.355 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -127.69 148.6 50.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.494 -0.754 . . . . 0.0 109.21 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.4 mt -87.64 142.73 27.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.927 . . . . 0.0 110.151 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.76 145.58 54.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.19 98.23 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.728 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -61.71 -46.8 88.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.318 . . . . 0.0 109.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.87 -28.81 65.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.9 tt -73.08 -58.75 3.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.358 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -60.27 -44.28 95.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.36 -44.13 97.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 110.802 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 m -60.54 -40.2 90.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.813 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.96 -47.63 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.38 -40.11 95.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.263 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -66.63 -20.58 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.0 111.022 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.505 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -82.12 -9.47 59.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.731 -1.231 . . . . 0.0 110.506 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.519 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 110.0 7.06 27.56 Favored Glycine 0 N--CA 1.503 3.126 0 O-C-N 121.125 -0.984 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.689 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 35.7 m-85 -78.04 150.89 33.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.775 -1.427 . . . . 0.0 110.105 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.3 mt -126.39 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.84 110.63 1.6 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 110.191 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -100.09 171.89 23.93 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -63.78 -163.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 109.033 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.7 mtp 57.19 19.81 5.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.0 109.816 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 m120 50.71 39.06 20.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.69 -0.631 . . . . 0.0 111.485 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.05 167.02 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.013 -1.054 . . . . 0.0 108.176 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.07 121.47 35.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.976 -1.077 . . . . 0.0 111.035 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 50.8 m80 -110.2 130.27 55.57 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.625 -0.672 . . . . 0.0 109.207 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 37.6 ttm180 -103.8 132.87 49.65 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.78 -1.2 . . . . 0.0 108.643 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.55 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 84.1 m-70 -95.74 169.8 9.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 109.684 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.8 tp -55.98 -51.15 68.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 108.938 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -92.93 145.94 31.11 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.48 -2.29 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.715 0.943 . . . . 0.0 111.839 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.65 -2.56 51.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.86 86.61 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.024 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -70.01 -40.57 75.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.001 -1.293 . . . . 0.0 109.311 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.55 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -82.56 168.03 47.37 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.548 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.7 Cg_endo -70.28 174.86 9.33 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.433 1.422 . . . . 0.0 112.019 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.12 126.3 30.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 108.854 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.82 -39.92 7.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.106 -0.996 . . . . 0.0 109.532 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -149.39 165.45 32.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 108.617 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 45.2 m -133.32 -179.91 5.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.201 -0.937 . . . . 0.0 111.333 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tt -136.95 134.58 36.87 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -135.14 163.6 29.55 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.732 -0.605 . . . . 0.0 109.74 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 89.5 m-20 -77.02 164.77 25.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.527 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.6 mmm -69.94 -28.0 65.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.94 121.53 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.102 -0.999 . . . . 0.0 110.493 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -60.95 152.82 68.71 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.687 -0.633 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.93 5.02 19.43 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.377 -0.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.88 19.2 70.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.395 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.0 p -86.36 165.12 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -1.21 . . . . 0.0 109.671 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 82.5 m-85 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.627 -0.67 . . . . 0.0 109.638 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' H ' ' CG ' ' A' ' 74' ' ' MET . 90.7 m-20 -120.83 151.19 54.32 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -50.59 -12.55 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 CA-C-N 119.553 0.876 . . . . 0.0 112.178 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -88.9 4.36 48.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.428 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 72.5 mmm -81.71 16.86 1.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 44.7 mmtm -88.23 -4.72 58.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.004 -1.06 . . . . 0.0 108.584 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 78.2 m-20 -148.57 79.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.26 171.02 20.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.0 109.218 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.7 p -135.34 150.3 49.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.375 -0.828 . . . . 0.0 109.043 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.27 150.86 23.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.34 -44.08 20.77 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 120.529 0.82 . . . . 0.0 111.861 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.97 -154.56 12.1 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.97 160.51 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.688 -0.889 . . . . 0.0 109.502 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.2 m -112.81 127.96 56.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.677 0.751 . . . . 0.0 110.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -111.34 130.06 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.27 169.71 19.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.701 -1.249 . . . . 0.0 110.245 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.2 ttp -137.52 132.39 33.15 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.442 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.6 mt-30 -91.1 118.76 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.023 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.26 150.37 37.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.37 136.17 43.24 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 123.724 -1.365 . . . . 0.0 111.964 0.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 35.3 m -106.6 159.45 16.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.515 -0.74 . . . . 0.0 110.601 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -73.53 146.56 44.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 0.0 109.294 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.74 -160.9 29.18 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.93 111.55 23.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.173 . . . . 0.0 109.422 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.48 -25.0 22.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.364 -0.835 . . . . 0.0 108.777 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.51 -40.14 73.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.095 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -70.88 -40.0 72.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -60.62 -40.01 90.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.64 -43.54 89.78 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.614 -0.679 . . . . 0.0 109.283 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.48 -41.7 96.31 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.366 -0.833 . . . . 0.0 109.66 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.94 -41.07 95.54 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 109.097 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.3 mtp -58.54 -48.61 80.29 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.45 -0.781 . . . . 0.0 108.989 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.34 -47.66 78.5 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.482 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.52 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.0 mt-30 -60.5 -40.79 92.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 108.978 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.8 p -70.04 -40.82 74.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.02 -59.48 5.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.805 -0.559 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.97 -38.07 84.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 110.01 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 11.9 m-70 -60.06 -46.54 89.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.825 -1.172 . . . . 0.0 109.049 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.15 -48.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 108.592 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.27 -50.01 40.92 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.47 -39.92 89.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.676 -0.64 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.02 -40.82 74.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.166 -0.959 . . . . 0.0 111.453 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.87 3.39 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.083 -1.011 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.01 29.53 75.18 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.22 46.51 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.9 138.54 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.694 -0.886 . . . . 0.0 108.843 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.05 135.66 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.963 -1.086 . . . . 0.0 109.58 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.0 mt -133.51 155.24 49.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.309 -0.87 . . . . 0.0 109.6 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -84.23 -170.2 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.454 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.3 m-20 -61.94 -33.28 73.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 109.89 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -78.07 10.43 2.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.202 -0.936 . . . . 0.0 108.62 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.539 HH11 ' HG2' ' A' ' 121' ' ' ARG . 10.7 mtt-85 59.67 40.44 19.94 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.494 0.664 . . . . 0.0 109.292 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -124.64 153.8 41.71 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.4 mtp -50.86 126.46 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.1 mtp -60.04 140.07 57.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -127.66 150.38 72.9 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -40.75 -47.42 4.69 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.83 1.02 . . . . 0.0 112.604 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.05 -39.84 87.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.391 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -65.71 -42.13 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.153 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.02 -40.44 89.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 108.833 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -63.65 -38.66 91.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.457 -0.777 . . . . 0.0 109.399 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -60.05 -46.64 88.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -59.99 -40.07 87.91 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.553 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.64 -40.01 93.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.95 -40.84 97.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.85 -40.52 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.39 -45.09 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.691 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -62.48 -36.74 83.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.173 . . . . 0.0 110.124 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.426 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.02 -44.29 94.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.166 -0.959 . . . . 0.0 110.94 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.8 -30.81 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.969 -1.082 . . . . 0.0 110.92 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 144' ' ' ALA . 25.5 mtpp -59.69 -39.86 85.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.956 -1.09 . . . . 0.0 111.003 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.03 -29.72 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.559 -1.338 . . . . 0.0 109.002 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.72 95.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.714 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -101.03 -27.83 13.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.204 -0.935 . . . . 0.0 109.817 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.594 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' OD1' ' OE2' ' A' ' 131' ' ' GLU . 96.4 m-20 -86.05 -11.03 53.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 109.111 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -130.07 71.46 82.2 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 6' ' ' ARG . 1.2 Cg_endo -61.79 140.49 85.96 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 120.613 0.876 . . . . 0.0 112.315 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -80.0 31.04 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 4' ' ' PRO . 14.0 mmm180 -75.06 127.28 32.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.999 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -85.65 -23.93 27.27 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.9 145.99 28.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.33 169.09 21.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.74 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -115.8 130.35 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mm -92.16 129.07 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.3 mt -124.22 143.95 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.832 0.825 . . . . 0.0 110.461 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.0 mtt -142.96 149.46 38.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -132.26 128.59 38.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.977 -1.077 . . . . 0.0 111.187 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.97 119.73 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.16 157.93 43.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.56 -176.04 2.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -63.15 147.34 51.14 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.092 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 4.5 p80 -51.57 147.22 6.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.01 78.38 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -131.54 149.99 52.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.586 -0.95 . . . . 0.0 109.595 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.6 mt-10 -127.59 150.0 49.91 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.2 mt -84.26 141.97 30.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -0.975 . . . . 0.0 109.673 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -66.27 140.04 58.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.256 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.49 95.88 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.771 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.07 -47.72 83.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.967 -1.313 . . . . 0.0 110.246 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.71 -29.96 67.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 108.991 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.51 -59.74 2.6 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.9 -45.88 91.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -60.09 -42.25 94.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 109.998 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 t -64.08 -40.3 95.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 0.0 109.494 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.11 -45.33 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.089 -1.007 . . . . 0.0 109.221 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.68 -39.96 95.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.279 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -65.91 -21.95 66.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.17 7.89 10.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.358 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.11 15.46 78.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.048 -1.072 . . . . 0.0 110.894 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -81.63 150.08 28.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.896 -1.355 . . . . 0.0 109.504 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 38' ' ' ILE . 86.9 mt -119.98 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.9 103.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -0.924 . . . . 0.0 109.595 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.0 170.78 34.94 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -163.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 59.4 22.97 11.46 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.431 0.634 . . . . 0.0 110.202 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 50.96 36.15 14.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.751 . . . . 0.0 111.153 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 44' ' ' ILE . 14.0 pt -139.96 161.33 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.127 -0.983 . . . . 0.0 109.297 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -90.88 134.2 34.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.51 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 39.8 m-70 -123.02 127.86 49.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.803 -0.561 . . . . 0.0 109.505 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.4 ttt180 -100.0 123.92 44.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 25.9 m-70 -93.36 170.09 9.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.742 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.95 -51.74 66.63 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.369 -0.832 . . . . 0.0 108.92 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -97.59 148.89 35.09 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.0 108.855 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.69 -4.22 11.76 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.546 0.831 . . . . 0.0 111.611 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.14 -1.6 57.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.68 14.17 82.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -68.61 -44.21 74.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -1.198 . . . . 0.0 109.332 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.17 162.35 44.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -69.61 -176.68 1.52 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.587 1.194 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.22 127.45 33.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 109.438 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.4 mp -99.16 -39.33 8.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.203 -0.936 . . . . 0.0 108.696 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -149.38 154.37 38.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 29.9 m -129.97 170.48 13.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.263 -0.898 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.5 tt -126.36 134.52 51.05 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.574 0.702 . . . . 0.0 109.493 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -133.64 161.81 33.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.543 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.0 m-20 -73.91 160.82 30.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.008 -1.057 . . . . 0.0 110.189 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.8 mmm -69.23 -22.03 63.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.0 110.013 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.29 120.59 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.208 -0.932 . . . . 0.0 110.048 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -60.67 150.91 73.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.53 8.26 11.87 Favored 'Cis proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.317 -0.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.55 79.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.7 p -87.74 171.06 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.249 -1.147 . . . . 0.0 109.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 88.4 m-85 -120.73 161.53 21.28 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.288 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t70 -136.65 137.63 24.24 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -45.19 -12.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 120.12 1.079 . . . . 0.0 111.802 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.8 mt-10 -85.19 12.88 7.09 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.2 ptt? -80.89 9.87 5.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.295 0.569 . . . . 0.0 109.578 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -84.39 -6.72 59.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.41 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 74.1 m-20 -150.16 75.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -0.847 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -155.78 169.99 23.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 108.849 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 67.1 p -133.88 153.63 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.325 -0.859 . . . . 0.0 109.136 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 148.62 19.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 109.182 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -47.43 -53.64 6.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 120.524 0.816 . . . . 0.0 111.646 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.24 -154.0 8.04 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.685 -0.891 . . . . 0.0 109.03 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 62' ' ' ALA . 44.0 m -112.0 120.13 40.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.824 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.8 mt -105.03 130.05 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.8 170.0 17.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 34.8 ttm -138.94 129.8 26.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.458 ' O ' ' OG ' ' A' ' 90' ' ' SER . 94.7 mt-30 -90.09 112.63 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.4 142.33 24.39 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.49 138.92 57.18 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 124.022 -1.241 . . . . 0.0 112.927 0.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 6.9 m -114.05 164.72 13.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.337 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -71.12 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.52 -165.71 39.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -94.9 117.77 30.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -1.115 . . . . 0.0 108.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -55.71 -29.48 59.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.432 -0.792 . . . . 0.0 109.621 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.43 -39.97 77.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.236 -0.915 . . . . 0.0 108.947 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -70.19 -39.99 74.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.917 -1.115 . . . . 0.0 108.557 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.38 -40.07 92.97 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -58.2 -42.95 87.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.93 -44.84 95.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 108.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.53 -39.99 93.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.8 mmm -57.56 -50.05 74.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.83 -44.27 81.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.975 . . . . 0.0 109.421 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.469 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -59.99 -40.52 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.948 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 p -70.18 -41.84 73.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.64 7.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.819 . . . . 0.0 110.146 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.8 m-70 -60.08 -50.03 75.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.082 . . . . 0.0 109.235 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.98 -50.02 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.176 -0.953 . . . . 0.0 109.561 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.05 -50.58 58.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 110.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.98 -39.97 75.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.956 . . . . 0.0 111.076 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 m -98.86 -0.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.044 . . . . 0.0 109.509 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.47 23.9 77.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.48 -170.7 47.41 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.4 t -134.5 139.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -1.027 . . . . 0.0 109.337 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.5 133.57 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.44 154.8 49.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 25.6 p-10 -84.86 -174.86 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.8 m-20 -59.93 -36.96 78.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 109.252 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.497 ' OE1' ' NH2' ' A' ' 122' ' ' ARG . 96.1 mt-30 -77.4 16.87 0.56 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.396 -0.815 . . . . 0.0 109.31 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.2 mtt180 60.07 20.81 10.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.967 -0.458 . . . . 0.0 111.0 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.542 ' NH2' ' NZ ' ' A' ' 128' ' ' LYS . 34.4 mtm-85 -106.18 147.63 28.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.209 -0.932 . . . . 0.0 108.518 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.96 137.14 21.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.161 -0.962 . . . . 0.0 110.542 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.9 mtt -59.93 144.22 49.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.623 -0.673 . . . . 0.0 110.327 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.6 p -132.94 152.23 79.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -42.09 -47.69 6.7 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 120.639 0.893 . . . . 0.0 112.074 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -60.85 -43.22 98.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' NZ ' ' NH2' ' A' ' 122' ' ' ARG . 98.4 mttt -67.29 -39.97 86.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 110.218 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.93 -39.93 87.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.997 -1.064 . . . . 0.0 108.275 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -67.8 -38.59 83.5 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.684 -0.635 . . . . 0.0 109.909 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' OE2' ' OD1' ' A' ' 2' ' ' ASP . 58.9 mm-40 -59.75 -46.07 90.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.73 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -60.06 -41.08 91.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.044 . . . . 0.0 108.239 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.5 -39.99 95.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.558 -0.714 . . . . 0.0 109.125 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.04 -40.03 92.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.511 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -43.45 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 108.769 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.98 -42.08 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 137' ' ' ARG . 49.3 mtt-85 -62.23 -39.85 94.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 74.9 mm-40 -60.02 -39.97 87.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.107 -0.995 . . . . 0.0 109.35 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.19 -27.96 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 mmtt -60.04 -45.3 93.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.0 110.173 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.95 -31.06 70.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.309 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.63 96.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 46.4 p-10 -105.31 -3.3 22.93 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.29 -0.881 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.693 ' H ' ' HZ3' ' A' ' 3' ' ' LYS . 96.0 m-20 -91.66 42.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 109.601 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.693 ' HZ3' ' H ' ' A' ' 2' ' ' ASP . 4.4 mtmm -130.02 78.03 75.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.495 -0.753 . . . . 0.0 109.513 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -65.7 37.6 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.161 1.24 . . . . 0.0 111.747 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 3' ' ' LYS . 88.0 mttt -70.86 -26.45 63.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -83.71 119.31 24.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -86.42 -19.25 29.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.6 149.55 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.579 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.46 162.59 27.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 109.69 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.32 130.67 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 0.0 109.145 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mm -90.82 132.49 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.9 mt -129.93 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 122.279 1.038 . . . . 0.0 111.344 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.3 mtt -142.87 151.66 41.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -131.55 121.71 24.89 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.833 -1.167 . . . . 0.0 111.113 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.1 t -99.71 110.01 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.54 159.79 42.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.11 -166.3 0.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.11 159.96 32.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -58.38 145.14 39.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.45 10.26 82.22 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -130.06 147.52 51.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -1.043 . . . . 0.0 109.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.71 145.75 50.8 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.7 mt -85.19 147.68 26.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.777 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.14 142.98 55.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.024 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.31 99.36 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.918 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.33 -43.74 98.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.374 . . . . 0.0 109.835 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.94 -28.51 65.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.1 tt -71.04 -59.58 2.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.16 -39.95 88.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.6 p -66.45 -39.82 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 109.968 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.409 HG21 HD11 ' A' ' 32' ' ' ILE . 94.8 mt -59.87 -49.94 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -62.16 -40.0 94.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.956 -1.09 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.81 -22.88 66.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.99 7.72 12.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.029 -1.045 . . . . 0.0 110.266 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.58 75.98 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.138 -0.976 . . . . 0.0 111.118 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.78 150.01 26.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.323 . . . . 0.0 110.051 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.78 132.39 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.62 100.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.908 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.34 171.72 32.56 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.76 -161.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -1.156 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 98.0 mtp 60.0 20.55 9.65 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.51 0.671 . . . . 0.0 109.914 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 m120 51.93 33.56 11.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.567 -0.708 . . . . 0.0 111.565 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 pt -141.65 168.13 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.0 109.189 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.06 121.5 33.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.459 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 63.3 m-70 -106.51 130.03 54.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.784 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 47' ' ' ARG . 7.2 ttt-85 -102.8 126.89 50.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.274 -0.892 . . . . 0.0 109.184 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 28.5 m-70 -97.35 170.92 8.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.0 -49.99 74.08 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -91.36 145.72 31.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 -2.72 9.4 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.668 0.912 . . . . 0.0 111.833 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.54 -3.68 52.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 109.85 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.0 9.78 86.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -70.9 -42.61 69.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.294 . . . . 0.0 110.229 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.01 164.99 54.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -68.4 175.12 7.28 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.997 1.131 . . . . 0.0 111.374 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.8 121.84 26.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.004 . . . . 0.0 109.323 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.1 mp -97.68 -38.1 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.207 -0.933 . . . . 0.0 108.741 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.57 167.52 29.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 67.5 m -137.33 -179.08 5.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 111.173 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -136.51 131.65 34.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.1 160.29 34.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 109.543 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.59 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 94.0 m-20 -74.5 159.45 32.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.03 -21.32 63.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 110.177 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.15 121.24 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.056 -1.028 . . . . 0.0 109.901 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -60.69 150.66 74.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 109.189 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.34 12.21 20.22 Favored 'Cis proline' 0 N--CA 1.494 1.526 0 C-N-CA 123.584 -1.423 . . . . 0.0 111.723 -0.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 19.03 67.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.6 167.18 14.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.285 -1.127 . . . . 0.0 110.443 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 88.7 m-85 -122.39 141.87 51.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.573 -0.705 . . . . 0.0 109.484 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 73' ' ' GLU . 47.8 m-20 -128.79 150.0 73.76 Favored Pre-proline 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.68 -6.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.548 0.874 . . . . 0.0 111.778 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 71' ' ' ASP . 97.2 mt-10 -89.32 0.22 56.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.404 ' CE ' ' ND2' ' A' ' 63' ' ' ASN . 65.8 mmm -85.33 13.68 6.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.46 -0.775 . . . . 0.0 109.585 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -85.42 -8.6 58.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.164 . . . . 0.0 108.75 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -150.76 79.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -155.8 174.14 15.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.1 p -129.84 150.28 51.21 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.28 150.22 19.5 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.156 -0.965 . . . . 0.0 109.095 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -44.76 -43.61 14.69 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 120.415 0.743 . . . . 0.0 111.619 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -149.54 10.9 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 159.95 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.985 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -113.22 120.88 42.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 109.537 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.0 mt -103.03 130.5 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -145.85 170.6 16.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.936 -1.102 . . . . 0.0 110.496 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -138.45 130.68 28.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.35 123.91 33.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.579 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 4.4 m -102.26 148.81 35.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.857 . . . . 0.0 109.016 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.42 141.93 72.76 Favored 'Cis proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.94 -1.275 . . . . 0.0 111.87 -1.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -107.0 155.72 19.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.971 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 92' ' ' GLY . 64.7 t80 -72.33 155.3 40.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 109.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CD2' ' A' ' 91' ' ' TYR . . . 80.75 -157.85 40.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -97.49 118.05 33.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -1.095 . . . . 0.0 109.076 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.38 -32.9 70.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.583 -0.698 . . . . 0.0 110.432 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.1 mt -69.9 -40.07 75.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.931 -1.106 . . . . 0.0 109.973 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -71.64 -40.02 70.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.923 -1.111 . . . . 0.0 108.361 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.9 -39.83 93.34 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.891 0.853 . . . . 0.0 108.811 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 64.8 t80 -59.51 -50.0 75.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -62.42 -39.94 94.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.01 -41.92 93.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.27 -46.06 89.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.375 -0.828 . . . . 0.0 109.473 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.17 -41.4 98.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.015 -1.053 . . . . 0.0 108.764 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.483 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.1 mt-30 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.349 -0.844 . . . . 0.0 108.803 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 p -71.76 -40.25 69.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.9 67.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.58 -35.64 80.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 109.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.2 m-70 -60.09 -45.84 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.074 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 108' ' ' ILE . 96.7 mt -60.27 -49.9 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 108.948 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.61 -49.7 55.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.51 -0.744 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.55 -39.98 89.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.18 -40.08 78.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.319 -0.863 . . . . 0.0 110.909 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.3 m -103.14 0.02 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.99 22.93 77.29 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.66 -171.24 47.89 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.06 141.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.988 . . . . 0.0 109.561 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.76 130.04 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 108.985 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' ' SD ' ' A' ' 124' ' ' MET . 76.0 mt -132.0 159.97 37.2 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' N ' ' SD ' ' A' ' 124' ' ' MET . 35.7 p-10 -85.31 -172.59 4.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.6 m-20 -59.97 -37.94 81.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.986 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -76.95 14.02 0.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 108.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.7 mtt180 55.91 32.81 20.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.732 -0.605 . . . . 0.0 109.526 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.54 156.58 19.34 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.9 mmm -50.92 133.97 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 117' ' ' LEU . 96.5 mmm -58.27 139.91 54.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.742 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.519 ' HG1' ' H ' ' A' ' 128' ' ' LYS . 27.9 p -129.4 148.71 70.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -49.96 -43.76 40.2 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 119.43 0.832 . . . . 0.0 111.947 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.42 -40.1 89.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.519 ' H ' ' HG1' ' A' ' 125' ' ' THR . 63.6 mmtt -65.76 -39.95 91.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.049 -1.032 . . . . 0.0 109.878 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.98 -40.05 87.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 108.675 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.63 -39.22 91.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.06 -46.37 88.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -59.98 -46.31 89.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.564 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 37.4 mm-40 -60.01 -39.98 87.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.396 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.95 -41.64 92.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.69 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.6 mt -63.36 -43.64 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.741 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.08 -44.96 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.803 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.474 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.1 mmt180 -60.03 -39.93 87.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 96.2 mt-10 -60.17 -38.63 83.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.529 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 75.0 t -66.42 -39.73 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 110.537 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.8 mttt -59.88 -50.08 75.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.887 -1.133 . . . . 0.0 110.889 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 2.1 p-10 -62.38 -36.99 84.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.822 -1.174 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.42 99.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.305 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -102.27 -0.76 32.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.22 -0.925 . . . . 0.0 109.783 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 109.526 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.8 7.89 37.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.549 -0.719 . . . . 0.0 109.332 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -77.81 131.11 71.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.15 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 6' ' ' ARG . 13.2 Cg_exo -50.21 118.06 3.65 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.992 1.033 . . . . 0.0 112.918 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.89 33.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 4' ' ' PRO . 93.8 mtt180 -69.97 150.53 46.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.489 -0.757 . . . . 0.0 110.249 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -81.15 -9.31 59.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -148.89 142.02 24.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.87 171.91 17.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 109.607 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.63 129.92 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.07 129.94 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.3 mt -128.72 146.12 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.083 0.944 . . . . 0.0 110.775 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -145.76 151.09 37.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.405 ' OD1' ' SD ' ' A' ' 64' ' ' MET . 67.3 m-80 -136.86 130.28 31.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.647 -1.283 . . . . 0.0 111.244 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.25 129.96 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.74 159.9 41.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 110.577 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.39 -172.47 1.46 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -65.96 155.99 34.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.839 -1.163 . . . . 0.0 108.298 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -55.53 133.1 50.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.128 . . . . 0.0 109.636 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.29 5.8 75.49 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.5 m -127.04 153.69 45.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.478 -1.013 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.98 153.67 45.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.533 -0.73 . . . . 0.0 109.083 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.87 138.37 32.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.989 . . . . 0.0 109.693 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -69.75 145.19 52.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.14 -42.97 98.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.1 -46.66 89.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -1.191 . . . . 0.0 109.906 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' O ' ' OG ' ' A' ' 31' ' ' SER . 93.0 mt -69.73 -28.48 65.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.7 -57.31 4.48 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.593 -0.692 . . . . 0.0 109.549 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.97 -46.12 90.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.045 . . . . 0.0 110.824 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -64.79 -41.36 95.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.002 -1.062 . . . . 0.0 111.067 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 27' ' ' LEU . 52.2 m -63.03 -39.99 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.027 -1.046 . . . . 0.0 110.098 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.12 -49.82 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 110.695 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -63.26 -40.06 96.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.926 -1.109 . . . . 0.0 109.806 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -61.65 -23.62 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 110.761 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.597 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.32 -8.69 59.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.831 -1.168 . . . . 0.0 110.614 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 109.37 9.96 24.55 Favored Glycine 0 N--CA 1.503 3.105 0 O-C-N 121.01 -1.056 . . . . 0.0 110.845 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.748 ' N ' HH21 ' A' ' 47' ' ' ARG . 30.0 m-85 -79.89 148.95 31.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.683 -1.481 . . . . 0.0 109.972 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.6 133.56 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.24 105.69 0.53 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 110.265 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -94.59 171.38 30.48 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.45 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.125 -1.221 . . . . 0.0 110.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.9 mtt 59.96 22.68 11.77 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.406 0.622 . . . . 0.0 110.198 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.1 m120 52.57 36.21 19.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 111.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 44' ' ' ILE . 19.8 pt -140.08 161.6 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.995 -1.066 . . . . 0.0 108.572 178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.08 120.94 33.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.064 -1.022 . . . . 0.0 110.677 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 54.3 m80 -106.79 131.5 53.83 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.748 HH21 ' N ' ' A' ' 37' ' ' PHE . 32.6 ttm180 -104.5 130.22 52.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.006 -1.059 . . . . 0.0 108.497 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.443 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 69.6 m-70 -100.15 169.42 9.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.844 . . . . 0.0 109.979 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.1 tp -57.06 -50.0 74.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -89.91 148.32 39.41 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.49 -4.45 15.02 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.597 0.865 . . . . 0.0 111.83 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -94.96 -0.17 54.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.187 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 9.05 87.2 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -69.91 -40.4 75.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -1.187 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.49 166.01 52.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.443 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.5 Cg_endo -68.63 175.03 7.63 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 120.916 1.078 . . . . 0.0 111.737 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.35 123.36 29.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.1 mp -99.84 -37.14 9.18 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.09 161.93 41.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 108.672 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 49.2 m -134.44 -177.97 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.859 0.838 . . . . 0.0 110.844 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -136.66 130.85 32.8 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.82 162.67 30.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.545 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.5 m120 -78.49 164.9 24.34 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.045 -1.034 . . . . 0.0 110.547 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 14' ' ' ASN . 89.8 mmm -70.03 -22.61 63.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 0.0 110.461 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 94.2 t -86.95 119.24 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.978 -1.076 . . . . 0.0 110.115 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.91 147.72 78.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.151 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.64 14.56 6.93 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.552 -1.437 . . . . 0.0 111.842 -0.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 72.13 17.75 77.47 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 p -87.29 175.92 7.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -1.229 . . . . 0.0 109.728 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 80.1 m-85 -119.59 147.9 43.95 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 0.0 109.52 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 27.0 m-20 -134.0 150.2 73.72 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -46.66 -8.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.641 0.894 . . . . 0.0 112.306 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.7 mt-10 -85.66 10.36 13.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.74 -1.29 53.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.766 -0.584 . . . . 0.0 109.87 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.7 mttp -84.3 -6.78 59.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.5 m-20 -150.1 78.01 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -162.31 171.39 17.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.842 -1.161 . . . . 0.0 109.814 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.8 p -131.86 156.99 45.1 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.04 18.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.024 -1.048 . . . . 0.0 109.141 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 -24.36 54.05 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 120.515 0.81 . . . . 0.0 111.89 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.4 -164.02 36.27 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.731 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.11 166.52 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.751 -0.852 . . . . 0.0 108.735 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -119.89 129.97 54.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.532 -0.73 . . . . 0.0 110.387 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.52 128.96 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.72 164.08 32.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.001 -1.062 . . . . 0.0 110.827 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.7 ttm -132.19 130.22 40.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.73 105.35 17.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.3 m -97.38 148.72 34.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.82 134.43 35.74 Favored 'Cis proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.364 0.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -105.56 159.89 15.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.07 145.49 49.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.339 -0.851 . . . . 0.0 109.214 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.31 -161.55 23.29 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 89.6 m-20 -96.25 108.96 21.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.013 -1.286 . . . . 0.0 109.05 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.29 -31.34 65.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.46 -0.775 . . . . 0.0 110.065 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.05 -40.63 74.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.014 . . . . 0.0 110.338 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -77.09 -40.61 45.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.619 -1.3 . . . . 0.0 108.925 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 81.0 m-20 -60.05 -38.09 81.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -58.45 -40.96 84.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -63.68 -40.08 95.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.941 -1.099 . . . . 0.0 108.604 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.56 -39.96 89.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.93 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.8 mtp -58.13 -49.88 75.44 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.537 -0.727 . . . . 0.0 109.36 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.53 -45.53 86.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 109.294 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.5 mt-30 -60.25 -40.17 89.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 108.445 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.564 ' HG ' ' H ' ' A' ' 105' ' ' ALA . 93.7 p -70.39 -44.0 68.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -59.89 -54.57 44.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.517 -0.739 . . . . 0.0 110.197 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.096 -1.002 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.6 m-70 -59.98 -43.66 94.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.0 108.506 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.24 -49.99 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.71 -49.41 68.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.09 -39.97 91.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.9 -40.0 75.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.895 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.17 2.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.018 -1.052 . . . . 0.0 109.532 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 67.13 25.36 73.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -162.67 38.52 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.417 -1.049 . . . . 0.0 110.487 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.59 154.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.646 -0.914 . . . . 0.0 109.203 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.2 t -94.93 129.82 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.426 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.1 mt -122.05 160.08 25.71 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.563 -0.711 . . . . 0.0 110.102 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.11 -171.29 3.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.7 m-20 -60.09 -40.04 88.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 109.697 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -76.23 17.76 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.478 ' H ' ' C ' ' A' ' 119' ' ' ASP . 87.1 mtm180 56.2 35.02 25.01 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.468 0.651 . . . . 0.0 109.756 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -110.24 144.2 39.29 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.7 mtp -51.3 129.56 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 108.943 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.2 mtt -59.08 141.19 54.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 110.106 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 p -129.56 150.4 75.58 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -42.5 -45.17 8.26 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.469 0.78 . . . . 0.0 112.237 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -61.34 -40.01 92.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.188 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.054 -1.029 . . . . 0.0 110.544 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.92 -40.11 83.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.872 . . . . 0.0 108.765 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -65.95 -39.88 90.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.462 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.83 -43.57 94.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 109.839 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 58.1 m-85 -60.14 -44.03 95.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.019 -1.051 . . . . 0.0 108.394 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.72 -40.07 96.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.49 ' OD2' ' NZ ' ' A' ' 3' ' ' LYS . 96.1 m-20 -61.58 -40.04 93.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.615 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.53 -40.95 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.145 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.67 -38.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 108.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 137' ' ' ARG . 27.2 mtt-85 -59.86 -38.91 83.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.045 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.6 -39.99 90.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.117 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.58 -28.77 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 111.025 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 144' ' ' ALA . 68.5 mttm -60.03 -45.24 93.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.663 -1.273 . . . . 0.0 110.179 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.07 -30.13 69.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.906 -1.121 . . . . 0.0 109.192 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.52 93.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.963 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -100.48 -25.62 14.13 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.354 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -88.79 -9.17 52.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -80.0 150.0 71.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.036 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.53 111.37 0.52 Allowed 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 120.572 0.848 . . . . 0.0 111.637 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.04 7.94 8.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.281 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.452 ' HG2' HH11 ' A' ' 6' ' ' ARG . 0.1 OUTLIER -78.68 118.39 20.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.005 . . . . 0.0 110.723 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.56 -11.15 52.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -147.5 130.85 16.6 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.3 -166.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.699 -1.251 . . . . 0.0 110.272 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.2 t -140.02 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 11' ' ' ILE . 23.2 mm -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 95.5 mt -120.0 147.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.281 1.039 . . . . 0.0 111.652 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.0 mtt -146.2 158.82 43.9 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' CG ' ' NH1' ' A' ' 121' ' ' ARG . 34.6 m120 -141.15 121.77 14.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.658 -1.277 . . . . 0.0 111.457 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.49 113.48 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.42 44.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.82 -169.91 0.51 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.88 157.34 37.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.03 -1.044 . . . . 0.0 109.1 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -60.06 140.13 57.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.709 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.81 2.08 63.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.1 m -127.19 149.7 49.86 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.577 -0.955 . . . . 0.0 109.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -131.18 145.07 51.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.553 -0.717 . . . . 0.0 109.218 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.3 mt -87.6 146.78 25.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.02 146.42 51.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 108.948 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.45 97.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mm-40 -61.19 -44.1 97.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.338 . . . . 0.0 109.857 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 89.5 mt -69.95 -27.85 65.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 tt -76.07 -59.62 2.68 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.71 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -47.93 83.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.288 -0.883 . . . . 0.0 111.579 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.3 p-10 -61.27 -39.99 92.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.894 -1.129 . . . . 0.0 110.342 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 56.5 m -62.21 -40.25 95.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.871 -1.143 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 32' ' ' ILE . 89.3 mt -60.59 -45.92 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.225 -0.922 . . . . 0.0 109.805 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -60.7 -40.03 90.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.31 -19.87 65.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.911 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.56 8.7 9.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.945 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.89 81.76 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -81.51 151.78 27.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.297 . . . . 0.0 110.113 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.98 139.95 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.62 107.41 0.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 109.572 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.83 171.49 34.52 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.43 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.235 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 72.1 mtm 56.73 26.1 10.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 110.09 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.9 m120 50.03 39.44 19.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 111.293 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 pt -141.67 161.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.5 130.76 37.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' HD1' ' CB ' ' A' ' 60' ' ' SER . 12.9 m-70 -117.79 127.97 54.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -99.99 127.08 46.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.158 -0.964 . . . . 0.0 108.545 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.7 m-70 -95.8 170.05 9.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.492 -0.755 . . . . 0.0 109.701 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -49.99 -53.93 23.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.089 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -90.82 149.23 39.98 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.305 -0.872 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.66 -5.18 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.814 1.009 . . . . 0.0 112.452 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -93.04 0.04 57.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.135 -0.978 . . . . 0.0 110.041 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.1 81.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.4 p -70.0 -40.0 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -1.173 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -85.8 173.52 47.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.0 Cg_endo -73.96 178.4 6.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.37 1.38 . . . . 0.0 111.658 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.64 123.08 27.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.884 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.6 mp -97.38 -47.05 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.157 -0.965 . . . . 0.0 109.03 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -138.08 160.11 40.25 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.546 ' CB ' ' HD1' ' A' ' 46' ' ' HIS . 2.9 m -127.66 178.2 6.29 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.196 0.998 . . . . 0.0 111.694 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 tt -138.6 130.07 27.44 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.599 0.714 . . . . 0.0 109.146 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.63 160.11 34.33 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.62 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.5 m-20 -73.73 161.79 29.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.991 -1.068 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mtp -69.66 -29.96 67.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 110.906 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 p -86.35 131.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.804 -1.185 . . . . 0.0 110.126 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -59.97 150.04 71.17 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -76.91 5.93 18.49 Favored 'Cis proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.552 -0.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.82 83.08 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -88.55 169.97 11.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.101 -1.235 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.62 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 75.3 m-85 -120.05 143.49 48.07 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -119.82 149.99 49.66 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.439 -0.788 . . . . 0.0 108.889 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.3 -20.15 61.23 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 120.498 0.798 . . . . 0.0 112.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.95 -2.71 58.21 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -0.927 . . . . 0.0 109.121 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.594 ' CE ' ' ND2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -89.24 25.24 1.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.526 -0.734 . . . . 0.0 110.652 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 29.4 mmtm -80.96 0.88 33.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.885 -1.134 . . . . 0.0 109.351 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 91.6 m-20 -142.0 86.77 2.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.96 177.97 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 109.724 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 p -131.73 150.12 52.26 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.56 149.48 19.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 0.0 109.219 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -45.28 -41.44 17.12 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 120.366 0.711 . . . . 0.0 111.393 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.59 -150.79 10.28 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.11 159.98 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.607 -0.937 . . . . 0.0 109.726 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 m -114.72 124.88 52.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.87 129.94 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -146.65 149.45 33.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.919 -1.113 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.2 ttm -102.31 133.33 47.4 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.464 -0.772 . . . . 0.0 109.526 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.7 mt-30 -91.07 105.36 17.76 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 16.0 m -97.46 147.21 32.65 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.185 -0.947 . . . . 0.0 108.537 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -74.23 133.64 31.97 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.377 0.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.6 m -105.29 158.85 16.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -72.73 149.9 43.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.732 . . . . 0.0 109.94 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.1 -160.36 34.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.1 116.15 28.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -1.159 . . . . 0.0 108.952 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.55 -31.81 69.76 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 110.219 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.07 -41.47 74.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.155 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -74.29 -39.98 62.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.63 -39.81 89.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 133' ' ' GLN . 55.9 t80 -53.09 -40.06 63.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -59.99 -40.0 87.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.198 -0.939 . . . . 0.0 108.713 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.82 -39.97 93.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 109.177 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mtp -56.61 -50.01 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.156 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.32 -44.7 90.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.91 . . . . 0.0 109.608 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 84.3 mt-30 -60.02 -40.84 90.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 108.826 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 p -70.17 -40.04 74.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.418 -0.801 . . . . 0.0 109.711 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.85 52.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.162 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -62.09 -37.2 84.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 0.0 109.971 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 10.9 m-70 -60.12 -47.63 85.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.987 -1.071 . . . . 0.0 109.126 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 108' ' ' ILE . 96.7 mt -60.11 -49.95 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.78 -47.72 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.69 -40.32 91.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 110.096 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -71.14 -39.99 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 0.0 111.158 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.33 2.33 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.76 23.1 68.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.08 -173.24 45.54 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 134.83 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.606 -0.938 . . . . 0.0 109.136 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.8 t -70.69 135.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.62 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 mt -132.4 156.19 47.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.459 -0.776 . . . . 0.0 109.732 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -87.89 -173.62 4.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.6 m-20 -60.03 -34.47 73.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.021 . . . . 0.0 108.996 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.34 14.98 0.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 108.961 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 119' ' ' ASP . 20.2 mmt180 60.11 24.12 13.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.656 -0.652 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -110.96 150.85 28.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.44 -0.788 . . . . 0.0 109.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.9 mtm -50.52 129.39 22.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.081 -1.012 . . . . 0.0 109.597 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.0 mtp -59.93 139.7 57.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.778 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -125.6 151.01 69.86 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -40.34 -46.43 4.31 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 120.911 1.074 . . . . 0.0 112.532 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -60.14 -39.99 88.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.616 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.82 -39.73 83.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.188 -0.945 . . . . 0.0 110.341 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.65 -40.53 75.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.973 -1.079 . . . . 0.0 108.128 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.406 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 34.3 ttm-85 -65.29 -39.33 92.42 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.84 -46.85 87.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.68 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 62.0 m-85 -60.13 -42.7 95.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.053 -1.029 . . . . 0.0 108.258 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 98' ' ' PHE . 23.6 mm100 -62.97 -40.1 96.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 95.6 m-20 -61.65 -40.97 96.83 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.419 -0.801 . . . . 0.0 109.838 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -40.05 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.906 -1.121 . . . . 0.0 109.432 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.25 -39.23 81.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 99.1 mtt180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.886 -1.134 . . . . 0.0 111.303 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 15.2 mp0 -60.09 -39.09 84.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.794 -1.191 . . . . 0.0 110.164 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.07 -39.33 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.916 -1.115 . . . . 0.0 110.391 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.96 -50.08 75.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.779 -1.2 . . . . 0.0 110.929 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -60.91 -32.54 72.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.684 -1.26 . . . . 0.0 109.253 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.34 -23.78 67.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 108.826 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -98.74 -2.2 38.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.064 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.465 -179.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -86.59 -33.19 20.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' N ' ' OE2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -134.57 74.43 65.6 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -70.97 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.048 1.165 . . . . 0.0 111.834 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 3' ' ' LYS . 9.0 mtpm? -74.14 -37.91 63.91 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.72 -0.612 . . . . 0.0 109.626 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.43 120.91 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.712 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -81.85 -69.85 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -99.79 139.16 35.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.07 -175.93 5.55 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.738 -1.226 . . . . 0.0 110.231 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.04 133.32 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 11' ' ' ILE . 19.4 mm -88.93 135.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.468 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.1 mt -130.73 143.16 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.992 0.901 . . . . 0.0 110.701 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.512 ' C ' HD21 ' A' ' 14' ' ' ASN . 58.5 mtm -149.31 152.09 35.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.512 HD21 ' C ' ' A' ' 13' ' ' MET . 5.7 m120 -129.13 130.36 46.34 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.099 -1.0 . . . . 0.0 111.013 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.97 113.8 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.09 153.32 38.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.175 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.24 -175.94 1.34 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -60.07 150.52 29.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 108.99 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -59.9 148.27 35.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.04 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.54 -5.57 77.27 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -128.98 142.1 51.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.941 . . . . 0.0 108.894 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -121.93 150.15 42.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.746 . . . . 0.0 109.305 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.27 142.46 29.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.343 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -67.69 141.03 56.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.0 108.795 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.1 96.47 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -62.59 -46.52 87.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.217 . . . . 0.0 109.573 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.1 -29.16 66.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 109.031 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.2 tt -73.65 -58.92 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.07 -44.11 94.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.64 -40.7 95.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.501 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -64.82 -40.08 94.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.86 -50.26 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.353 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -63.97 -40.07 95.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.05 -20.39 66.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.416 -0.802 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.53 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.47 1.07 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 109.657 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.86 16.84 43.36 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 121.156 -0.965 . . . . 0.0 111.166 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -82.35 152.46 26.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.403 . . . . 0.0 110.242 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.86 134.81 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.12 104.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.067 -1.021 . . . . 0.0 109.996 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -93.63 171.31 31.77 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -65.56 -163.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.249 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.6 mmm 58.7 19.96 7.33 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.643 0.735 . . . . 0.0 109.688 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 51.76 38.19 22.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.526 -0.734 . . . . 0.0 111.898 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 pt -140.56 166.29 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.875 -1.14 . . . . 0.0 108.505 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -92.63 122.58 35.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.829 -1.169 . . . . 0.0 110.201 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.9 m80 -106.45 127.33 53.21 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.457 -0.777 . . . . 0.0 109.092 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 37.5 ttt180 -103.88 128.71 51.36 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.06 -1.025 . . . . 0.0 109.05 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 64.4 m-70 -98.66 171.41 8.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.33 -0.856 . . . . 0.0 109.733 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.9 -49.68 72.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.8 m -91.15 147.79 36.41 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 109.015 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.45 -7.97 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.747 0.964 . . . . 0.0 111.905 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -91.44 -0.25 57.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 109.974 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.79 12.01 84.9 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.197 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.2 p -70.59 -40.59 73.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.008 -1.289 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.3 167.83 51.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.512 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 15.0 Cg_endo -69.67 170.42 16.51 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 120.934 1.089 . . . . 0.0 111.427 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.71 126.2 30.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.0 mp -99.39 -30.72 12.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 109.098 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CB ' ' SD ' ' A' ' 101' ' ' MET . 28.2 p90 -159.15 159.98 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 108.615 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 17.6 m -129.88 175.88 8.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 110.564 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.4 tt -133.24 132.45 41.47 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.506 0.669 . . . . 0.0 109.604 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -130.1 162.39 28.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.571 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 89.2 m-20 -75.28 160.92 29.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.974 -1.078 . . . . 0.0 110.782 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.6 mmm -69.51 -35.27 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.716 -0.615 . . . . 0.0 111.047 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.57 136.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.879 -1.138 . . . . 0.0 110.303 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -58.98 151.94 52.93 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -78.48 4.08 27.88 Favored 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.232 -0.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.31 86.0 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.6 p -85.91 170.32 12.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -1.133 . . . . 0.0 109.633 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.571 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 91.3 m-85 -113.99 155.99 24.88 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' GLU . 32.9 m-20 -135.52 148.75 67.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 74' ' ' MET . 21.7 Cg_exo -44.05 -14.37 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.64 0.893 . . . . 0.0 112.498 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mp0 -86.17 16.3 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.5 ptt? -83.78 -4.96 59.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.33 0.586 . . . . 0.0 110.005 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 97.1 mttt -83.34 -4.61 58.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.785 -1.197 . . . . 0.0 109.429 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.4 m-20 -150.03 78.31 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 109.326 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.61 170.48 20.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.984 -1.072 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -131.49 150.74 52.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.443 ' HG1' ' N ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -154.65 149.68 20.47 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 0.0 109.19 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' N ' ' HG1' ' A' ' 79' ' ' THR . 2.8 Cg_exo -48.84 -47.15 22.17 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 120.554 0.836 . . . . 0.0 111.916 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.14 -150.38 7.61 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.02 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.823 . . . . 0.0 109.886 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.3 m -113.2 122.81 48.61 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.99 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -145.09 150.21 36.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.0 ttm -110.15 135.7 50.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.675 -0.641 . . . . 0.0 109.404 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -91.83 104.02 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 m -98.32 149.04 35.33 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -74.46 137.59 51.05 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.263 0.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 74.3 m -103.35 168.0 9.45 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 0.0 110.541 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 65.3 t80 -72.32 154.6 40.86 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.377 0.608 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 72.85 -146.87 39.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.13 114.87 26.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.298 -1.119 . . . . 0.0 109.057 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -57.77 -31.04 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.928 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.06 -39.8 75.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.67 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.29 -36.0 74.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.895 -1.128 . . . . 0.0 108.251 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 97' ' ' ASN . 3.0 m120 -59.95 -40.03 87.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.91 -44.36 94.34 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -63.05 -40.13 96.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.258 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.77 -45.2 94.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.471 ' SD ' ' CB ' ' A' ' 59' ' ' PHE . 20.5 mtm -59.92 -43.57 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.884 -1.135 . . . . 0.0 109.787 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.88 -40.2 95.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.454 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 88.7 mm-40 -60.08 -40.93 91.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.0 109.791 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.1 p -70.48 -40.05 73.87 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 109.429 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.3 70.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.3 -40.44 94.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.872 -1.143 . . . . 0.0 109.206 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 26.4 m-70 -60.17 -49.36 77.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 108' ' ' ILE . 81.9 mt -60.29 -49.85 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.253 -0.905 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.2 -48.98 64.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.673 . . . . 0.0 109.441 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.14 -40.02 88.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.93 -40.07 75.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 m -99.98 -0.93 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.99 -1.069 . . . . 0.0 109.838 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.48 20.79 75.76 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.57 -178.35 52.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.2 t -130.37 139.8 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.592 -0.946 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.72 130.78 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.311 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.06 155.79 45.57 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.375 -0.828 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -84.73 -174.91 5.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.465 -0.772 . . . . 0.0 109.963 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.588 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 98.5 m-20 -60.07 -35.12 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -78.53 11.53 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 108.82 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 119' ' ' ASP . 57.7 mtp180 56.41 38.45 29.71 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -116.08 145.82 42.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.7 mtt -51.16 126.7 17.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 45.7 mtt -61.26 151.28 32.19 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.845 0.831 . . . . 0.0 111.195 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.6 p -133.74 149.24 71.39 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -42.43 -50.12 5.84 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 CA-C-N 119.574 0.884 . . . . 0.0 112.628 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.29 -40.0 88.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -65.14 -40.87 94.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.155 . . . . 0.0 110.461 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.84 -40.32 88.13 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 108.485 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 130' ' ' ARG . 19.9 ttt-85 -63.93 -38.54 91.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.686 -0.634 . . . . 0.0 109.664 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.42 -44.85 89.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.989 -1.07 . . . . 0.0 109.815 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.588 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 60.5 m-85 -59.93 -40.13 87.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -59.87 -39.92 86.9 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -38.39 84.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.466 -0.771 . . . . 0.0 109.301 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.7 mm -56.52 -46.42 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.01 -43.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 137' ' ' ARG . 30.8 mtt-85 -60.08 -40.05 88.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 3' ' ' LYS . 95.9 mt-10 -62.92 -38.68 91.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.44 -24.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 110.883 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.3 mttm -60.03 -40.03 87.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.793 -1.192 . . . . 0.0 109.748 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 2.3 p30 -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.88 -1.137 . . . . 0.0 109.206 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.09 99.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 47.1 p-10 -102.87 -0.11 31.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.351 -0.843 . . . . 0.0 109.607 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.296 0.57 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.17 -1.78 57.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 108.563 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -79.93 123.71 83.53 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.47 129.96 15.47 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.016 1.041 . . . . 0.0 112.511 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -82.49 -9.93 59.22 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.36 102.36 14.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -93.29 -20.34 20.49 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -146.18 136.15 23.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.592 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -161.82 166.36 26.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.56 -1.338 . . . . 0.0 110.492 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.98 129.32 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.428 HD12 HG23 ' A' ' 11' ' ' ILE . 26.3 mm -91.38 123.06 43.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.62 148.86 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 122.469 1.128 . . . . 0.0 111.59 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mtt -145.71 154.25 41.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -137.09 122.8 19.88 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.735 -1.228 . . . . 0.0 111.076 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.05 116.75 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.04 153.18 39.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.939 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.09 -177.0 1.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -59.96 146.58 41.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 108.845 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.97 141.78 13.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 -3.88 74.29 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -117.74 152.63 34.88 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.591 -0.946 . . . . 0.0 109.5 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.78 147.69 50.81 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.472 -0.767 . . . . 0.0 109.149 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.66 143.65 27.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.225 -0.922 . . . . 0.0 109.831 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -70.58 141.36 51.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 108.875 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.95 98.24 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 97.2 mt-10 -61.41 -46.07 91.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.958 -1.319 . . . . 0.0 109.636 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.94 -27.08 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tt -72.97 -60.23 2.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.54 -0.725 . . . . 0.0 109.171 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.48 -39.99 89.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 26' ' ' GLU . 96.2 m-20 -61.11 -40.98 95.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.7 p -67.69 -40.2 84.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.129 -0.982 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 32' ' ' ILE . 81.7 mt -60.11 -48.18 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.334 -0.853 . . . . 0.0 109.534 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.56 -40.14 96.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 109.697 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.48 -20.39 63.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.564 -0.71 . . . . 0.0 110.552 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.85 2.76 32.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 110.296 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.95 15.05 65.91 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.845 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -80.05 153.9 28.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.849 -1.383 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 ' CD1' ' CA ' ' A' ' 53' ' ' GLY . 96.6 mt -124.7 136.75 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -62.75 106.32 0.78 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.678 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.78 171.52 28.93 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -62.59 -164.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -1.093 . . . . 0.0 109.344 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.0 mtt 57.76 21.26 7.23 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.573 0.702 . . . . 0.0 109.827 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.2 m120 50.02 39.39 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.594 -0.691 . . . . 0.0 111.723 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 44' ' ' ILE . 24.5 pt -140.01 165.86 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.809 -1.182 . . . . 0.0 108.983 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -91.52 118.44 30.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 110.417 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.542 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 42.1 m80 -105.15 128.46 53.39 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.419 -0.801 . . . . 0.0 109.085 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -100.15 129.23 46.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.993 -1.067 . . . . 0.0 108.7 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.405 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 52.1 m-70 -97.38 170.14 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.99 -49.99 74.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.167 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 m -91.25 144.23 29.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.28 -0.887 . . . . 0.0 109.102 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -67.23 -5.47 13.87 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.574 0.849 . . . . 0.0 111.738 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.45 -0.53 54.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.93 . . . . 0.0 110.157 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' CA ' ' CD1' ' A' ' 38' ' ' ILE . . . 77.67 10.03 86.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -68.23 -39.99 82.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -1.104 . . . . 0.0 109.854 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.79 165.67 46.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.405 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.9 Cg_endo -67.38 175.98 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.194 1.262 . . . . 0.0 112.087 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.94 29.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.1 mp -101.0 -46.81 4.97 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.274 -0.892 . . . . 0.0 109.764 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -143.84 167.4 22.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.004 -1.06 . . . . 0.0 108.501 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.542 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 1.9 m -137.51 -177.04 4.61 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.869 -1.144 . . . . 0.0 112.04 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 tt -139.97 132.09 28.01 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.514 0.673 . . . . 0.0 109.992 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.66 166.66 22.71 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.3 m-20 -77.69 170.19 17.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.842 -1.161 . . . . 0.0 110.472 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mtp -68.97 -29.57 67.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.498 -0.752 . . . . 0.0 111.818 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' GLY . 34.0 m -86.2 118.82 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.51 -1.369 . . . . 0.0 109.749 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -61.5 147.81 87.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.538 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.91 2.87 17.87 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.175 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 69.99 33.32 69.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.3 p -84.34 169.95 14.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.042 -1.269 . . . . 0.0 109.887 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 70.8 m-85 -119.7 150.73 39.88 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 73' ' ' GLU . 53.9 m-20 -139.16 150.26 64.02 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 74' ' ' MET . 16.6 Cg_exo -42.89 -15.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.901 1.067 . . . . 0.0 112.316 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.5 mt-10 -85.09 16.21 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.2 ptt? -83.53 -0.0 48.42 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.024 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -85.02 -4.39 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.66 -1.275 . . . . 0.0 109.694 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -147.83 77.42 1.42 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.53 169.71 24.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 109.498 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -135.51 156.94 48.08 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.62 19.35 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.083 . . . . 0.0 109.37 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.77 -30.67 77.22 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 120.418 0.745 . . . . 0.0 111.744 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.86 -160.85 27.57 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.09 159.94 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.488 -1.007 . . . . 0.0 109.47 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -115.45 119.66 36.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.0 109.745 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -104.75 129.93 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -147.08 170.05 17.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.92 -1.113 . . . . 0.0 110.491 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.0 ttp -133.19 130.96 39.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.729 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.56 123.16 35.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.592 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 3.7 m -98.43 150.07 36.36 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.262 -0.899 . . . . 0.0 108.62 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -76.06 142.72 74.48 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.386 -0.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 m -109.99 157.81 18.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.513 -0.742 . . . . 0.0 109.73 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 64.2 t80 -75.88 154.61 35.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.16 -159.39 45.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -93.78 114.95 27.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -1.107 . . . . 0.0 108.848 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.09 -27.22 43.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.936 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.99 -38.22 75.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.546 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.05 -39.32 75.78 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.87 -41.06 86.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.13 -43.05 99.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 108.673 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.0 -39.87 93.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.026 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.0 mmm -56.79 -49.99 73.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.036 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.6 mm-40 -60.28 -41.4 93.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.153 -0.967 . . . . 0.0 109.0 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.8 p -71.93 -39.94 69.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -56.04 26.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.911 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.48 -40.69 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.608 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.7 m-70 -60.06 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.422 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.06 -49.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 108.856 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.69 -51.69 53.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.624 -0.673 . . . . 0.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 110.814 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.36 -39.9 77.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.409 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.87 0.06 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.27 20.53 76.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.4 -178.35 51.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.95 131.55 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.538 -0.978 . . . . 0.0 108.939 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.8 130.68 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.949 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.7 mt -132.7 159.91 38.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 37.8 p-10 -86.59 -172.2 3.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.611 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 91.5 m-20 -60.06 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.0 . . . . 0.0 109.735 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -76.31 13.91 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 108.653 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.5 mtt180 59.87 34.6 21.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.135 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -110.03 151.27 27.38 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.7 mtp -52.96 129.99 32.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.089 . . . . 0.0 109.319 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 39.5 mtt -59.6 140.86 56.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.98 . . . . 0.0 109.932 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.6 p -133.63 151.1 76.58 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -43.57 -47.74 9.18 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.486 0.791 . . . . 0.0 111.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.99 -41.58 92.37 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 27.4 mmtp -69.99 -39.98 75.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.2 mt -60.0 -39.96 87.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 108.501 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -62.43 -39.9 94.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.46 -46.97 85.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.085 -1.009 . . . . 0.0 109.549 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.611 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 67.9 m-85 -60.01 -45.43 92.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.943 -1.098 . . . . 0.0 108.587 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.02 -39.57 86.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -45.73 91.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.82 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 135' ' ' ILE . 86.1 mt -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.84 -1.162 . . . . 0.0 108.698 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.05 -45.25 95.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.066 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -61.97 -38.18 87.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.84 . . . . 0.0 109.603 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.4 mt-10 -59.97 -39.7 86.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.421 -0.799 . . . . 0.0 110.715 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 -33.63 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.428 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.4 mttm -59.91 -45.5 92.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.82 -1.175 . . . . 0.0 110.545 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.23 -33.31 72.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.665 -1.272 . . . . 0.0 109.681 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.34 -39.96 93.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 110.936 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 41.3 p-10 -98.54 3.01 48.05 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.061 -1.024 . . . . 0.0 109.592 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.389 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.9 1.92 55.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.917 . . . . 0.0 109.652 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 5' ' ' LYS . 1.6 mptp? -77.54 119.18 76.42 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.153 -0.967 . . . . 0.0 108.771 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.39 19.0 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.277 1.135 . . . . 0.0 112.455 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 3' ' ' LYS . 99.4 mttt -88.49 15.77 7.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.407 ' HG3' HH11 ' A' ' 6' ' ' ARG . 11.4 mmm-85 -78.81 135.1 36.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.922 . . . . 0.0 111.907 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 7.7 mtpm? -85.23 -28.33 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -146.51 146.97 30.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.17 -166.22 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.436 -1.415 . . . . 0.0 111.393 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -131.5 134.89 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.433 HD13 HG23 ' A' ' 11' ' ' ILE . 24.9 mm -90.27 127.81 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -119.98 148.03 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.385 1.088 . . . . 0.0 111.684 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.528 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.9 mtt -145.36 159.05 43.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.39 119.71 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.835 -1.166 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -101.96 110.02 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.58 159.34 44.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.98 179.0 3.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.02 156.26 15.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.108 -0.995 . . . . 0.0 108.773 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -59.95 145.49 45.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.071 -1.018 . . . . 0.0 109.336 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 1.52 68.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.2 m -131.26 147.54 52.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.973 . . . . 0.0 109.276 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.94 145.31 51.42 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.378 -0.826 . . . . 0.0 109.433 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.61 145.81 26.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.718 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.04 146.83 50.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.46 97.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 62.0 mm-40 -61.87 -45.69 92.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.004 -1.292 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 84.4 mt -70.01 -29.14 66.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 108.627 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.5 tt -74.1 -57.14 4.16 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.391 0.615 . . . . 0.0 110.022 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.0 -49.99 75.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 111.63 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.9 p-10 -62.13 -40.07 94.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.841 -1.162 . . . . 0.0 110.315 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.458 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -60.42 -43.17 97.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 32' ' ' ILE . 96.6 mt -59.94 -46.57 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.428 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.14 -41.13 99.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 110.054 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.79 -18.96 64.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.2 3.96 21.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 5.41 65.9 Favored Glycine 0 N--CA 1.497 2.759 0 O-C-N 120.821 -1.174 . . . . 0.0 111.041 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.46 149.61 33.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.708 -1.466 . . . . 0.0 109.185 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.14 139.71 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.99 116.18 3.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.774 -1.204 . . . . 0.0 108.755 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -91.99 172.12 34.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.36 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.767 -0.843 . . . . 0.0 110.431 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mmm 58.18 -99.71 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 42' ' ' MET . 56.6 m-80 -164.81 28.47 0.06 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.74 168.21 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.355 -0.84 . . . . 0.0 110.556 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.58 119.96 32.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.327 -0.858 . . . . 0.0 109.95 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.526 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 47.4 m80 -103.2 141.19 36.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.299 -0.876 . . . . 0.0 109.04 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 45.8 ttt180 -120.49 131.29 54.66 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.476 -0.765 . . . . 0.0 109.047 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.558 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.3 m-70 -94.69 174.55 7.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.2 tp -53.56 -49.97 66.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 108.469 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -92.26 146.03 31.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.84 -3.01 10.52 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 120.593 0.862 . . . . 0.0 111.985 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.75 1.35 57.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.209 -0.932 . . . . 0.0 109.831 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.6 10.01 75.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.83 -41.89 70.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.015 -1.285 . . . . 0.0 110.167 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.558 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.37 173.41 54.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.538 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.8 Cg_endo -73.75 173.0 14.68 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.085 1.19 . . . . 0.0 111.431 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.57 122.05 26.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.065 -1.022 . . . . 0.0 109.213 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' CD2' HD22 ' A' ' 97' ' ' ASN . 9.0 mp -103.17 -33.76 9.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.372 -0.83 . . . . 0.0 109.844 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.08 169.12 24.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.056 . . . . 0.0 108.685 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 8.2 m -139.13 -176.46 4.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 0.0 111.232 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -137.32 132.91 34.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.387 0.613 . . . . 0.0 109.397 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.06 162.32 31.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.0 m-20 -76.26 169.02 19.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.885 -1.134 . . . . 0.0 109.682 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.3 mmm -69.47 -28.75 66.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 110.648 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.32 118.08 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.767 -1.208 . . . . 0.0 110.234 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -62.54 152.02 81.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.477 -0.765 . . . . 0.0 108.944 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -78.12 1.95 28.08 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.711 -1.37 . . . . 0.0 111.964 -0.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.0 38.35 19.48 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.93 157.63 19.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -1.195 . . . . 0.0 109.744 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -120.0 139.97 51.67 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.53 -0.731 . . . . 0.0 109.373 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.19 149.98 67.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.86 -13.37 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 120.651 0.901 . . . . 0.0 112.561 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.35 -10.1 57.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 92.9 mtp -89.04 22.07 2.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.87 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -85.31 -7.8 58.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 108.558 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 89.3 m-20 -144.7 83.57 1.71 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.64 174.35 15.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.256 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -128.64 148.14 50.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 109.152 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.74 150.58 20.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 108.926 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -45.77 -50.6 9.36 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 CA-C-N 119.299 0.785 . . . . 0.0 111.763 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.6 -150.17 8.34 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -130.01 160.07 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.488 -1.007 . . . . 0.0 110.067 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 62' ' ' ALA . 24.6 m -107.89 119.96 40.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.0 109.458 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.35 129.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -146.94 168.01 22.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 110.916 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.7 ttp -136.75 129.97 31.29 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -91.39 114.64 27.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.39 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.4 151.98 37.63 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -78.51 134.19 32.38 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.394 -0.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.3 m -108.53 162.04 14.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.489 -0.757 . . . . 0.0 109.856 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.06 146.72 50.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -0.802 . . . . 0.0 109.938 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.24 -159.52 27.53 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -97.31 112.65 24.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.99 -29.14 65.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.822 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.29 -39.97 78.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -71.15 -40.13 71.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.012 -1.055 . . . . 0.0 108.868 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.518 HD22 ' CD2' ' A' ' 58' ' ' LEU . 28.1 m120 -60.97 -39.9 91.38 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 109.098 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 87.1 t80 -59.24 -49.96 75.83 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.82 -40.05 96.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.6 -47.46 86.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 110.68 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.8 mtm -59.96 -39.97 87.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.893 -1.129 . . . . 0.0 109.319 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.47 -41.5 98.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 109.103 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.13 -41.2 92.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 109.002 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 p -72.18 -40.03 68.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 108.941 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.0 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.552 -0.718 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -62.13 -39.2 91.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.94 -1.1 . . . . 0.0 109.689 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 14.9 m-70 -59.97 -44.14 94.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.674 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.01 -49.45 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.35 -50.16 51.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.589 -0.695 . . . . 0.0 109.607 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.99 -40.19 92.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.792 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -39.92 75.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.805 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.0 m -97.76 -1.44 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.0 109.704 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.73 19.89 75.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.58 -174.68 48.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.8 t -131.12 138.14 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.517 -0.99 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 t -70.44 133.2 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.658 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.5 159.99 35.44 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.556 -0.715 . . . . 0.0 109.759 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -87.76 -171.62 3.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 109.419 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.5 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -76.88 15.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.049 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.3 mtt180 55.6 38.96 30.86 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.4 0.619 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 122' ' ' ARG . 29.7 mtt-85 -112.07 151.9 28.85 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -51.5 130.65 28.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.0 mmm -59.16 139.97 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -137.6 150.31 67.81 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -47.9 -44.06 28.2 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.844 1.029 . . . . 0.0 112.401 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -39.91 87.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -67.89 -40.03 83.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 110.123 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.1 -39.88 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -61.96 -40.14 94.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.556 -0.715 . . . . 0.0 109.078 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -59.94 -48.2 82.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.862 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.414 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 55.8 m-85 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.584 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 94.5 mm-40 -59.97 -40.12 87.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.72 -40.39 97.03 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.81 -45.16 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 108.859 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.09 -49.38 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -60.05 -39.98 87.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 54.2 mm-40 -60.26 -41.66 93.71 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 109.821 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -40.79 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 144' ' ' ALA . 26.4 mtpp -59.98 -48.06 83.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.963 -1.086 . . . . 0.0 111.266 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 4.2 p30 -60.08 -32.34 70.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.999 -1.063 . . . . 0.0 110.357 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -62.26 -39.95 94.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -104.04 -1.64 27.16 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.169 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.407 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -90.97 7.12 41.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.335 -0.853 . . . . 0.0 109.096 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -127.31 80.24 72.0 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.532 -0.73 . . . . 0.0 109.24 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 16.4 Cg_exo -56.91 -145.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.511 1.474 . . . . 0.0 113.549 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -76.34 36.46 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.226 0.536 . . . . 0.0 110.159 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 4' ' ' PRO . 46.3 mtt-85 -60.15 146.78 42.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.614 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -83.64 -9.84 58.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -145.17 133.71 22.01 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -159.93 170.47 21.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.85 -1.156 . . . . 0.0 110.355 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.82 131.4 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.364 -0.835 . . . . 0.0 109.069 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.58 130.92 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.2 mt -125.46 146.02 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.184 0.993 . . . . 0.0 111.937 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.5 mtt -145.96 157.36 43.89 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -141.28 129.94 22.8 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.628 -1.295 . . . . 0.0 111.169 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.29 116.45 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.03 38.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -170.69 0.85 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -68.02 158.09 33.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.99 -1.069 . . . . 0.0 108.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -59.96 145.58 45.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.382 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.23 82.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 m -118.0 148.47 42.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.512 -0.993 . . . . 0.0 108.801 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 63.6 mm-40 -129.31 143.06 50.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.5 mt -86.35 139.21 31.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 109.458 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.6 145.16 52.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.343 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.91 97.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.91 -41.55 98.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.095 -1.238 . . . . 0.0 109.7 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.03 -27.1 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -71.31 -59.03 2.99 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.418 -0.801 . . . . 0.0 109.383 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.989 -1.069 . . . . 0.0 109.706 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.96 -42.85 94.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 109.958 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -69.97 -46.92 64.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 110.52 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.8 mt -60.06 -44.23 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 0.0 110.102 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.24 -43.12 98.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 109.724 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -68.72 -16.39 63.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.513 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.25 3.91 25.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.875 . . . . 0.0 110.056 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.0 9.91 83.66 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -80.22 154.39 27.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.283 . . . . 0.0 109.398 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.17 141.69 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -59.64 111.7 1.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.973 -1.079 . . . . 0.0 109.083 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.72 171.85 33.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.34 -169.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.567 -0.961 . . . . 0.0 109.171 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.1 mtm 56.19 29.42 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.809 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 m120 49.94 38.66 16.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.558 -0.714 . . . . 0.0 111.493 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 pt -140.22 159.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.877 -1.14 . . . . 0.0 109.182 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.34 129.99 35.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.089 -1.007 . . . . 0.0 109.872 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.596 ' HD1' ' CB ' ' A' ' 60' ' ' SER . 12.3 m-70 -118.44 127.87 54.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 59.2 ttt180 -100.02 124.98 45.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.0 108.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 19.8 m-70 -95.05 169.68 9.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.8 tp -55.54 -50.06 70.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.7 m -92.34 144.55 29.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 108.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.44 -3.14 10.41 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.518 0.863 . . . . 0.0 111.975 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.25 0.06 57.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.1 11.36 84.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 m -70.06 -45.43 67.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -1.197 . . . . 0.0 109.878 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.49 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.59 166.35 54.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.74 177.92 4.43 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.081 1.187 . . . . 0.0 111.456 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.49 124.6 30.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.96 . . . . 0.0 109.053 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.9 mp -100.73 -39.76 7.68 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.099 -1.0 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -148.19 159.86 43.53 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.596 ' CB ' ' HD1' ' A' ' 46' ' ' HIS . 2.5 m -130.21 -179.85 5.48 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.204 1.002 . . . . 0.0 112.342 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.94 129.95 24.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.215 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.75 160.97 35.29 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 17.0 m120 -75.32 159.09 31.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.098 -1.002 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -69.98 -25.22 63.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.64 -0.662 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.7 t -85.21 126.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.733 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -59.73 149.99 69.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.102 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.29 9.87 15.94 Favored 'Cis proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.727 -0.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 14.5 80.98 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 69' ' ' THR . 16.9 p -88.99 170.14 10.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 110.877 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 39.3 m-85 -119.27 158.78 25.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.6 m-20 -143.07 150.65 53.41 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.197 -0.94 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -48.98 -8.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.125 0 CA-C-N 119.171 0.74 . . . . 0.0 110.94 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.3 mt-10 -86.77 18.18 3.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.417 ' SD ' ' CD1' ' A' ' 70' ' ' PHE . 47.5 mtm -73.89 1.24 11.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.9 mmtp -88.75 -0.07 56.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 109.943 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 60.7 m-20 -154.8 77.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.012 -1.055 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -167.76 170.66 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.7 p -137.11 159.17 42.67 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.97 148.3 18.43 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.932 -1.105 . . . . 0.0 109.251 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 3.5 Cg_endo -57.8 -35.58 98.72 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.577 0.851 . . . . 0.0 112.0 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.23 -161.09 25.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.99 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.51 -0.994 . . . . 0.0 108.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -114.7 128.08 56.11 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.488 -0.758 . . . . 0.0 110.454 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.6 mt -111.56 129.19 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 24.9 p90 -149.09 159.96 43.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.877 -1.139 . . . . 0.0 110.976 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.6 ttm -113.64 130.55 56.37 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.44 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.1 mt-30 -91.94 115.18 27.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 1.2 m -98.58 150.4 36.68 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 120.978 -1.076 . . . . 0.0 109.379 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.24 134.72 36.92 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.902 -1.291 . . . . 0.0 111.561 -1.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.9 m -104.56 154.2 20.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.409 -0.807 . . . . 0.0 110.097 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -71.31 148.59 46.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 109.509 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.61 -164.61 39.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.63 114.39 26.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -1.179 . . . . 0.0 109.322 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -52.99 -18.56 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.04 -40.02 75.39 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -75.98 -41.45 51.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 108.962 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.61 -41.27 80.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.34 -40.11 89.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.074 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.09 -40.11 94.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.3 mtp -59.47 -49.91 75.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.99 -45.9 92.93 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.062 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.2 mt-30 -60.28 -40.46 90.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 p -73.15 -40.03 65.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.76 -54.01 51.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.447 -0.783 . . . . 0.0 109.907 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -63.23 -40.0 96.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 109.638 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 3.9 m-70 -60.15 -45.94 91.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.366 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.95 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.15 -49.96 59.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -0.824 . . . . 0.0 109.291 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.36 -40.05 89.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.39 -40.15 77.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 110.796 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.9 m -98.41 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.01 20.02 74.3 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.28 -170.24 46.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 132.92 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.934 . . . . 0.0 109.098 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.47 132.88 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.513 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 mt -132.13 159.96 37.4 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.481 -0.762 . . . . 0.0 109.795 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 44.7 p-10 -88.55 -169.34 2.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 121' ' ' ARG . 94.1 m-20 -59.97 -39.61 86.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.181 -0.95 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -76.44 16.61 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.244 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 119' ' ' ASP . 49.6 mtm-85 57.75 28.88 16.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.584 . . . . 0.0 109.953 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.492 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 51.0 mtt-85 -110.32 155.66 21.8 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.514 -0.741 . . . . 0.0 109.441 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.1 mtm -53.76 132.23 40.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.3 mtt -60.0 140.75 56.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -129.78 150.29 75.42 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -43.58 -41.07 10.95 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 CA-C-N 119.354 0.805 . . . . 0.0 111.744 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.3 -40.01 88.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.946 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -69.37 -39.31 78.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 109.791 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.74 -40.49 79.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 108.781 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -65.88 -38.95 90.12 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.93 -47.79 84.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.943 . . . . 0.0 109.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -59.95 -42.77 94.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 108.486 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.72 -40.02 95.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.539 -0.726 . . . . 0.0 109.047 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -40.02 87.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.447 -0.783 . . . . 0.0 109.692 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 135' ' ' ILE . 96.9 mt -62.51 -40.03 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.953 -1.092 . . . . 0.0 109.259 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.406 ' CG2' ' HZ2' ' A' ' 140' ' ' LYS . 82.0 mt -59.93 -42.95 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.946 -1.096 . . . . 0.0 109.391 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 0.8 OUTLIER -60.08 -37.14 79.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 97.3 mt-10 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.198 -0.939 . . . . 0.0 109.751 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.73 -33.88 45.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 144' ' ' ALA . 39.3 mmtm -59.63 -45.96 90.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 109.958 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -62.44 -36.44 82.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.647 -1.283 . . . . 0.0 108.807 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 110.197 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -97.81 0.36 46.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 108.803 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.497 -0.752 . . . . 0.0 109.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' NE ' ' A' ' 6' ' ' ARG . 95.7 mmm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.235 0.541 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 -4.69 54.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.95 . . . . 0.0 109.873 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 5' ' ' LYS . 8.3 mptt -80.55 149.77 68.86 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.127 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 6' ' ' ARG . 14.5 Cg_endo -67.69 9.7 0.33 Allowed 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 120.481 0.787 . . . . 0.0 111.489 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 3' ' ' LYS . 44.2 mtmt -81.29 27.37 0.42 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 1' ' ' MET . 94.2 mtt180 -79.85 100.82 8.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.286 -0.884 . . . . 0.0 111.635 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.8 -16.78 29.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -148.46 145.02 27.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.486 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -164.66 160.1 19.62 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.328 -1.482 . . . . 0.0 110.743 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.53 129.92 59.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -88.43 129.95 38.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.8 mt -122.0 147.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.303 1.049 . . . . 0.0 111.49 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -145.79 154.14 41.7 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -133.21 120.91 21.76 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.898 -1.126 . . . . 0.0 111.088 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.01 112.48 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.93 158.67 43.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 110.124 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.7 -170.55 0.7 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.555 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -59.93 154.3 19.14 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 108.762 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -59.83 141.56 55.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.071 -1.018 . . . . 0.0 109.606 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.19 -8.59 79.26 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 m -112.2 151.93 28.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.473 -1.016 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.97 150.54 49.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.425 -0.797 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.31 145.82 27.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.903 . . . . 0.0 109.908 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.42 140.62 57.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 109.016 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.22 -40.48 97.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.56 -47.74 82.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.2 mt -68.2 -24.5 64.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.53 -58.28 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.956 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.89 -49.93 75.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.214 -0.928 . . . . 0.0 111.084 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.4 p-10 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 110.023 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 53.7 m -61.99 -40.66 96.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.971 -1.081 . . . . 0.0 109.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.29 -48.45 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 108.886 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -60.22 -40.01 88.64 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.91 -21.56 64.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 9.87 7.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.956 -1.09 . . . . 0.0 110.376 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.21 9.67 86.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -80.4 155.47 27.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.296 . . . . 0.0 109.583 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 140.65 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 108.24 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 171.82 33.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.27 -167.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -1.107 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.8 mmm 57.22 26.87 12.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.475 -0.766 . . . . 0.0 109.654 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 51.11 39.91 24.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.446 -0.784 . . . . 0.0 111.514 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.6 pt -141.65 160.88 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.014 -1.054 . . . . 0.0 109.402 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.38 136.56 32.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 18.6 m-70 -125.72 128.13 47.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.0 ttt-85 -101.09 126.2 47.76 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.388 -0.82 . . . . 0.0 109.083 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.532 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 58.6 m-70 -96.51 170.08 9.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.729 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.3 tp -55.83 -49.83 72.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -92.04 149.06 38.12 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.295 -0.878 . . . . 0.0 109.333 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.16 -5.89 17.52 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 120.926 1.084 . . . . 0.0 112.234 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 49.8 p-10 -94.18 -0.04 55.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.074 -1.016 . . . . 0.0 110.299 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.4 85.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.433 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 27.0 m -70.03 -41.71 73.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.749 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.61 165.35 52.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.532 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.6 Cg_endo -69.14 174.25 9.24 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.03 1.153 . . . . 0.0 111.602 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.56 125.88 30.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 109.134 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.1 mp -99.06 -39.63 8.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.18 158.59 44.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.499 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 29.0 m -129.68 179.46 5.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.244 1.021 . . . . 0.0 112.159 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 tt -139.51 132.94 30.15 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.1 167.17 22.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.7 m120 -74.9 160.23 30.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.002 -1.061 . . . . 0.0 109.773 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.88 -20.51 63.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.862 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.95 113.57 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.002 -1.061 . . . . 0.0 109.114 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -62.74 151.73 83.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.501 -0.749 . . . . 0.0 109.563 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -76.67 10.97 12.62 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.6 -1.416 . . . . 0.0 112.34 -0.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.39 30.82 57.95 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.374 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -85.85 163.83 17.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -1.19 . . . . 0.0 109.836 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.1 m-85 -120.82 143.13 49.03 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.3 m-20 -129.12 149.93 73.99 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.1 -9.07 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.138 0.728 . . . . 0.0 111.569 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 71' ' ' ASP . 98.0 mt-10 -89.77 3.92 51.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.548 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 67.6 mmm -88.1 16.46 6.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 62.6 mttp -85.34 -6.32 59.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.962 -1.086 . . . . 0.0 109.182 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 68.6 m-20 -151.91 79.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.75 171.69 19.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.1 p -128.64 151.75 49.14 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.95 149.04 19.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.07 -1.019 . . . . 0.0 109.308 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -43.58 -49.98 7.35 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.666 0.911 . . . . 0.0 111.896 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.09 -154.75 13.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.97 160.02 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.395 -1.062 . . . . 0.0 109.82 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.5 m -109.08 120.93 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.719 -0.613 . . . . 0.0 110.146 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mt -103.71 130.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 31.8 p90 -147.17 169.98 18.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 111.215 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.8 ttm -128.26 130.07 47.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.417 ' O ' ' OG ' ' A' ' 90' ' ' SER . 92.0 mm-40 -91.51 115.62 28.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.486 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 1.7 m -98.8 149.92 36.2 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.18 -0.95 . . . . 0.0 109.093 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.61 137.02 46.73 Favored 'Cis proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.867 -1.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.1 m -107.74 154.15 21.92 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.487 -0.758 . . . . 0.0 109.397 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.11 145.49 51.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 110.043 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.51 -165.61 33.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -96.39 112.29 24.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.34 -1.094 . . . . 0.0 109.114 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -55.3 -25.53 34.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.946 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.81 -40.14 76.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 109.591 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.28 -41.63 66.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.785 -1.197 . . . . 0.0 108.065 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.69 -39.79 95.09 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -51.34 -40.65 59.55 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.5 -40.02 94.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.86 -40.04 96.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 0.0 109.287 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mtp -58.66 -50.03 75.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.079 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.95 -47.32 75.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.353 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 77.1 mt-30 -59.95 -40.81 90.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 108.977 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.5 p -70.4 -40.16 74.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.14 -56.42 22.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.823 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -61.21 -37.82 84.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.462 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.9 m-70 -59.94 -50.13 74.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.06 -1.025 . . . . 0.0 108.746 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.8 mt -60.99 -49.01 86.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.73 -49.23 65.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -70.03 -40.15 75.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.72 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.6 m -97.44 -0.03 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 0.0 109.873 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.03 26.01 74.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.77 -176.54 50.21 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -130.21 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.702 -0.881 . . . . 0.0 109.202 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -74.96 130.26 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.132 -0.98 . . . . 0.0 109.352 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -130.56 159.88 35.82 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 40.3 p-10 -85.7 -170.69 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 0.0 108.989 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 121' ' ' ARG . 95.6 m-20 -60.13 -39.49 86.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.78 16.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.328 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 58.46 29.37 18.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 110.395 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.516 ' NE ' ' HZ3' ' A' ' 128' ' ' LYS . 84.5 mtm180 -107.91 154.33 21.76 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.336 -0.852 . . . . 0.0 108.969 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.2 mtt -52.42 125.17 15.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 109.722 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 mtp -60.14 140.49 56.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.522 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.2 p -127.18 150.53 72.53 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -43.64 -43.23 11.44 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.185 0.745 . . . . 0.0 112.018 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.431 ' O ' ' CD ' ' A' ' 131' ' ' GLU . 27.3 mt-30 -60.08 -44.74 94.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.516 ' HZ3' ' NE ' ' A' ' 122' ' ' ARG . 97.9 mttt -62.59 -39.76 94.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 109.772 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.64 -39.01 76.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -65.83 -39.99 91.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -59.43 -48.6 81.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.701 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -60.08 -45.99 91.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 108.548 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.0 -40.02 96.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.491 -0.756 . . . . 0.0 108.961 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.4 -42.11 98.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.2 -42.8 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.003 -1.06 . . . . 0.0 109.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.07 -41.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 31.2 mmt180 -60.05 -40.91 91.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 108.962 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -61.11 -37.46 82.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 0.0 108.98 178.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.93 -39.86 78.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 110.27 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.02 -48.6 81.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 111.379 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 2.8 p-10 -59.91 -32.86 71.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.558 -1.339 . . . . 0.0 109.221 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.12 82.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 110.148 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -98.6 -11.35 22.22 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 109.506 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -90.44 23.53 2.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 0.0 109.338 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -129.01 77.67 77.56 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 121.435 -0.791 . . . . 0.0 109.58 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 44.8 Cg_endo -82.46 46.91 2.31 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.352 1.368 . . . . 0.0 111.928 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -77.44 18.66 0.4 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.609 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 4' ' ' PRO . 42.9 mtt-85 -78.25 153.37 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.377 -0.827 . . . . 0.0 110.942 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -85.42 -5.26 59.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -147.89 150.4 34.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.1 -175.1 3.84 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.562 -1.336 . . . . 0.0 110.811 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.98 136.3 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 11' ' ' ILE . 22.7 mm -93.59 124.64 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.9 mt -121.36 151.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.043 0.925 . . . . 0.0 111.091 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 84' ' ' ILE . 67.5 mtt -148.88 159.02 44.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -140.17 121.29 14.75 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.973 -1.08 . . . . 0.0 110.603 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.28 117.27 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.42 155.0 40.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.14 -174.21 1.49 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.447 -0.783 . . . . 0.0 108.901 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -64.26 149.03 48.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.073 -1.017 . . . . 0.0 108.763 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 30.1 p-80 -55.81 149.85 13.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 109.756 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.57 -7.18 82.43 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -121.06 154.69 35.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.564 -0.962 . . . . 0.0 109.477 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -129.16 147.34 50.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.07 137.68 33.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 55.3 t-20 -67.95 142.05 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.05 -41.42 97.99 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.795 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.73 -47.24 86.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.309 . . . . 0.0 110.095 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.01 -30.26 67.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tt -70.4 -57.48 4.77 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.551 -0.718 . . . . 0.0 109.252 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.99 -44.23 94.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.385 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' OD1' ' OE1' ' A' ' 34' ' ' GLN . 60.3 t-20 -60.45 -40.27 90.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 110.192 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 p -65.82 -39.82 91.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 32' ' ' ILE . 92.5 mt -59.87 -48.82 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -62.35 -39.97 94.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.902 -1.124 . . . . 0.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' OD1' ' A' ' 30' ' ' ASN . 27.5 mt-30 -67.84 -22.41 65.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.377 -0.827 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.98 6.09 14.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.953 -1.092 . . . . 0.0 109.997 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.83 76.19 Favored Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.947 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -78.6 150.35 32.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.76 -1.435 . . . . 0.0 109.726 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 38' ' ' ILE . 96.6 mt -127.34 139.57 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -60.69 105.34 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.03 172.14 29.19 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.51 -165.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -1.035 . . . . 0.0 109.598 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mmm 58.36 20.12 7.02 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.689 . . . . 0.0 109.81 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 49.99 39.63 19.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.086 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.2 pt -140.51 166.98 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -91.91 127.02 37.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.917 -1.114 . . . . 0.0 110.487 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 36.5 m-70 -116.07 128.82 56.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.528 -0.732 . . . . 0.0 109.75 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 47' ' ' ARG . 17.6 ttt-85 -102.97 126.95 50.35 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 70.9 m-70 -94.76 171.22 8.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.963 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.54 -50.14 70.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.9 . . . . 0.0 108.739 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -93.34 143.73 27.16 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -66.97 -2.65 8.24 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 119.552 0.876 . . . . 0.0 111.952 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -94.25 0.19 55.5 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 0.0 110.109 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.92 86.61 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.452 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 91.3 p -70.1 -40.0 75.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.914 -1.345 . . . . 0.0 109.762 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.77 162.82 52.18 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 12.3 Cg_endo -67.26 176.93 4.2 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.994 1.129 . . . . 0.0 111.247 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.23 118.67 22.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.017 -1.052 . . . . 0.0 109.319 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 6.6 mp -96.72 -47.97 5.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -142.95 159.99 41.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.993 . . . . 0.0 109.395 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.546 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.0 m -136.55 159.92 40.33 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.82 0.819 . . . . 0.0 111.208 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.5 tt -113.11 131.69 55.73 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.361 0.601 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -137.57 162.78 32.84 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.9 m-20 -77.69 153.55 32.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.884 -1.135 . . . . 0.0 109.886 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.05 -29.86 66.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.094 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.43 134.94 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.972 -1.08 . . . . 0.0 109.774 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -56.87 154.02 20.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -79.77 2.06 36.52 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 123.753 -1.353 . . . . 0.0 112.464 -0.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.85 -4.73 73.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.5 p -89.6 169.89 10.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -1.051 . . . . 0.0 110.078 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 79.6 m-85 -121.76 152.47 39.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.5 m-20 -135.17 149.74 70.91 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -49.04 -11.11 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 120.47 0.78 . . . . 0.0 111.792 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.4 mm-40 -89.95 4.46 50.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.401 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 73.9 mmm -87.92 20.24 3.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.0 110.155 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.0 mttp -88.23 -1.69 58.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 81.7 m-20 -146.73 81.55 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -160.33 172.49 17.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 p -130.67 151.58 50.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.31 150.02 21.48 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.263 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.48 -38.37 95.49 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 CA-C-N 119.092 0.712 . . . . 0.0 111.566 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.08 -156.47 15.17 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.51 160.08 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.768 -0.843 . . . . 0.0 109.066 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.5 m -114.14 120.26 39.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.473 -0.767 . . . . 0.0 110.432 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 13' ' ' MET . 97.5 mt -105.95 128.19 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -145.27 152.34 39.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.176 -0.953 . . . . 0.0 110.136 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttp -121.2 130.04 53.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.444 ' O ' ' OG ' ' A' ' 90' ' ' SER . 97.3 mt-30 -86.33 110.88 19.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 108.96 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.19 147.44 33.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.403 ' CG ' HD21 ' A' ' 143' ' ' ASN . 4.1 Cg_endo -75.8 131.49 24.43 Favored 'Cis proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.605 0.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 43.5 m -100.36 166.73 10.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.736 0.779 . . . . 0.0 110.186 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.13 146.02 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.771 -0.581 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.4 -156.46 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -93.77 119.09 32.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -1.209 . . . . 0.0 108.537 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -57.44 -32.64 67.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.838 -0.539 . . . . 0.0 110.511 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.96 -40.11 75.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.85 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.11 -40.62 68.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.004 -1.06 . . . . 0.0 109.157 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.253 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -58.83 -45.03 90.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -61.11 -39.73 91.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.448 -0.783 . . . . 0.0 109.43 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.11 -43.78 95.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 109.678 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.15 -44.92 94.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.49 -46.2 91.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.054 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 78.3 mt-30 -60.05 -43.93 95.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -70.42 -40.01 74.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.23 -55.58 33.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.041 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -60.28 -35.93 76.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.925 -1.11 . . . . 0.0 108.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 9.0 m-70 -60.08 -45.88 91.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.11 -0.994 . . . . 0.0 108.839 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -60.01 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.048 -1.032 . . . . 0.0 108.568 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.2 -48.99 61.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.487 0.66 . . . . 0.0 109.286 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.09 -40.01 88.1 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.926 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.9 -40.04 75.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 111.349 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.75 -0.39 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.075 -1.015 . . . . 0.0 109.566 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.83 25.96 74.89 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.06 -169.3 44.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.51 134.04 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -1.016 . . . . 0.0 109.238 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.14 130.89 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.054 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.0 mt -126.74 159.02 34.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 108.907 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -86.49 -171.51 3.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 109.069 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.476 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 97.2 m-20 -60.07 -35.01 74.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.323 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.84 16.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 119' ' ' ASP . 45.1 mtm-85 58.16 26.28 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.641 . . . . 0.0 109.914 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 54.0 mtp180 -109.18 151.49 26.4 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.593 -0.692 . . . . 0.0 109.331 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -52.51 134.69 34.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.886 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.4 mmm -59.9 133.61 56.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.0 p -132.72 151.15 77.58 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -41.36 -45.99 5.78 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 120.926 1.084 . . . . 0.0 113.04 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -60.09 -39.97 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.95 -1.094 . . . . 0.0 109.409 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.36 -40.11 85.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.32 -39.97 84.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 108.828 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -62.58 -39.54 94.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.474 -0.766 . . . . 0.0 109.143 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.59 -48.59 81.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.123 -0.986 . . . . 0.0 109.75 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.476 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 65.3 m-85 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.041 -1.037 . . . . 0.0 109.398 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.87 87.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.316 -0.865 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.21 -44.42 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 108.702 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.07 -45.78 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.383 -0.823 . . . . 0.0 109.379 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 99.0 mtt180 -60.31 -37.41 80.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 110.161 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.6 mt-10 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.866 . . . . 0.0 110.29 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.6 t -73.35 -35.56 46.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 110.8 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 144' ' ' ALA . 49.4 mtpt -60.15 -46.61 89.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 111.464 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.7 p-10 -61.17 -29.15 69.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.606 -1.309 . . . . 0.0 110.125 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.07 99.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.403 HD21 ' CG ' ' A' ' 89' ' ' PRO . 98.6 m-20 -112.44 -11.55 13.63 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.382 -0.824 . . . . 0.0 110.192 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.49 ' N ' HH12 ' A' ' 6' ' ' ARG . 73.6 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.78 2.77 36.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.12 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.572 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -72.97 130.17 85.43 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.75 18.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.854 0.984 . . . . 0.0 112.226 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 3' ' ' LYS . 68.3 mttm -85.37 -9.8 57.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.616 -0.677 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.49 HH12 ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -82.33 98.74 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 110.293 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -88.57 -17.07 30.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -150.02 133.56 16.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.63 8.36 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.67 -1.269 . . . . 0.0 110.477 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -125.03 132.29 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.94 134.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.1 mt -131.2 141.84 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.947 0.88 . . . . 0.0 111.196 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.43 148.01 29.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -128.01 130.54 48.5 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.054 -1.029 . . . . 0.0 110.901 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.73 117.94 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.01 159.82 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 110.383 -178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.12 -164.96 0.2 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.704 -0.622 . . . . 0.0 109.645 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -70.0 155.97 39.82 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -57.57 135.78 56.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 5.18 65.0 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -126.31 144.41 50.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -1.019 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.4 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.5 mt-10 -124.52 147.69 48.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.51 137.04 33.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.167 -0.958 . . . . 0.0 110.233 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.43 143.07 57.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 108.862 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.49 -41.85 97.34 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.084 -1.01 . . . . 0.0 111.061 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.98 -43.15 95.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.889 -1.359 . . . . 0.0 108.877 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 95.5 mt -69.95 -27.12 64.48 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -76.57 -56.3 4.74 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 110.463 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.98 -49.0 79.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.03 -1.044 . . . . 0.0 111.312 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 31' ' ' SER . 42.8 p-10 -61.85 -39.15 90.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 110.866 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 93.4 p -62.62 -40.43 96.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.789 -1.194 . . . . 0.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.29 -49.71 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -65.66 -39.93 91.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 109.817 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -63.72 -22.42 66.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.03 -1.24 52.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.0 . . . . 0.0 109.602 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.08 19.08 44.03 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.041 -1.037 . . . . 0.0 111.418 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -81.23 160.61 24.25 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.356 . . . . 0.0 110.281 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.22 137.01 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.96 102.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.061 . . . . 0.0 109.841 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 171.02 41.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.4 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.443 -1.034 . . . . 0.0 109.242 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 95.4 mtp 56.66 23.52 7.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.664 -0.647 . . . . 0.0 110.222 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.71 40.26 23.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 111.259 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.552 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.9 pt -139.84 163.82 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.024 -1.047 . . . . 0.0 109.179 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -90.51 131.77 36.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.043 -1.035 . . . . 0.0 110.167 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 17.5 m-70 -123.68 132.07 53.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.687 -0.633 . . . . 0.0 109.869 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 30.9 ttt180 -104.86 121.71 44.26 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 48.1 m-70 -95.4 171.0 8.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.393 -0.817 . . . . 0.0 109.562 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.63 -50.05 71.2 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.8 m -92.37 144.23 28.59 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.33 -6.0 17.3 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.7 0.933 . . . . 0.0 112.104 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -93.15 0.89 57.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.154 -0.967 . . . . 0.0 109.407 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.48 14.25 82.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 55' ' ' GLY . 50.1 p -70.43 -40.45 73.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.081 -1.246 . . . . 0.0 109.237 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.46 166.86 48.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.459 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 20.8 Cg_endo -70.86 -179.49 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.195 1.263 . . . . 0.0 111.751 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.25 121.69 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.137 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.0 mp -95.96 -20.54 18.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.995 -1.066 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -169.63 158.15 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.937 . . . . 0.0 108.948 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.473 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.6 m -127.26 171.86 11.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.935 0.874 . . . . 0.0 111.822 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -140.08 130.2 25.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.543 0.687 . . . . 0.0 109.189 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.17 163.89 28.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.522 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 12.4 m120 -74.11 158.03 34.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.062 . . . . 0.0 110.127 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.02 -23.8 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.62 -0.675 . . . . 0.0 110.537 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 p -87.17 129.88 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.978 -1.076 . . . . 0.0 109.775 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -60.45 149.86 75.83 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.481 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.31 4.72 26.34 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.546 -0.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.88 85.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -85.48 170.98 12.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -1.202 . . . . 0.0 109.473 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 82.7 m-85 -116.46 150.58 37.62 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 7.5 m-20 -139.06 152.31 69.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.89 -15.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.045 1.163 . . . . 0.0 112.65 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.1 mt-10 -85.24 13.33 6.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' ASP . 24.3 ptt? -82.7 -7.3 59.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.77 -0.581 . . . . 0.0 110.243 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.8 mttt -85.25 -4.03 59.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.08 -1.013 . . . . 0.0 110.222 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 71.1 m-20 -150.29 73.23 1.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.933 -1.104 . . . . 0.0 109.885 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -158.1 169.86 23.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.4 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 49.9 p -131.96 150.11 52.25 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.218 -0.926 . . . . 0.0 109.093 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.75 147.78 19.66 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.972 -1.08 . . . . 0.0 108.77 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.99 -33.53 5.52 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.62 0.88 . . . . 0.0 111.866 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.44 -146.42 9.8 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.481 -1.343 . . . . 0.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.03 159.11 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.602 -0.94 . . . . 0.0 109.655 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 m -114.23 121.12 42.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.592 -0.692 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -102.55 125.72 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -149.86 161.96 41.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.953 -1.092 . . . . 0.0 110.65 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 4.9 tpt -146.31 147.46 31.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.72 . . . . 0.0 109.238 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' N ' ' SD ' ' A' ' 86' ' ' MET . 92.9 mt-30 -94.07 121.88 36.01 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.44 151.59 37.74 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.89 172.5 56.33 Favored 'Cis proline' 0 N--CA 1.503 2.033 0 C-N-CA 124.057 -1.226 . . . . 0.0 113.055 0.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.562 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 15.9 m -130.32 167.11 19.03 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.841 0.829 . . . . 0.0 111.031 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -72.8 144.47 47.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.05 -151.01 34.64 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -97.31 123.22 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.359 -1.083 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' N ' ' A' ' 90' ' ' SER . 53.5 mm-40 -56.21 -30.05 61.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 0.0 109.532 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.95 -40.02 79.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.258 -0.901 . . . . 0.0 109.077 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -73.05 -40.37 65.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.928 -1.108 . . . . 0.0 108.093 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -64.65 -40.01 94.69 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.14 -46.02 91.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.739 -0.601 . . . . 0.0 109.97 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.5 -39.87 89.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.417 ' O ' ' OG ' ' A' ' 104' ' ' SER . 64.9 mtp -60.03 -49.65 76.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.161 -0.962 . . . . 0.0 108.793 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.98 -45.98 83.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.427 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.1 mt-30 -59.98 -39.93 87.37 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 101' ' ' MET . 16.4 p -69.91 -41.49 74.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.369 -0.832 . . . . 0.0 109.035 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.01 -57.71 11.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.415 -0.803 . . . . 0.0 110.085 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.61 -39.62 88.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.693 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.5 m-70 -59.82 -49.8 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 108.775 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 108' ' ' ILE . 96.5 mt -60.17 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.19 -48.87 61.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.98 -39.84 93.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 110.281 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.66 -40.11 84.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.22 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.8 m -100.65 -0.68 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.267 -0.896 . . . . 0.0 109.903 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 20.89 74.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.44 -173.76 49.35 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.47 132.96 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -1.049 . . . . 0.0 109.851 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.17 131.96 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.7 158.23 39.16 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.615 0.721 . . . . 0.0 109.645 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -86.23 -174.31 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.517 -0.74 . . . . 0.0 109.564 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.9 m-20 -59.97 -36.09 76.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.011 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 120' ' ' GLN . 27.4 mp0 -78.73 16.32 0.88 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 119' ' ' ASP . 51.4 mtm-85 56.19 39.52 30.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.521 -0.737 . . . . 0.0 110.582 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.84 155.59 33.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.463 -0.773 . . . . 0.0 109.202 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.5 mtm -54.14 132.75 43.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.373 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 79.4 mmm -60.35 140.04 57.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.257 -0.902 . . . . 0.0 110.193 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.7 p -130.81 150.56 76.85 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -48.43 -39.44 36.11 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 CA-C-N 119.36 0.807 . . . . 0.0 111.974 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.32 -40.77 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.439 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.84 -39.42 76.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.49 -0.756 . . . . 0.0 110.087 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.39 -40.08 77.46 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 130' ' ' ARG . 26.4 ttm-85 -62.91 -40.01 96.27 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.358 -0.839 . . . . 0.0 109.1 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.83 -47.9 83.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.958 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.07 -41.93 93.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.986 -1.071 . . . . 0.0 108.182 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -62.29 -38.25 88.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 96.0 m-20 -60.35 -40.78 91.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.329 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.421 HG22 HD13 ' A' ' 135' ' ' ILE . 88.3 mt -64.8 -39.84 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.988 . . . . 0.0 108.994 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.1 mt -60.06 -49.2 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.3 mtm180 -61.59 -39.58 91.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.019 -1.051 . . . . 0.0 110.396 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.9 mt-10 -60.23 -39.99 88.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.972 -1.08 . . . . 0.0 110.769 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.88 -36.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 144' ' ' ALA . 60.5 mttm -59.94 -45.5 92.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.97 -1.081 . . . . 0.0 111.702 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 1.1 p-10 -60.85 -34.27 74.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.713 -1.242 . . . . 0.0 110.036 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.65 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.769 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.76 -2.23 30.61 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.087 -1.008 . . . . 0.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.131 0.491 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.19 -10.26 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.3 76.96 75.09 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 6' ' ' ARG . 9.2 Cg_endo -73.95 135.87 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.807 1.005 . . . . 0.0 111.339 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.18 29.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.082 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' H ' ' C ' ' A' ' 4' ' ' PRO . 98.7 mtt180 -76.39 149.44 36.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.543 -0.723 . . . . 0.0 110.274 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -82.9 -53.81 5.57 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.11 141.17 35.37 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.538 ' H ' ' CG2' ' A' ' 88' ' ' VAL . . . -157.84 159.97 37.23 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.697 -1.252 . . . . 0.0 110.469 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.86 132.34 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.628 -0.67 . . . . 0.0 109.98 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.05 139.23 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 93.8 mt -127.85 143.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 122.203 1.002 . . . . 0.0 111.558 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -144.32 151.05 38.81 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.459 HD21 ' HG1' ' A' ' 83' ' ' THR . 31.7 m120 -134.56 126.14 28.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.712 -1.242 . . . . 0.0 110.951 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.71 114.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.53 152.83 38.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.862 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.26 -164.49 0.11 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.391 -0.818 . . . . 0.0 109.274 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -62.55 153.03 33.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.99 140.78 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.05 -1.031 . . . . 0.0 109.14 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.12 -1.97 80.83 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.2 m -118.67 151.4 38.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.566 -0.961 . . . . 0.0 109.185 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 96.2 mt-10 -128.15 148.9 50.61 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.49 -0.756 . . . . 0.0 108.999 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.16 144.46 28.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.511 HD21 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.92 141.99 56.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.094 -1.004 . . . . 0.0 108.929 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' H ' HD21 ' A' ' 24' ' ' ASN . . . -59.92 -42.33 98.19 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.576 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.27 -47.64 85.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.044 -1.268 . . . . 0.0 110.153 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.74 -28.26 66.65 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tt -73.44 -59.8 2.54 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.115 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.07 -41.43 92.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 109.264 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.529 ' CG ' HE21 ' A' ' 34' ' ' GLN . 42.7 t30 -62.91 -43.3 99.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 110.02 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.1 p -65.55 -38.59 90.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.417 HG23 HD12 ' A' ' 32' ' ' ILE . 89.1 mt -60.03 -46.21 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.998 -1.064 . . . . 0.0 109.358 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.5 -40.85 98.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.734 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.529 HE21 ' CG ' ' A' ' 30' ' ' ASN . 74.7 mt-30 -67.8 -22.3 65.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 110.036 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.06 8.09 9.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 82.28 12.64 80.37 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.36 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -81.19 153.74 27.05 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.741 -1.446 . . . . 0.0 109.856 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.4 mt -124.38 133.89 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -60.89 98.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.908 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.91 171.1 44.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.99 -163.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -1.219 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.3 mtt 58.46 20.0 7.04 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 49.95 39.95 19.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.671 -0.643 . . . . 0.0 111.248 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 pt -141.08 167.25 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.052 -1.03 . . . . 0.0 108.817 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -93.49 123.33 36.72 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.971 -1.08 . . . . 0.0 110.552 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.446 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 39.9 m80 -106.53 136.45 46.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.686 -0.634 . . . . 0.0 109.367 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 47' ' ' ARG . 0.0 OUTLIER -99.89 128.43 45.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 108.598 178.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.41 165.18 11.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.534 -0.729 . . . . 0.0 109.14 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 tp -59.73 -49.32 78.21 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.2 m -90.54 145.0 31.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.855 . . . . 0.0 109.142 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -67.2 -10.72 29.59 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 120.679 0.919 . . . . 0.0 111.712 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 44.8 t0 -92.91 -1.33 56.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 109.815 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.4 t -70.03 -40.06 75.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.942 -1.328 . . . . 0.0 109.391 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.61 160.99 45.93 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.46 170.97 10.09 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.397 1.099 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.34 129.94 35.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.277 -0.89 . . . . 0.0 109.638 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.3 mp -101.76 -39.58 7.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.188 -0.945 . . . . 0.0 109.679 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -150.0 162.88 39.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.09 -1.006 . . . . 0.0 108.692 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 14.1 m -129.61 173.06 10.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.961 0.886 . . . . 0.0 111.273 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.7 tt -131.79 129.96 41.2 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.37 162.94 29.82 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 93.8 m-20 -74.25 157.22 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 109.651 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -69.92 -28.21 65.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.747 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.68 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -60.06 152.25 62.09 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.95 1.9 48.71 Favored 'Cis proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.58 0.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.62 -0.11 79.74 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.9 p -87.81 169.55 11.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -1.111 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 94.0 m-85 -121.3 140.8 51.6 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 73' ' ' GLU . 75.9 m-20 -121.7 150.21 54.81 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -50.45 -9.17 0.17 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 119.267 0.774 . . . . 0.0 111.63 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 71' ' ' ASP . 80.1 mm-40 -90.12 6.84 40.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.856 . . . . 0.0 109.498 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 68.9 mmm -86.39 21.84 1.99 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 26.7 mtpp -86.0 -6.9 58.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.901 -1.124 . . . . 0.0 109.07 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.2 m-20 -149.94 80.12 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.2 170.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.834 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 77.7 p -133.98 152.28 51.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.16 148.43 18.38 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.077 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -46.66 -44.17 22.0 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 CA-C-N 119.094 0.712 . . . . 0.0 111.232 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.16 -152.98 11.05 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.98 160.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.994 . . . . 0.0 109.4 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.459 ' HG1' HD21 ' A' ' 14' ' ' ASN . 76.5 m -114.42 120.52 40.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.2 129.98 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -145.7 152.97 40.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.022 -1.048 . . . . 0.0 110.592 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.5 ttm -109.2 129.92 55.49 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.702 -0.624 . . . . 0.0 109.376 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 108.758 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.538 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 2.1 m -98.16 151.14 37.38 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.207 -0.933 . . . . 0.0 108.569 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.91 138.19 53.8 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.043 -1.232 . . . . 0.0 112.57 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.9 m -113.24 149.41 33.83 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.488 0.661 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -70.95 149.2 46.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -0.772 . . . . 0.0 110.023 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.04 -164.16 32.2 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -98.38 114.66 27.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -1.145 . . . . 0.0 109.359 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.89 -27.95 63.76 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.0 -41.68 61.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 108.133 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.14 -34.55 77.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.13 -50.02 74.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.53 -39.97 89.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -61.17 -40.0 92.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.95 -45.02 93.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 108.997 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.24 -42.53 99.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.328 -0.858 . . . . 0.0 108.866 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.7 mm-40 -60.18 -40.13 88.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 109.135 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.3 p -70.48 -40.0 73.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.515 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.73 43.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 110.044 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.83 -37.68 85.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 5.7 m-70 -59.94 -49.36 77.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.074 -1.016 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 89.2 mt -60.06 -46.44 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.303 -0.873 . . . . 0.0 108.729 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.66 -46.81 63.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.443 -0.785 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.49 -40.08 90.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 110.547 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.89 -40.1 75.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -0.965 . . . . 0.0 110.931 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 m -100.18 0.75 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.187 -0.946 . . . . 0.0 110.018 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.58 25.32 70.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.07 -173.04 49.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -129.9 132.76 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.691 -0.887 . . . . 0.0 109.285 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.52 134.68 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.302 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.9 mt -135.05 159.95 39.87 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -86.47 -169.2 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 96.8 m-20 -60.06 -38.95 84.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -75.4 12.42 0.98 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.28 37.58 28.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.803 -0.56 . . . . 0.0 109.764 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -117.11 158.72 23.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.713 -0.617 . . . . 0.0 109.747 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.1 mmm -51.17 120.67 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.297 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 mtp -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.195 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -130.18 152.12 79.58 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -43.96 -42.97 12.49 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 120.582 0.855 . . . . 0.0 111.976 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.88 -39.93 91.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.83 -40.02 83.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.854 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.1 mt -57.54 -40.04 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.95 -39.96 93.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.592 -0.692 . . . . 0.0 109.265 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.42 -47.25 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.125 -0.985 . . . . 0.0 109.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 55.7 m-85 -60.06 -41.98 93.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 108.983 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.36 -40.09 89.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.3 m-20 -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.63 -43.82 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.118 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 78.6 mt -60.18 -39.95 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.964 . . . . 0.0 109.798 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.0 -39.98 87.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.961 -1.087 . . . . 0.0 109.104 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.15 -30.72 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.0 mmtt -59.98 -45.0 94.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.023 -1.048 . . . . 0.0 110.446 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -59.92 -36.2 76.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.845 -1.16 . . . . 0.0 109.805 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.29 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -103.7 -0.56 29.29 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.328 -0.858 . . . . 0.0 110.353 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' O ' ' NH2' ' A' ' 6' ' ' ARG . 92.3 mmm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.325 0.584 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -90.24 5.93 45.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 108.806 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' O ' ' NH1' ' A' ' 6' ' ' ARG . 23.2 mmtp -92.76 112.34 55.34 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.4 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' CB ' ' OE2' ' A' ' 138' ' ' GLU . 18.7 Cg_endo -73.18 23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.144 0 CA-C-N 120.236 1.12 . . . . 0.0 111.705 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 3' ' ' LYS . 53.5 mtpt -87.18 -0.36 56.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.276 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 3' ' ' LYS . 59.7 mtm-85 -79.11 130.67 35.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 111.356 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -89.22 -9.73 49.66 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -150.56 135.45 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.01 177.99 10.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.208 -1.557 . . . . 0.0 112.011 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.54 138.88 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -91.28 126.37 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -125.78 145.05 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 121.961 0.886 . . . . 0.0 110.806 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.5 mtm -148.33 154.37 39.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 117' ' ' LEU . 15.1 m120 -132.15 131.84 42.64 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.963 -1.086 . . . . 0.0 111.383 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -109.17 118.81 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 156.79 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.21 175.63 5.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.473 -0.767 . . . . 0.0 109.059 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -56.08 160.14 3.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.228 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -60.07 141.72 55.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.389 -0.82 . . . . 0.0 109.832 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.28 2.02 74.47 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.1 m -125.52 148.52 48.86 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.422 -1.046 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.0 151.37 50.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.452 -0.78 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.17 139.54 30.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.323 -0.86 . . . . 0.0 110.331 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.63 141.42 56.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.813 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.23 96.43 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.39 -47.46 85.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.324 . . . . 0.0 109.56 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.34 -25.81 64.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 108.817 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 tt -74.13 -55.61 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.566 -0.709 . . . . 0.0 109.869 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.86 -49.03 79.29 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 0.0 110.315 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 39.9 t30 -60.07 -44.52 94.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 111.591 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.7 m -61.83 -42.92 99.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.866 -1.146 . . . . 0.0 110.369 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.79 -44.86 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.964 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.22 -40.0 95.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.71 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 50.9 mt-30 -69.48 -19.72 63.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.19 -0.944 . . . . 0.0 111.431 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -81.47 -9.89 59.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.626 -1.296 . . . . 0.0 110.83 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.532 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.72 8.75 22.17 Favored Glycine 0 N--CA 1.502 3.086 0 O-C-N 121.029 -1.044 . . . . 0.0 110.817 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.677 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 38.1 m-85 -81.59 144.6 31.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.827 -1.396 . . . . 0.0 110.094 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.47 132.23 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.07 106.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 110.131 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.6 171.9 29.54 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.78 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -1.109 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.2 mtt 58.12 20.09 6.67 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.687 0.756 . . . . 0.0 109.777 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 52.94 33.7 15.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 111.613 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.97 163.28 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -89.75 129.2 36.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.981 -1.075 . . . . 0.0 110.689 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.6 m80 -115.72 130.02 56.69 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.677 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 39.9 ttm180 -104.64 124.31 49.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 24.9 m-70 -92.89 170.01 10.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 0.0 109.562 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.8 tp -55.66 -49.3 73.3 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -89.17 148.42 40.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -71.2 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.739 0.96 . . . . 0.0 112.372 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.69 0.23 54.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.01 -1.056 . . . . 0.0 110.383 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.82 86.3 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -72.25 -44.62 62.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.155 -1.203 . . . . 0.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -70.49 168.15 49.15 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.32 175.65 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.18 1.253 . . . . 0.0 111.837 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.85 121.25 26.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.5 mp -98.06 -55.21 2.85 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.068 -1.02 . . . . 0.0 109.715 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -142.97 160.54 40.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.07 . . . . 0.0 108.702 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 19.7 m -129.36 -179.05 4.93 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.231 1.015 . . . . 0.0 111.35 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.1 tt -139.77 130.23 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -133.25 168.46 18.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.47 -0.769 . . . . 0.0 109.61 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.8 m120 -77.85 166.37 22.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.753 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 80.2 mmm -69.97 -22.2 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.89 -0.506 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 68' ' ' GLY . 14.3 t -87.66 118.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -62.27 149.31 87.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.206 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.47 10.73 15.5 Favored 'Cis proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.91 -1.287 . . . . 0.0 111.484 -1.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 79.04 29.12 52.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.7 p -86.03 169.04 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -1.108 . . . . 0.0 110.676 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.3 m-85 -126.06 156.38 40.06 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.1 p-10 -135.6 148.49 65.88 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.01 -16.82 6.76 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.503 0.858 . . . . 0.0 111.665 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -89.91 6.98 39.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.083 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.546 ' SD ' ' O ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.51 21.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.82 . . . . 0.0 109.808 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -86.05 -8.58 57.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.997 . . . . 0.0 109.911 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 83.7 m-20 -144.57 82.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.256 -0.903 . . . . 0.0 108.912 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.03 172.31 18.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 109.065 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.4 p -131.18 152.32 50.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.368 -0.833 . . . . 0.0 108.76 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.28 149.44 19.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -43.91 -49.73 8.02 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 120.495 0.796 . . . . 0.0 111.719 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.39 -152.26 8.7 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.99 160.89 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.6 -0.941 . . . . 0.0 109.573 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 62' ' ' ALA . 52.8 m -112.15 128.03 56.1 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.558 -0.714 . . . . 0.0 110.103 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.98 130.0 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -149.64 167.08 27.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.565 -1.335 . . . . 0.0 110.879 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 ttp -132.94 130.8 40.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' O ' ' OG ' ' A' ' 90' ' ' SER . 91.8 mt-30 -87.59 108.52 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 108.953 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.54 144.05 27.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -74.04 134.91 37.73 Favored 'Cis proline' 0 N--CA 1.498 1.761 0 C-N-CA 124.341 -1.108 . . . . 0.0 113.371 0.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.3 m -110.41 159.91 17.06 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.54 0.686 . . . . 0.0 109.828 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -70.75 142.18 51.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.174 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.33 -159.71 26.41 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.59 123.55 39.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.16 -1.2 . . . . 0.0 109.562 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 39.5 mp0 -59.93 -36.61 77.41 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 110.402 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.69 -38.81 80.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.958 . . . . 0.0 109.955 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -69.97 -39.96 75.66 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.892 -1.13 . . . . 0.0 108.123 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -61.34 -39.99 92.6 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.85 -41.37 97.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.087 -1.008 . . . . 0.0 109.007 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.24 -39.98 94.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.897 . . . . 0.0 109.041 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.1 mtp -58.13 -48.36 80.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.429 -0.794 . . . . 0.0 109.312 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.66 -42.68 98.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.922 -1.111 . . . . 0.0 109.184 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -41.72 92.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.711 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -69.94 -39.98 75.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.39 58.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -62.2 -40.63 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.001 -1.062 . . . . 0.0 110.084 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -60.47 -47.45 86.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.174 . . . . 0.0 108.749 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.92 -50.02 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.03 -49.97 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.661 -0.649 . . . . 0.0 109.844 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.18 -40.19 89.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.282 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.9 -40.01 75.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.937 . . . . 0.0 111.151 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.3 m -100.69 -1.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.084 -1.01 . . . . 0.0 109.826 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 24.63 75.38 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.9 -176.42 51.14 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.46 133.03 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.636 -0.92 . . . . 0.0 108.905 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 t -70.24 130.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.013 -1.054 . . . . 0.0 109.096 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 14' ' ' ASN . 77.4 mt -129.23 155.99 44.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.587 -0.695 . . . . 0.0 109.286 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 30.4 p-10 -85.42 -172.64 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 109.481 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.1 m-20 -60.01 -38.71 83.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.65 16.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.377 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.0 mtm180 56.1 33.55 22.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -109.87 149.1 30.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 0.0 109.144 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 65.5 mtt -50.75 135.73 23.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.977 . . . . 0.0 109.265 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.67 137.15 57.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -134.47 150.35 73.56 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.02 -42.37 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 119.162 0.736 . . . . 0.0 111.879 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -60.6 -39.98 90.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 51.0 mmtt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.058 -1.026 . . . . 0.0 110.051 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.9 -43.15 94.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -69.3 -32.9 72.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.799 -1.188 . . . . 0.0 109.747 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -59.98 -45.31 93.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.005 -1.06 . . . . 0.0 108.876 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -60.78 -41.07 94.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.69 -39.96 93.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 0.0 109.085 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.54 -40.2 96.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.65 -42.06 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 136' ' ' ILE . 81.7 mt -60.03 -41.93 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.208 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.5 mtt180 -61.92 -37.65 85.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.486 ' OE2' ' CB ' ' A' ' 4' ' ' PRO . 94.7 mt-10 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.778 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.35 -32.16 30.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.9 mmmm -60.07 -45.92 91.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.075 -1.016 . . . . 0.0 110.17 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.79 -31.83 71.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.754 -1.216 . . . . 0.0 108.892 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.01 94.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 110.385 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 55.6 p30 -97.91 0.37 46.41 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 0.0 110.104 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.545 -179.88 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 tpp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.368 0.604 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.12 30.87 1.04 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -130.02 75.79 78.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 6' ' ' ARG . 2.5 Cg_endo -65.85 122.05 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 120.858 1.039 . . . . 0.0 111.816 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -78.95 32.43 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 4' ' ' PRO . 98.9 mtt180 -72.13 153.13 41.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.54 -0.725 . . . . 0.0 109.338 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -80.45 -9.94 59.75 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -145.0 151.86 39.24 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.29 160.34 32.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 109.932 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.16 129.99 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 HG21 HD12 ' A' ' 11' ' ' ILE . 12.0 mm -92.27 117.16 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 84.2 mt -121.58 142.16 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 121.946 0.879 . . . . 0.0 111.191 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.0 mtm -146.1 150.18 35.45 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -129.71 128.67 42.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.972 -1.08 . . . . 0.0 111.291 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.45 116.4 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' VAL . . . -147.34 157.24 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 109.97 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.89 -174.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 109.063 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -61.02 156.65 17.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 108.88 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -60.02 140.12 57.01 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.51 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.18 70.23 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -121.11 147.3 45.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.551 -0.97 . . . . 0.0 109.699 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -125.87 145.5 50.22 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.42 149.18 25.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 110.564 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -70.84 145.27 50.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.129 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.56 -42.05 99.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.51 -43.75 98.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.301 . . . . 0.0 110.166 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.79 -27.02 64.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -75.12 -57.86 3.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.541 -0.724 . . . . 0.0 109.912 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.32 -42.33 95.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.0 110.532 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -64.04 -40.06 95.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.2 m -65.19 -41.38 94.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 110.419 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.02 -46.88 93.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.009 -1.057 . . . . 0.0 109.4 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -65.38 -43.25 91.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 0.0 109.401 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -17.24 64.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.35 1.57 36.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.023 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.71 9.55 66.2 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 121.071 -1.018 . . . . 0.0 111.016 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -80.75 151.07 29.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.822 -1.399 . . . . 0.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.9 mt -120.0 130.67 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.88 101.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.995 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.05 171.22 38.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.3 -163.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.469 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.7 mtm 58.03 23.25 9.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.428 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.36 39.41 20.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 111.231 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.0 pt -142.0 164.84 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.026 -1.047 . . . . 0.0 109.429 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -91.89 136.28 33.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.072 -1.017 . . . . 0.0 109.886 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.672 ' CG ' ' HG ' ' A' ' 60' ' ' SER . 43.8 m-70 -125.16 125.11 43.18 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.726 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.7 ttt180 -105.09 125.53 51.08 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.475 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 34.2 m-70 -94.73 173.99 7.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.442 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.64 -50.76 65.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.261 -0.899 . . . . 0.0 108.832 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -93.83 144.06 27.52 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 0.0 108.784 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.36 -4.42 11.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 120.57 0.847 . . . . 0.0 112.149 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -91.48 -0.94 57.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.383 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.28 86.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 t -69.95 -41.01 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -1.198 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.37 169.13 54.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.475 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.1 Cg_endo -69.55 173.47 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.2 1.266 . . . . 0.0 111.427 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 120.8 25.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.034 . . . . 0.0 108.649 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' CD2' HD22 ' A' ' 97' ' ' ASN . 9.7 mp -100.81 -35.08 9.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.234 -0.916 . . . . 0.0 109.75 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -153.47 165.45 35.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.924 -1.11 . . . . 0.0 108.762 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.672 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 5.4 m -138.48 161.97 35.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.037 -1.039 . . . . 0.0 111.229 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 tt -114.75 135.07 54.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -132.41 162.08 32.01 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.587 -0.696 . . . . 0.0 109.29 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.606 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 76.6 m-20 -78.64 166.85 22.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.015 -1.053 . . . . 0.0 110.053 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.4 mmm -69.92 -23.09 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.465 -0.772 . . . . 0.0 110.205 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -88.14 112.5 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 110.521 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -60.3 150.42 72.41 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -77.87 8.55 19.93 Favored 'Cis proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.114 -1.202 . . . . 0.0 111.982 -0.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.43 35.83 25.16 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.6 p -85.94 160.47 19.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.256 -1.143 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 32.7 m-85 -128.52 139.02 52.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 t70 -127.77 137.82 31.57 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -48.13 -4.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.591 1.247 . . . . 0.0 112.888 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -90.83 3.96 53.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.054 -1.028 . . . . 0.0 111.345 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.5 mtm -79.72 26.14 0.32 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.567 -1.333 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.0 mmtp -81.91 2.39 30.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.581 -1.325 . . . . 0.0 109.261 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 70.1 m-20 -153.79 81.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 108.76 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -158.84 171.41 20.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.11 -0.994 . . . . 0.0 109.964 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.7 p -137.88 154.68 49.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.23 149.12 17.35 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 109.19 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -46.93 -45.22 21.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 120.786 0.991 . . . . 0.0 112.027 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.23 -152.84 10.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.94 159.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -1.05 . . . . 0.0 109.396 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' ALA . 51.9 m -111.53 124.94 53.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.226 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.11 130.61 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.77 160.41 41.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 110.85 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.9 ttp -141.46 131.73 25.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.658 -0.651 . . . . 0.0 109.622 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.18 115.21 27.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.048 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.24 152.38 38.65 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.357 -0.839 . . . . 0.0 109.065 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.603 ' CG ' HD21 ' A' ' 143' ' ' ASN . 6.5 Cg_endo -77.63 136.77 44.29 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.655 -1.394 . . . . 0.0 112.149 -0.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.9 m -104.59 166.52 10.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.574 -0.704 . . . . 0.0 109.721 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -68.93 141.5 54.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.446 -0.784 . . . . 0.0 109.045 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.78 28.4 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -94.19 115.33 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.966 -1.314 . . . . 0.0 109.703 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 50.5 mp0 -58.05 -28.0 64.11 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.696 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.8 mt -69.73 -40.04 76.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.196 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -73.05 -40.51 65.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.901 -1.124 . . . . 0.0 108.948 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.43 HD22 ' CD2' ' A' ' 58' ' ' LEU . 26.9 m120 -61.86 -41.96 98.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -59.86 -49.92 75.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.75 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.13 -39.96 94.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -43.39 95.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.0 mtp -57.78 -44.57 86.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 108.746 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.0 -41.21 97.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 108.726 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.2 mt-30 -60.15 -41.54 92.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.086 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -70.28 -39.89 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 109.147 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.82 68.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 110.435 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -60.76 -37.83 83.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.87 -1.144 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 19.3 m-70 -60.06 -50.05 75.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.048 -1.033 . . . . 0.0 109.151 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.9 -50.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.539 -0.725 . . . . 0.0 109.652 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.46 -49.36 55.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.58 -39.78 89.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 110.338 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.11 -40.06 75.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.675 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.1 m -98.84 0.4 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.055 -1.028 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.22 21.87 75.9 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.94 -176.8 49.96 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 16' ' ' ALA . 58.4 t -135.33 140.74 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.6 -0.941 . . . . 0.0 108.952 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -73.3 127.95 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.978 . . . . 0.0 109.945 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 mt -128.8 153.62 47.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.76 -178.04 6.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' NH1' ' A' ' 121' ' ' ARG . 97.9 m-20 -59.39 -28.89 67.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.049 -1.032 . . . . 0.0 109.082 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -82.13 12.36 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 108.972 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 119' ' ' ASP . 14.6 mmt-85 61.48 27.59 17.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.7 -0.625 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -107.88 147.8 30.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 0.0 109.328 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 92.2 mmm -50.41 121.6 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.665 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 35.2 mtp -59.79 139.93 56.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.839 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -130.29 151.0 77.74 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -41.94 -41.64 6.54 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 120.503 0.802 . . . . 0.0 111.622 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.07 -42.19 94.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.445 -0.784 . . . . 0.0 109.235 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.49 -39.88 77.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.862 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.5 mt -56.61 -40.09 74.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.814 -1.179 . . . . 0.0 108.373 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -64.63 -38.23 90.29 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.017 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.98 -45.56 92.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.971 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.23 -41.96 94.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.862 -1.149 . . . . 0.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.62 -39.78 92.49 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 97.6 m-20 -60.06 -39.63 86.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.513 -0.742 . . . . 0.0 109.183 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.1 mt -59.93 -41.73 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 108.65 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.21 -39.87 81.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.36 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 137' ' ' ARG . 16.3 mtt-85 -59.99 -40.14 88.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.576 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -60.39 -39.8 88.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.925 -1.109 . . . . 0.0 109.035 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.6 -32.03 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.6 mttt -60.0 -42.68 94.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.841 -1.162 . . . . 0.0 110.923 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.985 -1.072 . . . . 0.0 109.854 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.89 -59.13 3.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.924 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.603 HD21 ' CG ' ' A' ' 89' ' ' PRO . 80.9 m-20 -103.9 -14.57 15.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.296 -0.878 . . . . 0.0 110.478 -178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.542 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -90.46 28.32 1.5 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.942 . . . . 0.0 109.609 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.546 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -119.94 82.92 29.17 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 109.475 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.41 14.66 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 120.575 0.85 . . . . 0.0 112.053 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 3' ' ' LYS . 64.1 mttp -85.79 -4.23 59.11 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.634 -0.666 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' HG2' HH11 ' A' ' 6' ' ' ARG . 35.7 mtt-85 -82.42 115.8 21.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.952 -1.093 . . . . 0.0 110.052 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -85.66 -10.42 55.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.4 148.11 29.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.47 175.97 8.6 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.67 -1.269 . . . . 0.0 110.359 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.08 131.44 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 11' ' ' ILE . 21.0 mm -91.25 125.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.12 144.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.896 0.855 . . . . 0.0 110.867 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.5 mtt -144.6 156.16 43.99 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.5 126.72 24.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.959 -1.088 . . . . 0.0 111.022 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.01 119.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.3 158.63 44.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.775 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.65 -164.49 0.09 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -69.26 159.42 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 108.815 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -60.07 140.79 56.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.09 80.39 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.8 m -110.04 152.4 25.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.391 -1.064 . . . . 0.0 109.216 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -130.25 149.03 52.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.8 140.36 29.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.02 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.82 143.42 54.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.12 96.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.03 -44.83 96.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -1.209 . . . . 0.0 109.545 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.02 -29.48 66.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -0.812 . . . . 0.0 108.931 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.3 tt -71.14 -57.3 4.64 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.6 -0.687 . . . . 0.0 109.456 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.99 -43.41 95.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.187 -0.946 . . . . 0.0 110.476 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.93 -40.02 94.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 110.056 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 32' ' ' ILE . 79.4 p -65.51 -40.16 92.68 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.928 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.538 ' N ' ' HG ' ' A' ' 31' ' ' SER . 96.6 mt -60.07 -48.34 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -62.23 -43.32 99.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.982 . . . . 0.0 110.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.87 -20.01 66.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.5 5.62 17.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.35 85.14 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -81.22 154.37 26.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.038 -1.272 . . . . 0.0 109.619 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.9 mt -128.63 142.81 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -59.04 99.92 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.113 -0.992 . . . . 0.0 109.542 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.22 168.85 45.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -62.99 -163.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.496 -1.003 . . . . 0.0 108.923 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt 56.5 22.2 6.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -0.819 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.6 m120 51.89 40.09 27.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 111.146 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.08 170.03 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 109.327 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.22 135.08 34.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.978 -1.076 . . . . 0.0 109.836 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.571 ' HD1' ' HG ' ' A' ' 60' ' ' SER . 6.2 m-70 -119.53 133.91 55.46 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 7.5 tpt180 -102.38 120.97 41.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.385 -0.822 . . . . 0.0 108.972 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 68.7 m-70 -98.26 170.06 9.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 109.723 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.26 -49.98 74.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 108.988 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.8 m -91.93 147.78 35.61 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.95 -6.18 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.671 0.914 . . . . 0.0 112.794 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -93.23 -0.89 56.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.917 -1.115 . . . . 0.0 110.158 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.43 12.09 84.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.466 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.9 p -70.2 -39.9 74.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.53 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.88 167.1 51.05 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 16.0 Cg_endo -69.03 171.31 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.228 1.285 . . . . 0.0 112.113 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.35 122.82 28.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.209 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.4 mp -98.91 -36.87 9.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.228 -0.92 . . . . 0.0 109.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.8 162.31 40.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 108.589 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.571 ' HG ' ' HD1' ' A' ' 46' ' ' HIS . 4.4 m -131.06 175.99 8.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.081 -1.012 . . . . 0.0 111.859 -177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -136.65 131.69 33.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -138.44 162.17 35.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.4 m120 -77.2 162.92 27.01 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.212 -0.93 . . . . 0.0 110.751 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mtt -69.96 -23.72 63.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.598 -0.689 . . . . 0.0 110.396 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -85.85 119.99 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.971 -1.081 . . . . 0.0 109.632 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -59.89 149.71 71.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.52 -0.738 . . . . 0.0 109.064 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -77.12 8.94 16.4 Favored 'Cis proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.758 -0.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 16.69 76.52 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.1 p -87.99 173.56 8.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.079 -1.247 . . . . 0.0 109.924 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.04 140.12 51.49 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLU . 5.6 m-20 -126.52 150.08 69.66 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 74' ' ' MET . 21.3 Cg_exo -45.39 -12.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.6 0.867 . . . . 0.0 111.93 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -83.54 13.22 4.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.4 ptt? -83.82 -1.39 54.25 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.513 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 98.9 mttt -85.94 -3.78 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.798 -1.189 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.0 m-20 -150.45 75.75 1.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.686 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -159.06 168.98 25.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.118 -0.989 . . . . 0.0 109.414 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.8 p -136.53 155.56 49.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.44 150.43 20.7 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 109.449 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -47.22 -46.72 18.86 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 120.366 0.711 . . . . 0.0 111.24 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.38 -151.04 8.06 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.98 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.529 -0.983 . . . . 0.0 109.322 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.5 m -113.02 120.18 40.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 0.0 109.489 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.21 129.97 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -143.71 163.69 32.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.125 -0.984 . . . . 0.0 110.496 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.0 ttp -138.97 129.74 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.713 -0.617 . . . . 0.0 109.563 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -92.28 119.71 32.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 0.0 109.117 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -102.75 150.31 37.6 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.24 133.76 32.69 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.568 0.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.8 m -102.18 170.23 8.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.95 139.95 55.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.377 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.82 -154.38 24.65 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -99.58 122.02 42.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.299 -1.118 . . . . 0.0 109.652 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 56.6 mp0 -55.87 -28.61 57.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.5 -39.93 77.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.037 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -40.34 70.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.095 -1.003 . . . . 0.0 109.102 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.59 -40.04 90.3 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -57.02 -41.43 78.54 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.41 -42.03 99.14 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.137 -0.977 . . . . 0.0 108.733 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.01 -39.99 95.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 108.71 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mmm -57.23 -50.12 73.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.832 . . . . 0.0 109.497 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.35 -47.75 78.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.24 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.529 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -60.0 -40.84 90.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.782 . . . . 0.0 109.217 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 p -71.96 -42.93 65.99 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.167 -0.958 . . . . 0.0 109.298 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.12 -54.53 44.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -62.78 -35.09 78.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.585 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.8 m-70 -60.05 -49.94 75.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 108' ' ' ILE . 81.5 mt -59.97 -49.91 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.889 -1.132 . . . . 0.0 108.011 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.95 -49.22 66.49 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.04 -40.01 91.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.558 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.94 77.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.8 m -96.12 0.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.975 -1.078 . . . . 0.0 108.873 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 21.67 76.91 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . -84.07 -169.68 45.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -131.97 138.11 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.602 -0.94 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.8 t -73.69 138.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.284 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.28 160.0 37.5 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.436 -0.79 . . . . 0.0 109.649 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -84.13 -171.67 3.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.402 -0.811 . . . . 0.0 109.672 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.438 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 94.7 m-20 -60.01 -39.86 87.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.217 -0.927 . . . . 0.0 110.083 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.43 14.47 0.97 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -0.909 . . . . 0.0 109.396 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 57.4 37.63 28.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.745 -0.597 . . . . 0.0 109.744 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -112.13 151.48 29.42 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 19.5 mmt -50.2 126.37 14.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.957 -1.09 . . . . 0.0 109.284 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.9 mtt -58.9 139.97 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.788 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -129.12 151.36 77.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -41.47 -45.0 6.1 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 120.762 0.975 . . . . 0.0 112.184 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -60.8 -39.9 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.768 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -63.74 -40.05 95.79 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.243 -0.91 . . . . 0.0 109.717 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.57 -40.05 86.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.706 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -66.26 -37.94 86.64 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.615 -0.678 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.13 -49.99 75.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.528 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 73.1 m-85 -59.97 -49.37 77.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 108.738 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.17 -38.05 82.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.08 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.1 -40.96 91.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.149 -0.969 . . . . 0.0 109.67 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.65 -40.06 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.639 -1.288 . . . . 0.0 108.467 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.97 -47.57 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.15 -39.89 87.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.863 . . . . 0.0 108.915 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 89.6 mt-10 -60.98 -41.1 95.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.85 -39.95 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -60.01 -44.92 94.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.349 -0.844 . . . . 0.0 111.592 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.6 p30 -59.97 -34.15 72.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.574 -1.329 . . . . 0.0 109.112 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.39 -35.92 82.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.027 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -97.31 -0.23 46.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.741 . . . . 0.0 109.382 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.314 0.578 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.9 -0.1 57.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -80.64 143.53 54.88 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.0 109.71 -179.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.43 23.46 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.505 0.859 . . . . 0.0 111.915 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 3' ' ' LYS . 64.2 mttp -81.82 -22.63 36.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.785 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -86.19 119.62 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.042 . . . . 0.0 110.261 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -88.21 -10.19 50.58 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.39 144.11 27.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.17 9.83 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.584 -1.322 . . . . 0.0 110.148 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.81 130.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 11' ' ' ILE . 26.3 mm -93.17 122.67 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.2 mt -120.06 147.63 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.23 1.014 . . . . 0.0 111.372 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -143.81 147.37 34.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.43 120.96 25.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.5 117.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.54 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.452 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.53 -164.49 0.12 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.9 155.03 39.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.925 -1.109 . . . . 0.0 108.482 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -59.93 139.99 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.076 . . . . 0.0 109.349 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.57 3.5 66.6 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -124.42 149.43 46.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.501 -1.0 . . . . 0.0 109.248 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.4 mt-10 -126.73 145.81 50.46 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.21 146.34 27.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -68.67 143.62 54.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 109.156 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.55 -43.43 98.88 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.28 -45.67 92.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -1.214 . . . . 0.0 110.152 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.79 -29.83 67.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.32 -58.79 3.2 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.583 -0.698 . . . . 0.0 109.347 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.7 mt -60.09 -41.63 92.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.62 -39.89 94.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -64.26 -40.81 96.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.695 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 32' ' ' ILE . 93.8 mt -60.19 -44.64 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.333 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.34 -40.37 95.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.029 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' OE1' ' OE2' ' A' ' 111' ' ' GLU . 78.0 mt-30 -68.27 -20.04 64.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.279 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.71 7.29 15.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.196 -0.94 . . . . 0.0 110.292 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.63 83.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.988 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -80.63 152.53 28.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.434 . . . . 0.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.39 145.26 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.82 118.86 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.0 108.966 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.67 171.57 41.59 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.6 -162.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.569 -0.96 . . . . 0.0 109.711 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 89.8 mmm 54.78 -101.34 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' MET . 26.7 m120 -163.27 31.85 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 pt -134.69 163.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.494 -0.754 . . . . 0.0 110.115 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -88.07 134.41 33.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.296 -0.878 . . . . 0.0 110.143 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.528 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 8.0 m-70 -118.34 129.79 55.64 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 15.9 ttt180 -106.11 125.42 50.97 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 49.4 m-70 -95.13 174.12 7.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.824 . . . . 0.0 110.222 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.33 -49.97 74.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.8 m -92.7 147.89 35.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.28 -0.887 . . . . 0.0 108.693 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.12 -5.95 17.07 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.68 0.92 . . . . 0.0 112.06 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -92.65 1.28 57.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.179 -0.95 . . . . 0.0 110.204 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.74 11.45 84.53 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -70.15 -40.07 74.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.241 . . . . 0.0 110.091 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.547 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.0 169.82 53.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.537 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.4 Cg_endo -72.78 -179.96 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.133 1.222 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.43 123.4 29.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 108.729 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -101.02 -28.3 12.8 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -159.94 165.31 32.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.599 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.528 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 17.2 m -132.48 170.11 15.6 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.129 -0.982 . . . . 0.0 111.53 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.7 tt -132.63 130.96 40.88 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 169.68 17.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.417 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 91.7 m-20 -75.14 163.49 27.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 109.617 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -70.02 -21.68 63.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.44 -0.788 . . . . 0.0 110.464 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.17 114.85 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.109 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -60.13 149.75 73.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.417 -0.802 . . . . 0.0 109.422 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -76.49 6.8 16.3 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.858 -1.309 . . . . 0.0 111.374 -1.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.89 31.23 49.5 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 p -86.09 165.85 16.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.286 . . . . 0.0 109.944 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.548 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.24 148.65 43.42 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' MET . 1.8 p30 -133.96 151.4 76.7 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 74' ' ' MET . 2.9 Cg_exo -50.34 -11.86 0.41 Allowed 'Trans proline' 0 N--CA 1.486 1.072 0 CA-C-N 119.429 0.832 . . . . 0.0 110.362 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 71' ' ' ASP . 75.3 mm-40 -82.17 6.48 16.42 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 23.3 ptt? -79.61 1.65 25.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -85.02 -2.15 57.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.82 -1.175 . . . . 0.0 108.267 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -154.09 78.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -159.3 167.61 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.221 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.414 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 42.6 p -140.72 154.58 46.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.235 -0.916 . . . . 0.0 108.936 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.83 150.16 21.02 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.075 -1.015 . . . . 0.0 109.248 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -41.93 -36.87 3.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 120.724 0.95 . . . . 0.0 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.41 -150.63 12.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.97 159.97 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 109.58 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -113.17 125.9 54.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.675 . . . . 0.0 109.632 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.12 129.97 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -146.79 166.26 27.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.972 -1.08 . . . . 0.0 110.274 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 50.3 ttp -137.33 131.32 32.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 90' ' ' SER . 90.4 mm-40 -88.15 117.73 27.25 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -105.5 148.2 35.94 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 137.5 50.24 Favored 'Cis proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.695 -1.377 . . . . 0.0 112.262 -0.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 51.2 m -103.73 166.94 10.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.502 -0.749 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -72.19 146.22 47.51 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.587 -0.696 . . . . 0.0 109.352 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 -156.35 31.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.14 111.95 23.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -1.135 . . . . 0.0 109.019 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.8 mp0 -54.18 -26.46 28.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.467 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.9 mt -70.02 -39.95 75.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.0 108.68 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -71.61 -40.02 70.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 97' ' ' ASN . 1.7 m120 -59.99 -40.41 89.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.91 -45.45 92.52 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.44 -40.59 97.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.98 -40.04 91.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 108.842 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp -59.41 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.26 -43.46 91.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.176 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 77.8 mt-30 -60.1 -39.98 88.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 p -70.47 -40.06 73.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.413 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.13 -53.78 54.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 110.239 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -61.88 -41.09 97.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.876 -1.14 . . . . 0.0 109.244 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 28.0 m-70 -60.34 -50.01 75.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.14 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.5 mt -60.8 -49.99 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.101 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.49 -49.47 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.503 -0.748 . . . . 0.0 109.135 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.07 -40.1 88.32 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.428 -0.795 . . . . 0.0 110.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' OE2' ' OE1' ' A' ' 34' ' ' GLN . 41.4 mt-10 -69.57 -39.92 77.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.975 -1.078 . . . . 0.0 110.721 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.6 m -99.65 -2.24 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.059 -1.026 . . . . 0.0 109.628 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.06 23.76 76.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.07 -176.15 51.07 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.289 -1.124 . . . . 0.0 110.57 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.03 136.32 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.945 . . . . 0.0 109.692 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.64 133.13 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -133.15 161.81 33.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.802 . . . . 0.0 109.168 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -84.23 -170.57 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.915 . . . . 0.0 109.702 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 89.4 m-20 -60.09 -39.94 87.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.85 . . . . 0.0 110.046 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.539 ' CB ' HH12 ' A' ' 122' ' ' ARG . 96.6 mt-30 -80.33 14.18 2.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 59.68 34.52 22.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.983 -0.448 . . . . 0.0 111.702 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.539 HH12 ' CB ' ' A' ' 120' ' ' GLN . 50.9 mtm-85 -107.19 158.0 17.44 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.042 -1.036 . . . . 0.0 108.821 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.9 mtm -52.59 130.52 32.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.942 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mmm -59.94 141.57 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 110.066 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.0 p -132.25 150.04 74.88 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -47.3 -42.37 27.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.513 0.862 . . . . 0.0 112.082 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.09 -39.87 87.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.312 -0.868 . . . . 0.0 109.579 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -66.72 -40.02 88.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.94 -40.25 88.29 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.835 -1.166 . . . . 0.0 109.412 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.9 -37.66 86.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.349 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.87 -48.89 79.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.951 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.02 -45.36 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.986 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.8 -39.99 93.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.21 -40.02 88.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.28 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.07 -40.7 84.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.922 -1.112 . . . . 0.0 108.711 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.447 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.6 mmt180 -63.55 -36.15 82.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.18 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.02 -39.93 87.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.515 -0.741 . . . . 0.0 109.856 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.33 -35.15 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -59.77 -47.19 86.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 0.0 110.109 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -60.59 -31.96 71.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.871 -1.143 . . . . 0.0 109.3 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.99 92.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.563 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.79 0.26 44.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 108.904 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.322 0.582 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -90.07 -0.02 57.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 78.3 75.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.53 -0.731 . . . . 0.0 109.693 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 7.1 Cg_exo -62.9 121.39 9.26 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.653 1.569 . . . . 0.0 113.175 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -80.92 33.0 0.32 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 4' ' ' PRO . 93.2 mtt180 -69.89 156.36 39.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.482 -0.761 . . . . 0.0 110.802 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -82.08 -8.65 59.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -144.36 142.59 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.73 -175.65 4.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.724 -1.235 . . . . 0.0 110.602 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -133.39 139.06 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 11' ' ' ILE . 36.7 mm -91.62 131.12 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.0 mt -121.11 147.29 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.989 0.9 . . . . 0.0 110.979 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.3 mtt -147.39 156.49 42.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -136.97 118.37 14.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.879 -1.138 . . . . 0.0 110.632 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.9 t -101.24 111.19 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.72 43.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.67 -164.11 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -68.39 161.47 27.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 108.624 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -61.93 140.04 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.047 -1.033 . . . . 0.0 109.895 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.35 2.13 85.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -116.94 146.33 43.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.446 -1.032 . . . . 0.0 109.054 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.7 144.98 50.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.92 147.94 26.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.43 138.25 55.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.44 97.07 Favored Glycine 0 N--CA 1.493 2.433 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.287 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.1 -45.49 94.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.284 . . . . 0.0 109.338 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.84 -27.02 64.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tt -74.41 -59.61 2.65 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.558 -0.714 . . . . 0.0 109.593 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.99 -43.52 95.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.291 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.01 -41.85 97.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -64.3 -40.99 97.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.165 -0.96 . . . . 0.0 109.676 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.412 HG23 HD11 ' A' ' 32' ' ' ILE . 96.5 mt -60.08 -48.22 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.89 -40.99 95.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 109.667 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.68 -19.79 63.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.489 -0.757 . . . . 0.0 110.468 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.86 6.16 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 0.0 110.136 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.34 78.37 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -1.2 . . . . 0.0 109.995 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.74 138.82 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.46 98.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.082 . . . . 0.0 109.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 171.46 53.9 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.14 -170.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.464 -1.021 . . . . 0.0 109.578 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 70.8 mtm 56.74 30.11 17.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.484 -0.76 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 48.78 40.05 15.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 111.642 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.24 162.33 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.03 -1.044 . . . . 0.0 109.541 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.1 121.55 32.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.565 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 7.2 m-70 -103.92 130.5 51.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.296 -0.878 . . . . 0.0 109.818 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 7.5 tpt180 -101.75 120.62 40.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 59.1 m-70 -98.19 169.43 9.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -0.896 . . . . 0.0 109.735 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.67 -49.48 76.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -90.65 138.82 26.41 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.335 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.56 -7.29 14.04 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 CA-C-N 119.69 0.925 . . . . 0.0 111.616 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -92.61 -0.17 57.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.85 86.58 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.19 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -68.63 -41.38 79.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.499 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.42 163.39 50.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 15.3 Cg_endo -67.77 171.38 12.25 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.002 1.134 . . . . 0.0 112.05 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.65 120.61 24.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 108.723 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.1 mp -97.04 -31.28 12.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.181 -0.949 . . . . 0.0 108.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -156.84 164.52 37.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.565 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 1.7 m -135.72 -179.09 5.44 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.104 -0.997 . . . . 0.0 111.223 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -136.68 132.54 35.08 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.04 160.78 33.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.2 m-20 -73.66 159.27 33.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 109.266 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.02 -21.28 63.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.867 . . . . 0.0 110.573 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 68' ' ' GLY . 5.1 m -88.16 126.21 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.844 -1.16 . . . . 0.0 109.526 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -62.29 148.82 88.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 108.529 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.92 14.91 8.8 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.609 -1.413 . . . . 0.0 112.057 -0.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 71.26 20.42 78.11 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 p -88.01 167.97 13.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -1.138 . . . . 0.0 110.494 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 51.6 m-85 -120.28 143.46 48.32 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.683 -0.635 . . . . 0.0 109.476 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -126.87 136.66 29.13 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -49.1 -11.96 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 119.852 0.983 . . . . 0.0 113.17 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -87.46 -0.69 57.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.898 -1.126 . . . . 0.0 108.714 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 93.1 mtp -88.93 24.69 2.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.1 mttm -82.69 -3.96 57.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.841 -1.162 . . . . 0.0 109.282 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 84.0 m-20 -145.14 82.8 1.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.849 . . . . 0.0 108.734 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.42 176.43 11.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.7 p -130.24 153.44 48.6 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.57 150.42 19.42 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.801 -1.187 . . . . 0.0 110.506 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -46.4 -40.23 22.49 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 120.794 0.996 . . . . 0.0 111.912 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.89 -151.71 17.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.14 159.99 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.444 -1.033 . . . . 0.0 109.411 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.5 m -114.82 119.34 36.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.7 mt -102.6 134.48 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.44 163.21 35.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 110.025 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.5 ttp -137.74 129.55 28.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.713 . . . . 0.0 109.496 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.01 117.7 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 108.673 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.37 153.25 39.2 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.45 137.72 51.6 Favored 'Cis proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.789 -1.338 . . . . 0.0 112.132 0.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.0 m -106.15 165.71 11.04 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.55 -0.718 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -70.29 142.69 52.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 0.0 110.421 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.45 -152.97 22.36 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -97.37 116.97 30.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.328 -1.101 . . . . 0.0 108.951 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 32.5 mp0 -59.55 -34.11 72.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 110.165 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.09 -39.96 78.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.032 -1.042 . . . . 0.0 109.838 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -73.0 -39.5 66.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.791 -1.193 . . . . 0.0 108.368 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.1 -40.04 88.29 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 84.7 t80 -60.0 -46.48 89.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.08 -40.06 95.41 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.99 -44.28 94.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 90.9 mtp -57.47 -44.82 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 108.915 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.33 -43.71 98.18 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 108.765 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.534 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 91.7 mt-30 -59.87 -41.13 90.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.377 -0.827 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -71.31 -41.45 69.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.25 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.08 71.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.435 -0.79 . . . . 0.0 110.255 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -61.62 -37.02 82.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.794 -1.191 . . . . 0.0 109.157 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.0 m-70 -59.97 -47.6 85.17 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.07 -1.019 . . . . 0.0 109.128 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 108' ' ' ILE . 96.9 mt -60.04 -49.94 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 108.927 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -54.13 -50.31 67.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.93 -40.19 88.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 110.052 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -70.05 -40.44 75.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 111.341 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 m -99.35 -0.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.949 -1.094 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.28 19.61 72.51 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.77 -172.34 43.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -127.83 133.61 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.483 -1.01 . . . . 0.0 109.221 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.95 131.52 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.702 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.61 159.52 36.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.454 -0.779 . . . . 0.0 109.448 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 42.9 p-10 -88.58 -170.26 2.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.4 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 109.881 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -76.13 14.61 0.69 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 108.645 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.2 mtm180 57.4 27.87 14.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.861 -0.525 . . . . 0.0 110.432 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.643 ' NH2' ' HZ3' ' A' ' 128' ' ' LYS . 84.8 mtm180 -105.25 157.07 17.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.83 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 99.2 mtp -51.93 134.17 31.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.7 mmm -58.08 140.25 53.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -131.08 151.25 78.6 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.73 -42.96 62.04 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 120.524 0.816 . . . . 0.0 111.829 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.95 -39.95 87.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.643 ' HZ3' ' NH2' ' A' ' 122' ' ' ARG . 27.5 mmtp -64.74 -40.0 94.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 110.166 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.19 -40.11 84.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 108.616 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -64.11 -39.99 95.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.476 -0.765 . . . . 0.0 109.261 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -46.64 88.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 110.228 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 59.9 m-85 -60.01 -38.59 83.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.134 -0.979 . . . . 0.0 109.628 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -59.92 -38.81 83.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 108.536 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.75 -37.32 81.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 108.739 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.02 -43.38 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.75 -39.98 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -60.23 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.526 -0.733 . . . . 0.0 109.581 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.03 -37.56 80.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.32 -28.62 20.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.638 -0.664 . . . . 0.0 111.568 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.576 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 33.1 mttm -60.11 -40.07 88.38 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 111.535 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 50.7 p-10 -59.97 -29.48 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.444 -1.41 . . . . 0.0 109.627 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.59 -40.54 92.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 111.089 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -100.51 -11.44 20.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.156 -0.965 . . . . 0.0 110.264 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.07 . . . . 0.0 109.382 179.362 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -92.32 26.63 2.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -124.44 82.03 58.82 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.484 -0.76 . . . . 0.0 108.955 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.04 18.2 0.38 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.158 1.239 . . . . 0.0 112.762 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 3' ' ' LYS . 98.4 mttt -86.98 1.03 54.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.437 -0.789 . . . . 0.0 109.72 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -82.05 133.12 35.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.238 -0.914 . . . . 0.0 112.22 -178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -90.11 -8.38 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -147.41 134.76 20.68 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.6 -174.44 3.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.292 -1.505 . . . . 0.0 111.066 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.8 134.72 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.94 122.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -119.89 147.76 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 122.148 0.975 . . . . 0.0 111.407 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -146.68 156.37 43.13 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -137.11 127.74 26.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.961 -1.087 . . . . 0.0 110.599 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.9 t -109.93 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.48 156.76 42.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.0 -177.23 1.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.66 159.93 17.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.265 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -60.1 141.16 56.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.135 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.1 71.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -127.79 147.27 50.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.955 . . . . 0.0 109.105 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -130.19 148.37 52.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.8 137.4 32.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.585 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -68.23 145.93 53.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.052 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.31 -42.6 98.86 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.208 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 77.2 mm-40 -61.04 -44.28 97.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.952 -1.322 . . . . 0.0 109.416 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.0 mt -69.58 -27.19 64.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 108.819 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.71 -58.28 3.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 110.027 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.2 -48.33 82.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 111.043 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 31' ' ' SER . 35.7 p-10 -62.73 -39.93 95.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.781 -1.199 . . . . 0.0 109.957 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -61.47 -45.75 92.94 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.023 -1.048 . . . . 0.0 109.21 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.05 -44.88 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.158 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.77 -40.05 91.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.25 -20.39 64.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 110.253 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.86 5.36 21.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.988 -1.07 . . . . 0.0 110.174 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.35 15.19 62.62 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 121.049 -1.032 . . . . 0.0 111.711 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -80.3 153.85 28.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.617 -1.52 . . . . 0.0 109.151 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.68 139.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -58.68 101.64 0.09 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.29 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.07 49.72 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.45 -167.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -1.064 . . . . 0.0 108.774 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.6 mtm 57.67 22.43 8.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.144 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 m120 51.93 40.12 27.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.754 -0.591 . . . . 0.0 111.598 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 pt -140.0 166.94 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.123 -0.986 . . . . 0.0 108.689 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.39 129.61 38.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 60' ' ' SER . 12.6 m-70 -119.57 126.45 51.26 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 55.0 ttt180 -100.45 127.12 46.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.095 -1.003 . . . . 0.0 109.299 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 23.5 m-70 -97.83 169.92 9.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.501 -0.75 . . . . 0.0 110.109 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.1 tp -56.94 -49.93 74.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -91.48 145.94 32.31 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 109.036 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.31 -6.61 17.86 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.57 0.847 . . . . 0.0 112.082 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 39.4 p-10 -94.11 -1.78 53.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.023 -1.048 . . . . 0.0 110.274 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 10.3 85.78 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.3 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 8.3 m -69.95 -39.96 75.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.333 . . . . 0.0 109.401 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.73 166.44 50.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -71.54 173.68 12.13 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.074 1.182 . . . . 0.0 111.732 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.93 125.06 29.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 108.977 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.8 mp -97.4 -25.71 15.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 109.303 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -159.66 159.84 33.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 109.136 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 4.0 m -126.53 172.75 9.97 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.021 0.915 . . . . 0.0 111.427 -177.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -139.64 128.66 23.63 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.533 0.682 . . . . 0.0 109.298 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -138.62 163.21 32.67 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.476 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -77.53 156.07 31.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.885 -1.135 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' NH1' ' A' ' 121' ' ' ARG . 77.6 mtm -69.89 -19.75 63.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.256 -0.902 . . . . 0.0 110.076 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -87.06 123.65 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 109.502 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -60.03 149.97 71.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 109.672 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -78.32 4.46 26.66 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.823 -1.324 . . . . 0.0 112.239 -0.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.58 9.32 85.85 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p -89.2 170.14 10.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.134 -1.215 . . . . 0.0 109.711 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 96.9 m-85 -120.33 150.26 41.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.572 -0.705 . . . . 0.0 109.533 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 74' ' ' MET . 84.9 m-20 -128.81 151.48 77.34 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.98 -11.13 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 120.503 0.802 . . . . 0.0 111.628 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 71' ' ' ASP . 77.1 mm-40 -90.94 5.52 48.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.635 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.506 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 70.8 mmm -85.56 14.1 6.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.9 mttm -85.99 -4.03 59.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.011 -1.055 . . . . 0.0 108.595 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 80.8 m-20 -148.27 80.74 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -159.67 171.11 20.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.9 p -126.01 149.35 48.89 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.418 -0.801 . . . . 0.0 109.045 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.0 149.91 20.42 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.048 -1.033 . . . . 0.0 109.21 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.83 -47.07 27.01 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 CA-C-N 119.16 0.736 . . . . 0.0 111.665 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.63 -152.5 7.94 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.484 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.16 160.05 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.865 . . . . 0.0 109.184 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ALA . 6.6 m -109.54 120.82 43.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.558 -0.714 . . . . 0.0 110.246 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.5 mt -108.99 127.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -147.68 170.53 17.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.505 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -142.24 129.99 21.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.6 -0.688 . . . . 0.0 109.158 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.602 ' N ' ' SD ' ' A' ' 86' ' ' MET . 96.4 mt-30 -93.5 121.73 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.32 153.7 38.32 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.091 -1.006 . . . . 0.0 108.714 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.12 147.62 87.83 Favored 'Cis proline' 0 N--CA 1.505 2.17 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.211 -0.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.535 ' OG ' ' SD ' ' A' ' 86' ' ' MET . 1.8 m -107.0 167.96 9.53 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.633 0.73 . . . . 0.0 110.7 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.64 149.33 42.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 110.167 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.5 -138.35 33.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -99.2 120.74 40.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -1.06 . . . . 0.0 109.777 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.21 -31.12 67.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.779 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.04 -39.66 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.915 . . . . 0.0 109.357 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -69.89 -40.06 75.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 108.173 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 97' ' ' ASN . 2.1 m120 -59.93 -40.06 87.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -59.61 -41.55 90.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.706 -0.621 . . . . 0.0 109.545 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.72 -42.0 96.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.63 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 109.753 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 97.5 mtp -57.62 -49.96 74.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.98 -43.66 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 109.191 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.6 mm-40 -60.03 -41.83 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.912 . . . . 0.0 109.006 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p -70.94 -40.42 72.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.782 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.39 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.291 -0.88 . . . . 0.0 110.014 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -62.01 -37.77 86.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 109.789 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.93 -49.18 78.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 0.0 109.296 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 108' ' ' ILE . 94.8 mt -60.2 -49.89 82.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.88 -48.06 64.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.703 -0.623 . . . . 0.0 109.794 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.18 -40.37 89.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -69.92 -40.11 75.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 111.053 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.91 2.32 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 109.935 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.51 24.45 72.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.31 -176.95 51.38 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.91 133.89 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.973 . . . . 0.0 109.089 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.61 132.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.237 -0.914 . . . . 0.0 109.425 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.7 mt -130.54 160.02 35.39 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.415 -0.803 . . . . 0.0 109.803 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -86.63 -170.25 2.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 109.163 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.508 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 96.3 m-20 -60.13 -39.87 87.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 109.739 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.68 18.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 121' ' ' ARG . 24.3 mtt-85 59.84 22.58 11.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.1 mtt180 -102.44 145.25 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.449 -0.782 . . . . 0.0 109.478 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.2 mtp -50.08 126.14 13.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.4 mtp -60.04 140.0 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.811 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p -131.55 153.17 81.48 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.83 -44.87 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 120.848 1.032 . . . . 0.0 112.081 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.12 -41.2 92.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.222 -0.924 . . . . 0.0 109.166 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.06 -40.06 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 110.197 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.57 -40.1 82.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.387 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 130' ' ' ARG . 0.1 OUTLIER -63.14 -40.06 96.49 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.417 -0.802 . . . . 0.0 109.189 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.835 . . . . 0.0 109.662 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 71.0 m-85 -60.02 -43.35 95.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 108.445 179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -63.01 -40.09 96.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.353 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.06 -39.97 94.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.682 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.95 -44.72 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 108.709 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -41.3 85.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.804 . . . . 0.0 109.069 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 137' ' ' ARG . 51.3 mtt-85 -60.5 -39.96 89.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.224 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 73.9 mm-40 -62.4 -39.94 94.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 109.571 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -32.19 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 111.021 -177.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -59.98 -40.24 88.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.927 -1.108 . . . . 0.0 109.871 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.3 p30 -61.56 -30.61 70.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.0 108.717 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.65 -22.34 66.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -95.72 -1.81 49.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.812 . . . . 0.0 110.001 179.626 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.32 -8.6 58.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 0.0 109.665 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.57 70.83 76.02 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.416 -0.803 . . . . 0.0 108.965 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 6' ' ' ARG . 32.6 Cg_endo -77.44 112.89 3.44 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.227 1.285 . . . . 0.0 112.161 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.08 29.55 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' A' ' 4' ' ' PRO . 50.9 mtt-85 -78.5 150.97 32.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.735 . . . . 0.0 110.462 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.58 -6.83 59.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -143.08 150.01 38.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.27 164.5 27.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.835 -1.166 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -120.0 131.4 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 11' ' ' ILE . 25.0 mm -90.62 133.38 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.456 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -129.26 143.32 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 122.092 0.949 . . . . 0.0 110.811 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -142.76 149.86 39.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -131.04 126.57 36.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.73 -1.231 . . . . 0.0 110.951 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.14 119.99 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.23 160.25 43.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.068 . . . . 0.0 110.025 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -168.38 0.35 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -61.54 157.82 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.815 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -59.97 139.97 57.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.55 74.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.8 m -129.31 144.27 51.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.474 -1.016 . . . . 0.0 109.309 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 42.3 mp0 -120.28 147.51 44.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.729 . . . . 0.0 109.311 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.17 143.99 30.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -68.99 144.51 54.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.136 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -42.16 98.3 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.1 -45.52 93.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -1.234 . . . . 0.0 109.773 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -69.97 -30.19 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 108.889 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tt -72.15 -55.76 6.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.666 -0.647 . . . . 0.0 109.605 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.01 -48.64 80.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.844 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -64.62 -40.08 94.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.235 -0.916 . . . . 0.0 111.683 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.1 p -64.81 -41.0 96.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 110.235 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.63 -44.07 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 109.824 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.47 -40.0 85.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.0 110.455 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.01 -19.66 64.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 111.024 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.54 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.57 -11.47 58.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.175 . . . . 0.0 110.87 -178.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.518 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.4 11.12 18.47 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.015 -1.053 . . . . 0.0 111.14 178.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' N ' HH21 ' A' ' 47' ' ' ARG . 36.3 m-85 -80.87 152.87 27.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.669 -1.489 . . . . 0.0 109.712 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 38' ' ' ILE . 95.3 mt -127.4 139.35 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.52 104.7 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -0.999 . . . . 0.0 110.055 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.2 171.58 34.08 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -67.12 -166.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -1.073 . . . . 0.0 109.315 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.7 mtm 57.42 25.58 11.53 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.603 0.716 . . . . 0.0 109.887 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 50.02 39.37 18.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.644 -0.66 . . . . 0.0 111.601 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.6 pt -140.85 167.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.021 -1.05 . . . . 0.0 109.005 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -92.42 136.77 32.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.037 -1.039 . . . . 0.0 110.333 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 19.4 m-70 -126.3 126.82 44.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.706 HH21 ' N ' ' A' ' 37' ' ' PHE . 28.9 ttm180 -99.21 124.28 44.15 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.517 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 56.9 m-70 -95.6 171.84 8.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 109.717 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -56.89 -50.01 73.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.762 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -91.67 141.99 26.28 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 109.071 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.53 -10.23 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.555 0.877 . . . . 0.0 112.08 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -91.87 -0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 109.947 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.42 83.51 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.0 p -69.9 -40.05 75.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.83 -1.394 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.28 168.24 50.1 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.517 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.5 Cg_endo -70.91 174.88 9.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.286 1.324 . . . . 0.0 112.223 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.22 122.4 27.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.9 mp -97.97 -43.81 6.92 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' SD ' ' A' ' 101' ' ' MET . 20.9 p90 -144.91 160.01 42.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.934 -1.104 . . . . 0.0 109.51 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.61 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 9.0 m -132.74 165.51 24.37 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.031 0.92 . . . . 0.0 111.44 -177.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.3 tt -119.96 134.79 55.14 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.02 159.95 39.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.599 . . . . 0.0 109.413 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -76.45 160.71 29.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.432 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.7 mtp -70.03 -25.56 63.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 110.254 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -86.8 121.51 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.963 -1.086 . . . . 0.0 109.738 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -59.43 151.03 62.12 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -77.57 5.02 22.42 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.686 -1.381 . . . . 0.0 112.479 -0.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.43 55.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.8 p -91.26 169.55 10.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.223 -1.163 . . . . 0.0 110.69 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -124.1 140.68 52.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.691 -0.63 . . . . 0.0 109.376 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -130.37 150.76 77.11 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.0 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -50.72 -7.0 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.42 0.829 . . . . 0.0 112.001 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' ASP . 49.3 mt-10 -89.45 2.53 54.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.431 -0.793 . . . . 0.0 109.556 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.3 mmm -86.83 16.32 4.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 -179.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.2 mttm -87.42 -3.16 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 108.805 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -149.68 77.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.06 169.41 24.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.994 -1.066 . . . . 0.0 109.251 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -130.04 150.19 51.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.68 150.21 21.31 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.08 -52.83 5.94 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 120.438 0.759 . . . . 0.0 111.726 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.25 -151.82 8.12 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.05 160.0 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.963 . . . . 0.0 109.545 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.4 m -112.07 123.78 51.01 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.115 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.87 132.02 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.08 164.43 33.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.828 -1.17 . . . . 0.0 110.89 -178.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.2 ttp -138.15 128.63 26.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -92.96 112.57 24.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 109.236 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.41 154.3 37.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -75.72 134.36 35.44 Favored 'Cis proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.679 0.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.7 m -107.39 160.2 15.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.529 0.68 . . . . 0.0 109.624 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -70.51 150.43 46.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.928 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -158.96 26.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.16 117.11 30.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -1.146 . . . . 0.0 109.292 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.03 -37.56 80.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.635 . . . . 0.0 110.851 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.81 -39.88 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.99 -39.98 75.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.047 -1.033 . . . . 0.0 108.894 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 179.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -60.01 -50.03 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.59 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.8 -41.52 97.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.4 tp -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 59' ' ' PHE . 23.4 mmm -56.11 -46.81 78.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.416 -0.803 . . . . 0.0 109.255 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.85 -40.76 97.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.103 -0.998 . . . . 0.0 109.061 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.533 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 0.0 109.881 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.6 p -69.38 -41.0 77.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.02 -1.05 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.92 52.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 110.272 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -62.33 -34.93 77.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 15.0 m-70 -60.02 -46.54 89.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 108.767 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 108' ' ' ILE . 93.4 mt -60.1 -49.97 81.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.4 -0.813 . . . . 0.0 108.988 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.55 -47.7 63.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.541 -0.724 . . . . 0.0 109.97 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.73 -179.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.22 -40.01 74.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.047 -1.033 . . . . 0.0 111.165 -178.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.92 1.99 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.68 27.22 71.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.85 -172.0 45.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.19 139.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.608 -0.937 . . . . 0.0 108.881 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.56 134.94 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 109.736 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.11 160.01 37.23 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 -179.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -87.25 -168.86 2.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 94.9 m-20 -60.01 -39.57 86.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 109.849 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.17 21.75 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 119' ' ' ASP . 58.9 mtp180 55.85 31.33 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 110.039 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.41 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 98.4 mtt180 -109.16 150.9 27.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.438 -0.789 . . . . 0.0 109.297 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mmm -52.08 125.66 16.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 109.152 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.1 mtp -60.0 139.94 57.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.8 p -130.06 150.65 76.59 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -42.58 -43.49 8.47 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.849 1.032 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.389 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.72 -39.97 80.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.4 mt -55.69 -42.29 74.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 0.0 108.937 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.71 -38.87 90.4 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -59.97 -44.61 94.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.993 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -60.01 -42.18 93.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.52 179.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.78 -39.72 89.9 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 98.3 m-20 -60.03 -40.03 87.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.354 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.0 -41.13 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.048 -1.033 . . . . 0.0 108.833 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.11 -44.93 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 108.996 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 79.9 mtm180 -62.22 -35.25 78.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -0.969 . . . . 0.0 110.424 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 66.4 mm-40 -59.94 -38.86 83.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.736 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.1 t -73.31 -30.07 29.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 110.674 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.8 mttm -60.04 -41.1 91.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.759 -1.213 . . . . 0.0 110.987 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -59.94 -29.02 68.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.756 -1.215 . . . . 0.0 109.176 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.852 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 43.4 p-10 -104.57 -3.71 23.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.34 -0.85 . . . . 0.0 109.495 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.899 . . . . 0.0 109.524 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -86.83 -8.96 56.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' CB ' ' HZ1' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -135.18 70.01 69.25 Favored Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.206 -0.934 . . . . 0.0 110.482 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -76.23 -160.87 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.562 1.508 . . . . 0.0 111.421 178.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -81.88 -10.76 59.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.01 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 6' ' ' ARG . 47.4 mtm-85 -83.48 91.03 7.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.967 -1.083 . . . . 0.0 110.208 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.31 -70.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -102.24 143.68 31.72 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -160.96 179.54 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.49 -1.381 . . . . 0.0 110.633 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -125.65 130.0 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 11' ' ' ILE . 26.6 mm -92.26 127.95 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.8 mt -120.21 147.47 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.33 1.062 . . . . 0.0 111.712 -177.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -145.8 159.03 43.78 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -139.26 125.26 19.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.715 -1.241 . . . . 0.0 111.34 -179.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.51 124.97 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.61 164.59 30.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.046 -1.034 . . . . 0.0 111.979 -177.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.71 -164.51 0.36 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -71.37 160.05 33.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -58.79 130.01 44.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.746 -1.221 . . . . 0.0 109.356 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.47 -2.23 84.68 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 m -110.92 155.55 22.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.365 -1.079 . . . . 0.0 109.757 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -129.98 150.09 51.42 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.27 140.48 29.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -65.62 141.16 58.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' PHE . . . -60.06 -39.99 96.49 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.107 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.51 -46.69 88.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 109.662 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -30.01 68.17 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 tt -71.41 -58.78 3.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.03 -40.05 88.0 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.349 -0.844 . . . . 0.0 109.708 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -64.28 -40.73 96.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -65.73 -39.64 91.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.304 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.02 -48.4 88.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.074 -1.017 . . . . 0.0 109.859 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -63.37 -39.96 95.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.138 . . . . 0.0 109.704 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.358 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.02 8.3 10.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . 80.09 10.47 85.49 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.39 148.61 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.722 -1.458 . . . . 0.0 108.972 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.6 mt -122.14 134.52 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -58.3 102.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.108 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.74 170.6 38.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.28 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.322 -1.105 . . . . 0.0 109.006 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.1 mtt 58.09 21.38 7.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 51.79 40.06 26.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.797 . . . . 0.0 111.48 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.26 159.29 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.881 -1.137 . . . . 0.0 109.187 178.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -90.49 119.55 30.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.058 -1.026 . . . . 0.0 109.118 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.525 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 13.9 m-70 -104.12 134.94 46.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.481 -0.762 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' NH1' ' O ' ' A' ' 36' ' ' GLY . 21.6 tpt180 -100.03 115.62 30.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 72.5 m-70 -95.25 169.31 10.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.225 -0.922 . . . . 0.0 109.907 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.12 -49.96 75.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.855 . . . . 0.0 109.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -96.1 150.0 36.67 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -70.6 -7.1 20.52 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.869 1.046 . . . . 0.0 112.455 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.85 0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.046 -1.034 . . . . 0.0 110.095 -179.195 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.34 7.66 86.97 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.317 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.07 -40.05 75.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.249 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.72 160.42 50.49 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.445 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 12.9 Cg_endo -68.02 175.09 6.95 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.068 1.179 . . . . 0.0 112.218 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.19 127.06 33.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.37 -0.831 . . . . 0.0 109.209 179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 6.2 mp -100.56 -35.38 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.135 -0.978 . . . . 0.0 108.8 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 2.5 p90 -151.01 166.53 30.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.1 m -134.73 179.44 6.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.08 -1.013 . . . . 0.0 111.525 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.5 tt -139.95 131.65 27.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.94 159.74 35.72 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.526 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -76.93 161.53 28.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.05 -22.99 63.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 110.373 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.89 119.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.757 -1.215 . . . . 0.0 109.879 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -61.24 151.37 76.34 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.38 8.89 17.51 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.486 -0.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.1 63.23 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.9 p -83.92 167.89 16.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -1.2 . . . . 0.0 109.344 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.4 m-85 -120.29 143.8 48.15 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.638 -0.664 . . . . 0.0 109.784 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 73' ' ' GLU . 20.5 t70 -126.41 134.32 25.88 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -49.5 -9.34 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 119.959 1.021 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -88.38 1.0 55.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.42 ' CE ' ' CZ ' ' A' ' 77' ' ' PHE . 90.6 mtp -86.99 22.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 109.996 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 94.9 mttt -83.65 -4.81 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.021 -1.049 . . . . 0.0 108.955 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.0 m-20 -148.12 83.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' ' CE ' ' A' ' 74' ' ' MET . 7.1 p90 -158.85 177.65 10.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.551 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.0 p -134.03 149.98 51.2 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.12 150.3 23.64 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.063 -1.023 . . . . 0.0 109.35 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.93 -26.06 30.12 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.46 0.773 . . . . 0.0 111.657 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.33 33.96 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.036 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.886 . . . . 0.0 108.952 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.7 m -109.76 125.2 52.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.659 -0.651 . . . . 0.0 109.686 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.79 128.41 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -146.74 149.78 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.968 -1.082 . . . . 0.0 110.952 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.1 ttm -104.91 129.91 53.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.836 -0.54 . . . . 0.0 109.581 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -92.84 108.38 19.95 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.7 m -97.2 151.04 37.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 109.133 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.0 139.24 60.44 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.914 -1.286 . . . . 0.0 112.839 -0.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.2 m -105.22 159.51 15.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.627 -0.671 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -71.1 150.62 45.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.98 -152.38 38.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -98.96 121.09 40.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.414 -1.05 . . . . 0.0 109.29 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.94 -32.24 69.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.589 -0.694 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.03 -39.91 75.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.663 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.04 -42.2 73.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.953 -1.092 . . . . 0.0 108.088 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.94 -39.88 95.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.14 -40.1 73.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.19 -40.03 94.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.16 -39.9 91.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.132 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.2 mtp -57.84 -50.33 73.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.84 -42.91 89.92 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.986 -1.071 . . . . 0.0 108.961 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.8 mt-30 -61.99 -39.99 94.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 108.796 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.428 ' HG ' ' N ' ' A' ' 105' ' ' ALA . 25.9 p -73.14 -43.74 61.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' N ' ' HG ' ' A' ' 104' ' ' SER . . . -60.05 -53.04 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 0.0 110.014 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -60.31 -39.82 88.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.052 -1.03 . . . . 0.0 109.358 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 4.1 m-70 -59.9 -43.37 94.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.985 . . . . 0.0 108.891 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.0 -50.11 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.26 -48.33 68.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.607 -0.683 . . . . 0.0 109.263 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.64 -40.13 90.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 109.899 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -40.0 75.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.36 -0.838 . . . . 0.0 111.346 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -101.03 -0.81 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.116 -0.99 . . . . 0.0 109.678 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.37 23.39 76.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.33 -167.56 41.01 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.211 -1.17 . . . . 0.0 110.249 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.0 159.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.596 -0.944 . . . . 0.0 109.372 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 t -96.93 129.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.234 -0.916 . . . . 0.0 108.712 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.1 mt -124.49 163.63 21.45 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.82 0.819 . . . . 0.0 110.639 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -86.27 -170.92 3.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.752 -0.593 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.492 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 85.4 m-20 -60.12 -39.99 88.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.872 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.99 15.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.068 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 119' ' ' ASP . 86.4 mtm180 57.25 37.16 28.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.837 -0.539 . . . . 0.0 109.769 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 122' ' ' ARG . 20.0 mtt-85 -112.23 151.97 28.97 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.9 mtp -50.92 122.1 6.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.929 -1.107 . . . . 0.0 109.133 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.96 140.01 57.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.264 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.5 p -122.25 152.17 60.19 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -43.49 -43.61 10.92 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 120.61 0.873 . . . . 0.0 112.017 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -60.11 -40.5 89.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.277 -0.89 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.7 -40.01 84.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.794 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.82 -39.95 78.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 108.409 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.49 -39.97 89.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.457 -0.777 . . . . 0.0 109.397 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.46 77.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.492 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 67.3 m-85 -59.93 -46.05 90.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.956 -1.09 . . . . 0.0 108.779 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.98 -39.93 93.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.36 -0.838 . . . . 0.0 109.124 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.72 -46.15 90.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.521 -0.737 . . . . 0.0 110.57 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.19 -37.59 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 108.997 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.05 -42.54 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.052 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 81.7 mtm180 -60.02 -38.69 83.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.853 -1.154 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 40.4 mm-40 -59.98 -39.96 87.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.46 -0.775 . . . . 0.0 109.867 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.5 -33.64 63.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.596 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 144' ' ' ALA . 87.8 mttt -59.95 -50.0 75.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.817 -1.177 . . . . 0.0 110.027 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -61.19 -37.57 83.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.982 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.93 95.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.447 -0.783 . . . . 0.0 110.17 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 50.5 p30 -98.85 -2.98 36.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.309 -0.869 . . . . 0.0 109.406 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.34 -0.36 57.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.138 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 75.9 72.48 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.478 -0.764 . . . . 0.0 109.549 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' ARG . 18.6 Cg_endo -78.22 83.63 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.382 1.388 . . . . 0.0 112.122 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -80.54 30.01 0.3 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.272 -0.892 . . . . 0.0 109.589 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.521 ' N ' ' CD ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -78.47 171.5 15.02 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.749 -179.1 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -79.26 -3.76 47.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.984 -1.072 . . . . 0.0 108.345 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -144.64 132.56 21.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.85 -172.14 3.17 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.015 -1.053 . . . . 0.0 110.536 -178.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.92 140.59 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.49 130.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.0 mt -118.45 144.13 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 122.245 1.021 . . . . 0.0 111.681 -177.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -142.0 150.02 40.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' ND2' ' HG1' ' A' ' 83' ' ' THR . 35.0 m120 -128.02 119.62 25.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.019 -1.051 . . . . 0.0 111.037 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.62 110.86 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.99 160.79 42.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -165.25 0.25 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.56 142.42 55.42 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 108.826 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -51.47 137.15 24.59 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.039 -1.038 . . . . 0.0 109.237 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.27 1.22 66.93 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.1 m -121.02 149.95 41.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.516 -0.991 . . . . 0.0 108.697 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -125.41 146.87 49.42 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.764 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 148.62 25.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -68.93 142.48 54.71 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.42 96.99 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.31 -46.85 86.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 0.0 109.83 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.81 -30.17 67.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.197 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 5.5 tt -71.15 -58.67 3.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.23 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -59.99 -46.02 90.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.659 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.81 -42.26 97.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.698 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 t -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.479 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.94 -47.0 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -63.83 -41.57 97.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.69 -21.89 66.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.6 11.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.47 75.73 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.15 -0.969 . . . . 0.0 111.338 178.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -81.65 147.51 29.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.661 -1.494 . . . . 0.0 109.584 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -120.03 132.33 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.74 101.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -89.72 170.82 37.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.34 -162.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -1.044 . . . . 0.0 109.265 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 91.0 mmm 59.78 20.61 9.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.683 -0.635 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 51.21 34.97 12.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 111.362 178.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.2 165.83 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.006 -1.058 . . . . 0.0 108.999 178.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -89.72 141.51 28.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.947 -1.096 . . . . 0.0 110.464 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.526 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 29.0 m80 -130.19 130.07 44.22 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 47' ' ' ARG . 4.0 ttt-85 -103.0 127.29 50.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 17.9 m-70 -91.45 169.84 10.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.664 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.69 -49.96 73.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -92.65 144.81 29.26 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.58 -6.37 16.45 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.798 0.999 . . . . 0.0 112.213 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -92.71 1.92 57.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.949 . . . . 0.0 110.031 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.14 10.67 85.27 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.4 p -70.14 -40.8 74.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -1.184 . . . . 0.0 110.0 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.48 164.0 50.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -66.68 179.74 2.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.473 1.136 . . . . 0.0 111.852 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.56 29.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.65 -70.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.355 -0.841 . . . . 0.0 109.691 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 1.7 p90 -114.41 160.0 19.66 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.97 -1.081 . . . . 0.0 109.909 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 15.1 m -121.88 161.47 22.73 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.573 0.701 . . . . 0.0 109.927 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.5 tt -132.26 130.59 41.11 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.43 165.3 26.13 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.489 -0.757 . . . . 0.0 110.073 -178.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 88.7 m-20 -75.05 156.92 35.62 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.4 mtt -69.88 -23.88 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 p -87.5 121.12 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.068 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -58.06 151.78 43.79 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -80.43 -0.2 41.15 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.979 0.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.62 18.83 61.12 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.4 p -85.92 167.3 15.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.991 -1.299 . . . . 0.0 109.618 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.4 m-85 -124.33 141.85 51.75 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.519 -0.738 . . . . 0.0 109.808 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -129.8 151.09 77.57 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.58 -12.5 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 120.497 0.798 . . . . 0.0 112.409 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.91 -3.01 58.86 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.072 -1.017 . . . . 0.0 109.322 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.2 mtp -88.65 22.68 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.4 mttp -83.06 -4.84 58.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 94.0 m-20 -143.75 84.63 1.8 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.376 -0.828 . . . . 0.0 108.776 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.7 177.24 11.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 110.362 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.5 p -129.67 146.8 51.43 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.19 148.22 18.19 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 108.862 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -45.16 -31.65 6.17 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 120.611 0.874 . . . . 0.0 111.768 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.65 -147.71 16.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.49 159.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.457 -1.025 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.424 ' HG1' ' ND2' ' A' ' 14' ' ' ASN . 54.7 m -108.74 122.48 47.23 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -105.77 130.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.323 -0.861 . . . . 0.0 108.727 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.47 148.03 32.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.12 -0.988 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.9 tpp -104.02 130.28 51.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' OG ' ' A' ' 90' ' ' SER . 95.0 mt-30 -90.54 108.6 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.2 m -98.67 150.03 36.31 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.211 -0.93 . . . . 0.0 109.238 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.65 135.07 38.67 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.859 -1.309 . . . . 0.0 112.564 -0.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.5 m -108.05 162.58 13.91 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.632 0.73 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 59.6 t80 -73.78 158.14 35.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 110.041 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.72 -160.28 44.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -98.15 111.96 24.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.38 -1.07 . . . . 0.0 108.971 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.62 -30.33 68.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.768 . . . . 0.0 110.602 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.33 -40.06 77.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 109.363 -179.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.81 -40.35 63.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.743 -1.223 . . . . 0.0 108.242 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -61.2 -37.5 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.093 0.949 . . . . 0.0 108.606 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -56.33 -50.09 72.46 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.25 -39.19 92.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.12 -46.02 91.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.608 -0.683 . . . . 0.0 110.219 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.8 mtm -58.91 -42.67 90.21 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.667 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.61 -46.61 87.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.913 . . . . 0.0 108.937 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.4 mm-40 -60.17 -42.63 95.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 108.928 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.428 ' HG ' ' H ' ' A' ' 105' ' ' ALA . 67.6 p -71.55 -41.07 69.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 109.375 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -58.56 -55.41 35.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.601 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -61.25 -35.7 77.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.148 -0.97 . . . . 0.0 109.103 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.89 -47.08 87.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.98 -49.95 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.9 -47.7 60.63 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.77 -39.96 93.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.43 -40.02 77.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.05 -1.031 . . . . 0.0 110.703 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 m -98.44 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 109.275 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.85 24.88 76.15 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.34 -169.83 46.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.8 138.0 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.128 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 t -77.57 132.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 109.475 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.17 160.33 35.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.415 -0.803 . . . . 0.0 110.022 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -84.58 -173.12 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.477 -0.764 . . . . 0.0 108.976 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.588 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 93.3 m-20 -60.02 -36.07 76.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.088 -1.007 . . . . 0.0 109.994 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -79.61 15.3 1.37 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.916 . . . . 0.0 110.219 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.401 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 19.8 mmm-85 58.19 30.84 19.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -106.43 151.93 24.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 81.0 mmm -51.72 133.37 31.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.026 -1.046 . . . . 0.0 109.45 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.2 mmm -56.08 138.66 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.096 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.3 p -136.81 151.28 72.12 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.426 -0.797 . . . . 0.0 109.034 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -44.58 -45.72 12.85 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 120.449 0.766 . . . . 0.0 111.73 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.08 -40.01 88.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -68.48 -39.92 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.02 -40.13 88.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.995 -1.065 . . . . 0.0 109.011 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -65.28 -39.67 92.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.445 -0.785 . . . . 0.0 109.405 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.75 -47.6 85.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.195 -0.941 . . . . 0.0 110.348 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.588 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 71.3 m-85 -60.07 -46.59 89.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.928 -1.107 . . . . 0.0 108.526 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.2 -40.35 93.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.194 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.416 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.7 m-20 -62.35 -40.09 95.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.32 -40.68 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.052 -1.03 . . . . 0.0 108.596 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.56 -40.03 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.504 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HG2' HH11 ' A' ' 137' ' ' ARG . 7.4 mmt-85 -60.04 -39.96 87.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.066 -1.021 . . . . 0.0 110.554 -179.12 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.99 -40.07 92.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.725 -1.235 . . . . 0.0 109.524 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.15 -29.74 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' ALA . 47.4 mmtt -60.07 -39.47 86.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.835 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 2.2 p30 -60.07 -30.01 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.659 -1.276 . . . . 0.0 108.566 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.888 . . . . 0.0 109.218 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -101.22 -13.38 18.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.372 -0.83 . . . . 0.0 110.409 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.891 -1.13 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.597 ' H2 ' ' HE ' ' A' ' 6' ' ' ARG . 96.0 mmm . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.317 0.579 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.61 17.92 6.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -97.73 109.96 53.15 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' CB ' ' OE2' ' A' ' 138' ' ' GLU . 19.0 Cg_endo -74.34 13.97 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 CA-C-N 119.981 1.029 . . . . 0.0 112.663 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -88.28 0.04 56.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.466 -0.771 . . . . 0.0 109.005 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.597 ' HE ' ' H2 ' ' A' ' 1' ' ' MET . 57.9 mtt-85 -80.71 135.02 35.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.566 -0.709 . . . . 0.0 111.586 -178.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -89.88 -12.43 39.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.32 147.11 31.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.61 -177.64 6.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.322 -1.486 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.99 131.46 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 mm -92.87 125.31 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 90.8 mt -123.66 143.71 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-O 122.166 0.984 . . . . 0.0 111.248 -177.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.402 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.4 mtt -142.88 138.18 30.07 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -120.85 127.46 51.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.992 -1.068 . . . . 0.0 111.251 -178.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.38 114.67 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.71 152.27 38.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.288 -0.882 . . . . 0.0 109.647 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.91 -166.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.64 152.89 44.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.161 -0.962 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.06 141.23 56.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.609 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.09 1.91 64.7 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.4 m -129.01 150.01 50.6 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.438 -1.036 . . . . 0.0 109.137 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.11 148.16 49.44 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.45 146.67 26.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.721 HD21 ' H ' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -71.0 142.15 50.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 109.115 179.065 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.9 99.83 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.871 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.721 ' H ' HD21 ' A' ' 24' ' ' ASN . 99.0 mt-10 -61.62 -44.65 96.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.964 -1.315 . . . . 0.0 109.669 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.87 -26.58 64.26 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.409 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.0 tt -74.71 -59.88 2.53 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.652 -0.655 . . . . 0.0 109.76 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.86 -40.9 94.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 110.581 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.09 94.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 109.911 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 t -66.05 -41.05 91.33 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.16 -0.962 . . . . 0.0 109.806 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.13 -46.28 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 110.027 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.59 -40.2 96.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.974 -1.079 . . . . 0.0 109.395 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.56 -19.61 64.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.601 -0.687 . . . . 0.0 109.975 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.53 8.18 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.915 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.5 10.68 85.0 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.584 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -80.8 151.55 28.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.993 -1.299 . . . . 0.0 109.735 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.06 148.11 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.13 112.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.06 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.65 30.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.2 -170.18 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.596 -0.943 . . . . 0.0 108.626 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mtp 55.27 24.95 6.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.861 . . . . 0.0 109.726 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.04 42.1 24.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.745 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.7 pt -138.31 167.02 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.099 -1.0 . . . . 0.0 108.303 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -93.34 120.42 33.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.821 -1.174 . . . . 0.0 110.427 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.429 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 16.4 m170 -108.53 128.11 54.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.421 -0.8 . . . . 0.0 109.611 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 47' ' ' ARG . 9.3 ttt-85 -100.08 123.77 44.7 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.214 -0.928 . . . . 0.0 108.775 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 26.0 m-70 -92.46 171.59 8.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.57 -50.01 66.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 109.031 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -93.07 147.29 33.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 0.0 109.158 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -69.15 -4.2 13.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.65 0.9 . . . . 0.0 112.092 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -93.67 -1.07 55.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 0.0 109.746 -179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 13.42 83.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -68.93 -43.22 75.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -1.201 . . . . 0.0 109.533 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.435 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.33 171.62 54.26 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.67 176.36 8.28 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.018 1.145 . . . . 0.0 111.463 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.16 126.63 32.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 108.906 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.4 mp -101.16 -35.88 9.15 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.078 -1.014 . . . . 0.0 109.74 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -146.68 160.78 41.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.029 -1.044 . . . . 0.0 109.006 178.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 63.2 m -129.99 160.29 34.08 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.002 0.906 . . . . 0.0 111.437 -177.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.97 129.48 53.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 161.73 36.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.521 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 81.9 m-20 -77.66 159.93 28.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 48.7 mtm -67.83 -18.84 64.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 12.7 p -88.16 121.28 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.818 -1.176 . . . . 0.0 109.844 -179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -61.11 147.76 85.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.35 -0.843 . . . . 0.0 109.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.6 -0.53 19.46 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.763 -1.349 . . . . 0.0 111.741 -0.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.99 17.43 74.68 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 p -88.79 169.05 11.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.196 -1.179 . . . . 0.0 110.601 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.4 m-85 -119.91 143.8 47.77 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.27 150.01 72.91 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.349 -0.844 . . . . 0.0 109.146 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.23 -19.32 2.62 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.689 0.926 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -89.94 -4.36 57.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.95 -1.093 . . . . 0.0 109.131 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 85.6 mtp -93.51 23.51 4.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 110.372 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -85.49 -8.99 58.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.911 -1.118 . . . . 0.0 108.476 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -136.96 87.27 2.27 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 7.7 p90 -157.96 179.65 8.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.387 -0.821 . . . . 0.0 109.522 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.5 p -128.76 149.96 50.49 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.73 149.17 19.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.051 -1.03 . . . . 0.0 109.221 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.95 -40.64 80.14 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.669 0.913 . . . . 0.0 111.907 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.39 -156.54 17.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -130.38 159.96 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.617 -0.931 . . . . 0.0 109.506 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 m -114.21 120.68 41.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.526 -0.733 . . . . 0.0 109.476 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.64 128.49 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -149.28 159.92 43.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.699 -1.251 . . . . 0.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 44.2 ttm -120.25 129.95 54.28 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.31 102.08 14.5 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' CG1' ' OE1' ' A' ' 94' ' ' GLU . 15.9 m -96.04 148.31 34.34 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.308 -0.87 . . . . 0.0 108.894 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.67 130.24 19.96 Favored 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.796 -1.335 . . . . 0.0 112.957 0.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 m -105.42 161.36 14.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.64 -0.662 . . . . 0.0 109.644 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.04 150.02 47.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.694 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -164.65 31.29 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 96.0 m-20 -96.09 116.74 29.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.198 -1.178 . . . . 0.0 108.921 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE1' ' CG1' ' A' ' 88' ' ' VAL . 41.9 mt-10 -59.95 -34.86 73.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.649 . . . . 0.0 110.799 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.06 -39.99 75.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.535 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.22 -42.21 55.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.717 -1.239 . . . . 0.0 108.701 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 31.3 m120 -61.53 -39.89 92.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 73.0 t80 -52.44 -40.01 61.72 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.607 -0.683 . . . . 0.0 109.207 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -60.96 -40.01 91.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.112 -0.992 . . . . 0.0 109.1 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.37 -40.08 89.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 109.177 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.6 mtp -57.09 -50.33 73.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.17 -45.28 81.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.15 -39.99 88.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 108.822 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 p -70.14 -41.07 74.37 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.199 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.6 -55.62 31.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.319 -0.863 . . . . 0.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -60.73 -39.95 90.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 109.704 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 8.1 m-70 -59.83 -46.32 89.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 108' ' ' ILE . 82.3 mt -60.76 -47.45 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 108.977 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.86 -47.01 64.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.92 -40.67 94.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.851 . . . . 0.0 110.949 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.03 -40.08 75.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.708 -178.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.59 0.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.224 -0.923 . . . . 0.0 109.877 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.31 21.76 74.28 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.62 -176.8 51.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.49 132.02 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.604 -0.939 . . . . 0.0 109.272 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.96 131.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.188 -0.945 . . . . 0.0 108.898 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.6 mt -131.49 158.62 40.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.411 -0.806 . . . . 0.0 109.377 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 34.1 p-10 -84.03 -170.77 3.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.253 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.0 m-20 -60.06 -36.37 77.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.834 . . . . 0.0 109.623 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.59 14.91 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.6 mtt180 56.35 38.64 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 109.765 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.431 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.2 mtt180 -122.18 152.2 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.2 mtp -50.72 129.24 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.07 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.95 139.81 57.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -120.66 151.33 54.13 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -43.02 -43.92 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 120.8 1.0 . . . . 0.0 112.603 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.06 -40.0 87.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.31 -39.83 92.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 110.124 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.03 -40.05 83.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.954 -1.091 . . . . 0.0 108.543 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -65.07 -39.5 93.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.597 -0.689 . . . . 0.0 109.86 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.12 -47.65 85.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.304 -0.873 . . . . 0.0 110.565 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -59.98 -43.86 94.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 0.0 109.322 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.38 -39.94 89.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.704 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.58 -40.17 90.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 135' ' ' ILE . 96.6 mt -65.13 -39.94 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 108.904 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.9 -44.63 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.2 mtm180 -60.1 -38.0 81.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 4' ' ' PRO . 95.4 mt-10 -60.09 -37.33 79.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 0.0 109.52 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.88 -38.17 74.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.369 -0.832 . . . . 0.0 110.38 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -60.06 -46.56 89.16 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.077 -1.015 . . . . 0.0 111.558 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -60.08 -35.06 74.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.697 -1.252 . . . . 0.0 109.588 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.49 -19.51 65.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.781 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -99.52 -8.7 24.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 109.832 -179.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 0.0 109.524 179.894 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' H3 ' ' CB ' ' A' ' 134' ' ' ASP . 9.3 ptp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.65 -16.09 27.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.176 -0.953 . . . . 0.0 110.026 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -134.02 77.16 62.74 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.81 1.61 5.59 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.786 0.991 . . . . 0.0 111.822 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -87.01 -0.83 57.26 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -81.75 103.72 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 110.615 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -87.7 -11.54 48.0 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -152.21 140.58 20.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.403 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.75 164.56 26.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.426 -1.421 . . . . 0.0 110.734 -178.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.99 129.47 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.31 122.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -122.29 144.27 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 122.039 0.923 . . . . 0.0 110.835 -177.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.8 mtt -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -130.81 119.5 22.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.978 -1.076 . . . . 0.0 110.392 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.27 112.89 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.79 44.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.65 -164.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.175 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -67.25 155.03 39.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.962 . . . . 0.0 108.716 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -59.56 140.01 56.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.33 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -6.19 77.11 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 m -115.26 148.44 39.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.448 -1.031 . . . . 0.0 109.042 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -126.8 146.49 50.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.461 -0.774 . . . . 0.0 109.606 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.34 141.91 28.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -69.95 146.12 51.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.243 -0.911 . . . . 0.0 108.876 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.0 98.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.0 -45.73 93.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.061 -1.258 . . . . 0.0 109.755 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.1 mt -69.85 -24.48 63.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 tt -79.8 -57.49 3.63 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 110.46 -179.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.94 -45.21 93.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 0.0 111.585 -178.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 31' ' ' SER . 39.4 p-10 -61.62 -39.8 92.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.0 110.28 -178.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.532 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 9.3 p -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 0.0 110.316 -179.406 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.04 -50.04 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 0.0 110.335 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.72 -39.96 95.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 0.0 110.127 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.26 -20.09 66.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.59 1.02 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.94 -1.1 . . . . 0.0 110.022 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 13.58 56.87 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.011 -1.056 . . . . 0.0 110.921 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.93 150.81 28.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.973 -1.31 . . . . 0.0 109.692 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.62 138.84 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.58 106.75 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.687 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.83 171.51 26.19 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.41 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 109.481 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 56.9 19.98 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.502 -0.749 . . . . 0.0 110.014 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.4 m120 49.86 40.04 19.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 111.379 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.16 167.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.973 -1.079 . . . . 0.0 108.574 178.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -93.18 120.91 33.99 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.787 -1.196 . . . . 0.0 110.68 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 47.1 m-70 -109.18 124.58 51.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 47' ' ' ARG . 13.9 ttt-85 -100.02 127.25 46.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.257 -0.902 . . . . 0.0 108.661 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 18.5 m-70 -95.67 171.55 8.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.37 -0.831 . . . . 0.0 110.399 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.97 -50.08 71.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 108.848 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.2 m -94.09 146.91 32.48 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 179.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.2 -6.37 18.16 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 CA-C-N 119.436 0.834 . . . . 0.0 112.368 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -92.54 -2.24 56.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 109.773 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.05 86.02 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -67.64 -40.43 84.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.011 -1.288 . . . . 0.0 109.189 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.507 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.54 162.66 49.4 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.89 179.25 2.84 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 118.448 1.124 . . . . 0.0 111.716 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.69 119.83 23.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.156 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 10.3 mp -96.56 -47.52 5.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CG ' ' SD ' ' A' ' 101' ' ' MET . 40.2 p90 -145.33 159.16 43.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.904 -1.122 . . . . 0.0 109.01 178.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.2 m -132.02 169.74 15.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.856 0.836 . . . . 0.0 111.526 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.6 tt -123.48 133.0 54.09 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.512 0.672 . . . . 0.0 109.211 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -135.77 159.08 42.76 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.3 m-20 -76.27 152.48 36.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 0.0 108.732 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.7 mtm -70.02 -20.26 63.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.996 -1.065 . . . . 0.0 109.663 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.66 131.94 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 109.555 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -59.5 150.95 63.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.068 -1.02 . . . . 0.0 108.485 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -80.25 5.3 36.31 Favored 'Cis proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.243 -0.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.69 3.51 90.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.3 p -92.4 174.89 7.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.268 -1.137 . . . . 0.0 110.818 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.5 m-85 -126.24 146.76 49.86 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 73' ' ' GLU . 51.3 m-20 -129.99 149.82 74.22 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -49.13 -7.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.567 0.881 . . . . 0.0 111.85 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 71' ' ' ASP . 99.0 mt-10 -90.0 3.26 53.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.413 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 65.1 mmm -86.16 21.0 2.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -0.852 . . . . 0.0 109.866 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -85.93 -5.82 59.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 108.882 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -149.85 80.0 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.424 -0.797 . . . . 0.0 109.159 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -157.45 170.54 22.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.195 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.0 p -129.4 150.25 50.84 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.03 149.27 20.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.024 -1.047 . . . . 0.0 109.213 -179.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -48.05 -45.11 26.26 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.509 0.806 . . . . 0.0 111.639 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.16 -149.11 7.83 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.45 162.13 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.539 -0.977 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 62' ' ' ALA . 5.6 m -114.87 116.6 28.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.53 126.79 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -146.5 160.23 42.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.003 -1.061 . . . . 0.0 111.221 -178.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.0 ttm -124.15 131.08 53.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -90.15 120.0 30.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 108.545 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m -98.38 150.02 36.31 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.26 -0.9 . . . . 0.0 109.375 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.69 137.05 48.0 Favored 'Cis proline' 0 N--CA 1.498 1.784 0 C-N-CA 124.084 -1.215 . . . . 0.0 111.94 -2.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.3 m -105.26 150.31 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.394 -0.816 . . . . 0.0 110.047 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.7 152.06 41.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.587 -0.696 . . . . 0.0 109.83 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -163.02 31.94 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 95.8 m-20 -95.25 113.06 24.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.144 -1.209 . . . . 0.0 109.254 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 57.1 mp0 -58.99 -29.5 67.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.0 -42.9 72.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.99 -42.28 60.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.053 -1.03 . . . . 0.0 108.613 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 80.9 m-20 -62.2 -40.63 96.73 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.601 -0.687 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.498 -0.751 . . . . 0.0 109.02 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.5 -39.79 94.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tt -60.01 -42.41 94.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.743 -0.598 . . . . 0.0 109.541 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' CG ' ' A' ' 59' ' ' PHE . 21.7 mtm -59.92 -41.64 92.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.82 -1.175 . . . . 0.0 108.576 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.26 -43.14 98.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 108.676 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.2 mt-30 -60.07 -41.32 92.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.098 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 p -70.95 -40.03 72.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.57 -53.83 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 -179.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.102 . . . . 0.0 109.127 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.3 m-70 -60.02 -49.57 77.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.077 -1.014 . . . . 0.0 108.608 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.1 -50.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.87 -51.09 42.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.667 -0.646 . . . . 0.0 109.828 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.04 -40.07 88.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 110.617 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.09 -39.92 78.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 -178.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.73 0.34 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 20.25 76.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.78 -173.04 46.61 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.33 139.29 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.504 -0.998 . . . . 0.0 108.872 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 t -76.62 129.96 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.081 -1.012 . . . . 0.0 108.824 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' C ' ' SD ' ' A' ' 124' ' ' MET . 52.5 mt -131.4 159.85 36.8 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -0.767 . . . . 0.0 109.72 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' ' SD ' ' A' ' 124' ' ' MET . 43.6 p-10 -84.78 -173.97 5.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 109.173 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.7 m-20 -60.04 -36.45 77.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.472 ' CB ' ' NH1' ' A' ' 122' ' ' ARG . 96.5 mm-40 -77.17 13.24 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.7 mtm180 55.42 33.78 21.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.87 -0.518 . . . . 0.0 110.422 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 120' ' ' GLN . 25.1 mtm-85 -109.67 156.67 19.96 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.5 mtm -51.9 133.24 32.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 118' ' ' ASP . 97.6 mmm -60.68 139.95 57.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.653 ' N ' ' HZ1' ' A' ' 128' ' ' LYS . 74.6 p -130.43 149.87 74.63 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -48.63 -43.9 32.42 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 119.38 0.814 . . . . 0.0 111.963 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -60.3 -42.99 96.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.653 ' HZ1' ' N ' ' A' ' 125' ' ' THR . 9.8 mtmp? -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.105 . . . . 0.0 110.288 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.44 -39.99 81.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.738 -1.226 . . . . 0.0 108.409 179.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.08 -36.87 85.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.391 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.07 -49.44 77.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -60.05 -43.75 95.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.45 -39.83 94.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.45 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 95.9 m-20 -60.0 -40.99 91.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.268 -0.895 . . . . 0.0 109.294 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.93 -41.03 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.885 -1.134 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.03 -46.28 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.493 ' HG2' HH11 ' A' ' 137' ' ' ARG . 1.6 mmt-85 -60.27 -40.02 88.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.098 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.5 mt-10 -60.93 -38.84 87.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.52 0.676 . . . . 0.0 109.63 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.81 -39.61 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 110.673 -179.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' ALA . 56.6 mttm -58.23 -46.9 85.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.927 -1.108 . . . . 0.0 110.572 -178.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.11 -33.02 71.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.704 -1.248 . . . . 0.0 108.622 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.26 93.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.56 -0.713 . . . . 0.0 110.289 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -99.96 -18.58 17.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.407 0.622 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.29 6.72 31.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.4 81.45 10.98 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 6' ' ' ARG . 38.9 Cg_exo -45.01 118.27 1.9 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.961 1.107 . . . . 0.0 113.105 -178.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -80.06 32.77 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' H ' ' C ' ' A' ' 4' ' ' PRO . 97.0 mtt180 -69.98 150.27 46.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.798 . . . . 0.0 110.709 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -82.94 -9.34 59.34 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -146.4 141.78 27.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -165.8 166.82 17.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 109.799 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.3 129.97 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 11' ' ' ILE . 24.8 mm -92.57 131.83 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.0 mt -131.13 142.09 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 122.165 0.983 . . . . 0.0 110.971 -178.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.85 135.06 32.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -116.24 122.68 45.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.048 -1.033 . . . . 0.0 111.342 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.46 111.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.27 155.69 40.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.111 -0.993 . . . . 0.0 110.55 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.48 -164.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.559 -0.713 . . . . 0.0 109.096 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -74.51 157.44 35.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.096 -1.003 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.24 143.56 52.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.73 0.24 72.55 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.7 m -130.01 141.78 50.7 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.587 -0.949 . . . . 0.0 109.341 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.72 149.11 44.52 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.451 -0.78 . . . . 0.0 108.936 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.4 145.34 26.9 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 62.6 t-20 -68.07 138.82 56.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.527 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.8 -40.42 98.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.351 . . . . 0.0 109.489 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -29.73 67.81 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -70.37 -57.93 4.29 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.2 -40.89 91.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.0 109.926 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -64.0 -40.37 96.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.4 t -65.77 -39.06 90.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 111.105 -179.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.82 -42.24 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.197 . . . . 0.0 109.972 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -64.88 -39.94 94.34 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.153 -0.967 . . . . 0.0 108.549 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -64.71 -20.62 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.492 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.62 2.01 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.779 . . . . 0.0 110.114 -178.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.68 13.49 82.35 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.425 179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -79.99 153.17 29.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.049 -1.266 . . . . 0.0 110.059 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 83.0 mt -120.21 133.84 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 110.182 -178.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.95 169.07 27.93 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -59.95 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -1.115 . . . . 0.0 109.189 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.9 mtt 58.89 19.86 7.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.5 m120 51.32 37.62 19.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.222 -0.924 . . . . 0.0 111.336 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.58 164.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.945 -1.097 . . . . 0.0 108.717 178.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -91.72 123.14 34.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.115 -0.991 . . . . 0.0 110.47 -178.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 44.8 m-70 -114.67 131.3 56.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.609 -0.682 . . . . 0.0 109.654 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 17.4 ttp180 -107.32 126.76 52.86 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.567 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 44.9 m-70 -92.75 171.47 8.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.378 -0.826 . . . . 0.0 110.676 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.41 -49.98 72.93 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.2 m -90.49 148.05 37.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.239 -0.913 . . . . 0.0 108.948 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.97 -12.0 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 120.748 0.966 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 56.3 p-10 -90.24 0.78 57.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 0.0 109.901 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.15 10.67 85.87 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 53.5 m -66.88 -40.06 87.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.848 -1.383 . . . . 0.0 109.726 -179.51 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.98 166.21 51.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.567 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.4 Cg_endo -71.16 175.78 8.75 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.493 1.462 . . . . 0.0 112.125 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.29 124.04 27.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.037 . . . . 0.0 109.25 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 86' ' ' MET . 10.2 mp -102.94 -57.25 2.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.405 -0.809 . . . . 0.0 110.026 -179.216 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -130.5 159.49 36.96 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.77 -1.207 . . . . 0.0 108.518 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.8 m -137.3 162.26 34.01 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.017 -1.052 . . . . 0.0 111.731 -177.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -113.58 136.16 53.12 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -136.36 160.53 38.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -75.92 161.5 28.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.095 -1.003 . . . . 0.0 109.904 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.1 mtp -69.83 -19.41 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 110.492 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 68' ' ' GLY . 7.9 p -89.49 117.44 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.741 -1.224 . . . . 0.0 109.747 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -62.04 148.86 87.71 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -75.43 9.29 10.7 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.828 -1.322 . . . . 0.0 112.234 0.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 73.86 21.76 78.88 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.926 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.2 p -86.08 171.85 11.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.1 -1.235 . . . . 0.0 109.789 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 84.0 m-85 -121.43 144.81 48.47 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.562 -0.711 . . . . 0.0 109.943 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 73' ' ' GLU . 11.9 m-20 -129.98 150.44 75.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.59 -8.79 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 120.512 0.808 . . . . 0.0 112.123 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 71' ' ' ASP . 48.7 mt-10 -89.94 2.61 54.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.6 mmm -86.23 17.28 3.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -87.41 -7.84 57.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 108.939 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.1 m-20 -150.3 79.99 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -156.25 172.44 18.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.2 p -129.81 150.97 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.177 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.12 148.15 18.18 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.912 . . . . 0.0 109.341 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -45.34 -43.1 17.35 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 120.594 0.863 . . . . 0.0 111.547 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.9 10.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.6 m -129.98 160.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.325 -1.103 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 62' ' ' ALA . 97.9 m -116.47 129.99 56.51 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.617 0.722 . . . . 0.0 110.517 -179.298 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.9 131.96 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 22.3 p90 -147.03 170.65 16.68 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.916 -1.115 . . . . 0.0 111.172 -178.068 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 4.9 tpp -139.61 122.63 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.3 mt-30 -88.94 114.98 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 0.0 108.66 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.4 m -101.43 152.08 37.93 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.411 -0.805 . . . . 0.0 109.103 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.27 140.51 61.11 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 C-N-CA 123.7 -1.375 . . . . 0.0 112.214 -0.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 20.4 m -119.47 154.38 33.85 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.471 -0.768 . . . . 0.0 109.788 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -71.04 152.61 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.323 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.47 -163.53 26.3 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 92.7 m-20 -95.82 110.41 22.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.276 -1.132 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -59.89 -32.53 70.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.565 -0.709 . . . . 0.0 110.228 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.75 -40.08 76.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.961 -1.087 . . . . 0.0 109.875 -178.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -72.06 -40.26 68.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.636 -1.29 . . . . 0.0 108.627 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 35.7 m120 -60.49 -40.07 90.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.4 ' CE2' ' NE2' ' A' ' 133' ' ' GLN . 63.3 t80 -58.18 -43.12 87.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.83 -41.23 95.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.98 -40.18 94.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 108.872 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.92 -49.06 79.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.008 179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.27 -41.47 89.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.96 . . . . 0.0 110.046 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.536 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 32.5 mt-30 -59.95 -41.83 92.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.966 -1.084 . . . . 0.0 108.873 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -71.13 -40.28 71.5 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.433 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.28 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.069 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.71 -42.21 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 20.0 m-70 -60.1 -46.73 88.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.894 179.387 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.04 -50.0 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.353 -0.842 . . . . 0.0 109.076 179.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.73 -49.57 62.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.77 -40.22 91.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 110.578 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.41 -39.87 77.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.931 -1.105 . . . . 0.0 110.568 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 m -98.78 -0.0 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.95 -1.094 . . . . 0.0 109.741 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.17 22.88 77.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.03 -170.17 46.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.29 137.12 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.578 -0.954 . . . . 0.0 108.93 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -72.01 133.19 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 0.0 108.953 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.01 159.32 39.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 36.7 p-10 -87.47 -172.0 3.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.078 179.315 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 121' ' ' ARG . 73.6 m-20 -60.02 -39.84 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.809 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.465 ' OE1' ' NH2' ' A' ' 122' ' ' ARG . 79.0 mt-30 -76.38 17.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.34 -0.85 . . . . 0.0 109.388 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.478 HH11 ' HG2' ' A' ' 121' ' ' ARG . 22.3 mtt-85 58.24 25.49 12.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.688 -0.633 . . . . 0.0 110.185 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 85.7 mtm180 -105.12 151.87 23.48 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.325 -0.86 . . . . 0.0 109.267 179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 98.2 mtp -51.93 136.55 28.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.2 mmm -58.81 139.95 55.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.588 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.1 p -132.2 150.65 76.62 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -41.45 -49.92 4.85 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.804 1.003 . . . . 0.0 112.878 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 110.039 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -66.56 -39.94 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.928 -1.108 . . . . 0.0 110.329 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.82 -40.15 87.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 0.0 108.044 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.22 -38.79 85.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.16 -48.94 79.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.876 -1.14 . . . . 0.0 109.721 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -59.94 -46.32 89.79 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.4 ' NE2' ' CE2' ' A' ' 98' ' ' PHE . 98.1 mt-30 -61.89 -39.48 92.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.607 -0.683 . . . . 0.0 109.187 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.24 -40.97 96.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 135' ' ' ILE . 86.2 mt -62.47 -41.78 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.875 -1.141 . . . . 0.0 109.133 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.21 -46.25 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 59.6 mtp180 -60.21 -40.16 89.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.703 . . . . 0.0 109.83 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.85 -40.45 88.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.04 -1.038 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.67 -38.05 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' ALA . 24.6 mtpp -59.83 -42.87 94.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.718 -1.239 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.08 -34.07 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.432 -1.417 . . . . 0.0 109.072 179.685 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.68 92.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.159 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.14 0.44 45.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.48 -0.763 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.153 -0.967 . . . . 0.0 109.313 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mtp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.202 0.525 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.0 1.65 55.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.3 125.17 89.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.041 -1.037 . . . . 0.0 108.649 179.858 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.49 25.2 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 CA-C-N 120.111 1.075 . . . . 0.0 112.486 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 3' ' ' LYS . 96.5 mttt -85.46 -11.06 55.21 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.69 124.4 32.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.922 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -87.22 -10.06 53.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -149.65 145.2 26.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.79 -172.66 3.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.886 -1.134 . . . . 0.0 110.394 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.08 133.47 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mm -88.46 132.71 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.458 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 91.0 mt -131.42 140.63 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 122.346 1.07 . . . . 0.0 111.514 -177.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.9 mtm -147.21 138.39 23.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -118.82 132.56 56.13 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.196 -0.94 . . . . 0.0 111.908 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.56 118.94 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.23 38.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.62 -173.24 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 108.672 178.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -68.76 160.06 31.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.989 -1.07 . . . . 0.0 109.255 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -59.46 142.5 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.95 -6.22 79.16 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -121.9 148.9 44.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.2 mp0 -130.71 149.36 52.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 109.091 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.3 mt -84.91 136.23 33.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.25 146.32 53.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.156 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.87 98.56 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.79 -47.14 87.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.248 . . . . 0.0 109.581 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.07 -32.68 73.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -73.99 -56.93 4.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.638 -0.664 . . . . 0.0 109.842 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.97 -46.91 87.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -61.8 -40.78 96.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.23 -0.919 . . . . 0.0 110.586 -179.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 t -63.89 -40.04 95.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 110.139 -179.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -40.96 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 108.993 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.53 -40.27 95.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.352 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -68.81 -18.09 64.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.459 -0.776 . . . . 0.0 109.804 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -80.76 5.41 15.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.09 11.94 83.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -80.17 156.7 26.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.245 . . . . 0.0 110.031 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.84 137.19 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -62.13 105.89 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.955 -1.091 . . . . 0.0 109.77 -179.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.69 172.6 31.46 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.31 -164.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -1.03 . . . . 0.0 109.85 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 68.2 mtt 58.84 20.06 7.62 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.828 0.823 . . . . 0.0 109.092 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 53.14 40.06 30.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.727 -0.608 . . . . 0.0 111.691 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.13 169.7 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.8 -1.188 . . . . 0.0 109.052 178.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -94.53 115.51 27.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.0 110.629 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 52.2 m80 -101.06 127.93 47.36 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.356 -0.84 . . . . 0.0 109.437 178.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 61.9 ttt180 -106.05 127.55 53.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.099 -1.001 . . . . 0.0 108.514 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 48' ' ' HIS . 15.2 m-70 -97.44 177.1 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 109.648 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -56.51 -49.66 74.06 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 108.833 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -90.28 149.16 40.71 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.362 -0.836 . . . . 0.0 109.224 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.96 -12.22 33.83 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 120.967 1.112 . . . . 0.0 112.95 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -93.03 0.01 57.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.894 -1.129 . . . . 0.0 110.34 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 13.41 82.23 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.705 179.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -69.86 -39.99 76.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.835 -1.391 . . . . 0.0 109.523 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.64 170.57 54.23 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -68.76 169.22 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.355 1.37 . . . . 0.0 111.891 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.94 121.71 26.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.918 . . . . 0.0 109.089 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 8.7 mp -101.34 -37.36 8.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.273 -0.892 . . . . 0.0 109.533 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -151.38 159.86 44.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.418 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.0 m -133.69 -179.56 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.841 0.829 . . . . 0.0 110.723 -177.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 5.9 tt -134.02 134.08 42.02 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.77 160.0 36.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.733 -0.605 . . . . 0.0 109.74 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 70' ' ' PHE . 9.0 m120 -73.36 160.74 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.99 -1.069 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mmm -68.88 -29.84 68.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 110.673 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -86.79 121.78 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.398 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -59.59 152.58 55.7 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -79.14 3.94 31.36 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.799 -1.334 . . . . 0.0 112.86 0.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.41 21.61 61.98 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.9 p -85.3 160.45 19.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.112 -1.228 . . . . 0.0 109.883 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 63' ' ' ASN . 28.3 m-85 -125.13 139.95 53.31 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.624 -0.672 . . . . 0.0 109.426 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' N ' ' SD ' ' A' ' 74' ' ' MET . 41.9 m-20 -120.25 149.51 49.63 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.04 -14.49 41.87 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 119.345 0.802 . . . . 0.0 111.936 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.71 -0.0 57.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.279 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 71' ' ' ASP . 10.9 ptm -84.59 25.75 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.336 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 56.5 mtpt -79.08 2.44 20.66 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.546 -1.346 . . . . 0.0 109.282 -179.07 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 90.8 m-20 -142.76 84.25 1.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -161.29 174.13 14.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.977 -1.077 . . . . 0.0 109.977 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -130.09 152.54 49.43 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.72 149.03 18.51 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.14 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -49.33 -49.51 15.33 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-N 119.058 0.699 . . . . 0.0 111.732 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.93 18.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.99 159.91 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.492 -1.005 . . . . 0.0 110.132 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.6 m -108.82 122.43 47.17 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.356 0.598 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.2 mt -104.07 129.72 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -148.73 157.28 43.34 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.803 -1.186 . . . . 0.0 111.655 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.4 ttm -121.62 134.58 55.0 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.464 ' O ' ' OG ' ' A' ' 90' ' ' SER . 98.4 mm-40 -90.64 104.01 16.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 m -97.75 149.18 35.45 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.192 -0.943 . . . . 0.0 109.471 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.65 131.81 25.46 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.636 -1.402 . . . . 0.0 112.205 -0.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 60.8 m -103.82 166.68 10.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.75 148.54 47.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.641 -0.662 . . . . 0.0 109.398 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.75 -160.02 33.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.45 113.27 24.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.105 . . . . 0.0 109.443 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.99 -33.01 71.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.619 -0.675 . . . . 0.0 109.916 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.01 -41.49 74.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 110.597 -178.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.32 -42.1 62.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.834 -1.167 . . . . 0.0 108.681 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -62.6 -33.84 75.8 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.07 -48.69 80.67 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -59.96 -39.97 87.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.77 -40.16 91.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.7 mtp -59.89 -42.81 94.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 108.763 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.39 -40.04 96.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.28 -0.887 . . . . 0.0 109.211 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 27.7 mt-30 -60.15 -40.04 88.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 p -71.62 -40.06 70.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.92 71.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.98 -40.06 96.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.246 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.4 m-70 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.997 . . . . 0.0 108.961 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 108' ' ' ILE . 83.3 mt -59.91 -49.22 84.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.4 -49.61 66.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.831 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.88 -39.97 75.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.256 -0.903 . . . . 0.0 111.046 -178.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -102.0 -1.02 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.04 -1.037 . . . . 0.0 110.388 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.09 20.76 73.21 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.93 -172.58 48.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.36 139.23 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.588 -0.948 . . . . 0.0 109.077 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 t -77.18 133.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.155 -0.966 . . . . 0.0 108.894 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.0 mt -130.08 156.87 43.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.359 -0.838 . . . . 0.0 109.213 -179.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -86.29 -173.36 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 0.0 109.358 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 87.5 m-20 -60.08 -38.26 82.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.92 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -77.59 15.29 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.5 mtm180 56.37 39.58 30.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.702 . . . . 0.0 109.776 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 122' ' ' ARG . 43.4 mtt-85 -116.23 151.16 36.32 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.682 . . . . 0.0 109.292 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.3 mtt -50.56 134.79 23.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.8 mmm -58.39 138.63 56.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.396 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -140.0 152.85 68.67 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -48.0 -43.56 29.95 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 CA-C-N 119.018 0.685 . . . . 0.0 111.391 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.18 -40.81 91.27 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -69.92 -41.04 75.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.052 . . . . 0.0 108.974 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.166 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -62.53 -40.03 95.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.95 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.77 . . . . 0.0 110.277 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' O ' ' A' ' 12' ' ' ILE . 65.0 m-85 -60.04 -42.56 94.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.065 . . . . 0.0 108.692 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -62.56 -39.96 95.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 92.8 m-20 -62.01 -43.07 99.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 0.0 110.236 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.37 -40.64 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.828 -1.17 . . . . 0.0 109.673 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 136' ' ' ILE . 85.2 mt -60.21 -43.45 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 110.169 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 85.5 mtm180 -60.04 -40.18 88.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.043 . . . . 0.0 110.385 -179.149 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -61.51 -39.9 92.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.005 -1.059 . . . . 0.0 110.172 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.09 -26.19 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 111.987 -178.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -59.86 -39.65 85.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.581 -1.324 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 57.0 p-10 -59.99 -30.03 68.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.697 -1.252 . . . . 0.0 109.54 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.595 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -63.54 -37.43 87.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -96.99 -13.27 22.43 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.237 -0.915 . . . . 0.0 109.481 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.707 179.869 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.26 15.11 11.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.451 -0.781 . . . . 0.0 109.857 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' CB ' ' HZ3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -129.99 77.77 76.03 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.422 -0.799 . . . . 0.0 109.6 -179.079 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 3.8 Cg_exo -64.76 138.5 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.796 0.997 . . . . 0.0 111.878 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -79.79 33.32 0.26 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 110.288 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -69.7 148.81 48.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 109.949 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -80.51 -7.36 59.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.79 104.37 3.32 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' H ' ' CG2' ' A' ' 139' ' ' VAL . . . -99.34 175.23 5.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 110.443 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.42 130.16 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mm -95.8 123.83 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.17 144.21 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 121.777 0.799 . . . . 0.0 109.979 -178.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.6 mtt -143.81 151.32 39.78 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -133.52 125.06 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 110.59 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.87 117.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 159.43 44.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.117 -0.989 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.64 174.05 8.12 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -59.34 151.96 22.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 108.567 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -53.21 148.51 8.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.178 -0.951 . . . . 0.0 108.936 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.13 -1.3 79.92 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -130.04 148.47 51.9 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.426 -1.044 . . . . 0.0 109.026 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 55.8 mm-40 -127.53 148.7 50.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.426 -0.796 . . . . 0.0 108.942 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.5 mt -87.92 139.02 30.94 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.117 -0.989 . . . . 0.0 110.007 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -70.85 145.57 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.78 -40.85 98.73 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.44 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -48.49 81.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.94 -1.33 . . . . 0.0 109.715 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.45 -27.43 65.24 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -59.31 2.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.589 -179.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.71 -45.44 92.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 -179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 14.1 t-20 -61.29 -40.4 93.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.407 ' OG ' ' OE1' ' A' ' 111' ' ' GLU . 35.0 t -64.45 -39.74 94.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 32' ' ' ILE . 96.6 mt -60.04 -49.16 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.973 -1.079 . . . . 0.0 110.051 -178.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.13 -40.26 97.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.995 -1.066 . . . . 0.0 109.296 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 34.9 mt-30 -68.1 -16.5 64.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 110.117 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -84.79 -0.63 54.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.994 -1.066 . . . . 0.0 109.96 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.33 13.2 57.63 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.907 -1.12 . . . . 0.0 110.49 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -82.94 149.92 26.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -1.226 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.9 mt -120.4 133.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.04 104.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 -178.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.86 171.34 32.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.72 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -1.169 . . . . 0.0 109.27 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.0 mmm 57.9 20.28 6.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.461 -0.775 . . . . 0.0 109.851 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 50.61 39.45 21.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 111.59 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.2 pt -140.04 160.69 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -91.03 118.57 30.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.005 -1.059 . . . . 0.0 110.409 -179.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 29.4 m-70 -103.49 127.08 50.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 58.5 ttt180 -102.22 124.27 47.52 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.555 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 57.9 m-70 -94.06 171.14 9.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.64 -47.94 78.62 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -91.45 147.1 34.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.758 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.85 -8.85 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.622 0.881 . . . . 0.0 111.941 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -94.67 -0.33 54.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.08 -1.013 . . . . 0.0 110.742 -179.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.76 86.43 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.9 p -70.22 -40.13 74.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.048 -1.266 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.35 162.8 51.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.537 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.3 Cg_endo -66.53 176.25 4.35 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.067 1.178 . . . . 0.0 112.103 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 118.95 23.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 108.771 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.5 mp -97.6 -42.08 7.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.79 159.54 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.988 -1.07 . . . . 0.0 108.549 178.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.4 m -132.32 175.21 9.47 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.326 -0.858 . . . . 0.0 111.078 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 7.2 tt -128.37 131.78 48.55 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.597 0.713 . . . . 0.0 109.138 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -129.31 160.21 33.73 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.611 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 84.2 m-20 -74.6 158.24 34.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.92 -1.112 . . . . 0.0 110.334 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -70.11 -27.57 64.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.633 -0.667 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.69 135.51 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.951 -1.093 . . . . 0.0 109.592 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -62.88 149.81 89.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.525 -0.734 . . . . 0.0 110.114 -179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.13 5.35 24.78 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.962 -0.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.16 4.97 80.83 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -88.81 170.48 10.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.611 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.6 m-85 -118.61 140.09 50.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.574 -0.703 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' H ' ' HG3' ' A' ' 74' ' ' MET . 58.2 m-20 -124.33 150.02 62.83 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.79 -10.99 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.441 0.836 . . . . 0.0 112.551 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' ASP . 31.0 mp0 -88.9 2.37 53.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.001 . . . . 0.0 109.344 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.443 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 63.5 mmm -86.51 18.42 3.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.605 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.7 mttm -85.92 -4.66 59.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.082 -1.011 . . . . 0.0 108.941 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.9 m-20 -149.92 80.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 108.914 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.66 173.11 17.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 109.898 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.4 p -130.24 149.85 51.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.57 149.41 20.11 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.016 -1.053 . . . . 0.0 109.286 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.533 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 18.1 Cg_exo -44.71 -53.59 4.93 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.312 0.675 . . . . 0.0 111.39 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.09 -147.34 5.48 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.97 160.0 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.84 -0.8 . . . . 0.0 109.51 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.453 ' N ' ' O ' ' A' ' 62' ' ' ALA . 88.2 m -113.42 118.59 34.96 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.9 mt -105.04 129.1 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.77 165.53 27.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.256 -179.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.0 ttp -140.08 127.78 21.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -90.33 117.58 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.998 . . . . 0.0 108.573 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.7 150.72 36.98 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 108.704 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -74.87 139.08 59.7 Favored 'Cis proline' 0 N--CA 1.496 1.645 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.639 -0.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.6 m -104.86 167.12 9.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -70.24 141.93 52.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.02 -155.74 27.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -95.34 119.39 33.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 108.724 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' OE1' ' N ' ' A' ' 94' ' ' GLU . 56.7 mp0 -57.54 -31.55 66.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.534 -0.729 . . . . 0.0 110.442 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.51 -40.4 77.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.394 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.48 -40.18 70.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.24 -40.02 94.77 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -59.89 -50.11 75.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 108.699 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -60.01 -40.11 88.14 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 tp -60.52 -41.49 94.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.433 ' O ' ' OG ' ' A' ' 104' ' ' SER . 86.5 mtp -59.61 -45.4 92.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.116 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.12 -42.9 95.77 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.045 -1.034 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.03 -40.84 90.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.265 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 101' ' ' MET . 15.8 p -70.33 -40.12 74.35 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.339 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.96 -55.54 32.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.537 -0.727 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.37 -37.25 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.008 -179.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -60.07 -44.6 94.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.042 -1.036 . . . . 0.0 108.963 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 108' ' ' ILE . 84.5 mt -60.39 -49.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.27 -47.69 65.7 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.33 -40.02 89.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.149 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.407 ' OE1' ' OG ' ' A' ' 31' ' ' SER . 98.9 mt-10 -68.8 -40.38 79.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.1 -1.0 . . . . 0.0 110.938 -178.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.7 1.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.083 -1.011 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.44 25.58 72.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.68 -167.84 43.92 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.2 t -137.43 140.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.412 -1.052 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 t -71.66 130.65 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.163 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -127.01 157.51 39.37 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.0 109.297 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -84.62 -173.41 4.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.312 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.9 m-20 -60.65 -38.65 85.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.268 -0.895 . . . . 0.0 108.69 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.63 17.74 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.49 -0.756 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.15 32.44 20.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.606 -0.684 . . . . 0.0 110.709 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -111.7 147.65 35.12 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.4 mtt -52.14 125.55 16.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.609 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -60.88 136.24 58.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.904 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 128' ' ' LYS . 30.7 p -122.93 149.99 57.94 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -41.19 -44.07 5.35 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 120.662 0.908 . . . . 0.0 112.185 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.67 -39.89 90.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.291 -0.881 . . . . 0.0 109.056 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' THR . 68.6 mttm -67.89 -39.61 83.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.42 -40.18 74.3 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 130' ' ' ARG . 48.6 mtt-85 -63.37 -39.48 94.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -59.96 -44.19 94.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.121 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -62.58 -40.11 95.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 108.676 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -60.91 -39.03 87.78 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.297 -0.877 . . . . 0.0 108.841 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.58 -39.99 93.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.33 -40.89 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.007 -1.058 . . . . 0.0 108.852 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.29 -41.97 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.1 mtt180 -61.82 -28.87 69.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.916 -0.49 . . . . 0.0 110.725 -179.415 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 97.3 mt-10 -60.12 -40.1 88.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.831 -1.168 . . . . 0.0 109.645 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.431 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 64.1 t -71.97 -34.03 49.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.466 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 144' ' ' ALA . 62.9 mttm -59.88 -43.15 94.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.929 -1.107 . . . . 0.0 110.902 -179.025 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.89 -26.62 68.27 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.172 179.736 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.51 -59.7 3.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -112.21 -28.01 8.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.488 -0.757 . . . . 0.0 110.133 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.329 -0.857 . . . . 0.0 109.809 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -86.96 -7.57 58.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 69.99 79.2 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.333 -0.855 . . . . 0.0 109.763 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 6' ' ' ARG . 9.6 Cg_endo -71.05 99.4 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.943 1.096 . . . . 0.0 111.834 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.28 31.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 108.581 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.505 ' H ' ' C ' ' A' ' 4' ' ' PRO . 92.0 mtt180 -73.54 158.55 34.64 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.478 0.656 . . . . 0.0 110.415 -179.064 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -83.32 -7.64 59.55 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.83 142.71 30.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.7 -174.27 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.566 -1.334 . . . . 0.0 110.5 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.8 t -131.46 136.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.2 mm -91.27 129.43 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.486 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 81.4 mt -131.64 142.72 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.056 0.931 . . . . 0.0 110.912 -177.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.8 mtm -147.85 152.17 37.18 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -129.92 129.3 43.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.921 -1.112 . . . . 0.0 111.434 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.03 112.19 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.11 154.85 39.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.119 -0.988 . . . . 0.0 110.848 -178.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.77 168.45 17.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -56.08 160.18 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.073 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.71 150.14 33.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.77 -4.41 78.9 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 m -130.14 147.48 51.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.523 -0.986 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.53 150.2 50.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.502 -0.749 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.95 145.04 27.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.109 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -70.77 141.13 51.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 108.841 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.23 97.98 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.379 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.06 -45.03 96.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.294 . . . . 0.0 109.425 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mt -69.95 -24.1 63.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.102 179.261 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 tt -77.1 -55.43 5.45 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.956 -179.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.97 -48.7 80.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.127 -0.983 . . . . 0.0 111.104 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 31' ' ' SER . 43.2 p-10 -64.19 -40.02 95.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.858 -1.151 . . . . 0.0 110.66 -178.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 75.5 m -60.9 -40.55 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.888 -1.133 . . . . 0.0 109.797 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 32' ' ' ILE . 96.8 mt -60.05 -48.27 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -61.63 -40.06 93.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.26 -20.03 65.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 0.0 110.245 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.552 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.74 1.05 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.663 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.5 61.66 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -80.0 154.68 28.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.264 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.12 136.94 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.12 106.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.051 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' HA3' ' HD1' ' A' ' 46' ' ' HIS . . . -94.66 172.83 31.71 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.54 -168.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 110.061 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 77.1 mtm 59.24 25.4 13.99 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.613 0.721 . . . . 0.0 109.844 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 50.64 36.35 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.641 -0.662 . . . . 0.0 111.823 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -140.09 167.52 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.004 -1.06 . . . . 0.0 108.594 177.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 111.083 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 56.4 m80 -103.85 131.05 51.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.425 -0.797 . . . . 0.0 109.392 178.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.0 ttt180 -105.96 127.29 53.05 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.223 -0.923 . . . . 0.0 108.702 178.085 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.532 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 60.7 m-70 -97.37 171.71 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.0 110.173 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.28 -49.95 68.41 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -90.36 148.15 38.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.828 . . . . 0.0 109.014 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -70.27 -7.39 21.09 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.844 1.029 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.86 -0.27 55.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.116 -0.99 . . . . 0.0 110.283 -179.16 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.07 86.1 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -69.99 -41.26 74.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -1.145 . . . . 0.0 110.243 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.83 166.98 52.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.532 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.5 Cg_endo -65.62 168.54 14.65 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.068 1.179 . . . . 0.0 111.393 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.996 -1.065 . . . . 0.0 109.231 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mp -101.66 -40.12 7.14 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.891 . . . . 0.0 109.563 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -150.12 163.14 38.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 109.316 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 74.8 m -134.1 178.71 6.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.881 0.848 . . . . 0.0 111.137 -177.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.0 tt -132.5 131.43 41.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.44 162.57 31.86 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.704 -0.623 . . . . 0.0 109.48 -179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.48 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 11.6 m120 -74.93 159.68 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 110.53 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.0 -23.52 63.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.593 -0.692 . . . . 0.0 110.119 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -85.36 121.73 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.922 -1.111 . . . . 0.0 109.55 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -59.59 149.92 68.6 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.314 -0.866 . . . . 0.0 108.929 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -77.28 12.12 13.02 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.16 -0.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.19 85.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -87.14 170.58 11.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -1.088 . . . . 0.0 110.062 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -116.89 144.8 44.1 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' GLU . 78.1 m-20 -129.21 150.6 75.9 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 74' ' ' MET . 22.8 Cg_exo -44.81 -12.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.697 0.931 . . . . 0.0 112.16 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -85.13 15.23 4.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 71' ' ' ASP . 7.8 ptp -81.79 -5.12 57.9 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.376 -179.14 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.9 mttm -88.11 -4.63 58.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.88 -1.137 . . . . 0.0 110.468 -179.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.0 m-20 -150.96 69.7 0.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.885 -1.134 . . . . 0.0 109.822 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -154.44 170.0 22.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.6 p -129.68 154.03 47.55 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.6 148.87 17.67 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.95 -1.094 . . . . 0.0 109.329 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.69 -51.17 9.45 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 120.416 0.744 . . . . 0.0 111.62 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.98 -149.52 7.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.03 163.07 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.608 -0.936 . . . . 0.0 110.068 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.6 m -115.04 126.54 54.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 84' ' ' ILE . 85.8 mt -109.88 130.02 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.98 155.15 40.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.785 -1.197 . . . . 0.0 111.556 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.6 ttm -119.51 131.18 55.52 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.5 mm-40 -90.38 112.33 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.8 m -97.93 150.36 36.68 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.73 132.3 26.48 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.47 0.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 49.6 m -106.4 158.37 16.94 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.595 -0.691 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -73.01 153.07 41.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.61 -164.47 33.02 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 71.5 m-20 -95.29 107.92 20.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -1.067 . . . . 0.0 108.918 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -59.88 -30.26 68.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.667 -0.646 . . . . 0.0 110.529 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.71 -39.99 76.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.274 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.88 -40.6 60.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.042 -1.036 . . . . 0.0 108.815 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 72.3 m-80 -62.47 -35.83 80.56 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -59.6 -49.98 75.66 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -60.79 -40.08 91.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.96 -43.22 95.2 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.0 mtp -58.5 -41.17 84.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 0.0 109.1 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.15 -40.76 86.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.601 179.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.8 mt-30 -60.04 -40.13 88.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 0.0 109.526 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.405 ' HG ' ' N ' ' A' ' 105' ' ' ALA . 53.6 p -72.53 -40.01 67.11 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 109.458 179.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.405 ' N ' ' HG ' ' A' ' 104' ' ' SER . . . -59.54 -53.51 57.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 110.102 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.62 -37.74 82.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.975 -1.078 . . . . 0.0 109.314 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 12.5 m-70 -59.98 -47.48 85.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.048 179.546 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 108' ' ' ILE . 92.7 mt -60.03 -49.95 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.401 -0.812 . . . . 0.0 109.208 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.16 -50.39 49.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.571 -0.705 . . . . 0.0 109.513 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.07 -39.99 87.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.327 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.64 -39.95 80.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 110.591 -178.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -100.2 -0.16 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.58 24.33 76.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.29 -173.53 49.21 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.76 134.38 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.631 -0.923 . . . . 0.0 108.956 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.71 128.25 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 108.94 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.06 159.99 35.96 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.395 -0.816 . . . . 0.0 109.824 -179.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -85.95 -170.07 2.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.757 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.2 m-20 -60.12 -39.85 87.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.295 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.88 14.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 108.962 -179.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.4 mtt180 56.23 35.13 25.24 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.382 0.61 . . . . 0.0 109.371 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 122' ' ' ARG . 13.0 mtt-85 -109.7 153.33 24.42 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.619 -0.676 . . . . 0.0 109.315 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.2 mtm -50.27 124.37 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.3 mtp -60.03 140.0 57.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.866 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 p -131.65 150.83 77.39 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -43.64 -42.75 11.47 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.706 0.937 . . . . 0.0 112.411 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.01 -39.92 87.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.59 -39.61 88.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 109.528 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.9 -39.96 83.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 108.071 179.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.73 -40.06 96.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.01 -47.87 84.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 109.688 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -60.08 -42.58 94.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.862 -1.149 . . . . 0.0 108.585 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -60.79 -40.01 91.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.69 -38.93 86.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.631 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.0 -43.34 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.031 . . . . 0.0 108.608 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.35 85.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 108.684 179.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 57.0 mtp180 -59.89 -39.97 87.16 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.443 -0.786 . . . . 0.0 109.431 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 80.8 mm-40 -60.01 -41.36 91.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 109.805 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.92 -32.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.845 -179.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -60.04 -40.28 88.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.953 -1.092 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -59.98 -30.96 69.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.266 179.878 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.57 94.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 109.953 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -96.84 -2.67 43.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.0 109.433 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -142.89 149.9 39.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.66 170.98 16.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.601 -1.312 . . . . 0.0 110.605 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.04 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.95 128.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.65 140.84 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.844 0.83 . . . . 0.0 110.63 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -136.88 127.32 26.68 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.848 -1.158 . . . . 0.0 111.335 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.7 114.45 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.06 153.03 41.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.91 -165.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -69.89 155.71 40.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.065 -1.022 . . . . 0.0 109.178 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.89 140.51 55.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 109.64 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.76 6.12 73.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -129.76 143.1 50.65 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.607 -0.937 . . . . 0.0 108.856 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.2 mt-10 -123.07 150.94 42.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.409 -0.807 . . . . 0.0 109.324 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -87.5 142.44 27.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.222 -0.924 . . . . 0.0 109.864 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -67.9 140.32 56.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -0.923 . . . . 0.0 108.736 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.14 97.68 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.768 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.68 -46.58 87.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.961 -1.317 . . . . 0.0 109.783 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.02 -30.64 67.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.314 -0.866 . . . . 0.0 108.919 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.19 -56.8 4.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.627 -0.671 . . . . 0.0 109.352 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.04 -42.86 95.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.35 -40.98 92.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.503 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -64.82 -41.98 95.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.929 -1.107 . . . . 0.0 110.033 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.53 -46.67 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.328 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.56 -40.13 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 0.0 110.022 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -65.99 -17.77 64.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.56 5.43 24.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.911 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.33 72.14 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 121.05 -1.031 . . . . 0.0 110.697 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.68 150.36 30.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.355 . . . . 0.0 109.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.05 133.05 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 109.67 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.773 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -99.92 171.29 23.54 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.79 -163.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -1.116 . . . . 0.0 109.725 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 92.4 mmm 58.2 20.35 7.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.71 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m120 50.08 39.11 18.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.559 -0.713 . . . . 0.0 111.396 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.94 161.56 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.098 -1.001 . . . . 0.0 108.558 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 120.62 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.05 -1.031 . . . . 0.0 110.352 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.437 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 56.0 m-70 -105.12 127.9 53.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.5 ttt180 -102.67 129.23 49.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.052 -1.03 . . . . 0.0 108.893 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 13.4 m-70 -93.27 168.77 10.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.422 -0.799 . . . . 0.0 109.052 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.3 tp -52.71 -52.59 55.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.6 m -93.58 149.99 38.09 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.22 -2.14 10.01 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.57 0.846 . . . . 0.0 111.713 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -95.94 0.03 51.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.02 14.07 82.12 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.8 p -68.41 -38.59 81.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.155 -1.203 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -90.44 171.43 36.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 27.6 Cg_endo -74.55 178.67 6.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 120.944 1.096 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.57 118.83 22.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.129 -0.982 . . . . 0.0 108.847 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.81 -26.55 14.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -159.25 160.61 35.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.067 -1.02 . . . . 0.0 108.927 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -134.32 -178.56 5.1 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.915 -1.115 . . . . 0.0 112.094 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -137.9 134.06 34.57 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.322 0.582 . . . . 0.0 109.476 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.636 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.15 162.22 32.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -75.32 160.81 29.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 109.849 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -69.93 -22.98 63.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 110.92 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 71.8 t -86.76 121.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.822 -1.174 . . . . 0.0 109.719 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -58.57 147.31 70.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.054 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -76.33 15.98 6.95 Favored 'Cis proline' 0 N--CA 1.492 1.435 0 C-N-CA 123.402 -1.499 . . . . 0.0 111.76 -0.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 70.05 18.66 74.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.2 p -90.76 171.47 9.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -114.6 151.94 32.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 77.8 m-20 -131.2 148.42 70.12 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -46.08 -13.96 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.562 0.842 . . . . 0.0 111.668 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.4 mt-10 -85.46 16.12 4.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 21.8 ptt? -81.94 -2.82 52.7 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 58.9 mttm -86.24 -0.76 56.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.029 -1.044 . . . . 0.0 108.773 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.5 m-20 -152.15 69.34 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.559 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -155.32 169.94 23.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.909 -1.119 . . . . 0.0 109.53 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.411 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 80.4 p -130.41 154.49 47.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.69 149.88 20.75 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.872 -1.142 . . . . 0.0 109.57 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.24 -36.43 99.02 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.508 0.805 . . . . 0.0 112.185 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.68 -157.78 19.94 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.159 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.0 160.3 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.594 -0.945 . . . . 0.0 109.116 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.5 m -116.62 124.36 49.6 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.549 0.69 . . . . 0.0 109.867 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.05 129.48 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.24 163.61 34.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 110.282 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -140.02 128.56 22.89 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -88.97 118.67 28.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 108.735 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.14 152.52 39.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.45 138.13 53.87 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.275 -1.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.7 m -105.46 160.94 14.76 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.799 0.809 . . . . 0.0 110.736 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.17 143.73 52.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.709 -0.62 . . . . 0.0 109.953 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.74 -152.96 24.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -93.72 110.15 21.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -1.115 . . . . 0.0 109.068 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -56.21 -31.05 63.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.678 -0.639 . . . . 0.0 109.713 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 -37.02 75.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.99 -38.98 76.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 108.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 58' ' ' LEU . 91.8 m-20 -60.16 -41.16 92.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CG ' ' NE2' ' A' ' 133' ' ' GLN . 70.7 t80 -59.79 -46.09 90.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -61.24 -46.59 89.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.11 -40.05 88.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.099 -1.001 . . . . 0.0 110.248 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.3 mtp -59.02 -49.14 79.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.0 110.124 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.478 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 96.8 mt -66.09 -40.04 90.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 109.782 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -60.02 -42.59 94.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 108.92 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 p -70.11 -39.9 75.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.454 -0.779 . . . . 0.0 109.19 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.41 -57.8 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 110.275 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -60.12 -39.69 87.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.999 -1.063 . . . . 0.0 109.764 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -59.99 -48.3 82.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.913 -1.117 . . . . 0.0 108.636 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.14 -49.9 82.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.63 -50.13 66.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.504 -0.747 . . . . 0.0 109.327 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.81 -40.0 91.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 110.275 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.94 -40.18 75.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.1 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.12 1.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.163 -0.961 . . . . 0.0 109.609 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.45 23.07 77.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.87 -176.58 49.6 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.146 -1.208 . . . . 0.0 110.349 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.06 130.37 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.696 -0.884 . . . . 0.0 108.791 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 116' ' ' VAL . 2.6 t -71.54 130.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 108.953 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -130.34 159.61 36.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.369 -0.832 . . . . 0.0 109.411 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -88.34 -173.31 4.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.74 -38.51 85.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -76.4 14.6 0.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 121' ' ' ARG . 18.7 mtt-85 57.56 36.8 27.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 122' ' ' ARG . 52.4 mtt-85 -112.0 149.28 32.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.2 mtp -52.27 130.3 30.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.3 mmm -60.52 138.98 57.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 p -134.87 150.94 74.67 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.7 -46.49 10.33 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 120.813 1.008 . . . . 0.0 112.708 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.27 -41.34 93.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.0 -39.88 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.927 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.0 -40.02 79.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.199 -0.938 . . . . 0.0 108.476 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.12 -36.68 82.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.621 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.58 -46.57 86.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.005 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -60.01 -40.15 88.29 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 108.741 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.576 ' NE2' ' CG ' ' A' ' 98' ' ' PHE . 85.6 mm-40 -60.94 -40.05 91.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 0.0 109.009 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.31 -40.05 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.953 . . . . 0.0 108.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.86 -42.8 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.343 -0.848 . . . . 0.0 108.754 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.07 -40.49 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 32.2 mmt180 -61.33 -37.31 82.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.38 -0.825 . . . . 0.0 109.706 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.0 mt-10 -59.88 -40.2 87.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.18 -32.97 27.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 111.008 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.9 mttt -59.79 -41.85 92.08 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.877 -1.139 . . . . 0.0 110.903 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.2 -29.48 68.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.83 -1.169 . . . . 0.0 109.811 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.43 91.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -104.62 -1.07 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.814 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -154.76 131.37 10.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.06 -170.2 1.87 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.576 -1.327 . . . . 0.0 110.88 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.06 132.3 65.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -86.87 130.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -126.94 144.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.091 0.948 . . . . 0.0 110.964 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.2 mtt -145.12 151.28 38.23 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -131.24 130.13 42.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.142 . . . . 0.0 111.153 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.0 t -109.31 118.43 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 154.75 39.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.978 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.02 -165.8 0.13 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.67 155.49 35.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.934 -1.104 . . . . 0.0 108.826 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -58.73 139.45 56.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.102 -0.999 . . . . 0.0 109.589 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.22 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -128.49 143.3 50.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.575 -0.956 . . . . 0.0 108.936 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -120.39 140.46 51.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.437 -0.789 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.64 142.12 28.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 109.944 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -68.99 137.78 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.44 -0.787 . . . . 0.0 109.347 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.26 96.82 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.581 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.05 -46.32 89.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.772 -1.428 . . . . 0.0 109.512 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.41 -24.69 63.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -72.6 -56.54 5.18 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' MET . 36.0 mt -60.11 -45.06 94.23 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.955 -1.09 . . . . 0.0 110.301 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.03 -45.99 90.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 111.518 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.4 p -63.47 -43.17 98.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.88 -1.138 . . . . 0.0 110.192 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.15 -47.14 93.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 110.202 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.0 -40.07 94.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -68.13 -19.56 64.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.536 -0.728 . . . . 0.0 109.833 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.54 7.85 11.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 109.693 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.85 9.39 84.54 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -79.76 147.6 31.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.386 . . . . 0.0 109.266 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 88.9 mt -122.91 134.37 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.98 102.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.253 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.44 168.09 29.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.53 -162.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.195 -1.179 . . . . 0.0 109.186 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.7 mtt 59.92 20.15 9.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.81 -0.557 . . . . 0.0 110.609 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.6 m120 52.35 33.19 12.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.129 -0.982 . . . . 0.0 111.362 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 12.2 pt -139.61 155.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.008 -1.058 . . . . 0.0 108.483 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -88.02 120.19 29.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.883 -1.136 . . . . 0.0 110.019 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 52.7 m-70 -105.41 127.14 52.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.638 -0.664 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 47' ' ' ARG . 15.4 ttt-85 -101.82 128.87 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -93.84 175.74 6.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.44 -49.97 68.75 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.167 -0.958 . . . . 0.0 108.53 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 55.2 m -92.65 149.24 37.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -71.34 -2.19 10.84 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.695 0.93 . . . . 0.0 111.644 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.01 -2.78 52.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.933 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.68 85.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.8 p -69.95 -40.0 75.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -1.184 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.58 171.51 54.05 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.49 177.23 7.0 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.04 1.16 . . . . 0.0 111.306 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.58 122.25 26.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 108.925 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -101.06 -47.58 4.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 163.08 33.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.123 -0.986 . . . . 0.0 108.526 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.489 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.2 m -136.15 -177.01 4.51 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.125 -0.984 . . . . 0.0 111.842 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -136.79 130.37 31.81 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.47 0.652 . . . . 0.0 109.43 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.48 160.54 33.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 93.8 m-20 -75.06 157.89 34.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.317 -0.865 . . . . 0.0 110.674 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.6 mtp -69.94 -22.19 63.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 65' ' ' VAL . 10.3 p -87.04 120.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.88 151.3 64.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 110.07 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.38 15.7 7.25 Favored 'Cis proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.042 -1.232 . . . . 0.0 112.344 -1.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.94 18.61 80.17 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.9 p -87.88 175.61 7.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -1.158 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.563 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 40.4 m-85 -125.31 156.4 38.72 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 73' ' ' GLU . 39.4 m-20 -140.02 147.24 49.96 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 121.175 -0.953 . . . . 0.0 110.676 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -47.56 -11.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.36 0.807 . . . . 0.0 110.806 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 71' ' ' ASP . 44.5 mp0 -85.56 22.37 1.59 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 29' ' ' LEU . 41.1 mtm -73.57 -0.1 14.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.0 mttm -88.13 -1.45 58.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.005 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.2 m-20 -151.23 74.78 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.725 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -160.05 164.61 33.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.01 -1.056 . . . . 0.0 109.544 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.5 p -139.11 155.88 47.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.62 149.02 16.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.826 -1.172 . . . . 0.0 109.353 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.85 -36.42 95.43 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.412 0.741 . . . . 0.0 111.812 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.43 -157.1 15.06 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 61' ' ' LEU . 30.8 m -130.02 158.8 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.697 -0.884 . . . . 0.0 109.114 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.8 m -110.03 118.3 36.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 109.842 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 94.5 mt -100.56 130.04 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.98 168.97 20.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.898 -1.126 . . . . 0.0 111.021 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 ttp -141.28 135.24 30.41 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -88.32 108.62 19.42 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 88' ' ' VAL . 3.8 p -97.41 141.36 22.9 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.53 135.25 34.39 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.498 0.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.594 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.0 m -105.32 168.52 9.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.394 -0.816 . . . . 0.0 109.289 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -69.98 149.96 47.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.97 -157.63 32.37 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.71 117.84 31.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -1.079 . . . . 0.0 109.575 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 90' ' ' SER . 57.8 mm-40 -57.6 -28.38 63.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.3 mt -69.91 -38.14 76.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 109.247 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.86 -40.0 76.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.522 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.6 m-20 -61.39 -40.55 94.77 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.3 t80 -59.21 -48.38 81.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.27 -46.45 89.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 108.94 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.29 -40.1 95.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.98 -46.68 88.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.023 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' A' ' 98' ' ' PHE . 90.4 mt -65.54 -45.04 84.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.519 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.2 mm-40 -60.03 -40.23 88.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.164 -0.96 . . . . 0.0 108.448 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 p -70.02 -40.52 75.14 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.67 7.62 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.456 -0.777 . . . . 0.0 109.561 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -61.02 -40.89 95.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 57.4 m170 -60.63 -50.38 73.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.054 -1.029 . . . . 0.0 108.912 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.9 -50.09 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.71 -49.0 63.34 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.95 -40.02 87.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 110.227 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.89 -40.01 75.91 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.148 -0.97 . . . . 0.0 110.958 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.34 0.79 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.06 -1.025 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.04 21.52 76.94 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.52 50.39 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.01 136.43 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.602 -0.94 . . . . 0.0 108.916 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.03 135.05 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 109.938 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -134.85 160.21 38.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.356 -0.84 . . . . 0.0 109.425 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -86.41 -174.85 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.38 -0.825 . . . . 0.0 109.115 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.5 m-20 -60.04 -36.02 76.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.357 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -77.25 12.76 1.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 109.103 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 40.8 mtm-85 55.91 39.54 30.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.741 -0.6 . . . . 0.0 109.853 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -117.69 153.22 33.72 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.6 mmm -50.46 130.03 23.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 75.4 mmm -60.08 139.81 57.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.518 -0.739 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -134.45 151.21 75.74 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -43.98 -46.84 10.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.873 1.049 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -60.08 -39.99 88.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.1 -39.97 82.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 110.287 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.43 -40.04 85.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.949 -1.094 . . . . 0.0 108.603 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 130' ' ' ARG . 35.1 ttt-85 -63.64 -39.59 94.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.591 -0.693 . . . . 0.0 109.431 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.62 -46.97 87.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -59.86 -41.55 91.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -62.6 -40.13 95.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.83 -41.0 94.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.08 -43.3 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 108.891 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.97 -47.46 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.538 -0.727 . . . . 0.0 109.361 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.3 mtt180 -61.06 -39.9 91.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.11 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.441 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 51.5 mt-10 -60.48 -40.06 89.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.213 -0.93 . . . . 0.0 110.971 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 88' ' ' VAL . 62.6 t -70.52 -34.04 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.062 -1.024 . . . . 0.0 110.794 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 144' ' ' ALA . 98.1 mttt -60.01 -44.45 94.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.538 -1.352 . . . . 0.0 110.571 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.17 -31.08 69.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.924 -1.11 . . . . 0.0 109.566 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.96 95.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 109.671 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -104.76 -3.86 23.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.764 . . . . 0.0 109.679 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -150.86 149.25 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -163.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 109.675 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.54 130.45 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mm -93.33 122.87 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.429 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.7 mt -119.18 151.34 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.26 1.029 . . . . 0.0 111.77 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.2 mtt -148.25 158.66 44.22 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -141.46 127.33 19.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.747 -1.221 . . . . 0.0 111.066 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.97 118.72 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 157.93 43.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.955 -1.091 . . . . 0.0 110.484 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -175.32 1.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.507 -0.745 . . . . 0.0 109.346 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -65.55 158.38 27.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -59.29 143.35 49.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.145 -0.972 . . . . 0.0 109.42 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.53 77.26 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -129.98 140.23 50.93 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.973 . . . . 0.0 109.355 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -127.69 148.6 50.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.494 -0.754 . . . . 0.0 109.21 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 112' ' ' VAL . 74.4 mt -87.64 142.73 27.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.927 . . . . 0.0 110.151 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.76 145.58 54.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.19 98.23 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.728 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -61.71 -46.8 88.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.318 . . . . 0.0 109.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.87 -28.81 65.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.9 tt -73.08 -58.75 3.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.358 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 74' ' ' MET . 97.5 mt -60.27 -44.28 95.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.36 -44.13 97.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 110.802 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 m -60.54 -40.2 90.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.813 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.96 -47.63 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.38 -40.11 95.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.263 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -66.63 -20.58 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.0 111.022 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.505 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -82.12 -9.47 59.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.731 -1.231 . . . . 0.0 110.506 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.524 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 110.0 7.06 27.56 Favored Glycine 0 N--CA 1.503 3.126 0 O-C-N 121.125 -0.984 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.689 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 35.7 m-85 -78.04 150.89 33.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.775 -1.427 . . . . 0.0 110.105 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.3 mt -126.39 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.84 110.63 1.6 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 110.191 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -100.09 171.89 23.93 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -63.78 -163.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 109.033 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.7 mtp 57.19 19.81 5.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.0 109.816 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 50.71 39.06 20.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.69 -0.631 . . . . 0.0 111.485 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.05 167.02 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.013 -1.054 . . . . 0.0 108.176 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.07 121.47 35.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.976 -1.077 . . . . 0.0 111.035 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.457 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 66.6 m-70 -110.2 130.27 55.57 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.625 -0.672 . . . . 0.0 109.207 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.689 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 37.6 ttm180 -103.8 132.87 49.65 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.78 -1.2 . . . . 0.0 108.643 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.55 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 84.1 m-70 -95.74 169.8 9.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 109.684 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.8 tp -55.98 -51.15 68.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 108.938 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -92.93 145.94 31.11 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.48 -2.29 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.715 0.943 . . . . 0.0 111.839 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.65 -2.56 51.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.86 86.61 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.024 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -70.01 -40.57 75.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.001 -1.293 . . . . 0.0 109.311 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.55 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -82.56 168.03 47.37 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.28 174.86 9.33 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.433 1.422 . . . . 0.0 112.019 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.12 126.3 30.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 108.854 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.9 mp -99.82 -39.92 7.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.106 -0.996 . . . . 0.0 109.532 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -149.39 165.45 32.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 108.617 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 m -133.32 -179.91 5.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.201 -0.937 . . . . 0.0 111.333 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.5 tt -136.95 134.58 36.87 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.659 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.14 163.6 29.55 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.732 -0.605 . . . . 0.0 109.74 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 89.5 m-20 -77.02 164.77 25.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.527 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.6 mmm -69.94 -28.0 65.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.2 p -89.94 121.53 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.102 -0.999 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -60.95 152.82 68.71 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.687 -0.633 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.93 5.02 19.43 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.377 -0.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.88 19.2 70.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.395 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.0 p -86.36 165.12 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -1.21 . . . . 0.0 109.671 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 82.5 m-85 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.627 -0.67 . . . . 0.0 109.638 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' A' ' 74' ' ' MET . 90.7 m-20 -120.83 151.19 54.32 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -50.59 -12.55 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 CA-C-N 119.553 0.876 . . . . 0.0 112.178 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -88.9 4.36 48.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.474 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 72.5 mmm -81.71 16.86 1.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 44.7 mmtm -88.23 -4.72 58.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.004 -1.06 . . . . 0.0 108.584 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 78.2 m-20 -148.57 79.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.26 171.02 20.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.0 109.218 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.7 p -135.34 150.3 49.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.375 -0.828 . . . . 0.0 109.043 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.27 150.86 23.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.34 -44.08 20.77 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 120.529 0.82 . . . . 0.0 111.861 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.97 -154.56 12.1 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -129.97 160.51 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.688 -0.889 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.2 m -112.81 127.96 56.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.677 0.751 . . . . 0.0 110.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -111.34 130.06 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.27 169.71 19.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.701 -1.249 . . . . 0.0 110.245 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.2 ttp -137.52 132.39 33.15 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.415 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.6 mt-30 -91.1 118.76 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.023 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.26 150.37 37.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.37 136.17 43.24 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 123.724 -1.365 . . . . 0.0 111.964 0.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 35.3 m -106.6 159.45 16.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.515 -0.74 . . . . 0.0 110.601 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -73.53 146.56 44.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 0.0 109.294 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.74 -160.9 29.18 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.93 111.55 23.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.173 . . . . 0.0 109.422 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.48 -25.0 22.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.364 -0.835 . . . . 0.0 108.777 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.51 -40.14 73.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.095 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.88 -40.0 72.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.536 HD22 HD23 ' A' ' 58' ' ' LEU . 66.1 m-20 -60.62 -40.01 90.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.8 t80 -58.64 -43.54 89.78 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.614 -0.679 . . . . 0.0 109.283 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.48 -41.7 96.31 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.366 -0.833 . . . . 0.0 109.66 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.94 -41.07 95.54 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 109.097 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.3 mtp -58.54 -48.61 80.29 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.45 -0.781 . . . . 0.0 108.989 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 98' ' ' PHE . 96.2 mt -64.34 -47.66 78.5 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.482 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.5 -40.79 92.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 108.978 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.8 p -70.04 -40.82 74.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.02 -59.48 5.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.805 -0.559 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.97 -38.07 84.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 110.01 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.06 -46.54 89.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.825 -1.172 . . . . 0.0 109.049 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.15 -48.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 108.592 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.27 -50.01 40.92 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.47 -39.92 89.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.676 -0.64 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.02 -40.82 74.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.166 -0.959 . . . . 0.0 111.453 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 23' ' ' LEU . 12.3 m -101.87 3.39 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.083 -1.011 . . . . 0.0 109.978 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.01 29.53 75.18 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.22 46.51 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.9 138.54 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.694 -0.886 . . . . 0.0 108.843 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.05 135.66 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.963 -1.086 . . . . 0.0 109.58 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.0 mt -133.51 155.24 49.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.309 -0.87 . . . . 0.0 109.6 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -84.23 -170.2 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.454 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.3 m-20 -61.94 -33.28 73.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 109.89 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -78.07 10.43 2.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.202 -0.936 . . . . 0.0 108.62 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.579 HH11 ' HG2' ' A' ' 121' ' ' ARG . 10.7 mtt-85 59.67 40.44 19.94 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.494 0.664 . . . . 0.0 109.292 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -124.64 153.8 41.71 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.4 mtp -50.86 126.46 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.1 mtp -60.04 140.07 57.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -127.66 150.38 72.9 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -40.75 -47.42 4.69 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.83 1.02 . . . . 0.0 112.604 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.05 -39.84 87.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.391 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -65.71 -42.13 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.153 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.02 -40.44 89.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 108.833 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -63.65 -38.66 91.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.457 -0.777 . . . . 0.0 109.399 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -60.05 -46.64 88.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -59.99 -40.07 87.91 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.553 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.64 -40.01 93.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.95 -40.84 97.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.85 -40.52 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.39 -45.09 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.691 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -62.48 -36.74 83.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.173 . . . . 0.0 110.124 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.426 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.02 -44.29 94.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.166 -0.959 . . . . 0.0 110.94 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 139' ' ' VAL . 16.6 m -74.8 -30.81 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.969 -1.082 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.69 -39.86 85.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.956 -1.09 . . . . 0.0 111.003 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.03 -29.72 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.559 -1.338 . . . . 0.0 109.002 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.72 95.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.714 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -101.03 -27.83 13.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.204 -0.935 . . . . 0.0 109.817 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.594 -179.783 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.9 mttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.9 145.99 28.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.33 169.09 21.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.74 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -115.8 130.35 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mm -92.16 129.07 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.3 mt -124.22 143.95 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.832 0.825 . . . . 0.0 110.461 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.0 mtt -142.96 149.46 38.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -132.26 128.59 38.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.977 -1.077 . . . . 0.0 111.187 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.97 119.73 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.16 157.93 43.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.56 -176.04 2.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -63.15 147.34 51.14 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.092 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 4.5 p80 -51.57 147.22 6.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.01 78.38 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -131.54 149.99 52.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.586 -0.95 . . . . 0.0 109.595 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -127.59 150.0 49.91 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.2 mt -84.26 141.97 30.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -0.975 . . . . 0.0 109.673 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -66.27 140.04 58.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.256 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.49 95.88 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.771 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.07 -47.72 83.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.967 -1.313 . . . . 0.0 110.246 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.71 -29.96 67.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 108.991 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -71.51 -59.74 2.6 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.9 -45.88 91.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -60.09 -42.25 94.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 109.998 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 t -64.08 -40.3 95.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 0.0 109.494 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.11 -45.33 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.089 -1.007 . . . . 0.0 109.221 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.68 -39.96 95.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.279 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -65.91 -21.95 66.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.17 7.89 10.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.358 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.11 15.46 78.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.048 -1.072 . . . . 0.0 110.894 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -81.63 150.08 28.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.896 -1.355 . . . . 0.0 109.504 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.9 mt -119.98 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.9 103.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -0.924 . . . . 0.0 109.595 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.0 170.78 34.94 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -163.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 59.4 22.97 11.46 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.431 0.634 . . . . 0.0 110.202 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 50.96 36.15 14.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.751 . . . . 0.0 111.153 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.96 161.33 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.127 -0.983 . . . . 0.0 109.297 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -90.88 134.2 34.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.51 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 39.8 m-70 -123.02 127.86 49.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.803 -0.561 . . . . 0.0 109.505 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.4 ttt180 -100.0 123.92 44.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 25.9 m-70 -93.36 170.09 9.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.742 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.95 -51.74 66.63 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.369 -0.832 . . . . 0.0 108.92 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -97.59 148.89 35.09 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.0 108.855 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.69 -4.22 11.76 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.546 0.831 . . . . 0.0 111.611 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.14 -1.6 57.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.68 14.17 82.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -68.61 -44.21 74.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -1.198 . . . . 0.0 109.332 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.17 162.35 44.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -69.61 -176.68 1.52 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.587 1.194 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.22 127.45 33.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 109.438 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.4 mp -99.16 -39.33 8.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.203 -0.936 . . . . 0.0 108.696 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -149.38 154.37 38.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 29.9 m -129.97 170.48 13.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.263 -0.898 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -126.36 134.52 51.05 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.574 0.702 . . . . 0.0 109.493 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.64 161.81 33.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.543 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.0 m-20 -73.91 160.82 30.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.008 -1.057 . . . . 0.0 110.189 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.8 mmm -69.23 -22.03 63.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.0 110.013 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.29 120.59 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.208 -0.932 . . . . 0.0 110.048 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -60.67 150.91 73.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.53 8.26 11.87 Favored 'Cis proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.317 -0.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.55 79.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.7 p -87.74 171.06 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.249 -1.147 . . . . 0.0 109.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 88.4 m-85 -120.73 161.53 21.28 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.288 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t70 -136.65 137.63 24.24 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -45.19 -12.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 120.12 1.079 . . . . 0.0 111.802 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.8 mt-10 -85.19 12.88 7.09 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.2 ptt? -80.89 9.87 5.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.295 0.569 . . . . 0.0 109.578 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -84.39 -6.72 59.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.41 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 74.1 m-20 -150.16 75.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -0.847 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -155.78 169.99 23.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 108.849 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -133.88 153.63 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.325 -0.859 . . . . 0.0 109.136 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 148.62 19.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 109.182 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -47.43 -53.64 6.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 120.524 0.816 . . . . 0.0 111.646 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.24 -154.0 8.04 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.49 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.685 -0.891 . . . . 0.0 109.03 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 m -112.0 120.13 40.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.824 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.8 mt -105.03 130.05 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.8 170.0 17.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 34.8 ttm -138.94 129.8 26.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -90.09 112.63 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.4 142.33 24.39 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 88' ' ' VAL . 8.9 Cg_endo -76.49 138.92 57.18 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 124.022 -1.241 . . . . 0.0 112.927 0.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -114.05 164.72 13.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.337 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -71.12 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.52 -165.71 39.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -94.9 117.77 30.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -1.115 . . . . 0.0 108.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -55.71 -29.48 59.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.432 -0.792 . . . . 0.0 109.621 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.43 -39.97 77.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.236 -0.915 . . . . 0.0 108.947 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.19 -39.99 74.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.917 -1.115 . . . . 0.0 108.557 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.604 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.9 m-20 -61.38 -40.07 92.97 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE2' HD11 ' A' ' 102' ' ' LEU . 84.7 t80 -58.2 -42.95 87.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.93 -44.84 95.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 108.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.53 -39.99 93.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.8 mmm -57.56 -50.05 74.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.5 mt -66.83 -44.27 81.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.975 . . . . 0.0 109.421 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.469 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -59.99 -40.52 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.948 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 p -70.18 -41.84 73.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.64 7.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.819 . . . . 0.0 110.146 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.8 m-70 -60.08 -50.03 75.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.082 . . . . 0.0 109.235 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.98 -50.02 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.176 -0.953 . . . . 0.0 109.561 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.05 -50.58 58.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 110.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.98 -39.97 75.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.956 . . . . 0.0 111.076 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 m -98.86 -0.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.044 . . . . 0.0 109.509 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.47 23.9 77.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.48 -170.7 47.41 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.4 t -134.5 139.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -1.027 . . . . 0.0 109.337 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.5 133.57 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.44 154.8 49.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 25.6 p-10 -84.86 -174.86 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.8 m-20 -59.93 -36.96 78.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 109.252 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.501 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.1 mt-30 -77.4 16.87 0.56 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.396 -0.815 . . . . 0.0 109.31 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.2 mtt180 60.07 20.81 10.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.967 -0.458 . . . . 0.0 111.0 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.542 ' NH2' ' NZ ' ' A' ' 128' ' ' LYS . 34.4 mtm-85 -106.18 147.63 28.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.209 -0.932 . . . . 0.0 108.518 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.96 137.14 21.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.161 -0.962 . . . . 0.0 110.542 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.9 mtt -59.93 144.22 49.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.623 -0.673 . . . . 0.0 110.327 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 5.6 p -132.94 152.23 79.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -42.09 -47.69 6.7 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 120.639 0.893 . . . . 0.0 112.074 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.401 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 27.7 mp0 -60.85 -43.22 98.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.542 ' NZ ' ' NH2' ' A' ' 122' ' ' ARG . 98.4 mttt -67.29 -39.97 86.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 110.218 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.93 -39.93 87.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.997 -1.064 . . . . 0.0 108.275 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -67.8 -38.59 83.5 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.684 -0.635 . . . . 0.0 109.909 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -59.75 -46.07 90.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.73 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -60.06 -41.08 91.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.044 . . . . 0.0 108.239 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.5 -39.99 95.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.558 -0.714 . . . . 0.0 109.125 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.04 -40.03 92.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.511 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -43.45 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 108.769 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.98 -42.08 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 137' ' ' ARG . 49.3 mtt-85 -62.23 -39.85 94.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 74.9 mm-40 -60.02 -39.97 87.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.107 -0.995 . . . . 0.0 109.35 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.19 -27.96 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 mmtt -60.04 -45.3 93.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.0 110.173 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.95 -31.06 70.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.309 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.63 96.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 46.4 p-10 -105.31 -3.3 22.93 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.29 -0.881 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.8 mttt . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.6 149.55 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.46 162.59 27.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 109.69 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.32 130.67 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 0.0 109.145 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mm -90.82 132.49 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.9 mt -129.93 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 122.279 1.038 . . . . 0.0 111.344 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.3 mtt -142.87 151.66 41.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -131.55 121.71 24.89 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.833 -1.167 . . . . 0.0 111.113 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.1 t -99.71 110.01 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.54 159.79 42.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.11 -166.3 0.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.11 159.96 32.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -58.38 145.14 39.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.45 10.26 82.22 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -130.06 147.52 51.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -1.043 . . . . 0.0 109.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.71 145.75 50.8 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 17' ' ' ALA . 58.7 mt -85.19 147.68 26.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.777 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.14 142.98 55.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.024 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.31 99.36 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.918 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.33 -43.74 98.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.374 . . . . 0.0 109.835 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.94 -28.51 65.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.1 tt -71.04 -59.58 2.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.16 -39.95 88.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.6 p -66.45 -39.82 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 109.968 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.87 -49.94 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -62.16 -40.0 94.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.956 -1.09 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.81 -22.88 66.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.99 7.72 12.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.029 -1.045 . . . . 0.0 110.266 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.58 75.98 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.138 -0.976 . . . . 0.0 111.118 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.78 150.01 26.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.323 . . . . 0.0 110.051 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.78 132.39 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.62 100.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.908 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.34 171.72 32.56 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.76 -161.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -1.156 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 98.0 mtp 60.0 20.55 9.65 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.51 0.671 . . . . 0.0 109.914 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 m120 51.93 33.56 11.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.567 -0.708 . . . . 0.0 111.565 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 pt -141.65 168.13 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.0 109.189 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.06 121.5 33.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.459 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 63.3 m-70 -106.51 130.03 54.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.784 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 7.2 ttt-85 -102.8 126.89 50.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.274 -0.892 . . . . 0.0 109.184 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 28.5 m-70 -97.35 170.92 8.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.0 -49.99 74.08 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -91.36 145.72 31.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 -2.72 9.4 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.668 0.912 . . . . 0.0 111.833 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.54 -3.68 52.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 109.85 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.0 9.78 86.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -70.9 -42.61 69.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.294 . . . . 0.0 110.229 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.01 164.99 54.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -68.4 175.12 7.28 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.997 1.131 . . . . 0.0 111.374 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.8 121.84 26.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.004 . . . . 0.0 109.323 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -97.68 -38.1 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.207 -0.933 . . . . 0.0 108.741 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.57 167.52 29.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 67.5 m -137.33 -179.08 5.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 111.173 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -136.51 131.65 34.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.538 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 160.29 34.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 109.543 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.59 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 94.0 m-20 -74.5 159.45 32.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.03 -21.32 63.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 110.177 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.15 121.24 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.056 -1.028 . . . . 0.0 109.901 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -60.69 150.66 74.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 109.189 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.34 12.21 20.22 Favored 'Cis proline' 0 N--CA 1.494 1.526 0 C-N-CA 123.584 -1.423 . . . . 0.0 111.723 -0.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 19.03 67.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.6 167.18 14.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.285 -1.127 . . . . 0.0 110.443 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 88.7 m-85 -122.39 141.87 51.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.573 -0.705 . . . . 0.0 109.484 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' GLU . 47.8 m-20 -128.79 150.0 73.76 Favored Pre-proline 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.68 -6.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.548 0.874 . . . . 0.0 111.778 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' ASP . 97.2 mt-10 -89.32 0.22 56.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.433 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 65.8 mmm -85.33 13.68 6.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.46 -0.775 . . . . 0.0 109.585 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -85.42 -8.6 58.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.164 . . . . 0.0 108.75 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -150.76 79.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -155.8 174.14 15.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.1 p -129.84 150.28 51.21 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.28 150.22 19.5 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.156 -0.965 . . . . 0.0 109.095 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -44.76 -43.61 14.69 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 120.415 0.743 . . . . 0.0 111.619 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -149.54 10.9 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 159.95 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.985 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -113.22 120.88 42.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 109.537 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.0 mt -103.03 130.5 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -145.85 170.6 16.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.936 -1.102 . . . . 0.0 110.496 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -138.45 130.68 28.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.35 123.91 33.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 9' ' ' ALA . 4.4 m -102.26 148.81 35.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.857 . . . . 0.0 109.016 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.42 141.93 72.76 Favored 'Cis proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.94 -1.275 . . . . 0.0 111.87 -1.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -107.0 155.72 19.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.971 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 92' ' ' GLY . 64.7 t80 -72.33 155.3 40.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 109.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CD2' ' A' ' 91' ' ' TYR . . . 80.75 -157.85 40.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -97.49 118.05 33.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -1.095 . . . . 0.0 109.076 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.38 -32.9 70.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.583 -0.698 . . . . 0.0 110.432 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.1 mt -69.9 -40.07 75.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.931 -1.106 . . . . 0.0 109.973 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -71.64 -40.02 70.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.923 -1.111 . . . . 0.0 108.361 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -61.9 -39.83 93.34 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.891 0.853 . . . . 0.0 108.811 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 64.8 t80 -59.51 -50.0 75.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -62.42 -39.94 94.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.01 -41.92 93.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.27 -46.06 89.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.375 -0.828 . . . . 0.0 109.473 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.17 -41.4 98.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.015 -1.053 . . . . 0.0 108.764 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.349 -0.844 . . . . 0.0 108.803 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 p -71.76 -40.25 69.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.9 67.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.58 -35.64 80.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 109.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -60.09 -45.84 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.074 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.27 -49.9 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 108.948 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.61 -49.7 55.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.51 -0.744 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.55 -39.98 89.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.18 -40.08 78.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.319 -0.863 . . . . 0.0 110.909 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 114' ' ' GLY . 10.3 m -103.14 0.02 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.99 22.93 77.29 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -85.66 -171.24 47.89 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.06 141.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.988 . . . . 0.0 109.561 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.76 130.04 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 108.985 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' ' SD ' ' A' ' 124' ' ' MET . 76.0 mt -132.0 159.97 37.2 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' N ' ' SD ' ' A' ' 124' ' ' MET . 35.7 p-10 -85.31 -172.59 4.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -59.97 -37.94 81.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.986 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -76.95 14.02 0.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 108.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.7 mtt180 55.91 32.81 20.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.732 -0.605 . . . . 0.0 109.526 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.54 156.58 19.34 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.9 mmm -50.92 133.97 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 117' ' ' LEU . 96.5 mmm -58.27 139.91 54.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.742 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 p -129.4 148.71 70.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -49.96 -43.76 40.2 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 119.43 0.832 . . . . 0.0 111.947 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.42 -40.1 89.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.76 -39.95 91.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.049 -1.032 . . . . 0.0 109.878 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.98 -40.05 87.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 108.675 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.63 -39.22 91.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.06 -46.37 88.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -59.98 -46.31 89.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.564 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 37.4 mm-40 -60.01 -39.98 87.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.396 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.95 -41.64 92.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.69 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.6 mt -63.36 -43.64 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.741 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.08 -44.96 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.803 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.474 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.1 mmt180 -60.03 -39.93 87.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 96.2 mt-10 -60.17 -38.63 83.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.529 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 88' ' ' VAL . 75.0 t -66.42 -39.73 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 110.537 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.8 mttt -59.88 -50.08 75.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.887 -1.133 . . . . 0.0 110.889 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 2.1 p-10 -62.38 -36.99 84.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.822 -1.174 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.42 99.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.305 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -102.27 -0.76 32.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.22 -0.925 . . . . 0.0 109.783 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 109.526 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -148.89 142.02 24.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.87 171.91 17.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 109.607 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.63 129.92 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.07 129.94 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.3 mt -128.72 146.12 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.083 0.944 . . . . 0.0 110.775 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -145.76 151.09 37.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.405 ' OD1' ' SD ' ' A' ' 64' ' ' MET . 67.3 m-80 -136.86 130.28 31.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.647 -1.283 . . . . 0.0 111.244 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.25 129.96 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.74 159.9 41.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 110.577 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.39 -172.47 1.46 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -65.96 155.99 34.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.839 -1.163 . . . . 0.0 108.298 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -55.53 133.1 50.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.128 . . . . 0.0 109.636 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.29 5.8 75.49 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.5 m -127.04 153.69 45.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.478 -1.013 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.98 153.67 45.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.533 -0.73 . . . . 0.0 109.083 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.87 138.37 32.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.989 . . . . 0.0 109.693 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -69.75 145.19 52.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.14 -42.97 98.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.1 -46.66 89.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -1.191 . . . . 0.0 109.906 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.73 -28.48 65.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.1 tt -71.7 -57.31 4.48 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.593 -0.692 . . . . 0.0 109.549 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.97 -46.12 90.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.045 . . . . 0.0 110.824 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -64.79 -41.36 95.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.002 -1.062 . . . . 0.0 111.067 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 m -63.03 -39.99 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.027 -1.046 . . . . 0.0 110.098 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.12 -49.82 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 110.695 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -63.26 -40.06 96.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.926 -1.109 . . . . 0.0 109.806 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -61.65 -23.62 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 110.761 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.616 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.32 -8.69 59.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.831 -1.168 . . . . 0.0 110.614 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 109.37 9.96 24.55 Favored Glycine 0 N--CA 1.503 3.105 0 O-C-N 121.01 -1.056 . . . . 0.0 110.845 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.768 ' N ' HH21 ' A' ' 47' ' ' ARG . 30.0 m-85 -79.89 148.95 31.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.683 -1.481 . . . . 0.0 109.972 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.6 133.56 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.24 105.69 0.53 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 110.265 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.472 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -94.59 171.38 30.48 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.45 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.125 -1.221 . . . . 0.0 110.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.9 mtt 59.96 22.68 11.77 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.406 0.622 . . . . 0.0 110.198 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.1 m120 52.57 36.21 19.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 111.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.08 161.6 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.995 -1.066 . . . . 0.0 108.572 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.08 120.94 33.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.064 -1.022 . . . . 0.0 110.677 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.472 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 68.3 m-70 -106.79 131.5 53.83 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 37' ' ' PHE . 32.6 ttm180 -104.5 130.22 52.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.006 -1.059 . . . . 0.0 108.497 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -100.15 169.42 9.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.844 . . . . 0.0 109.979 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.1 tp -57.06 -50.0 74.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -89.91 148.32 39.41 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.49 -4.45 15.02 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.597 0.865 . . . . 0.0 111.83 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -94.96 -0.17 54.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.187 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 9.05 87.2 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -69.91 -40.4 75.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -1.187 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.49 166.01 52.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.63 175.03 7.63 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 120.916 1.078 . . . . 0.0 111.737 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.408 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.35 123.36 29.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.84 -37.14 9.18 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.09 161.93 41.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 108.672 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -134.44 -177.97 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.859 0.838 . . . . 0.0 110.844 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.4 tt -136.66 130.85 32.8 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.82 162.67 30.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.695 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.6 m-20 -78.49 164.9 24.34 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.045 -1.034 . . . . 0.0 110.547 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 14' ' ' ASN . 89.8 mmm -70.03 -22.61 63.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 0.0 110.461 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 94.2 t -86.95 119.24 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.978 -1.076 . . . . 0.0 110.115 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.91 147.72 78.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.151 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.64 14.56 6.93 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.552 -1.437 . . . . 0.0 111.842 -0.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 72.13 17.75 77.47 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 p -87.29 175.92 7.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -1.229 . . . . 0.0 109.728 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.695 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 80.1 m-85 -119.59 147.9 43.95 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 0.0 109.52 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 27.0 m-20 -134.0 150.2 73.72 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -46.66 -8.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.641 0.894 . . . . 0.0 112.306 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.7 mt-10 -85.66 10.36 13.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.74 -1.29 53.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.766 -0.584 . . . . 0.0 109.87 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.7 mttp -84.3 -6.78 59.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.5 m-20 -150.1 78.01 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -162.31 171.39 17.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.842 -1.161 . . . . 0.0 109.814 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.8 p -131.86 156.99 45.1 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.04 18.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.024 -1.048 . . . . 0.0 109.141 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 -24.36 54.05 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 120.515 0.81 . . . . 0.0 111.89 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.4 -164.02 36.27 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.731 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.11 166.52 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.751 -0.852 . . . . 0.0 108.735 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -119.89 129.97 54.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.532 -0.73 . . . . 0.0 110.387 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.52 128.96 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.72 164.08 32.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.001 -1.062 . . . . 0.0 110.827 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.7 ttm -132.19 130.22 40.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -88.73 105.35 17.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 88' ' ' VAL . 15.3 m -97.38 148.72 34.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.82 134.43 35.74 Favored 'Cis proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.364 0.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -105.56 159.89 15.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.07 145.49 49.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.339 -0.851 . . . . 0.0 109.214 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.31 -161.55 23.29 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.25 108.96 21.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.013 -1.286 . . . . 0.0 109.05 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.29 -31.34 65.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.46 -0.775 . . . . 0.0 110.065 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.05 -40.63 74.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.014 . . . . 0.0 110.338 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -77.09 -40.61 45.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.619 -1.3 . . . . 0.0 108.925 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -60.05 -38.09 81.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -58.45 -40.96 84.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -63.68 -40.08 95.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.941 -1.099 . . . . 0.0 108.604 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.56 -39.96 89.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.93 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.8 mtp -58.13 -49.88 75.44 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.537 -0.727 . . . . 0.0 109.36 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 102' ' ' LEU . 89.0 mt -64.53 -45.53 86.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 109.294 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 97.5 mt-30 -60.25 -40.17 89.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 108.445 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' HH12 ' A' ' 47' ' ' ARG . 93.7 p -70.39 -44.0 68.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.57 44.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.517 -0.739 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.096 -1.002 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 47.7 m170 -59.98 -43.66 94.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.0 108.506 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.24 -49.99 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.71 -49.41 68.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.09 -39.97 91.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.9 -40.0 75.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.895 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.17 2.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.018 -1.052 . . . . 0.0 109.532 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 67.13 25.36 73.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -162.67 38.52 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.417 -1.049 . . . . 0.0 110.487 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.59 154.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.646 -0.914 . . . . 0.0 109.203 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.2 t -94.93 129.82 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.426 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.1 mt -122.05 160.08 25.71 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.563 -0.711 . . . . 0.0 110.102 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.11 -171.29 3.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.7 m-20 -60.09 -40.04 88.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 109.697 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -76.23 17.76 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 119' ' ' ASP . 87.1 mtm180 56.2 35.02 25.01 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.468 0.651 . . . . 0.0 109.756 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -110.24 144.2 39.29 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.7 mtp -51.3 129.56 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 108.943 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.2 mtt -59.08 141.19 54.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 110.106 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 p -129.56 150.4 75.58 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -42.5 -45.17 8.26 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.469 0.78 . . . . 0.0 112.237 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.34 -40.01 92.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.188 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.054 -1.029 . . . . 0.0 110.544 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.92 -40.11 83.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.872 . . . . 0.0 108.765 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -65.95 -39.88 90.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.462 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.83 -43.57 94.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 109.839 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -60.14 -44.03 95.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.019 -1.051 . . . . 0.0 108.394 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.72 -40.07 96.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.58 -40.04 93.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.615 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.53 -40.95 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.145 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.67 -38.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 108.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 137' ' ' ARG . 27.2 mtt-85 -59.86 -38.91 83.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.045 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.6 -39.99 90.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.117 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.58 -28.77 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 111.025 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 144' ' ' ALA . 68.5 mttm -60.03 -45.24 93.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.663 -1.273 . . . . 0.0 110.179 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.07 -30.13 69.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.906 -1.121 . . . . 0.0 109.192 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.52 93.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.963 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -100.48 -25.62 14.13 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.354 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -147.5 130.85 16.6 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.3 -166.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.699 -1.251 . . . . 0.0 110.272 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.2 t -140.02 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 95.5 mt -120.0 147.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.281 1.039 . . . . 0.0 111.652 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.0 mtt -146.2 158.82 43.9 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' CG ' ' NH1' ' A' ' 121' ' ' ARG . 66.5 m-80 -141.15 121.77 14.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.658 -1.277 . . . . 0.0 111.457 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.49 113.48 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.42 44.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.82 -169.91 0.51 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.88 157.34 37.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.03 -1.044 . . . . 0.0 109.1 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -60.06 140.13 57.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.709 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.81 2.08 63.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.1 m -127.19 149.7 49.86 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.577 -0.955 . . . . 0.0 109.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -131.18 145.07 51.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.553 -0.717 . . . . 0.0 109.218 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 112' ' ' VAL . 85.3 mt -87.6 146.78 25.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.02 146.42 51.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 108.948 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.45 97.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mm-40 -61.19 -44.1 97.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.338 . . . . 0.0 109.857 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 89.5 mt -69.95 -27.85 65.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.3 tt -76.07 -59.62 2.68 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.71 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -47.93 83.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.288 -0.883 . . . . 0.0 111.579 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.3 p-10 -61.27 -39.99 92.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.894 -1.129 . . . . 0.0 110.342 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 56.5 m -62.21 -40.25 95.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.871 -1.143 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.59 -45.92 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.225 -0.922 . . . . 0.0 109.805 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -60.7 -40.03 90.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.31 -19.87 65.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.911 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.56 8.7 9.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.945 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.89 81.76 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -81.51 151.78 27.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.297 . . . . 0.0 110.113 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.98 139.95 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.62 107.41 0.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 109.572 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.83 171.49 34.52 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.43 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.235 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 72.1 mtm 56.73 26.1 10.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 110.09 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.9 m120 50.03 39.44 19.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 111.293 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 pt -141.67 161.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.5 130.76 37.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.532 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.9 m-70 -117.79 127.97 54.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 47' ' ' ARG . 14.5 ttt-85 -99.99 127.08 46.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.158 -0.964 . . . . 0.0 108.545 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.7 m-70 -95.8 170.05 9.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.492 -0.755 . . . . 0.0 109.701 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -49.99 -53.93 23.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.089 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -90.82 149.23 39.98 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.305 -0.872 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.66 -5.18 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.814 1.009 . . . . 0.0 112.452 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -93.04 0.04 57.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.135 -0.978 . . . . 0.0 110.041 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.1 81.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.4 p -70.0 -40.0 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -1.173 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -85.8 173.52 47.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.404 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 24.0 Cg_endo -73.96 178.4 6.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.37 1.38 . . . . 0.0 111.658 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.64 123.08 27.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.884 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.6 mp -97.38 -47.05 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.157 -0.965 . . . . 0.0 109.03 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -138.08 160.11 40.25 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.532 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.9 m -127.66 178.2 6.29 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.196 0.998 . . . . 0.0 111.694 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.2 tt -138.6 130.07 27.44 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.599 0.714 . . . . 0.0 109.146 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.63 160.11 34.33 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.683 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 8.3 m120 -73.73 161.79 29.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.991 -1.068 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mtp -69.66 -29.96 67.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 110.906 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 65' ' ' VAL . 13.2 p -86.35 131.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.804 -1.185 . . . . 0.0 110.126 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -59.97 150.04 71.17 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -76.91 5.93 18.49 Favored 'Cis proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.552 -0.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.82 83.08 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -88.55 169.97 11.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.101 -1.235 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.683 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 75.3 m-85 -120.05 143.49 48.07 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -119.82 149.99 49.66 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.439 -0.788 . . . . 0.0 108.889 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.3 -20.15 61.23 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 120.498 0.798 . . . . 0.0 112.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.95 -2.71 58.21 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -0.927 . . . . 0.0 109.121 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.439 ' CE ' ' OD1' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -89.24 25.24 1.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.526 -0.734 . . . . 0.0 110.652 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 29.4 mmtm -80.96 0.88 33.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.885 -1.134 . . . . 0.0 109.351 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 91.6 m-20 -142.0 86.77 2.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.96 177.97 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 109.724 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 p -131.73 150.12 52.26 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.56 149.48 19.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 0.0 109.219 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -45.28 -41.44 17.12 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 120.366 0.711 . . . . 0.0 111.393 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.59 -150.79 10.28 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HB ' HD21 ' A' ' 61' ' ' LEU . 23.4 m -130.11 159.98 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.607 -0.937 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 m -114.72 124.88 52.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.87 129.94 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -146.65 149.45 33.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.919 -1.113 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.2 ttm -102.31 133.33 47.4 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.464 -0.772 . . . . 0.0 109.526 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 90' ' ' SER . 94.0 mt-30 -91.07 105.36 17.76 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 16.0 m -97.46 147.21 32.65 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.185 -0.947 . . . . 0.0 108.537 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -74.23 133.64 31.97 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.377 0.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.6 m -105.29 158.85 16.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -72.73 149.9 43.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.732 . . . . 0.0 109.94 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.1 -160.36 34.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.1 116.15 28.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -1.159 . . . . 0.0 108.952 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.55 -31.81 69.76 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 110.219 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.07 -41.47 74.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.155 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -74.29 -39.98 62.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.63 -39.81 89.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 133' ' ' GLN . 55.9 t80 -53.09 -40.06 63.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -59.99 -40.0 87.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.198 -0.939 . . . . 0.0 108.713 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.82 -39.97 93.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 109.177 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mtp -56.61 -50.01 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.156 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.32 -44.7 90.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.91 . . . . 0.0 109.608 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -60.02 -40.84 90.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 108.826 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 p -70.17 -40.04 74.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.418 -0.801 . . . . 0.0 109.711 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.85 52.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.162 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -62.09 -37.2 84.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 0.0 109.971 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -60.12 -47.63 85.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.987 -1.071 . . . . 0.0 109.126 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.11 -49.95 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.78 -47.72 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.69 -40.32 91.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 110.096 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -71.14 -39.99 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 0.0 111.158 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.4 m -101.33 2.33 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.76 23.1 68.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.08 -173.24 45.54 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 134.83 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.606 -0.938 . . . . 0.0 109.136 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.416 HG12 ' SD ' ' A' ' 124' ' ' MET . 16.8 t -70.69 135.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.62 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 mt -132.4 156.19 47.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.459 -0.776 . . . . 0.0 109.732 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -87.89 -173.62 4.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.581 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 95.6 m-20 -60.03 -34.47 73.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.021 . . . . 0.0 108.996 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.34 14.98 0.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 108.961 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' NH1' ' CG ' ' A' ' 14' ' ' ASN . 20.2 mmt180 60.11 24.12 13.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.656 -0.652 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -110.96 150.85 28.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.44 -0.788 . . . . 0.0 109.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.9 mtm -50.52 129.39 22.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.081 -1.012 . . . . 0.0 109.597 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.416 ' SD ' HG12 ' A' ' 116' ' ' VAL . 57.0 mtp -59.93 139.7 57.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -125.6 151.01 69.86 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -40.34 -46.43 4.31 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 120.911 1.074 . . . . 0.0 112.532 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -60.14 -39.99 88.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.616 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.82 -39.73 83.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.188 -0.945 . . . . 0.0 110.341 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.65 -40.53 75.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.973 -1.079 . . . . 0.0 108.128 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 34.3 ttm-85 -65.29 -39.33 92.42 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.84 -46.85 87.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.68 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.581 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 62.0 m-85 -60.13 -42.7 95.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.053 -1.029 . . . . 0.0 108.258 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 98' ' ' PHE . 23.6 mm100 -62.97 -40.1 96.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 95.6 m-20 -61.65 -40.97 96.83 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.419 -0.801 . . . . 0.0 109.838 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -40.05 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.906 -1.121 . . . . 0.0 109.432 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.25 -39.23 81.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 99.1 mtt180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.886 -1.134 . . . . 0.0 111.303 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 15.2 mp0 -60.09 -39.09 84.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.794 -1.191 . . . . 0.0 110.164 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.07 -39.33 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.916 -1.115 . . . . 0.0 110.391 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.96 -50.08 75.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.779 -1.2 . . . . 0.0 110.929 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -60.91 -32.54 72.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.684 -1.26 . . . . 0.0 109.253 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.34 -23.78 67.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 108.826 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -98.74 -2.2 38.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.064 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.465 -179.835 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -99.79 139.16 35.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.07 -175.93 5.55 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.738 -1.226 . . . . 0.0 110.231 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.04 133.32 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.93 135.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.468 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.1 mt -130.73 143.16 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.992 0.901 . . . . 0.0 110.701 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.5 mtm -149.31 152.09 35.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -129.13 130.36 46.34 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.099 -1.0 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.97 113.8 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.09 153.32 38.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.175 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.24 -175.94 1.34 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -60.07 150.52 29.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 108.99 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -59.9 148.27 35.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.04 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.54 -5.57 77.27 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -128.98 142.1 51.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.941 . . . . 0.0 108.894 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -121.93 150.15 42.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.746 . . . . 0.0 109.305 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.27 142.46 29.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.343 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -67.69 141.03 56.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.0 108.795 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.1 96.47 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -62.59 -46.52 87.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.217 . . . . 0.0 109.573 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.1 -29.16 66.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 109.031 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -73.65 -58.92 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.07 -44.11 94.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.64 -40.7 95.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.501 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -64.82 -40.08 94.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.86 -50.26 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.353 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -63.97 -40.07 95.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.05 -20.39 66.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.416 -0.802 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.53 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.47 1.07 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 109.657 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.86 16.84 43.36 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 121.156 -0.965 . . . . 0.0 111.166 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -82.35 152.46 26.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.403 . . . . 0.0 110.242 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.86 134.81 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.12 104.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.067 -1.021 . . . . 0.0 109.996 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -93.63 171.31 31.77 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -65.56 -163.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.249 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.6 mmm 58.7 19.96 7.33 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.643 0.735 . . . . 0.0 109.688 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 51.76 38.19 22.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.526 -0.734 . . . . 0.0 111.898 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 pt -140.56 166.29 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.875 -1.14 . . . . 0.0 108.505 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -92.63 122.58 35.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.829 -1.169 . . . . 0.0 110.201 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.448 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 58.9 m-70 -106.45 127.33 53.21 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.457 -0.777 . . . . 0.0 109.092 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 37.5 ttt180 -103.88 128.71 51.36 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.06 -1.025 . . . . 0.0 109.05 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 64.4 m-70 -98.66 171.41 8.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.33 -0.856 . . . . 0.0 109.733 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.9 -49.68 72.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.8 m -91.15 147.79 36.41 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 109.015 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.45 -7.97 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.747 0.964 . . . . 0.0 111.905 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -91.44 -0.25 57.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 109.974 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.79 12.01 84.9 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.197 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.2 p -70.59 -40.59 73.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.008 -1.289 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.3 167.83 51.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -69.67 170.42 16.51 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 120.934 1.089 . . . . 0.0 111.427 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -78.71 126.2 30.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 109.301 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.0 mp -99.39 -30.72 12.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 109.098 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CB ' ' SD ' ' A' ' 101' ' ' MET . 28.2 p90 -159.15 159.98 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 108.615 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.42 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 17.6 m -129.88 175.88 8.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 110.564 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -133.24 132.45 41.47 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.506 0.669 . . . . 0.0 109.604 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 162.39 28.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 89.2 m-20 -75.28 160.92 29.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.974 -1.078 . . . . 0.0 110.782 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.6 mmm -69.51 -35.27 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.716 -0.615 . . . . 0.0 111.047 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.57 136.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.879 -1.138 . . . . 0.0 110.303 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -58.98 151.94 52.93 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -78.48 4.08 27.88 Favored 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.232 -0.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.31 86.0 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.6 p -85.91 170.32 12.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -1.133 . . . . 0.0 109.633 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 91.3 m-85 -113.99 155.99 24.88 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' GLU . 32.9 m-20 -135.52 148.75 67.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -44.05 -14.37 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.64 0.893 . . . . 0.0 112.498 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mp0 -86.17 16.3 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.5 ptt? -83.78 -4.96 59.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.33 0.586 . . . . 0.0 110.005 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 97.1 mttt -83.34 -4.61 58.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.785 -1.197 . . . . 0.0 109.429 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.4 m-20 -150.03 78.31 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 109.326 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.61 170.48 20.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.984 -1.072 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -131.49 150.74 52.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.65 149.68 20.47 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 0.0 109.19 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.84 -47.15 22.17 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 120.554 0.836 . . . . 0.0 111.916 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.14 -150.38 7.61 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -130.02 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.823 . . . . 0.0 109.886 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.3 m -113.2 122.81 48.61 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.99 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -145.09 150.21 36.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.0 ttm -110.15 135.7 50.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.675 -0.641 . . . . 0.0 109.404 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -91.83 104.02 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 m -98.32 149.04 35.33 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -74.46 137.59 51.05 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.263 0.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 74.3 m -103.35 168.0 9.45 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 0.0 110.541 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 65.3 t80 -72.32 154.6 40.86 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.377 0.608 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 72.85 -146.87 39.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.13 114.87 26.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.298 -1.119 . . . . 0.0 109.057 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -57.77 -31.04 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.928 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.4 ' CD1' HH12 ' A' ' 137' ' ' ARG . 90.2 mt -70.06 -39.8 75.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.67 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -70.29 -36.0 74.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.895 -1.128 . . . . 0.0 108.251 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -59.95 -40.03 87.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 78.2 t80 -59.91 -44.36 94.34 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -63.05 -40.13 96.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.258 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.77 -45.2 94.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.471 ' SD ' ' CB ' ' A' ' 59' ' ' PHE . 20.5 mtm -59.92 -43.57 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.884 -1.135 . . . . 0.0 109.787 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.9 mt -63.88 -40.2 95.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.08 -40.93 91.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.0 109.791 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.1 p -70.48 -40.05 73.87 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 109.429 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.3 70.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.3 -40.44 94.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.872 -1.143 . . . . 0.0 109.206 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.17 -49.36 77.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.29 -49.85 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.253 -0.905 . . . . 0.0 108.724 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.2 -48.98 64.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.673 . . . . 0.0 109.441 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.14 -40.02 88.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.93 -40.07 75.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.4 m -99.98 -0.93 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.99 -1.069 . . . . 0.0 109.838 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.48 20.79 75.76 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -80.57 -178.35 52.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.2 t -130.37 139.8 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.592 -0.946 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.505 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.8 t -74.72 130.78 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.311 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.06 155.79 45.57 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.375 -0.828 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -84.73 -174.91 5.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.465 -0.772 . . . . 0.0 109.963 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.5 m-20 -60.07 -35.12 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -78.53 11.53 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 108.82 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 56.41 38.45 29.71 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -116.08 145.82 42.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.7 mtt -51.16 126.7 17.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 129' ' ' LEU . 45.7 mtt -61.26 151.28 32.19 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.845 0.831 . . . . 0.0 111.195 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.6 p -133.74 149.24 71.39 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -42.43 -50.12 5.84 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 CA-C-N 119.574 0.884 . . . . 0.0 112.628 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -60.29 -40.0 88.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -65.14 -40.87 94.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.155 . . . . 0.0 110.461 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 124' ' ' MET . 87.7 mt -59.84 -40.32 88.13 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 108.485 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 130' ' ' ARG . 19.9 ttt-85 -63.93 -38.54 91.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.686 -0.634 . . . . 0.0 109.664 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.42 -44.85 89.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.989 -1.07 . . . . 0.0 109.815 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.93 -40.13 87.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 108.969 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -59.87 -39.92 86.9 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -38.39 84.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.466 -0.771 . . . . 0.0 109.301 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 139' ' ' VAL . 6.7 mm -56.52 -46.42 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.01 -43.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 137' ' ' ARG . 30.8 mtt-85 -60.08 -40.05 88.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 95.9 mt-10 -62.92 -38.68 91.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 135' ' ' ILE . 92.2 t -69.44 -24.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 110.883 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.3 mttm -60.03 -40.03 87.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.793 -1.192 . . . . 0.0 109.748 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 2.3 p30 -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.88 -1.137 . . . . 0.0 109.206 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.09 99.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 47.1 p-10 -102.87 -0.11 31.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.351 -0.843 . . . . 0.0 109.607 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -146.18 136.15 23.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -161.82 166.36 26.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.56 -1.338 . . . . 0.0 110.492 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.98 129.32 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -91.38 123.06 43.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.62 148.86 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 122.469 1.128 . . . . 0.0 111.59 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mtt -145.71 154.25 41.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -137.09 122.8 19.88 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.735 -1.228 . . . . 0.0 111.076 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.05 116.75 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.04 153.18 39.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.939 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.09 -177.0 1.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -59.96 146.58 41.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 108.845 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.97 141.78 13.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 -3.88 74.29 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -117.74 152.63 34.88 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.591 -0.946 . . . . 0.0 109.5 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.78 147.69 50.81 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.472 -0.767 . . . . 0.0 109.149 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.66 143.65 27.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.225 -0.922 . . . . 0.0 109.831 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -70.58 141.36 51.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 108.875 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.95 98.24 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 97.2 mt-10 -61.41 -46.07 91.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.958 -1.319 . . . . 0.0 109.636 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.94 -27.08 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.97 -60.23 2.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.54 -0.725 . . . . 0.0 109.171 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.48 -39.99 89.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 26' ' ' GLU . 96.2 m-20 -61.11 -40.98 95.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.7 p -67.69 -40.2 84.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.129 -0.982 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.11 -48.18 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.334 -0.853 . . . . 0.0 109.534 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.56 -40.14 96.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 109.697 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.48 -20.39 63.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.564 -0.71 . . . . 0.0 110.552 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.85 2.76 32.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 110.296 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.95 15.05 65.91 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.845 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -80.05 153.9 28.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.849 -1.383 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.446 HD12 ' CD2' ' A' ' 48' ' ' HIS . 96.6 mt -124.7 136.75 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -62.75 106.32 0.78 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.678 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -95.78 171.52 28.93 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -62.59 -164.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -1.093 . . . . 0.0 109.344 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.0 mtt 57.76 21.26 7.23 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.573 0.702 . . . . 0.0 109.827 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.2 m120 50.02 39.39 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.594 -0.691 . . . . 0.0 111.723 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 pt -140.01 165.86 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.809 -1.182 . . . . 0.0 108.983 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -91.52 118.44 30.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 110.417 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.401 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 53.5 m-70 -105.15 128.46 53.39 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.419 -0.801 . . . . 0.0 109.085 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -100.15 129.23 46.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.993 -1.067 . . . . 0.0 108.7 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.446 ' CD2' HD12 ' A' ' 38' ' ' ILE . 52.1 m-70 -97.38 170.14 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.99 -49.99 74.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.167 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 m -91.25 144.23 29.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.28 -0.887 . . . . 0.0 109.102 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -67.23 -5.47 13.87 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.574 0.849 . . . . 0.0 111.738 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.45 -0.53 54.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.93 . . . . 0.0 110.157 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' CA ' ' CD1' ' A' ' 38' ' ' ILE . . . 77.67 10.03 86.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -68.23 -39.99 82.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -1.104 . . . . 0.0 109.854 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.79 165.67 46.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.434 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.9 Cg_endo -67.38 175.98 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.194 1.262 . . . . 0.0 112.087 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.475 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.41 124.94 29.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -101.0 -46.81 4.97 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.274 -0.892 . . . . 0.0 109.764 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -143.84 167.4 22.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.004 -1.06 . . . . 0.0 108.501 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -137.51 -177.04 4.61 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.869 -1.144 . . . . 0.0 112.04 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.9 tt -139.97 132.09 28.01 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.514 0.673 . . . . 0.0 109.992 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.66 166.66 22.71 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.3 m-20 -77.69 170.19 17.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.842 -1.161 . . . . 0.0 110.472 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mtp -68.97 -29.57 67.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.498 -0.752 . . . . 0.0 111.818 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 65' ' ' VAL . 34.0 m -86.2 118.82 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.51 -1.369 . . . . 0.0 109.749 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -61.5 147.81 87.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.538 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.91 2.87 17.87 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.175 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 69.99 33.32 69.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.3 p -84.34 169.95 14.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.042 -1.269 . . . . 0.0 109.887 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 70.8 m-85 -119.7 150.73 39.88 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 73' ' ' GLU . 53.9 m-20 -139.16 150.26 64.02 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -42.89 -15.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.901 1.067 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.5 mt-10 -85.09 16.21 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.2 ptt? -83.53 -0.0 48.42 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.024 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -85.02 -4.39 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.66 -1.275 . . . . 0.0 109.694 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -147.83 77.42 1.42 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.53 169.71 24.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 109.498 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -135.51 156.94 48.08 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.62 19.35 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.083 . . . . 0.0 109.37 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.77 -30.67 77.22 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 120.418 0.745 . . . . 0.0 111.744 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.86 -160.85 27.57 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 HD11 ' A' ' 28' ' ' LEU . 33.1 m -130.09 159.94 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.488 -1.007 . . . . 0.0 109.47 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -115.45 119.66 36.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.0 109.745 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -104.75 129.93 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -147.08 170.05 17.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.92 -1.113 . . . . 0.0 110.491 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.0 ttp -133.19 130.96 39.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.729 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.56 123.16 35.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 9' ' ' ALA . 3.7 m -98.43 150.07 36.36 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.262 -0.899 . . . . 0.0 108.62 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -76.06 142.72 74.48 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.386 -0.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 m -109.99 157.81 18.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.513 -0.742 . . . . 0.0 109.73 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 64.2 t80 -75.88 154.61 35.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.16 -159.39 45.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -93.78 114.95 27.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -1.107 . . . . 0.0 108.848 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.09 -27.22 43.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.936 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 95' ' ' LEU . 95.4 mt -69.99 -38.22 75.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.546 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.05 -39.32 75.78 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' ND2' HD23 ' A' ' 58' ' ' LEU . 53.5 m-20 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.87 -41.06 86.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.13 -43.05 99.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 108.673 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.0 -39.87 93.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.026 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.0 mmm -56.79 -49.99 73.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.036 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.6 mm-40 -60.28 -41.4 93.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.153 -0.967 . . . . 0.0 109.0 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.8 p -71.93 -39.94 69.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -56.04 26.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.911 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.48 -40.69 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.608 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.7 m-70 -60.06 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.422 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.06 -49.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 108.856 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.69 -51.69 53.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.624 -0.673 . . . . 0.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 110.814 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.36 -39.9 77.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.409 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.87 0.06 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.27 20.53 76.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.4 -178.35 51.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.95 131.55 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.538 -0.978 . . . . 0.0 108.939 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.8 130.68 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.949 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.7 mt -132.7 159.91 38.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 37.8 p-10 -86.59 -172.2 3.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.5 m-20 -60.06 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.0 . . . . 0.0 109.735 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -76.31 13.91 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 108.653 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.5 mtt180 59.87 34.6 21.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.135 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -110.03 151.27 27.38 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.7 mtp -52.96 129.99 32.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.089 . . . . 0.0 109.319 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 39.5 mtt -59.6 140.86 56.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.98 . . . . 0.0 109.932 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 15.6 p -133.63 151.1 76.58 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -43.57 -47.74 9.18 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.486 0.791 . . . . 0.0 111.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.99 -41.58 92.37 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 125' ' ' THR . 27.4 mmtp -69.99 -39.98 75.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.2 mt -60.0 -39.96 87.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 108.501 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -62.43 -39.9 94.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.46 -46.97 85.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.085 -1.009 . . . . 0.0 109.549 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -60.01 -45.43 92.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.943 -1.098 . . . . 0.0 108.587 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.02 -39.57 86.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -45.73 91.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.82 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.84 -1.162 . . . . 0.0 108.698 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.05 -45.25 95.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.066 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -61.97 -38.18 87.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.84 . . . . 0.0 109.603 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.4 mt-10 -59.97 -39.7 86.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.421 -0.799 . . . . 0.0 110.715 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 -33.63 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.428 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.4 mttm -59.91 -45.5 92.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.82 -1.175 . . . . 0.0 110.545 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.23 -33.31 72.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.665 -1.272 . . . . 0.0 109.681 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.34 -39.96 93.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 110.936 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 41.3 p-10 -98.54 3.01 48.05 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.061 -1.024 . . . . 0.0 109.592 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.389 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 7.7 mtpm? . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -146.51 146.97 30.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.17 -166.22 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.436 -1.415 . . . . 0.0 111.393 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -131.5 134.89 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -90.27 127.81 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -119.98 148.03 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.385 1.088 . . . . 0.0 111.684 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.528 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.9 mtt -145.36 159.05 43.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.39 119.71 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.835 -1.166 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -101.96 110.02 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.58 159.34 44.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.98 179.0 3.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.02 156.26 15.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.108 -0.995 . . . . 0.0 108.773 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -59.95 145.49 45.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.071 -1.018 . . . . 0.0 109.336 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 1.52 68.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.2 m -131.26 147.54 52.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.973 . . . . 0.0 109.276 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.94 145.31 51.42 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.378 -0.826 . . . . 0.0 109.433 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.61 145.81 26.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.718 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.04 146.83 50.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.46 97.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 62.0 mm-40 -61.87 -45.69 92.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.004 -1.292 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 84.4 mt -70.01 -29.14 66.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 108.627 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.606 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.1 -57.14 4.16 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.391 0.615 . . . . 0.0 110.022 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.0 -49.99 75.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 111.63 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.9 p-10 -62.13 -40.07 94.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.841 -1.162 . . . . 0.0 110.315 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.458 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -60.42 -43.17 97.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.94 -46.57 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.428 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.14 -41.13 99.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 110.054 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.79 -18.96 64.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.2 3.96 21.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 5.41 65.9 Favored Glycine 0 N--CA 1.497 2.759 0 O-C-N 120.821 -1.174 . . . . 0.0 111.041 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.46 149.61 33.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.708 -1.466 . . . . 0.0 109.185 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.14 139.71 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.99 116.18 3.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.774 -1.204 . . . . 0.0 108.755 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.521 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -91.99 172.12 34.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.36 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.767 -0.843 . . . . 0.0 110.431 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mmm 58.18 -99.71 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 42' ' ' MET . 56.6 m-80 -164.81 28.47 0.06 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.74 168.21 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.355 -0.84 . . . . 0.0 110.556 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.58 119.96 32.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.327 -0.858 . . . . 0.0 109.95 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.521 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 37.7 m-70 -103.2 141.19 36.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.299 -0.876 . . . . 0.0 109.04 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 45.8 ttt180 -120.49 131.29 54.66 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.476 -0.765 . . . . 0.0 109.047 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.558 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.3 m-70 -94.69 174.55 7.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.2 tp -53.56 -49.97 66.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 108.469 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -92.26 146.03 31.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.84 -3.01 10.52 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 120.593 0.862 . . . . 0.0 111.985 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.75 1.35 57.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.209 -0.932 . . . . 0.0 109.831 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.6 10.01 75.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.83 -41.89 70.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.015 -1.285 . . . . 0.0 110.167 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.558 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.37 173.41 54.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.454 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.8 Cg_endo -73.75 173.0 14.68 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.085 1.19 . . . . 0.0 111.431 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.57 122.05 26.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.065 -1.022 . . . . 0.0 109.213 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -103.17 -33.76 9.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.372 -0.83 . . . . 0.0 109.844 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.08 169.12 24.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.056 . . . . 0.0 108.685 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.435 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 8.2 m -139.13 -176.46 4.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 0.0 111.232 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -137.32 132.91 34.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.387 0.613 . . . . 0.0 109.397 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.594 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.06 162.32 31.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.0 m-20 -76.26 169.02 19.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.885 -1.134 . . . . 0.0 109.682 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.3 mmm -69.47 -28.75 66.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 110.648 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.32 118.08 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.767 -1.208 . . . . 0.0 110.234 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -62.54 152.02 81.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.477 -0.765 . . . . 0.0 108.944 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -78.12 1.95 28.08 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.711 -1.37 . . . . 0.0 111.964 -0.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.0 38.35 19.48 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.93 157.63 19.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -1.195 . . . . 0.0 109.744 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -120.0 139.97 51.67 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.53 -0.731 . . . . 0.0 109.373 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.19 149.98 67.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.86 -13.37 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 120.651 0.901 . . . . 0.0 112.561 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.35 -10.1 57.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 92.9 mtp -89.04 22.07 2.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.87 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -85.31 -7.8 58.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 108.558 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 89.3 m-20 -144.7 83.57 1.71 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.64 174.35 15.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.256 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -128.64 148.14 50.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 109.152 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.74 150.58 20.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 108.926 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -45.77 -50.6 9.36 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 CA-C-N 119.299 0.785 . . . . 0.0 111.763 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.6 -150.17 8.34 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 HD21 ' A' ' 28' ' ' LEU . 33.0 m -130.01 160.07 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.488 -1.007 . . . . 0.0 110.067 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' ALA . 24.6 m -107.89 119.96 40.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.0 109.458 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.35 129.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -146.94 168.01 22.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 110.916 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.7 ttp -136.75 129.97 31.29 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -91.39 114.64 27.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.39 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.4 151.98 37.63 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -78.51 134.19 32.38 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.394 -0.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.3 m -108.53 162.04 14.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.489 -0.757 . . . . 0.0 109.856 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.06 146.72 50.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -0.802 . . . . 0.0 109.938 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.24 -159.52 27.53 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -97.31 112.65 24.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.99 -29.14 65.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.822 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.29 -39.97 78.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -71.15 -40.13 71.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.012 -1.055 . . . . 0.0 108.868 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.466 ' ND2' HD23 ' A' ' 58' ' ' LEU . 83.7 m-20 -60.97 -39.9 91.38 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 109.098 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 87.1 t80 -59.24 -49.96 75.83 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.82 -40.05 96.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.6 -47.46 86.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 110.68 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.8 mtm -59.96 -39.97 87.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.893 -1.129 . . . . 0.0 109.319 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.47 -41.5 98.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 109.103 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.13 -41.2 92.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 109.002 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 p -72.18 -40.03 68.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 108.941 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.0 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.552 -0.718 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -62.13 -39.2 91.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.94 -1.1 . . . . 0.0 109.689 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -59.97 -44.14 94.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.674 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.2 mt -60.01 -49.45 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.35 -50.16 51.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.589 -0.695 . . . . 0.0 109.607 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.99 -40.19 92.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.792 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -39.92 75.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.805 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 114' ' ' GLY . 6.0 m -97.76 -1.44 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.0 109.704 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.73 19.89 75.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -87.58 -174.68 48.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.8 t -131.12 138.14 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.517 -0.99 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 t -70.44 133.2 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.658 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.5 159.99 35.44 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.556 -0.715 . . . . 0.0 109.759 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -87.76 -171.62 3.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 109.419 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.5 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -76.88 15.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.049 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.3 mtt180 55.6 38.96 30.86 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.4 0.619 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 122' ' ' ARG . 29.7 mtt-85 -112.07 151.9 28.85 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -51.5 130.65 28.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.0 mmm -59.16 139.97 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -137.6 150.31 67.81 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -47.9 -44.06 28.2 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.844 1.029 . . . . 0.0 112.401 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.01 -39.91 87.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -67.89 -40.03 83.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 110.123 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.1 -39.88 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -61.96 -40.14 94.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.556 -0.715 . . . . 0.0 109.078 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -59.94 -48.2 82.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.862 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.584 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 94.5 mm-40 -59.97 -40.12 87.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.72 -40.39 97.03 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.81 -45.16 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 108.859 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.09 -49.38 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -60.05 -39.98 87.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 54.2 mm-40 -60.26 -41.66 93.71 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 109.821 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' GLU . 54.6 t -71.36 -40.79 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 111.073 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 144' ' ' ALA . 26.4 mtpp -59.98 -48.06 83.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.963 -1.086 . . . . 0.0 111.266 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 4.2 p30 -60.08 -32.34 70.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.999 -1.063 . . . . 0.0 110.357 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -62.26 -39.95 94.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -104.04 -1.64 27.16 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.169 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.407 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -145.17 133.71 22.01 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -159.93 170.47 21.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.85 -1.156 . . . . 0.0 110.355 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.82 131.4 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.364 -0.835 . . . . 0.0 109.069 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.58 130.92 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.2 mt -125.46 146.02 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.184 0.993 . . . . 0.0 111.937 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.5 mtt -145.96 157.36 43.89 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.562 ' OD1' HG23 ' A' ' 83' ' ' THR . 67.1 m-80 -141.28 129.94 22.8 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.628 -1.295 . . . . 0.0 111.169 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.29 116.45 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.03 38.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -170.69 0.85 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -68.02 158.09 33.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.99 -1.069 . . . . 0.0 108.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -59.96 145.58 45.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.382 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.23 82.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 m -118.0 148.47 42.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.512 -0.993 . . . . 0.0 108.801 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 63.6 mm-40 -129.31 143.06 50.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.5 mt -86.35 139.21 31.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 109.458 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -69.6 145.16 52.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.343 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.91 97.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.91 -41.55 98.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.095 -1.238 . . . . 0.0 109.7 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.03 -27.1 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.612 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.0 tt -71.31 -59.03 2.99 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.418 -0.801 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' SD ' ' A' ' 74' ' ' MET . 83.0 mt -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.989 -1.069 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.96 -42.85 94.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 109.958 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -69.97 -46.92 64.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 110.52 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.8 mt -60.06 -44.23 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 0.0 110.102 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.24 -43.12 98.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 109.724 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -68.72 -16.39 63.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.513 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.25 3.91 25.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.875 . . . . 0.0 110.056 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.0 9.91 83.66 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -80.22 154.39 27.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.283 . . . . 0.0 109.398 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.17 141.69 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -59.64 111.7 1.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.973 -1.079 . . . . 0.0 109.083 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -92.72 171.85 33.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.34 -169.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.567 -0.961 . . . . 0.0 109.171 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.1 mtm 56.19 29.42 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.809 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 m120 49.94 38.66 16.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.558 -0.714 . . . . 0.0 111.493 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 pt -140.22 159.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.877 -1.14 . . . . 0.0 109.182 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 45.2 m-85 -89.34 129.99 35.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.089 -1.007 . . . . 0.0 109.872 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.551 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.3 m-70 -118.44 127.87 54.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 59.2 ttt180 -100.02 124.98 45.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.0 108.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 19.8 m-70 -95.05 169.68 9.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.8 tp -55.54 -50.06 70.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.7 m -92.34 144.55 29.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 108.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.44 -3.14 10.41 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.518 0.863 . . . . 0.0 111.975 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.25 0.06 57.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.1 11.36 84.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 m -70.06 -45.43 67.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -1.197 . . . . 0.0 109.878 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.49 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.59 166.35 54.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.74 177.92 4.43 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.081 1.187 . . . . 0.0 111.456 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.49 124.6 30.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.96 . . . . 0.0 109.053 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.9 mp -100.73 -39.76 7.68 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.099 -1.0 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -148.19 159.86 43.53 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.551 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.5 m -130.21 -179.85 5.48 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.204 1.002 . . . . 0.0 112.342 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -139.94 129.95 24.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.75 160.97 35.29 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.696 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 82.7 m-20 -75.32 159.09 31.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.098 -1.002 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -69.98 -25.22 63.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.64 -0.662 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.7 t -85.21 126.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.733 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -59.73 149.99 69.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.102 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.29 9.87 15.94 Favored 'Cis proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.727 -0.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 14.5 80.98 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -88.99 170.14 10.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 110.877 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.696 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 39.3 m-85 -119.27 158.78 25.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.6 m-20 -143.07 150.65 53.41 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.197 -0.94 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -48.98 -8.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.125 0 CA-C-N 119.171 0.74 . . . . 0.0 110.94 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.3 mt-10 -86.77 18.18 3.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.831 ' SD ' HD21 ' A' ' 29' ' ' LEU . 47.5 mtm -73.89 1.24 11.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.9 mmtp -88.75 -0.07 56.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 109.943 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 60.7 m-20 -154.8 77.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.012 -1.055 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -167.76 170.66 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.7 p -137.11 159.17 42.67 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.97 148.3 18.43 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.932 -1.105 . . . . 0.0 109.251 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 3.5 Cg_endo -57.8 -35.58 98.72 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.577 0.851 . . . . 0.0 112.0 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.23 -161.09 25.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.99 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.51 -0.994 . . . . 0.0 108.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.562 HG23 ' OD1' ' A' ' 14' ' ' ASN . 94.2 m -114.7 128.08 56.11 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.488 -0.758 . . . . 0.0 110.454 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.6 mt -111.56 129.19 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 24.9 p90 -149.09 159.96 43.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.877 -1.139 . . . . 0.0 110.976 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.6 ttm -113.64 130.55 56.37 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.1 mt-30 -91.94 115.18 27.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.2 m -98.58 150.4 36.68 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 120.978 -1.076 . . . . 0.0 109.379 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.24 134.72 36.92 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.902 -1.291 . . . . 0.0 111.561 -1.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.9 m -104.56 154.2 20.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.409 -0.807 . . . . 0.0 110.097 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -71.31 148.59 46.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 109.509 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.61 -164.61 39.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.63 114.39 26.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -1.179 . . . . 0.0 109.322 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -52.99 -18.56 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.04 -40.02 75.39 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -75.98 -41.45 51.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 108.962 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.582 ' OD1' HD23 ' A' ' 58' ' ' LEU . 92.7 m-20 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 102' ' ' LEU . 90.5 t80 -57.61 -41.27 80.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.34 -40.11 89.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.074 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.09 -40.11 94.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.3 mtp -59.47 -49.91 75.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.1 mt -60.99 -45.9 92.93 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.062 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.2 mt-30 -60.28 -40.46 90.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 p -73.15 -40.03 65.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.76 -54.01 51.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.447 -0.783 . . . . 0.0 109.907 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.406 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 14.5 pt20 -63.23 -40.0 96.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 109.638 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 65.0 m170 -60.15 -45.94 91.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.366 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.95 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.15 -49.96 59.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -0.824 . . . . 0.0 109.291 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.36 -40.05 89.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.39 -40.15 77.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 110.796 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 114' ' ' GLY . 9.9 m -98.41 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.01 20.02 74.3 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.44 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -84.28 -170.24 46.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 132.92 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.934 . . . . 0.0 109.098 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.47 132.88 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.513 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 mt -132.13 159.96 37.4 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.481 -0.762 . . . . 0.0 109.795 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -88.55 -169.34 2.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 121' ' ' ARG . 94.1 m-20 -59.97 -39.61 86.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.181 -0.95 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -76.44 16.61 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.244 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 119' ' ' ASP . 49.6 mtm-85 57.75 28.88 16.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.584 . . . . 0.0 109.953 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 122' ' ' ARG . 51.0 mtt-85 -110.32 155.66 21.8 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.514 -0.741 . . . . 0.0 109.441 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.1 mtm -53.76 132.23 40.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.3 mtt -60.0 140.75 56.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -129.78 150.29 75.42 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -43.58 -41.07 10.95 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 CA-C-N 119.354 0.805 . . . . 0.0 111.744 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.3 -40.01 88.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.946 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -69.37 -39.31 78.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 109.791 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.74 -40.49 79.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 108.781 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -65.88 -38.95 90.12 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.93 -47.79 84.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.943 . . . . 0.0 109.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -59.95 -42.77 94.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 108.486 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.72 -40.02 95.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.539 -0.726 . . . . 0.0 109.047 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -40.02 87.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.447 -0.783 . . . . 0.0 109.692 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -40.03 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.953 -1.092 . . . . 0.0 109.259 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.93 -42.95 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.946 -1.096 . . . . 0.0 109.391 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 0.8 OUTLIER -60.08 -37.14 79.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.198 -0.939 . . . . 0.0 109.751 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 88' ' ' VAL . 97.8 t -72.73 -33.88 45.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 144' ' ' ALA . 39.3 mmtm -59.63 -45.96 90.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 109.958 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -62.44 -36.44 82.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.647 -1.283 . . . . 0.0 108.807 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 110.197 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -97.81 0.36 46.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 108.803 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.497 -0.752 . . . . 0.0 109.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mttt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -148.46 145.02 27.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -164.66 160.1 19.62 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.328 -1.482 . . . . 0.0 110.743 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.53 129.92 59.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -88.43 129.95 38.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.8 mt -122.0 147.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.303 1.049 . . . . 0.0 111.49 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -145.79 154.14 41.7 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -133.21 120.91 21.76 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.898 -1.126 . . . . 0.0 111.088 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.01 112.48 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.93 158.67 43.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 110.124 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.7 -170.55 0.7 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.555 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -59.93 154.3 19.14 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 108.762 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -59.83 141.56 55.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.071 -1.018 . . . . 0.0 109.606 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.19 -8.59 79.26 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 m -112.2 151.93 28.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.473 -1.016 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.97 150.54 49.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.425 -0.797 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.31 145.82 27.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.903 . . . . 0.0 109.908 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.42 140.62 57.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 109.016 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.22 -40.48 97.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.56 -47.74 82.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.2 mt -68.2 -24.5 64.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -76.53 -58.28 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.89 -49.93 75.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.214 -0.928 . . . . 0.0 111.084 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.4 p-10 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 110.023 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 53.7 m -61.99 -40.66 96.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.971 -1.081 . . . . 0.0 109.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.29 -48.45 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 108.886 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -60.22 -40.01 88.64 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.91 -21.56 64.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 9.87 7.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.956 -1.09 . . . . 0.0 110.376 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.21 9.67 86.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -80.4 155.47 27.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.296 . . . . 0.0 109.583 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 140.65 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 108.24 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 171.82 33.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.27 -167.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -1.107 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.8 mmm 57.22 26.87 12.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.475 -0.766 . . . . 0.0 109.654 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 51.11 39.91 24.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.446 -0.784 . . . . 0.0 111.514 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.6 pt -141.65 160.88 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.014 -1.054 . . . . 0.0 109.402 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.38 136.56 32.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 18.6 m-70 -125.72 128.13 47.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 47' ' ' ARG . 30.0 ttt-85 -101.09 126.2 47.76 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.388 -0.82 . . . . 0.0 109.083 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.555 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 58.6 m-70 -96.51 170.08 9.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.729 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.3 tp -55.83 -49.83 72.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -92.04 149.06 38.12 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.295 -0.878 . . . . 0.0 109.333 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.16 -5.89 17.52 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 120.926 1.084 . . . . 0.0 112.234 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 49.8 p-10 -94.18 -0.04 55.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.074 -1.016 . . . . 0.0 110.299 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.4 85.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.433 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 27.0 m -70.03 -41.71 73.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.749 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.61 165.35 52.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.555 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.6 Cg_endo -69.14 174.25 9.24 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.03 1.153 . . . . 0.0 111.602 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.56 125.88 30.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 109.134 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.06 -39.63 8.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.18 158.59 44.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.499 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 29.0 m -129.68 179.46 5.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.244 1.021 . . . . 0.0 112.159 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.8 tt -139.51 132.94 30.15 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.1 167.17 22.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.632 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -74.9 160.23 30.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.002 -1.061 . . . . 0.0 109.773 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.88 -20.51 63.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.862 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -87.95 113.57 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.002 -1.061 . . . . 0.0 109.114 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -62.74 151.73 83.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.501 -0.749 . . . . 0.0 109.563 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -76.67 10.97 12.62 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.6 -1.416 . . . . 0.0 112.34 -0.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.39 30.82 57.95 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.374 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -85.85 163.83 17.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -1.19 . . . . 0.0 109.836 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 71.1 m-85 -120.82 143.13 49.03 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.3 m-20 -129.12 149.93 73.99 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.1 -9.07 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.138 0.728 . . . . 0.0 111.569 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.0 mt-10 -89.77 3.92 51.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.548 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.455 ' O ' HD11 ' A' ' 29' ' ' LEU . 67.6 mmm -88.1 16.46 6.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 62.6 mttp -85.34 -6.32 59.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.962 -1.086 . . . . 0.0 109.182 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 68.6 m-20 -151.91 79.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.75 171.69 19.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.1 p -128.64 151.75 49.14 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.95 149.04 19.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.07 -1.019 . . . . 0.0 109.308 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -43.58 -49.98 7.35 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.666 0.911 . . . . 0.0 111.896 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.09 -154.75 13.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.401 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.8 m -129.97 160.02 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.395 -1.062 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.5 m -109.08 120.93 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.719 -0.613 . . . . 0.0 110.146 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mt -103.71 130.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 31.8 p90 -147.17 169.98 18.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 111.215 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.8 ttm -128.26 130.07 47.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.414 ' O ' ' OG ' ' A' ' 90' ' ' SER . 92.0 mm-40 -91.51 115.62 28.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.7 m -98.8 149.92 36.2 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.18 -0.95 . . . . 0.0 109.093 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.61 137.02 46.73 Favored 'Cis proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.867 -1.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.1 m -107.74 154.15 21.92 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.487 -0.758 . . . . 0.0 109.397 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.11 145.49 51.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 110.043 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.51 -165.61 33.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -96.39 112.29 24.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.34 -1.094 . . . . 0.0 109.114 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' OE1' HG23 ' A' ' 136' ' ' ILE . 88.3 mt-10 -55.3 -25.53 34.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.946 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.81 -40.14 76.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 109.591 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.28 -41.63 66.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.785 -1.197 . . . . 0.0 108.065 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.411 ' ND2' HD23 ' A' ' 58' ' ' LEU . 94.9 m-20 -62.69 -39.79 95.09 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 102' ' ' LEU . 76.0 t80 -51.34 -40.65 59.55 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.5 -40.02 94.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.86 -40.04 96.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 0.0 109.287 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mtp -58.66 -50.03 75.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.079 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.9 mt -65.95 -47.32 75.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.353 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 77.1 mt-30 -59.95 -40.81 90.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 108.977 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.5 p -70.4 -40.16 74.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.14 -56.42 22.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.823 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.21 -37.82 84.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.462 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.9 m-70 -59.94 -50.13 74.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.06 -1.025 . . . . 0.0 108.746 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.8 mt -60.99 -49.01 86.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.73 -49.23 65.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -70.03 -40.15 75.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.72 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 108' ' ' ILE . 13.6 m -97.44 -0.03 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 0.0 109.873 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.03 26.01 74.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.77 -176.54 50.21 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -130.21 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.702 -0.881 . . . . 0.0 109.202 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.488 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -74.96 130.26 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.132 -0.98 . . . . 0.0 109.352 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -130.56 159.88 35.82 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 40.3 p-10 -85.7 -170.69 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 0.0 108.989 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -60.13 -39.49 86.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 78.5 mt-30 -76.78 16.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.328 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 58.46 29.37 18.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 110.395 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HE ' ' HB2' ' A' ' 120' ' ' GLN . 84.5 mtm180 -107.91 154.33 21.76 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.336 -0.852 . . . . 0.0 108.969 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.2 mtt -52.42 125.17 15.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 109.722 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' HG12 ' A' ' 116' ' ' VAL . 51.5 mtp -60.14 140.49 56.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.522 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.2 p -127.18 150.53 72.53 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -43.64 -43.23 11.44 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.185 0.745 . . . . 0.0 112.018 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.431 ' O ' ' CD ' ' A' ' 131' ' ' GLU . 94.2 mt-30 -60.08 -44.74 94.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.59 -39.76 94.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 109.772 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.64 -39.01 76.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -65.83 -39.99 91.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -59.43 -48.6 81.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.701 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -60.08 -45.99 91.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 108.548 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.0 -40.02 96.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.491 -0.756 . . . . 0.0 108.961 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.4 -42.11 98.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.2 -42.8 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.003 -1.06 . . . . 0.0 109.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 94' ' ' GLU . 82.2 mt -60.07 -41.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 31.2 mmt180 -60.05 -40.91 91.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 108.962 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -61.11 -37.46 82.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 0.0 108.98 178.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.93 -39.86 78.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 110.27 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.02 -48.6 81.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 111.379 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 2.8 p-10 -59.91 -32.86 71.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.558 -1.339 . . . . 0.0 109.221 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.12 82.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 110.148 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -98.6 -11.35 22.22 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 109.506 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -147.89 150.4 34.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.1 -175.1 3.84 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.562 -1.336 . . . . 0.0 110.811 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.98 136.3 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -93.59 124.64 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.9 mt -121.36 151.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.043 0.925 . . . . 0.0 111.091 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 84' ' ' ILE . 67.5 mtt -148.88 159.02 44.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -140.17 121.29 14.75 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.973 -1.08 . . . . 0.0 110.603 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.28 117.27 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.42 155.0 40.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.14 -174.21 1.49 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.447 -0.783 . . . . 0.0 108.901 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -64.26 149.03 48.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.073 -1.017 . . . . 0.0 108.763 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -55.81 149.85 13.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 109.756 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.57 -7.18 82.43 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -121.06 154.69 35.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.564 -0.962 . . . . 0.0 109.477 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -129.16 147.34 50.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.07 137.68 33.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 55.3 t-20 -67.95 142.05 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.05 -41.42 97.99 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.795 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.73 -47.24 86.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.309 . . . . 0.0 110.095 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.01 -30.26 67.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -70.4 -57.48 4.77 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.551 -0.718 . . . . 0.0 109.252 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 74' ' ' MET . 96.2 mt -59.99 -44.23 94.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.385 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.567 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 60.3 t-20 -60.45 -40.27 90.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 110.192 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 p -65.82 -39.82 91.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.87 -48.82 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -62.35 -39.97 94.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.902 -1.124 . . . . 0.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.567 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 80.3 mt-30 -67.84 -22.41 65.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.377 -0.827 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.98 6.09 14.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.953 -1.092 . . . . 0.0 109.997 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.83 76.19 Favored Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.947 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -78.6 150.35 32.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.76 -1.435 . . . . 0.0 109.726 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.34 139.57 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -60.69 105.34 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.03 172.14 29.19 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.51 -165.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -1.035 . . . . 0.0 109.598 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mmm 58.36 20.12 7.02 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.689 . . . . 0.0 109.81 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 49.99 39.63 19.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.086 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.2 pt -140.51 166.98 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -91.91 127.02 37.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.917 -1.114 . . . . 0.0 110.487 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 36.5 m-70 -116.07 128.82 56.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.528 -0.732 . . . . 0.0 109.75 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 17.6 ttt-85 -102.97 126.95 50.35 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 70.9 m-70 -94.76 171.22 8.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.963 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.54 -50.14 70.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.9 . . . . 0.0 108.739 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -93.34 143.73 27.16 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -66.97 -2.65 8.24 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 119.552 0.876 . . . . 0.0 111.952 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -94.25 0.19 55.5 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 0.0 110.109 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.92 86.61 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.452 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 91.3 p -70.1 -40.0 75.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.914 -1.345 . . . . 0.0 109.762 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.77 162.82 52.18 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 12.3 Cg_endo -67.26 176.93 4.2 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.994 1.129 . . . . 0.0 111.247 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.23 118.67 22.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.017 -1.052 . . . . 0.0 109.319 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.6 mp -96.72 -47.97 5.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -142.95 159.99 41.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.993 . . . . 0.0 109.395 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.546 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.0 m -136.55 159.92 40.33 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.82 0.819 . . . . 0.0 111.208 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -113.11 131.69 55.73 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.361 0.601 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.637 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.57 162.78 32.84 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.9 m-20 -77.69 153.55 32.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.884 -1.135 . . . . 0.0 109.886 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.05 -29.86 66.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.094 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.43 134.94 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.972 -1.08 . . . . 0.0 109.774 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -56.87 154.02 20.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -79.77 2.06 36.52 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 123.753 -1.353 . . . . 0.0 112.464 -0.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.85 -4.73 73.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.5 p -89.6 169.89 10.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -1.051 . . . . 0.0 110.078 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 79.6 m-85 -121.76 152.47 39.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.5 m-20 -135.17 149.74 70.91 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -49.04 -11.11 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 120.47 0.78 . . . . 0.0 111.792 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.4 mm-40 -89.95 4.46 50.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 73.9 mmm -87.92 20.24 3.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.0 110.155 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.0 mttp -88.23 -1.69 58.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 81.7 m-20 -146.73 81.55 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -160.33 172.49 17.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 p -130.67 151.58 50.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.31 150.02 21.48 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.263 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.48 -38.37 95.49 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 CA-C-N 119.092 0.712 . . . . 0.0 111.566 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.08 -156.47 15.17 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 24.4 m -131.51 160.08 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.768 -0.843 . . . . 0.0 109.066 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.5 m -114.14 120.26 39.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.473 -0.767 . . . . 0.0 110.432 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 13' ' ' MET . 97.5 mt -105.95 128.19 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -145.27 152.34 39.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.176 -0.953 . . . . 0.0 110.136 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttp -121.2 130.04 53.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -86.33 110.88 19.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 108.96 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 2.4 m -98.19 147.44 33.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.8 131.49 24.43 Favored 'Cis proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.605 0.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m -100.36 166.73 10.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.736 0.779 . . . . 0.0 110.186 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.13 146.02 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.771 -0.581 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.4 -156.46 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -93.77 119.09 32.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -1.209 . . . . 0.0 108.537 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -57.44 -32.64 67.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.838 -0.539 . . . . 0.0 110.511 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.96 -40.11 75.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.85 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.11 -40.62 68.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.004 -1.06 . . . . 0.0 109.157 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.253 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.481 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.8 t80 -58.83 -45.03 90.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -61.11 -39.73 91.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.448 -0.783 . . . . 0.0 109.43 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.11 -43.78 95.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 109.678 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.15 -44.92 94.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.481 HD11 ' CE2' ' A' ' 98' ' ' PHE . 86.5 mt -61.49 -46.2 91.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.054 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -43.93 95.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -70.42 -40.01 74.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.23 -55.58 33.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.041 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -60.28 -35.93 76.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.925 -1.11 . . . . 0.0 108.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -60.08 -45.88 91.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.11 -0.994 . . . . 0.0 108.839 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -60.01 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.048 -1.032 . . . . 0.0 108.568 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.2 -48.99 61.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.487 0.66 . . . . 0.0 109.286 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.09 -40.01 88.1 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.926 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.9 -40.04 75.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 111.349 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.75 -0.39 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.075 -1.015 . . . . 0.0 109.566 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.83 25.96 74.89 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.06 -169.3 44.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.51 134.04 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -1.016 . . . . 0.0 109.238 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.14 130.89 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.054 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.0 mt -126.74 159.02 34.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 108.907 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -86.49 -171.51 3.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 109.069 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.532 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 97.2 m-20 -60.07 -35.01 74.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.323 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.84 16.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 45.1 mtm-85 58.16 26.28 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.641 . . . . 0.0 109.914 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 54.0 mtp180 -109.18 151.49 26.4 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.593 -0.692 . . . . 0.0 109.331 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -52.51 134.69 34.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.886 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.4 mmm -59.9 133.61 56.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.0 p -132.72 151.15 77.58 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -41.36 -45.99 5.78 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 120.926 1.084 . . . . 0.0 113.04 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -60.09 -39.97 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.95 -1.094 . . . . 0.0 109.409 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.36 -40.11 85.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.32 -39.97 84.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 108.828 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -62.58 -39.54 94.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.474 -0.766 . . . . 0.0 109.143 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.59 -48.59 81.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.123 -0.986 . . . . 0.0 109.75 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 65.3 m-85 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.041 -1.037 . . . . 0.0 109.398 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.87 87.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.316 -0.865 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.21 -44.42 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 108.702 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.07 -45.78 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.383 -0.823 . . . . 0.0 109.379 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 99.0 mtt180 -60.31 -37.41 80.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 110.161 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.6 mt-10 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.866 . . . . 0.0 110.29 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.6 t -73.35 -35.56 46.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 110.8 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 144' ' ' ALA . 49.4 mtpt -60.15 -46.61 89.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 111.464 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.7 p-10 -61.17 -29.15 69.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.606 -1.309 . . . . 0.0 110.125 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.07 99.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.44 -11.55 13.63 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.382 -0.824 . . . . 0.0 110.192 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -150.02 133.56 16.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.63 8.36 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.67 -1.269 . . . . 0.0 110.477 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -125.03 132.29 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.94 134.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.1 mt -131.2 141.84 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.947 0.88 . . . . 0.0 111.196 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.43 148.01 29.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -128.01 130.54 48.5 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.054 -1.029 . . . . 0.0 110.901 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.73 117.94 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.01 159.82 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 110.383 -178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.12 -164.96 0.2 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.704 -0.622 . . . . 0.0 109.645 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -70.0 155.97 39.82 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -57.57 135.78 56.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 5.18 65.0 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -126.31 144.41 50.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -1.019 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -124.52 147.69 48.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.51 137.04 33.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.167 -0.958 . . . . 0.0 110.233 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.43 143.07 57.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 108.862 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.49 -41.85 97.34 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.084 -1.01 . . . . 0.0 111.061 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.98 -43.15 95.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.889 -1.359 . . . . 0.0 108.877 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 95.5 mt -69.95 -27.12 64.48 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.6 tt -76.57 -56.3 4.74 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 110.463 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.98 -49.0 79.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.03 -1.044 . . . . 0.0 111.312 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 31' ' ' SER . 42.8 p-10 -61.85 -39.15 90.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 110.866 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 93.4 p -62.62 -40.43 96.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.789 -1.194 . . . . 0.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.415 HG21 ' CG ' ' A' ' 45' ' ' TYR . 95.9 mt -60.29 -49.71 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.989 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -65.66 -39.93 91.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 109.817 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -63.72 -22.42 66.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.03 -1.24 52.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.0 . . . . 0.0 109.602 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.08 19.08 44.03 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.041 -1.037 . . . . 0.0 111.418 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -81.23 160.61 24.25 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.356 . . . . 0.0 110.281 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.22 137.01 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.96 102.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.061 . . . . 0.0 109.841 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 171.02 41.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.4 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.443 -1.034 . . . . 0.0 109.242 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 95.4 mtp 56.66 23.52 7.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.664 -0.647 . . . . 0.0 110.222 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.71 40.26 23.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 111.259 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.552 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.9 pt -139.84 163.82 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.024 -1.047 . . . . 0.0 109.179 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 32' ' ' ILE . 80.2 m-85 -90.51 131.77 36.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.043 -1.035 . . . . 0.0 110.167 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 17.5 m-70 -123.68 132.07 53.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.687 -0.633 . . . . 0.0 109.869 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 30.9 ttt180 -104.86 121.71 44.26 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 48.1 m-70 -95.4 171.0 8.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.393 -0.817 . . . . 0.0 109.562 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.63 -50.05 71.2 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.8 m -92.37 144.23 28.59 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.33 -6.0 17.3 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.7 0.933 . . . . 0.0 112.104 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -93.15 0.89 57.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.154 -0.967 . . . . 0.0 109.407 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.48 14.25 82.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 p -70.43 -40.45 73.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.081 -1.246 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.46 166.86 48.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.483 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 20.8 Cg_endo -70.86 -179.49 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.195 1.263 . . . . 0.0 111.751 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.25 121.69 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -95.96 -20.54 18.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.995 -1.066 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -169.63 158.15 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.937 . . . . 0.0 108.948 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.473 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.6 m -127.26 171.86 11.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.935 0.874 . . . . 0.0 111.822 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.2 tt -140.08 130.2 25.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.543 0.687 . . . . 0.0 109.189 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.17 163.89 28.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.672 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 83.7 m-20 -74.11 158.03 34.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.062 . . . . 0.0 110.127 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.02 -23.8 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.62 -0.675 . . . . 0.0 110.537 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.5 p -87.17 129.88 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.978 -1.076 . . . . 0.0 109.775 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -60.45 149.86 75.83 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.481 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.31 4.72 26.34 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.546 -0.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.88 85.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -85.48 170.98 12.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -1.202 . . . . 0.0 109.473 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.672 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 82.7 m-85 -116.46 150.58 37.62 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 7.5 m-20 -139.06 152.31 69.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.89 -15.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.045 1.163 . . . . 0.0 112.65 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.1 mt-10 -85.24 13.33 6.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' ASP . 24.3 ptt? -82.7 -7.3 59.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.77 -0.581 . . . . 0.0 110.243 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.8 mttt -85.25 -4.03 59.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.08 -1.013 . . . . 0.0 110.222 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 71.1 m-20 -150.29 73.23 1.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.933 -1.104 . . . . 0.0 109.885 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -158.1 169.86 23.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 p -131.96 150.11 52.25 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.218 -0.926 . . . . 0.0 109.093 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.75 147.78 19.66 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.972 -1.08 . . . . 0.0 108.77 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.99 -33.53 5.52 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.62 0.88 . . . . 0.0 111.866 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.44 -146.42 9.8 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.481 -1.343 . . . . 0.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 28.1 m -130.03 159.11 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.602 -0.94 . . . . 0.0 109.655 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 m -114.23 121.12 42.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.592 -0.692 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -102.55 125.72 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -149.86 161.96 41.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.953 -1.092 . . . . 0.0 110.65 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 4.9 tpt -146.31 147.46 31.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.72 . . . . 0.0 109.238 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' N ' ' SD ' ' A' ' 86' ' ' MET . 92.9 mt-30 -94.07 121.88 36.01 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.44 151.59 37.74 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.89 172.5 56.33 Favored 'Cis proline' 0 N--CA 1.503 2.033 0 C-N-CA 124.057 -1.226 . . . . 0.0 113.055 0.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.562 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 15.9 m -130.32 167.11 19.03 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.841 0.829 . . . . 0.0 111.031 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -72.8 144.47 47.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.05 -151.01 34.64 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -97.31 123.22 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.359 -1.083 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' N ' ' A' ' 90' ' ' SER . 53.5 mm-40 -56.21 -30.05 61.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 0.0 109.532 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.95 -40.02 79.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.258 -0.901 . . . . 0.0 109.077 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -73.05 -40.37 65.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.928 -1.108 . . . . 0.0 108.093 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 58' ' ' LEU . 77.7 m-20 -64.65 -40.01 94.69 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.14 -46.02 91.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.739 -0.601 . . . . 0.0 109.97 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.5 -39.87 89.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.417 ' O ' ' OG ' ' A' ' 104' ' ' SER . 64.9 mtp -60.03 -49.65 76.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.161 -0.962 . . . . 0.0 108.793 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.98 -45.98 83.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.427 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 92.7 mt-30 -59.98 -39.93 87.37 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 101' ' ' MET . 16.4 p -69.91 -41.49 74.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.369 -0.832 . . . . 0.0 109.035 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.01 -57.71 11.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.415 -0.803 . . . . 0.0 110.085 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.61 -39.62 88.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.693 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.5 m-70 -59.82 -49.8 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 108.775 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.19 -48.87 61.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.98 -39.84 93.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 110.281 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.66 -40.11 84.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.22 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 114' ' ' GLY . 5.8 m -100.65 -0.68 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.267 -0.896 . . . . 0.0 109.903 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 20.89 74.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -82.44 -173.76 49.35 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.47 132.96 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -1.049 . . . . 0.0 109.851 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.17 131.96 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.7 158.23 39.16 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.615 0.721 . . . . 0.0 109.645 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -86.23 -174.31 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.517 -0.74 . . . . 0.0 109.564 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.9 m-20 -59.97 -36.09 76.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.011 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 120' ' ' GLN . 27.4 mp0 -78.73 16.32 0.88 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.4 mtm-85 56.19 39.52 30.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.521 -0.737 . . . . 0.0 110.582 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.84 155.59 33.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.463 -0.773 . . . . 0.0 109.202 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.5 mtm -54.14 132.75 43.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.373 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 79.4 mmm -60.35 140.04 57.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.257 -0.902 . . . . 0.0 110.193 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.7 p -130.81 150.56 76.85 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -48.43 -39.44 36.11 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 CA-C-N 119.36 0.807 . . . . 0.0 111.974 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.32 -40.77 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.439 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.84 -39.42 76.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.49 -0.756 . . . . 0.0 110.087 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.39 -40.08 77.46 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 130' ' ' ARG . 26.4 ttm-85 -62.91 -40.01 96.27 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.358 -0.839 . . . . 0.0 109.1 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.83 -47.9 83.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.958 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.07 -41.93 93.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.986 -1.071 . . . . 0.0 108.182 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.423 ' HA ' HD12 ' A' ' 136' ' ' ILE . 97.3 mt-30 -62.29 -38.25 88.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 96.0 m-20 -60.35 -40.78 91.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.329 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.8 -39.84 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.988 . . . . 0.0 108.994 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 133' ' ' GLN . 83.1 mt -60.06 -49.2 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.3 mtm180 -61.59 -39.58 91.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.019 -1.051 . . . . 0.0 110.396 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.9 mt-10 -60.23 -39.99 88.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.972 -1.08 . . . . 0.0 110.769 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.88 -36.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 144' ' ' ALA . 60.5 mttm -59.94 -45.5 92.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.97 -1.081 . . . . 0.0 111.702 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 1.1 p-10 -60.85 -34.27 74.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.713 -1.242 . . . . 0.0 110.036 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.65 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.769 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.76 -2.23 30.61 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.087 -1.008 . . . . 0.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 mttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.11 141.17 35.37 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -157.84 159.97 37.23 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.697 -1.252 . . . . 0.0 110.469 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.86 132.34 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.628 -0.67 . . . . 0.0 109.98 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.05 139.23 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 93.8 mt -127.85 143.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 122.203 1.002 . . . . 0.0 111.558 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -144.32 151.05 38.81 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.56 126.14 28.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.712 -1.242 . . . . 0.0 110.951 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.71 114.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.53 152.83 38.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.862 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.26 -164.49 0.11 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.391 -0.818 . . . . 0.0 109.274 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -62.55 153.03 33.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.99 140.78 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.05 -1.031 . . . . 0.0 109.14 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.12 -1.97 80.83 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.2 m -118.67 151.4 38.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.566 -0.961 . . . . 0.0 109.185 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -128.15 148.9 50.61 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.49 -0.756 . . . . 0.0 108.999 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.16 144.46 28.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -67.92 141.99 56.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.094 -1.004 . . . . 0.0 108.929 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.92 -42.33 98.19 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.576 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.27 -47.64 85.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.044 -1.268 . . . . 0.0 110.153 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.74 -28.26 66.65 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.9 tt -73.44 -59.8 2.54 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.115 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.07 -41.43 92.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 109.264 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -62.91 -43.3 99.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 110.02 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.1 p -65.55 -38.59 90.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.03 -46.21 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.998 -1.064 . . . . 0.0 109.358 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.5 -40.85 98.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.734 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.8 -22.3 65.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.06 8.09 9.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 82.28 12.64 80.37 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.36 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -81.19 153.74 27.05 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.741 -1.446 . . . . 0.0 109.856 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.4 mt -124.38 133.89 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -60.89 98.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.908 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.91 171.1 44.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.99 -163.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -1.219 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.3 mtt 58.46 20.0 7.04 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 49.95 39.95 19.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.671 -0.643 . . . . 0.0 111.248 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 pt -141.08 167.25 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.052 -1.03 . . . . 0.0 108.817 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -93.49 123.33 36.72 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.971 -1.08 . . . . 0.0 110.552 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -106.53 136.45 46.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.686 -0.634 . . . . 0.0 109.367 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HG2' HH11 ' A' ' 47' ' ' ARG . 0.0 OUTLIER -99.89 128.43 45.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 108.598 178.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.41 165.18 11.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.534 -0.729 . . . . 0.0 109.14 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 tp -59.73 -49.32 78.21 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.2 m -90.54 145.0 31.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.855 . . . . 0.0 109.142 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -67.2 -10.72 29.59 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 120.679 0.919 . . . . 0.0 111.712 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 44.8 t0 -92.91 -1.33 56.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 109.815 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.4 t -70.03 -40.06 75.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.942 -1.328 . . . . 0.0 109.391 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.61 160.99 45.93 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.46 170.97 10.09 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.397 1.099 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.509 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.34 129.94 35.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.277 -0.89 . . . . 0.0 109.638 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.3 mp -101.76 -39.58 7.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.188 -0.945 . . . . 0.0 109.679 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -150.0 162.88 39.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.09 -1.006 . . . . 0.0 108.692 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -129.61 173.06 10.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.961 0.886 . . . . 0.0 111.273 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.7 tt -131.79 129.96 41.2 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.37 162.94 29.82 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 93.8 m-20 -74.25 157.22 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 109.651 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -69.92 -28.21 65.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.747 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.68 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -60.06 152.25 62.09 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.95 1.9 48.71 Favored 'Cis proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.58 0.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.62 -0.11 79.74 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.9 p -87.81 169.55 11.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -1.111 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 94.0 m-85 -121.3 140.8 51.6 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 73' ' ' GLU . 75.9 m-20 -121.7 150.21 54.81 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -50.45 -9.17 0.17 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 119.267 0.774 . . . . 0.0 111.63 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.1 mm-40 -90.12 6.84 40.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.856 . . . . 0.0 109.498 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.439 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 68.9 mmm -86.39 21.84 1.99 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 26.7 mtpp -86.0 -6.9 58.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.901 -1.124 . . . . 0.0 109.07 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.2 m-20 -149.94 80.12 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.2 170.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.834 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.7 p -133.98 152.28 51.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.16 148.43 18.38 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.077 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -46.66 -44.17 22.0 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 CA-C-N 119.094 0.712 . . . . 0.0 111.232 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.16 -152.98 11.05 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.453 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -129.98 160.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.994 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.5 m -114.42 120.52 40.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.2 129.98 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -145.7 152.97 40.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.022 -1.048 . . . . 0.0 110.592 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.5 ttm -109.2 129.92 55.49 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.702 -0.624 . . . . 0.0 109.376 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 108.758 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 9' ' ' ALA . 2.1 m -98.16 151.14 37.38 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.207 -0.933 . . . . 0.0 108.569 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.91 138.19 53.8 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.043 -1.232 . . . . 0.0 112.57 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.9 m -113.24 149.41 33.83 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.488 0.661 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -70.95 149.2 46.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -0.772 . . . . 0.0 110.023 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.04 -164.16 32.2 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -98.38 114.66 27.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -1.145 . . . . 0.0 109.359 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.89 -27.95 63.76 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.0 -41.68 61.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 108.133 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -63.14 -34.55 77.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.13 -50.02 74.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.53 -39.97 89.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -61.17 -40.0 92.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.95 -45.02 93.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 108.997 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.24 -42.53 99.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.328 -0.858 . . . . 0.0 108.866 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.494 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.7 mm-40 -60.18 -40.13 88.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 109.135 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.3 p -70.48 -40.0 73.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.515 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.73 43.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 110.044 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.83 -37.68 85.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 64.4 m170 -59.94 -49.36 77.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.074 -1.016 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 89.2 mt -60.06 -46.44 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.303 -0.873 . . . . 0.0 108.729 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.66 -46.81 63.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.443 -0.785 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.49 -40.08 90.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 110.547 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.89 -40.1 75.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -0.965 . . . . 0.0 110.931 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 114' ' ' GLY . 12.8 m -100.18 0.75 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.187 -0.946 . . . . 0.0 110.018 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.58 25.32 70.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -86.07 -173.04 49.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -129.9 132.76 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.691 -0.887 . . . . 0.0 109.285 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.52 134.68 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.302 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.9 mt -135.05 159.95 39.87 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -86.47 -169.2 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.506 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 96.8 m-20 -60.06 -38.95 84.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -75.4 12.42 0.98 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.28 37.58 28.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.803 -0.56 . . . . 0.0 109.764 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -117.11 158.72 23.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.713 -0.617 . . . . 0.0 109.747 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.1 mmm -51.17 120.67 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.297 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 mtp -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.195 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -130.18 152.12 79.58 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -43.96 -42.97 12.49 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 120.582 0.855 . . . . 0.0 111.976 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.88 -39.93 91.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.83 -40.02 83.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.854 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.1 mt -57.54 -40.04 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.95 -39.96 93.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.592 -0.692 . . . . 0.0 109.265 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.42 -47.25 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.125 -0.985 . . . . 0.0 109.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 55.7 m-85 -60.06 -41.98 93.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 108.983 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.36 -40.09 89.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.3 m-20 -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.63 -43.82 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.118 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 78.6 mt -60.18 -39.95 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.964 . . . . 0.0 109.798 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.0 -39.98 87.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.961 -1.087 . . . . 0.0 109.104 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.15 -30.72 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.0 mmtt -59.98 -45.0 94.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.023 -1.048 . . . . 0.0 110.446 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -59.92 -36.2 76.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.845 -1.16 . . . . 0.0 109.805 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.29 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -103.7 -0.56 29.29 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.328 -0.858 . . . . 0.0 110.353 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -150.56 135.45 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.01 177.99 10.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.208 -1.557 . . . . 0.0 112.011 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.54 138.88 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -91.28 126.37 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -125.78 145.05 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 121.961 0.886 . . . . 0.0 110.806 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.5 mtm -148.33 154.37 39.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 117' ' ' LEU . 73.3 m-20 -132.15 131.84 42.64 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.963 -1.086 . . . . 0.0 111.383 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -109.17 118.81 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 156.79 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.21 175.63 5.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.473 -0.767 . . . . 0.0 109.059 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -56.08 160.14 3.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.228 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -60.07 141.72 55.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.389 -0.82 . . . . 0.0 109.832 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.28 2.02 74.47 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.1 m -125.52 148.52 48.86 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.422 -1.046 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.0 151.37 50.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.452 -0.78 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.17 139.54 30.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.323 -0.86 . . . . 0.0 110.331 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.63 141.42 56.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.813 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.23 96.43 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.39 -47.46 85.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.324 . . . . 0.0 109.56 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.34 -25.81 64.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 108.817 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.13 -55.61 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.566 -0.709 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.86 -49.03 79.29 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 0.0 110.315 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.07 -44.52 94.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.7 m -61.83 -42.92 99.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.866 -1.146 . . . . 0.0 110.369 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.79 -44.86 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.964 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.22 -40.0 95.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.71 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.48 -19.72 63.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.19 -0.944 . . . . 0.0 111.431 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.502 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -81.47 -9.89 59.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.626 -1.296 . . . . 0.0 110.83 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.551 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.72 8.75 22.17 Favored Glycine 0 N--CA 1.502 3.086 0 O-C-N 121.029 -1.044 . . . . 0.0 110.817 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.677 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 38.1 m-85 -81.59 144.6 31.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.827 -1.396 . . . . 0.0 110.094 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.47 132.23 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.07 106.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 110.131 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -95.6 171.9 29.54 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.78 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -1.109 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.2 mtt 58.12 20.09 6.67 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.687 0.756 . . . . 0.0 109.777 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 52.94 33.7 15.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 111.613 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.97 163.28 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -89.75 129.2 36.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.981 -1.075 . . . . 0.0 110.689 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 55.2 m-70 -115.72 130.02 56.69 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.677 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 39.9 ttm180 -104.64 124.31 49.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 24.9 m-70 -92.89 170.01 10.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 0.0 109.562 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.8 tp -55.66 -49.3 73.3 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -89.17 148.42 40.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -71.2 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.739 0.96 . . . . 0.0 112.372 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.69 0.23 54.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.01 -1.056 . . . . 0.0 110.383 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.82 86.3 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -72.25 -44.62 62.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.155 -1.203 . . . . 0.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -70.49 168.15 49.15 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.32 175.65 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.18 1.253 . . . . 0.0 111.837 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.85 121.25 26.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.5 mp -98.06 -55.21 2.85 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.068 -1.02 . . . . 0.0 109.715 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -142.97 160.54 40.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.07 . . . . 0.0 108.702 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -129.36 -179.05 4.93 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.231 1.015 . . . . 0.0 111.35 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.1 tt -139.77 130.23 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.624 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.25 168.46 18.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.47 -0.769 . . . . 0.0 109.61 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.697 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.3 m-20 -77.85 166.37 22.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.753 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 80.2 mmm -69.97 -22.2 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.89 -0.506 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 68' ' ' GLY . 14.3 t -87.66 118.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -62.27 149.31 87.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.206 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.47 10.73 15.5 Favored 'Cis proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.91 -1.287 . . . . 0.0 111.484 -1.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 79.04 29.12 52.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.7 p -86.03 169.04 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -1.108 . . . . 0.0 110.676 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.697 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 71.3 m-85 -126.06 156.38 40.06 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.1 p-10 -135.6 148.49 65.88 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.01 -16.82 6.76 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.503 0.858 . . . . 0.0 111.665 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -89.91 6.98 39.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.083 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.546 ' SD ' ' O ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.51 21.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.82 . . . . 0.0 109.808 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -86.05 -8.58 57.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.997 . . . . 0.0 109.911 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 83.7 m-20 -144.57 82.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.256 -0.903 . . . . 0.0 108.912 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.03 172.31 18.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 109.065 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.4 p -131.18 152.32 50.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.368 -0.833 . . . . 0.0 108.76 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.28 149.44 19.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -43.91 -49.73 8.02 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 120.495 0.796 . . . . 0.0 111.719 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.39 -152.26 8.7 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.99 160.89 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.6 -0.941 . . . . 0.0 109.573 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ALA . 52.8 m -112.15 128.03 56.1 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.558 -0.714 . . . . 0.0 110.103 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.98 130.0 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -149.64 167.08 27.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.565 -1.335 . . . . 0.0 110.879 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 ttp -132.94 130.8 40.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' OG ' ' A' ' 90' ' ' SER . 91.8 mt-30 -87.59 108.52 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 108.953 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.4 OUTLIER -97.54 144.05 27.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 88' ' ' VAL . 5.9 Cg_exo -74.04 134.91 37.73 Favored 'Cis proline' 0 N--CA 1.498 1.761 0 C-N-CA 124.341 -1.108 . . . . 0.0 113.371 0.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.3 m -110.41 159.91 17.06 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.54 0.686 . . . . 0.0 109.828 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -70.75 142.18 51.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.174 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.33 -159.71 26.41 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.59 123.55 39.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.16 -1.2 . . . . 0.0 109.562 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 39.5 mp0 -59.93 -36.61 77.41 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 110.402 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.69 -38.81 80.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.958 . . . . 0.0 109.955 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -69.97 -39.96 75.66 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.892 -1.13 . . . . 0.0 108.123 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -61.34 -39.99 92.6 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 102' ' ' LEU . 91.1 t80 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.85 -41.37 97.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.087 -1.008 . . . . 0.0 109.007 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.24 -39.98 94.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.897 . . . . 0.0 109.041 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.1 mtp -58.13 -48.36 80.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.429 -0.794 . . . . 0.0 109.312 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 98' ' ' PHE . 98.7 mt -63.66 -42.68 98.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.922 -1.111 . . . . 0.0 109.184 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.01 -41.72 92.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.711 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -69.94 -39.98 75.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.39 58.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -62.2 -40.63 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.001 -1.062 . . . . 0.0 110.084 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -60.47 -47.45 86.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.174 . . . . 0.0 108.749 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.92 -50.02 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.03 -49.97 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.661 -0.649 . . . . 0.0 109.844 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.18 -40.19 89.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.282 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.9 -40.01 75.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.937 . . . . 0.0 111.151 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.3 m -100.69 -1.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.084 -1.01 . . . . 0.0 109.826 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 24.63 75.38 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.9 -176.42 51.14 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.46 133.03 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.636 -0.92 . . . . 0.0 108.905 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 t -70.24 130.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.013 -1.054 . . . . 0.0 109.096 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 14' ' ' ASN . 77.4 mt -129.23 155.99 44.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.587 -0.695 . . . . 0.0 109.286 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.515 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 30.4 p-10 -85.42 -172.64 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 109.481 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.1 m-20 -60.01 -38.71 83.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.65 16.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.377 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.0 mtm180 56.1 33.55 22.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -109.87 149.1 30.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 0.0 109.144 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 65.5 mtt -50.75 135.73 23.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.977 . . . . 0.0 109.265 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.67 137.15 57.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -134.47 150.35 73.56 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.02 -42.37 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 119.162 0.736 . . . . 0.0 111.879 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -60.6 -39.98 90.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 51.0 mmtt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.058 -1.026 . . . . 0.0 110.051 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.9 -43.15 94.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -69.3 -32.9 72.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.799 -1.188 . . . . 0.0 109.747 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -59.98 -45.31 93.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.005 -1.06 . . . . 0.0 108.876 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -60.78 -41.07 94.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -39.96 93.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 0.0 109.085 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.54 -40.2 96.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.65 -42.06 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.03 -41.93 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.208 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.5 mtt180 -61.92 -37.65 85.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.7 mt-10 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.778 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.35 -32.16 30.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.9 mmmm -60.07 -45.92 91.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.075 -1.016 . . . . 0.0 110.17 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.79 -31.83 71.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.754 -1.216 . . . . 0.0 108.892 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.01 94.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 110.385 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 55.6 p30 -97.91 0.37 46.41 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 0.0 110.104 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.545 -179.88 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -145.0 151.86 39.24 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.29 160.34 32.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 109.932 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.16 129.99 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.27 117.16 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 84.2 mt -121.58 142.16 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 121.946 0.879 . . . . 0.0 111.191 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.0 mtm -146.1 150.18 35.45 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -129.71 128.67 42.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.972 -1.08 . . . . 0.0 111.291 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.45 116.4 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' VAL . . . -147.34 157.24 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 109.97 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.89 -174.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 109.063 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -61.02 156.65 17.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 108.88 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -60.02 140.12 57.01 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.51 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.18 70.23 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -121.11 147.3 45.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.551 -0.97 . . . . 0.0 109.699 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -125.87 145.5 50.22 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.42 149.18 25.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 110.564 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -70.84 145.27 50.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.129 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.56 -42.05 99.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.51 -43.75 98.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.301 . . . . 0.0 110.166 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.79 -27.02 64.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.0 tt -75.12 -57.86 3.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.541 -0.724 . . . . 0.0 109.912 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.32 -42.33 95.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.0 110.532 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -64.04 -40.06 95.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.2 m -65.19 -41.38 94.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 110.419 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.02 -46.88 93.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.009 -1.057 . . . . 0.0 109.4 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -65.38 -43.25 91.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 0.0 109.401 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -17.24 64.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.432 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.35 1.57 36.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.023 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.71 9.55 66.2 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 121.071 -1.018 . . . . 0.0 111.016 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -80.75 151.07 29.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.822 -1.399 . . . . 0.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.9 mt -120.0 130.67 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.88 101.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.995 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.05 171.22 38.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.3 -163.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.469 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.7 mtm 58.03 23.25 9.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.428 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.36 39.41 20.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 111.231 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.0 pt -142.0 164.84 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.026 -1.047 . . . . 0.0 109.429 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -91.89 136.28 33.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.072 -1.017 . . . . 0.0 109.886 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 43.8 m-70 -125.16 125.11 43.18 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.726 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.7 ttt180 -105.09 125.53 51.08 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.501 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 34.2 m-70 -94.73 173.99 7.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.442 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.64 -50.76 65.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.261 -0.899 . . . . 0.0 108.832 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -93.83 144.06 27.52 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 0.0 108.784 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.36 -4.42 11.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 120.57 0.847 . . . . 0.0 112.149 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -91.48 -0.94 57.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.383 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.28 86.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 t -69.95 -41.01 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -1.198 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.37 169.13 54.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.501 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.1 Cg_endo -69.55 173.47 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.2 1.266 . . . . 0.0 111.427 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 120.8 25.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.034 . . . . 0.0 108.649 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.7 mp -100.81 -35.08 9.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.234 -0.916 . . . . 0.0 109.75 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -153.47 165.45 35.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.924 -1.11 . . . . 0.0 108.762 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 5.4 m -138.48 161.97 35.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.037 -1.039 . . . . 0.0 111.229 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.6 tt -114.75 135.07 54.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.547 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.41 162.08 32.01 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.587 -0.696 . . . . 0.0 109.29 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.606 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 76.6 m-20 -78.64 166.85 22.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.015 -1.053 . . . . 0.0 110.053 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.4 mmm -69.92 -23.09 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.465 -0.772 . . . . 0.0 110.205 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -88.14 112.5 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 110.521 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -60.3 150.42 72.41 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -77.87 8.55 19.93 Favored 'Cis proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.114 -1.202 . . . . 0.0 111.982 -0.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.43 35.83 25.16 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.6 p -85.94 160.47 19.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.256 -1.143 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 32.7 m-85 -128.52 139.02 52.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 t70 -127.77 137.82 31.57 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -48.13 -4.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.591 1.247 . . . . 0.0 112.888 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -90.83 3.96 53.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.054 -1.028 . . . . 0.0 111.345 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.502 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 21.5 mtm -79.72 26.14 0.32 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.567 -1.333 . . . . 0.0 110.099 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.0 mmtp -81.91 2.39 30.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.581 -1.325 . . . . 0.0 109.261 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 70.1 m-20 -153.79 81.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 108.76 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -158.84 171.41 20.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.11 -0.994 . . . . 0.0 109.964 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.7 p -137.88 154.68 49.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.23 149.12 17.35 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 109.19 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -46.93 -45.22 21.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 120.786 0.991 . . . . 0.0 112.027 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.23 -152.84 10.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.94 159.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -1.05 . . . . 0.0 109.396 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ALA . 51.9 m -111.53 124.94 53.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.226 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.11 130.61 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.77 160.41 41.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 110.85 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.9 ttp -141.46 131.73 25.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.658 -0.651 . . . . 0.0 109.622 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.18 115.21 27.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.048 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.24 152.38 38.65 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.357 -0.839 . . . . 0.0 109.065 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -77.63 136.77 44.29 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.655 -1.394 . . . . 0.0 112.149 -0.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.9 m -104.59 166.52 10.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.574 -0.704 . . . . 0.0 109.721 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -68.93 141.5 54.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.446 -0.784 . . . . 0.0 109.045 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.78 28.4 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -94.19 115.33 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.966 -1.314 . . . . 0.0 109.703 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 50.5 mp0 -58.05 -28.0 64.11 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.696 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.8 mt -69.73 -40.04 76.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.196 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -73.05 -40.51 65.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.901 -1.124 . . . . 0.0 108.948 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.445 ' OD1' HD23 ' A' ' 58' ' ' LEU . 84.0 m-20 -61.86 -41.96 98.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 102' ' ' LEU . 73.8 t80 -59.86 -49.92 75.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.75 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.13 -39.96 94.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -43.39 95.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.0 mtp -57.78 -44.57 86.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 108.746 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.4 mt -62.0 -41.21 97.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 108.726 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.15 -41.54 92.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.086 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -70.28 -39.89 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 109.147 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.82 68.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 110.435 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -60.76 -37.83 83.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.87 -1.144 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -60.06 -50.05 75.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.048 -1.033 . . . . 0.0 109.151 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.9 -50.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.539 -0.725 . . . . 0.0 109.652 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.46 -49.36 55.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.58 -39.78 89.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 110.338 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.11 -40.06 75.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.675 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.1 m -98.84 0.4 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.055 -1.028 . . . . 0.0 109.491 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.22 21.87 75.9 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -79.94 -176.8 49.96 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 16' ' ' ALA . 58.4 t -135.33 140.74 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.6 -0.941 . . . . 0.0 108.952 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.536 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -73.3 127.95 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.978 . . . . 0.0 109.945 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 mt -128.8 153.62 47.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.76 -178.04 6.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' NH1' ' A' ' 121' ' ' ARG . 97.9 m-20 -59.39 -28.89 67.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.049 -1.032 . . . . 0.0 109.082 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -82.13 12.36 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 108.972 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 119' ' ' ASP . 14.6 mmt-85 61.48 27.59 17.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.7 -0.625 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -107.88 147.8 30.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 0.0 109.328 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . 0.402 ' SD ' HG11 ' A' ' 115' ' ' VAL . 92.2 mmm -50.41 121.6 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.665 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.536 ' SD ' HG12 ' A' ' 116' ' ' VAL . 35.2 mtp -59.79 139.93 56.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.839 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -130.29 151.0 77.74 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -41.94 -41.64 6.54 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 120.503 0.802 . . . . 0.0 111.622 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.07 -42.19 94.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.445 -0.784 . . . . 0.0 109.235 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.49 -39.88 77.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.862 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.5 mt -56.61 -40.09 74.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.814 -1.179 . . . . 0.0 108.373 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -64.63 -38.23 90.29 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.017 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.98 -45.56 92.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.971 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.23 -41.96 94.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.862 -1.149 . . . . 0.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.62 -39.78 92.49 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 97.6 m-20 -60.06 -39.63 86.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.513 -0.742 . . . . 0.0 109.183 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.1 mt -59.93 -41.73 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 108.65 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.21 -39.87 81.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.36 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.528 ' HG2' HH11 ' A' ' 137' ' ' ARG . 16.3 mtt-85 -59.99 -40.14 88.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.576 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -60.39 -39.8 88.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.925 -1.109 . . . . 0.0 109.035 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.6 -32.03 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.6 mttt -60.0 -42.68 94.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.841 -1.162 . . . . 0.0 110.923 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.985 -1.072 . . . . 0.0 109.854 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.89 -59.13 3.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.924 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -103.9 -14.57 15.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.296 -0.878 . . . . 0.0 110.478 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.4 148.11 29.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.47 175.97 8.6 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.67 -1.269 . . . . 0.0 110.359 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.08 131.44 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -91.25 125.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.12 144.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.896 0.855 . . . . 0.0 110.867 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.5 mtt -144.6 156.16 43.99 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.5 126.72 24.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.959 -1.088 . . . . 0.0 111.022 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.01 119.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.3 158.63 44.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.775 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.65 -164.49 0.09 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -69.26 159.42 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 108.815 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -60.07 140.79 56.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.09 80.39 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.8 m -110.04 152.4 25.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.391 -1.064 . . . . 0.0 109.216 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -130.25 149.03 52.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.8 140.36 29.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.02 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.82 143.42 54.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.12 96.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.03 -44.83 96.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -1.209 . . . . 0.0 109.545 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.02 -29.48 66.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -0.812 . . . . 0.0 108.931 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.3 tt -71.14 -57.3 4.64 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.6 -0.687 . . . . 0.0 109.456 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.99 -43.41 95.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.187 -0.946 . . . . 0.0 110.476 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.93 -40.02 94.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 110.056 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -65.51 -40.16 92.68 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.928 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -48.34 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -62.23 -43.32 99.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.982 . . . . 0.0 110.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.87 -20.01 66.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.5 5.62 17.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.35 85.14 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -81.22 154.37 26.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.038 -1.272 . . . . 0.0 109.619 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.9 mt -128.63 142.81 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -59.04 99.92 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.113 -0.992 . . . . 0.0 109.542 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.22 168.85 45.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -62.99 -163.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.496 -1.003 . . . . 0.0 108.923 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt 56.5 22.2 6.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -0.819 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 51.89 40.09 27.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 111.146 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.08 170.03 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 109.327 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.22 135.08 34.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.978 -1.076 . . . . 0.0 109.836 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 6.2 m-70 -119.53 133.91 55.46 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.407 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 7.5 tpt180 -102.38 120.97 41.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.385 -0.822 . . . . 0.0 108.972 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 68.7 m-70 -98.26 170.06 9.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 109.723 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.26 -49.98 74.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 108.988 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.8 m -91.93 147.78 35.61 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.95 -6.18 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.671 0.914 . . . . 0.0 112.794 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -93.23 -0.89 56.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.917 -1.115 . . . . 0.0 110.158 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.43 12.09 84.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.466 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.9 p -70.2 -39.9 74.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.53 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.88 167.1 51.05 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.03 171.31 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.228 1.285 . . . . 0.0 112.113 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.35 122.82 28.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.209 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' OD1' ' A' ' 97' ' ' ASN . 8.4 mp -98.91 -36.87 9.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.228 -0.92 . . . . 0.0 109.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.8 162.31 40.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 108.589 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.529 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 4.4 m -131.06 175.99 8.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.081 -1.012 . . . . 0.0 111.859 -177.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.65 131.69 33.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.44 162.17 35.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.679 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.7 m-20 -77.2 162.92 27.01 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.212 -0.93 . . . . 0.0 110.751 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mtt -69.96 -23.72 63.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.598 -0.689 . . . . 0.0 110.396 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -85.85 119.99 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.971 -1.081 . . . . 0.0 109.632 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -59.89 149.71 71.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.52 -0.738 . . . . 0.0 109.064 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -77.12 8.94 16.4 Favored 'Cis proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.758 -0.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 16.69 76.52 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.1 p -87.99 173.56 8.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.079 -1.247 . . . . 0.0 109.924 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.679 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.04 140.12 51.49 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLU . 5.6 m-20 -126.52 150.08 69.66 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -45.39 -12.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.6 0.867 . . . . 0.0 111.93 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -83.54 13.22 4.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.4 ptt? -83.82 -1.39 54.25 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.513 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 98.9 mttt -85.94 -3.78 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.798 -1.189 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.0 m-20 -150.45 75.75 1.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.686 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -159.06 168.98 25.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.118 -0.989 . . . . 0.0 109.414 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.8 p -136.53 155.56 49.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.44 150.43 20.7 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 109.449 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -47.22 -46.72 18.86 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 120.366 0.711 . . . . 0.0 111.24 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.38 -151.04 8.06 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.98 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.529 -0.983 . . . . 0.0 109.322 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.5 m -113.02 120.18 40.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 0.0 109.489 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.21 129.97 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -143.71 163.69 32.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.125 -0.984 . . . . 0.0 110.496 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.0 ttp -138.97 129.74 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.713 -0.617 . . . . 0.0 109.563 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -92.28 119.71 32.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 0.0 109.117 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -102.75 150.31 37.6 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.24 133.76 32.69 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.568 0.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.8 m -102.18 170.23 8.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.95 139.95 55.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.377 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.82 -154.38 24.65 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -99.58 122.02 42.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.299 -1.118 . . . . 0.0 109.652 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.6 mp0 -55.87 -28.61 57.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.5 -39.93 77.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.037 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -40.34 70.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.095 -1.003 . . . . 0.0 109.102 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.741 ' OD1' HD23 ' A' ' 58' ' ' LEU . 98.6 m-20 -60.59 -40.04 90.3 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 102' ' ' LEU . 86.2 t80 -57.02 -41.43 78.54 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.41 -42.03 99.14 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.137 -0.977 . . . . 0.0 108.733 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.01 -39.99 95.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 108.71 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mmm -57.23 -50.12 73.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.832 . . . . 0.0 109.497 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.545 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.8 mt -64.35 -47.75 78.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.24 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.3 mt-30 -60.0 -40.84 90.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.782 . . . . 0.0 109.217 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 p -71.96 -42.93 65.99 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.167 -0.958 . . . . 0.0 109.298 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.12 -54.53 44.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -62.78 -35.09 78.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.585 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 30.7 m170 -60.05 -49.94 75.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 112' ' ' VAL . 81.5 mt -59.97 -49.91 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.889 -1.132 . . . . 0.0 108.011 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.95 -49.22 66.49 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.04 -40.01 91.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.558 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.94 77.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.8 m -96.12 0.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.975 -1.078 . . . . 0.0 108.873 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 21.67 76.91 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . -84.07 -169.68 45.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -131.97 138.11 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.602 -0.94 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG12 ' SD ' ' A' ' 124' ' ' MET . 19.8 t -73.69 138.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.284 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.28 160.0 37.5 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.436 -0.79 . . . . 0.0 109.649 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -84.13 -171.67 3.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.402 -0.811 . . . . 0.0 109.672 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.512 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 94.7 m-20 -60.01 -39.86 87.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.217 -0.927 . . . . 0.0 110.083 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.43 14.47 0.97 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -0.909 . . . . 0.0 109.396 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 57.4 37.63 28.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.745 -0.597 . . . . 0.0 109.744 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -112.13 151.48 29.42 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 19.5 mmt -50.2 126.37 14.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.957 -1.09 . . . . 0.0 109.284 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 116' ' ' VAL . 24.9 mtt -58.9 139.97 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.788 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -129.12 151.36 77.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -41.47 -45.0 6.1 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 120.762 0.975 . . . . 0.0 112.184 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -60.8 -39.9 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.768 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -63.74 -40.05 95.79 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.243 -0.91 . . . . 0.0 109.717 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.57 -40.05 86.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.706 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -66.26 -37.94 86.64 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.615 -0.678 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.13 -49.99 75.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.528 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.512 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 73.1 m-85 -59.97 -49.37 77.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 108.738 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.17 -38.05 82.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.08 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.1 -40.96 91.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.149 -0.969 . . . . 0.0 109.67 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.65 -40.06 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.639 -1.288 . . . . 0.0 108.467 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.97 -47.57 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.15 -39.89 87.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.863 . . . . 0.0 108.915 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 89.6 mt-10 -60.98 -41.1 95.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.85 -39.95 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -60.01 -44.92 94.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.349 -0.844 . . . . 0.0 111.592 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.6 p30 -59.97 -34.15 72.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.574 -1.329 . . . . 0.0 109.112 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.39 -35.92 82.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.027 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -97.31 -0.23 46.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.741 . . . . 0.0 109.382 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.39 144.11 27.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.17 9.83 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.584 -1.322 . . . . 0.0 110.148 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.81 130.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.17 122.67 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.2 mt -120.06 147.63 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.23 1.014 . . . . 0.0 111.372 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -143.81 147.37 34.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.43 120.96 25.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.5 117.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.54 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.452 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.53 -164.49 0.12 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.9 155.03 39.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.925 -1.109 . . . . 0.0 108.482 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -59.93 139.99 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.076 . . . . 0.0 109.349 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.57 3.5 66.6 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -124.42 149.43 46.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.501 -1.0 . . . . 0.0 109.248 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.73 145.81 50.46 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.21 146.34 27.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 143.62 54.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 109.156 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.55 -43.43 98.88 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.28 -45.67 92.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -1.214 . . . . 0.0 110.152 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.79 -29.83 67.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -71.32 -58.79 3.2 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.583 -0.698 . . . . 0.0 109.347 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.7 mt -60.09 -41.63 92.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.62 -39.89 94.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -64.26 -40.81 96.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.695 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.19 -44.64 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.333 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -64.34 -40.37 95.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.029 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' OE1' ' OE2' ' A' ' 111' ' ' GLU . 78.0 mt-30 -68.27 -20.04 64.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.279 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.71 7.29 15.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.196 -0.94 . . . . 0.0 110.292 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.63 83.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.988 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -80.63 152.53 28.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.434 . . . . 0.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.39 145.26 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.82 118.86 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.0 108.966 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -87.67 171.57 41.59 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.6 -162.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.569 -0.96 . . . . 0.0 109.711 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 89.8 mmm 54.78 -101.34 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' MET . 26.7 m120 -163.27 31.85 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 pt -134.69 163.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.494 -0.754 . . . . 0.0 110.115 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 66.8 m-85 -88.07 134.41 33.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.296 -0.878 . . . . 0.0 110.143 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.451 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 8.0 m-70 -118.34 129.79 55.64 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.55 HH21 HD22 ' A' ' 100' ' ' LEU . 15.9 ttt180 -106.11 125.42 50.97 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.568 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 49.4 m-70 -95.13 174.12 7.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.824 . . . . 0.0 110.222 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.33 -49.97 74.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.8 m -92.7 147.89 35.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.28 -0.887 . . . . 0.0 108.693 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.12 -5.95 17.07 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.68 0.92 . . . . 0.0 112.06 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -92.65 1.28 57.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.179 -0.95 . . . . 0.0 110.204 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.74 11.45 84.53 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -70.15 -40.07 74.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.241 . . . . 0.0 110.091 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.547 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.0 169.82 53.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.568 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.4 Cg_endo -72.78 -179.96 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.133 1.222 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.43 123.4 29.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 108.729 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.2 mp -101.02 -28.3 12.8 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -159.94 165.31 32.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.599 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.451 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 17.2 m -132.48 170.11 15.6 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.129 -0.982 . . . . 0.0 111.53 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.7 tt -132.63 130.96 40.88 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.625 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.14 169.68 17.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 91.7 m-20 -75.14 163.49 27.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 109.617 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -70.02 -21.68 63.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.44 -0.788 . . . . 0.0 110.464 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.17 114.85 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.109 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -60.13 149.75 73.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.417 -0.802 . . . . 0.0 109.422 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -76.49 6.8 16.3 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.858 -1.309 . . . . 0.0 111.374 -1.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.89 31.23 49.5 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 p -86.09 165.85 16.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.286 . . . . 0.0 109.944 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.548 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.24 148.65 43.42 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' MET . 1.8 p30 -133.96 151.4 76.7 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.34 -11.86 0.41 Allowed 'Trans proline' 0 N--CA 1.486 1.072 0 CA-C-N 119.429 0.832 . . . . 0.0 110.362 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 75.3 mm-40 -82.17 6.48 16.42 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 23.3 ptt? -79.61 1.65 25.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -85.02 -2.15 57.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.82 -1.175 . . . . 0.0 108.267 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -154.09 78.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -159.3 167.61 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.221 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.6 p -140.72 154.58 46.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.235 -0.916 . . . . 0.0 108.936 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.83 150.16 21.02 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.075 -1.015 . . . . 0.0 109.248 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -41.93 -36.87 3.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 120.724 0.95 . . . . 0.0 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.41 -150.63 12.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.97 159.97 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 109.58 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -113.17 125.9 54.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.675 . . . . 0.0 109.632 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.12 129.97 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -146.79 166.26 27.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.972 -1.08 . . . . 0.0 110.274 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 50.3 ttp -137.33 131.32 32.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 90' ' ' SER . 90.4 mm-40 -88.15 117.73 27.25 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -105.5 148.2 35.94 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 137.5 50.24 Favored 'Cis proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.695 -1.377 . . . . 0.0 112.262 -0.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 51.2 m -103.73 166.94 10.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.502 -0.749 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -72.19 146.22 47.51 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.587 -0.696 . . . . 0.0 109.352 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 -156.35 31.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.14 111.95 23.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -1.135 . . . . 0.0 109.019 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.8 mp0 -54.18 -26.46 28.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.467 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.9 mt -70.02 -39.95 75.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.0 108.68 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -71.61 -40.02 70.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.478 ' ND2' HD23 ' A' ' 58' ' ' LEU . 10.2 m-20 -59.99 -40.41 89.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 102' ' ' LEU . 89.8 t80 -59.91 -45.45 92.52 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.44 -40.59 97.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 HH21 ' A' ' 47' ' ' ARG . 92.6 mt -60.98 -40.04 91.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 108.842 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp -59.41 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 98' ' ' PHE . 99.5 mt -65.26 -43.46 91.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.176 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -60.1 -39.98 88.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 p -70.47 -40.06 73.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.413 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.13 -53.78 54.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 110.239 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -61.88 -41.09 97.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.876 -1.14 . . . . 0.0 109.244 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -60.34 -50.01 75.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.14 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 112' ' ' VAL . 90.5 mt -60.8 -49.99 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.101 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.49 -49.47 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.503 -0.748 . . . . 0.0 109.135 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.07 -40.1 88.32 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.428 -0.795 . . . . 0.0 110.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.406 ' OE2' ' OE1' ' A' ' 34' ' ' GLN . 41.4 mt-10 -69.57 -39.92 77.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.975 -1.078 . . . . 0.0 110.721 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.6 m -99.65 -2.24 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.059 -1.026 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.06 23.76 76.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.07 -176.15 51.07 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.289 -1.124 . . . . 0.0 110.57 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.03 136.32 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.945 . . . . 0.0 109.692 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.64 133.13 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -133.15 161.81 33.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.802 . . . . 0.0 109.168 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -84.23 -170.57 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.915 . . . . 0.0 109.702 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 89.4 m-20 -60.09 -39.94 87.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.85 . . . . 0.0 110.046 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.547 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.6 mt-30 -80.33 14.18 2.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 59.68 34.52 22.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.983 -0.448 . . . . 0.0 111.702 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.547 HH12 ' CD ' ' A' ' 120' ' ' GLN . 50.9 mtm-85 -107.19 158.0 17.44 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.042 -1.036 . . . . 0.0 108.821 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.9 mtm -52.59 130.52 32.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.942 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mmm -59.94 141.57 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 110.066 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.0 p -132.25 150.04 74.88 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -47.3 -42.37 27.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.513 0.862 . . . . 0.0 112.082 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.09 -39.87 87.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.312 -0.868 . . . . 0.0 109.579 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -66.72 -40.02 88.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.94 -40.25 88.29 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.835 -1.166 . . . . 0.0 109.412 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.9 -37.66 86.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.349 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.87 -48.89 79.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.951 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.02 -45.36 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.986 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.8 -39.99 93.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.21 -40.02 88.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.28 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.07 -40.7 84.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.922 -1.112 . . . . 0.0 108.711 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.447 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.6 mmt180 -63.55 -36.15 82.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.18 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.02 -39.93 87.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.515 -0.741 . . . . 0.0 109.856 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.33 -35.15 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -59.77 -47.19 86.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 0.0 110.109 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -60.59 -31.96 71.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.871 -1.143 . . . . 0.0 109.3 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.99 92.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.79 0.26 44.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 108.904 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -144.36 142.59 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.73 -175.65 4.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.724 -1.235 . . . . 0.0 110.602 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -133.39 139.06 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mm -91.62 131.12 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.0 mt -121.11 147.29 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.989 0.9 . . . . 0.0 110.979 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.3 mtt -147.39 156.49 42.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -136.97 118.37 14.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.879 -1.138 . . . . 0.0 110.632 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.9 t -101.24 111.19 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.72 43.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.67 -164.11 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -68.39 161.47 27.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 108.624 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -61.93 140.04 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.047 -1.033 . . . . 0.0 109.895 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.35 2.13 85.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -116.94 146.33 43.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.446 -1.032 . . . . 0.0 109.054 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.7 144.98 50.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.92 147.94 26.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.43 138.25 55.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.44 97.07 Favored Glycine 0 N--CA 1.493 2.433 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.287 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.1 -45.49 94.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.284 . . . . 0.0 109.338 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.84 -27.02 64.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.1 tt -74.41 -59.61 2.65 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.558 -0.714 . . . . 0.0 109.593 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.99 -43.52 95.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.291 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.01 -41.85 97.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -64.3 -40.99 97.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.165 -0.96 . . . . 0.0 109.676 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.08 -48.22 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.89 -40.99 95.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 109.667 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.68 -19.79 63.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.489 -0.757 . . . . 0.0 110.468 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.86 6.16 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 0.0 110.136 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.34 78.37 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -1.2 . . . . 0.0 109.995 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.74 138.82 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.46 98.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.082 . . . . 0.0 109.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 171.46 53.9 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.14 -170.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.464 -1.021 . . . . 0.0 109.578 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 70.8 mtm 56.74 30.11 17.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.484 -0.76 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 48.78 40.05 15.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 111.642 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.24 162.33 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.03 -1.044 . . . . 0.0 109.541 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.1 121.55 32.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.614 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 7.2 m-70 -103.92 130.5 51.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.296 -0.878 . . . . 0.0 109.818 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 7.5 tpt180 -101.75 120.62 40.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 59.1 m-70 -98.19 169.43 9.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -0.896 . . . . 0.0 109.735 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.67 -49.48 76.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -90.65 138.82 26.41 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.335 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.56 -7.29 14.04 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 CA-C-N 119.69 0.925 . . . . 0.0 111.616 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -92.61 -0.17 57.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.85 86.58 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.19 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -68.63 -41.38 79.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.499 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.42 163.39 50.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 15.3 Cg_endo -67.77 171.38 12.25 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.002 1.134 . . . . 0.0 112.05 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.65 120.61 24.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 108.723 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.663 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -97.04 -31.28 12.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.181 -0.949 . . . . 0.0 108.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -156.84 164.52 37.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.614 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 1.7 m -135.72 -179.09 5.44 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.104 -0.997 . . . . 0.0 111.223 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.68 132.54 35.08 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.04 160.78 33.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.2 m-20 -73.66 159.27 33.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 109.266 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.02 -21.28 63.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.867 . . . . 0.0 110.573 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 65' ' ' VAL . 5.1 m -88.16 126.21 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.844 -1.16 . . . . 0.0 109.526 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -62.29 148.82 88.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 108.529 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.92 14.91 8.8 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.609 -1.413 . . . . 0.0 112.057 -0.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 71.26 20.42 78.11 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 p -88.01 167.97 13.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -1.138 . . . . 0.0 110.494 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 51.6 m-85 -120.28 143.46 48.32 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.683 -0.635 . . . . 0.0 109.476 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -126.87 136.66 29.13 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -49.1 -11.96 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 119.852 0.983 . . . . 0.0 113.17 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -87.46 -0.69 57.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.898 -1.126 . . . . 0.0 108.714 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 93.1 mtp -88.93 24.69 2.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.1 mttm -82.69 -3.96 57.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.841 -1.162 . . . . 0.0 109.282 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 84.0 m-20 -145.14 82.8 1.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.849 . . . . 0.0 108.734 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.42 176.43 11.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.7 p -130.24 153.44 48.6 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.57 150.42 19.42 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.801 -1.187 . . . . 0.0 110.506 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -46.4 -40.23 22.49 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 120.794 0.996 . . . . 0.0 111.912 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.89 -151.71 17.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.14 159.99 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.444 -1.033 . . . . 0.0 109.411 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.5 m -114.82 119.34 36.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.7 mt -102.6 134.48 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.44 163.21 35.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 110.025 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.5 ttp -137.74 129.55 28.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.713 . . . . 0.0 109.496 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -90.01 117.7 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 108.673 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.37 153.25 39.2 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.45 137.72 51.6 Favored 'Cis proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.789 -1.338 . . . . 0.0 112.132 0.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.0 m -106.15 165.71 11.04 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.55 -0.718 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -70.29 142.69 52.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 0.0 110.421 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.45 -152.97 22.36 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -97.37 116.97 30.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.328 -1.101 . . . . 0.0 108.951 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 32.5 mp0 -59.55 -34.11 72.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 110.165 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.09 -39.96 78.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.032 -1.042 . . . . 0.0 109.838 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -73.0 -39.5 66.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.791 -1.193 . . . . 0.0 108.368 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.1 -40.04 88.29 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 84.7 t80 -60.0 -46.48 89.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.08 -40.06 95.41 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.99 -44.28 94.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 90.9 mtp -57.47 -44.82 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 108.915 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.33 -43.71 98.18 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 108.765 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.87 -41.13 90.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.377 -0.827 . . . . 0.0 108.959 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -71.31 -41.45 69.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.25 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.08 71.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.435 -0.79 . . . . 0.0 110.255 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -61.62 -37.02 82.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.794 -1.191 . . . . 0.0 109.157 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -59.97 -47.6 85.17 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.07 -1.019 . . . . 0.0 109.128 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.9 mt -60.04 -49.94 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 108.927 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -54.13 -50.31 67.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.93 -40.19 88.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 110.052 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -70.05 -40.44 75.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 111.341 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 114' ' ' GLY . 10.2 m -99.35 -0.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.949 -1.094 . . . . 0.0 109.382 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.28 19.61 72.51 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -79.77 -172.34 43.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -127.83 133.61 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.483 -1.01 . . . . 0.0 109.221 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.95 131.52 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.702 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.61 159.52 36.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.454 -0.779 . . . . 0.0 109.448 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 42.9 p-10 -88.58 -170.26 2.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.4 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 109.881 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 93.8 mm-40 -76.13 14.61 0.69 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 108.645 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.2 mtm180 57.4 27.87 14.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.861 -0.525 . . . . 0.0 110.432 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.467 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 84.8 mtm180 -105.25 157.07 17.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.83 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 99.2 mtp -51.93 134.17 31.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.7 mmm -58.08 140.25 53.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -131.08 151.25 78.6 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.73 -42.96 62.04 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 120.524 0.816 . . . . 0.0 111.829 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.95 -39.95 87.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.493 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 27.5 mmtp -64.74 -40.0 94.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 110.166 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.19 -40.11 84.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 108.616 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.409 HH11 ' HG2' ' A' ' 130' ' ' ARG . 40.4 ttt-85 -64.11 -39.99 95.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.476 -0.765 . . . . 0.0 109.261 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -46.64 88.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 110.228 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -60.01 -38.59 83.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.134 -0.979 . . . . 0.0 109.628 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -59.92 -38.81 83.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 108.536 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.75 -37.32 81.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 108.739 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.02 -43.38 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.75 -39.98 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -60.23 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.526 -0.733 . . . . 0.0 109.581 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.03 -37.56 80.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.32 -28.62 20.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.638 -0.664 . . . . 0.0 111.568 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 33.1 mttm -60.11 -40.07 88.38 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 111.535 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 50.7 p-10 -59.97 -29.48 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.444 -1.41 . . . . 0.0 109.627 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.59 -40.54 92.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 111.089 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 34.2 p-10 -100.51 -11.44 20.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.156 -0.965 . . . . 0.0 110.264 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.07 . . . . 0.0 109.382 179.362 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -147.41 134.76 20.68 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.6 -174.44 3.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.292 -1.505 . . . . 0.0 111.066 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.8 134.72 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.94 122.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -119.89 147.76 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 122.148 0.975 . . . . 0.0 111.407 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -146.68 156.37 43.13 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 83' ' ' THR . 73.8 m-20 -137.11 127.74 26.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.961 -1.087 . . . . 0.0 110.599 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.9 t -109.93 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.48 156.76 42.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.0 -177.23 1.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.66 159.93 17.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.265 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -60.1 141.16 56.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.135 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.1 71.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -127.79 147.27 50.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.955 . . . . 0.0 109.105 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -130.19 148.37 52.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.8 137.4 32.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.585 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -68.23 145.93 53.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.052 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.31 -42.6 98.86 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.208 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 77.2 mm-40 -61.04 -44.28 97.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.952 -1.322 . . . . 0.0 109.416 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.0 mt -69.58 -27.19 64.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 108.819 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.71 -58.28 3.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 110.027 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.2 -48.33 82.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 111.043 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 31' ' ' SER . 35.7 p-10 -62.73 -39.93 95.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.781 -1.199 . . . . 0.0 109.957 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -61.47 -45.75 92.94 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.023 -1.048 . . . . 0.0 109.21 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.05 -44.88 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.158 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.77 -40.05 91.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.25 -20.39 64.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 110.253 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.86 5.36 21.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.988 -1.07 . . . . 0.0 110.174 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.35 15.19 62.62 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 121.049 -1.032 . . . . 0.0 111.711 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -80.3 153.85 28.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.617 -1.52 . . . . 0.0 109.151 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.68 139.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -58.68 101.64 0.09 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.29 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.07 49.72 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.45 -167.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -1.064 . . . . 0.0 108.774 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.6 mtm 57.67 22.43 8.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.144 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 m120 51.93 40.12 27.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.754 -0.591 . . . . 0.0 111.598 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 pt -140.0 166.94 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.123 -0.986 . . . . 0.0 108.689 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.39 129.61 38.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 60' ' ' SER . 12.6 m-70 -119.57 126.45 51.26 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 55.0 ttt180 -100.45 127.12 46.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.095 -1.003 . . . . 0.0 109.299 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 23.5 m-70 -97.83 169.92 9.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.501 -0.75 . . . . 0.0 110.109 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.1 tp -56.94 -49.93 74.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -91.48 145.94 32.31 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 109.036 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.31 -6.61 17.86 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.57 0.847 . . . . 0.0 112.082 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -94.11 -1.78 53.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.023 -1.048 . . . . 0.0 110.274 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 10.3 85.78 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.3 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 m -69.95 -39.96 75.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.333 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.73 166.44 50.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -71.54 173.68 12.13 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.074 1.182 . . . . 0.0 111.732 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.93 125.06 29.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.4 -25.71 15.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 109.303 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -159.66 159.84 33.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 109.136 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 4.0 m -126.53 172.75 9.97 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.021 0.915 . . . . 0.0 111.427 -177.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -139.64 128.66 23.63 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.533 0.682 . . . . 0.0 109.298 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.62 163.21 32.67 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.7 m-20 -77.53 156.07 31.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.885 -1.135 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' NH1' ' A' ' 121' ' ' ARG . 77.6 mtm -69.89 -19.75 63.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.256 -0.902 . . . . 0.0 110.076 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.7 p -87.06 123.65 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 109.502 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -60.03 149.97 71.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 109.672 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -78.32 4.46 26.66 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.823 -1.324 . . . . 0.0 112.239 -0.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.58 9.32 85.85 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p -89.2 170.14 10.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.134 -1.215 . . . . 0.0 109.711 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.626 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 96.9 m-85 -120.33 150.26 41.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.572 -0.705 . . . . 0.0 109.533 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' H ' ' CG ' ' A' ' 74' ' ' MET . 84.9 m-20 -128.81 151.48 77.34 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.98 -11.13 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 120.503 0.802 . . . . 0.0 111.628 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 77.1 mm-40 -90.94 5.52 48.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.635 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.55 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 70.8 mmm -85.56 14.1 6.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.9 mttm -85.99 -4.03 59.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.011 -1.055 . . . . 0.0 108.595 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 80.8 m-20 -148.27 80.74 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -159.67 171.11 20.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.9 p -126.01 149.35 48.89 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.418 -0.801 . . . . 0.0 109.045 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.0 149.91 20.42 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.048 -1.033 . . . . 0.0 109.21 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.83 -47.07 27.01 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 CA-C-N 119.16 0.736 . . . . 0.0 111.665 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.63 -152.5 7.94 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.484 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -133.16 160.05 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.865 . . . . 0.0 109.184 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ALA . 6.6 m -109.54 120.82 43.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.558 -0.714 . . . . 0.0 110.246 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.5 mt -108.99 127.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -147.68 170.53 17.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.505 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -142.24 129.99 21.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.6 -0.688 . . . . 0.0 109.158 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.602 ' N ' ' SD ' ' A' ' 86' ' ' MET . 96.4 mt-30 -93.5 121.73 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.32 153.7 38.32 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.091 -1.006 . . . . 0.0 108.714 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.12 147.62 87.83 Favored 'Cis proline' 0 N--CA 1.505 2.17 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.211 -0.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.451 ' OG ' ' SD ' ' A' ' 86' ' ' MET . 1.8 m -107.0 167.96 9.53 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.633 0.73 . . . . 0.0 110.7 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.64 149.33 42.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 110.167 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.5 -138.35 33.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -99.2 120.74 40.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -1.06 . . . . 0.0 109.777 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.21 -31.12 67.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.779 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.04 -39.66 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.915 . . . . 0.0 109.357 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.89 -40.06 75.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 108.173 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -59.93 -40.06 87.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -59.61 -41.55 90.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.706 -0.621 . . . . 0.0 109.545 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.72 -42.0 96.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.63 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 109.753 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 97.5 mtp -57.62 -49.96 74.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.98 -43.66 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 109.191 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.6 mm-40 -60.03 -41.83 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.912 . . . . 0.0 109.006 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p -70.94 -40.42 72.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.782 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.39 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.291 -0.88 . . . . 0.0 110.014 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.01 -37.77 86.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 109.789 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.93 -49.18 78.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 0.0 109.296 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 94.8 mt -60.2 -49.89 82.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.88 -48.06 64.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.703 -0.623 . . . . 0.0 109.794 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.18 -40.37 89.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -69.92 -40.11 75.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 111.053 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 108' ' ' ILE . 11.1 m -100.91 2.32 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 109.935 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.51 24.45 72.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.31 -176.95 51.38 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.91 133.89 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.973 . . . . 0.0 109.089 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.61 132.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.237 -0.914 . . . . 0.0 109.425 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.7 mt -130.54 160.02 35.39 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.415 -0.803 . . . . 0.0 109.803 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -86.63 -170.25 2.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 109.163 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 96.3 m-20 -60.13 -39.87 87.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 109.739 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.68 18.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 121' ' ' ARG . 24.3 mtt-85 59.84 22.58 11.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.1 mtt180 -102.44 145.25 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.449 -0.782 . . . . 0.0 109.478 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.2 mtp -50.08 126.14 13.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.4 mtp -60.04 140.0 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.811 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 3.9 p -131.55 153.17 81.48 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.83 -44.87 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 120.848 1.032 . . . . 0.0 112.081 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.12 -41.2 92.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.222 -0.924 . . . . 0.0 109.166 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 125' ' ' THR . 98.9 mttt -70.06 -40.06 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 110.197 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.57 -40.1 82.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.387 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 130' ' ' ARG . 0.1 OUTLIER -63.14 -40.06 96.49 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.417 -0.802 . . . . 0.0 109.189 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.835 . . . . 0.0 109.662 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -60.02 -43.35 95.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 108.445 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -63.01 -40.09 96.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.353 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.06 -39.97 94.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.682 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.95 -44.72 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 108.709 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -41.3 85.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.804 . . . . 0.0 109.069 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 137' ' ' ARG . 51.3 mtt-85 -60.5 -39.96 89.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.224 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 73.9 mm-40 -62.4 -39.94 94.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 109.571 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -32.19 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 111.021 -177.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -59.98 -40.24 88.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.927 -1.108 . . . . 0.0 109.871 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.3 p30 -61.56 -30.61 70.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.0 108.717 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.65 -22.34 66.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -95.72 -1.81 49.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.812 . . . . 0.0 110.001 179.626 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -143.08 150.01 38.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.27 164.5 27.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.835 -1.166 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -120.0 131.4 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mm -90.62 133.38 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.456 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -129.26 143.32 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 122.092 0.949 . . . . 0.0 110.811 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -142.76 149.86 39.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -131.04 126.57 36.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.73 -1.231 . . . . 0.0 110.951 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.14 119.99 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.23 160.25 43.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.068 . . . . 0.0 110.025 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -168.38 0.35 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -61.54 157.82 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.815 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -59.97 139.97 57.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.55 74.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.8 m -129.31 144.27 51.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.474 -1.016 . . . . 0.0 109.309 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 42.3 mp0 -120.28 147.51 44.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.729 . . . . 0.0 109.311 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.17 143.99 30.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -68.99 144.51 54.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.136 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -42.16 98.3 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.1 -45.52 93.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -1.234 . . . . 0.0 109.773 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -69.97 -30.19 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 108.889 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.3 tt -72.15 -55.76 6.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.666 -0.647 . . . . 0.0 109.605 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 74' ' ' MET . 90.9 mt -60.01 -48.64 80.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.844 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -64.62 -40.08 94.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.235 -0.916 . . . . 0.0 111.683 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.1 p -64.81 -41.0 96.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 110.235 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.63 -44.07 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 109.824 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.47 -40.0 85.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.0 110.455 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.01 -19.66 64.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 111.024 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.558 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.57 -11.47 58.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.175 . . . . 0.0 110.87 -178.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.538 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.4 11.12 18.47 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.015 -1.053 . . . . 0.0 111.14 178.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.723 ' N ' HH21 ' A' ' 47' ' ' ARG . 36.3 m-85 -80.87 152.87 27.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.669 -1.489 . . . . 0.0 109.712 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.4 139.35 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.52 104.7 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -0.999 . . . . 0.0 110.055 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.2 171.58 34.08 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -67.12 -166.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -1.073 . . . . 0.0 109.315 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.7 mtm 57.42 25.58 11.53 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.603 0.716 . . . . 0.0 109.887 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 50.02 39.37 18.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.644 -0.66 . . . . 0.0 111.601 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.6 pt -140.85 167.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.021 -1.05 . . . . 0.0 109.005 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -92.42 136.77 32.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.037 -1.039 . . . . 0.0 110.333 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.497 ' CG ' ' OG ' ' A' ' 60' ' ' SER . 19.4 m-70 -126.3 126.82 44.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.723 HH21 ' N ' ' A' ' 37' ' ' PHE . 28.9 ttm180 -99.21 124.28 44.15 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 56.9 m-70 -95.6 171.84 8.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 109.717 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -56.89 -50.01 73.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.762 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -91.67 141.99 26.28 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 109.071 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.53 -10.23 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.555 0.877 . . . . 0.0 112.08 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -91.87 -0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 109.947 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.42 83.51 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.0 p -69.9 -40.05 75.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.83 -1.394 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.28 168.24 50.1 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 18.5 Cg_endo -70.91 174.88 9.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.286 1.324 . . . . 0.0 112.223 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.22 122.4 27.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.9 mp -97.97 -43.81 6.92 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' SD ' ' A' ' 101' ' ' MET . 20.9 p90 -144.91 160.01 42.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.934 -1.104 . . . . 0.0 109.51 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.497 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 9.0 m -132.74 165.51 24.37 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.031 0.92 . . . . 0.0 111.44 -177.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.3 tt -119.96 134.79 55.14 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.696 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.02 159.95 39.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.599 . . . . 0.0 109.413 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.673 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.9 m-20 -76.45 160.71 29.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.432 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.7 mtp -70.03 -25.56 63.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 110.254 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -86.8 121.51 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.963 -1.086 . . . . 0.0 109.738 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -59.43 151.03 62.12 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -77.57 5.02 22.42 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.686 -1.381 . . . . 0.0 112.479 -0.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.43 55.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.8 p -91.26 169.55 10.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.223 -1.163 . . . . 0.0 110.69 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.673 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -124.1 140.68 52.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.691 -0.63 . . . . 0.0 109.376 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -130.37 150.76 77.11 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.0 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -50.72 -7.0 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.42 0.829 . . . . 0.0 112.001 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mt-10 -89.45 2.53 54.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.431 -0.793 . . . . 0.0 109.556 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.415 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.3 mmm -86.83 16.32 4.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.2 mttm -87.42 -3.16 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 108.805 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -149.68 77.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.06 169.41 24.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.994 -1.066 . . . . 0.0 109.251 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -130.04 150.19 51.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.68 150.21 21.31 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.08 -52.83 5.94 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 120.438 0.759 . . . . 0.0 111.726 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.25 -151.82 8.12 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.6 m -130.05 160.0 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.963 . . . . 0.0 109.545 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.4 m -112.07 123.78 51.01 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.115 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.87 132.02 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.08 164.43 33.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.828 -1.17 . . . . 0.0 110.89 -178.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.2 ttp -138.15 128.63 26.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -92.96 112.57 24.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 109.236 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.41 154.3 37.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -75.72 134.36 35.44 Favored 'Cis proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.679 0.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.7 m -107.39 160.2 15.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.529 0.68 . . . . 0.0 109.624 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -70.51 150.43 46.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.928 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -158.96 26.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.16 117.11 30.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -1.146 . . . . 0.0 109.292 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.03 -37.56 80.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.635 . . . . 0.0 110.851 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.81 -39.88 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.99 -39.98 75.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.047 -1.033 . . . . 0.0 108.894 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.436 ' OD1' HD23 ' A' ' 58' ' ' LEU . 78.0 m-20 -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 102' ' ' LEU . 79.1 t80 -60.01 -50.03 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.59 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.8 -41.52 97.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.4 tp -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 59' ' ' PHE . 23.4 mmm -56.11 -46.81 78.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.416 -0.803 . . . . 0.0 109.255 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.9 mt -63.85 -40.76 97.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.103 -0.998 . . . . 0.0 109.061 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 0.0 109.881 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.6 p -69.38 -41.0 77.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.02 -1.05 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.92 52.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 110.272 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -62.33 -34.93 77.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -60.02 -46.54 89.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 108.767 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.1 -49.97 81.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.4 -0.813 . . . . 0.0 108.988 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.55 -47.7 63.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.541 -0.724 . . . . 0.0 109.97 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.73 -179.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.22 -40.01 74.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.047 -1.033 . . . . 0.0 111.165 -178.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.92 1.99 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.68 27.22 71.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.85 -172.0 45.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.19 139.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.608 -0.937 . . . . 0.0 108.881 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.484 HG12 ' SD ' ' A' ' 124' ' ' MET . 4.5 t -80.56 134.94 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 109.736 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.11 160.01 37.23 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 -179.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -87.25 -168.86 2.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 94.9 m-20 -60.01 -39.57 86.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 109.849 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.17 21.75 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 55.85 31.33 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.16 150.9 27.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.438 -0.789 . . . . 0.0 109.297 179.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mmm -52.08 125.66 16.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 109.152 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 116' ' ' VAL . 64.1 mtp -60.0 139.94 57.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.8 p -130.06 150.65 76.59 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -42.58 -43.49 8.47 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.849 1.032 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.418 ' HG2' HH21 ' A' ' 130' ' ' ARG . 96.5 mt-30 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.389 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.72 -39.97 80.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.4 mt -55.69 -42.29 74.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 0.0 108.937 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.418 HH21 ' HG2' ' A' ' 127' ' ' GLN . 85.4 mtm180 -65.71 -38.87 90.4 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -59.97 -44.61 94.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.993 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 53.1 m-85 -60.01 -42.18 93.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.52 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.78 -39.72 89.9 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 98.3 m-20 -60.03 -40.03 87.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.354 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.0 -41.13 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.048 -1.033 . . . . 0.0 108.833 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.11 -44.93 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 108.996 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 79.9 mtm180 -62.22 -35.25 78.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -0.969 . . . . 0.0 110.424 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 66.4 mm-40 -59.94 -38.86 83.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.736 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.1 t -73.31 -30.07 29.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 110.674 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.8 mttm -60.04 -41.1 91.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.759 -1.213 . . . . 0.0 110.987 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -59.94 -29.02 68.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.756 -1.215 . . . . 0.0 109.176 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.852 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 43.4 p-10 -104.57 -3.71 23.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.34 -0.85 . . . . 0.0 109.495 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.899 . . . . 0.0 109.524 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -102.24 143.68 31.72 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -160.96 179.54 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.49 -1.381 . . . . 0.0 110.633 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -125.65 130.0 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 mm -92.26 127.95 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.8 mt -120.21 147.47 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.33 1.062 . . . . 0.0 111.712 -177.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -145.8 159.03 43.78 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -139.26 125.26 19.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.715 -1.241 . . . . 0.0 111.34 -179.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.51 124.97 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -144.61 164.59 30.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.046 -1.034 . . . . 0.0 111.979 -177.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.71 -164.51 0.36 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -71.37 160.05 33.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -58.79 130.01 44.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.746 -1.221 . . . . 0.0 109.356 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.47 -2.23 84.68 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 m -110.92 155.55 22.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.365 -1.079 . . . . 0.0 109.757 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -129.98 150.09 51.42 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.27 140.48 29.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -65.62 141.16 58.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' PHE . . . -60.06 -39.99 96.49 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.107 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.51 -46.69 88.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 109.662 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -30.01 68.17 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -71.41 -58.78 3.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.03 -40.05 88.0 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.349 -0.844 . . . . 0.0 109.708 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -64.28 -40.73 96.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -65.73 -39.64 91.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.304 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.02 -48.4 88.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.074 -1.017 . . . . 0.0 109.859 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -63.37 -39.96 95.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.138 . . . . 0.0 109.704 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.358 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.02 8.3 10.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . 80.09 10.47 85.49 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.39 148.61 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.722 -1.458 . . . . 0.0 108.972 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.6 mt -122.14 134.52 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -58.3 102.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.108 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.74 170.6 38.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.28 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.322 -1.105 . . . . 0.0 109.006 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.1 mtt 58.09 21.38 7.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 51.79 40.06 26.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.797 . . . . 0.0 111.48 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.26 159.29 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.881 -1.137 . . . . 0.0 109.187 178.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -90.49 119.55 30.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.058 -1.026 . . . . 0.0 109.118 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 13.9 m-70 -104.12 134.94 46.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.481 -0.762 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' NH1' ' O ' ' A' ' 36' ' ' GLY . 21.6 tpt180 -100.03 115.62 30.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 72.5 m-70 -95.25 169.31 10.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.225 -0.922 . . . . 0.0 109.907 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.12 -49.96 75.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.855 . . . . 0.0 109.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -96.1 150.0 36.67 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -70.6 -7.1 20.52 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.869 1.046 . . . . 0.0 112.455 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.85 0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.046 -1.034 . . . . 0.0 110.095 -179.195 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.34 7.66 86.97 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.317 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.07 -40.05 75.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.249 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.72 160.42 50.49 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.468 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 12.9 Cg_endo -68.02 175.09 6.95 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.068 1.179 . . . . 0.0 112.218 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.544 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -84.19 127.06 33.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.37 -0.831 . . . . 0.0 109.209 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.2 mp -100.56 -35.38 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.135 -0.978 . . . . 0.0 108.8 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 2.5 p90 -151.01 166.53 30.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.521 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 2.1 m -134.73 179.44 6.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.08 -1.013 . . . . 0.0 111.525 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -139.95 131.65 27.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.611 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.94 159.74 35.72 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.675 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.2 m-20 -76.93 161.53 28.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.05 -22.99 63.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 110.373 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 65' ' ' VAL . 26.8 m -88.89 119.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.757 -1.215 . . . . 0.0 109.879 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -61.24 151.37 76.34 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.38 8.89 17.51 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.486 -0.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.1 63.23 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.9 p -83.92 167.89 16.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -1.2 . . . . 0.0 109.344 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.675 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 71.4 m-85 -120.29 143.8 48.15 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.638 -0.664 . . . . 0.0 109.784 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLU . 20.5 t70 -126.41 134.32 25.88 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -49.5 -9.34 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 119.959 1.021 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -88.38 1.0 55.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.42 ' HE2' ' CZ ' ' A' ' 77' ' ' PHE . 90.6 mtp -86.99 22.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 109.996 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 94.9 mttt -83.65 -4.81 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.021 -1.049 . . . . 0.0 108.955 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.0 m-20 -148.12 83.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' ' HE2' ' A' ' 74' ' ' MET . 7.1 p90 -158.85 177.65 10.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.551 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.0 p -134.03 149.98 51.2 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.12 150.3 23.64 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.063 -1.023 . . . . 0.0 109.35 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.93 -26.06 30.12 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.46 0.773 . . . . 0.0 111.657 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.33 33.96 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.036 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 28' ' ' LEU . 34.3 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.886 . . . . 0.0 108.952 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.7 m -109.76 125.2 52.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.659 -0.651 . . . . 0.0 109.686 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.79 128.41 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -146.74 149.78 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.968 -1.082 . . . . 0.0 110.952 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.1 ttm -104.91 129.91 53.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.836 -0.54 . . . . 0.0 109.581 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -92.84 108.38 19.95 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.7 m -97.2 151.04 37.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 109.133 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.0 139.24 60.44 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.914 -1.286 . . . . 0.0 112.839 -0.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.2 m -105.22 159.51 15.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.627 -0.671 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -71.1 150.62 45.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.98 -152.38 38.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -98.96 121.09 40.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.414 -1.05 . . . . 0.0 109.29 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.94 -32.24 69.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.589 -0.694 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.03 -39.91 75.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.663 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.04 -42.2 73.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.953 -1.092 . . . . 0.0 108.088 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.684 ' OD1' HD23 ' A' ' 58' ' ' LEU . 89.8 m-20 -62.94 -39.88 95.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.14 -40.1 73.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.19 -40.03 94.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.16 -39.9 91.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.132 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.2 mtp -57.84 -50.33 73.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.84 -42.91 89.92 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.986 -1.071 . . . . 0.0 108.961 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.8 mt-30 -61.99 -39.99 94.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 108.796 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -73.14 -43.74 61.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.04 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 0.0 110.014 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -60.31 -39.82 88.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.052 -1.03 . . . . 0.0 109.358 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 4.1 m-70 -59.9 -43.37 94.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.985 . . . . 0.0 108.891 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.0 -50.11 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.26 -48.33 68.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.607 -0.683 . . . . 0.0 109.263 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.64 -40.13 90.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 109.899 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -40.0 75.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.36 -0.838 . . . . 0.0 111.346 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -101.03 -0.81 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.116 -0.99 . . . . 0.0 109.678 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.37 23.39 76.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . -91.33 -167.56 41.01 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.211 -1.17 . . . . 0.0 110.249 -179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 16' ' ' ALA . 3.6 m -130.0 159.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.596 -0.944 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.421 HG12 ' SD ' ' A' ' 124' ' ' MET . 11.4 t -96.93 129.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.234 -0.916 . . . . 0.0 108.712 179.492 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.1 mt -124.49 163.63 21.45 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.82 0.819 . . . . 0.0 110.639 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -86.27 -170.92 3.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.752 -0.593 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 85.4 m-20 -60.12 -39.99 88.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.872 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.99 15.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.068 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' ASP . 86.4 mtm180 57.25 37.16 28.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.837 -0.539 . . . . 0.0 109.769 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 122' ' ' ARG . 20.0 mtt-85 -112.23 151.97 28.97 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.9 mtp -50.92 122.1 6.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.929 -1.107 . . . . 0.0 109.133 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.421 ' SD ' HG12 ' A' ' 116' ' ' VAL . 61.4 mtp -59.96 140.01 57.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.264 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.5 p -122.25 152.17 60.19 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -43.49 -43.61 10.92 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 120.61 0.873 . . . . 0.0 112.017 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -60.11 -40.5 89.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.277 -0.89 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.7 -40.01 84.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.794 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.82 -39.95 78.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 108.409 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.49 -39.97 89.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.457 -0.777 . . . . 0.0 109.397 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.46 77.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.93 -46.05 90.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.956 -1.09 . . . . 0.0 108.779 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.98 -39.93 93.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.36 -0.838 . . . . 0.0 109.124 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 87.8 m-20 -61.72 -46.15 90.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.521 -0.737 . . . . 0.0 110.57 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.19 -37.59 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 108.997 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.05 -42.54 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.052 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 81.7 mtm180 -60.02 -38.69 83.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.853 -1.154 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 40.4 mm-40 -59.98 -39.96 87.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.46 -0.775 . . . . 0.0 109.867 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.5 -33.64 63.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.596 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 144' ' ' ALA . 87.8 mttt -59.95 -50.0 75.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.817 -1.177 . . . . 0.0 110.027 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -61.19 -37.57 83.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.982 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.93 95.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.447 -0.783 . . . . 0.0 110.17 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 50.5 p30 -98.85 -2.98 36.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.309 -0.869 . . . . 0.0 109.406 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -144.64 132.56 21.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.85 -172.14 3.17 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.015 -1.053 . . . . 0.0 110.536 -178.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.92 140.59 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.49 130.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.0 mt -118.45 144.13 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 122.245 1.021 . . . . 0.0 111.681 -177.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -142.0 150.02 40.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.02 119.62 25.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.019 -1.051 . . . . 0.0 111.037 -178.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.62 110.86 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 80' ' ' PRO . . . -148.99 160.79 42.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -165.25 0.25 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.56 142.42 55.42 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 108.826 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -51.47 137.15 24.59 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.039 -1.038 . . . . 0.0 109.237 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.27 1.22 66.93 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.1 m -121.02 149.95 41.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.516 -0.991 . . . . 0.0 108.697 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -125.41 146.87 49.42 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.764 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 148.62 25.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -68.93 142.48 54.71 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.42 96.99 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.31 -46.85 86.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 0.0 109.83 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.81 -30.17 67.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.197 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.607 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -71.15 -58.67 3.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.23 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -59.99 -46.02 90.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.659 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.81 -42.26 97.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.698 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 t -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.479 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.94 -47.0 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -63.83 -41.57 97.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.69 -21.89 66.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.6 11.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.47 75.73 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.15 -0.969 . . . . 0.0 111.338 178.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -81.65 147.51 29.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.661 -1.494 . . . . 0.0 109.584 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -120.03 132.33 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.74 101.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -89.72 170.82 37.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.34 -162.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -1.044 . . . . 0.0 109.265 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 91.0 mmm 59.78 20.61 9.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.683 -0.635 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 51.21 34.97 12.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 111.362 178.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.2 165.83 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.006 -1.058 . . . . 0.0 108.999 178.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -89.72 141.51 28.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.947 -1.096 . . . . 0.0 110.464 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.467 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 61.6 m-70 -130.19 130.07 44.22 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.511 ' HG2' HH11 ' A' ' 47' ' ' ARG . 4.0 ttt-85 -103.0 127.29 50.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 17.9 m-70 -91.45 169.84 10.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.664 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.69 -49.96 73.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -92.65 144.81 29.26 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.58 -6.37 16.45 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.798 0.999 . . . . 0.0 112.213 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -92.71 1.92 57.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.949 . . . . 0.0 110.031 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.14 10.67 85.27 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.4 p -70.14 -40.8 74.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -1.184 . . . . 0.0 110.0 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.48 164.0 50.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -66.68 179.74 2.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.473 1.136 . . . . 0.0 111.852 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.56 29.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -97.65 -70.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.355 -0.841 . . . . 0.0 109.691 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 1.7 p90 -114.41 160.0 19.66 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.97 -1.081 . . . . 0.0 109.909 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.429 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.1 m -121.88 161.47 22.73 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.573 0.701 . . . . 0.0 109.927 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -132.26 130.59 41.11 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.43 165.3 26.13 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.489 -0.757 . . . . 0.0 110.073 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 88.7 m-20 -75.05 156.92 35.62 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.4 mtt -69.88 -23.88 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.0 p -87.5 121.12 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.068 -179.102 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -58.06 151.78 43.79 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -80.43 -0.2 41.15 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.979 0.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.62 18.83 61.12 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.4 p -85.92 167.3 15.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.991 -1.299 . . . . 0.0 109.618 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.4 m-85 -124.33 141.85 51.75 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.519 -0.738 . . . . 0.0 109.808 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -129.8 151.09 77.57 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.58 -12.5 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 120.497 0.798 . . . . 0.0 112.409 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.91 -3.01 58.86 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.072 -1.017 . . . . 0.0 109.322 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.2 mtp -88.65 22.68 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.4 mttp -83.06 -4.84 58.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 94.0 m-20 -143.75 84.63 1.8 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.376 -0.828 . . . . 0.0 108.776 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.7 177.24 11.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 110.362 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.5 p -129.67 146.8 51.43 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.19 148.22 18.19 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 108.862 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.411 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 14.2 Cg_exo -45.16 -31.65 6.17 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 120.611 0.874 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.65 -147.71 16.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.49 159.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.457 -1.025 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.7 m -108.74 122.48 47.23 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -105.77 130.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.323 -0.861 . . . . 0.0 108.727 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.47 148.03 32.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.12 -0.988 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.9 tpp -104.02 130.28 51.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' O ' ' OG ' ' A' ' 90' ' ' SER . 95.0 mt-30 -90.54 108.6 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 88' ' ' VAL . 9.2 m -98.67 150.03 36.31 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.211 -0.93 . . . . 0.0 109.238 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.65 135.07 38.67 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.859 -1.309 . . . . 0.0 112.564 -0.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.5 m -108.05 162.58 13.91 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.632 0.73 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 59.6 t80 -73.78 158.14 35.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 110.041 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.72 -160.28 44.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -98.15 111.96 24.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.38 -1.07 . . . . 0.0 108.971 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.62 -30.33 68.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.768 . . . . 0.0 110.602 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.33 -40.06 77.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 109.363 -179.027 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.81 -40.35 63.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.743 -1.223 . . . . 0.0 108.242 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -61.2 -37.5 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.093 0.949 . . . . 0.0 108.606 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -56.33 -50.09 72.46 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.25 -39.19 92.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.12 -46.02 91.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.608 -0.683 . . . . 0.0 110.219 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.8 mtm -58.91 -42.67 90.21 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.667 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.61 -46.61 87.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.913 . . . . 0.0 108.937 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.4 mm-40 -60.17 -42.63 95.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 108.928 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -71.55 -41.07 69.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 109.375 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.56 -55.41 35.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.601 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -61.25 -35.7 77.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.148 -0.97 . . . . 0.0 109.103 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 58.1 m170 -59.89 -47.08 87.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 112' ' ' VAL . 82.2 mt -59.98 -49.95 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.9 -47.7 60.63 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.77 -39.96 93.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.43 -40.02 77.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.05 -1.031 . . . . 0.0 110.703 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.7 m -98.44 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 109.275 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.85 24.88 76.15 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.34 -169.83 46.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.8 138.0 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.128 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 t -77.57 132.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 109.475 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.17 160.33 35.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.415 -0.803 . . . . 0.0 110.022 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -84.58 -173.12 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.477 -0.764 . . . . 0.0 108.976 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.514 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 93.3 m-20 -60.02 -36.07 76.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.088 -1.007 . . . . 0.0 109.994 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -79.61 15.3 1.37 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.916 . . . . 0.0 110.219 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 19.8 mmm-85 58.19 30.84 19.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -106.43 151.93 24.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 81.0 mmm -51.72 133.37 31.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.026 -1.046 . . . . 0.0 109.45 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.2 mmm -56.08 138.66 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.096 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.3 p -136.81 151.28 72.12 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.426 -0.797 . . . . 0.0 109.034 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -44.58 -45.72 12.85 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 120.449 0.766 . . . . 0.0 111.73 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.08 -40.01 88.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -68.48 -39.92 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.02 -40.13 88.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.995 -1.065 . . . . 0.0 109.011 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -65.28 -39.67 92.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.445 -0.785 . . . . 0.0 109.405 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.75 -47.6 85.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.195 -0.941 . . . . 0.0 110.348 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.514 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 71.3 m-85 -60.07 -46.59 89.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.928 -1.107 . . . . 0.0 108.526 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.2 -40.35 93.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.194 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.416 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.7 m-20 -62.35 -40.09 95.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.32 -40.68 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.052 -1.03 . . . . 0.0 108.596 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.56 -40.03 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.504 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 137' ' ' ARG . 7.4 mmt-85 -60.04 -39.96 87.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.066 -1.021 . . . . 0.0 110.554 -179.12 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.99 -40.07 92.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.725 -1.235 . . . . 0.0 109.524 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.15 -29.74 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' ALA . 47.4 mmtt -60.07 -39.47 86.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.835 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 2.2 p30 -60.07 -30.01 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.659 -1.276 . . . . 0.0 108.566 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.888 . . . . 0.0 109.218 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -101.22 -13.38 18.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.372 -0.83 . . . . 0.0 110.409 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.891 -1.13 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.32 147.11 31.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.61 -177.64 6.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.322 -1.486 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.99 131.46 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 mm -92.87 125.31 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 90.8 mt -123.66 143.71 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-O 122.166 0.984 . . . . 0.0 111.248 -177.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.402 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.4 mtt -142.88 138.18 30.07 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -120.85 127.46 51.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.992 -1.068 . . . . 0.0 111.251 -178.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.38 114.67 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.71 152.27 38.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.288 -0.882 . . . . 0.0 109.647 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.91 -166.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.64 152.89 44.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.161 -0.962 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.06 141.23 56.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.609 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.09 1.91 64.7 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.4 m -129.01 150.01 50.6 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.438 -1.036 . . . . 0.0 109.137 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.11 148.16 49.44 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.45 146.67 26.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -71.0 142.15 50.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 109.115 179.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.9 99.83 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.871 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.62 -44.65 96.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.964 -1.315 . . . . 0.0 109.669 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.87 -26.58 64.26 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -74.71 -59.88 2.53 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.652 -0.655 . . . . 0.0 109.76 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.86 -40.9 94.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 110.581 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.09 94.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 109.911 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 t -66.05 -41.05 91.33 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.16 -0.962 . . . . 0.0 109.806 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.13 -46.28 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 110.027 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.59 -40.2 96.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.974 -1.079 . . . . 0.0 109.395 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.56 -19.61 64.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.601 -0.687 . . . . 0.0 109.975 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.53 8.18 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.915 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.5 10.68 85.0 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.584 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -80.8 151.55 28.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.993 -1.299 . . . . 0.0 109.735 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.06 148.11 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.13 112.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.06 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.65 30.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.2 -170.18 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.596 -0.943 . . . . 0.0 108.626 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mtp 55.27 24.95 6.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.861 . . . . 0.0 109.726 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.04 42.1 24.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.745 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.7 pt -138.31 167.02 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.099 -1.0 . . . . 0.0 108.303 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -93.34 120.42 33.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.821 -1.174 . . . . 0.0 110.427 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.429 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 16.4 m170 -108.53 128.11 54.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.421 -0.8 . . . . 0.0 109.611 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 47' ' ' ARG . 9.3 ttt-85 -100.08 123.77 44.7 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.214 -0.928 . . . . 0.0 108.775 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 26.0 m-70 -92.46 171.59 8.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.57 -50.01 66.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 109.031 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -93.07 147.29 33.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 0.0 109.158 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -69.15 -4.2 13.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.65 0.9 . . . . 0.0 112.092 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -93.67 -1.07 55.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 0.0 109.746 -179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 13.42 83.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -68.93 -43.22 75.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -1.201 . . . . 0.0 109.533 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.435 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.33 171.62 54.26 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.415 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.2 Cg_endo -71.67 176.36 8.28 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.018 1.145 . . . . 0.0 111.463 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.406 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.16 126.63 32.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 108.906 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.4 mp -101.16 -35.88 9.15 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.078 -1.014 . . . . 0.0 109.74 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -146.68 160.78 41.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.029 -1.044 . . . . 0.0 109.006 178.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 63.2 m -129.99 160.29 34.08 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.002 0.906 . . . . 0.0 111.437 -177.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -120.97 129.48 53.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.537 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -139.6 161.73 36.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.521 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 81.9 m-20 -77.66 159.93 28.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 48.7 mtm -67.83 -18.84 64.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.7 p -88.16 121.28 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.818 -1.176 . . . . 0.0 109.844 -179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -61.11 147.76 85.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.35 -0.843 . . . . 0.0 109.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.6 -0.53 19.46 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.763 -1.349 . . . . 0.0 111.741 -0.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.99 17.43 74.68 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 p -88.79 169.05 11.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.196 -1.179 . . . . 0.0 110.601 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.4 m-85 -119.91 143.8 47.77 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.27 150.01 72.91 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.349 -0.844 . . . . 0.0 109.146 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.23 -19.32 2.62 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.689 0.926 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -89.94 -4.36 57.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.95 -1.093 . . . . 0.0 109.131 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 85.6 mtp -93.51 23.51 4.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 110.372 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -85.49 -8.99 58.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.911 -1.118 . . . . 0.0 108.476 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -136.96 87.27 2.27 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 7.7 p90 -157.96 179.65 8.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.387 -0.821 . . . . 0.0 109.522 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.5 p -128.76 149.96 50.49 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.73 149.17 19.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.051 -1.03 . . . . 0.0 109.221 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.95 -40.64 80.14 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.669 0.913 . . . . 0.0 111.907 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.39 -156.54 17.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -130.38 159.96 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.617 -0.931 . . . . 0.0 109.506 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 m -114.21 120.68 41.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.526 -0.733 . . . . 0.0 109.476 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.64 128.49 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -149.28 159.92 43.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.699 -1.251 . . . . 0.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 44.2 ttm -120.25 129.95 54.28 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.31 102.08 14.5 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' CG1' ' OE1' ' A' ' 94' ' ' GLU . 15.9 m -96.04 148.31 34.34 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.308 -0.87 . . . . 0.0 108.894 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HG3' HD21 ' A' ' 143' ' ' ASN . 10.3 Cg_endo -73.67 130.24 19.96 Favored 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.796 -1.335 . . . . 0.0 112.957 0.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 m -105.42 161.36 14.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.64 -0.662 . . . . 0.0 109.644 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.04 150.02 47.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.694 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -164.65 31.29 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 96.0 m-20 -96.09 116.74 29.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.198 -1.178 . . . . 0.0 108.921 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE1' ' CG1' ' A' ' 88' ' ' VAL . 41.9 mt-10 -59.95 -34.86 73.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.649 . . . . 0.0 110.799 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.06 -39.99 75.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.535 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.22 -42.21 55.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.717 -1.239 . . . . 0.0 108.701 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 31.3 m120 -61.53 -39.89 92.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 73.0 t80 -52.44 -40.01 61.72 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.607 -0.683 . . . . 0.0 109.207 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -60.96 -40.01 91.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.112 -0.992 . . . . 0.0 109.1 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.37 -40.08 89.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 109.177 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.6 mtp -57.09 -50.33 73.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.17 -45.28 81.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.15 -39.99 88.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 108.822 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 p -70.14 -41.07 74.37 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.199 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.6 -55.62 31.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.319 -0.863 . . . . 0.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -60.73 -39.95 90.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 109.704 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 48.7 m170 -59.83 -46.32 89.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.76 -47.45 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 108.977 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.86 -47.01 64.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.92 -40.67 94.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.851 . . . . 0.0 110.949 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.03 -40.08 75.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.708 -178.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 114' ' ' GLY . 6.3 m -99.59 0.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.224 -0.923 . . . . 0.0 109.877 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.31 21.76 74.28 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.62 -176.8 51.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.49 132.02 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.604 -0.939 . . . . 0.0 109.272 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.96 131.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.188 -0.945 . . . . 0.0 108.898 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.6 mt -131.49 158.62 40.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.411 -0.806 . . . . 0.0 109.377 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.03 -170.77 3.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.253 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 92.0 m-20 -60.06 -36.37 77.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.834 . . . . 0.0 109.623 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.59 14.91 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.6 mtt180 56.35 38.64 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 109.765 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.18 152.2 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.2 mtp -50.72 129.24 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.07 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.95 139.81 57.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -120.66 151.33 54.13 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -43.02 -43.92 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 120.8 1.0 . . . . 0.0 112.603 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.06 -40.0 87.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.31 -39.83 92.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 110.124 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.03 -40.05 83.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.954 -1.091 . . . . 0.0 108.543 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -65.07 -39.5 93.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.597 -0.689 . . . . 0.0 109.86 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.12 -47.65 85.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.304 -0.873 . . . . 0.0 110.565 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -59.98 -43.86 94.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 0.0 109.322 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 136' ' ' ILE . 78.3 mt-30 -60.38 -39.94 89.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.704 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 95.8 m-20 -60.58 -40.17 90.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.13 -39.94 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 108.904 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 133' ' ' GLN . 96.5 mt -59.9 -44.63 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.2 mtm180 -60.1 -38.0 81.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.46 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.4 mt-10 -60.09 -37.33 79.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 0.0 109.52 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.88 -38.17 74.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.369 -0.832 . . . . 0.0 110.38 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -60.06 -46.56 89.16 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.077 -1.015 . . . . 0.0 111.558 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -60.08 -35.06 74.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.697 -1.252 . . . . 0.0 109.588 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.49 -19.51 65.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.781 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.436 HD21 ' HG3' ' A' ' 89' ' ' PRO . 12.1 m120 -99.52 -8.7 24.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 109.832 -179.177 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 0.0 109.524 179.894 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -152.21 140.58 20.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.75 164.56 26.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.426 -1.421 . . . . 0.0 110.734 -178.567 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.99 129.47 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.31 122.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -122.29 144.27 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 122.039 0.923 . . . . 0.0 110.835 -177.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.8 mtt -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -130.81 119.5 22.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.978 -1.076 . . . . 0.0 110.392 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.27 112.89 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.79 44.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.65 -164.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.175 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -67.25 155.03 39.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.962 . . . . 0.0 108.716 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -59.56 140.01 56.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.33 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -6.19 77.11 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 m -115.26 148.44 39.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.448 -1.031 . . . . 0.0 109.042 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -126.8 146.49 50.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.461 -0.774 . . . . 0.0 109.606 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.34 141.91 28.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -69.95 146.12 51.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.243 -0.911 . . . . 0.0 108.876 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.0 98.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.0 -45.73 93.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.061 -1.258 . . . . 0.0 109.755 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.1 mt -69.85 -24.48 63.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.537 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -79.8 -57.49 3.63 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 110.46 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.94 -45.21 93.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 0.0 111.585 -178.273 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 31' ' ' SER . 39.4 p-10 -61.62 -39.8 92.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.0 110.28 -178.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.532 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 9.3 p -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 0.0 110.316 -179.406 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.04 -50.04 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 0.0 110.335 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.72 -39.96 95.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 0.0 110.127 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.26 -20.09 66.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.59 1.02 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.94 -1.1 . . . . 0.0 110.022 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 13.58 56.87 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.011 -1.056 . . . . 0.0 110.921 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.93 150.81 28.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.973 -1.31 . . . . 0.0 109.692 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.62 138.84 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.58 106.75 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.687 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.83 171.51 26.19 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.41 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 109.481 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 56.9 19.98 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.502 -0.749 . . . . 0.0 110.014 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.4 m120 49.86 40.04 19.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 111.379 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.16 167.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.973 -1.079 . . . . 0.0 108.574 178.686 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -93.18 120.91 33.99 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.787 -1.196 . . . . 0.0 110.68 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.53 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 47.1 m-70 -109.18 124.58 51.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.523 ' NH1' HD21 ' A' ' 100' ' ' LEU . 13.9 ttt-85 -100.02 127.25 46.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.257 -0.902 . . . . 0.0 108.661 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 18.5 m-70 -95.67 171.55 8.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.37 -0.831 . . . . 0.0 110.399 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.97 -50.08 71.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 108.848 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.2 m -94.09 146.91 32.48 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 179.361 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.2 -6.37 18.16 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 CA-C-N 119.436 0.834 . . . . 0.0 112.368 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -92.54 -2.24 56.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 109.773 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.05 86.02 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -67.64 -40.43 84.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.011 -1.288 . . . . 0.0 109.189 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.507 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.54 162.66 49.4 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.89 179.25 2.84 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 118.448 1.124 . . . . 0.0 111.716 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.69 119.83 23.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.156 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 58' ' ' LEU . 10.3 mp -96.56 -47.52 5.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CG ' ' SD ' ' A' ' 101' ' ' MET . 40.2 p90 -145.33 159.16 43.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.904 -1.122 . . . . 0.0 109.01 178.704 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.2 m -132.02 169.74 15.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.856 0.836 . . . . 0.0 111.526 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.667 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.6 tt -123.48 133.0 54.09 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.512 0.672 . . . . 0.0 109.211 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.568 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.77 159.08 42.76 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.3 m-20 -76.27 152.48 36.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 0.0 108.732 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.7 mtm -70.02 -20.26 63.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.996 -1.065 . . . . 0.0 109.663 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.0 p -88.66 131.94 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 109.555 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -59.5 150.95 63.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.068 -1.02 . . . . 0.0 108.485 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -80.25 5.3 36.31 Favored 'Cis proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.243 -0.446 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.69 3.51 90.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.3 p -92.4 174.89 7.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.268 -1.137 . . . . 0.0 110.818 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.5 m-85 -126.24 146.76 49.86 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLU . 51.3 m-20 -129.99 149.82 74.22 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -49.13 -7.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.567 0.881 . . . . 0.0 111.85 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.0 mt-10 -90.0 3.26 53.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.475 ' O ' HD11 ' A' ' 29' ' ' LEU . 65.1 mmm -86.16 21.0 2.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -0.852 . . . . 0.0 109.866 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -85.93 -5.82 59.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 108.882 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -149.85 80.0 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.424 -0.797 . . . . 0.0 109.159 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -157.45 170.54 22.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.195 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.0 p -129.4 150.25 50.84 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.03 149.27 20.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.024 -1.047 . . . . 0.0 109.213 -179.434 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -48.05 -45.11 26.26 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.509 0.806 . . . . 0.0 111.639 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.16 -149.11 7.83 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.45 162.13 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.539 -0.977 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' ALA . 5.6 m -114.87 116.6 28.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.53 126.79 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -146.5 160.23 42.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.003 -1.061 . . . . 0.0 111.221 -178.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.0 ttm -124.15 131.08 53.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -90.15 120.0 30.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 108.545 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.5 m -98.38 150.02 36.31 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.26 -0.9 . . . . 0.0 109.375 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.69 137.05 48.0 Favored 'Cis proline' 0 N--CA 1.498 1.784 0 C-N-CA 124.084 -1.215 . . . . 0.0 111.94 -2.063 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.3 m -105.26 150.31 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.394 -0.816 . . . . 0.0 110.047 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.7 152.06 41.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.587 -0.696 . . . . 0.0 109.83 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -163.02 31.94 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -95.25 113.06 24.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.144 -1.209 . . . . 0.0 109.254 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 57.1 mp0 -58.99 -29.5 67.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.0 -42.9 72.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.99 -42.28 60.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.053 -1.03 . . . . 0.0 108.613 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.2 -40.63 96.73 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.601 -0.687 . . . . 0.0 109.196 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.498 -0.751 . . . . 0.0 109.02 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.5 -39.79 94.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.523 HD21 ' NH1' ' A' ' 47' ' ' ARG . 7.1 tt -60.01 -42.41 94.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.743 -0.598 . . . . 0.0 109.541 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' CG ' ' A' ' 59' ' ' PHE . 21.7 mtm -59.92 -41.64 92.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.82 -1.175 . . . . 0.0 108.576 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.26 -43.14 98.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 108.676 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -60.07 -41.32 92.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.098 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 p -70.95 -40.03 72.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.57 -53.83 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 -179.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.102 . . . . 0.0 109.127 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -60.02 -49.57 77.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.077 -1.014 . . . . 0.0 108.608 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.1 -50.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.87 -51.09 42.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.667 -0.646 . . . . 0.0 109.828 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.04 -40.07 88.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 110.617 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.09 -39.92 78.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 -178.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.73 0.34 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 20.25 76.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.78 -173.04 46.61 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.33 139.29 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.504 -0.998 . . . . 0.0 108.872 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 t -76.62 129.96 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.081 -1.012 . . . . 0.0 108.824 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' C ' ' SD ' ' A' ' 124' ' ' MET . 52.5 mt -131.4 159.85 36.8 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -0.767 . . . . 0.0 109.72 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' ' SD ' ' A' ' 124' ' ' MET . 43.6 p-10 -84.78 -173.97 5.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 109.173 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.7 m-20 -60.04 -36.45 77.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.472 ' CB ' ' NH1' ' A' ' 122' ' ' ARG . 96.5 mm-40 -77.17 13.24 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.7 mtm180 55.42 33.78 21.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.87 -0.518 . . . . 0.0 110.422 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 120' ' ' GLN . 25.1 mtm-85 -109.67 156.67 19.96 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.5 mtm -51.9 133.24 32.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 118' ' ' ASP . 97.6 mmm -60.68 139.95 57.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.627 ' N ' ' NZ ' ' A' ' 128' ' ' LYS . 74.6 p -130.43 149.87 74.63 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -48.63 -43.9 32.42 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 119.38 0.814 . . . . 0.0 111.963 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -60.3 -42.99 96.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.627 ' NZ ' ' N ' ' A' ' 125' ' ' THR . 9.8 mtmp? -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.105 . . . . 0.0 110.288 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.44 -39.99 81.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.738 -1.226 . . . . 0.0 108.409 179.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.08 -36.87 85.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.391 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.07 -49.44 77.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -60.05 -43.75 95.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.45 -39.83 94.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.036 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.0 -40.99 91.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.268 -0.895 . . . . 0.0 109.294 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.93 -41.03 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.885 -1.134 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.03 -46.28 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.188 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 137' ' ' ARG . 1.6 mmt-85 -60.27 -40.02 88.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.098 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.5 mt-10 -60.93 -38.84 87.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.52 0.676 . . . . 0.0 109.63 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 88' ' ' VAL . 71.7 t -68.81 -39.61 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 110.673 -179.007 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' ALA . 56.6 mttm -58.23 -46.9 85.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.927 -1.108 . . . . 0.0 110.572 -178.22 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.11 -33.02 71.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.704 -1.248 . . . . 0.0 108.622 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.26 93.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.56 -0.713 . . . . 0.0 110.289 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -99.96 -18.58 17.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -146.4 141.78 27.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -165.8 166.82 17.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 109.799 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.3 129.97 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mm -92.57 131.83 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.0 mt -131.13 142.09 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 122.165 0.983 . . . . 0.0 110.971 -178.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.85 135.06 32.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -116.24 122.68 45.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.048 -1.033 . . . . 0.0 111.342 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.46 111.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.27 155.69 40.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.111 -0.993 . . . . 0.0 110.55 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.48 -164.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.559 -0.713 . . . . 0.0 109.096 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -74.51 157.44 35.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.096 -1.003 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.24 143.56 52.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.73 0.24 72.55 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.7 m -130.01 141.78 50.7 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.587 -0.949 . . . . 0.0 109.341 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.72 149.11 44.52 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.451 -0.78 . . . . 0.0 108.936 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.4 145.34 26.9 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 62.6 t-20 -68.07 138.82 56.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.527 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.8 -40.42 98.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.351 . . . . 0.0 109.489 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -29.73 67.81 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.54 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -70.37 -57.93 4.29 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 74' ' ' MET . 83.7 mt -60.2 -40.89 91.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.0 109.926 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -64.0 -40.37 96.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.4 t -65.77 -39.06 90.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 111.105 -179.012 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.82 -42.24 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.197 . . . . 0.0 109.972 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -64.88 -39.94 94.34 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.153 -0.967 . . . . 0.0 108.549 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -64.71 -20.62 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.492 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.62 2.01 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.779 . . . . 0.0 110.114 -178.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.68 13.49 82.35 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.425 179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -79.99 153.17 29.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.049 -1.266 . . . . 0.0 110.059 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 83.0 mt -120.21 133.84 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 110.182 -178.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.95 169.07 27.93 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -59.95 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -1.115 . . . . 0.0 109.189 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.9 mtt 58.89 19.86 7.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.5 m120 51.32 37.62 19.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.222 -0.924 . . . . 0.0 111.336 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.58 164.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.945 -1.097 . . . . 0.0 108.717 178.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -91.72 123.14 34.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.115 -0.991 . . . . 0.0 110.47 -178.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 44.8 m-70 -114.67 131.3 56.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.609 -0.682 . . . . 0.0 109.654 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 17.4 ttp180 -107.32 126.76 52.86 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.384 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.9 m-70 -92.75 171.47 8.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.378 -0.826 . . . . 0.0 110.676 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.41 -49.98 72.93 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.2 m -90.49 148.05 37.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.239 -0.913 . . . . 0.0 108.948 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.97 -12.0 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 120.748 0.966 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 56.3 p-10 -90.24 0.78 57.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 0.0 109.901 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.15 10.67 85.87 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 53.5 m -66.88 -40.06 87.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.848 -1.383 . . . . 0.0 109.726 -179.51 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.521 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.98 166.21 51.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 19.4 Cg_endo -71.16 175.78 8.75 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.493 1.462 . . . . 0.0 112.125 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.29 124.04 27.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.037 . . . . 0.0 109.25 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 86' ' ' MET . 10.2 mp -102.94 -57.25 2.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.405 -0.809 . . . . 0.0 110.026 -179.216 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -130.5 159.49 36.96 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.77 -1.207 . . . . 0.0 108.518 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.8 m -137.3 162.26 34.01 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.017 -1.052 . . . . 0.0 111.731 -177.508 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 62' ' ' ALA . 8.1 tt -113.58 136.16 53.12 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.663 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.36 160.53 38.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.692 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 85.5 m-20 -75.92 161.5 28.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.095 -1.003 . . . . 0.0 109.904 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.1 mtp -69.83 -19.41 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 110.492 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.9 p -89.49 117.44 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.741 -1.224 . . . . 0.0 109.747 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -62.04 148.86 87.71 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -75.43 9.29 10.7 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.828 -1.322 . . . . 0.0 112.234 0.099 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 73.86 21.76 78.88 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.926 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.2 p -86.08 171.85 11.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.1 -1.235 . . . . 0.0 109.789 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.692 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 84.0 m-85 -121.43 144.81 48.47 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.562 -0.711 . . . . 0.0 109.943 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.9 m-20 -129.98 150.44 75.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.59 -8.79 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 120.512 0.808 . . . . 0.0 112.123 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 48.7 mt-10 -89.94 2.61 54.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.448 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.6 mmm -86.23 17.28 3.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -87.41 -7.84 57.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 108.939 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.1 m-20 -150.3 79.99 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -156.25 172.44 18.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.2 p -129.81 150.97 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.177 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.12 148.15 18.18 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.912 . . . . 0.0 109.341 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -45.34 -43.1 17.35 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 120.594 0.863 . . . . 0.0 111.547 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.9 10.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.6 m -129.98 160.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.325 -1.103 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' ALA . 97.9 m -116.47 129.99 56.51 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.617 0.722 . . . . 0.0 110.517 -179.298 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.9 131.96 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 22.3 p90 -147.03 170.65 16.68 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.916 -1.115 . . . . 0.0 111.172 -178.068 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 4.9 tpp -139.61 122.63 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.709 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OG ' ' A' ' 90' ' ' SER . 94.1 mt-30 -88.94 114.98 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 0.0 108.66 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.4 m -101.43 152.08 37.93 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.411 -0.805 . . . . 0.0 109.103 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.27 140.51 61.11 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 C-N-CA 123.7 -1.375 . . . . 0.0 112.214 -0.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 20.4 m -119.47 154.38 33.85 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.471 -0.768 . . . . 0.0 109.788 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -71.04 152.61 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.323 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.47 -163.53 26.3 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 92.7 m-20 -95.82 110.41 22.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.276 -1.132 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -59.89 -32.53 70.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.565 -0.709 . . . . 0.0 110.228 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.75 -40.08 76.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.961 -1.087 . . . . 0.0 109.875 -178.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -72.06 -40.26 68.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.636 -1.29 . . . . 0.0 108.627 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 35.7 m120 -60.49 -40.07 90.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.3 t80 -58.18 -43.12 87.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.83 -41.23 95.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.98 -40.18 94.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 108.872 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.92 -49.06 79.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.008 179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.6 mt -66.27 -41.47 89.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.96 . . . . 0.0 110.046 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -59.95 -41.83 92.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.966 -1.084 . . . . 0.0 108.873 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -71.13 -40.28 71.5 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.433 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.28 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.069 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.71 -42.21 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -60.1 -46.73 88.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.894 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.04 -50.0 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.353 -0.842 . . . . 0.0 109.076 179.242 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.73 -49.57 62.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.77 -40.22 91.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 110.578 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.41 -39.87 77.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.931 -1.105 . . . . 0.0 110.568 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 m -98.78 -0.0 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.95 -1.094 . . . . 0.0 109.741 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.17 22.88 77.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.03 -170.17 46.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.29 137.12 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.578 -0.954 . . . . 0.0 108.93 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -72.01 133.19 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 0.0 108.953 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.01 159.32 39.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 36.7 p-10 -87.47 -172.0 3.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.078 179.315 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 121' ' ' ARG . 73.6 m-20 -60.02 -39.84 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.809 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.465 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 79.0 mt-30 -76.38 17.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.34 -0.85 . . . . 0.0 109.388 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 121' ' ' ARG . 22.3 mtt-85 58.24 25.49 12.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.688 -0.633 . . . . 0.0 110.185 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 85.7 mtm180 -105.12 151.87 23.48 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.325 -0.86 . . . . 0.0 109.267 179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 98.2 mtp -51.93 136.55 28.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.2 mmm -58.81 139.95 55.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.588 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.1 p -132.2 150.65 76.62 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -41.45 -49.92 4.85 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.804 1.003 . . . . 0.0 112.878 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 110.039 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -66.56 -39.94 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.928 -1.108 . . . . 0.0 110.329 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.82 -40.15 87.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 0.0 108.044 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.22 -38.79 85.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.16 -48.94 79.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.876 -1.14 . . . . 0.0 109.721 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -59.94 -46.32 89.79 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.4 ' NE2' ' CE2' ' A' ' 98' ' ' PHE . 98.1 mt-30 -61.89 -39.48 92.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.607 -0.683 . . . . 0.0 109.187 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.24 -40.97 96.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.47 -41.78 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.875 -1.141 . . . . 0.0 109.133 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.21 -46.25 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.062 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 59.6 mtp180 -60.21 -40.16 89.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.703 . . . . 0.0 109.83 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.85 -40.45 88.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.04 -1.038 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.67 -38.05 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' ALA . 24.6 mtpp -59.83 -42.87 94.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.718 -1.239 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.08 -34.07 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.432 -1.417 . . . . 0.0 109.072 179.685 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.68 92.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.159 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.14 0.44 45.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.48 -0.763 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.153 -0.967 . . . . 0.0 109.313 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -149.65 145.2 26.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.79 -172.66 3.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.886 -1.134 . . . . 0.0 110.394 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.08 133.47 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mm -88.46 132.71 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.458 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 91.0 mt -131.42 140.63 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 122.346 1.07 . . . . 0.0 111.514 -177.398 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.9 mtm -147.21 138.39 23.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.23 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -118.82 132.56 56.13 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.196 -0.94 . . . . 0.0 111.908 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.56 118.94 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.23 38.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.62 -173.24 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 108.672 178.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -68.76 160.06 31.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.989 -1.07 . . . . 0.0 109.255 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -59.46 142.5 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.95 -6.22 79.16 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -121.9 148.9 44.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.2 mp0 -130.71 149.36 52.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 109.091 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.3 mt -84.91 136.23 33.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.25 146.32 53.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.156 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.87 98.56 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.79 -47.14 87.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.248 . . . . 0.0 109.581 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.07 -32.68 73.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -73.99 -56.93 4.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.638 -0.664 . . . . 0.0 109.842 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.97 -46.91 87.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -61.8 -40.78 96.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.23 -0.919 . . . . 0.0 110.586 -179.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 t -63.89 -40.04 95.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 110.139 -179.164 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -40.96 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 108.993 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.53 -40.27 95.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.352 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -68.81 -18.09 64.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.459 -0.776 . . . . 0.0 109.804 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -80.76 5.41 15.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.09 11.94 83.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -80.17 156.7 26.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.245 . . . . 0.0 110.031 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.84 137.19 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -62.13 105.89 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.955 -1.091 . . . . 0.0 109.77 -179.134 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -94.69 172.6 31.46 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.31 -164.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -1.03 . . . . 0.0 109.85 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 68.2 mtt 58.84 20.06 7.62 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.828 0.823 . . . . 0.0 109.092 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 53.14 40.06 30.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.727 -0.608 . . . . 0.0 111.691 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.13 169.7 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.8 -1.188 . . . . 0.0 109.052 178.254 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -94.53 115.51 27.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.0 110.629 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.457 ' CG ' ' HG ' ' A' ' 60' ' ' SER . 53.1 m-70 -101.06 127.93 47.36 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.356 -0.84 . . . . 0.0 109.437 178.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 61.9 ttt180 -106.05 127.55 53.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.099 -1.001 . . . . 0.0 108.514 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 48' ' ' HIS . 15.2 m-70 -97.44 177.1 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 109.648 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -56.51 -49.66 74.06 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 108.833 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -90.28 149.16 40.71 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.362 -0.836 . . . . 0.0 109.224 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.96 -12.22 33.83 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 120.967 1.112 . . . . 0.0 112.95 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -93.03 0.01 57.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.894 -1.129 . . . . 0.0 110.34 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 13.41 82.23 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.705 179.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -69.86 -39.99 76.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.835 -1.391 . . . . 0.0 109.523 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.64 170.57 54.23 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -68.76 169.22 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.355 1.37 . . . . 0.0 111.891 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.94 121.71 26.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.918 . . . . 0.0 109.089 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.7 mp -101.34 -37.36 8.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.273 -0.892 . . . . 0.0 109.533 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -151.38 159.86 44.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.418 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.457 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 2.0 m -133.69 -179.56 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.841 0.829 . . . . 0.0 110.723 -177.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.695 HD23 ' C ' ' A' ' 61' ' ' LEU . 5.9 tt -134.02 134.08 42.02 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.77 160.0 36.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.733 -0.605 . . . . 0.0 109.74 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.576 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 77.2 m-20 -73.36 160.74 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.99 -1.069 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mmm -68.88 -29.84 68.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 110.673 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.0 m -86.79 121.78 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.398 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -59.59 152.58 55.7 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -79.14 3.94 31.36 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.799 -1.334 . . . . 0.0 112.86 0.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.41 21.61 61.98 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.9 p -85.3 160.45 19.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.112 -1.228 . . . . 0.0 109.883 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 28.3 m-85 -125.13 139.95 53.31 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.624 -0.672 . . . . 0.0 109.426 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.429 ' N ' ' SD ' ' A' ' 74' ' ' MET . 41.9 m-20 -120.25 149.51 49.63 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.04 -14.49 41.87 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 119.345 0.802 . . . . 0.0 111.936 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.71 -0.0 57.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.279 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 71' ' ' ASP . 10.9 ptm -84.59 25.75 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.336 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 56.5 mtpt -79.08 2.44 20.66 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.546 -1.346 . . . . 0.0 109.282 -179.07 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 90.8 m-20 -142.76 84.25 1.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -161.29 174.13 14.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.977 -1.077 . . . . 0.0 109.977 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -130.09 152.54 49.43 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.72 149.03 18.51 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.14 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -49.33 -49.51 15.33 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-N 119.058 0.699 . . . . 0.0 111.732 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.93 18.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG11 HD21 ' A' ' 28' ' ' LEU . 33.4 m -129.99 159.91 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.492 -1.005 . . . . 0.0 110.132 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.6 m -108.82 122.43 47.17 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.356 0.598 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.2 mt -104.07 129.72 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -148.73 157.28 43.34 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.803 -1.186 . . . . 0.0 111.655 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.4 ttm -121.62 134.58 55.0 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' OG ' ' A' ' 90' ' ' SER . 98.4 mm-40 -90.64 104.01 16.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 88' ' ' VAL . 10.6 m -97.75 149.18 35.45 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.192 -0.943 . . . . 0.0 109.471 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.65 131.81 25.46 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.636 -1.402 . . . . 0.0 112.205 -0.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 60.8 m -103.82 166.68 10.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.75 148.54 47.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.641 -0.662 . . . . 0.0 109.398 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.75 -160.02 33.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.45 113.27 24.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.105 . . . . 0.0 109.443 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.99 -33.01 71.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.619 -0.675 . . . . 0.0 109.916 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.01 -41.49 74.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 110.597 -178.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.32 -42.1 62.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.834 -1.167 . . . . 0.0 108.681 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -62.6 -33.84 75.8 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.07 -48.69 80.67 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -59.96 -39.97 87.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.77 -40.16 91.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.7 mtp -59.89 -42.81 94.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 108.763 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.39 -40.04 96.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.28 -0.887 . . . . 0.0 109.211 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.15 -40.04 88.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 109.486 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 p -71.62 -40.06 70.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.92 71.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -62.98 -40.06 96.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.246 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.997 . . . . 0.0 108.961 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.91 -49.22 84.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.4 -49.61 66.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.831 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.88 -39.97 75.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.256 -0.903 . . . . 0.0 111.046 -178.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 114' ' ' GLY . 4.4 m -102.0 -1.02 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.04 -1.037 . . . . 0.0 110.388 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.09 20.76 73.21 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -82.93 -172.58 48.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.36 139.23 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.588 -0.948 . . . . 0.0 109.077 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 t -77.18 133.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.155 -0.966 . . . . 0.0 108.894 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.0 mt -130.08 156.87 43.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.359 -0.838 . . . . 0.0 109.213 -179.417 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -86.29 -173.36 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 0.0 109.358 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 87.5 m-20 -60.08 -38.26 82.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.92 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -77.59 15.29 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 56.37 39.58 30.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.702 . . . . 0.0 109.776 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 122' ' ' ARG . 43.4 mtt-85 -116.23 151.16 36.32 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.682 . . . . 0.0 109.292 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.3 mtt -50.56 134.79 23.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.8 mmm -58.39 138.63 56.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.396 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -140.0 152.85 68.67 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -48.0 -43.56 29.95 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 CA-C-N 119.018 0.685 . . . . 0.0 111.391 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.18 -40.81 91.27 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -69.92 -41.04 75.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.052 . . . . 0.0 108.974 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.166 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -62.53 -40.03 95.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.95 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.77 . . . . 0.0 110.277 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' O ' ' A' ' 12' ' ' ILE . 65.0 m-85 -60.04 -42.56 94.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.065 . . . . 0.0 108.692 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -62.56 -39.96 95.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 92.8 m-20 -62.01 -43.07 99.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 0.0 110.236 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.37 -40.64 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.828 -1.17 . . . . 0.0 109.673 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.21 -43.45 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 85.5 mtm180 -60.04 -40.18 88.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.043 . . . . 0.0 110.385 -179.149 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -61.51 -39.9 92.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.005 -1.059 . . . . 0.0 110.172 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.09 -26.19 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 111.987 -178.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -59.86 -39.65 85.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.581 -1.324 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 57.0 p-10 -59.99 -30.03 68.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.697 -1.252 . . . . 0.0 109.54 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.595 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -63.54 -37.43 87.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -96.99 -13.27 22.43 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.237 -0.915 . . . . 0.0 109.481 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.707 179.869 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.79 104.37 3.32 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' H ' ' CG2' ' A' ' 139' ' ' VAL . . . -99.34 175.23 5.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 110.443 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.42 130.16 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mm -95.8 123.83 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.17 144.21 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 121.777 0.799 . . . . 0.0 109.979 -178.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.6 mtt -143.81 151.32 39.78 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -133.52 125.06 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 110.59 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.87 117.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 159.43 44.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.117 -0.989 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.64 174.05 8.12 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -59.34 151.96 22.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 108.567 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -53.21 148.51 8.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.178 -0.951 . . . . 0.0 108.936 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.13 -1.3 79.92 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -130.04 148.47 51.9 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.426 -1.044 . . . . 0.0 109.026 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 55.8 mm-40 -127.53 148.7 50.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.426 -0.796 . . . . 0.0 108.942 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 17' ' ' ALA . 51.5 mt -87.92 139.02 30.94 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.117 -0.989 . . . . 0.0 110.007 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -70.85 145.57 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.78 -40.85 98.73 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.44 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -48.49 81.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.94 -1.33 . . . . 0.0 109.715 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.45 -27.43 65.24 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -75.0 -59.31 2.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.589 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 74' ' ' MET . 92.5 mt -59.71 -45.44 92.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.29 -40.4 93.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.0 t -64.45 -39.74 94.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -49.16 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.973 -1.079 . . . . 0.0 110.051 -178.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.13 -40.26 97.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.995 -1.066 . . . . 0.0 109.296 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.1 -16.5 64.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 110.117 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -84.79 -0.63 54.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.994 -1.066 . . . . 0.0 109.96 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.33 13.2 57.63 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.907 -1.12 . . . . 0.0 110.49 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -82.94 149.92 26.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -1.226 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.9 mt -120.4 133.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.003 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.04 104.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 -178.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.86 171.34 32.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.72 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -1.169 . . . . 0.0 109.27 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.0 mmm 57.9 20.28 6.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.461 -0.775 . . . . 0.0 109.851 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 50.61 39.45 21.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 111.59 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.2 pt -140.04 160.69 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -91.03 118.57 30.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.005 -1.059 . . . . 0.0 110.409 -179.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.445 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 29.4 m-70 -103.49 127.08 50.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 58.5 ttt180 -102.22 124.27 47.52 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.56 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 57.9 m-70 -94.06 171.14 9.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.64 -47.94 78.62 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -91.45 147.1 34.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.758 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.85 -8.85 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.622 0.881 . . . . 0.0 111.941 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -94.67 -0.33 54.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.08 -1.013 . . . . 0.0 110.742 -179.106 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.76 86.43 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.9 p -70.22 -40.13 74.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.048 -1.266 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.35 162.8 51.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.56 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.3 Cg_endo -66.53 176.25 4.35 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.067 1.178 . . . . 0.0 112.103 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.57 118.95 23.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 108.771 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.5 mp -97.6 -42.08 7.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.79 159.54 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.988 -1.07 . . . . 0.0 108.549 178.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.4 m -132.32 175.21 9.47 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.326 -0.858 . . . . 0.0 111.078 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.665 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -128.37 131.78 48.55 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.597 0.713 . . . . 0.0 109.138 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.542 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.31 160.21 33.73 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.611 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 84.2 m-20 -74.6 158.24 34.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.92 -1.112 . . . . 0.0 110.334 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -70.11 -27.57 64.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.633 -0.667 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.69 135.51 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.951 -1.093 . . . . 0.0 109.592 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -62.88 149.81 89.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.525 -0.734 . . . . 0.0 110.114 -179.371 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.13 5.35 24.78 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.962 -0.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.16 4.97 80.83 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -88.81 170.48 10.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.611 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.6 m-85 -118.61 140.09 50.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.574 -0.703 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 74' ' ' MET . 58.2 m-20 -124.33 150.02 62.83 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.79 -10.99 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.441 0.836 . . . . 0.0 112.551 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' ASP . 31.0 mp0 -88.9 2.37 53.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.001 . . . . 0.0 109.344 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.523 ' O ' HD11 ' A' ' 29' ' ' LEU . 63.5 mmm -86.51 18.42 3.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.605 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.7 mttm -85.92 -4.66 59.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.082 -1.011 . . . . 0.0 108.941 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.9 m-20 -149.92 80.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 108.914 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.66 173.11 17.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 109.898 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.4 p -130.24 149.85 51.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.57 149.41 20.11 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.016 -1.053 . . . . 0.0 109.286 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.533 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 18.1 Cg_exo -44.71 -53.59 4.93 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.312 0.675 . . . . 0.0 111.39 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.09 -147.34 5.48 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.97 160.0 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.84 -0.8 . . . . 0.0 109.51 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.2 m -113.42 118.59 34.96 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.988 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.9 mt -105.04 129.1 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.77 165.53 27.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.256 -179.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.0 ttp -140.08 127.78 21.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -90.33 117.58 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.998 . . . . 0.0 108.573 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 88' ' ' VAL . 5.5 m -98.7 150.72 36.98 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 108.704 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -74.87 139.08 59.7 Favored 'Cis proline' 0 N--CA 1.496 1.645 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.639 -0.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.6 m -104.86 167.12 9.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -70.24 141.93 52.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.02 -155.74 27.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -95.34 119.39 33.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 108.724 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.7 mp0 -57.54 -31.55 66.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.534 -0.729 . . . . 0.0 110.442 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.51 -40.4 77.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.394 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.48 -40.18 70.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.24 -40.02 94.77 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -59.89 -50.11 75.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 108.699 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -60.01 -40.11 88.14 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 tp -60.52 -41.49 94.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -59.61 -45.4 92.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.116 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.12 -42.9 95.77 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.045 -1.034 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.03 -40.84 90.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.265 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -70.33 -40.12 74.35 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.339 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.96 -55.54 32.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.537 -0.727 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.37 -37.25 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.008 -179.444 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -60.07 -44.6 94.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.042 -1.036 . . . . 0.0 108.963 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.39 -49.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.005 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.27 -47.69 65.7 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.33 -40.02 89.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.149 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.8 -40.38 79.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.1 -1.0 . . . . 0.0 110.938 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.7 1.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.083 -1.011 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.44 25.58 72.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.68 -167.84 43.92 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.2 t -137.43 140.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.412 -1.052 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG12 ' SD ' ' A' ' 124' ' ' MET . 10.7 t -71.66 130.65 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.163 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -127.01 157.51 39.37 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.0 109.297 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -84.62 -173.41 4.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.312 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.9 m-20 -60.65 -38.65 85.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.268 -0.895 . . . . 0.0 108.69 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.63 17.74 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.49 -0.756 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.15 32.44 20.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.606 -0.684 . . . . 0.0 110.709 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -111.7 147.65 35.12 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.4 mtt -52.14 125.55 16.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.609 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.437 ' SD ' HG12 ' A' ' 116' ' ' VAL . 58.2 mtp -60.88 136.24 58.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.904 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 30.7 p -122.93 149.99 57.94 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -41.19 -44.07 5.35 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 120.662 0.908 . . . . 0.0 112.185 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.67 -39.89 90.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.291 -0.881 . . . . 0.0 109.056 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 125' ' ' THR . 68.6 mttm -67.89 -39.61 83.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.42 -40.18 74.3 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 130' ' ' ARG . 48.6 mtt-85 -63.37 -39.48 94.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -59.96 -44.19 94.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.121 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -62.58 -40.11 95.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 108.676 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -60.91 -39.03 87.78 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.297 -0.877 . . . . 0.0 108.841 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.58 -39.99 93.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.33 -40.89 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.007 -1.058 . . . . 0.0 108.852 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.29 -41.97 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.1 mtt180 -61.82 -28.87 69.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.916 -0.49 . . . . 0.0 110.725 -179.415 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 97.3 mt-10 -60.12 -40.1 88.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.831 -1.168 . . . . 0.0 109.645 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.462 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 64.1 t -71.97 -34.03 49.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.466 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 144' ' ' ALA . 62.9 mttm -59.88 -43.15 94.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.929 -1.107 . . . . 0.0 110.902 -179.025 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.89 -26.62 68.27 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.172 179.736 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.51 -59.7 3.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.451 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -112.21 -28.01 8.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.488 -0.757 . . . . 0.0 110.133 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.329 -0.857 . . . . 0.0 109.809 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.83 142.71 30.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.7 -174.27 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.566 -1.334 . . . . 0.0 110.5 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.8 t -131.46 136.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.2 mm -91.27 129.43 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.486 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 81.4 mt -131.64 142.72 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.056 0.931 . . . . 0.0 110.912 -177.859 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.8 mtm -147.85 152.17 37.18 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.112 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -129.92 129.3 43.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.921 -1.112 . . . . 0.0 111.434 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.03 112.19 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.11 154.85 39.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.119 -0.988 . . . . 0.0 110.848 -178.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.77 168.45 17.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -56.08 160.18 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.073 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.71 150.14 33.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.77 -4.41 78.9 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 m -130.14 147.48 51.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.523 -0.986 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.53 150.2 50.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.502 -0.749 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.95 145.04 27.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.109 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -70.77 141.13 51.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 108.841 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.23 97.98 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.379 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.06 -45.03 96.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.294 . . . . 0.0 109.425 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mt -69.95 -24.1 63.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.102 179.261 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.5 tt -77.1 -55.43 5.45 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.956 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.97 -48.7 80.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.127 -0.983 . . . . 0.0 111.104 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 31' ' ' SER . 43.2 p-10 -64.19 -40.02 95.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.858 -1.151 . . . . 0.0 110.66 -178.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 75.5 m -60.9 -40.55 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.888 -1.133 . . . . 0.0 109.797 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 28' ' ' LEU . 96.8 mt -60.05 -48.27 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -61.63 -40.06 93.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.26 -20.03 65.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 0.0 110.245 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.552 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.74 1.05 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.663 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.5 61.66 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -80.0 154.68 28.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.264 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.12 136.94 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.12 106.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.051 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 46' ' ' HIS . . . -94.66 172.83 31.71 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.54 -168.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 110.061 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 77.1 mtm 59.24 25.4 13.99 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.613 0.721 . . . . 0.0 109.844 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 50.64 36.35 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.641 -0.662 . . . . 0.0 111.823 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -140.09 167.52 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.004 -1.06 . . . . 0.0 108.594 177.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 111.083 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.497 ' CD2' ' HA3' ' A' ' 40' ' ' GLY . 37.7 m-70 -103.85 131.05 51.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.425 -0.797 . . . . 0.0 109.392 178.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.0 ttt180 -105.96 127.29 53.05 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.223 -0.923 . . . . 0.0 108.702 178.085 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 60.7 m-70 -97.37 171.71 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.0 110.173 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.28 -49.95 68.41 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -90.36 148.15 38.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.828 . . . . 0.0 109.014 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -70.27 -7.39 21.09 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.844 1.029 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.86 -0.27 55.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.116 -0.99 . . . . 0.0 110.283 -179.16 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.07 86.1 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -69.99 -41.26 74.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -1.145 . . . . 0.0 110.243 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.83 166.98 52.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.62 168.54 14.65 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.068 1.179 . . . . 0.0 111.393 179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.996 -1.065 . . . . 0.0 109.231 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.4 mp -101.66 -40.12 7.14 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.891 . . . . 0.0 109.563 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -150.12 163.14 38.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 109.316 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -134.1 178.71 6.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.881 0.848 . . . . 0.0 111.137 -177.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.0 tt -132.5 131.43 41.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.44 162.57 31.86 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.704 -0.623 . . . . 0.0 109.48 -179.352 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.633 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 84.1 m-20 -74.93 159.68 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 110.53 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.0 -23.52 63.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.593 -0.692 . . . . 0.0 110.119 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 65' ' ' VAL . 17.4 m -85.36 121.73 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.922 -1.111 . . . . 0.0 109.55 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -59.59 149.92 68.6 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.314 -0.866 . . . . 0.0 108.929 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -77.28 12.12 13.02 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.16 -0.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.19 85.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -87.14 170.58 11.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -1.088 . . . . 0.0 110.062 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.633 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -116.89 144.8 44.1 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' GLU . 78.1 m-20 -129.21 150.6 75.9 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -44.81 -12.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.697 0.931 . . . . 0.0 112.16 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -85.13 15.23 4.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 71' ' ' ASP . 7.8 ptp -81.79 -5.12 57.9 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.376 -179.14 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.9 mttm -88.11 -4.63 58.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.88 -1.137 . . . . 0.0 110.468 -179.073 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.0 m-20 -150.96 69.7 0.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.885 -1.134 . . . . 0.0 109.822 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -154.44 170.0 22.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.6 p -129.68 154.03 47.55 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.6 148.87 17.67 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.95 -1.094 . . . . 0.0 109.329 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.69 -51.17 9.45 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 120.416 0.744 . . . . 0.0 111.62 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.98 -149.52 7.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.03 163.07 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.608 -0.936 . . . . 0.0 110.068 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.6 m -115.04 126.54 54.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -109.88 130.02 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.341 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.98 155.15 40.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.785 -1.197 . . . . 0.0 111.556 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.6 ttm -119.51 131.18 55.52 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.5 mm-40 -90.38 112.33 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 88' ' ' VAL . 7.8 m -97.93 150.36 36.68 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.73 132.3 26.48 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.47 0.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 49.6 m -106.4 158.37 16.94 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.595 -0.691 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -73.01 153.07 41.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.61 -164.47 33.02 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -95.29 107.92 20.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -1.067 . . . . 0.0 108.918 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 136' ' ' ILE . 90.8 mt-10 -59.88 -30.26 68.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.667 -0.646 . . . . 0.0 110.529 -179.292 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.71 -39.99 76.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.274 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.88 -40.6 60.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.042 -1.036 . . . . 0.0 108.815 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -62.47 -35.83 80.56 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -59.6 -49.98 75.66 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -60.79 -40.08 91.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.96 -43.22 95.2 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.0 mtp -58.5 -41.17 84.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 0.0 109.1 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.15 -40.76 86.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.601 179.513 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.04 -40.13 88.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 0.0 109.526 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.6 p -72.53 -40.01 67.11 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 109.458 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.54 -53.51 57.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 110.102 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.62 -37.74 82.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.975 -1.078 . . . . 0.0 109.314 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.98 -47.48 85.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.048 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.03 -49.95 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.401 -0.812 . . . . 0.0 109.208 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.16 -50.39 49.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.571 -0.705 . . . . 0.0 109.513 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.07 -39.99 87.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.327 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.64 -39.95 80.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 110.591 -178.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -100.2 -0.16 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.58 24.33 76.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.29 -173.53 49.21 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.76 134.38 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.631 -0.923 . . . . 0.0 108.956 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.601 HG12 ' SD ' ' A' ' 124' ' ' MET . 2.5 t -71.71 128.25 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 108.94 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.06 159.99 35.96 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.395 -0.816 . . . . 0.0 109.824 -179.006 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -85.95 -170.07 2.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.757 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.2 m-20 -60.12 -39.85 87.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.295 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.88 14.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 108.962 -179.608 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.4 mtt180 56.23 35.13 25.24 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.382 0.61 . . . . 0.0 109.371 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 122' ' ' ARG . 13.0 mtt-85 -109.7 153.33 24.42 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.619 -0.676 . . . . 0.0 109.315 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.2 mtm -50.27 124.37 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.601 ' SD ' HG12 ' A' ' 116' ' ' VAL . 52.3 mtp -60.03 140.0 57.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.866 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 p -131.65 150.83 77.39 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.34 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -43.64 -42.75 11.47 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.706 0.937 . . . . 0.0 112.411 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.01 -39.92 87.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.59 -39.61 88.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 109.528 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.9 -39.96 83.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 108.071 179.36 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.73 -40.06 96.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.01 -47.87 84.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 109.688 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -60.08 -42.58 94.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.862 -1.149 . . . . 0.0 108.585 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -60.79 -40.01 91.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.69 -38.93 86.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.631 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.0 -43.34 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.031 . . . . 0.0 108.608 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 94' ' ' GLU . 81.7 mt -59.94 -41.35 85.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 108.684 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 57.0 mtp180 -59.89 -39.97 87.16 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.443 -0.786 . . . . 0.0 109.431 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.443 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 80.8 mm-40 -60.01 -41.36 91.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 109.805 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.92 -32.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.845 -179.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -60.04 -40.28 88.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.953 -1.092 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -59.98 -30.96 69.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.266 179.878 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.57 94.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 109.953 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -96.84 -2.67 43.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.0 109.433 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.45 ' O ' HD11 ' A' ' 135' ' ' ILE . 81.9 m-20 -90.47 6.43 43.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.114 . . . . 0.0 109.699 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.89 72.85 79.25 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 6' ' ' ARG . 11.5 Cg_exo -58.18 129.37 32.63 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.047 1.165 . . . . 0.0 112.583 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -78.77 32.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 108.563 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 4' ' ' PRO . 97.7 mtt180 -75.38 156.66 35.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.645 -0.659 . . . . 0.0 110.791 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -83.78 -6.88 59.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -142.89 149.9 39.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.66 170.98 16.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.601 -1.312 . . . . 0.0 110.605 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.04 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.95 128.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.65 140.84 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.844 0.83 . . . . 0.0 110.63 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -136.88 127.32 26.68 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.848 -1.158 . . . . 0.0 111.335 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.7 114.45 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.06 153.03 41.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.91 -165.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -69.89 155.71 40.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.065 -1.022 . . . . 0.0 109.178 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.89 140.51 55.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 109.64 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.76 6.12 73.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -129.76 143.1 50.65 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.607 -0.937 . . . . 0.0 108.856 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.2 mt-10 -123.07 150.94 42.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.409 -0.807 . . . . 0.0 109.324 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -87.5 142.44 27.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.222 -0.924 . . . . 0.0 109.864 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -67.9 140.32 56.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -0.923 . . . . 0.0 108.736 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.14 97.68 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.768 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.68 -46.58 87.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.961 -1.317 . . . . 0.0 109.783 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.02 -30.64 67.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.314 -0.866 . . . . 0.0 108.919 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.19 -56.8 4.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.627 -0.671 . . . . 0.0 109.352 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.04 -42.86 95.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.35 -40.98 92.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.503 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -64.82 -41.98 95.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.929 -1.107 . . . . 0.0 110.033 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.53 -46.67 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.328 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.56 -40.13 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 0.0 110.022 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -65.99 -17.77 64.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.56 5.43 24.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.911 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.33 72.14 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 121.05 -1.031 . . . . 0.0 110.697 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.68 150.36 30.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.355 . . . . 0.0 109.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.05 133.05 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 109.67 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.773 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -99.92 171.29 23.54 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.79 -163.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -1.116 . . . . 0.0 109.725 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 92.4 mmm 58.2 20.35 7.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.71 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m120 50.08 39.11 18.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.559 -0.713 . . . . 0.0 111.396 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.94 161.56 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.098 -1.001 . . . . 0.0 108.558 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 120.62 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.05 -1.031 . . . . 0.0 110.352 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.437 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 56.0 m-70 -105.12 127.9 53.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.5 ttt180 -102.67 129.23 49.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.052 -1.03 . . . . 0.0 108.893 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 13.4 m-70 -93.27 168.77 10.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.422 -0.799 . . . . 0.0 109.052 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.3 tp -52.71 -52.59 55.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.6 m -93.58 149.99 38.09 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.22 -2.14 10.01 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.57 0.846 . . . . 0.0 111.713 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -95.94 0.03 51.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.02 14.07 82.12 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.8 p -68.41 -38.59 81.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.155 -1.203 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -90.44 171.43 36.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 27.6 Cg_endo -74.55 178.67 6.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 120.944 1.096 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.57 118.83 22.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.129 -0.982 . . . . 0.0 108.847 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.81 -26.55 14.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -159.25 160.61 35.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.067 -1.02 . . . . 0.0 108.927 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -134.32 -178.56 5.1 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.915 -1.115 . . . . 0.0 112.094 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -137.9 134.06 34.57 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.322 0.582 . . . . 0.0 109.476 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.636 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.15 162.22 32.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -75.32 160.81 29.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 109.849 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -69.93 -22.98 63.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 110.92 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 71.8 t -86.76 121.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.822 -1.174 . . . . 0.0 109.719 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -58.57 147.31 70.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.054 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -76.33 15.98 6.95 Favored 'Cis proline' 0 N--CA 1.492 1.435 0 C-N-CA 123.402 -1.499 . . . . 0.0 111.76 -0.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 70.05 18.66 74.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.2 p -90.76 171.47 9.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -114.6 151.94 32.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 77.8 m-20 -131.2 148.42 70.12 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -46.08 -13.96 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.562 0.842 . . . . 0.0 111.668 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.4 mt-10 -85.46 16.12 4.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 21.8 ptt? -81.94 -2.82 52.7 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 58.9 mttm -86.24 -0.76 56.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.029 -1.044 . . . . 0.0 108.773 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.5 m-20 -152.15 69.34 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.559 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -155.32 169.94 23.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.909 -1.119 . . . . 0.0 109.53 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.411 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 80.4 p -130.41 154.49 47.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.69 149.88 20.75 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.872 -1.142 . . . . 0.0 109.57 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.24 -36.43 99.02 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.508 0.805 . . . . 0.0 112.185 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.68 -157.78 19.94 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.159 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.0 160.3 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.594 -0.945 . . . . 0.0 109.116 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.5 m -116.62 124.36 49.6 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.549 0.69 . . . . 0.0 109.867 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.05 129.48 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.24 163.61 34.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 110.282 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -140.02 128.56 22.89 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -88.97 118.67 28.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 108.735 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.14 152.52 39.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.45 138.13 53.87 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.275 -1.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.7 m -105.46 160.94 14.76 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.799 0.809 . . . . 0.0 110.736 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.17 143.73 52.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.709 -0.62 . . . . 0.0 109.953 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.74 -152.96 24.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -93.72 110.15 21.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -1.115 . . . . 0.0 109.068 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -56.21 -31.05 63.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.678 -0.639 . . . . 0.0 109.713 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 -37.02 75.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.99 -38.98 76.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 108.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 58' ' ' LEU . 91.8 m-20 -60.16 -41.16 92.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CG ' ' NE2' ' A' ' 133' ' ' GLN . 70.7 t80 -59.79 -46.09 90.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -61.24 -46.59 89.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.11 -40.05 88.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.099 -1.001 . . . . 0.0 110.248 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.3 mtp -59.02 -49.14 79.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.0 110.124 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.478 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 96.8 mt -66.09 -40.04 90.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 109.782 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -60.02 -42.59 94.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 108.92 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 p -70.11 -39.9 75.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.454 -0.779 . . . . 0.0 109.19 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.41 -57.8 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 110.275 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -60.12 -39.69 87.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.999 -1.063 . . . . 0.0 109.764 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -59.99 -48.3 82.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.913 -1.117 . . . . 0.0 108.636 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.14 -49.9 82.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.63 -50.13 66.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.504 -0.747 . . . . 0.0 109.327 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.81 -40.0 91.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 110.275 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.94 -40.18 75.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.1 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.12 1.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.163 -0.961 . . . . 0.0 109.609 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.45 23.07 77.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.87 -176.58 49.6 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.146 -1.208 . . . . 0.0 110.349 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.06 130.37 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.696 -0.884 . . . . 0.0 108.791 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 116' ' ' VAL . 2.6 t -71.54 130.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 108.953 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -130.34 159.61 36.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.369 -0.832 . . . . 0.0 109.411 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -88.34 -173.31 4.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.74 -38.51 85.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -76.4 14.6 0.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 121' ' ' ARG . 18.7 mtt-85 57.56 36.8 27.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 122' ' ' ARG . 52.4 mtt-85 -112.0 149.28 32.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.2 mtp -52.27 130.3 30.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.3 mmm -60.52 138.98 57.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 p -134.87 150.94 74.67 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.7 -46.49 10.33 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 120.813 1.008 . . . . 0.0 112.708 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.27 -41.34 93.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.0 -39.88 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.927 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.0 -40.02 79.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.199 -0.938 . . . . 0.0 108.476 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.12 -36.68 82.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.621 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.58 -46.57 86.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.005 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -60.01 -40.15 88.29 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 108.741 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.576 ' NE2' ' CG ' ' A' ' 98' ' ' PHE . 85.6 mm-40 -60.94 -40.05 91.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 0.0 109.009 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.31 -40.05 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.953 . . . . 0.0 108.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 2' ' ' ASP . 89.7 mt -61.86 -42.8 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.343 -0.848 . . . . 0.0 108.754 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.07 -40.49 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 32.2 mmt180 -61.33 -37.31 82.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.38 -0.825 . . . . 0.0 109.706 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 94.0 mt-10 -59.88 -40.2 87.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.18 -32.97 27.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 111.008 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.9 mttt -59.79 -41.85 92.08 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.877 -1.139 . . . . 0.0 110.903 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.2 -29.48 68.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.83 -1.169 . . . . 0.0 109.811 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.43 91.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -104.62 -1.07 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.814 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG3' ' H ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 1' ' ' MET . 94.8 m-20 -87.07 -9.73 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.116 . . . . 0.0 108.849 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -91.07 149.94 40.84 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 52.3 Cg_exo -35.71 158.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.4 1.4 . . . . 0.0 113.271 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.18 29.89 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -78.28 92.34 4.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.085 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -85.98 -16.15 39.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -154.76 131.37 10.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.06 -170.2 1.87 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.576 -1.327 . . . . 0.0 110.88 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.06 132.3 65.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -86.87 130.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -126.94 144.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.091 0.948 . . . . 0.0 110.964 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.2 mtt -145.12 151.28 38.23 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -131.24 130.13 42.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.142 . . . . 0.0 111.153 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.0 t -109.31 118.43 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 154.75 39.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.978 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.02 -165.8 0.13 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.67 155.49 35.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.934 -1.104 . . . . 0.0 108.826 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -58.73 139.45 56.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.102 -0.999 . . . . 0.0 109.589 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.22 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -128.49 143.3 50.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.575 -0.956 . . . . 0.0 108.936 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -120.39 140.46 51.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.437 -0.789 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.64 142.12 28.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 109.944 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -68.99 137.78 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.44 -0.787 . . . . 0.0 109.347 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.26 96.82 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.581 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.05 -46.32 89.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.772 -1.428 . . . . 0.0 109.512 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.41 -24.69 63.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -72.6 -56.54 5.18 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' MET . 36.0 mt -60.11 -45.06 94.23 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.955 -1.09 . . . . 0.0 110.301 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.03 -45.99 90.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 111.518 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.4 p -63.47 -43.17 98.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.88 -1.138 . . . . 0.0 110.192 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.15 -47.14 93.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 110.202 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.0 -40.07 94.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -68.13 -19.56 64.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.536 -0.728 . . . . 0.0 109.833 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.54 7.85 11.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 109.693 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.85 9.39 84.54 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -79.76 147.6 31.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.386 . . . . 0.0 109.266 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 88.9 mt -122.91 134.37 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.98 102.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.253 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.44 168.09 29.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.53 -162.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.195 -1.179 . . . . 0.0 109.186 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.7 mtt 59.92 20.15 9.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.81 -0.557 . . . . 0.0 110.609 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.6 m120 52.35 33.19 12.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.129 -0.982 . . . . 0.0 111.362 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 12.2 pt -139.61 155.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.008 -1.058 . . . . 0.0 108.483 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -88.02 120.19 29.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.883 -1.136 . . . . 0.0 110.019 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 52.7 m-70 -105.41 127.14 52.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.638 -0.664 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 47' ' ' ARG . 15.4 ttt-85 -101.82 128.87 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -93.84 175.74 6.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.44 -49.97 68.75 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.167 -0.958 . . . . 0.0 108.53 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 55.2 m -92.65 149.24 37.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -71.34 -2.19 10.84 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.695 0.93 . . . . 0.0 111.644 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.01 -2.78 52.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.933 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.68 85.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.8 p -69.95 -40.0 75.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -1.184 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.58 171.51 54.05 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.49 177.23 7.0 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.04 1.16 . . . . 0.0 111.306 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.58 122.25 26.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 108.925 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -101.06 -47.58 4.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 163.08 33.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.123 -0.986 . . . . 0.0 108.526 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.489 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.2 m -136.15 -177.01 4.51 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.125 -0.984 . . . . 0.0 111.842 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -136.79 130.37 31.81 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.47 0.652 . . . . 0.0 109.43 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.48 160.54 33.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 93.8 m-20 -75.06 157.89 34.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.317 -0.865 . . . . 0.0 110.674 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.6 mtp -69.94 -22.19 63.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 65' ' ' VAL . 10.3 p -87.04 120.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.88 151.3 64.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 110.07 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.38 15.7 7.25 Favored 'Cis proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.042 -1.232 . . . . 0.0 112.344 -1.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.94 18.61 80.17 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.9 p -87.88 175.61 7.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -1.158 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.563 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 40.4 m-85 -125.31 156.4 38.72 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 73' ' ' GLU . 39.4 m-20 -140.02 147.24 49.96 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 121.175 -0.953 . . . . 0.0 110.676 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -47.56 -11.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.36 0.807 . . . . 0.0 110.806 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 71' ' ' ASP . 44.5 mp0 -85.56 22.37 1.59 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 29' ' ' LEU . 41.1 mtm -73.57 -0.1 14.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.0 mttm -88.13 -1.45 58.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.005 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.2 m-20 -151.23 74.78 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.725 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -160.05 164.61 33.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.01 -1.056 . . . . 0.0 109.544 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.5 p -139.11 155.88 47.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.62 149.02 16.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.826 -1.172 . . . . 0.0 109.353 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.85 -36.42 95.43 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.412 0.741 . . . . 0.0 111.812 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.43 -157.1 15.06 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 61' ' ' LEU . 30.8 m -130.02 158.8 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.697 -0.884 . . . . 0.0 109.114 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.8 m -110.03 118.3 36.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 109.842 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 94.5 mt -100.56 130.04 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.98 168.97 20.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.898 -1.126 . . . . 0.0 111.021 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 ttp -141.28 135.24 30.41 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -88.32 108.62 19.42 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 88' ' ' VAL . 3.8 p -97.41 141.36 22.9 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.53 135.25 34.39 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.498 0.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.594 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.0 m -105.32 168.52 9.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.394 -0.816 . . . . 0.0 109.289 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -69.98 149.96 47.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.97 -157.63 32.37 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.71 117.84 31.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -1.079 . . . . 0.0 109.575 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 90' ' ' SER . 57.8 mm-40 -57.6 -28.38 63.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.3 mt -69.91 -38.14 76.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 109.247 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.86 -40.0 76.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.522 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.6 m-20 -61.39 -40.55 94.77 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.3 t80 -59.21 -48.38 81.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.27 -46.45 89.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 108.94 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.29 -40.1 95.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.98 -46.68 88.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.023 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' A' ' 98' ' ' PHE . 90.4 mt -65.54 -45.04 84.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.519 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.2 mm-40 -60.03 -40.23 88.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.164 -0.96 . . . . 0.0 108.448 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 p -70.02 -40.52 75.14 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.67 7.62 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.456 -0.777 . . . . 0.0 109.561 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -61.02 -40.89 95.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 57.4 m170 -60.63 -50.38 73.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.054 -1.029 . . . . 0.0 108.912 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.9 -50.09 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.71 -49.0 63.34 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.95 -40.02 87.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 110.227 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.89 -40.01 75.91 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.148 -0.97 . . . . 0.0 110.958 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.34 0.79 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.06 -1.025 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.04 21.52 76.94 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.52 50.39 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.01 136.43 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.602 -0.94 . . . . 0.0 108.916 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.03 135.05 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 109.938 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -134.85 160.21 38.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.356 -0.84 . . . . 0.0 109.425 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -86.41 -174.85 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.38 -0.825 . . . . 0.0 109.115 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.5 m-20 -60.04 -36.02 76.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.357 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -77.25 12.76 1.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 109.103 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 40.8 mtm-85 55.91 39.54 30.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.741 -0.6 . . . . 0.0 109.853 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -117.69 153.22 33.72 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.6 mmm -50.46 130.03 23.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 75.4 mmm -60.08 139.81 57.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.518 -0.739 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -134.45 151.21 75.74 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -43.98 -46.84 10.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.873 1.049 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -60.08 -39.99 88.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.1 -39.97 82.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 110.287 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.43 -40.04 85.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.949 -1.094 . . . . 0.0 108.603 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 130' ' ' ARG . 35.1 ttt-85 -63.64 -39.59 94.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.591 -0.693 . . . . 0.0 109.431 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.62 -46.97 87.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -59.86 -41.55 91.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -62.6 -40.13 95.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.83 -41.0 94.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.08 -43.3 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 108.891 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.97 -47.46 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.538 -0.727 . . . . 0.0 109.361 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.3 mtt180 -61.06 -39.9 91.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.11 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 51.5 mt-10 -60.48 -40.06 89.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.213 -0.93 . . . . 0.0 110.971 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 88' ' ' VAL . 62.6 t -70.52 -34.04 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.062 -1.024 . . . . 0.0 110.794 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 144' ' ' ALA . 98.1 mttt -60.01 -44.45 94.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.538 -1.352 . . . . 0.0 110.571 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.17 -31.08 69.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.924 -1.11 . . . . 0.0 109.566 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.96 95.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 109.671 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -104.76 -3.86 23.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.764 . . . . 0.0 109.679 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.368 0.604 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.9 10.05 25.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 109.572 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -129.73 79.99 72.43 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.514 -0.741 . . . . 0.0 109.448 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -72.94 10.02 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.027 1.152 . . . . 0.0 111.473 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -88.15 5.43 41.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -75.73 143.93 41.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.705 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -85.83 -17.42 35.74 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -150.86 149.25 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -163.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 109.675 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.54 130.45 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mm -93.33 122.87 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.429 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.7 mt -119.18 151.34 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.26 1.029 . . . . 0.0 111.77 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.2 mtt -148.25 158.66 44.22 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -141.46 127.33 19.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.747 -1.221 . . . . 0.0 111.066 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.97 118.72 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 157.93 43.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.955 -1.091 . . . . 0.0 110.484 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -175.32 1.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.507 -0.745 . . . . 0.0 109.346 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -65.55 158.38 27.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -59.29 143.35 49.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.145 -0.972 . . . . 0.0 109.42 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.53 77.26 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -129.98 140.23 50.93 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.973 . . . . 0.0 109.355 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -127.69 148.6 50.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.494 -0.754 . . . . 0.0 109.21 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 112' ' ' VAL . 74.4 mt -87.64 142.73 27.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.927 . . . . 0.0 110.151 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.76 145.58 54.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.19 98.23 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.728 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -61.71 -46.8 88.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.318 . . . . 0.0 109.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.87 -28.81 65.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.9 tt -73.08 -58.75 3.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.358 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 74' ' ' MET . 97.5 mt -60.27 -44.28 95.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.36 -44.13 97.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 110.802 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 m -60.54 -40.2 90.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.813 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.96 -47.63 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.38 -40.11 95.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.263 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -66.63 -20.58 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.0 111.022 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.505 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -82.12 -9.47 59.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.731 -1.231 . . . . 0.0 110.506 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.524 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 110.0 7.06 27.56 Favored Glycine 0 N--CA 1.503 3.126 0 O-C-N 121.125 -0.984 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.689 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 35.7 m-85 -78.04 150.89 33.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.775 -1.427 . . . . 0.0 110.105 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.3 mt -126.39 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.84 110.63 1.6 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 110.191 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -100.09 171.89 23.93 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -63.78 -163.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 109.033 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.7 mtp 57.19 19.81 5.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.0 109.816 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 50.71 39.06 20.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.69 -0.631 . . . . 0.0 111.485 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.05 167.02 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.013 -1.054 . . . . 0.0 108.176 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.07 121.47 35.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.976 -1.077 . . . . 0.0 111.035 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.457 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 66.6 m-70 -110.2 130.27 55.57 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.625 -0.672 . . . . 0.0 109.207 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 37.6 ttm180 -103.8 132.87 49.65 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.78 -1.2 . . . . 0.0 108.643 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.55 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 84.1 m-70 -95.74 169.8 9.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 109.684 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.8 tp -55.98 -51.15 68.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 108.938 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -92.93 145.94 31.11 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.48 -2.29 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.715 0.943 . . . . 0.0 111.839 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.65 -2.56 51.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.86 86.61 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.024 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -70.01 -40.57 75.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.001 -1.293 . . . . 0.0 109.311 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.55 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -82.56 168.03 47.37 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.28 174.86 9.33 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.433 1.422 . . . . 0.0 112.019 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.12 126.3 30.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 108.854 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.9 mp -99.82 -39.92 7.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.106 -0.996 . . . . 0.0 109.532 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -149.39 165.45 32.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 108.617 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 m -133.32 -179.91 5.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.201 -0.937 . . . . 0.0 111.333 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.5 tt -136.95 134.58 36.87 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.659 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.14 163.6 29.55 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.732 -0.605 . . . . 0.0 109.74 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 89.5 m-20 -77.02 164.77 25.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.527 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.6 mmm -69.94 -28.0 65.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.2 p -89.94 121.53 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.102 -0.999 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -60.95 152.82 68.71 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.687 -0.633 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.93 5.02 19.43 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.377 -0.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.88 19.2 70.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.395 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.0 p -86.36 165.12 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -1.21 . . . . 0.0 109.671 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 82.5 m-85 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.627 -0.67 . . . . 0.0 109.638 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' A' ' 74' ' ' MET . 90.7 m-20 -120.83 151.19 54.32 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -50.59 -12.55 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 CA-C-N 119.553 0.876 . . . . 0.0 112.178 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -88.9 4.36 48.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.474 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 72.5 mmm -81.71 16.86 1.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 44.7 mmtm -88.23 -4.72 58.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.004 -1.06 . . . . 0.0 108.584 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 78.2 m-20 -148.57 79.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.26 171.02 20.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.0 109.218 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.7 p -135.34 150.3 49.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.375 -0.828 . . . . 0.0 109.043 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.27 150.86 23.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.34 -44.08 20.77 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 120.529 0.82 . . . . 0.0 111.861 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.97 -154.56 12.1 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -129.97 160.51 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.688 -0.889 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.2 m -112.81 127.96 56.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.677 0.751 . . . . 0.0 110.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -111.34 130.06 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.27 169.71 19.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.701 -1.249 . . . . 0.0 110.245 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.2 ttp -137.52 132.39 33.15 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.415 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.6 mt-30 -91.1 118.76 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.023 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.26 150.37 37.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.37 136.17 43.24 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 123.724 -1.365 . . . . 0.0 111.964 0.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 35.3 m -106.6 159.45 16.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.515 -0.74 . . . . 0.0 110.601 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -73.53 146.56 44.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 0.0 109.294 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.74 -160.9 29.18 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.93 111.55 23.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.173 . . . . 0.0 109.422 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.48 -25.0 22.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.364 -0.835 . . . . 0.0 108.777 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.51 -40.14 73.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.095 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.88 -40.0 72.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.536 HD22 HD23 ' A' ' 58' ' ' LEU . 66.1 m-20 -60.62 -40.01 90.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.8 t80 -58.64 -43.54 89.78 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.614 -0.679 . . . . 0.0 109.283 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.48 -41.7 96.31 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.366 -0.833 . . . . 0.0 109.66 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.94 -41.07 95.54 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 109.097 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.3 mtp -58.54 -48.61 80.29 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.45 -0.781 . . . . 0.0 108.989 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 98' ' ' PHE . 96.2 mt -64.34 -47.66 78.5 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.482 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.5 -40.79 92.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 108.978 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.8 p -70.04 -40.82 74.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.02 -59.48 5.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.805 -0.559 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.97 -38.07 84.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 110.01 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -60.06 -46.54 89.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.825 -1.172 . . . . 0.0 109.049 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.15 -48.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 108.592 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.27 -50.01 40.92 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.47 -39.92 89.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.676 -0.64 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.02 -40.82 74.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.166 -0.959 . . . . 0.0 111.453 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 23' ' ' LEU . 12.3 m -101.87 3.39 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.083 -1.011 . . . . 0.0 109.978 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.01 29.53 75.18 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.22 46.51 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.9 138.54 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.694 -0.886 . . . . 0.0 108.843 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.05 135.66 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.963 -1.086 . . . . 0.0 109.58 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.0 mt -133.51 155.24 49.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.309 -0.87 . . . . 0.0 109.6 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -84.23 -170.2 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.454 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.3 m-20 -61.94 -33.28 73.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 109.89 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -78.07 10.43 2.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.202 -0.936 . . . . 0.0 108.62 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.579 HH11 ' HG2' ' A' ' 121' ' ' ARG . 10.7 mtt-85 59.67 40.44 19.94 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.494 0.664 . . . . 0.0 109.292 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -124.64 153.8 41.71 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.4 mtp -50.86 126.46 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.1 mtp -60.04 140.07 57.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -127.66 150.38 72.9 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -40.75 -47.42 4.69 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.83 1.02 . . . . 0.0 112.604 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.05 -39.84 87.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.391 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -65.71 -42.13 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.153 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.02 -40.44 89.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 108.833 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -63.65 -38.66 91.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.457 -0.777 . . . . 0.0 109.399 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -60.05 -46.64 88.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -59.99 -40.07 87.91 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.553 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.64 -40.01 93.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.95 -40.84 97.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.85 -40.52 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.39 -45.09 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.691 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -62.48 -36.74 83.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.173 . . . . 0.0 110.124 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.426 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.02 -44.29 94.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.166 -0.959 . . . . 0.0 110.94 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 139' ' ' VAL . 16.6 m -74.8 -30.81 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.969 -1.082 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.69 -39.86 85.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.956 -1.09 . . . . 0.0 111.003 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.03 -29.72 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.559 -1.338 . . . . 0.0 109.002 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.72 95.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.714 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -101.03 -27.83 13.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.204 -0.935 . . . . 0.0 109.817 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.594 -179.783 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' OD1' ' OE2' ' A' ' 131' ' ' GLU . 96.4 m-20 -86.05 -11.03 53.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 109.111 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -130.07 71.46 82.2 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 6' ' ' ARG . 1.2 Cg_endo -61.79 140.49 85.96 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 120.613 0.876 . . . . 0.0 112.315 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -80.0 31.04 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 4' ' ' PRO . 14.0 mmm180 -75.06 127.28 32.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.999 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -85.65 -23.93 27.27 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.9 145.99 28.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.33 169.09 21.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.74 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -115.8 130.35 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mm -92.16 129.07 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.3 mt -124.22 143.95 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.832 0.825 . . . . 0.0 110.461 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.0 mtt -142.96 149.46 38.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -132.26 128.59 38.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.977 -1.077 . . . . 0.0 111.187 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.97 119.73 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.16 157.93 43.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.56 -176.04 2.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -63.15 147.34 51.14 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.092 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 4.5 p80 -51.57 147.22 6.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.01 78.38 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -131.54 149.99 52.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.586 -0.95 . . . . 0.0 109.595 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -127.59 150.0 49.91 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.2 mt -84.26 141.97 30.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -0.975 . . . . 0.0 109.673 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -66.27 140.04 58.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.256 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.49 95.88 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.771 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.07 -47.72 83.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.967 -1.313 . . . . 0.0 110.246 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.71 -29.96 67.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 108.991 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -71.51 -59.74 2.6 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.9 -45.88 91.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -60.09 -42.25 94.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 109.998 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 t -64.08 -40.3 95.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 0.0 109.494 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.11 -45.33 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.089 -1.007 . . . . 0.0 109.221 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -62.68 -39.96 95.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.279 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -65.91 -21.95 66.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.17 7.89 10.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.358 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.11 15.46 78.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.048 -1.072 . . . . 0.0 110.894 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -81.63 150.08 28.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.896 -1.355 . . . . 0.0 109.504 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.9 mt -119.98 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.9 103.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -0.924 . . . . 0.0 109.595 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.0 170.78 34.94 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -163.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 59.4 22.97 11.46 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.431 0.634 . . . . 0.0 110.202 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 50.96 36.15 14.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.751 . . . . 0.0 111.153 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.96 161.33 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.127 -0.983 . . . . 0.0 109.297 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -90.88 134.2 34.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.51 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 39.8 m-70 -123.02 127.86 49.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.803 -0.561 . . . . 0.0 109.505 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.4 ttt180 -100.0 123.92 44.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 25.9 m-70 -93.36 170.09 9.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.742 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.95 -51.74 66.63 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.369 -0.832 . . . . 0.0 108.92 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -97.59 148.89 35.09 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.0 108.855 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.69 -4.22 11.76 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.546 0.831 . . . . 0.0 111.611 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.14 -1.6 57.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.68 14.17 82.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -68.61 -44.21 74.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -1.198 . . . . 0.0 109.332 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.17 162.35 44.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -69.61 -176.68 1.52 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.587 1.194 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.22 127.45 33.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 109.438 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.4 mp -99.16 -39.33 8.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.203 -0.936 . . . . 0.0 108.696 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -149.38 154.37 38.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 29.9 m -129.97 170.48 13.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.263 -0.898 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -126.36 134.52 51.05 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.574 0.702 . . . . 0.0 109.493 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.64 161.81 33.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.543 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.0 m-20 -73.91 160.82 30.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.008 -1.057 . . . . 0.0 110.189 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.8 mmm -69.23 -22.03 63.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.0 110.013 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.29 120.59 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.208 -0.932 . . . . 0.0 110.048 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -60.67 150.91 73.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.53 8.26 11.87 Favored 'Cis proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.317 -0.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.55 79.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.7 p -87.74 171.06 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.249 -1.147 . . . . 0.0 109.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 88.4 m-85 -120.73 161.53 21.28 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.288 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t70 -136.65 137.63 24.24 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -45.19 -12.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 120.12 1.079 . . . . 0.0 111.802 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.8 mt-10 -85.19 12.88 7.09 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.2 ptt? -80.89 9.87 5.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.295 0.569 . . . . 0.0 109.578 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -84.39 -6.72 59.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.41 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 74.1 m-20 -150.16 75.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -0.847 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -155.78 169.99 23.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 108.849 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -133.88 153.63 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.325 -0.859 . . . . 0.0 109.136 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 148.62 19.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 109.182 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -47.43 -53.64 6.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 120.524 0.816 . . . . 0.0 111.646 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.24 -154.0 8.04 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.49 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.685 -0.891 . . . . 0.0 109.03 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 m -112.0 120.13 40.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.824 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.8 mt -105.03 130.05 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.8 170.0 17.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 34.8 ttm -138.94 129.8 26.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -90.09 112.63 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.4 142.33 24.39 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 88' ' ' VAL . 8.9 Cg_endo -76.49 138.92 57.18 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 124.022 -1.241 . . . . 0.0 112.927 0.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -114.05 164.72 13.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.337 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -71.12 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.52 -165.71 39.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -94.9 117.77 30.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -1.115 . . . . 0.0 108.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -55.71 -29.48 59.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.432 -0.792 . . . . 0.0 109.621 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.43 -39.97 77.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.236 -0.915 . . . . 0.0 108.947 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.19 -39.99 74.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.917 -1.115 . . . . 0.0 108.557 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.604 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.9 m-20 -61.38 -40.07 92.97 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE2' HD11 ' A' ' 102' ' ' LEU . 84.7 t80 -58.2 -42.95 87.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.93 -44.84 95.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 108.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.53 -39.99 93.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.8 mmm -57.56 -50.05 74.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.5 mt -66.83 -44.27 81.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.975 . . . . 0.0 109.421 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.469 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -59.99 -40.52 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.948 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 p -70.18 -41.84 73.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.64 7.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.819 . . . . 0.0 110.146 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.8 m-70 -60.08 -50.03 75.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.082 . . . . 0.0 109.235 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.98 -50.02 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.176 -0.953 . . . . 0.0 109.561 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.05 -50.58 58.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 110.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.98 -39.97 75.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.956 . . . . 0.0 111.076 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 m -98.86 -0.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.044 . . . . 0.0 109.509 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.47 23.9 77.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.48 -170.7 47.41 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.4 t -134.5 139.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -1.027 . . . . 0.0 109.337 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.5 133.57 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.44 154.8 49.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 25.6 p-10 -84.86 -174.86 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.8 m-20 -59.93 -36.96 78.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 109.252 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.501 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.1 mt-30 -77.4 16.87 0.56 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.396 -0.815 . . . . 0.0 109.31 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.2 mtt180 60.07 20.81 10.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.967 -0.458 . . . . 0.0 111.0 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.542 ' NH2' ' NZ ' ' A' ' 128' ' ' LYS . 34.4 mtm-85 -106.18 147.63 28.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.209 -0.932 . . . . 0.0 108.518 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.96 137.14 21.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.161 -0.962 . . . . 0.0 110.542 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.9 mtt -59.93 144.22 49.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.623 -0.673 . . . . 0.0 110.327 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 5.6 p -132.94 152.23 79.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -42.09 -47.69 6.7 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 120.639 0.893 . . . . 0.0 112.074 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.401 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 27.7 mp0 -60.85 -43.22 98.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' NZ ' ' NH2' ' A' ' 122' ' ' ARG . 98.4 mttt -67.29 -39.97 86.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 110.218 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.93 -39.93 87.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.997 -1.064 . . . . 0.0 108.275 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -67.8 -38.59 83.5 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.684 -0.635 . . . . 0.0 109.909 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' OE2' ' OD1' ' A' ' 2' ' ' ASP . 58.9 mm-40 -59.75 -46.07 90.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.73 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -60.06 -41.08 91.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.044 . . . . 0.0 108.239 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.5 -39.99 95.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.558 -0.714 . . . . 0.0 109.125 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.04 -40.03 92.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.511 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -43.45 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 108.769 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.98 -42.08 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 137' ' ' ARG . 49.3 mtt-85 -62.23 -39.85 94.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 74.9 mm-40 -60.02 -39.97 87.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.107 -0.995 . . . . 0.0 109.35 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.19 -27.96 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 mmtt -60.04 -45.3 93.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.0 110.173 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.95 -31.06 70.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.309 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.63 96.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 46.4 p-10 -105.31 -3.3 22.93 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.29 -0.881 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.66 42.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 109.601 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 5' ' ' LYS . 4.4 mtmm -130.02 78.03 75.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.495 -0.753 . . . . 0.0 109.513 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -65.7 37.6 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.161 1.24 . . . . 0.0 111.747 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 3' ' ' LYS . 88.0 mttt -70.86 -26.45 63.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 49.9 mtm-85 -83.71 119.31 24.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -86.42 -19.25 29.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.6 149.55 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.46 162.59 27.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 109.69 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.32 130.67 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 0.0 109.145 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mm -90.82 132.49 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.9 mt -129.93 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 122.279 1.038 . . . . 0.0 111.344 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.3 mtt -142.87 151.66 41.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -131.55 121.71 24.89 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.833 -1.167 . . . . 0.0 111.113 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.1 t -99.71 110.01 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.54 159.79 42.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.11 -166.3 0.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.11 159.96 32.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -58.38 145.14 39.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.45 10.26 82.22 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -130.06 147.52 51.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -1.043 . . . . 0.0 109.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.71 145.75 50.8 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 17' ' ' ALA . 58.7 mt -85.19 147.68 26.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.777 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.14 142.98 55.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.024 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.31 99.36 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.918 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.33 -43.74 98.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.374 . . . . 0.0 109.835 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.94 -28.51 65.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.1 tt -71.04 -59.58 2.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.16 -39.95 88.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.6 p -66.45 -39.82 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 109.968 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.87 -49.94 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -62.16 -40.0 94.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.956 -1.09 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.81 -22.88 66.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.99 7.72 12.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.029 -1.045 . . . . 0.0 110.266 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.58 75.98 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.138 -0.976 . . . . 0.0 111.118 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.78 150.01 26.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.323 . . . . 0.0 110.051 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.78 132.39 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.62 100.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.908 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.34 171.72 32.56 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.76 -161.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -1.156 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 98.0 mtp 60.0 20.55 9.65 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.51 0.671 . . . . 0.0 109.914 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 m120 51.93 33.56 11.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.567 -0.708 . . . . 0.0 111.565 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 pt -141.65 168.13 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.0 109.189 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.06 121.5 33.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.459 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 63.3 m-70 -106.51 130.03 54.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.784 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 7.2 ttt-85 -102.8 126.89 50.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.274 -0.892 . . . . 0.0 109.184 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 28.5 m-70 -97.35 170.92 8.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.0 -49.99 74.08 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -91.36 145.72 31.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 -2.72 9.4 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.668 0.912 . . . . 0.0 111.833 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.54 -3.68 52.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 109.85 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.0 9.78 86.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -70.9 -42.61 69.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.294 . . . . 0.0 110.229 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.01 164.99 54.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -68.4 175.12 7.28 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.997 1.131 . . . . 0.0 111.374 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.8 121.84 26.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.004 . . . . 0.0 109.323 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -97.68 -38.1 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.207 -0.933 . . . . 0.0 108.741 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.57 167.52 29.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 67.5 m -137.33 -179.08 5.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 111.173 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -136.51 131.65 34.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.538 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 160.29 34.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 109.543 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.59 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 94.0 m-20 -74.5 159.45 32.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.03 -21.32 63.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 110.177 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.15 121.24 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.056 -1.028 . . . . 0.0 109.901 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -60.69 150.66 74.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 109.189 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.34 12.21 20.22 Favored 'Cis proline' 0 N--CA 1.494 1.526 0 C-N-CA 123.584 -1.423 . . . . 0.0 111.723 -0.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 19.03 67.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.6 167.18 14.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.285 -1.127 . . . . 0.0 110.443 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 88.7 m-85 -122.39 141.87 51.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.573 -0.705 . . . . 0.0 109.484 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' GLU . 47.8 m-20 -128.79 150.0 73.76 Favored Pre-proline 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.68 -6.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.548 0.874 . . . . 0.0 111.778 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' ASP . 97.2 mt-10 -89.32 0.22 56.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.433 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 65.8 mmm -85.33 13.68 6.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.46 -0.775 . . . . 0.0 109.585 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -85.42 -8.6 58.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.164 . . . . 0.0 108.75 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -150.76 79.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -155.8 174.14 15.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.1 p -129.84 150.28 51.21 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.28 150.22 19.5 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.156 -0.965 . . . . 0.0 109.095 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -44.76 -43.61 14.69 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 120.415 0.743 . . . . 0.0 111.619 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -149.54 10.9 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 159.95 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.985 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -113.22 120.88 42.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 109.537 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.0 mt -103.03 130.5 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -145.85 170.6 16.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.936 -1.102 . . . . 0.0 110.496 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -138.45 130.68 28.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.35 123.91 33.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 9' ' ' ALA . 4.4 m -102.26 148.81 35.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.857 . . . . 0.0 109.016 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.42 141.93 72.76 Favored 'Cis proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.94 -1.275 . . . . 0.0 111.87 -1.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -107.0 155.72 19.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.971 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 92' ' ' GLY . 64.7 t80 -72.33 155.3 40.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 109.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CD2' ' A' ' 91' ' ' TYR . . . 80.75 -157.85 40.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -97.49 118.05 33.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -1.095 . . . . 0.0 109.076 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.38 -32.9 70.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.583 -0.698 . . . . 0.0 110.432 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.1 mt -69.9 -40.07 75.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.931 -1.106 . . . . 0.0 109.973 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -71.64 -40.02 70.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.923 -1.111 . . . . 0.0 108.361 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -61.9 -39.83 93.34 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.891 0.853 . . . . 0.0 108.811 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 64.8 t80 -59.51 -50.0 75.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -62.42 -39.94 94.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.01 -41.92 93.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.27 -46.06 89.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.375 -0.828 . . . . 0.0 109.473 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.17 -41.4 98.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.015 -1.053 . . . . 0.0 108.764 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.349 -0.844 . . . . 0.0 108.803 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 p -71.76 -40.25 69.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.9 67.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.58 -35.64 80.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 109.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -60.09 -45.84 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.074 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.27 -49.9 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 108.948 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.61 -49.7 55.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.51 -0.744 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.55 -39.98 89.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.18 -40.08 78.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.319 -0.863 . . . . 0.0 110.909 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 114' ' ' GLY . 10.3 m -103.14 0.02 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.99 22.93 77.29 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -85.66 -171.24 47.89 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.06 141.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.988 . . . . 0.0 109.561 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.76 130.04 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 108.985 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' ' SD ' ' A' ' 124' ' ' MET . 76.0 mt -132.0 159.97 37.2 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' N ' ' SD ' ' A' ' 124' ' ' MET . 35.7 p-10 -85.31 -172.59 4.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -59.97 -37.94 81.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.986 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -76.95 14.02 0.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 108.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.7 mtt180 55.91 32.81 20.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.732 -0.605 . . . . 0.0 109.526 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.54 156.58 19.34 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.9 mmm -50.92 133.97 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 117' ' ' LEU . 96.5 mmm -58.27 139.91 54.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.742 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 p -129.4 148.71 70.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -49.96 -43.76 40.2 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 119.43 0.832 . . . . 0.0 111.947 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.42 -40.1 89.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.76 -39.95 91.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.049 -1.032 . . . . 0.0 109.878 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.98 -40.05 87.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 108.675 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.63 -39.22 91.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.06 -46.37 88.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -59.98 -46.31 89.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.564 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 37.4 mm-40 -60.01 -39.98 87.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.396 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.95 -41.64 92.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.69 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.6 mt -63.36 -43.64 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.741 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.08 -44.96 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.803 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.474 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.1 mmt180 -60.03 -39.93 87.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 96.2 mt-10 -60.17 -38.63 83.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.529 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 88' ' ' VAL . 75.0 t -66.42 -39.73 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 110.537 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.8 mttt -59.88 -50.08 75.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.887 -1.133 . . . . 0.0 110.889 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 2.1 p-10 -62.38 -36.99 84.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.822 -1.174 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.42 99.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.305 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -102.27 -0.76 32.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.22 -0.925 . . . . 0.0 109.783 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 109.526 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.8 7.89 37.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.549 -0.719 . . . . 0.0 109.332 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -77.81 131.11 71.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.15 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -50.21 118.06 3.65 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.992 1.033 . . . . 0.0 112.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.89 33.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -69.97 150.53 46.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.489 -0.757 . . . . 0.0 110.249 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -81.15 -9.31 59.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -148.89 142.02 24.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.87 171.91 17.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 109.607 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.63 129.92 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.07 129.94 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.3 mt -128.72 146.12 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.083 0.944 . . . . 0.0 110.775 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -145.76 151.09 37.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.405 ' OD1' ' SD ' ' A' ' 64' ' ' MET . 67.3 m-80 -136.86 130.28 31.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.647 -1.283 . . . . 0.0 111.244 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.25 129.96 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.74 159.9 41.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 110.577 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.39 -172.47 1.46 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -65.96 155.99 34.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.839 -1.163 . . . . 0.0 108.298 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -55.53 133.1 50.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.128 . . . . 0.0 109.636 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.29 5.8 75.49 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.5 m -127.04 153.69 45.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.478 -1.013 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.98 153.67 45.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.533 -0.73 . . . . 0.0 109.083 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.87 138.37 32.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.989 . . . . 0.0 109.693 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -69.75 145.19 52.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.14 -42.97 98.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.1 -46.66 89.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -1.191 . . . . 0.0 109.906 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.73 -28.48 65.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.1 tt -71.7 -57.31 4.48 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.593 -0.692 . . . . 0.0 109.549 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.97 -46.12 90.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.045 . . . . 0.0 110.824 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -64.79 -41.36 95.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.002 -1.062 . . . . 0.0 111.067 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 m -63.03 -39.99 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.027 -1.046 . . . . 0.0 110.098 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.12 -49.82 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 110.695 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -63.26 -40.06 96.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.926 -1.109 . . . . 0.0 109.806 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -61.65 -23.62 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 110.761 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.616 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.32 -8.69 59.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.831 -1.168 . . . . 0.0 110.614 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 109.37 9.96 24.55 Favored Glycine 0 N--CA 1.503 3.105 0 O-C-N 121.01 -1.056 . . . . 0.0 110.845 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.768 ' N ' HH21 ' A' ' 47' ' ' ARG . 30.0 m-85 -79.89 148.95 31.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.683 -1.481 . . . . 0.0 109.972 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.6 133.56 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.24 105.69 0.53 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 110.265 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.472 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -94.59 171.38 30.48 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.45 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.125 -1.221 . . . . 0.0 110.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.9 mtt 59.96 22.68 11.77 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.406 0.622 . . . . 0.0 110.198 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.1 m120 52.57 36.21 19.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 111.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.08 161.6 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.995 -1.066 . . . . 0.0 108.572 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.08 120.94 33.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.064 -1.022 . . . . 0.0 110.677 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.472 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 68.3 m-70 -106.79 131.5 53.83 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 37' ' ' PHE . 32.6 ttm180 -104.5 130.22 52.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.006 -1.059 . . . . 0.0 108.497 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -100.15 169.42 9.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.844 . . . . 0.0 109.979 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.1 tp -57.06 -50.0 74.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -89.91 148.32 39.41 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.49 -4.45 15.02 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.597 0.865 . . . . 0.0 111.83 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -94.96 -0.17 54.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.187 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 9.05 87.2 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -69.91 -40.4 75.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -1.187 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.49 166.01 52.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.63 175.03 7.63 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 120.916 1.078 . . . . 0.0 111.737 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.408 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.35 123.36 29.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.84 -37.14 9.18 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.09 161.93 41.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 108.672 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m -134.44 -177.97 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.859 0.838 . . . . 0.0 110.844 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.4 tt -136.66 130.85 32.8 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.82 162.67 30.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.695 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.6 m-20 -78.49 164.9 24.34 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.045 -1.034 . . . . 0.0 110.547 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 14' ' ' ASN . 89.8 mmm -70.03 -22.61 63.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 0.0 110.461 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 94.2 t -86.95 119.24 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.978 -1.076 . . . . 0.0 110.115 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.91 147.72 78.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.151 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.64 14.56 6.93 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.552 -1.437 . . . . 0.0 111.842 -0.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 72.13 17.75 77.47 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 p -87.29 175.92 7.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -1.229 . . . . 0.0 109.728 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.695 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 80.1 m-85 -119.59 147.9 43.95 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 0.0 109.52 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 27.0 m-20 -134.0 150.2 73.72 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -46.66 -8.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.641 0.894 . . . . 0.0 112.306 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.7 mt-10 -85.66 10.36 13.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.74 -1.29 53.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.766 -0.584 . . . . 0.0 109.87 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.7 mttp -84.3 -6.78 59.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.5 m-20 -150.1 78.01 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -162.31 171.39 17.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.842 -1.161 . . . . 0.0 109.814 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.8 p -131.86 156.99 45.1 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.04 18.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.024 -1.048 . . . . 0.0 109.141 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 -24.36 54.05 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 120.515 0.81 . . . . 0.0 111.89 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.4 -164.02 36.27 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.731 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.11 166.52 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.751 -0.852 . . . . 0.0 108.735 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -119.89 129.97 54.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.532 -0.73 . . . . 0.0 110.387 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.52 128.96 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.72 164.08 32.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.001 -1.062 . . . . 0.0 110.827 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.7 ttm -132.19 130.22 40.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -88.73 105.35 17.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 88' ' ' VAL . 15.3 m -97.38 148.72 34.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.82 134.43 35.74 Favored 'Cis proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.364 0.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -105.56 159.89 15.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.07 145.49 49.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.339 -0.851 . . . . 0.0 109.214 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.31 -161.55 23.29 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.25 108.96 21.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.013 -1.286 . . . . 0.0 109.05 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.29 -31.34 65.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.46 -0.775 . . . . 0.0 110.065 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.05 -40.63 74.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.014 . . . . 0.0 110.338 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -77.09 -40.61 45.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.619 -1.3 . . . . 0.0 108.925 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -60.05 -38.09 81.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -58.45 -40.96 84.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -63.68 -40.08 95.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.941 -1.099 . . . . 0.0 108.604 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.56 -39.96 89.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.93 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.8 mtp -58.13 -49.88 75.44 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.537 -0.727 . . . . 0.0 109.36 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 102' ' ' LEU . 89.0 mt -64.53 -45.53 86.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 109.294 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 97.5 mt-30 -60.25 -40.17 89.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 108.445 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' HH12 ' A' ' 47' ' ' ARG . 93.7 p -70.39 -44.0 68.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.57 44.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.517 -0.739 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.096 -1.002 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 47.7 m170 -59.98 -43.66 94.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.0 108.506 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.24 -49.99 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.71 -49.41 68.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.09 -39.97 91.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.9 -40.0 75.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.895 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.17 2.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.018 -1.052 . . . . 0.0 109.532 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 67.13 25.36 73.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -162.67 38.52 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.417 -1.049 . . . . 0.0 110.487 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.59 154.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.646 -0.914 . . . . 0.0 109.203 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.2 t -94.93 129.82 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.426 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.1 mt -122.05 160.08 25.71 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.563 -0.711 . . . . 0.0 110.102 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.11 -171.29 3.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.7 m-20 -60.09 -40.04 88.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 109.697 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -76.23 17.76 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 119' ' ' ASP . 87.1 mtm180 56.2 35.02 25.01 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.468 0.651 . . . . 0.0 109.756 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -110.24 144.2 39.29 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.7 mtp -51.3 129.56 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 108.943 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.2 mtt -59.08 141.19 54.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 110.106 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 p -129.56 150.4 75.58 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -42.5 -45.17 8.26 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.469 0.78 . . . . 0.0 112.237 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.34 -40.01 92.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.188 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.054 -1.029 . . . . 0.0 110.544 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.92 -40.11 83.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.872 . . . . 0.0 108.765 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -65.95 -39.88 90.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.462 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.83 -43.57 94.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 109.839 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -60.14 -44.03 95.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.019 -1.051 . . . . 0.0 108.394 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.72 -40.07 96.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.47 ' OD2' ' NZ ' ' A' ' 3' ' ' LYS . 96.1 m-20 -61.58 -40.04 93.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.615 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.53 -40.95 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.145 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.67 -38.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 108.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 137' ' ' ARG . 27.2 mtt-85 -59.86 -38.91 83.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.045 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.6 -39.99 90.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.117 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.58 -28.77 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 111.025 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 144' ' ' ALA . 68.5 mttm -60.03 -45.24 93.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.663 -1.273 . . . . 0.0 110.179 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.07 -30.13 69.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.906 -1.121 . . . . 0.0 109.192 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.52 93.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.963 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -100.48 -25.62 14.13 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.354 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -88.79 -9.17 52.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -80.0 150.0 71.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.036 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.53 111.37 0.52 Allowed 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 120.572 0.848 . . . . 0.0 111.637 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.04 7.94 8.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.281 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' HG2' HH11 ' A' ' 6' ' ' ARG . 0.1 OUTLIER -78.68 118.39 20.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.005 . . . . 0.0 110.723 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.56 -11.15 52.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -147.5 130.85 16.6 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -162.3 -166.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.699 -1.251 . . . . 0.0 110.272 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.2 t -140.02 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 95.5 mt -120.0 147.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.281 1.039 . . . . 0.0 111.652 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.0 mtt -146.2 158.82 43.9 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' CG ' ' NH1' ' A' ' 121' ' ' ARG . 66.5 m-80 -141.15 121.77 14.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.658 -1.277 . . . . 0.0 111.457 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.49 113.48 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.42 44.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.82 -169.91 0.51 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.88 157.34 37.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.03 -1.044 . . . . 0.0 109.1 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -60.06 140.13 57.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.709 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.81 2.08 63.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.1 m -127.19 149.7 49.86 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.577 -0.955 . . . . 0.0 109.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -131.18 145.07 51.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.553 -0.717 . . . . 0.0 109.218 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 112' ' ' VAL . 85.3 mt -87.6 146.78 25.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.02 146.42 51.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 108.948 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.45 97.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mm-40 -61.19 -44.1 97.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.338 . . . . 0.0 109.857 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 89.5 mt -69.95 -27.85 65.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.3 tt -76.07 -59.62 2.68 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.71 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -47.93 83.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.288 -0.883 . . . . 0.0 111.579 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.3 p-10 -61.27 -39.99 92.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.894 -1.129 . . . . 0.0 110.342 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 56.5 m -62.21 -40.25 95.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.871 -1.143 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.59 -45.92 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.225 -0.922 . . . . 0.0 109.805 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -60.7 -40.03 90.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.31 -19.87 65.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.911 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.56 8.7 9.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.945 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.89 81.76 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -81.51 151.78 27.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.297 . . . . 0.0 110.113 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.98 139.95 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.62 107.41 0.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 109.572 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.83 171.49 34.52 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.43 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.235 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 72.1 mtm 56.73 26.1 10.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 110.09 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.9 m120 50.03 39.44 19.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 111.293 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 pt -141.67 161.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.5 130.76 37.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.532 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.9 m-70 -117.79 127.97 54.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 47' ' ' ARG . 14.5 ttt-85 -99.99 127.08 46.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.158 -0.964 . . . . 0.0 108.545 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.7 m-70 -95.8 170.05 9.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.492 -0.755 . . . . 0.0 109.701 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -49.99 -53.93 23.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.089 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -90.82 149.23 39.98 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.305 -0.872 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.66 -5.18 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.814 1.009 . . . . 0.0 112.452 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -93.04 0.04 57.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.135 -0.978 . . . . 0.0 110.041 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.1 81.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.4 p -70.0 -40.0 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -1.173 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -85.8 173.52 47.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.404 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 24.0 Cg_endo -73.96 178.4 6.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.37 1.38 . . . . 0.0 111.658 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.64 123.08 27.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.884 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.6 mp -97.38 -47.05 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.157 -0.965 . . . . 0.0 109.03 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -138.08 160.11 40.25 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.532 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.9 m -127.66 178.2 6.29 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.196 0.998 . . . . 0.0 111.694 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.2 tt -138.6 130.07 27.44 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.599 0.714 . . . . 0.0 109.146 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.63 160.11 34.33 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.683 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 8.3 m120 -73.73 161.79 29.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.991 -1.068 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mtp -69.66 -29.96 67.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 110.906 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 65' ' ' VAL . 13.2 p -86.35 131.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.804 -1.185 . . . . 0.0 110.126 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -59.97 150.04 71.17 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -76.91 5.93 18.49 Favored 'Cis proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.552 -0.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.82 83.08 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -88.55 169.97 11.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.101 -1.235 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.683 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 75.3 m-85 -120.05 143.49 48.07 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -119.82 149.99 49.66 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.439 -0.788 . . . . 0.0 108.889 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.3 -20.15 61.23 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 120.498 0.798 . . . . 0.0 112.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.95 -2.71 58.21 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -0.927 . . . . 0.0 109.121 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.439 ' CE ' ' OD1' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -89.24 25.24 1.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.526 -0.734 . . . . 0.0 110.652 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 29.4 mmtm -80.96 0.88 33.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.885 -1.134 . . . . 0.0 109.351 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 91.6 m-20 -142.0 86.77 2.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.96 177.97 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 109.724 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 p -131.73 150.12 52.26 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.56 149.48 19.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 0.0 109.219 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -45.28 -41.44 17.12 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 120.366 0.711 . . . . 0.0 111.393 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.59 -150.79 10.28 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HB ' HD21 ' A' ' 61' ' ' LEU . 23.4 m -130.11 159.98 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.607 -0.937 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 m -114.72 124.88 52.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.87 129.94 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -146.65 149.45 33.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.919 -1.113 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.2 ttm -102.31 133.33 47.4 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.464 -0.772 . . . . 0.0 109.526 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 90' ' ' SER . 94.0 mt-30 -91.07 105.36 17.76 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 16.0 m -97.46 147.21 32.65 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.185 -0.947 . . . . 0.0 108.537 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -74.23 133.64 31.97 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.377 0.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.6 m -105.29 158.85 16.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -72.73 149.9 43.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.732 . . . . 0.0 109.94 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.1 -160.36 34.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.1 116.15 28.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -1.159 . . . . 0.0 108.952 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.55 -31.81 69.76 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 110.219 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.07 -41.47 74.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.155 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -74.29 -39.98 62.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.63 -39.81 89.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 133' ' ' GLN . 55.9 t80 -53.09 -40.06 63.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -59.99 -40.0 87.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.198 -0.939 . . . . 0.0 108.713 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.82 -39.97 93.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 109.177 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mtp -56.61 -50.01 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.156 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.32 -44.7 90.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.91 . . . . 0.0 109.608 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -60.02 -40.84 90.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 108.826 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 p -70.17 -40.04 74.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.418 -0.801 . . . . 0.0 109.711 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.85 52.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.162 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -62.09 -37.2 84.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 0.0 109.971 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -60.12 -47.63 85.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.987 -1.071 . . . . 0.0 109.126 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.11 -49.95 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.78 -47.72 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.69 -40.32 91.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 110.096 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -71.14 -39.99 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 0.0 111.158 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.4 m -101.33 2.33 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.76 23.1 68.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.08 -173.24 45.54 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 134.83 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.606 -0.938 . . . . 0.0 109.136 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.416 HG12 ' SD ' ' A' ' 124' ' ' MET . 16.8 t -70.69 135.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.62 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 mt -132.4 156.19 47.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.459 -0.776 . . . . 0.0 109.732 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -87.89 -173.62 4.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.581 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 95.6 m-20 -60.03 -34.47 73.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.021 . . . . 0.0 108.996 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.34 14.98 0.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 108.961 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' NH1' ' CG ' ' A' ' 14' ' ' ASN . 20.2 mmt180 60.11 24.12 13.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.656 -0.652 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -110.96 150.85 28.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.44 -0.788 . . . . 0.0 109.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.9 mtm -50.52 129.39 22.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.081 -1.012 . . . . 0.0 109.597 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.416 ' SD ' HG12 ' A' ' 116' ' ' VAL . 57.0 mtp -59.93 139.7 57.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -125.6 151.01 69.86 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -40.34 -46.43 4.31 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 120.911 1.074 . . . . 0.0 112.532 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -60.14 -39.99 88.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.616 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.82 -39.73 83.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.188 -0.945 . . . . 0.0 110.341 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.65 -40.53 75.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.973 -1.079 . . . . 0.0 108.128 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 34.3 ttm-85 -65.29 -39.33 92.42 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.84 -46.85 87.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.68 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.581 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 62.0 m-85 -60.13 -42.7 95.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.053 -1.029 . . . . 0.0 108.258 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 98' ' ' PHE . 23.6 mm100 -62.97 -40.1 96.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 95.6 m-20 -61.65 -40.97 96.83 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.419 -0.801 . . . . 0.0 109.838 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -40.05 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.906 -1.121 . . . . 0.0 109.432 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.25 -39.23 81.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 99.1 mtt180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.886 -1.134 . . . . 0.0 111.303 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 15.2 mp0 -60.09 -39.09 84.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.794 -1.191 . . . . 0.0 110.164 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.07 -39.33 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.916 -1.115 . . . . 0.0 110.391 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.96 -50.08 75.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.779 -1.2 . . . . 0.0 110.929 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -60.91 -32.54 72.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.684 -1.26 . . . . 0.0 109.253 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.34 -23.78 67.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 108.826 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -98.74 -2.2 38.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.064 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.465 -179.835 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -86.59 -33.19 20.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' N ' ' OE2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -134.57 74.43 65.6 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -70.97 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.048 1.165 . . . . 0.0 111.834 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 3' ' ' LYS . 9.0 mtpm? -74.14 -37.91 63.91 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.72 -0.612 . . . . 0.0 109.626 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.43 120.91 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.712 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -81.85 -69.85 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -99.79 139.16 35.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.07 -175.93 5.55 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.738 -1.226 . . . . 0.0 110.231 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.04 133.32 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.93 135.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.468 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.1 mt -130.73 143.16 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.992 0.901 . . . . 0.0 110.701 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.5 mtm -149.31 152.09 35.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -129.13 130.36 46.34 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.099 -1.0 . . . . 0.0 111.013 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.97 113.8 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.09 153.32 38.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.175 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.24 -175.94 1.34 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -60.07 150.52 29.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 108.99 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -59.9 148.27 35.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.04 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.54 -5.57 77.27 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -128.98 142.1 51.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.941 . . . . 0.0 108.894 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -121.93 150.15 42.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.746 . . . . 0.0 109.305 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.27 142.46 29.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.343 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -67.69 141.03 56.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.0 108.795 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.1 96.47 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -62.59 -46.52 87.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.217 . . . . 0.0 109.573 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.1 -29.16 66.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 109.031 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -73.65 -58.92 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.07 -44.11 94.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.64 -40.7 95.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.501 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -64.82 -40.08 94.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.86 -50.26 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.353 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -63.97 -40.07 95.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.05 -20.39 66.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.416 -0.802 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.53 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.47 1.07 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 109.657 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.86 16.84 43.36 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 121.156 -0.965 . . . . 0.0 111.166 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -82.35 152.46 26.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.403 . . . . 0.0 110.242 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.86 134.81 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.12 104.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.067 -1.021 . . . . 0.0 109.996 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -93.63 171.31 31.77 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -65.56 -163.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.249 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.6 mmm 58.7 19.96 7.33 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.643 0.735 . . . . 0.0 109.688 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 51.76 38.19 22.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.526 -0.734 . . . . 0.0 111.898 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 pt -140.56 166.29 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.875 -1.14 . . . . 0.0 108.505 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -92.63 122.58 35.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.829 -1.169 . . . . 0.0 110.201 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.448 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 58.9 m-70 -106.45 127.33 53.21 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.457 -0.777 . . . . 0.0 109.092 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 37.5 ttt180 -103.88 128.71 51.36 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.06 -1.025 . . . . 0.0 109.05 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 64.4 m-70 -98.66 171.41 8.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.33 -0.856 . . . . 0.0 109.733 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.9 -49.68 72.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.8 m -91.15 147.79 36.41 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 109.015 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.45 -7.97 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.747 0.964 . . . . 0.0 111.905 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -91.44 -0.25 57.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 109.974 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.79 12.01 84.9 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.197 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.2 p -70.59 -40.59 73.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.008 -1.289 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.3 167.83 51.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -69.67 170.42 16.51 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 120.934 1.089 . . . . 0.0 111.427 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -78.71 126.2 30.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 109.301 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.0 mp -99.39 -30.72 12.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 109.098 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CB ' ' SD ' ' A' ' 101' ' ' MET . 28.2 p90 -159.15 159.98 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 108.615 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.42 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 17.6 m -129.88 175.88 8.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 110.564 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -133.24 132.45 41.47 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.506 0.669 . . . . 0.0 109.604 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 162.39 28.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 89.2 m-20 -75.28 160.92 29.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.974 -1.078 . . . . 0.0 110.782 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.6 mmm -69.51 -35.27 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.716 -0.615 . . . . 0.0 111.047 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.57 136.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.879 -1.138 . . . . 0.0 110.303 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -58.98 151.94 52.93 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -78.48 4.08 27.88 Favored 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.232 -0.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.31 86.0 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.6 p -85.91 170.32 12.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -1.133 . . . . 0.0 109.633 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 91.3 m-85 -113.99 155.99 24.88 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' GLU . 32.9 m-20 -135.52 148.75 67.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -44.05 -14.37 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.64 0.893 . . . . 0.0 112.498 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mp0 -86.17 16.3 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.5 ptt? -83.78 -4.96 59.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.33 0.586 . . . . 0.0 110.005 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 97.1 mttt -83.34 -4.61 58.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.785 -1.197 . . . . 0.0 109.429 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.4 m-20 -150.03 78.31 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 109.326 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.61 170.48 20.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.984 -1.072 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -131.49 150.74 52.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.65 149.68 20.47 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 0.0 109.19 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.84 -47.15 22.17 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 120.554 0.836 . . . . 0.0 111.916 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.14 -150.38 7.61 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -130.02 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.823 . . . . 0.0 109.886 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.3 m -113.2 122.81 48.61 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.99 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -145.09 150.21 36.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.0 ttm -110.15 135.7 50.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.675 -0.641 . . . . 0.0 109.404 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -91.83 104.02 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 m -98.32 149.04 35.33 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -74.46 137.59 51.05 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.263 0.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 74.3 m -103.35 168.0 9.45 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 0.0 110.541 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 65.3 t80 -72.32 154.6 40.86 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.377 0.608 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 72.85 -146.87 39.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.13 114.87 26.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.298 -1.119 . . . . 0.0 109.057 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -57.77 -31.04 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.928 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' CD1' HH12 ' A' ' 137' ' ' ARG . 90.2 mt -70.06 -39.8 75.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.67 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -70.29 -36.0 74.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.895 -1.128 . . . . 0.0 108.251 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -59.95 -40.03 87.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 78.2 t80 -59.91 -44.36 94.34 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -63.05 -40.13 96.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.258 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.77 -45.2 94.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.471 ' SD ' ' CB ' ' A' ' 59' ' ' PHE . 20.5 mtm -59.92 -43.57 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.884 -1.135 . . . . 0.0 109.787 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.9 mt -63.88 -40.2 95.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.08 -40.93 91.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.0 109.791 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.1 p -70.48 -40.05 73.87 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 109.429 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.3 70.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.3 -40.44 94.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.872 -1.143 . . . . 0.0 109.206 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.17 -49.36 77.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.29 -49.85 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.253 -0.905 . . . . 0.0 108.724 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.2 -48.98 64.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.673 . . . . 0.0 109.441 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.14 -40.02 88.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.93 -40.07 75.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.4 m -99.98 -0.93 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.99 -1.069 . . . . 0.0 109.838 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.48 20.79 75.76 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -80.57 -178.35 52.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.2 t -130.37 139.8 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.592 -0.946 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.505 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.8 t -74.72 130.78 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.311 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.06 155.79 45.57 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.375 -0.828 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -84.73 -174.91 5.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.465 -0.772 . . . . 0.0 109.963 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.5 m-20 -60.07 -35.12 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -78.53 11.53 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 108.82 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 56.41 38.45 29.71 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -116.08 145.82 42.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.7 mtt -51.16 126.7 17.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 129' ' ' LEU . 45.7 mtt -61.26 151.28 32.19 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.845 0.831 . . . . 0.0 111.195 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.6 p -133.74 149.24 71.39 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -42.43 -50.12 5.84 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 CA-C-N 119.574 0.884 . . . . 0.0 112.628 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -60.29 -40.0 88.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -65.14 -40.87 94.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.155 . . . . 0.0 110.461 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 124' ' ' MET . 87.7 mt -59.84 -40.32 88.13 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 108.485 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 130' ' ' ARG . 19.9 ttt-85 -63.93 -38.54 91.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.686 -0.634 . . . . 0.0 109.664 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.42 -44.85 89.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.989 -1.07 . . . . 0.0 109.815 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.93 -40.13 87.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 108.969 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -59.87 -39.92 86.9 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -38.39 84.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.466 -0.771 . . . . 0.0 109.301 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 139' ' ' VAL . 6.7 mm -56.52 -46.42 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.01 -43.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 137' ' ' ARG . 30.8 mtt-85 -60.08 -40.05 88.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 3' ' ' LYS . 95.9 mt-10 -62.92 -38.68 91.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 135' ' ' ILE . 92.2 t -69.44 -24.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 110.883 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.3 mttm -60.03 -40.03 87.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.793 -1.192 . . . . 0.0 109.748 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 2.3 p30 -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.88 -1.137 . . . . 0.0 109.206 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.09 99.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 47.1 p-10 -102.87 -0.11 31.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.351 -0.843 . . . . 0.0 109.607 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.296 0.57 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.17 -1.78 57.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 108.563 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -79.93 123.71 83.53 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.47 129.96 15.47 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.016 1.041 . . . . 0.0 112.511 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -82.49 -9.93 59.22 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.36 102.36 14.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -93.29 -20.34 20.49 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -146.18 136.15 23.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -161.82 166.36 26.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.56 -1.338 . . . . 0.0 110.492 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.98 129.32 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -91.38 123.06 43.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.62 148.86 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 122.469 1.128 . . . . 0.0 111.59 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mtt -145.71 154.25 41.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -137.09 122.8 19.88 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.735 -1.228 . . . . 0.0 111.076 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.05 116.75 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.04 153.18 39.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.939 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.09 -177.0 1.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -59.96 146.58 41.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 108.845 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.97 141.78 13.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 -3.88 74.29 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -117.74 152.63 34.88 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.591 -0.946 . . . . 0.0 109.5 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.78 147.69 50.81 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.472 -0.767 . . . . 0.0 109.149 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.66 143.65 27.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.225 -0.922 . . . . 0.0 109.831 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -70.58 141.36 51.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 108.875 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.95 98.24 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 97.2 mt-10 -61.41 -46.07 91.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.958 -1.319 . . . . 0.0 109.636 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.94 -27.08 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.97 -60.23 2.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.54 -0.725 . . . . 0.0 109.171 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.48 -39.99 89.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 26' ' ' GLU . 96.2 m-20 -61.11 -40.98 95.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.7 p -67.69 -40.2 84.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.129 -0.982 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.11 -48.18 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.334 -0.853 . . . . 0.0 109.534 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.56 -40.14 96.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 109.697 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.48 -20.39 63.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.564 -0.71 . . . . 0.0 110.552 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.85 2.76 32.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 110.296 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.95 15.05 65.91 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.845 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -80.05 153.9 28.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.849 -1.383 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.446 HD12 ' CD2' ' A' ' 48' ' ' HIS . 96.6 mt -124.7 136.75 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -62.75 106.32 0.78 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.678 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -95.78 171.52 28.93 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -62.59 -164.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -1.093 . . . . 0.0 109.344 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.0 mtt 57.76 21.26 7.23 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.573 0.702 . . . . 0.0 109.827 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.2 m120 50.02 39.39 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.594 -0.691 . . . . 0.0 111.723 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 pt -140.01 165.86 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.809 -1.182 . . . . 0.0 108.983 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -91.52 118.44 30.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 110.417 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.401 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 53.5 m-70 -105.15 128.46 53.39 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.419 -0.801 . . . . 0.0 109.085 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -100.15 129.23 46.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.993 -1.067 . . . . 0.0 108.7 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.446 ' CD2' HD12 ' A' ' 38' ' ' ILE . 52.1 m-70 -97.38 170.14 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.99 -49.99 74.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.167 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 m -91.25 144.23 29.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.28 -0.887 . . . . 0.0 109.102 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -67.23 -5.47 13.87 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.574 0.849 . . . . 0.0 111.738 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.45 -0.53 54.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.93 . . . . 0.0 110.157 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' CA ' ' CD1' ' A' ' 38' ' ' ILE . . . 77.67 10.03 86.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -68.23 -39.99 82.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -1.104 . . . . 0.0 109.854 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.79 165.67 46.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.434 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.9 Cg_endo -67.38 175.98 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.194 1.262 . . . . 0.0 112.087 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.475 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.41 124.94 29.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -101.0 -46.81 4.97 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.274 -0.892 . . . . 0.0 109.764 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -143.84 167.4 22.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.004 -1.06 . . . . 0.0 108.501 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -137.51 -177.04 4.61 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.869 -1.144 . . . . 0.0 112.04 -177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.9 tt -139.97 132.09 28.01 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.514 0.673 . . . . 0.0 109.992 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.66 166.66 22.71 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.3 m-20 -77.69 170.19 17.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.842 -1.161 . . . . 0.0 110.472 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mtp -68.97 -29.57 67.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.498 -0.752 . . . . 0.0 111.818 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 65' ' ' VAL . 34.0 m -86.2 118.82 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.51 -1.369 . . . . 0.0 109.749 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -61.5 147.81 87.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.538 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.91 2.87 17.87 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.175 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 69.99 33.32 69.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.3 p -84.34 169.95 14.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.042 -1.269 . . . . 0.0 109.887 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 70.8 m-85 -119.7 150.73 39.88 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 73' ' ' GLU . 53.9 m-20 -139.16 150.26 64.02 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -42.89 -15.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.901 1.067 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.5 mt-10 -85.09 16.21 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.2 ptt? -83.53 -0.0 48.42 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.024 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -85.02 -4.39 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.66 -1.275 . . . . 0.0 109.694 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -147.83 77.42 1.42 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.53 169.71 24.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 109.498 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -135.51 156.94 48.08 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.62 19.35 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.083 . . . . 0.0 109.37 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.77 -30.67 77.22 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 120.418 0.745 . . . . 0.0 111.744 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.86 -160.85 27.57 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 HD11 ' A' ' 28' ' ' LEU . 33.1 m -130.09 159.94 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.488 -1.007 . . . . 0.0 109.47 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -115.45 119.66 36.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.0 109.745 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -104.75 129.93 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -147.08 170.05 17.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.92 -1.113 . . . . 0.0 110.491 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.0 ttp -133.19 130.96 39.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.729 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.56 123.16 35.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 9' ' ' ALA . 3.7 m -98.43 150.07 36.36 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.262 -0.899 . . . . 0.0 108.62 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -76.06 142.72 74.48 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.386 -0.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 m -109.99 157.81 18.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.513 -0.742 . . . . 0.0 109.73 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 64.2 t80 -75.88 154.61 35.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.16 -159.39 45.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -93.78 114.95 27.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -1.107 . . . . 0.0 108.848 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.09 -27.22 43.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.936 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 95' ' ' LEU . 95.4 mt -69.99 -38.22 75.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.546 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.05 -39.32 75.78 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' ND2' HD23 ' A' ' 58' ' ' LEU . 53.5 m-20 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.87 -41.06 86.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.13 -43.05 99.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 108.673 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.0 -39.87 93.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.026 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.0 mmm -56.79 -49.99 73.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.036 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.6 mm-40 -60.28 -41.4 93.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.153 -0.967 . . . . 0.0 109.0 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.8 p -71.93 -39.94 69.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -56.04 26.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.911 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.48 -40.69 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.608 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.7 m-70 -60.06 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.422 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.06 -49.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 108.856 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.69 -51.69 53.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.624 -0.673 . . . . 0.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 110.814 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.36 -39.9 77.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.409 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.87 0.06 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.27 20.53 76.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.4 -178.35 51.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.95 131.55 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.538 -0.978 . . . . 0.0 108.939 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.8 130.68 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.949 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.7 mt -132.7 159.91 38.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 37.8 p-10 -86.59 -172.2 3.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.5 m-20 -60.06 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.0 . . . . 0.0 109.735 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -76.31 13.91 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 108.653 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.5 mtt180 59.87 34.6 21.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.135 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -110.03 151.27 27.38 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.7 mtp -52.96 129.99 32.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.089 . . . . 0.0 109.319 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 39.5 mtt -59.6 140.86 56.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.98 . . . . 0.0 109.932 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 15.6 p -133.63 151.1 76.58 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -43.57 -47.74 9.18 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.486 0.791 . . . . 0.0 111.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.99 -41.58 92.37 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 125' ' ' THR . 27.4 mmtp -69.99 -39.98 75.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.2 mt -60.0 -39.96 87.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 108.501 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -62.43 -39.9 94.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.46 -46.97 85.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.085 -1.009 . . . . 0.0 109.549 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -60.01 -45.43 92.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.943 -1.098 . . . . 0.0 108.587 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.02 -39.57 86.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -45.73 91.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.82 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.84 -1.162 . . . . 0.0 108.698 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.05 -45.25 95.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.066 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -61.97 -38.18 87.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.84 . . . . 0.0 109.603 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.4 mt-10 -59.97 -39.7 86.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.421 -0.799 . . . . 0.0 110.715 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 -33.63 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.428 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.4 mttm -59.91 -45.5 92.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.82 -1.175 . . . . 0.0 110.545 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.23 -33.31 72.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.665 -1.272 . . . . 0.0 109.681 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.34 -39.96 93.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 110.936 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 41.3 p-10 -98.54 3.01 48.05 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.061 -1.024 . . . . 0.0 109.592 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.389 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.9 1.92 55.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.917 . . . . 0.0 109.652 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 5' ' ' LYS . 1.6 mptp? -77.54 119.18 76.42 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.153 -0.967 . . . . 0.0 108.771 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.39 19.0 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.277 1.135 . . . . 0.0 112.455 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 3' ' ' LYS . 99.4 mttt -88.49 15.77 7.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HG3' HH11 ' A' ' 6' ' ' ARG . 11.4 mmm-85 -78.81 135.1 36.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.922 . . . . 0.0 111.907 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 7.7 mtpm? -85.23 -28.33 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -146.51 146.97 30.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.17 -166.22 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.436 -1.415 . . . . 0.0 111.393 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -131.5 134.89 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -90.27 127.81 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -119.98 148.03 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.385 1.088 . . . . 0.0 111.684 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.528 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.9 mtt -145.36 159.05 43.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.39 119.71 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.835 -1.166 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -101.96 110.02 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.58 159.34 44.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.98 179.0 3.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.02 156.26 15.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.108 -0.995 . . . . 0.0 108.773 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -59.95 145.49 45.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.071 -1.018 . . . . 0.0 109.336 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 1.52 68.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.2 m -131.26 147.54 52.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.973 . . . . 0.0 109.276 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.94 145.31 51.42 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.378 -0.826 . . . . 0.0 109.433 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.61 145.81 26.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.718 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.04 146.83 50.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.46 97.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 62.0 mm-40 -61.87 -45.69 92.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.004 -1.292 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 84.4 mt -70.01 -29.14 66.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 108.627 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.1 -57.14 4.16 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.391 0.615 . . . . 0.0 110.022 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.0 -49.99 75.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 111.63 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.9 p-10 -62.13 -40.07 94.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.841 -1.162 . . . . 0.0 110.315 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.458 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -60.42 -43.17 97.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.94 -46.57 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.428 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.14 -41.13 99.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 110.054 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.79 -18.96 64.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.2 3.96 21.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 5.41 65.9 Favored Glycine 0 N--CA 1.497 2.759 0 O-C-N 120.821 -1.174 . . . . 0.0 111.041 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.46 149.61 33.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.708 -1.466 . . . . 0.0 109.185 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.14 139.71 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.99 116.18 3.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.774 -1.204 . . . . 0.0 108.755 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.521 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -91.99 172.12 34.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.36 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.767 -0.843 . . . . 0.0 110.431 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mmm 58.18 -99.71 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 42' ' ' MET . 56.6 m-80 -164.81 28.47 0.06 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.74 168.21 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.355 -0.84 . . . . 0.0 110.556 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.58 119.96 32.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.327 -0.858 . . . . 0.0 109.95 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.521 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 37.7 m-70 -103.2 141.19 36.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.299 -0.876 . . . . 0.0 109.04 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 45.8 ttt180 -120.49 131.29 54.66 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.476 -0.765 . . . . 0.0 109.047 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.558 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.3 m-70 -94.69 174.55 7.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.2 tp -53.56 -49.97 66.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 108.469 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -92.26 146.03 31.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.84 -3.01 10.52 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 120.593 0.862 . . . . 0.0 111.985 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.75 1.35 57.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.209 -0.932 . . . . 0.0 109.831 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.6 10.01 75.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.83 -41.89 70.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.015 -1.285 . . . . 0.0 110.167 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.558 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.37 173.41 54.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.454 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.8 Cg_endo -73.75 173.0 14.68 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.085 1.19 . . . . 0.0 111.431 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.57 122.05 26.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.065 -1.022 . . . . 0.0 109.213 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -103.17 -33.76 9.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.372 -0.83 . . . . 0.0 109.844 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.08 169.12 24.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.056 . . . . 0.0 108.685 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.435 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 8.2 m -139.13 -176.46 4.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 0.0 111.232 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -137.32 132.91 34.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.387 0.613 . . . . 0.0 109.397 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.594 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.06 162.32 31.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.0 m-20 -76.26 169.02 19.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.885 -1.134 . . . . 0.0 109.682 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.3 mmm -69.47 -28.75 66.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 110.648 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.32 118.08 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.767 -1.208 . . . . 0.0 110.234 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -62.54 152.02 81.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.477 -0.765 . . . . 0.0 108.944 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -78.12 1.95 28.08 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.711 -1.37 . . . . 0.0 111.964 -0.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.0 38.35 19.48 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.93 157.63 19.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -1.195 . . . . 0.0 109.744 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -120.0 139.97 51.67 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.53 -0.731 . . . . 0.0 109.373 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.19 149.98 67.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.86 -13.37 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 120.651 0.901 . . . . 0.0 112.561 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.35 -10.1 57.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 92.9 mtp -89.04 22.07 2.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.87 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -85.31 -7.8 58.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 108.558 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 89.3 m-20 -144.7 83.57 1.71 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.64 174.35 15.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.256 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -128.64 148.14 50.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 109.152 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.74 150.58 20.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 108.926 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -45.77 -50.6 9.36 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 CA-C-N 119.299 0.785 . . . . 0.0 111.763 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.6 -150.17 8.34 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 HD21 ' A' ' 28' ' ' LEU . 33.0 m -130.01 160.07 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.488 -1.007 . . . . 0.0 110.067 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' ALA . 24.6 m -107.89 119.96 40.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.0 109.458 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.35 129.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -146.94 168.01 22.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 110.916 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.7 ttp -136.75 129.97 31.29 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -91.39 114.64 27.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.39 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.4 151.98 37.63 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -78.51 134.19 32.38 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.394 -0.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.3 m -108.53 162.04 14.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.489 -0.757 . . . . 0.0 109.856 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.06 146.72 50.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -0.802 . . . . 0.0 109.938 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.24 -159.52 27.53 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -97.31 112.65 24.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.99 -29.14 65.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.822 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.29 -39.97 78.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -71.15 -40.13 71.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.012 -1.055 . . . . 0.0 108.868 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.466 ' ND2' HD23 ' A' ' 58' ' ' LEU . 83.7 m-20 -60.97 -39.9 91.38 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 109.098 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 87.1 t80 -59.24 -49.96 75.83 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.82 -40.05 96.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.6 -47.46 86.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 110.68 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.8 mtm -59.96 -39.97 87.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.893 -1.129 . . . . 0.0 109.319 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.47 -41.5 98.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 109.103 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.13 -41.2 92.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 109.002 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 p -72.18 -40.03 68.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 108.941 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.0 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.552 -0.718 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -62.13 -39.2 91.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.94 -1.1 . . . . 0.0 109.689 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -59.97 -44.14 94.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.674 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.2 mt -60.01 -49.45 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.35 -50.16 51.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.589 -0.695 . . . . 0.0 109.607 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.99 -40.19 92.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.792 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -39.92 75.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.805 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 114' ' ' GLY . 6.0 m -97.76 -1.44 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.0 109.704 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.73 19.89 75.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -87.58 -174.68 48.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.8 t -131.12 138.14 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.517 -0.99 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 t -70.44 133.2 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.658 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.5 159.99 35.44 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.556 -0.715 . . . . 0.0 109.759 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -87.76 -171.62 3.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 109.419 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.5 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -76.88 15.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.049 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.3 mtt180 55.6 38.96 30.86 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.4 0.619 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 122' ' ' ARG . 29.7 mtt-85 -112.07 151.9 28.85 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -51.5 130.65 28.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.0 mmm -59.16 139.97 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -137.6 150.31 67.81 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -47.9 -44.06 28.2 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.844 1.029 . . . . 0.0 112.401 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.01 -39.91 87.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -67.89 -40.03 83.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 110.123 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.1 -39.88 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -61.96 -40.14 94.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.556 -0.715 . . . . 0.0 109.078 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -59.94 -48.2 82.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.862 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.584 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 94.5 mm-40 -59.97 -40.12 87.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.72 -40.39 97.03 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.81 -45.16 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 108.859 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.09 -49.38 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -60.05 -39.98 87.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 54.2 mm-40 -60.26 -41.66 93.71 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 109.821 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' GLU . 54.6 t -71.36 -40.79 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 111.073 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 144' ' ' ALA . 26.4 mtpp -59.98 -48.06 83.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.963 -1.086 . . . . 0.0 111.266 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 4.2 p30 -60.08 -32.34 70.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.999 -1.063 . . . . 0.0 110.357 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -62.26 -39.95 94.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -104.04 -1.64 27.16 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.169 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.407 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -90.97 7.12 41.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.335 -0.853 . . . . 0.0 109.096 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -127.31 80.24 72.0 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.532 -0.73 . . . . 0.0 109.24 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 16.4 Cg_exo -56.91 -145.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.511 1.474 . . . . 0.0 113.549 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -76.34 36.46 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.226 0.536 . . . . 0.0 110.159 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 46.3 mtt-85 -60.15 146.78 42.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.614 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -83.64 -9.84 58.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -145.17 133.71 22.01 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -159.93 170.47 21.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.85 -1.156 . . . . 0.0 110.355 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.82 131.4 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.364 -0.835 . . . . 0.0 109.069 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.58 130.92 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.2 mt -125.46 146.02 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.184 0.993 . . . . 0.0 111.937 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.5 mtt -145.96 157.36 43.89 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.562 ' OD1' HG23 ' A' ' 83' ' ' THR . 67.1 m-80 -141.28 129.94 22.8 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.628 -1.295 . . . . 0.0 111.169 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.29 116.45 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.03 38.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -170.69 0.85 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -68.02 158.09 33.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.99 -1.069 . . . . 0.0 108.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -59.96 145.58 45.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.382 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.23 82.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 m -118.0 148.47 42.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.512 -0.993 . . . . 0.0 108.801 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 63.6 mm-40 -129.31 143.06 50.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.5 mt -86.35 139.21 31.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 109.458 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -69.6 145.16 52.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.343 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.91 97.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.91 -41.55 98.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.095 -1.238 . . . . 0.0 109.7 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.03 -27.1 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.612 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.0 tt -71.31 -59.03 2.99 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.418 -0.801 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' SD ' ' A' ' 74' ' ' MET . 83.0 mt -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.989 -1.069 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.96 -42.85 94.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 109.958 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -69.97 -46.92 64.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 110.52 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.8 mt -60.06 -44.23 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 0.0 110.102 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.24 -43.12 98.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 109.724 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -68.72 -16.39 63.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.513 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.25 3.91 25.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.875 . . . . 0.0 110.056 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.0 9.91 83.66 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -80.22 154.39 27.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.283 . . . . 0.0 109.398 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.17 141.69 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -59.64 111.7 1.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.973 -1.079 . . . . 0.0 109.083 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -92.72 171.85 33.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.34 -169.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.567 -0.961 . . . . 0.0 109.171 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.1 mtm 56.19 29.42 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.809 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 m120 49.94 38.66 16.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.558 -0.714 . . . . 0.0 111.493 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 pt -140.22 159.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.877 -1.14 . . . . 0.0 109.182 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 45.2 m-85 -89.34 129.99 35.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.089 -1.007 . . . . 0.0 109.872 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.551 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.3 m-70 -118.44 127.87 54.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 59.2 ttt180 -100.02 124.98 45.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.0 108.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 19.8 m-70 -95.05 169.68 9.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.8 tp -55.54 -50.06 70.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.7 m -92.34 144.55 29.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 108.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.44 -3.14 10.41 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.518 0.863 . . . . 0.0 111.975 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.25 0.06 57.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.1 11.36 84.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 m -70.06 -45.43 67.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -1.197 . . . . 0.0 109.878 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.49 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.59 166.35 54.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.74 177.92 4.43 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.081 1.187 . . . . 0.0 111.456 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.49 124.6 30.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.96 . . . . 0.0 109.053 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.9 mp -100.73 -39.76 7.68 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.099 -1.0 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -148.19 159.86 43.53 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.551 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.5 m -130.21 -179.85 5.48 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.204 1.002 . . . . 0.0 112.342 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -139.94 129.95 24.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.75 160.97 35.29 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.696 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 82.7 m-20 -75.32 159.09 31.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.098 -1.002 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -69.98 -25.22 63.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.64 -0.662 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.7 t -85.21 126.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.733 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -59.73 149.99 69.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.102 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.29 9.87 15.94 Favored 'Cis proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.727 -0.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 14.5 80.98 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -88.99 170.14 10.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 110.877 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.696 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 39.3 m-85 -119.27 158.78 25.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.6 m-20 -143.07 150.65 53.41 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.197 -0.94 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -48.98 -8.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.125 0 CA-C-N 119.171 0.74 . . . . 0.0 110.94 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.3 mt-10 -86.77 18.18 3.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.831 ' SD ' HD21 ' A' ' 29' ' ' LEU . 47.5 mtm -73.89 1.24 11.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.9 mmtp -88.75 -0.07 56.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 109.943 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 60.7 m-20 -154.8 77.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.012 -1.055 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -167.76 170.66 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.7 p -137.11 159.17 42.67 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.97 148.3 18.43 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.932 -1.105 . . . . 0.0 109.251 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 3.5 Cg_endo -57.8 -35.58 98.72 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.577 0.851 . . . . 0.0 112.0 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.23 -161.09 25.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.99 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.51 -0.994 . . . . 0.0 108.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.562 HG23 ' OD1' ' A' ' 14' ' ' ASN . 94.2 m -114.7 128.08 56.11 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.488 -0.758 . . . . 0.0 110.454 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.6 mt -111.56 129.19 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 24.9 p90 -149.09 159.96 43.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.877 -1.139 . . . . 0.0 110.976 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.6 ttm -113.64 130.55 56.37 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.1 mt-30 -91.94 115.18 27.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.2 m -98.58 150.4 36.68 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 120.978 -1.076 . . . . 0.0 109.379 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.24 134.72 36.92 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.902 -1.291 . . . . 0.0 111.561 -1.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.9 m -104.56 154.2 20.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.409 -0.807 . . . . 0.0 110.097 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -71.31 148.59 46.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 109.509 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.61 -164.61 39.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.63 114.39 26.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -1.179 . . . . 0.0 109.322 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -52.99 -18.56 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.04 -40.02 75.39 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -75.98 -41.45 51.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 108.962 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.582 ' OD1' HD23 ' A' ' 58' ' ' LEU . 92.7 m-20 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 102' ' ' LEU . 90.5 t80 -57.61 -41.27 80.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.34 -40.11 89.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.074 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.09 -40.11 94.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.3 mtp -59.47 -49.91 75.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.1 mt -60.99 -45.9 92.93 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.062 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.2 mt-30 -60.28 -40.46 90.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 p -73.15 -40.03 65.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.76 -54.01 51.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.447 -0.783 . . . . 0.0 109.907 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.406 ' HG3' ' CD2' ' A' ' 107' ' ' HIS . 14.5 pt20 -63.23 -40.0 96.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 109.638 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 65.0 m170 -60.15 -45.94 91.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.366 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.95 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.15 -49.96 59.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -0.824 . . . . 0.0 109.291 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.36 -40.05 89.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.39 -40.15 77.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 110.796 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 114' ' ' GLY . 9.9 m -98.41 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.01 20.02 74.3 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.44 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -84.28 -170.24 46.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 132.92 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.934 . . . . 0.0 109.098 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.47 132.88 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.513 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 mt -132.13 159.96 37.4 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.481 -0.762 . . . . 0.0 109.795 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -88.55 -169.34 2.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 121' ' ' ARG . 94.1 m-20 -59.97 -39.61 86.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.181 -0.95 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -76.44 16.61 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.244 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 119' ' ' ASP . 49.6 mtm-85 57.75 28.88 16.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.584 . . . . 0.0 109.953 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 122' ' ' ARG . 51.0 mtt-85 -110.32 155.66 21.8 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.514 -0.741 . . . . 0.0 109.441 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.1 mtm -53.76 132.23 40.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.3 mtt -60.0 140.75 56.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -129.78 150.29 75.42 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -43.58 -41.07 10.95 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 CA-C-N 119.354 0.805 . . . . 0.0 111.744 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.3 -40.01 88.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.946 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -69.37 -39.31 78.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 109.791 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.74 -40.49 79.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 108.781 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -65.88 -38.95 90.12 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.93 -47.79 84.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.943 . . . . 0.0 109.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -59.95 -42.77 94.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 108.486 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.72 -40.02 95.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.539 -0.726 . . . . 0.0 109.047 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -40.02 87.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.447 -0.783 . . . . 0.0 109.692 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -40.03 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.953 -1.092 . . . . 0.0 109.259 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.93 -42.95 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.946 -1.096 . . . . 0.0 109.391 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 0.8 OUTLIER -60.08 -37.14 79.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 97.3 mt-10 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.198 -0.939 . . . . 0.0 109.751 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 88' ' ' VAL . 97.8 t -72.73 -33.88 45.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 144' ' ' ALA . 39.3 mmtm -59.63 -45.96 90.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 109.958 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -62.44 -36.44 82.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.647 -1.283 . . . . 0.0 108.807 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 110.197 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -97.81 0.36 46.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 108.803 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.497 -0.752 . . . . 0.0 109.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' NE ' ' A' ' 6' ' ' ARG . 95.7 mmm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.235 0.541 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 -4.69 54.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.95 . . . . 0.0 109.873 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 5' ' ' LYS . 8.3 mptt -80.55 149.77 68.86 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.127 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.69 9.7 0.33 Allowed 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 120.481 0.787 . . . . 0.0 111.489 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 3' ' ' LYS . 44.2 mtmt -81.29 27.37 0.42 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 1' ' ' MET . 94.2 mtt180 -79.85 100.82 8.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.286 -0.884 . . . . 0.0 111.635 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.8 -16.78 29.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -148.46 145.02 27.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -164.66 160.1 19.62 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.328 -1.482 . . . . 0.0 110.743 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.53 129.92 59.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -88.43 129.95 38.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.8 mt -122.0 147.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.303 1.049 . . . . 0.0 111.49 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -145.79 154.14 41.7 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -133.21 120.91 21.76 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.898 -1.126 . . . . 0.0 111.088 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.01 112.48 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.93 158.67 43.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 110.124 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.7 -170.55 0.7 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.555 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -59.93 154.3 19.14 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 108.762 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -59.83 141.56 55.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.071 -1.018 . . . . 0.0 109.606 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.19 -8.59 79.26 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 m -112.2 151.93 28.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.473 -1.016 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.97 150.54 49.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.425 -0.797 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.31 145.82 27.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.903 . . . . 0.0 109.908 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.42 140.62 57.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 109.016 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.22 -40.48 97.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.56 -47.74 82.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.2 mt -68.2 -24.5 64.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -76.53 -58.28 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.89 -49.93 75.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.214 -0.928 . . . . 0.0 111.084 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.4 p-10 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 110.023 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 53.7 m -61.99 -40.66 96.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.971 -1.081 . . . . 0.0 109.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.29 -48.45 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 108.886 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -60.22 -40.01 88.64 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.91 -21.56 64.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 9.87 7.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.956 -1.09 . . . . 0.0 110.376 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.21 9.67 86.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -80.4 155.47 27.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.296 . . . . 0.0 109.583 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 140.65 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 108.24 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 171.82 33.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.27 -167.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -1.107 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.8 mmm 57.22 26.87 12.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.475 -0.766 . . . . 0.0 109.654 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 51.11 39.91 24.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.446 -0.784 . . . . 0.0 111.514 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.6 pt -141.65 160.88 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.014 -1.054 . . . . 0.0 109.402 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.38 136.56 32.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 18.6 m-70 -125.72 128.13 47.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 47' ' ' ARG . 30.0 ttt-85 -101.09 126.2 47.76 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.388 -0.82 . . . . 0.0 109.083 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.555 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 58.6 m-70 -96.51 170.08 9.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.729 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.3 tp -55.83 -49.83 72.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -92.04 149.06 38.12 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.295 -0.878 . . . . 0.0 109.333 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.16 -5.89 17.52 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 120.926 1.084 . . . . 0.0 112.234 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 49.8 p-10 -94.18 -0.04 55.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.074 -1.016 . . . . 0.0 110.299 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.4 85.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.433 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 27.0 m -70.03 -41.71 73.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.749 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.61 165.35 52.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.555 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.6 Cg_endo -69.14 174.25 9.24 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.03 1.153 . . . . 0.0 111.602 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.56 125.88 30.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 109.134 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.06 -39.63 8.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.18 158.59 44.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.499 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 29.0 m -129.68 179.46 5.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.244 1.021 . . . . 0.0 112.159 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.8 tt -139.51 132.94 30.15 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.1 167.17 22.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.632 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -74.9 160.23 30.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.002 -1.061 . . . . 0.0 109.773 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.88 -20.51 63.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.862 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -87.95 113.57 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.002 -1.061 . . . . 0.0 109.114 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -62.74 151.73 83.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.501 -0.749 . . . . 0.0 109.563 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -76.67 10.97 12.62 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.6 -1.416 . . . . 0.0 112.34 -0.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.39 30.82 57.95 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.374 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -85.85 163.83 17.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -1.19 . . . . 0.0 109.836 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 71.1 m-85 -120.82 143.13 49.03 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.3 m-20 -129.12 149.93 73.99 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.1 -9.07 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.138 0.728 . . . . 0.0 111.569 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.0 mt-10 -89.77 3.92 51.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.548 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.455 ' O ' HD11 ' A' ' 29' ' ' LEU . 67.6 mmm -88.1 16.46 6.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 62.6 mttp -85.34 -6.32 59.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.962 -1.086 . . . . 0.0 109.182 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 68.6 m-20 -151.91 79.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.75 171.69 19.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.1 p -128.64 151.75 49.14 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.95 149.04 19.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.07 -1.019 . . . . 0.0 109.308 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -43.58 -49.98 7.35 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.666 0.911 . . . . 0.0 111.896 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.09 -154.75 13.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.401 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.8 m -129.97 160.02 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.395 -1.062 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.5 m -109.08 120.93 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.719 -0.613 . . . . 0.0 110.146 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mt -103.71 130.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 31.8 p90 -147.17 169.98 18.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 111.215 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.8 ttm -128.26 130.07 47.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.414 ' O ' ' OG ' ' A' ' 90' ' ' SER . 92.0 mm-40 -91.51 115.62 28.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.7 m -98.8 149.92 36.2 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.18 -0.95 . . . . 0.0 109.093 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.61 137.02 46.73 Favored 'Cis proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.867 -1.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.1 m -107.74 154.15 21.92 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.487 -0.758 . . . . 0.0 109.397 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.11 145.49 51.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 110.043 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.51 -165.61 33.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -96.39 112.29 24.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.34 -1.094 . . . . 0.0 109.114 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' OE1' HG23 ' A' ' 136' ' ' ILE . 88.3 mt-10 -55.3 -25.53 34.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.946 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.81 -40.14 76.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 109.591 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.28 -41.63 66.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.785 -1.197 . . . . 0.0 108.065 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.411 ' ND2' HD23 ' A' ' 58' ' ' LEU . 94.9 m-20 -62.69 -39.79 95.09 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 102' ' ' LEU . 76.0 t80 -51.34 -40.65 59.55 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.5 -40.02 94.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.86 -40.04 96.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 0.0 109.287 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mtp -58.66 -50.03 75.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.079 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.9 mt -65.95 -47.32 75.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.353 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 77.1 mt-30 -59.95 -40.81 90.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 108.977 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.5 p -70.4 -40.16 74.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.14 -56.42 22.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.823 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.21 -37.82 84.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.462 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.9 m-70 -59.94 -50.13 74.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.06 -1.025 . . . . 0.0 108.746 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.8 mt -60.99 -49.01 86.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.73 -49.23 65.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -70.03 -40.15 75.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.72 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 108' ' ' ILE . 13.6 m -97.44 -0.03 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 0.0 109.873 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.03 26.01 74.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.77 -176.54 50.21 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -130.21 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.702 -0.881 . . . . 0.0 109.202 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.488 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -74.96 130.26 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.132 -0.98 . . . . 0.0 109.352 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -130.56 159.88 35.82 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 40.3 p-10 -85.7 -170.69 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 0.0 108.989 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -60.13 -39.49 86.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 78.5 mt-30 -76.78 16.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.328 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 58.46 29.37 18.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 110.395 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HE ' ' HB2' ' A' ' 120' ' ' GLN . 84.5 mtm180 -107.91 154.33 21.76 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.336 -0.852 . . . . 0.0 108.969 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.2 mtt -52.42 125.17 15.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 109.722 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' HG12 ' A' ' 116' ' ' VAL . 51.5 mtp -60.14 140.49 56.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.522 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.2 p -127.18 150.53 72.53 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -43.64 -43.23 11.44 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.185 0.745 . . . . 0.0 112.018 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.431 ' O ' ' CD ' ' A' ' 131' ' ' GLU . 94.2 mt-30 -60.08 -44.74 94.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.59 -39.76 94.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 109.772 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.64 -39.01 76.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -65.83 -39.99 91.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -59.43 -48.6 81.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.701 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -60.08 -45.99 91.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 108.548 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.0 -40.02 96.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.491 -0.756 . . . . 0.0 108.961 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.4 -42.11 98.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.2 -42.8 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.003 -1.06 . . . . 0.0 109.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 94' ' ' GLU . 82.2 mt -60.07 -41.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 31.2 mmt180 -60.05 -40.91 91.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 108.962 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -61.11 -37.46 82.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 0.0 108.98 178.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.93 -39.86 78.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 110.27 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.02 -48.6 81.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 111.379 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 2.8 p-10 -59.91 -32.86 71.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.558 -1.339 . . . . 0.0 109.221 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.12 82.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 110.148 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -98.6 -11.35 22.22 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 109.506 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -90.44 23.53 2.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 0.0 109.338 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -129.01 77.67 77.56 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 121.435 -0.791 . . . . 0.0 109.58 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 44.8 Cg_endo -82.46 46.91 2.31 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.352 1.368 . . . . 0.0 111.928 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -77.44 18.66 0.4 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.609 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 4' ' ' PRO . 42.9 mtt-85 -78.25 153.37 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.377 -0.827 . . . . 0.0 110.942 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -85.42 -5.26 59.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -147.89 150.4 34.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.1 -175.1 3.84 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.562 -1.336 . . . . 0.0 110.811 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.98 136.3 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -93.59 124.64 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.9 mt -121.36 151.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.043 0.925 . . . . 0.0 111.091 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 84' ' ' ILE . 67.5 mtt -148.88 159.02 44.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -140.17 121.29 14.75 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.973 -1.08 . . . . 0.0 110.603 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.28 117.27 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.42 155.0 40.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.14 -174.21 1.49 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.447 -0.783 . . . . 0.0 108.901 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -64.26 149.03 48.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.073 -1.017 . . . . 0.0 108.763 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -55.81 149.85 13.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 109.756 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.57 -7.18 82.43 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -121.06 154.69 35.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.564 -0.962 . . . . 0.0 109.477 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -129.16 147.34 50.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.07 137.68 33.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 55.3 t-20 -67.95 142.05 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.05 -41.42 97.99 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.795 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.73 -47.24 86.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.309 . . . . 0.0 110.095 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.01 -30.26 67.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -70.4 -57.48 4.77 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.551 -0.718 . . . . 0.0 109.252 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 74' ' ' MET . 96.2 mt -59.99 -44.23 94.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.385 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.567 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 60.3 t-20 -60.45 -40.27 90.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 110.192 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 p -65.82 -39.82 91.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.87 -48.82 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -62.35 -39.97 94.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.902 -1.124 . . . . 0.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.567 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 80.3 mt-30 -67.84 -22.41 65.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.377 -0.827 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.98 6.09 14.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.953 -1.092 . . . . 0.0 109.997 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.83 76.19 Favored Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.947 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -78.6 150.35 32.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.76 -1.435 . . . . 0.0 109.726 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.34 139.57 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -60.69 105.34 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.03 172.14 29.19 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.51 -165.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -1.035 . . . . 0.0 109.598 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mmm 58.36 20.12 7.02 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.689 . . . . 0.0 109.81 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 49.99 39.63 19.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.086 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.2 pt -140.51 166.98 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -91.91 127.02 37.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.917 -1.114 . . . . 0.0 110.487 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 36.5 m-70 -116.07 128.82 56.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.528 -0.732 . . . . 0.0 109.75 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 17.6 ttt-85 -102.97 126.95 50.35 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 70.9 m-70 -94.76 171.22 8.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.963 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.54 -50.14 70.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.9 . . . . 0.0 108.739 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -93.34 143.73 27.16 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -66.97 -2.65 8.24 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 119.552 0.876 . . . . 0.0 111.952 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -94.25 0.19 55.5 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 0.0 110.109 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.92 86.61 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.452 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 91.3 p -70.1 -40.0 75.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.914 -1.345 . . . . 0.0 109.762 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.77 162.82 52.18 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 12.3 Cg_endo -67.26 176.93 4.2 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.994 1.129 . . . . 0.0 111.247 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.23 118.67 22.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.017 -1.052 . . . . 0.0 109.319 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.6 mp -96.72 -47.97 5.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -142.95 159.99 41.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.993 . . . . 0.0 109.395 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.546 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.0 m -136.55 159.92 40.33 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.82 0.819 . . . . 0.0 111.208 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -113.11 131.69 55.73 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.361 0.601 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.637 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.57 162.78 32.84 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.9 m-20 -77.69 153.55 32.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.884 -1.135 . . . . 0.0 109.886 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.05 -29.86 66.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.094 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.43 134.94 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.972 -1.08 . . . . 0.0 109.774 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -56.87 154.02 20.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -79.77 2.06 36.52 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 123.753 -1.353 . . . . 0.0 112.464 -0.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.85 -4.73 73.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.5 p -89.6 169.89 10.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -1.051 . . . . 0.0 110.078 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 79.6 m-85 -121.76 152.47 39.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.5 m-20 -135.17 149.74 70.91 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -49.04 -11.11 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 120.47 0.78 . . . . 0.0 111.792 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.4 mm-40 -89.95 4.46 50.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 73.9 mmm -87.92 20.24 3.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.0 110.155 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.0 mttp -88.23 -1.69 58.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 81.7 m-20 -146.73 81.55 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -160.33 172.49 17.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 p -130.67 151.58 50.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.31 150.02 21.48 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.263 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.48 -38.37 95.49 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 CA-C-N 119.092 0.712 . . . . 0.0 111.566 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.08 -156.47 15.17 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 24.4 m -131.51 160.08 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.768 -0.843 . . . . 0.0 109.066 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.5 m -114.14 120.26 39.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.473 -0.767 . . . . 0.0 110.432 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 13' ' ' MET . 97.5 mt -105.95 128.19 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -145.27 152.34 39.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.176 -0.953 . . . . 0.0 110.136 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttp -121.2 130.04 53.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -86.33 110.88 19.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 108.96 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 2.4 m -98.19 147.44 33.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.8 131.49 24.43 Favored 'Cis proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.605 0.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m -100.36 166.73 10.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.736 0.779 . . . . 0.0 110.186 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.13 146.02 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.771 -0.581 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.4 -156.46 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -93.77 119.09 32.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -1.209 . . . . 0.0 108.537 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -57.44 -32.64 67.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.838 -0.539 . . . . 0.0 110.511 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.96 -40.11 75.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.85 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.11 -40.62 68.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.004 -1.06 . . . . 0.0 109.157 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.253 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.481 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.8 t80 -58.83 -45.03 90.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -61.11 -39.73 91.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.448 -0.783 . . . . 0.0 109.43 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.11 -43.78 95.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 109.678 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.15 -44.92 94.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.481 HD11 ' CE2' ' A' ' 98' ' ' PHE . 86.5 mt -61.49 -46.2 91.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.054 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -43.93 95.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -70.42 -40.01 74.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.23 -55.58 33.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.041 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -60.28 -35.93 76.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.925 -1.11 . . . . 0.0 108.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -60.08 -45.88 91.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.11 -0.994 . . . . 0.0 108.839 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -60.01 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.048 -1.032 . . . . 0.0 108.568 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.2 -48.99 61.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.487 0.66 . . . . 0.0 109.286 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.09 -40.01 88.1 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.926 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.9 -40.04 75.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 111.349 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.75 -0.39 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.075 -1.015 . . . . 0.0 109.566 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.83 25.96 74.89 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.06 -169.3 44.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.51 134.04 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -1.016 . . . . 0.0 109.238 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.14 130.89 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.054 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.0 mt -126.74 159.02 34.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 108.907 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -86.49 -171.51 3.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 109.069 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.532 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 97.2 m-20 -60.07 -35.01 74.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.323 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.84 16.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 45.1 mtm-85 58.16 26.28 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.641 . . . . 0.0 109.914 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 54.0 mtp180 -109.18 151.49 26.4 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.593 -0.692 . . . . 0.0 109.331 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -52.51 134.69 34.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.886 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.4 mmm -59.9 133.61 56.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.0 p -132.72 151.15 77.58 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -41.36 -45.99 5.78 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 120.926 1.084 . . . . 0.0 113.04 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -60.09 -39.97 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.95 -1.094 . . . . 0.0 109.409 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.36 -40.11 85.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.32 -39.97 84.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 108.828 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -62.58 -39.54 94.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.474 -0.766 . . . . 0.0 109.143 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.59 -48.59 81.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.123 -0.986 . . . . 0.0 109.75 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 65.3 m-85 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.041 -1.037 . . . . 0.0 109.398 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.87 87.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.316 -0.865 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.21 -44.42 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 108.702 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.07 -45.78 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.383 -0.823 . . . . 0.0 109.379 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 99.0 mtt180 -60.31 -37.41 80.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 110.161 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.6 mt-10 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.866 . . . . 0.0 110.29 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.6 t -73.35 -35.56 46.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 110.8 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 144' ' ' ALA . 49.4 mtpt -60.15 -46.61 89.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 111.464 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.7 p-10 -61.17 -29.15 69.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.606 -1.309 . . . . 0.0 110.125 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.07 99.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -112.44 -11.55 13.63 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.382 -0.824 . . . . 0.0 110.192 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' N ' HH12 ' A' ' 6' ' ' ARG . 73.6 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.78 2.77 36.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.12 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -72.97 130.17 85.43 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.75 18.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.854 0.984 . . . . 0.0 112.226 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 3' ' ' LYS . 68.3 mttm -85.37 -9.8 57.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.616 -0.677 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.507 HH12 ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -82.33 98.74 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 110.293 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -88.57 -17.07 30.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -150.02 133.56 16.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.63 8.36 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.67 -1.269 . . . . 0.0 110.477 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -125.03 132.29 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.94 134.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.1 mt -131.2 141.84 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.947 0.88 . . . . 0.0 111.196 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.43 148.01 29.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -128.01 130.54 48.5 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.054 -1.029 . . . . 0.0 110.901 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.73 117.94 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.01 159.82 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 110.383 -178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.12 -164.96 0.2 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.704 -0.622 . . . . 0.0 109.645 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -70.0 155.97 39.82 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -57.57 135.78 56.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 5.18 65.0 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -126.31 144.41 50.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -1.019 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -124.52 147.69 48.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.51 137.04 33.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.167 -0.958 . . . . 0.0 110.233 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.43 143.07 57.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 108.862 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.49 -41.85 97.34 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.084 -1.01 . . . . 0.0 111.061 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.98 -43.15 95.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.889 -1.359 . . . . 0.0 108.877 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 95.5 mt -69.95 -27.12 64.48 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.6 tt -76.57 -56.3 4.74 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 110.463 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.98 -49.0 79.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.03 -1.044 . . . . 0.0 111.312 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 31' ' ' SER . 42.8 p-10 -61.85 -39.15 90.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 110.866 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 93.4 p -62.62 -40.43 96.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.789 -1.194 . . . . 0.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.415 HG21 ' CG ' ' A' ' 45' ' ' TYR . 95.9 mt -60.29 -49.71 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.989 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -65.66 -39.93 91.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 109.817 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -63.72 -22.42 66.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.03 -1.24 52.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.0 . . . . 0.0 109.602 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.08 19.08 44.03 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.041 -1.037 . . . . 0.0 111.418 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -81.23 160.61 24.25 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.356 . . . . 0.0 110.281 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.22 137.01 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.96 102.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.061 . . . . 0.0 109.841 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 171.02 41.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.4 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.443 -1.034 . . . . 0.0 109.242 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 95.4 mtp 56.66 23.52 7.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.664 -0.647 . . . . 0.0 110.222 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.71 40.26 23.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 111.259 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.552 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.9 pt -139.84 163.82 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.024 -1.047 . . . . 0.0 109.179 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 32' ' ' ILE . 80.2 m-85 -90.51 131.77 36.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.043 -1.035 . . . . 0.0 110.167 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 17.5 m-70 -123.68 132.07 53.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.687 -0.633 . . . . 0.0 109.869 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 30.9 ttt180 -104.86 121.71 44.26 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 48.1 m-70 -95.4 171.0 8.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.393 -0.817 . . . . 0.0 109.562 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.63 -50.05 71.2 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.8 m -92.37 144.23 28.59 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.33 -6.0 17.3 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.7 0.933 . . . . 0.0 112.104 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -93.15 0.89 57.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.154 -0.967 . . . . 0.0 109.407 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.48 14.25 82.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 p -70.43 -40.45 73.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.081 -1.246 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.46 166.86 48.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.483 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 20.8 Cg_endo -70.86 -179.49 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.195 1.263 . . . . 0.0 111.751 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.25 121.69 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -95.96 -20.54 18.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.995 -1.066 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -169.63 158.15 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.937 . . . . 0.0 108.948 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.473 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.6 m -127.26 171.86 11.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.935 0.874 . . . . 0.0 111.822 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.2 tt -140.08 130.2 25.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.543 0.687 . . . . 0.0 109.189 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.17 163.89 28.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.672 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 83.7 m-20 -74.11 158.03 34.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.062 . . . . 0.0 110.127 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.02 -23.8 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.62 -0.675 . . . . 0.0 110.537 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.5 p -87.17 129.88 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.978 -1.076 . . . . 0.0 109.775 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -60.45 149.86 75.83 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.481 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.31 4.72 26.34 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.546 -0.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.88 85.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -85.48 170.98 12.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -1.202 . . . . 0.0 109.473 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.672 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 82.7 m-85 -116.46 150.58 37.62 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 7.5 m-20 -139.06 152.31 69.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.89 -15.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.045 1.163 . . . . 0.0 112.65 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.1 mt-10 -85.24 13.33 6.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' ASP . 24.3 ptt? -82.7 -7.3 59.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.77 -0.581 . . . . 0.0 110.243 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.8 mttt -85.25 -4.03 59.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.08 -1.013 . . . . 0.0 110.222 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 71.1 m-20 -150.29 73.23 1.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.933 -1.104 . . . . 0.0 109.885 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -158.1 169.86 23.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 p -131.96 150.11 52.25 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.218 -0.926 . . . . 0.0 109.093 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.75 147.78 19.66 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.972 -1.08 . . . . 0.0 108.77 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.99 -33.53 5.52 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.62 0.88 . . . . 0.0 111.866 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.44 -146.42 9.8 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.481 -1.343 . . . . 0.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 28.1 m -130.03 159.11 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.602 -0.94 . . . . 0.0 109.655 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 m -114.23 121.12 42.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.592 -0.692 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -102.55 125.72 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -149.86 161.96 41.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.953 -1.092 . . . . 0.0 110.65 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 4.9 tpt -146.31 147.46 31.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.72 . . . . 0.0 109.238 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' N ' ' SD ' ' A' ' 86' ' ' MET . 92.9 mt-30 -94.07 121.88 36.01 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.44 151.59 37.74 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.89 172.5 56.33 Favored 'Cis proline' 0 N--CA 1.503 2.033 0 C-N-CA 124.057 -1.226 . . . . 0.0 113.055 0.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.562 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 15.9 m -130.32 167.11 19.03 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.841 0.829 . . . . 0.0 111.031 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -72.8 144.47 47.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.05 -151.01 34.64 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -97.31 123.22 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.359 -1.083 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' N ' ' A' ' 90' ' ' SER . 53.5 mm-40 -56.21 -30.05 61.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 0.0 109.532 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.95 -40.02 79.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.258 -0.901 . . . . 0.0 109.077 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -73.05 -40.37 65.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.928 -1.108 . . . . 0.0 108.093 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 58' ' ' LEU . 77.7 m-20 -64.65 -40.01 94.69 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.14 -46.02 91.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.739 -0.601 . . . . 0.0 109.97 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.5 -39.87 89.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.417 ' O ' ' OG ' ' A' ' 104' ' ' SER . 64.9 mtp -60.03 -49.65 76.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.161 -0.962 . . . . 0.0 108.793 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.98 -45.98 83.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.427 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 92.7 mt-30 -59.98 -39.93 87.37 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 101' ' ' MET . 16.4 p -69.91 -41.49 74.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.369 -0.832 . . . . 0.0 109.035 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.01 -57.71 11.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.415 -0.803 . . . . 0.0 110.085 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.61 -39.62 88.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.693 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.5 m-70 -59.82 -49.8 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 108.775 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.19 -48.87 61.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.98 -39.84 93.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 110.281 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.66 -40.11 84.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.22 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 114' ' ' GLY . 5.8 m -100.65 -0.68 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.267 -0.896 . . . . 0.0 109.903 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 20.89 74.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -82.44 -173.76 49.35 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.47 132.96 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -1.049 . . . . 0.0 109.851 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.17 131.96 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.7 158.23 39.16 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.615 0.721 . . . . 0.0 109.645 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -86.23 -174.31 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.517 -0.74 . . . . 0.0 109.564 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.9 m-20 -59.97 -36.09 76.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.011 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 120' ' ' GLN . 27.4 mp0 -78.73 16.32 0.88 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.4 mtm-85 56.19 39.52 30.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.521 -0.737 . . . . 0.0 110.582 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.84 155.59 33.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.463 -0.773 . . . . 0.0 109.202 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.5 mtm -54.14 132.75 43.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.373 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 79.4 mmm -60.35 140.04 57.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.257 -0.902 . . . . 0.0 110.193 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.7 p -130.81 150.56 76.85 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -48.43 -39.44 36.11 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 CA-C-N 119.36 0.807 . . . . 0.0 111.974 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.32 -40.77 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.439 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.84 -39.42 76.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.49 -0.756 . . . . 0.0 110.087 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.39 -40.08 77.46 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 130' ' ' ARG . 26.4 ttm-85 -62.91 -40.01 96.27 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.358 -0.839 . . . . 0.0 109.1 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.83 -47.9 83.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.958 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.07 -41.93 93.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.986 -1.071 . . . . 0.0 108.182 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.423 ' HA ' HD12 ' A' ' 136' ' ' ILE . 97.3 mt-30 -62.29 -38.25 88.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 96.0 m-20 -60.35 -40.78 91.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.329 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.8 -39.84 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.988 . . . . 0.0 108.994 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 133' ' ' GLN . 83.1 mt -60.06 -49.2 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.3 mtm180 -61.59 -39.58 91.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.019 -1.051 . . . . 0.0 110.396 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.9 mt-10 -60.23 -39.99 88.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.972 -1.08 . . . . 0.0 110.769 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.88 -36.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 144' ' ' ALA . 60.5 mttm -59.94 -45.5 92.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.97 -1.081 . . . . 0.0 111.702 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 1.1 p-10 -60.85 -34.27 74.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.713 -1.242 . . . . 0.0 110.036 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.65 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.769 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.76 -2.23 30.61 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.087 -1.008 . . . . 0.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.131 0.491 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.19 -10.26 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.3 76.96 75.09 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 6' ' ' ARG . 9.2 Cg_endo -73.95 135.87 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.807 1.005 . . . . 0.0 111.339 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.18 29.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.082 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 4' ' ' PRO . 98.7 mtt180 -76.39 149.44 36.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.543 -0.723 . . . . 0.0 110.274 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -82.9 -53.81 5.57 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.11 141.17 35.37 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -157.84 159.97 37.23 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.697 -1.252 . . . . 0.0 110.469 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.86 132.34 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.628 -0.67 . . . . 0.0 109.98 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.05 139.23 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 93.8 mt -127.85 143.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 122.203 1.002 . . . . 0.0 111.558 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -144.32 151.05 38.81 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.56 126.14 28.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.712 -1.242 . . . . 0.0 110.951 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.71 114.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.53 152.83 38.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.862 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.26 -164.49 0.11 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.391 -0.818 . . . . 0.0 109.274 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -62.55 153.03 33.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.99 140.78 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.05 -1.031 . . . . 0.0 109.14 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.12 -1.97 80.83 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.2 m -118.67 151.4 38.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.566 -0.961 . . . . 0.0 109.185 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -128.15 148.9 50.61 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.49 -0.756 . . . . 0.0 108.999 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.16 144.46 28.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -67.92 141.99 56.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.094 -1.004 . . . . 0.0 108.929 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.92 -42.33 98.19 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.576 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.27 -47.64 85.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.044 -1.268 . . . . 0.0 110.153 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.74 -28.26 66.65 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.9 tt -73.44 -59.8 2.54 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.115 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.07 -41.43 92.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 109.264 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -62.91 -43.3 99.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 110.02 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.1 p -65.55 -38.59 90.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.03 -46.21 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.998 -1.064 . . . . 0.0 109.358 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.5 -40.85 98.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.734 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.8 -22.3 65.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 110.036 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.06 8.09 9.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 82.28 12.64 80.37 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.36 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -81.19 153.74 27.05 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.741 -1.446 . . . . 0.0 109.856 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.4 mt -124.38 133.89 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -60.89 98.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.908 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.91 171.1 44.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.99 -163.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -1.219 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.3 mtt 58.46 20.0 7.04 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 49.95 39.95 19.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.671 -0.643 . . . . 0.0 111.248 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 pt -141.08 167.25 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.052 -1.03 . . . . 0.0 108.817 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -93.49 123.33 36.72 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.971 -1.08 . . . . 0.0 110.552 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -106.53 136.45 46.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.686 -0.634 . . . . 0.0 109.367 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HG2' HH11 ' A' ' 47' ' ' ARG . 0.0 OUTLIER -99.89 128.43 45.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 108.598 178.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.41 165.18 11.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.534 -0.729 . . . . 0.0 109.14 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 tp -59.73 -49.32 78.21 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.2 m -90.54 145.0 31.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.855 . . . . 0.0 109.142 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -67.2 -10.72 29.59 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 120.679 0.919 . . . . 0.0 111.712 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 44.8 t0 -92.91 -1.33 56.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 109.815 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.4 t -70.03 -40.06 75.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.942 -1.328 . . . . 0.0 109.391 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.61 160.99 45.93 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.46 170.97 10.09 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.397 1.099 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.34 129.94 35.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.277 -0.89 . . . . 0.0 109.638 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.3 mp -101.76 -39.58 7.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.188 -0.945 . . . . 0.0 109.679 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -150.0 162.88 39.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.09 -1.006 . . . . 0.0 108.692 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.1 m -129.61 173.06 10.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.961 0.886 . . . . 0.0 111.273 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.7 tt -131.79 129.96 41.2 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.37 162.94 29.82 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 93.8 m-20 -74.25 157.22 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 109.651 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -69.92 -28.21 65.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.747 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.68 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -60.06 152.25 62.09 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.95 1.9 48.71 Favored 'Cis proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.58 0.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.62 -0.11 79.74 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.9 p -87.81 169.55 11.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -1.111 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 94.0 m-85 -121.3 140.8 51.6 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 73' ' ' GLU . 75.9 m-20 -121.7 150.21 54.81 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -50.45 -9.17 0.17 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 119.267 0.774 . . . . 0.0 111.63 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.1 mm-40 -90.12 6.84 40.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.856 . . . . 0.0 109.498 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.439 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 68.9 mmm -86.39 21.84 1.99 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 26.7 mtpp -86.0 -6.9 58.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.901 -1.124 . . . . 0.0 109.07 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.2 m-20 -149.94 80.12 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.2 170.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.834 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.7 p -133.98 152.28 51.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.16 148.43 18.38 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.077 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -46.66 -44.17 22.0 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 CA-C-N 119.094 0.712 . . . . 0.0 111.232 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.16 -152.98 11.05 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.453 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -129.98 160.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.994 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.5 m -114.42 120.52 40.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.2 129.98 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -145.7 152.97 40.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.022 -1.048 . . . . 0.0 110.592 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.5 ttm -109.2 129.92 55.49 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.702 -0.624 . . . . 0.0 109.376 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 108.758 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 9' ' ' ALA . 2.1 m -98.16 151.14 37.38 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.207 -0.933 . . . . 0.0 108.569 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.91 138.19 53.8 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.043 -1.232 . . . . 0.0 112.57 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.9 m -113.24 149.41 33.83 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.488 0.661 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -70.95 149.2 46.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -0.772 . . . . 0.0 110.023 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.04 -164.16 32.2 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -98.38 114.66 27.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -1.145 . . . . 0.0 109.359 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.89 -27.95 63.76 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -74.0 -41.68 61.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 108.133 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -63.14 -34.55 77.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.13 -50.02 74.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.53 -39.97 89.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -61.17 -40.0 92.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.95 -45.02 93.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 108.997 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.24 -42.53 99.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.328 -0.858 . . . . 0.0 108.866 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.494 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.7 mm-40 -60.18 -40.13 88.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 109.135 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.3 p -70.48 -40.0 73.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.515 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.73 43.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 110.044 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.83 -37.68 85.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.494 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 64.4 m170 -59.94 -49.36 77.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.074 -1.016 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 89.2 mt -60.06 -46.44 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.303 -0.873 . . . . 0.0 108.729 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.66 -46.81 63.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.443 -0.785 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.49 -40.08 90.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 110.547 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.89 -40.1 75.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -0.965 . . . . 0.0 110.931 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 114' ' ' GLY . 12.8 m -100.18 0.75 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.187 -0.946 . . . . 0.0 110.018 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.58 25.32 70.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -86.07 -173.04 49.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -129.9 132.76 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.691 -0.887 . . . . 0.0 109.285 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.52 134.68 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.302 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.9 mt -135.05 159.95 39.87 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -86.47 -169.2 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 96.8 m-20 -60.06 -38.95 84.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -75.4 12.42 0.98 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.28 37.58 28.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.803 -0.56 . . . . 0.0 109.764 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -117.11 158.72 23.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.713 -0.617 . . . . 0.0 109.747 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.1 mmm -51.17 120.67 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.297 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 mtp -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.195 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -130.18 152.12 79.58 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -43.96 -42.97 12.49 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 120.582 0.855 . . . . 0.0 111.976 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.88 -39.93 91.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.83 -40.02 83.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.854 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.1 mt -57.54 -40.04 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.95 -39.96 93.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.592 -0.692 . . . . 0.0 109.265 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.42 -47.25 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.125 -0.985 . . . . 0.0 109.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 55.7 m-85 -60.06 -41.98 93.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 108.983 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -60.36 -40.09 89.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.3 m-20 -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.63 -43.82 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.118 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 78.6 mt -60.18 -39.95 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.964 . . . . 0.0 109.798 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.0 -39.98 87.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.961 -1.087 . . . . 0.0 109.104 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.15 -30.72 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.0 mmtt -59.98 -45.0 94.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.023 -1.048 . . . . 0.0 110.446 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -59.92 -36.2 76.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.845 -1.16 . . . . 0.0 109.805 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.29 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -103.7 -0.56 29.29 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.328 -0.858 . . . . 0.0 110.353 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.498 ' O ' ' NH2' ' A' ' 6' ' ' ARG . 92.3 mmm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.325 0.584 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -90.24 5.93 45.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 108.806 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' O ' ' NH1' ' A' ' 6' ' ' ARG . 23.2 mmtp -92.76 112.34 55.34 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.4 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' CB ' ' OE2' ' A' ' 138' ' ' GLU . 18.7 Cg_endo -73.18 23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.144 0 CA-C-N 120.236 1.12 . . . . 0.0 111.705 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 3' ' ' LYS . 53.5 mtpt -87.18 -0.36 56.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.276 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 3' ' ' LYS . 59.7 mtm-85 -79.11 130.67 35.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 111.356 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -89.22 -9.73 49.66 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -150.56 135.45 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.01 177.99 10.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.208 -1.557 . . . . 0.0 112.011 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.54 138.88 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -91.28 126.37 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -125.78 145.05 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 121.961 0.886 . . . . 0.0 110.806 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.5 mtm -148.33 154.37 39.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 117' ' ' LEU . 73.3 m-20 -132.15 131.84 42.64 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.963 -1.086 . . . . 0.0 111.383 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -109.17 118.81 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 156.79 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.21 175.63 5.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.473 -0.767 . . . . 0.0 109.059 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -56.08 160.14 3.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.228 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -60.07 141.72 55.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.389 -0.82 . . . . 0.0 109.832 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.28 2.02 74.47 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.1 m -125.52 148.52 48.86 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.422 -1.046 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.0 151.37 50.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.452 -0.78 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.17 139.54 30.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.323 -0.86 . . . . 0.0 110.331 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.63 141.42 56.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.813 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.23 96.43 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.39 -47.46 85.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.324 . . . . 0.0 109.56 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.34 -25.81 64.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 108.817 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.13 -55.61 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.566 -0.709 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.86 -49.03 79.29 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 0.0 110.315 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.07 -44.52 94.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 111.591 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.7 m -61.83 -42.92 99.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.866 -1.146 . . . . 0.0 110.369 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.79 -44.86 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.964 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -64.22 -40.0 95.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.71 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.48 -19.72 63.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.19 -0.944 . . . . 0.0 111.431 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -81.47 -9.89 59.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.626 -1.296 . . . . 0.0 110.83 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.72 8.75 22.17 Favored Glycine 0 N--CA 1.502 3.086 0 O-C-N 121.029 -1.044 . . . . 0.0 110.817 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.677 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 38.1 m-85 -81.59 144.6 31.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.827 -1.396 . . . . 0.0 110.094 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.47 132.23 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.07 106.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 110.131 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -95.6 171.9 29.54 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.78 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -1.109 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.2 mtt 58.12 20.09 6.67 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.687 0.756 . . . . 0.0 109.777 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 52.94 33.7 15.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 111.613 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.97 163.28 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -89.75 129.2 36.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.981 -1.075 . . . . 0.0 110.689 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 55.2 m-70 -115.72 130.02 56.69 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.677 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 39.9 ttm180 -104.64 124.31 49.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 24.9 m-70 -92.89 170.01 10.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 0.0 109.562 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.8 tp -55.66 -49.3 73.3 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -89.17 148.42 40.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -71.2 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.739 0.96 . . . . 0.0 112.372 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.69 0.23 54.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.01 -1.056 . . . . 0.0 110.383 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.82 86.3 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -72.25 -44.62 62.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.155 -1.203 . . . . 0.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -70.49 168.15 49.15 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.32 175.65 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.18 1.253 . . . . 0.0 111.837 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.85 121.25 26.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.5 mp -98.06 -55.21 2.85 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.068 -1.02 . . . . 0.0 109.715 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -142.97 160.54 40.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.07 . . . . 0.0 108.702 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -129.36 -179.05 4.93 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.231 1.015 . . . . 0.0 111.35 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.1 tt -139.77 130.23 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.624 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.25 168.46 18.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.47 -0.769 . . . . 0.0 109.61 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.697 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.3 m-20 -77.85 166.37 22.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.753 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 80.2 mmm -69.97 -22.2 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.89 -0.506 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 68' ' ' GLY . 14.3 t -87.66 118.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -62.27 149.31 87.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.206 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.47 10.73 15.5 Favored 'Cis proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.91 -1.287 . . . . 0.0 111.484 -1.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 79.04 29.12 52.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.7 p -86.03 169.04 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -1.108 . . . . 0.0 110.676 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.697 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 71.3 m-85 -126.06 156.38 40.06 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.1 p-10 -135.6 148.49 65.88 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.01 -16.82 6.76 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.503 0.858 . . . . 0.0 111.665 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -89.91 6.98 39.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.083 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.546 ' SD ' ' O ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.51 21.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.82 . . . . 0.0 109.808 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -86.05 -8.58 57.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.997 . . . . 0.0 109.911 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 83.7 m-20 -144.57 82.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.256 -0.903 . . . . 0.0 108.912 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.03 172.31 18.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 109.065 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.4 p -131.18 152.32 50.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.368 -0.833 . . . . 0.0 108.76 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.28 149.44 19.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -43.91 -49.73 8.02 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 120.495 0.796 . . . . 0.0 111.719 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.39 -152.26 8.7 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.99 160.89 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.6 -0.941 . . . . 0.0 109.573 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 62' ' ' ALA . 52.8 m -112.15 128.03 56.1 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.558 -0.714 . . . . 0.0 110.103 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.98 130.0 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -149.64 167.08 27.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.565 -1.335 . . . . 0.0 110.879 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 ttp -132.94 130.8 40.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' OG ' ' A' ' 90' ' ' SER . 91.8 mt-30 -87.59 108.52 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 108.953 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.4 OUTLIER -97.54 144.05 27.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 88' ' ' VAL . 5.9 Cg_exo -74.04 134.91 37.73 Favored 'Cis proline' 0 N--CA 1.498 1.761 0 C-N-CA 124.341 -1.108 . . . . 0.0 113.371 0.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.3 m -110.41 159.91 17.06 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.54 0.686 . . . . 0.0 109.828 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -70.75 142.18 51.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.174 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.33 -159.71 26.41 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.59 123.55 39.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.16 -1.2 . . . . 0.0 109.562 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 39.5 mp0 -59.93 -36.61 77.41 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 110.402 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.69 -38.81 80.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.958 . . . . 0.0 109.955 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -69.97 -39.96 75.66 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.892 -1.13 . . . . 0.0 108.123 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -61.34 -39.99 92.6 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 102' ' ' LEU . 91.1 t80 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.85 -41.37 97.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.087 -1.008 . . . . 0.0 109.007 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.24 -39.98 94.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.897 . . . . 0.0 109.041 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.1 mtp -58.13 -48.36 80.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.429 -0.794 . . . . 0.0 109.312 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 98' ' ' PHE . 98.7 mt -63.66 -42.68 98.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.922 -1.111 . . . . 0.0 109.184 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.01 -41.72 92.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.711 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -69.94 -39.98 75.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.39 58.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -62.2 -40.63 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.001 -1.062 . . . . 0.0 110.084 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -60.47 -47.45 86.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.174 . . . . 0.0 108.749 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.92 -50.02 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.03 -49.97 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.661 -0.649 . . . . 0.0 109.844 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.18 -40.19 89.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.282 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.9 -40.01 75.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.937 . . . . 0.0 111.151 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.3 m -100.69 -1.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.084 -1.01 . . . . 0.0 109.826 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 24.63 75.38 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.9 -176.42 51.14 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.46 133.03 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.636 -0.92 . . . . 0.0 108.905 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 t -70.24 130.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.013 -1.054 . . . . 0.0 109.096 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 14' ' ' ASN . 77.4 mt -129.23 155.99 44.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.587 -0.695 . . . . 0.0 109.286 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 30.4 p-10 -85.42 -172.64 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 109.481 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.1 m-20 -60.01 -38.71 83.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.65 16.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.377 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.0 mtm180 56.1 33.55 22.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -109.87 149.1 30.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 0.0 109.144 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 65.5 mtt -50.75 135.73 23.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.977 . . . . 0.0 109.265 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.67 137.15 57.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -134.47 150.35 73.56 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.02 -42.37 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 119.162 0.736 . . . . 0.0 111.879 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -60.6 -39.98 90.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 51.0 mmtt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.058 -1.026 . . . . 0.0 110.051 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.9 -43.15 94.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -69.3 -32.9 72.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.799 -1.188 . . . . 0.0 109.747 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -59.98 -45.31 93.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.005 -1.06 . . . . 0.0 108.876 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -60.78 -41.07 94.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -39.96 93.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 0.0 109.085 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.54 -40.2 96.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.65 -42.06 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.03 -41.93 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.208 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.5 mtt180 -61.92 -37.65 85.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.486 ' OE2' ' CB ' ' A' ' 4' ' ' PRO . 94.7 mt-10 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.778 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.35 -32.16 30.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.9 mmmm -60.07 -45.92 91.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.075 -1.016 . . . . 0.0 110.17 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.79 -31.83 71.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.754 -1.216 . . . . 0.0 108.892 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.01 94.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 110.385 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 55.6 p30 -97.91 0.37 46.41 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 0.0 110.104 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.545 -179.88 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 tpp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.368 0.604 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.12 30.87 1.04 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -130.02 75.79 78.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 6' ' ' ARG . 2.5 Cg_endo -65.85 122.05 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 120.858 1.039 . . . . 0.0 111.816 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -78.95 32.43 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 4' ' ' PRO . 98.9 mtt180 -72.13 153.13 41.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.54 -0.725 . . . . 0.0 109.338 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -80.45 -9.94 59.75 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -145.0 151.86 39.24 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.29 160.34 32.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 109.932 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.16 129.99 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.27 117.16 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 84.2 mt -121.58 142.16 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 121.946 0.879 . . . . 0.0 111.191 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.0 mtm -146.1 150.18 35.45 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -129.71 128.67 42.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.972 -1.08 . . . . 0.0 111.291 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.45 116.4 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' VAL . . . -147.34 157.24 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 109.97 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.89 -174.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 109.063 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -61.02 156.65 17.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 108.88 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -60.02 140.12 57.01 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.51 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.18 70.23 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -121.11 147.3 45.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.551 -0.97 . . . . 0.0 109.699 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -125.87 145.5 50.22 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.42 149.18 25.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 110.564 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -70.84 145.27 50.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.129 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.56 -42.05 99.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.51 -43.75 98.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.301 . . . . 0.0 110.166 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.79 -27.02 64.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.0 tt -75.12 -57.86 3.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.541 -0.724 . . . . 0.0 109.912 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.32 -42.33 95.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.0 110.532 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -64.04 -40.06 95.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.2 m -65.19 -41.38 94.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 110.419 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.02 -46.88 93.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.009 -1.057 . . . . 0.0 109.4 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -65.38 -43.25 91.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 0.0 109.401 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -17.24 64.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.35 1.57 36.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.023 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.71 9.55 66.2 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 121.071 -1.018 . . . . 0.0 111.016 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -80.75 151.07 29.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.822 -1.399 . . . . 0.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.9 mt -120.0 130.67 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.88 101.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.995 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.05 171.22 38.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.3 -163.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.469 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.7 mtm 58.03 23.25 9.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.428 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.36 39.41 20.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 111.231 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.0 pt -142.0 164.84 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.026 -1.047 . . . . 0.0 109.429 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -91.89 136.28 33.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.072 -1.017 . . . . 0.0 109.886 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 43.8 m-70 -125.16 125.11 43.18 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.726 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.7 ttt180 -105.09 125.53 51.08 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.501 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 34.2 m-70 -94.73 173.99 7.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.442 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.64 -50.76 65.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.261 -0.899 . . . . 0.0 108.832 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -93.83 144.06 27.52 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 0.0 108.784 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.36 -4.42 11.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 120.57 0.847 . . . . 0.0 112.149 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -91.48 -0.94 57.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.383 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.28 86.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 t -69.95 -41.01 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -1.198 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.37 169.13 54.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.501 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.1 Cg_endo -69.55 173.47 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.2 1.266 . . . . 0.0 111.427 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 120.8 25.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.034 . . . . 0.0 108.649 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.7 mp -100.81 -35.08 9.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.234 -0.916 . . . . 0.0 109.75 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -153.47 165.45 35.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.924 -1.11 . . . . 0.0 108.762 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 5.4 m -138.48 161.97 35.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.037 -1.039 . . . . 0.0 111.229 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.6 tt -114.75 135.07 54.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.547 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.41 162.08 32.01 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.587 -0.696 . . . . 0.0 109.29 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.606 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 76.6 m-20 -78.64 166.85 22.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.015 -1.053 . . . . 0.0 110.053 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.4 mmm -69.92 -23.09 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.465 -0.772 . . . . 0.0 110.205 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -88.14 112.5 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 110.521 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -60.3 150.42 72.41 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -77.87 8.55 19.93 Favored 'Cis proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.114 -1.202 . . . . 0.0 111.982 -0.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.43 35.83 25.16 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.6 p -85.94 160.47 19.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.256 -1.143 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 32.7 m-85 -128.52 139.02 52.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 t70 -127.77 137.82 31.57 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -48.13 -4.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.591 1.247 . . . . 0.0 112.888 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -90.83 3.96 53.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.054 -1.028 . . . . 0.0 111.345 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.502 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 21.5 mtm -79.72 26.14 0.32 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.567 -1.333 . . . . 0.0 110.099 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.0 mmtp -81.91 2.39 30.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.581 -1.325 . . . . 0.0 109.261 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 70.1 m-20 -153.79 81.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 108.76 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -158.84 171.41 20.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.11 -0.994 . . . . 0.0 109.964 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.7 p -137.88 154.68 49.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.23 149.12 17.35 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 109.19 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -46.93 -45.22 21.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 120.786 0.991 . . . . 0.0 112.027 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.23 -152.84 10.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.94 159.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -1.05 . . . . 0.0 109.396 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ALA . 51.9 m -111.53 124.94 53.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.226 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.11 130.61 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.77 160.41 41.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 110.85 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.9 ttp -141.46 131.73 25.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.658 -0.651 . . . . 0.0 109.622 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.18 115.21 27.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.048 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.24 152.38 38.65 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.357 -0.839 . . . . 0.0 109.065 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -77.63 136.77 44.29 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.655 -1.394 . . . . 0.0 112.149 -0.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.9 m -104.59 166.52 10.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.574 -0.704 . . . . 0.0 109.721 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -68.93 141.5 54.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.446 -0.784 . . . . 0.0 109.045 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.78 28.4 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -94.19 115.33 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.966 -1.314 . . . . 0.0 109.703 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 50.5 mp0 -58.05 -28.0 64.11 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.696 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.8 mt -69.73 -40.04 76.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.196 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -73.05 -40.51 65.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.901 -1.124 . . . . 0.0 108.948 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.445 ' OD1' HD23 ' A' ' 58' ' ' LEU . 84.0 m-20 -61.86 -41.96 98.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 102' ' ' LEU . 73.8 t80 -59.86 -49.92 75.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.75 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.13 -39.96 94.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -43.39 95.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.0 mtp -57.78 -44.57 86.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 108.746 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.4 mt -62.0 -41.21 97.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 108.726 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.15 -41.54 92.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.086 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -70.28 -39.89 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 109.147 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.82 68.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 110.435 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -60.76 -37.83 83.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.87 -1.144 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -60.06 -50.05 75.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.048 -1.033 . . . . 0.0 109.151 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.9 -50.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.539 -0.725 . . . . 0.0 109.652 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.46 -49.36 55.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.58 -39.78 89.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 110.338 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.11 -40.06 75.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.675 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.1 m -98.84 0.4 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.055 -1.028 . . . . 0.0 109.491 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.22 21.87 75.9 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -79.94 -176.8 49.96 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 16' ' ' ALA . 58.4 t -135.33 140.74 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.6 -0.941 . . . . 0.0 108.952 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.536 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -73.3 127.95 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.978 . . . . 0.0 109.945 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 mt -128.8 153.62 47.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.76 -178.04 6.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' NH1' ' A' ' 121' ' ' ARG . 97.9 m-20 -59.39 -28.89 67.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.049 -1.032 . . . . 0.0 109.082 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -82.13 12.36 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 108.972 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 119' ' ' ASP . 14.6 mmt-85 61.48 27.59 17.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.7 -0.625 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -107.88 147.8 30.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 0.0 109.328 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . 0.402 ' SD ' HG11 ' A' ' 115' ' ' VAL . 92.2 mmm -50.41 121.6 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.665 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.536 ' SD ' HG12 ' A' ' 116' ' ' VAL . 35.2 mtp -59.79 139.93 56.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.839 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -130.29 151.0 77.74 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -41.94 -41.64 6.54 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 120.503 0.802 . . . . 0.0 111.622 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -60.07 -42.19 94.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.445 -0.784 . . . . 0.0 109.235 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.49 -39.88 77.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.862 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.5 mt -56.61 -40.09 74.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.814 -1.179 . . . . 0.0 108.373 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -64.63 -38.23 90.29 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.017 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.98 -45.56 92.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.971 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.23 -41.96 94.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.862 -1.149 . . . . 0.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.62 -39.78 92.49 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 97.6 m-20 -60.06 -39.63 86.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.513 -0.742 . . . . 0.0 109.183 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.1 mt -59.93 -41.73 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 108.65 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.21 -39.87 81.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.36 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.528 ' HG2' HH11 ' A' ' 137' ' ' ARG . 16.3 mtt-85 -59.99 -40.14 88.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.576 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -60.39 -39.8 88.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.925 -1.109 . . . . 0.0 109.035 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.6 -32.03 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.6 mttt -60.0 -42.68 94.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.841 -1.162 . . . . 0.0 110.923 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.985 -1.072 . . . . 0.0 109.854 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.89 -59.13 3.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.924 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -103.9 -14.57 15.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.296 -0.878 . . . . 0.0 110.478 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -90.46 28.32 1.5 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.942 . . . . 0.0 109.609 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -119.94 82.92 29.17 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 109.475 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.41 14.66 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 120.575 0.85 . . . . 0.0 112.053 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 3' ' ' LYS . 64.1 mttp -85.79 -4.23 59.11 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.634 -0.666 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 6' ' ' ARG . 35.7 mtt-85 -82.42 115.8 21.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.952 -1.093 . . . . 0.0 110.052 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -85.66 -10.42 55.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.4 148.11 29.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.47 175.97 8.6 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.67 -1.269 . . . . 0.0 110.359 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.08 131.44 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -91.25 125.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.12 144.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.896 0.855 . . . . 0.0 110.867 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.5 mtt -144.6 156.16 43.99 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.5 126.72 24.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.959 -1.088 . . . . 0.0 111.022 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.01 119.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.3 158.63 44.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.775 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.65 -164.49 0.09 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -69.26 159.42 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 108.815 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -60.07 140.79 56.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.09 80.39 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.8 m -110.04 152.4 25.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.391 -1.064 . . . . 0.0 109.216 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -130.25 149.03 52.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.8 140.36 29.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.02 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.82 143.42 54.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.12 96.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.03 -44.83 96.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -1.209 . . . . 0.0 109.545 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.02 -29.48 66.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -0.812 . . . . 0.0 108.931 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.3 tt -71.14 -57.3 4.64 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.6 -0.687 . . . . 0.0 109.456 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.99 -43.41 95.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.187 -0.946 . . . . 0.0 110.476 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.93 -40.02 94.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 110.056 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -65.51 -40.16 92.68 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.928 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -48.34 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -62.23 -43.32 99.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.982 . . . . 0.0 110.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.87 -20.01 66.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.5 5.62 17.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.35 85.14 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -81.22 154.37 26.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.038 -1.272 . . . . 0.0 109.619 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.9 mt -128.63 142.81 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -59.04 99.92 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.113 -0.992 . . . . 0.0 109.542 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.22 168.85 45.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -62.99 -163.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.496 -1.003 . . . . 0.0 108.923 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt 56.5 22.2 6.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -0.819 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 51.89 40.09 27.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 111.146 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.08 170.03 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 109.327 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.22 135.08 34.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.978 -1.076 . . . . 0.0 109.836 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 6.2 m-70 -119.53 133.91 55.46 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.407 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 7.5 tpt180 -102.38 120.97 41.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.385 -0.822 . . . . 0.0 108.972 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 68.7 m-70 -98.26 170.06 9.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 109.723 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.26 -49.98 74.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 108.988 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.8 m -91.93 147.78 35.61 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.95 -6.18 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.671 0.914 . . . . 0.0 112.794 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -93.23 -0.89 56.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.917 -1.115 . . . . 0.0 110.158 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.43 12.09 84.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.466 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.9 p -70.2 -39.9 74.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.53 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.88 167.1 51.05 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.03 171.31 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.228 1.285 . . . . 0.0 112.113 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.35 122.82 28.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.209 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' OD1' ' A' ' 97' ' ' ASN . 8.4 mp -98.91 -36.87 9.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.228 -0.92 . . . . 0.0 109.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.8 162.31 40.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 108.589 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.529 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 4.4 m -131.06 175.99 8.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.081 -1.012 . . . . 0.0 111.859 -177.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.65 131.69 33.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.44 162.17 35.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.679 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.7 m-20 -77.2 162.92 27.01 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.212 -0.93 . . . . 0.0 110.751 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mtt -69.96 -23.72 63.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.598 -0.689 . . . . 0.0 110.396 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -85.85 119.99 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.971 -1.081 . . . . 0.0 109.632 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -59.89 149.71 71.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.52 -0.738 . . . . 0.0 109.064 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -77.12 8.94 16.4 Favored 'Cis proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.758 -0.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 16.69 76.52 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.1 p -87.99 173.56 8.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.079 -1.247 . . . . 0.0 109.924 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.679 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.04 140.12 51.49 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLU . 5.6 m-20 -126.52 150.08 69.66 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -45.39 -12.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.6 0.867 . . . . 0.0 111.93 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -83.54 13.22 4.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.4 ptt? -83.82 -1.39 54.25 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.513 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 98.9 mttt -85.94 -3.78 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.798 -1.189 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.0 m-20 -150.45 75.75 1.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.686 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -159.06 168.98 25.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.118 -0.989 . . . . 0.0 109.414 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.8 p -136.53 155.56 49.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.44 150.43 20.7 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 109.449 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -47.22 -46.72 18.86 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 120.366 0.711 . . . . 0.0 111.24 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.38 -151.04 8.06 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.98 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.529 -0.983 . . . . 0.0 109.322 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.5 m -113.02 120.18 40.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 0.0 109.489 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.21 129.97 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -143.71 163.69 32.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.125 -0.984 . . . . 0.0 110.496 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.0 ttp -138.97 129.74 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.713 -0.617 . . . . 0.0 109.563 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -92.28 119.71 32.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 0.0 109.117 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -102.75 150.31 37.6 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.24 133.76 32.69 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.568 0.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.8 m -102.18 170.23 8.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.95 139.95 55.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.377 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.82 -154.38 24.65 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -99.58 122.02 42.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.299 -1.118 . . . . 0.0 109.652 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.6 mp0 -55.87 -28.61 57.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.5 -39.93 77.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.037 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -40.34 70.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.095 -1.003 . . . . 0.0 109.102 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.741 ' OD1' HD23 ' A' ' 58' ' ' LEU . 98.6 m-20 -60.59 -40.04 90.3 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 102' ' ' LEU . 86.2 t80 -57.02 -41.43 78.54 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.41 -42.03 99.14 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.137 -0.977 . . . . 0.0 108.733 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.01 -39.99 95.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 108.71 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mmm -57.23 -50.12 73.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.832 . . . . 0.0 109.497 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.545 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.8 mt -64.35 -47.75 78.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.24 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.3 mt-30 -60.0 -40.84 90.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.782 . . . . 0.0 109.217 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 p -71.96 -42.93 65.99 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.167 -0.958 . . . . 0.0 109.298 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.12 -54.53 44.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -62.78 -35.09 78.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.585 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 30.7 m170 -60.05 -49.94 75.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 112' ' ' VAL . 81.5 mt -59.97 -49.91 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.889 -1.132 . . . . 0.0 108.011 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.95 -49.22 66.49 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.04 -40.01 91.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.558 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.94 77.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.8 m -96.12 0.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.975 -1.078 . . . . 0.0 108.873 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 21.67 76.91 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . -84.07 -169.68 45.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -131.97 138.11 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.602 -0.94 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG12 ' SD ' ' A' ' 124' ' ' MET . 19.8 t -73.69 138.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.284 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.28 160.0 37.5 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.436 -0.79 . . . . 0.0 109.649 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -84.13 -171.67 3.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.402 -0.811 . . . . 0.0 109.672 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.512 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 94.7 m-20 -60.01 -39.86 87.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.217 -0.927 . . . . 0.0 110.083 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.43 14.47 0.97 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -0.909 . . . . 0.0 109.396 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 57.4 37.63 28.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.745 -0.597 . . . . 0.0 109.744 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -112.13 151.48 29.42 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 19.5 mmt -50.2 126.37 14.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.957 -1.09 . . . . 0.0 109.284 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 116' ' ' VAL . 24.9 mtt -58.9 139.97 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.788 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -129.12 151.36 77.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -41.47 -45.0 6.1 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 120.762 0.975 . . . . 0.0 112.184 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -60.8 -39.9 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.768 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -63.74 -40.05 95.79 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.243 -0.91 . . . . 0.0 109.717 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.57 -40.05 86.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.706 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -66.26 -37.94 86.64 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.615 -0.678 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.13 -49.99 75.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.528 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.512 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 73.1 m-85 -59.97 -49.37 77.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 108.738 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.17 -38.05 82.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.08 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.1 -40.96 91.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.149 -0.969 . . . . 0.0 109.67 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.65 -40.06 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.639 -1.288 . . . . 0.0 108.467 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.97 -47.57 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.15 -39.89 87.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.863 . . . . 0.0 108.915 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 89.6 mt-10 -60.98 -41.1 95.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.85 -39.95 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -60.01 -44.92 94.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.349 -0.844 . . . . 0.0 111.592 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.6 p30 -59.97 -34.15 72.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.574 -1.329 . . . . 0.0 109.112 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.39 -35.92 82.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.027 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -97.31 -0.23 46.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.741 . . . . 0.0 109.382 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 78.5 mtm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.314 0.578 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.9 -0.1 57.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -80.64 143.53 54.88 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.0 109.71 -179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.43 23.46 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.505 0.859 . . . . 0.0 111.915 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 3' ' ' LYS . 64.2 mttp -81.82 -22.63 36.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.785 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' A' ' 1' ' ' MET . 60.1 mtt-85 -86.19 119.62 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.042 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -88.21 -10.19 50.58 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.39 144.11 27.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.17 9.83 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.584 -1.322 . . . . 0.0 110.148 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.81 130.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.17 122.67 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.2 mt -120.06 147.63 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.23 1.014 . . . . 0.0 111.372 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -143.81 147.37 34.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.43 120.96 25.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.5 117.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.54 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.452 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.53 -164.49 0.12 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.9 155.03 39.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.925 -1.109 . . . . 0.0 108.482 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -59.93 139.99 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.076 . . . . 0.0 109.349 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.57 3.5 66.6 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -124.42 149.43 46.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.501 -1.0 . . . . 0.0 109.248 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.73 145.81 50.46 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.21 146.34 27.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -68.67 143.62 54.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 109.156 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.55 -43.43 98.88 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.28 -45.67 92.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -1.214 . . . . 0.0 110.152 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.79 -29.83 67.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -71.32 -58.79 3.2 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.583 -0.698 . . . . 0.0 109.347 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.7 mt -60.09 -41.63 92.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.62 -39.89 94.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -64.26 -40.81 96.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.695 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.19 -44.64 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.333 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -64.34 -40.37 95.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.029 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' OE1' ' OE2' ' A' ' 111' ' ' GLU . 78.0 mt-30 -68.27 -20.04 64.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.279 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.71 7.29 15.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.196 -0.94 . . . . 0.0 110.292 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.63 83.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.988 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -80.63 152.53 28.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.434 . . . . 0.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.39 145.26 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.82 118.86 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.0 108.966 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -87.67 171.57 41.59 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.6 -162.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.569 -0.96 . . . . 0.0 109.711 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 89.8 mmm 54.78 -101.34 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' MET . 26.7 m120 -163.27 31.85 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 pt -134.69 163.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.494 -0.754 . . . . 0.0 110.115 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 66.8 m-85 -88.07 134.41 33.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.296 -0.878 . . . . 0.0 110.143 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.451 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 8.0 m-70 -118.34 129.79 55.64 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.55 HH21 HD22 ' A' ' 100' ' ' LEU . 15.9 ttt180 -106.11 125.42 50.97 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.568 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 49.4 m-70 -95.13 174.12 7.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.824 . . . . 0.0 110.222 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.33 -49.97 74.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.8 m -92.7 147.89 35.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.28 -0.887 . . . . 0.0 108.693 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.12 -5.95 17.07 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.68 0.92 . . . . 0.0 112.06 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -92.65 1.28 57.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.179 -0.95 . . . . 0.0 110.204 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.74 11.45 84.53 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -70.15 -40.07 74.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.241 . . . . 0.0 110.091 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.547 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.0 169.82 53.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.568 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.4 Cg_endo -72.78 -179.96 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.133 1.222 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.43 123.4 29.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 108.729 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.2 mp -101.02 -28.3 12.8 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -159.94 165.31 32.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.599 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.451 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 17.2 m -132.48 170.11 15.6 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.129 -0.982 . . . . 0.0 111.53 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.7 tt -132.63 130.96 40.88 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.14 169.68 17.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 91.7 m-20 -75.14 163.49 27.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 109.617 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -70.02 -21.68 63.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.44 -0.788 . . . . 0.0 110.464 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.17 114.85 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.109 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -60.13 149.75 73.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.417 -0.802 . . . . 0.0 109.422 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -76.49 6.8 16.3 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.858 -1.309 . . . . 0.0 111.374 -1.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.89 31.23 49.5 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 p -86.09 165.85 16.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.286 . . . . 0.0 109.944 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.548 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.24 148.65 43.42 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' MET . 1.8 p30 -133.96 151.4 76.7 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.34 -11.86 0.41 Allowed 'Trans proline' 0 N--CA 1.486 1.072 0 CA-C-N 119.429 0.832 . . . . 0.0 110.362 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 75.3 mm-40 -82.17 6.48 16.42 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 23.3 ptt? -79.61 1.65 25.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -85.02 -2.15 57.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.82 -1.175 . . . . 0.0 108.267 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -154.09 78.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -159.3 167.61 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.221 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.6 p -140.72 154.58 46.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.235 -0.916 . . . . 0.0 108.936 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.83 150.16 21.02 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.075 -1.015 . . . . 0.0 109.248 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -41.93 -36.87 3.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 120.724 0.95 . . . . 0.0 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.41 -150.63 12.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.97 159.97 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 109.58 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -113.17 125.9 54.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.675 . . . . 0.0 109.632 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.12 129.97 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -146.79 166.26 27.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.972 -1.08 . . . . 0.0 110.274 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 50.3 ttp -137.33 131.32 32.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 90' ' ' SER . 90.4 mm-40 -88.15 117.73 27.25 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -105.5 148.2 35.94 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 137.5 50.24 Favored 'Cis proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.695 -1.377 . . . . 0.0 112.262 -0.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 51.2 m -103.73 166.94 10.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.502 -0.749 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -72.19 146.22 47.51 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.587 -0.696 . . . . 0.0 109.352 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 -156.35 31.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.14 111.95 23.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -1.135 . . . . 0.0 109.019 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.8 mp0 -54.18 -26.46 28.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.467 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.9 mt -70.02 -39.95 75.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.0 108.68 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -71.61 -40.02 70.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.478 ' ND2' HD23 ' A' ' 58' ' ' LEU . 10.2 m-20 -59.99 -40.41 89.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 102' ' ' LEU . 89.8 t80 -59.91 -45.45 92.52 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.44 -40.59 97.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 HH21 ' A' ' 47' ' ' ARG . 92.6 mt -60.98 -40.04 91.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 108.842 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp -59.41 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 98' ' ' PHE . 99.5 mt -65.26 -43.46 91.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.176 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -60.1 -39.98 88.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 p -70.47 -40.06 73.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.413 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.13 -53.78 54.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 110.239 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -61.88 -41.09 97.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.876 -1.14 . . . . 0.0 109.244 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -60.34 -50.01 75.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.14 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 112' ' ' VAL . 90.5 mt -60.8 -49.99 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.101 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.49 -49.47 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.503 -0.748 . . . . 0.0 109.135 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.07 -40.1 88.32 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.428 -0.795 . . . . 0.0 110.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' OE2' ' OE1' ' A' ' 34' ' ' GLN . 41.4 mt-10 -69.57 -39.92 77.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.975 -1.078 . . . . 0.0 110.721 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.6 m -99.65 -2.24 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.059 -1.026 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.06 23.76 76.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.07 -176.15 51.07 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.289 -1.124 . . . . 0.0 110.57 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.03 136.32 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.945 . . . . 0.0 109.692 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.64 133.13 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -133.15 161.81 33.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.802 . . . . 0.0 109.168 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -84.23 -170.57 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.915 . . . . 0.0 109.702 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 89.4 m-20 -60.09 -39.94 87.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.85 . . . . 0.0 110.046 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.547 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.6 mt-30 -80.33 14.18 2.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 59.68 34.52 22.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.983 -0.448 . . . . 0.0 111.702 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.547 HH12 ' CD ' ' A' ' 120' ' ' GLN . 50.9 mtm-85 -107.19 158.0 17.44 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.042 -1.036 . . . . 0.0 108.821 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.9 mtm -52.59 130.52 32.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.942 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mmm -59.94 141.57 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 110.066 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.0 p -132.25 150.04 74.88 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -47.3 -42.37 27.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.513 0.862 . . . . 0.0 112.082 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -60.09 -39.87 87.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.312 -0.868 . . . . 0.0 109.579 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -66.72 -40.02 88.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.94 -40.25 88.29 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.835 -1.166 . . . . 0.0 109.412 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.9 -37.66 86.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.349 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.87 -48.89 79.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.951 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.02 -45.36 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.986 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.8 -39.99 93.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.21 -40.02 88.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.28 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.07 -40.7 84.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.922 -1.112 . . . . 0.0 108.711 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.447 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.6 mmt180 -63.55 -36.15 82.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.18 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.02 -39.93 87.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.515 -0.741 . . . . 0.0 109.856 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.33 -35.15 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -59.77 -47.19 86.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 0.0 110.109 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -60.59 -31.96 71.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.871 -1.143 . . . . 0.0 109.3 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.99 92.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -98.79 0.26 44.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 108.904 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.322 0.582 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -90.07 -0.02 57.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 78.3 75.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.53 -0.731 . . . . 0.0 109.693 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 7.1 Cg_exo -62.9 121.39 9.26 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.653 1.569 . . . . 0.0 113.175 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -80.92 33.0 0.32 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -69.89 156.36 39.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.482 -0.761 . . . . 0.0 110.802 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -82.08 -8.65 59.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -144.36 142.59 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.73 -175.65 4.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.724 -1.235 . . . . 0.0 110.602 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -133.39 139.06 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mm -91.62 131.12 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.0 mt -121.11 147.29 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.989 0.9 . . . . 0.0 110.979 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.3 mtt -147.39 156.49 42.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -136.97 118.37 14.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.879 -1.138 . . . . 0.0 110.632 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.9 t -101.24 111.19 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.72 43.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.67 -164.11 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -68.39 161.47 27.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 108.624 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -61.93 140.04 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.047 -1.033 . . . . 0.0 109.895 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.35 2.13 85.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -116.94 146.33 43.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.446 -1.032 . . . . 0.0 109.054 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.7 144.98 50.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.92 147.94 26.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.43 138.25 55.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.44 97.07 Favored Glycine 0 N--CA 1.493 2.433 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.287 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.1 -45.49 94.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.284 . . . . 0.0 109.338 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.84 -27.02 64.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.1 tt -74.41 -59.61 2.65 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.558 -0.714 . . . . 0.0 109.593 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.99 -43.52 95.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.291 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.01 -41.85 97.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -64.3 -40.99 97.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.165 -0.96 . . . . 0.0 109.676 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.08 -48.22 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.89 -40.99 95.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 109.667 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -69.68 -19.79 63.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.489 -0.757 . . . . 0.0 110.468 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.86 6.16 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 0.0 110.136 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.34 78.37 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -1.2 . . . . 0.0 109.995 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.74 138.82 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.46 98.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.082 . . . . 0.0 109.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 171.46 53.9 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.14 -170.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.464 -1.021 . . . . 0.0 109.578 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 70.8 mtm 56.74 30.11 17.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.484 -0.76 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 48.78 40.05 15.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 111.642 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.24 162.33 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.03 -1.044 . . . . 0.0 109.541 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.1 121.55 32.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.614 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 7.2 m-70 -103.92 130.5 51.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.296 -0.878 . . . . 0.0 109.818 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 7.5 tpt180 -101.75 120.62 40.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 59.1 m-70 -98.19 169.43 9.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -0.896 . . . . 0.0 109.735 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.67 -49.48 76.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -90.65 138.82 26.41 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.335 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.56 -7.29 14.04 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 CA-C-N 119.69 0.925 . . . . 0.0 111.616 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -92.61 -0.17 57.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.85 86.58 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.19 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -68.63 -41.38 79.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.499 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.42 163.39 50.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 15.3 Cg_endo -67.77 171.38 12.25 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.002 1.134 . . . . 0.0 112.05 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.65 120.61 24.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 108.723 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.663 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -97.04 -31.28 12.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.181 -0.949 . . . . 0.0 108.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -156.84 164.52 37.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.614 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 1.7 m -135.72 -179.09 5.44 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.104 -0.997 . . . . 0.0 111.223 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.68 132.54 35.08 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.04 160.78 33.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.2 m-20 -73.66 159.27 33.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 109.266 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.02 -21.28 63.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.867 . . . . 0.0 110.573 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 65' ' ' VAL . 5.1 m -88.16 126.21 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.844 -1.16 . . . . 0.0 109.526 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -62.29 148.82 88.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 108.529 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.92 14.91 8.8 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.609 -1.413 . . . . 0.0 112.057 -0.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 71.26 20.42 78.11 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 p -88.01 167.97 13.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -1.138 . . . . 0.0 110.494 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 51.6 m-85 -120.28 143.46 48.32 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.683 -0.635 . . . . 0.0 109.476 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -126.87 136.66 29.13 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -49.1 -11.96 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 119.852 0.983 . . . . 0.0 113.17 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -87.46 -0.69 57.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.898 -1.126 . . . . 0.0 108.714 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 93.1 mtp -88.93 24.69 2.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.1 mttm -82.69 -3.96 57.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.841 -1.162 . . . . 0.0 109.282 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 84.0 m-20 -145.14 82.8 1.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.849 . . . . 0.0 108.734 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.42 176.43 11.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.7 p -130.24 153.44 48.6 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.57 150.42 19.42 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.801 -1.187 . . . . 0.0 110.506 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -46.4 -40.23 22.49 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 120.794 0.996 . . . . 0.0 111.912 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.89 -151.71 17.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.14 159.99 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.444 -1.033 . . . . 0.0 109.411 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.5 m -114.82 119.34 36.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.7 mt -102.6 134.48 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.44 163.21 35.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 110.025 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.5 ttp -137.74 129.55 28.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.713 . . . . 0.0 109.496 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -90.01 117.7 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 108.673 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.37 153.25 39.2 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.45 137.72 51.6 Favored 'Cis proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.789 -1.338 . . . . 0.0 112.132 0.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.0 m -106.15 165.71 11.04 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.55 -0.718 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -70.29 142.69 52.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 0.0 110.421 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.45 -152.97 22.36 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -97.37 116.97 30.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.328 -1.101 . . . . 0.0 108.951 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 32.5 mp0 -59.55 -34.11 72.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 110.165 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.09 -39.96 78.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.032 -1.042 . . . . 0.0 109.838 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -73.0 -39.5 66.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.791 -1.193 . . . . 0.0 108.368 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.1 -40.04 88.29 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 84.7 t80 -60.0 -46.48 89.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.08 -40.06 95.41 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.99 -44.28 94.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 90.9 mtp -57.47 -44.82 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 108.915 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.33 -43.71 98.18 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 108.765 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.87 -41.13 90.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.377 -0.827 . . . . 0.0 108.959 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -71.31 -41.45 69.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.25 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.08 71.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.435 -0.79 . . . . 0.0 110.255 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -61.62 -37.02 82.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.794 -1.191 . . . . 0.0 109.157 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -59.97 -47.6 85.17 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.07 -1.019 . . . . 0.0 109.128 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.9 mt -60.04 -49.94 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 108.927 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -54.13 -50.31 67.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.93 -40.19 88.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 110.052 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -70.05 -40.44 75.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 111.341 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 114' ' ' GLY . 10.2 m -99.35 -0.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.949 -1.094 . . . . 0.0 109.382 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.28 19.61 72.51 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -79.77 -172.34 43.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -127.83 133.61 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.483 -1.01 . . . . 0.0 109.221 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.95 131.52 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.702 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.61 159.52 36.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.454 -0.779 . . . . 0.0 109.448 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 42.9 p-10 -88.58 -170.26 2.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.4 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 109.881 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 93.8 mm-40 -76.13 14.61 0.69 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 108.645 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.2 mtm180 57.4 27.87 14.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.861 -0.525 . . . . 0.0 110.432 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.467 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 84.8 mtm180 -105.25 157.07 17.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.83 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 99.2 mtp -51.93 134.17 31.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.7 mmm -58.08 140.25 53.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -131.08 151.25 78.6 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.73 -42.96 62.04 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 120.524 0.816 . . . . 0.0 111.829 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.95 -39.95 87.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.493 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 27.5 mmtp -64.74 -40.0 94.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 110.166 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.19 -40.11 84.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 108.616 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.409 HH11 ' HG2' ' A' ' 130' ' ' ARG . 40.4 ttt-85 -64.11 -39.99 95.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.476 -0.765 . . . . 0.0 109.261 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -46.64 88.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 110.228 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -60.01 -38.59 83.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.134 -0.979 . . . . 0.0 109.628 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -59.92 -38.81 83.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 108.536 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.75 -37.32 81.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 108.739 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.02 -43.38 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.75 -39.98 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -60.23 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.526 -0.733 . . . . 0.0 109.581 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.03 -37.56 80.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.32 -28.62 20.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.638 -0.664 . . . . 0.0 111.568 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 33.1 mttm -60.11 -40.07 88.38 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 111.535 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 50.7 p-10 -59.97 -29.48 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.444 -1.41 . . . . 0.0 109.627 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.59 -40.54 92.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 111.089 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 34.2 p-10 -100.51 -11.44 20.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.156 -0.965 . . . . 0.0 110.264 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.07 . . . . 0.0 109.382 179.362 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -92.32 26.63 2.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 82.03 58.82 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.484 -0.76 . . . . 0.0 108.955 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.04 18.2 0.38 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.158 1.239 . . . . 0.0 112.762 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.98 1.03 54.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.437 -0.789 . . . . 0.0 109.72 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 6' ' ' ARG . 54.2 mtt-85 -82.05 133.12 35.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.238 -0.914 . . . . 0.0 112.22 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -90.11 -8.38 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -147.41 134.76 20.68 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.6 -174.44 3.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.292 -1.505 . . . . 0.0 111.066 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.8 134.72 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.94 122.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -119.89 147.76 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 122.148 0.975 . . . . 0.0 111.407 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -146.68 156.37 43.13 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 83' ' ' THR . 73.8 m-20 -137.11 127.74 26.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.961 -1.087 . . . . 0.0 110.599 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.9 t -109.93 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.48 156.76 42.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.0 -177.23 1.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.66 159.93 17.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.265 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -60.1 141.16 56.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.135 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.1 71.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -127.79 147.27 50.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.955 . . . . 0.0 109.105 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -130.19 148.37 52.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.8 137.4 32.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.585 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -68.23 145.93 53.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.052 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.31 -42.6 98.86 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.208 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 77.2 mm-40 -61.04 -44.28 97.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.952 -1.322 . . . . 0.0 109.416 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.0 mt -69.58 -27.19 64.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 108.819 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.71 -58.28 3.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 110.027 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.2 -48.33 82.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 111.043 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 31' ' ' SER . 35.7 p-10 -62.73 -39.93 95.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.781 -1.199 . . . . 0.0 109.957 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -61.47 -45.75 92.94 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.023 -1.048 . . . . 0.0 109.21 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.05 -44.88 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.158 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.77 -40.05 91.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.25 -20.39 64.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 110.253 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.86 5.36 21.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.988 -1.07 . . . . 0.0 110.174 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.35 15.19 62.62 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 121.049 -1.032 . . . . 0.0 111.711 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -80.3 153.85 28.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.617 -1.52 . . . . 0.0 109.151 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.68 139.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -58.68 101.64 0.09 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.29 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.07 49.72 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.45 -167.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -1.064 . . . . 0.0 108.774 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.6 mtm 57.67 22.43 8.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.144 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 m120 51.93 40.12 27.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.754 -0.591 . . . . 0.0 111.598 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 pt -140.0 166.94 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.123 -0.986 . . . . 0.0 108.689 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.39 129.61 38.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 60' ' ' SER . 12.6 m-70 -119.57 126.45 51.26 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 55.0 ttt180 -100.45 127.12 46.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.095 -1.003 . . . . 0.0 109.299 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 23.5 m-70 -97.83 169.92 9.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.501 -0.75 . . . . 0.0 110.109 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.1 tp -56.94 -49.93 74.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -91.48 145.94 32.31 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 109.036 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.31 -6.61 17.86 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.57 0.847 . . . . 0.0 112.082 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -94.11 -1.78 53.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.023 -1.048 . . . . 0.0 110.274 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 10.3 85.78 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.3 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 m -69.95 -39.96 75.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.333 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.73 166.44 50.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -71.54 173.68 12.13 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.074 1.182 . . . . 0.0 111.732 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.93 125.06 29.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.4 -25.71 15.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 109.303 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -159.66 159.84 33.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 109.136 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 4.0 m -126.53 172.75 9.97 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.021 0.915 . . . . 0.0 111.427 -177.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -139.64 128.66 23.63 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.533 0.682 . . . . 0.0 109.298 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.62 163.21 32.67 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.7 m-20 -77.53 156.07 31.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.885 -1.135 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' NH1' ' A' ' 121' ' ' ARG . 77.6 mtm -69.89 -19.75 63.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.256 -0.902 . . . . 0.0 110.076 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.7 p -87.06 123.65 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 109.502 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -60.03 149.97 71.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 109.672 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -78.32 4.46 26.66 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.823 -1.324 . . . . 0.0 112.239 -0.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.58 9.32 85.85 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p -89.2 170.14 10.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.134 -1.215 . . . . 0.0 109.711 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.626 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 96.9 m-85 -120.33 150.26 41.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.572 -0.705 . . . . 0.0 109.533 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' H ' ' CG ' ' A' ' 74' ' ' MET . 84.9 m-20 -128.81 151.48 77.34 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.98 -11.13 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 120.503 0.802 . . . . 0.0 111.628 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 77.1 mm-40 -90.94 5.52 48.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.635 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.55 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 70.8 mmm -85.56 14.1 6.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.9 mttm -85.99 -4.03 59.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.011 -1.055 . . . . 0.0 108.595 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 80.8 m-20 -148.27 80.74 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -159.67 171.11 20.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.9 p -126.01 149.35 48.89 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.418 -0.801 . . . . 0.0 109.045 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.0 149.91 20.42 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.048 -1.033 . . . . 0.0 109.21 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.83 -47.07 27.01 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 CA-C-N 119.16 0.736 . . . . 0.0 111.665 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.63 -152.5 7.94 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.484 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -133.16 160.05 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.865 . . . . 0.0 109.184 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ALA . 6.6 m -109.54 120.82 43.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.558 -0.714 . . . . 0.0 110.246 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.5 mt -108.99 127.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -147.68 170.53 17.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.505 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -142.24 129.99 21.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.6 -0.688 . . . . 0.0 109.158 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.602 ' N ' ' SD ' ' A' ' 86' ' ' MET . 96.4 mt-30 -93.5 121.73 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.32 153.7 38.32 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.091 -1.006 . . . . 0.0 108.714 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.12 147.62 87.83 Favored 'Cis proline' 0 N--CA 1.505 2.17 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.211 -0.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.451 ' OG ' ' SD ' ' A' ' 86' ' ' MET . 1.8 m -107.0 167.96 9.53 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.633 0.73 . . . . 0.0 110.7 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.64 149.33 42.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 110.167 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.5 -138.35 33.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -99.2 120.74 40.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -1.06 . . . . 0.0 109.777 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.21 -31.12 67.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.779 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.04 -39.66 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.915 . . . . 0.0 109.357 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.89 -40.06 75.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 108.173 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -59.93 -40.06 87.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -59.61 -41.55 90.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.706 -0.621 . . . . 0.0 109.545 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.72 -42.0 96.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.63 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 109.753 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 97.5 mtp -57.62 -49.96 74.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.98 -43.66 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 109.191 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.6 mm-40 -60.03 -41.83 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.912 . . . . 0.0 109.006 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p -70.94 -40.42 72.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.782 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.39 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.291 -0.88 . . . . 0.0 110.014 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -62.01 -37.77 86.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 109.789 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.93 -49.18 78.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 0.0 109.296 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 94.8 mt -60.2 -49.89 82.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.88 -48.06 64.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.703 -0.623 . . . . 0.0 109.794 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.18 -40.37 89.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -69.92 -40.11 75.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 111.053 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 108' ' ' ILE . 11.1 m -100.91 2.32 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 109.935 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.51 24.45 72.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.31 -176.95 51.38 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.91 133.89 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.973 . . . . 0.0 109.089 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.61 132.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.237 -0.914 . . . . 0.0 109.425 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.7 mt -130.54 160.02 35.39 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.415 -0.803 . . . . 0.0 109.803 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -86.63 -170.25 2.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 109.163 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 96.3 m-20 -60.13 -39.87 87.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 109.739 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.68 18.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 121' ' ' ARG . 24.3 mtt-85 59.84 22.58 11.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.1 mtt180 -102.44 145.25 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.449 -0.782 . . . . 0.0 109.478 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.2 mtp -50.08 126.14 13.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.4 mtp -60.04 140.0 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.811 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 3.9 p -131.55 153.17 81.48 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.83 -44.87 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 120.848 1.032 . . . . 0.0 112.081 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.12 -41.2 92.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.222 -0.924 . . . . 0.0 109.166 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 125' ' ' THR . 98.9 mttt -70.06 -40.06 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 110.197 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.57 -40.1 82.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.387 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 130' ' ' ARG . 0.1 OUTLIER -63.14 -40.06 96.49 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.417 -0.802 . . . . 0.0 109.189 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.835 . . . . 0.0 109.662 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -60.02 -43.35 95.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 108.445 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -63.01 -40.09 96.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.353 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.06 -39.97 94.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.682 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.95 -44.72 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 108.709 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -41.3 85.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.804 . . . . 0.0 109.069 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 137' ' ' ARG . 51.3 mtt-85 -60.5 -39.96 89.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.224 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 73.9 mm-40 -62.4 -39.94 94.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 109.571 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -32.19 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 111.021 -177.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -59.98 -40.24 88.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.927 -1.108 . . . . 0.0 109.871 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.3 p30 -61.56 -30.61 70.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.0 108.717 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.65 -22.34 66.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -95.72 -1.81 49.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.812 . . . . 0.0 110.001 179.626 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.32 -8.6 58.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 0.0 109.665 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.57 70.83 76.02 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.416 -0.803 . . . . 0.0 108.965 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 6' ' ' ARG . 32.6 Cg_endo -77.44 112.89 3.44 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.227 1.285 . . . . 0.0 112.161 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.08 29.55 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 4' ' ' PRO . 50.9 mtt-85 -78.5 150.97 32.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.735 . . . . 0.0 110.462 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.58 -6.83 59.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -143.08 150.01 38.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.27 164.5 27.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.835 -1.166 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -120.0 131.4 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mm -90.62 133.38 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.456 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -129.26 143.32 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 122.092 0.949 . . . . 0.0 110.811 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -142.76 149.86 39.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -131.04 126.57 36.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.73 -1.231 . . . . 0.0 110.951 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.14 119.99 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.23 160.25 43.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.068 . . . . 0.0 110.025 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -168.38 0.35 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -61.54 157.82 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.815 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -59.97 139.97 57.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.55 74.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.8 m -129.31 144.27 51.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.474 -1.016 . . . . 0.0 109.309 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 42.3 mp0 -120.28 147.51 44.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.729 . . . . 0.0 109.311 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.17 143.99 30.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -68.99 144.51 54.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.136 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -42.16 98.3 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.1 -45.52 93.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -1.234 . . . . 0.0 109.773 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -69.97 -30.19 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 108.889 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.3 tt -72.15 -55.76 6.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.666 -0.647 . . . . 0.0 109.605 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 74' ' ' MET . 90.9 mt -60.01 -48.64 80.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.844 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -64.62 -40.08 94.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.235 -0.916 . . . . 0.0 111.683 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.1 p -64.81 -41.0 96.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 110.235 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.63 -44.07 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 109.824 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.47 -40.0 85.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.0 110.455 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.01 -19.66 64.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 111.024 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.558 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.57 -11.47 58.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.175 . . . . 0.0 110.87 -178.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.538 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.4 11.12 18.47 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.015 -1.053 . . . . 0.0 111.14 178.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.723 ' N ' HH21 ' A' ' 47' ' ' ARG . 36.3 m-85 -80.87 152.87 27.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.669 -1.489 . . . . 0.0 109.712 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.4 139.35 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.52 104.7 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -0.999 . . . . 0.0 110.055 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.2 171.58 34.08 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -67.12 -166.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -1.073 . . . . 0.0 109.315 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.7 mtm 57.42 25.58 11.53 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.603 0.716 . . . . 0.0 109.887 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 50.02 39.37 18.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.644 -0.66 . . . . 0.0 111.601 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.6 pt -140.85 167.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.021 -1.05 . . . . 0.0 109.005 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -92.42 136.77 32.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.037 -1.039 . . . . 0.0 110.333 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.497 ' CG ' ' OG ' ' A' ' 60' ' ' SER . 19.4 m-70 -126.3 126.82 44.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.723 HH21 ' N ' ' A' ' 37' ' ' PHE . 28.9 ttm180 -99.21 124.28 44.15 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 56.9 m-70 -95.6 171.84 8.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 109.717 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -56.89 -50.01 73.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.762 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -91.67 141.99 26.28 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 109.071 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.53 -10.23 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.555 0.877 . . . . 0.0 112.08 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -91.87 -0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 109.947 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.42 83.51 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.0 p -69.9 -40.05 75.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.83 -1.394 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.28 168.24 50.1 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 18.5 Cg_endo -70.91 174.88 9.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.286 1.324 . . . . 0.0 112.223 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.22 122.4 27.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.9 mp -97.97 -43.81 6.92 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' SD ' ' A' ' 101' ' ' MET . 20.9 p90 -144.91 160.01 42.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.934 -1.104 . . . . 0.0 109.51 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.497 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 9.0 m -132.74 165.51 24.37 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.031 0.92 . . . . 0.0 111.44 -177.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.3 tt -119.96 134.79 55.14 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.696 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.02 159.95 39.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.599 . . . . 0.0 109.413 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.673 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.9 m-20 -76.45 160.71 29.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.432 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.7 mtp -70.03 -25.56 63.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 110.254 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -86.8 121.51 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.963 -1.086 . . . . 0.0 109.738 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -59.43 151.03 62.12 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -77.57 5.02 22.42 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.686 -1.381 . . . . 0.0 112.479 -0.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.43 55.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.8 p -91.26 169.55 10.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.223 -1.163 . . . . 0.0 110.69 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.673 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -124.1 140.68 52.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.691 -0.63 . . . . 0.0 109.376 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -130.37 150.76 77.11 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.0 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -50.72 -7.0 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.42 0.829 . . . . 0.0 112.001 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mt-10 -89.45 2.53 54.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.431 -0.793 . . . . 0.0 109.556 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.415 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.3 mmm -86.83 16.32 4.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.2 mttm -87.42 -3.16 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 108.805 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -149.68 77.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.06 169.41 24.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.994 -1.066 . . . . 0.0 109.251 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -130.04 150.19 51.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.68 150.21 21.31 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.08 -52.83 5.94 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 120.438 0.759 . . . . 0.0 111.726 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.25 -151.82 8.12 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.6 m -130.05 160.0 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.963 . . . . 0.0 109.545 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.4 m -112.07 123.78 51.01 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.115 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.87 132.02 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.08 164.43 33.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.828 -1.17 . . . . 0.0 110.89 -178.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.2 ttp -138.15 128.63 26.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -92.96 112.57 24.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 109.236 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.41 154.3 37.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -75.72 134.36 35.44 Favored 'Cis proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.679 0.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.7 m -107.39 160.2 15.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.529 0.68 . . . . 0.0 109.624 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -70.51 150.43 46.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.928 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -158.96 26.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.16 117.11 30.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -1.146 . . . . 0.0 109.292 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.03 -37.56 80.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.635 . . . . 0.0 110.851 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.81 -39.88 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.99 -39.98 75.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.047 -1.033 . . . . 0.0 108.894 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.436 ' OD1' HD23 ' A' ' 58' ' ' LEU . 78.0 m-20 -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 102' ' ' LEU . 79.1 t80 -60.01 -50.03 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.59 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.8 -41.52 97.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.4 tp -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 59' ' ' PHE . 23.4 mmm -56.11 -46.81 78.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.416 -0.803 . . . . 0.0 109.255 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.9 mt -63.85 -40.76 97.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.103 -0.998 . . . . 0.0 109.061 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 0.0 109.881 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.6 p -69.38 -41.0 77.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.02 -1.05 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.92 52.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 110.272 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -62.33 -34.93 77.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -60.02 -46.54 89.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 108.767 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.1 -49.97 81.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.4 -0.813 . . . . 0.0 108.988 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.55 -47.7 63.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.541 -0.724 . . . . 0.0 109.97 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.73 -179.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.22 -40.01 74.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.047 -1.033 . . . . 0.0 111.165 -178.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.92 1.99 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.68 27.22 71.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.85 -172.0 45.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.19 139.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.608 -0.937 . . . . 0.0 108.881 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.484 HG12 ' SD ' ' A' ' 124' ' ' MET . 4.5 t -80.56 134.94 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 109.736 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.11 160.01 37.23 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 -179.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -87.25 -168.86 2.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 94.9 m-20 -60.01 -39.57 86.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 109.849 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.17 21.75 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 55.85 31.33 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.16 150.9 27.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.438 -0.789 . . . . 0.0 109.297 179.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mmm -52.08 125.66 16.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 109.152 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 116' ' ' VAL . 64.1 mtp -60.0 139.94 57.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.8 p -130.06 150.65 76.59 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -42.58 -43.49 8.47 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.849 1.032 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.418 ' HG2' HH21 ' A' ' 130' ' ' ARG . 96.5 mt-30 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.389 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.72 -39.97 80.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.4 mt -55.69 -42.29 74.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 0.0 108.937 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.418 HH21 ' HG2' ' A' ' 127' ' ' GLN . 85.4 mtm180 -65.71 -38.87 90.4 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -59.97 -44.61 94.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.993 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 53.1 m-85 -60.01 -42.18 93.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.52 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.78 -39.72 89.9 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 98.3 m-20 -60.03 -40.03 87.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.354 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.0 -41.13 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.048 -1.033 . . . . 0.0 108.833 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.11 -44.93 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 108.996 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 79.9 mtm180 -62.22 -35.25 78.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -0.969 . . . . 0.0 110.424 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 66.4 mm-40 -59.94 -38.86 83.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.736 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.1 t -73.31 -30.07 29.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 110.674 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.8 mttm -60.04 -41.1 91.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.759 -1.213 . . . . 0.0 110.987 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -59.94 -29.02 68.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.756 -1.215 . . . . 0.0 109.176 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.852 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 43.4 p-10 -104.57 -3.71 23.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.34 -0.85 . . . . 0.0 109.495 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.899 . . . . 0.0 109.524 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -86.83 -8.96 56.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 70.01 69.25 Favored Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.206 -0.934 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -76.23 -160.87 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.562 1.508 . . . . 0.0 111.421 178.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -81.88 -10.76 59.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.01 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 6' ' ' ARG . 47.4 mtm-85 -83.48 91.03 7.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.967 -1.083 . . . . 0.0 110.208 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.31 -70.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -102.24 143.68 31.72 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -160.96 179.54 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.49 -1.381 . . . . 0.0 110.633 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -125.65 130.0 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 mm -92.26 127.95 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.8 mt -120.21 147.47 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.33 1.062 . . . . 0.0 111.712 -177.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -145.8 159.03 43.78 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -139.26 125.26 19.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.715 -1.241 . . . . 0.0 111.34 -179.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.51 124.97 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -144.61 164.59 30.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.046 -1.034 . . . . 0.0 111.979 -177.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.71 -164.51 0.36 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -71.37 160.05 33.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -58.79 130.01 44.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.746 -1.221 . . . . 0.0 109.356 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.47 -2.23 84.68 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 m -110.92 155.55 22.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.365 -1.079 . . . . 0.0 109.757 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -129.98 150.09 51.42 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.27 140.48 29.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -65.62 141.16 58.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' PHE . . . -60.06 -39.99 96.49 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.107 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.51 -46.69 88.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 109.662 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -30.01 68.17 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -71.41 -58.78 3.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.03 -40.05 88.0 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.349 -0.844 . . . . 0.0 109.708 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -64.28 -40.73 96.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -65.73 -39.64 91.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.304 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.02 -48.4 88.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.074 -1.017 . . . . 0.0 109.859 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -63.37 -39.96 95.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.138 . . . . 0.0 109.704 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.358 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.02 8.3 10.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . 80.09 10.47 85.49 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.39 148.61 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.722 -1.458 . . . . 0.0 108.972 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.6 mt -122.14 134.52 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -58.3 102.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.108 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.74 170.6 38.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.28 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.322 -1.105 . . . . 0.0 109.006 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.1 mtt 58.09 21.38 7.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 51.79 40.06 26.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.797 . . . . 0.0 111.48 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.26 159.29 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.881 -1.137 . . . . 0.0 109.187 178.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -90.49 119.55 30.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.058 -1.026 . . . . 0.0 109.118 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 13.9 m-70 -104.12 134.94 46.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.481 -0.762 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' NH1' ' O ' ' A' ' 36' ' ' GLY . 21.6 tpt180 -100.03 115.62 30.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 72.5 m-70 -95.25 169.31 10.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.225 -0.922 . . . . 0.0 109.907 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.12 -49.96 75.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.855 . . . . 0.0 109.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -96.1 150.0 36.67 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -70.6 -7.1 20.52 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.869 1.046 . . . . 0.0 112.455 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.85 0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.046 -1.034 . . . . 0.0 110.095 -179.195 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.34 7.66 86.97 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.317 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.07 -40.05 75.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.249 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.72 160.42 50.49 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.468 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 12.9 Cg_endo -68.02 175.09 6.95 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.068 1.179 . . . . 0.0 112.218 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.544 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -84.19 127.06 33.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.37 -0.831 . . . . 0.0 109.209 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.2 mp -100.56 -35.38 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.135 -0.978 . . . . 0.0 108.8 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 2.5 p90 -151.01 166.53 30.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.521 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 2.1 m -134.73 179.44 6.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.08 -1.013 . . . . 0.0 111.525 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -139.95 131.65 27.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.611 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.94 159.74 35.72 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.675 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.2 m-20 -76.93 161.53 28.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.05 -22.99 63.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 110.373 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 65' ' ' VAL . 26.8 m -88.89 119.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.757 -1.215 . . . . 0.0 109.879 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -61.24 151.37 76.34 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.38 8.89 17.51 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.486 -0.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.1 63.23 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.9 p -83.92 167.89 16.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -1.2 . . . . 0.0 109.344 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.675 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 71.4 m-85 -120.29 143.8 48.15 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.638 -0.664 . . . . 0.0 109.784 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLU . 20.5 t70 -126.41 134.32 25.88 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -49.5 -9.34 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 119.959 1.021 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -88.38 1.0 55.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.42 ' HE2' ' CZ ' ' A' ' 77' ' ' PHE . 90.6 mtp -86.99 22.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 109.996 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 94.9 mttt -83.65 -4.81 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.021 -1.049 . . . . 0.0 108.955 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.0 m-20 -148.12 83.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' ' HE2' ' A' ' 74' ' ' MET . 7.1 p90 -158.85 177.65 10.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.551 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.0 p -134.03 149.98 51.2 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.12 150.3 23.64 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.063 -1.023 . . . . 0.0 109.35 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.93 -26.06 30.12 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.46 0.773 . . . . 0.0 111.657 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.33 33.96 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.036 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 28' ' ' LEU . 34.3 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.886 . . . . 0.0 108.952 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.7 m -109.76 125.2 52.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.659 -0.651 . . . . 0.0 109.686 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.79 128.41 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -146.74 149.78 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.968 -1.082 . . . . 0.0 110.952 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.1 ttm -104.91 129.91 53.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.836 -0.54 . . . . 0.0 109.581 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -92.84 108.38 19.95 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.7 m -97.2 151.04 37.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 109.133 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.0 139.24 60.44 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.914 -1.286 . . . . 0.0 112.839 -0.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.2 m -105.22 159.51 15.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.627 -0.671 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -71.1 150.62 45.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.98 -152.38 38.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -98.96 121.09 40.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.414 -1.05 . . . . 0.0 109.29 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.94 -32.24 69.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.589 -0.694 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.03 -39.91 75.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.663 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.04 -42.2 73.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.953 -1.092 . . . . 0.0 108.088 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.684 ' OD1' HD23 ' A' ' 58' ' ' LEU . 89.8 m-20 -62.94 -39.88 95.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.14 -40.1 73.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.19 -40.03 94.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.16 -39.9 91.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.132 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.2 mtp -57.84 -50.33 73.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.84 -42.91 89.92 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.986 -1.071 . . . . 0.0 108.961 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.8 mt-30 -61.99 -39.99 94.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 108.796 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -73.14 -43.74 61.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.04 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 0.0 110.014 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -60.31 -39.82 88.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.052 -1.03 . . . . 0.0 109.358 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 4.1 m-70 -59.9 -43.37 94.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.985 . . . . 0.0 108.891 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.0 -50.11 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.26 -48.33 68.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.607 -0.683 . . . . 0.0 109.263 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.64 -40.13 90.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 109.899 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -40.0 75.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.36 -0.838 . . . . 0.0 111.346 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -101.03 -0.81 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.116 -0.99 . . . . 0.0 109.678 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.37 23.39 76.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . -91.33 -167.56 41.01 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.211 -1.17 . . . . 0.0 110.249 -179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 16' ' ' ALA . 3.6 m -130.0 159.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.596 -0.944 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.421 HG12 ' SD ' ' A' ' 124' ' ' MET . 11.4 t -96.93 129.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.234 -0.916 . . . . 0.0 108.712 179.492 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.1 mt -124.49 163.63 21.45 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.82 0.819 . . . . 0.0 110.639 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -86.27 -170.92 3.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.752 -0.593 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 85.4 m-20 -60.12 -39.99 88.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.872 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.99 15.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.068 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' ASP . 86.4 mtm180 57.25 37.16 28.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.837 -0.539 . . . . 0.0 109.769 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 122' ' ' ARG . 20.0 mtt-85 -112.23 151.97 28.97 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.9 mtp -50.92 122.1 6.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.929 -1.107 . . . . 0.0 109.133 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.421 ' SD ' HG12 ' A' ' 116' ' ' VAL . 61.4 mtp -59.96 140.01 57.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.264 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.5 p -122.25 152.17 60.19 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -43.49 -43.61 10.92 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 120.61 0.873 . . . . 0.0 112.017 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -60.11 -40.5 89.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.277 -0.89 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.7 -40.01 84.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.794 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.82 -39.95 78.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 108.409 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.49 -39.97 89.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.457 -0.777 . . . . 0.0 109.397 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.46 77.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.93 -46.05 90.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.956 -1.09 . . . . 0.0 108.779 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.98 -39.93 93.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.36 -0.838 . . . . 0.0 109.124 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 87.8 m-20 -61.72 -46.15 90.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.521 -0.737 . . . . 0.0 110.57 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.19 -37.59 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 108.997 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.05 -42.54 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.052 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 81.7 mtm180 -60.02 -38.69 83.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.853 -1.154 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 40.4 mm-40 -59.98 -39.96 87.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.46 -0.775 . . . . 0.0 109.867 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.5 -33.64 63.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.596 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 144' ' ' ALA . 87.8 mttt -59.95 -50.0 75.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.817 -1.177 . . . . 0.0 110.027 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -61.19 -37.57 83.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.982 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.93 95.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.447 -0.783 . . . . 0.0 110.17 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 50.5 p30 -98.85 -2.98 36.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.309 -0.869 . . . . 0.0 109.406 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.34 -0.36 57.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.138 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 75.9 72.48 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.478 -0.764 . . . . 0.0 109.549 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.22 83.63 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.382 1.388 . . . . 0.0 112.122 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -80.54 30.01 0.3 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.272 -0.892 . . . . 0.0 109.589 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.521 ' N ' ' CD ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -78.47 171.5 15.02 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.749 -179.1 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -79.26 -3.76 47.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.984 -1.072 . . . . 0.0 108.345 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -144.64 132.56 21.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.85 -172.14 3.17 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.015 -1.053 . . . . 0.0 110.536 -178.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.92 140.59 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.49 130.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.0 mt -118.45 144.13 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 122.245 1.021 . . . . 0.0 111.681 -177.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -142.0 150.02 40.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -128.02 119.62 25.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.019 -1.051 . . . . 0.0 111.037 -178.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.62 110.86 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 80' ' ' PRO . . . -148.99 160.79 42.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -165.25 0.25 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.56 142.42 55.42 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 108.826 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -51.47 137.15 24.59 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.039 -1.038 . . . . 0.0 109.237 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.27 1.22 66.93 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.1 m -121.02 149.95 41.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.516 -0.991 . . . . 0.0 108.697 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -125.41 146.87 49.42 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.764 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 148.62 25.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -68.93 142.48 54.71 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.42 96.99 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.31 -46.85 86.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 0.0 109.83 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.81 -30.17 67.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.197 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.607 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -71.15 -58.67 3.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.23 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -59.99 -46.02 90.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.659 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.81 -42.26 97.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.698 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 t -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.479 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.94 -47.0 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -63.83 -41.57 97.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.69 -21.89 66.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.6 11.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.47 75.73 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.15 -0.969 . . . . 0.0 111.338 178.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -81.65 147.51 29.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.661 -1.494 . . . . 0.0 109.584 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -120.03 132.33 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.74 101.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -89.72 170.82 37.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.34 -162.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -1.044 . . . . 0.0 109.265 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 91.0 mmm 59.78 20.61 9.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.683 -0.635 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 51.21 34.97 12.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 111.362 178.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.2 165.83 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.006 -1.058 . . . . 0.0 108.999 178.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -89.72 141.51 28.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.947 -1.096 . . . . 0.0 110.464 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.467 ' HD2' ' HA3' ' A' ' 40' ' ' GLY . 61.6 m-70 -130.19 130.07 44.22 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.511 ' HG2' HH11 ' A' ' 47' ' ' ARG . 4.0 ttt-85 -103.0 127.29 50.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 17.9 m-70 -91.45 169.84 10.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.664 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.69 -49.96 73.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -92.65 144.81 29.26 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.58 -6.37 16.45 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.798 0.999 . . . . 0.0 112.213 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -92.71 1.92 57.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.949 . . . . 0.0 110.031 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.14 10.67 85.27 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.4 p -70.14 -40.8 74.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -1.184 . . . . 0.0 110.0 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.48 164.0 50.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -66.68 179.74 2.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.473 1.136 . . . . 0.0 111.852 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.56 29.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -97.65 -70.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.355 -0.841 . . . . 0.0 109.691 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 1.7 p90 -114.41 160.0 19.66 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.97 -1.081 . . . . 0.0 109.909 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.429 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.1 m -121.88 161.47 22.73 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.573 0.701 . . . . 0.0 109.927 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -132.26 130.59 41.11 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.43 165.3 26.13 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.489 -0.757 . . . . 0.0 110.073 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 88.7 m-20 -75.05 156.92 35.62 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.4 mtt -69.88 -23.88 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.0 p -87.5 121.12 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.068 -179.102 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -58.06 151.78 43.79 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -80.43 -0.2 41.15 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.979 0.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.62 18.83 61.12 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.4 p -85.92 167.3 15.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.991 -1.299 . . . . 0.0 109.618 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.4 m-85 -124.33 141.85 51.75 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.519 -0.738 . . . . 0.0 109.808 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -129.8 151.09 77.57 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.58 -12.5 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 120.497 0.798 . . . . 0.0 112.409 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.91 -3.01 58.86 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.072 -1.017 . . . . 0.0 109.322 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.2 mtp -88.65 22.68 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.4 mttp -83.06 -4.84 58.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 94.0 m-20 -143.75 84.63 1.8 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.376 -0.828 . . . . 0.0 108.776 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.7 177.24 11.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 110.362 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.5 p -129.67 146.8 51.43 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.19 148.22 18.19 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 108.862 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.411 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 14.2 Cg_exo -45.16 -31.65 6.17 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 120.611 0.874 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.65 -147.71 16.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.49 159.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.457 -1.025 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.7 m -108.74 122.48 47.23 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -105.77 130.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.323 -0.861 . . . . 0.0 108.727 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.47 148.03 32.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.12 -0.988 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.9 tpp -104.02 130.28 51.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' O ' ' OG ' ' A' ' 90' ' ' SER . 95.0 mt-30 -90.54 108.6 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 88' ' ' VAL . 9.2 m -98.67 150.03 36.31 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.211 -0.93 . . . . 0.0 109.238 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.65 135.07 38.67 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.859 -1.309 . . . . 0.0 112.564 -0.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.5 m -108.05 162.58 13.91 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.632 0.73 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 59.6 t80 -73.78 158.14 35.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 110.041 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.72 -160.28 44.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -98.15 111.96 24.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.38 -1.07 . . . . 0.0 108.971 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.62 -30.33 68.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.768 . . . . 0.0 110.602 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.33 -40.06 77.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 109.363 -179.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.81 -40.35 63.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.743 -1.223 . . . . 0.0 108.242 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -61.2 -37.5 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.093 0.949 . . . . 0.0 108.606 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -56.33 -50.09 72.46 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.25 -39.19 92.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.12 -46.02 91.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.608 -0.683 . . . . 0.0 110.219 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.8 mtm -58.91 -42.67 90.21 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.667 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.61 -46.61 87.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.913 . . . . 0.0 108.937 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.4 mm-40 -60.17 -42.63 95.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 108.928 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -71.55 -41.07 69.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 109.375 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.56 -55.41 35.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.601 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -61.25 -35.7 77.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.148 -0.97 . . . . 0.0 109.103 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 58.1 m170 -59.89 -47.08 87.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 112' ' ' VAL . 82.2 mt -59.98 -49.95 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.9 -47.7 60.63 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.77 -39.96 93.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.43 -40.02 77.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.05 -1.031 . . . . 0.0 110.703 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.7 m -98.44 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 109.275 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.85 24.88 76.15 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.34 -169.83 46.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.8 138.0 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.128 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 t -77.57 132.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 109.475 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.17 160.33 35.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.415 -0.803 . . . . 0.0 110.022 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -84.58 -173.12 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.477 -0.764 . . . . 0.0 108.976 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.514 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 93.3 m-20 -60.02 -36.07 76.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.088 -1.007 . . . . 0.0 109.994 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -79.61 15.3 1.37 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.916 . . . . 0.0 110.219 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 19.8 mmm-85 58.19 30.84 19.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -106.43 151.93 24.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 81.0 mmm -51.72 133.37 31.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.026 -1.046 . . . . 0.0 109.45 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.2 mmm -56.08 138.66 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.096 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.3 p -136.81 151.28 72.12 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.426 -0.797 . . . . 0.0 109.034 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -44.58 -45.72 12.85 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 120.449 0.766 . . . . 0.0 111.73 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.08 -40.01 88.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -68.48 -39.92 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.02 -40.13 88.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.995 -1.065 . . . . 0.0 109.011 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -65.28 -39.67 92.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.445 -0.785 . . . . 0.0 109.405 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.75 -47.6 85.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.195 -0.941 . . . . 0.0 110.348 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.514 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 71.3 m-85 -60.07 -46.59 89.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.928 -1.107 . . . . 0.0 108.526 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.2 -40.35 93.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.194 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.416 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.7 m-20 -62.35 -40.09 95.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.32 -40.68 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.052 -1.03 . . . . 0.0 108.596 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.56 -40.03 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.504 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 137' ' ' ARG . 7.4 mmt-85 -60.04 -39.96 87.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.066 -1.021 . . . . 0.0 110.554 -179.12 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.99 -40.07 92.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.725 -1.235 . . . . 0.0 109.524 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.15 -29.74 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' ALA . 47.4 mmtt -60.07 -39.47 86.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.835 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 2.2 p30 -60.07 -30.01 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.659 -1.276 . . . . 0.0 108.566 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.888 . . . . 0.0 109.218 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -101.22 -13.38 18.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.372 -0.83 . . . . 0.0 110.409 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.891 -1.13 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.553 ' N ' ' HE ' ' A' ' 6' ' ' ARG . 96.0 mmm . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.317 0.579 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.61 17.92 6.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -97.73 109.96 53.15 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' CB ' ' OE2' ' A' ' 138' ' ' GLU . 19.0 Cg_endo -74.34 13.97 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 CA-C-N 119.981 1.029 . . . . 0.0 112.663 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -88.28 0.04 56.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.466 -0.771 . . . . 0.0 109.005 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.553 ' HE ' ' N ' ' A' ' 1' ' ' MET . 57.9 mtt-85 -80.71 135.02 35.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.566 -0.709 . . . . 0.0 111.586 -178.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -89.88 -12.43 39.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.32 147.11 31.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.61 -177.64 6.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.322 -1.486 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.99 131.46 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 mm -92.87 125.31 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 90.8 mt -123.66 143.71 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-O 122.166 0.984 . . . . 0.0 111.248 -177.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.402 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.4 mtt -142.88 138.18 30.07 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -120.85 127.46 51.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.992 -1.068 . . . . 0.0 111.251 -178.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.38 114.67 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.71 152.27 38.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.288 -0.882 . . . . 0.0 109.647 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.91 -166.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.64 152.89 44.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.161 -0.962 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.06 141.23 56.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.609 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.09 1.91 64.7 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.4 m -129.01 150.01 50.6 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.438 -1.036 . . . . 0.0 109.137 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.11 148.16 49.44 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.45 146.67 26.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -71.0 142.15 50.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 109.115 179.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.9 99.83 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.871 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -61.62 -44.65 96.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.964 -1.315 . . . . 0.0 109.669 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.87 -26.58 64.26 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -74.71 -59.88 2.53 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.652 -0.655 . . . . 0.0 109.76 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.86 -40.9 94.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 110.581 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.09 94.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 109.911 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 t -66.05 -41.05 91.33 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.16 -0.962 . . . . 0.0 109.806 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.13 -46.28 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 110.027 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.59 -40.2 96.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.974 -1.079 . . . . 0.0 109.395 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.56 -19.61 64.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.601 -0.687 . . . . 0.0 109.975 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.53 8.18 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.915 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.5 10.68 85.0 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.584 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -80.8 151.55 28.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.993 -1.299 . . . . 0.0 109.735 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.06 148.11 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.13 112.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.06 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.65 30.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.2 -170.18 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.596 -0.943 . . . . 0.0 108.626 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mtp 55.27 24.95 6.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.861 . . . . 0.0 109.726 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.04 42.1 24.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.745 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.7 pt -138.31 167.02 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.099 -1.0 . . . . 0.0 108.303 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -93.34 120.42 33.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.821 -1.174 . . . . 0.0 110.427 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.429 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 16.4 m170 -108.53 128.11 54.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.421 -0.8 . . . . 0.0 109.611 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 47' ' ' ARG . 9.3 ttt-85 -100.08 123.77 44.7 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.214 -0.928 . . . . 0.0 108.775 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 26.0 m-70 -92.46 171.59 8.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.57 -50.01 66.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 109.031 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -93.07 147.29 33.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 0.0 109.158 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -69.15 -4.2 13.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.65 0.9 . . . . 0.0 112.092 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -93.67 -1.07 55.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 0.0 109.746 -179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 13.42 83.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -68.93 -43.22 75.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -1.201 . . . . 0.0 109.533 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.435 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.33 171.62 54.26 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.2 Cg_endo -71.67 176.36 8.28 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.018 1.145 . . . . 0.0 111.463 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.406 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.16 126.63 32.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 108.906 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.4 mp -101.16 -35.88 9.15 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.078 -1.014 . . . . 0.0 109.74 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -146.68 160.78 41.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.029 -1.044 . . . . 0.0 109.006 178.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 63.2 m -129.99 160.29 34.08 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.002 0.906 . . . . 0.0 111.437 -177.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -120.97 129.48 53.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.537 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -139.6 161.73 36.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.521 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 81.9 m-20 -77.66 159.93 28.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 48.7 mtm -67.83 -18.84 64.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.7 p -88.16 121.28 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.818 -1.176 . . . . 0.0 109.844 -179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -61.11 147.76 85.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.35 -0.843 . . . . 0.0 109.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.6 -0.53 19.46 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.763 -1.349 . . . . 0.0 111.741 -0.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.99 17.43 74.68 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 p -88.79 169.05 11.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.196 -1.179 . . . . 0.0 110.601 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.4 m-85 -119.91 143.8 47.77 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.27 150.01 72.91 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.349 -0.844 . . . . 0.0 109.146 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.23 -19.32 2.62 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.689 0.926 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -89.94 -4.36 57.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.95 -1.093 . . . . 0.0 109.131 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 85.6 mtp -93.51 23.51 4.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 110.372 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -85.49 -8.99 58.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.911 -1.118 . . . . 0.0 108.476 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -136.96 87.27 2.27 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 7.7 p90 -157.96 179.65 8.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.387 -0.821 . . . . 0.0 109.522 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.5 p -128.76 149.96 50.49 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.73 149.17 19.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.051 -1.03 . . . . 0.0 109.221 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.95 -40.64 80.14 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.669 0.913 . . . . 0.0 111.907 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.39 -156.54 17.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -130.38 159.96 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.617 -0.931 . . . . 0.0 109.506 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 m -114.21 120.68 41.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.526 -0.733 . . . . 0.0 109.476 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.64 128.49 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -149.28 159.92 43.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.699 -1.251 . . . . 0.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 44.2 ttm -120.25 129.95 54.28 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.31 102.08 14.5 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' CG1' ' OE1' ' A' ' 94' ' ' GLU . 15.9 m -96.04 148.31 34.34 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.308 -0.87 . . . . 0.0 108.894 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HG3' HD21 ' A' ' 143' ' ' ASN . 10.3 Cg_endo -73.67 130.24 19.96 Favored 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.796 -1.335 . . . . 0.0 112.957 0.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 m -105.42 161.36 14.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.64 -0.662 . . . . 0.0 109.644 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.04 150.02 47.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.694 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -164.65 31.29 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 96.0 m-20 -96.09 116.74 29.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.198 -1.178 . . . . 0.0 108.921 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE1' ' CG1' ' A' ' 88' ' ' VAL . 41.9 mt-10 -59.95 -34.86 73.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.649 . . . . 0.0 110.799 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.06 -39.99 75.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.535 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.22 -42.21 55.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.717 -1.239 . . . . 0.0 108.701 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 31.3 m120 -61.53 -39.89 92.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 73.0 t80 -52.44 -40.01 61.72 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.607 -0.683 . . . . 0.0 109.207 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -60.96 -40.01 91.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.112 -0.992 . . . . 0.0 109.1 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.37 -40.08 89.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 109.177 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.6 mtp -57.09 -50.33 73.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.17 -45.28 81.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.15 -39.99 88.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 108.822 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 p -70.14 -41.07 74.37 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.199 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.6 -55.62 31.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.319 -0.863 . . . . 0.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -60.73 -39.95 90.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 109.704 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 48.7 m170 -59.83 -46.32 89.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.76 -47.45 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 108.977 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.86 -47.01 64.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.92 -40.67 94.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.851 . . . . 0.0 110.949 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.03 -40.08 75.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.708 -178.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 114' ' ' GLY . 6.3 m -99.59 0.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.224 -0.923 . . . . 0.0 109.877 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.31 21.76 74.28 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.62 -176.8 51.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.49 132.02 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.604 -0.939 . . . . 0.0 109.272 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.96 131.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.188 -0.945 . . . . 0.0 108.898 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.6 mt -131.49 158.62 40.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.411 -0.806 . . . . 0.0 109.377 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.03 -170.77 3.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.253 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 92.0 m-20 -60.06 -36.37 77.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.834 . . . . 0.0 109.623 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.59 14.91 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.6 mtt180 56.35 38.64 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 109.765 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.18 152.2 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.2 mtp -50.72 129.24 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.07 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.95 139.81 57.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -120.66 151.33 54.13 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -43.02 -43.92 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 120.8 1.0 . . . . 0.0 112.603 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.06 -40.0 87.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.31 -39.83 92.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 110.124 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.03 -40.05 83.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.954 -1.091 . . . . 0.0 108.543 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -65.07 -39.5 93.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.597 -0.689 . . . . 0.0 109.86 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.12 -47.65 85.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.304 -0.873 . . . . 0.0 110.565 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -59.98 -43.86 94.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 0.0 109.322 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 136' ' ' ILE . 78.3 mt-30 -60.38 -39.94 89.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.704 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 95.8 m-20 -60.58 -40.17 90.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.13 -39.94 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 108.904 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 133' ' ' GLN . 96.5 mt -59.9 -44.63 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.2 mtm180 -60.1 -38.0 81.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 4' ' ' PRO . 95.4 mt-10 -60.09 -37.33 79.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 0.0 109.52 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.88 -38.17 74.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.369 -0.832 . . . . 0.0 110.38 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -60.06 -46.56 89.16 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.077 -1.015 . . . . 0.0 111.558 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -60.08 -35.06 74.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.697 -1.252 . . . . 0.0 109.588 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.49 -19.51 65.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.781 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.436 HD21 ' HG3' ' A' ' 89' ' ' PRO . 12.1 m120 -99.52 -8.7 24.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 109.832 -179.177 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 0.0 109.524 179.894 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.65 -16.09 27.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.176 -0.953 . . . . 0.0 110.026 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -134.02 77.16 62.74 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.81 1.61 5.59 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.786 0.991 . . . . 0.0 111.822 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -87.01 -0.83 57.26 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -81.75 103.72 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 110.615 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -87.7 -11.54 48.0 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -152.21 140.58 20.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.75 164.56 26.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.426 -1.421 . . . . 0.0 110.734 -178.567 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.99 129.47 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.31 122.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -122.29 144.27 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 122.039 0.923 . . . . 0.0 110.835 -177.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.8 mtt -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -130.81 119.5 22.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.978 -1.076 . . . . 0.0 110.392 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.27 112.89 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.79 44.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.65 -164.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.175 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -67.25 155.03 39.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.962 . . . . 0.0 108.716 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -59.56 140.01 56.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.33 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -6.19 77.11 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 m -115.26 148.44 39.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.448 -1.031 . . . . 0.0 109.042 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -126.8 146.49 50.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.461 -0.774 . . . . 0.0 109.606 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.34 141.91 28.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -69.95 146.12 51.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.243 -0.911 . . . . 0.0 108.876 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.0 98.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.0 -45.73 93.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.061 -1.258 . . . . 0.0 109.755 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.1 mt -69.85 -24.48 63.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.537 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -79.8 -57.49 3.63 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 110.46 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.94 -45.21 93.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 0.0 111.585 -178.273 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 31' ' ' SER . 39.4 p-10 -61.62 -39.8 92.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.0 110.28 -178.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.532 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 9.3 p -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 0.0 110.316 -179.406 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.04 -50.04 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 0.0 110.335 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.72 -39.96 95.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 0.0 110.127 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.26 -20.09 66.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.59 1.02 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.94 -1.1 . . . . 0.0 110.022 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 13.58 56.87 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.011 -1.056 . . . . 0.0 110.921 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.93 150.81 28.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.973 -1.31 . . . . 0.0 109.692 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.62 138.84 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.58 106.75 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.687 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.83 171.51 26.19 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.41 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 109.481 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 56.9 19.98 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.502 -0.749 . . . . 0.0 110.014 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.4 m120 49.86 40.04 19.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 111.379 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.16 167.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.973 -1.079 . . . . 0.0 108.574 178.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -93.18 120.91 33.99 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.787 -1.196 . . . . 0.0 110.68 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 47.1 m-70 -109.18 124.58 51.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.523 ' NH1' HD21 ' A' ' 100' ' ' LEU . 13.9 ttt-85 -100.02 127.25 46.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.257 -0.902 . . . . 0.0 108.661 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 18.5 m-70 -95.67 171.55 8.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.37 -0.831 . . . . 0.0 110.399 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.97 -50.08 71.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 108.848 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.2 m -94.09 146.91 32.48 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 179.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.2 -6.37 18.16 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 CA-C-N 119.436 0.834 . . . . 0.0 112.368 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -92.54 -2.24 56.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 109.773 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.05 86.02 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -67.64 -40.43 84.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.011 -1.288 . . . . 0.0 109.189 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.507 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.54 162.66 49.4 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.89 179.25 2.84 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 118.448 1.124 . . . . 0.0 111.716 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.69 119.83 23.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.156 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 58' ' ' LEU . 10.3 mp -96.56 -47.52 5.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CG ' ' SD ' ' A' ' 101' ' ' MET . 40.2 p90 -145.33 159.16 43.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.904 -1.122 . . . . 0.0 109.01 178.704 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.2 m -132.02 169.74 15.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.856 0.836 . . . . 0.0 111.526 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.667 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.6 tt -123.48 133.0 54.09 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.512 0.672 . . . . 0.0 109.211 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.568 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.77 159.08 42.76 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.3 m-20 -76.27 152.48 36.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 0.0 108.732 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.7 mtm -70.02 -20.26 63.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.996 -1.065 . . . . 0.0 109.663 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.0 p -88.66 131.94 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 109.555 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -59.5 150.95 63.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.068 -1.02 . . . . 0.0 108.485 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -80.25 5.3 36.31 Favored 'Cis proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.243 -0.446 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.69 3.51 90.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.3 p -92.4 174.89 7.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.268 -1.137 . . . . 0.0 110.818 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.5 m-85 -126.24 146.76 49.86 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLU . 51.3 m-20 -129.99 149.82 74.22 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -49.13 -7.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.567 0.881 . . . . 0.0 111.85 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.0 mt-10 -90.0 3.26 53.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.475 ' O ' HD11 ' A' ' 29' ' ' LEU . 65.1 mmm -86.16 21.0 2.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -0.852 . . . . 0.0 109.866 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -85.93 -5.82 59.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 108.882 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -149.85 80.0 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.424 -0.797 . . . . 0.0 109.159 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -157.45 170.54 22.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.195 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.0 p -129.4 150.25 50.84 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.03 149.27 20.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.024 -1.047 . . . . 0.0 109.213 -179.434 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -48.05 -45.11 26.26 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.509 0.806 . . . . 0.0 111.639 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.16 -149.11 7.83 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.45 162.13 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.539 -0.977 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' ALA . 5.6 m -114.87 116.6 28.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.53 126.79 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -146.5 160.23 42.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.003 -1.061 . . . . 0.0 111.221 -178.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.0 ttm -124.15 131.08 53.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -90.15 120.0 30.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 108.545 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.5 m -98.38 150.02 36.31 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.26 -0.9 . . . . 0.0 109.375 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.69 137.05 48.0 Favored 'Cis proline' 0 N--CA 1.498 1.784 0 C-N-CA 124.084 -1.215 . . . . 0.0 111.94 -2.063 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.3 m -105.26 150.31 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.394 -0.816 . . . . 0.0 110.047 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.7 152.06 41.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.587 -0.696 . . . . 0.0 109.83 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -163.02 31.94 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -95.25 113.06 24.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.144 -1.209 . . . . 0.0 109.254 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 57.1 mp0 -58.99 -29.5 67.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.0 -42.9 72.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.99 -42.28 60.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.053 -1.03 . . . . 0.0 108.613 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -62.2 -40.63 96.73 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.601 -0.687 . . . . 0.0 109.196 179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.498 -0.751 . . . . 0.0 109.02 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.5 -39.79 94.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.523 HD21 ' NH1' ' A' ' 47' ' ' ARG . 7.1 tt -60.01 -42.41 94.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.743 -0.598 . . . . 0.0 109.541 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' CG ' ' A' ' 59' ' ' PHE . 21.7 mtm -59.92 -41.64 92.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.82 -1.175 . . . . 0.0 108.576 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.26 -43.14 98.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 108.676 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -60.07 -41.32 92.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.098 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 p -70.95 -40.03 72.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.57 -53.83 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 -179.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.102 . . . . 0.0 109.127 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -60.02 -49.57 77.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.077 -1.014 . . . . 0.0 108.608 179.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.1 -50.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.87 -51.09 42.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.667 -0.646 . . . . 0.0 109.828 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.04 -40.07 88.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 110.617 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.09 -39.92 78.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 -178.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.73 0.34 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 20.25 76.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.78 -173.04 46.61 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.33 139.29 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.504 -0.998 . . . . 0.0 108.872 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 t -76.62 129.96 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.081 -1.012 . . . . 0.0 108.824 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' C ' ' SD ' ' A' ' 124' ' ' MET . 52.5 mt -131.4 159.85 36.8 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -0.767 . . . . 0.0 109.72 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' ' SD ' ' A' ' 124' ' ' MET . 43.6 p-10 -84.78 -173.97 5.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 109.173 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.7 m-20 -60.04 -36.45 77.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.472 ' CB ' ' NH1' ' A' ' 122' ' ' ARG . 96.5 mm-40 -77.17 13.24 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.7 mtm180 55.42 33.78 21.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.87 -0.518 . . . . 0.0 110.422 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 120' ' ' GLN . 25.1 mtm-85 -109.67 156.67 19.96 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.5 mtm -51.9 133.24 32.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 118' ' ' ASP . 97.6 mmm -60.68 139.95 57.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.627 ' N ' ' NZ ' ' A' ' 128' ' ' LYS . 74.6 p -130.43 149.87 74.63 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -48.63 -43.9 32.42 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 119.38 0.814 . . . . 0.0 111.963 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -60.3 -42.99 96.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.627 ' NZ ' ' N ' ' A' ' 125' ' ' THR . 9.8 mtmp? -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.105 . . . . 0.0 110.288 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.44 -39.99 81.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.738 -1.226 . . . . 0.0 108.409 179.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.08 -36.87 85.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.391 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.07 -49.44 77.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -60.05 -43.75 95.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.45 -39.83 94.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.0 -40.99 91.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.268 -0.895 . . . . 0.0 109.294 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.93 -41.03 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.885 -1.134 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.03 -46.28 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.188 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 137' ' ' ARG . 1.6 mmt-85 -60.27 -40.02 88.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.098 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.5 mt-10 -60.93 -38.84 87.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.52 0.676 . . . . 0.0 109.63 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 88' ' ' VAL . 71.7 t -68.81 -39.61 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 110.673 -179.007 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' ALA . 56.6 mttm -58.23 -46.9 85.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.927 -1.108 . . . . 0.0 110.572 -178.22 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.11 -33.02 71.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.704 -1.248 . . . . 0.0 108.622 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.26 93.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.56 -0.713 . . . . 0.0 110.289 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -99.96 -18.58 17.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.407 0.622 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.29 6.72 31.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.4 81.45 10.98 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -45.01 118.27 1.9 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.961 1.107 . . . . 0.0 113.105 -178.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -80.06 32.77 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -69.98 150.27 46.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.798 . . . . 0.0 110.709 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -82.94 -9.34 59.34 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -146.4 141.78 27.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -165.8 166.82 17.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 109.799 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.3 129.97 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mm -92.57 131.83 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.0 mt -131.13 142.09 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 122.165 0.983 . . . . 0.0 110.971 -178.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.85 135.06 32.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -116.24 122.68 45.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.048 -1.033 . . . . 0.0 111.342 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.46 111.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.27 155.69 40.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.111 -0.993 . . . . 0.0 110.55 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.48 -164.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.559 -0.713 . . . . 0.0 109.096 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -74.51 157.44 35.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.096 -1.003 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.24 143.56 52.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.73 0.24 72.55 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.7 m -130.01 141.78 50.7 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.587 -0.949 . . . . 0.0 109.341 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.72 149.11 44.52 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.451 -0.78 . . . . 0.0 108.936 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.4 145.34 26.9 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 62.6 t-20 -68.07 138.82 56.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.527 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.8 -40.42 98.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.351 . . . . 0.0 109.489 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -29.73 67.81 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.54 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -70.37 -57.93 4.29 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 74' ' ' MET . 83.7 mt -60.2 -40.89 91.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.0 109.926 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -64.0 -40.37 96.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.4 t -65.77 -39.06 90.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 111.105 -179.012 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.82 -42.24 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.197 . . . . 0.0 109.972 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -64.88 -39.94 94.34 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.153 -0.967 . . . . 0.0 108.549 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -64.71 -20.62 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.492 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.62 2.01 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.779 . . . . 0.0 110.114 -178.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.68 13.49 82.35 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.425 179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -79.99 153.17 29.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.049 -1.266 . . . . 0.0 110.059 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 83.0 mt -120.21 133.84 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 110.182 -178.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.95 169.07 27.93 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -59.95 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -1.115 . . . . 0.0 109.189 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.9 mtt 58.89 19.86 7.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.5 m120 51.32 37.62 19.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.222 -0.924 . . . . 0.0 111.336 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.58 164.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.945 -1.097 . . . . 0.0 108.717 178.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -91.72 123.14 34.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.115 -0.991 . . . . 0.0 110.47 -178.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 44.8 m-70 -114.67 131.3 56.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.609 -0.682 . . . . 0.0 109.654 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 17.4 ttp180 -107.32 126.76 52.86 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.384 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.9 m-70 -92.75 171.47 8.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.378 -0.826 . . . . 0.0 110.676 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.41 -49.98 72.93 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.2 m -90.49 148.05 37.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.239 -0.913 . . . . 0.0 108.948 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.97 -12.0 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 120.748 0.966 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 56.3 p-10 -90.24 0.78 57.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 0.0 109.901 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.15 10.67 85.87 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 53.5 m -66.88 -40.06 87.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.848 -1.383 . . . . 0.0 109.726 -179.51 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.98 166.21 51.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 19.4 Cg_endo -71.16 175.78 8.75 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.493 1.462 . . . . 0.0 112.125 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.29 124.04 27.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.037 . . . . 0.0 109.25 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 86' ' ' MET . 10.2 mp -102.94 -57.25 2.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.405 -0.809 . . . . 0.0 110.026 -179.216 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -130.5 159.49 36.96 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.77 -1.207 . . . . 0.0 108.518 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.8 m -137.3 162.26 34.01 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.017 -1.052 . . . . 0.0 111.731 -177.508 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 62' ' ' ALA . 8.1 tt -113.58 136.16 53.12 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.663 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.36 160.53 38.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.692 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 85.5 m-20 -75.92 161.5 28.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.095 -1.003 . . . . 0.0 109.904 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.1 mtp -69.83 -19.41 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 110.492 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.9 p -89.49 117.44 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.741 -1.224 . . . . 0.0 109.747 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -62.04 148.86 87.71 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -75.43 9.29 10.7 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.828 -1.322 . . . . 0.0 112.234 0.099 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 73.86 21.76 78.88 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.926 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.2 p -86.08 171.85 11.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.1 -1.235 . . . . 0.0 109.789 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.692 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 84.0 m-85 -121.43 144.81 48.47 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.562 -0.711 . . . . 0.0 109.943 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.9 m-20 -129.98 150.44 75.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.59 -8.79 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 120.512 0.808 . . . . 0.0 112.123 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 48.7 mt-10 -89.94 2.61 54.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.448 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.6 mmm -86.23 17.28 3.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -87.41 -7.84 57.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 108.939 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.1 m-20 -150.3 79.99 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -156.25 172.44 18.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.2 p -129.81 150.97 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.177 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.12 148.15 18.18 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.912 . . . . 0.0 109.341 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -45.34 -43.1 17.35 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 120.594 0.863 . . . . 0.0 111.547 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.9 10.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.6 m -129.98 160.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.325 -1.103 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' ALA . 97.9 m -116.47 129.99 56.51 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.617 0.722 . . . . 0.0 110.517 -179.298 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.9 131.96 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 22.3 p90 -147.03 170.65 16.68 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.916 -1.115 . . . . 0.0 111.172 -178.068 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 4.9 tpp -139.61 122.63 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.709 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OG ' ' A' ' 90' ' ' SER . 94.1 mt-30 -88.94 114.98 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 0.0 108.66 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.4 m -101.43 152.08 37.93 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.411 -0.805 . . . . 0.0 109.103 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.27 140.51 61.11 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 C-N-CA 123.7 -1.375 . . . . 0.0 112.214 -0.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 20.4 m -119.47 154.38 33.85 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.471 -0.768 . . . . 0.0 109.788 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -71.04 152.61 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.323 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.47 -163.53 26.3 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 92.7 m-20 -95.82 110.41 22.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.276 -1.132 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -59.89 -32.53 70.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.565 -0.709 . . . . 0.0 110.228 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.75 -40.08 76.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.961 -1.087 . . . . 0.0 109.875 -178.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -72.06 -40.26 68.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.636 -1.29 . . . . 0.0 108.627 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 35.7 m120 -60.49 -40.07 90.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.3 t80 -58.18 -43.12 87.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.83 -41.23 95.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.98 -40.18 94.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 108.872 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.92 -49.06 79.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.008 179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.6 mt -66.27 -41.47 89.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.96 . . . . 0.0 110.046 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -59.95 -41.83 92.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.966 -1.084 . . . . 0.0 108.873 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -71.13 -40.28 71.5 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.433 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.28 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.069 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.71 -42.21 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -60.1 -46.73 88.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.894 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.04 -50.0 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.353 -0.842 . . . . 0.0 109.076 179.242 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.73 -49.57 62.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.77 -40.22 91.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 110.578 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.41 -39.87 77.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.931 -1.105 . . . . 0.0 110.568 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 m -98.78 -0.0 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.95 -1.094 . . . . 0.0 109.741 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.17 22.88 77.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.03 -170.17 46.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.29 137.12 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.578 -0.954 . . . . 0.0 108.93 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -72.01 133.19 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 0.0 108.953 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.01 159.32 39.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 36.7 p-10 -87.47 -172.0 3.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.078 179.315 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 121' ' ' ARG . 73.6 m-20 -60.02 -39.84 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.809 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.465 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 79.0 mt-30 -76.38 17.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.34 -0.85 . . . . 0.0 109.388 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 121' ' ' ARG . 22.3 mtt-85 58.24 25.49 12.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.688 -0.633 . . . . 0.0 110.185 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 85.7 mtm180 -105.12 151.87 23.48 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.325 -0.86 . . . . 0.0 109.267 179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 98.2 mtp -51.93 136.55 28.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.2 mmm -58.81 139.95 55.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.588 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.1 p -132.2 150.65 76.62 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -41.45 -49.92 4.85 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.804 1.003 . . . . 0.0 112.878 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 110.039 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -66.56 -39.94 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.928 -1.108 . . . . 0.0 110.329 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.82 -40.15 87.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 0.0 108.044 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.22 -38.79 85.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.16 -48.94 79.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.876 -1.14 . . . . 0.0 109.721 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -59.94 -46.32 89.79 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.4 ' NE2' ' CE2' ' A' ' 98' ' ' PHE . 98.1 mt-30 -61.89 -39.48 92.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.607 -0.683 . . . . 0.0 109.187 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.24 -40.97 96.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.47 -41.78 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.875 -1.141 . . . . 0.0 109.133 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.21 -46.25 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 59.6 mtp180 -60.21 -40.16 89.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.703 . . . . 0.0 109.83 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.85 -40.45 88.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.04 -1.038 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.67 -38.05 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' ALA . 24.6 mtpp -59.83 -42.87 94.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.718 -1.239 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.08 -34.07 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.432 -1.417 . . . . 0.0 109.072 179.685 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.68 92.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.159 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.14 0.44 45.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.48 -0.763 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.153 -0.967 . . . . 0.0 109.313 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mtp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.202 0.525 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.0 1.65 55.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -75.3 125.17 89.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.041 -1.037 . . . . 0.0 108.649 179.858 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.49 25.2 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 CA-C-N 120.111 1.075 . . . . 0.0 112.486 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 -11.06 55.21 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.69 124.4 32.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.922 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -87.22 -10.06 53.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -149.65 145.2 26.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.79 -172.66 3.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.886 -1.134 . . . . 0.0 110.394 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.08 133.47 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mm -88.46 132.71 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.458 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 91.0 mt -131.42 140.63 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 122.346 1.07 . . . . 0.0 111.514 -177.398 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.9 mtm -147.21 138.39 23.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.23 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -118.82 132.56 56.13 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.196 -0.94 . . . . 0.0 111.908 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.56 118.94 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.23 38.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.62 -173.24 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 108.672 178.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -68.76 160.06 31.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.989 -1.07 . . . . 0.0 109.255 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -59.46 142.5 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.95 -6.22 79.16 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -121.9 148.9 44.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.2 mp0 -130.71 149.36 52.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 109.091 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.3 mt -84.91 136.23 33.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.25 146.32 53.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.156 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.87 98.56 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.79 -47.14 87.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.248 . . . . 0.0 109.581 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.07 -32.68 73.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -73.99 -56.93 4.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.638 -0.664 . . . . 0.0 109.842 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.97 -46.91 87.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -61.8 -40.78 96.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.23 -0.919 . . . . 0.0 110.586 -179.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 t -63.89 -40.04 95.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 110.139 -179.164 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -40.96 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 108.993 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.53 -40.27 95.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.352 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -68.81 -18.09 64.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.459 -0.776 . . . . 0.0 109.804 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -80.76 5.41 15.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.09 11.94 83.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -80.17 156.7 26.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.245 . . . . 0.0 110.031 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.84 137.19 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -62.13 105.89 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.955 -1.091 . . . . 0.0 109.77 -179.134 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' HA3' ' HD2' ' A' ' 46' ' ' HIS . . . -94.69 172.6 31.46 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.31 -164.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -1.03 . . . . 0.0 109.85 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 68.2 mtt 58.84 20.06 7.62 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.828 0.823 . . . . 0.0 109.092 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 53.14 40.06 30.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.727 -0.608 . . . . 0.0 111.691 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.13 169.7 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.8 -1.188 . . . . 0.0 109.052 178.254 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -94.53 115.51 27.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.0 110.629 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.457 ' CG ' ' HG ' ' A' ' 60' ' ' SER . 53.1 m-70 -101.06 127.93 47.36 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.356 -0.84 . . . . 0.0 109.437 178.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 61.9 ttt180 -106.05 127.55 53.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.099 -1.001 . . . . 0.0 108.514 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 48' ' ' HIS . 15.2 m-70 -97.44 177.1 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 109.648 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -56.51 -49.66 74.06 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 108.833 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -90.28 149.16 40.71 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.362 -0.836 . . . . 0.0 109.224 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.96 -12.22 33.83 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 120.967 1.112 . . . . 0.0 112.95 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -93.03 0.01 57.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.894 -1.129 . . . . 0.0 110.34 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 13.41 82.23 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.705 179.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -69.86 -39.99 76.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.835 -1.391 . . . . 0.0 109.523 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.64 170.57 54.23 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -68.76 169.22 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.355 1.37 . . . . 0.0 111.891 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.94 121.71 26.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.918 . . . . 0.0 109.089 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.7 mp -101.34 -37.36 8.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.273 -0.892 . . . . 0.0 109.533 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -151.38 159.86 44.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.418 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.457 ' HG ' ' CG ' ' A' ' 46' ' ' HIS . 2.0 m -133.69 -179.56 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.841 0.829 . . . . 0.0 110.723 -177.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.695 HD23 ' C ' ' A' ' 61' ' ' LEU . 5.9 tt -134.02 134.08 42.02 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.77 160.0 36.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.733 -0.605 . . . . 0.0 109.74 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.576 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 77.2 m-20 -73.36 160.74 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.99 -1.069 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mmm -68.88 -29.84 68.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 110.673 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.0 m -86.79 121.78 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.398 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -59.59 152.58 55.7 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -79.14 3.94 31.36 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.799 -1.334 . . . . 0.0 112.86 0.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.41 21.61 61.98 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.9 p -85.3 160.45 19.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.112 -1.228 . . . . 0.0 109.883 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 28.3 m-85 -125.13 139.95 53.31 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.624 -0.672 . . . . 0.0 109.426 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.429 ' N ' ' SD ' ' A' ' 74' ' ' MET . 41.9 m-20 -120.25 149.51 49.63 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.04 -14.49 41.87 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 119.345 0.802 . . . . 0.0 111.936 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.71 -0.0 57.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.279 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 71' ' ' ASP . 10.9 ptm -84.59 25.75 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.336 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 56.5 mtpt -79.08 2.44 20.66 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.546 -1.346 . . . . 0.0 109.282 -179.07 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 90.8 m-20 -142.76 84.25 1.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -161.29 174.13 14.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.977 -1.077 . . . . 0.0 109.977 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -130.09 152.54 49.43 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.72 149.03 18.51 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.14 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -49.33 -49.51 15.33 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-N 119.058 0.699 . . . . 0.0 111.732 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.93 18.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG11 HD21 ' A' ' 28' ' ' LEU . 33.4 m -129.99 159.91 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.492 -1.005 . . . . 0.0 110.132 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.6 m -108.82 122.43 47.17 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.356 0.598 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.2 mt -104.07 129.72 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -148.73 157.28 43.34 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.803 -1.186 . . . . 0.0 111.655 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.4 ttm -121.62 134.58 55.0 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' OG ' ' A' ' 90' ' ' SER . 98.4 mm-40 -90.64 104.01 16.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 88' ' ' VAL . 10.6 m -97.75 149.18 35.45 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.192 -0.943 . . . . 0.0 109.471 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.65 131.81 25.46 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.636 -1.402 . . . . 0.0 112.205 -0.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 60.8 m -103.82 166.68 10.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.75 148.54 47.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.641 -0.662 . . . . 0.0 109.398 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.75 -160.02 33.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.45 113.27 24.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.105 . . . . 0.0 109.443 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.99 -33.01 71.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.619 -0.675 . . . . 0.0 109.916 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.01 -41.49 74.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 110.597 -178.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.32 -42.1 62.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.834 -1.167 . . . . 0.0 108.681 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -62.6 -33.84 75.8 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.07 -48.69 80.67 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -59.96 -39.97 87.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.77 -40.16 91.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.7 mtp -59.89 -42.81 94.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 108.763 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.39 -40.04 96.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.28 -0.887 . . . . 0.0 109.211 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -60.15 -40.04 88.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 109.486 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 p -71.62 -40.06 70.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.92 71.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -62.98 -40.06 96.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.246 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.997 . . . . 0.0 108.961 179.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.91 -49.22 84.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.4 -49.61 66.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.831 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.88 -39.97 75.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.256 -0.903 . . . . 0.0 111.046 -178.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 114' ' ' GLY . 4.4 m -102.0 -1.02 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.04 -1.037 . . . . 0.0 110.388 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.09 20.76 73.21 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -82.93 -172.58 48.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.36 139.23 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.588 -0.948 . . . . 0.0 109.077 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 t -77.18 133.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.155 -0.966 . . . . 0.0 108.894 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.0 mt -130.08 156.87 43.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.359 -0.838 . . . . 0.0 109.213 -179.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -86.29 -173.36 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 0.0 109.358 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 87.5 m-20 -60.08 -38.26 82.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.92 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -77.59 15.29 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 56.37 39.58 30.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.702 . . . . 0.0 109.776 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 122' ' ' ARG . 43.4 mtt-85 -116.23 151.16 36.32 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.682 . . . . 0.0 109.292 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.3 mtt -50.56 134.79 23.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.8 mmm -58.39 138.63 56.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.396 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -140.0 152.85 68.67 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -48.0 -43.56 29.95 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 CA-C-N 119.018 0.685 . . . . 0.0 111.391 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.18 -40.81 91.27 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -69.92 -41.04 75.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.052 . . . . 0.0 108.974 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.166 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -62.53 -40.03 95.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.95 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.77 . . . . 0.0 110.277 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' O ' ' A' ' 12' ' ' ILE . 65.0 m-85 -60.04 -42.56 94.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.065 . . . . 0.0 108.692 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -62.56 -39.96 95.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 92.8 m-20 -62.01 -43.07 99.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 0.0 110.236 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.37 -40.64 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.828 -1.17 . . . . 0.0 109.673 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.21 -43.45 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 85.5 mtm180 -60.04 -40.18 88.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.043 . . . . 0.0 110.385 -179.149 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -61.51 -39.9 92.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.005 -1.059 . . . . 0.0 110.172 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.09 -26.19 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 111.987 -178.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -59.86 -39.65 85.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.581 -1.324 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 57.0 p-10 -59.99 -30.03 68.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.697 -1.252 . . . . 0.0 109.54 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.595 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -63.54 -37.43 87.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -96.99 -13.27 22.43 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.237 -0.915 . . . . 0.0 109.481 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.707 179.869 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.26 15.11 11.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.451 -0.781 . . . . 0.0 109.857 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -129.99 77.77 76.03 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.422 -0.799 . . . . 0.0 109.6 -179.079 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 3.8 Cg_exo -64.76 138.5 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.796 0.997 . . . . 0.0 111.878 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -79.79 33.32 0.26 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 110.288 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -69.7 148.81 48.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 109.949 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -80.51 -7.36 59.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.79 104.37 3.32 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' H ' ' CG2' ' A' ' 139' ' ' VAL . . . -99.34 175.23 5.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 110.443 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.42 130.16 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mm -95.8 123.83 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.17 144.21 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 121.777 0.799 . . . . 0.0 109.979 -178.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.6 mtt -143.81 151.32 39.78 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -133.52 125.06 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 110.59 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.87 117.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 159.43 44.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.117 -0.989 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.64 174.05 8.12 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -59.34 151.96 22.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 108.567 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -53.21 148.51 8.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.178 -0.951 . . . . 0.0 108.936 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.13 -1.3 79.92 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -130.04 148.47 51.9 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.426 -1.044 . . . . 0.0 109.026 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 55.8 mm-40 -127.53 148.7 50.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.426 -0.796 . . . . 0.0 108.942 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 17' ' ' ALA . 51.5 mt -87.92 139.02 30.94 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.117 -0.989 . . . . 0.0 110.007 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -70.85 145.57 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.78 -40.85 98.73 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.44 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -48.49 81.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.94 -1.33 . . . . 0.0 109.715 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.45 -27.43 65.24 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -75.0 -59.31 2.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.589 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 74' ' ' MET . 92.5 mt -59.71 -45.44 92.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.29 -40.4 93.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.0 t -64.45 -39.74 94.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -49.16 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.973 -1.079 . . . . 0.0 110.051 -178.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.13 -40.26 97.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.995 -1.066 . . . . 0.0 109.296 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -68.1 -16.5 64.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 110.117 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -84.79 -0.63 54.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.994 -1.066 . . . . 0.0 109.96 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.33 13.2 57.63 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.907 -1.12 . . . . 0.0 110.49 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -82.94 149.92 26.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -1.226 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.9 mt -120.4 133.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.04 104.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 -178.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.86 171.34 32.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.72 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -1.169 . . . . 0.0 109.27 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.0 mmm 57.9 20.28 6.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.461 -0.775 . . . . 0.0 109.851 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 50.61 39.45 21.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 111.59 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.2 pt -140.04 160.69 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -91.03 118.57 30.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.005 -1.059 . . . . 0.0 110.409 -179.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 29.4 m-70 -103.49 127.08 50.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 58.5 ttt180 -102.22 124.27 47.52 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.56 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 57.9 m-70 -94.06 171.14 9.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.64 -47.94 78.62 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -91.45 147.1 34.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.758 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.85 -8.85 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.622 0.881 . . . . 0.0 111.941 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -94.67 -0.33 54.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.08 -1.013 . . . . 0.0 110.742 -179.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.76 86.43 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.9 p -70.22 -40.13 74.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.048 -1.266 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.35 162.8 51.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.56 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.3 Cg_endo -66.53 176.25 4.35 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.067 1.178 . . . . 0.0 112.103 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.57 118.95 23.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 108.771 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.5 mp -97.6 -42.08 7.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.79 159.54 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.988 -1.07 . . . . 0.0 108.549 178.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.4 m -132.32 175.21 9.47 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.326 -0.858 . . . . 0.0 111.078 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.665 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -128.37 131.78 48.55 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.597 0.713 . . . . 0.0 109.138 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.542 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.31 160.21 33.73 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.611 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 84.2 m-20 -74.6 158.24 34.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.92 -1.112 . . . . 0.0 110.334 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -70.11 -27.57 64.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.633 -0.667 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.69 135.51 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.951 -1.093 . . . . 0.0 109.592 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -62.88 149.81 89.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.525 -0.734 . . . . 0.0 110.114 -179.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.13 5.35 24.78 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.962 -0.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.16 4.97 80.83 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -88.81 170.48 10.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.611 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.6 m-85 -118.61 140.09 50.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.574 -0.703 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 74' ' ' MET . 58.2 m-20 -124.33 150.02 62.83 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.79 -10.99 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.441 0.836 . . . . 0.0 112.551 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' ASP . 31.0 mp0 -88.9 2.37 53.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.001 . . . . 0.0 109.344 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.523 ' O ' HD11 ' A' ' 29' ' ' LEU . 63.5 mmm -86.51 18.42 3.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.605 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.7 mttm -85.92 -4.66 59.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.082 -1.011 . . . . 0.0 108.941 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.9 m-20 -149.92 80.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 108.914 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.66 173.11 17.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 109.898 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.4 p -130.24 149.85 51.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.57 149.41 20.11 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.016 -1.053 . . . . 0.0 109.286 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.533 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 18.1 Cg_exo -44.71 -53.59 4.93 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.312 0.675 . . . . 0.0 111.39 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.09 -147.34 5.48 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.97 160.0 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.84 -0.8 . . . . 0.0 109.51 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 88.2 m -113.42 118.59 34.96 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.988 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.9 mt -105.04 129.1 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.77 165.53 27.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.256 -179.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.0 ttp -140.08 127.78 21.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -90.33 117.58 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.998 . . . . 0.0 108.573 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 88' ' ' VAL . 5.5 m -98.7 150.72 36.98 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 108.704 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -74.87 139.08 59.7 Favored 'Cis proline' 0 N--CA 1.496 1.645 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.639 -0.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.6 m -104.86 167.12 9.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -70.24 141.93 52.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.02 -155.74 27.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -95.34 119.39 33.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 108.724 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.7 mp0 -57.54 -31.55 66.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.534 -0.729 . . . . 0.0 110.442 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.51 -40.4 77.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.394 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.48 -40.18 70.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.24 -40.02 94.77 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -59.89 -50.11 75.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 108.699 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -60.01 -40.11 88.14 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 tp -60.52 -41.49 94.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -59.61 -45.4 92.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.116 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.12 -42.9 95.77 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.045 -1.034 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.03 -40.84 90.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.265 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -70.33 -40.12 74.35 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.339 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.96 -55.54 32.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.537 -0.727 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.37 -37.25 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.008 -179.444 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -60.07 -44.6 94.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.042 -1.036 . . . . 0.0 108.963 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.39 -49.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.005 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.27 -47.69 65.7 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.33 -40.02 89.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.149 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.8 -40.38 79.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.1 -1.0 . . . . 0.0 110.938 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.7 1.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.083 -1.011 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.44 25.58 72.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.68 -167.84 43.92 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.2 t -137.43 140.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.412 -1.052 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG12 ' SD ' ' A' ' 124' ' ' MET . 10.7 t -71.66 130.65 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.163 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -127.01 157.51 39.37 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.0 109.297 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -84.62 -173.41 4.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.312 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.9 m-20 -60.65 -38.65 85.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.268 -0.895 . . . . 0.0 108.69 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.63 17.74 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.49 -0.756 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.15 32.44 20.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.606 -0.684 . . . . 0.0 110.709 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -111.7 147.65 35.12 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.4 mtt -52.14 125.55 16.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.609 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.437 ' SD ' HG12 ' A' ' 116' ' ' VAL . 58.2 mtp -60.88 136.24 58.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.904 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 30.7 p -122.93 149.99 57.94 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -41.19 -44.07 5.35 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 120.662 0.908 . . . . 0.0 112.185 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.67 -39.89 90.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.291 -0.881 . . . . 0.0 109.056 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 125' ' ' THR . 68.6 mttm -67.89 -39.61 83.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.42 -40.18 74.3 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 130' ' ' ARG . 48.6 mtt-85 -63.37 -39.48 94.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -59.96 -44.19 94.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.121 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -62.58 -40.11 95.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 108.676 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -60.91 -39.03 87.78 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.297 -0.877 . . . . 0.0 108.841 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.58 -39.99 93.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.33 -40.89 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.007 -1.058 . . . . 0.0 108.852 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.29 -41.97 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.1 mtt180 -61.82 -28.87 69.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.916 -0.49 . . . . 0.0 110.725 -179.415 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 97.3 mt-10 -60.12 -40.1 88.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.831 -1.168 . . . . 0.0 109.645 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.462 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 64.1 t -71.97 -34.03 49.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.466 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 144' ' ' ALA . 62.9 mttm -59.88 -43.15 94.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.929 -1.107 . . . . 0.0 110.902 -179.025 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.89 -26.62 68.27 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.172 179.736 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.51 -59.7 3.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.451 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -112.21 -28.01 8.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.488 -0.757 . . . . 0.0 110.133 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.329 -0.857 . . . . 0.0 109.809 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -86.96 -7.57 58.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 69.99 79.2 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.333 -0.855 . . . . 0.0 109.763 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 6' ' ' ARG . 9.6 Cg_endo -71.05 99.4 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.943 1.096 . . . . 0.0 111.834 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.28 31.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 108.581 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 4' ' ' PRO . 92.0 mtt180 -73.54 158.55 34.64 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.478 0.656 . . . . 0.0 110.415 -179.064 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -83.32 -7.64 59.55 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.83 142.71 30.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.7 -174.27 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.566 -1.334 . . . . 0.0 110.5 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.8 t -131.46 136.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.2 mm -91.27 129.43 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.486 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 81.4 mt -131.64 142.72 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.056 0.931 . . . . 0.0 110.912 -177.859 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.8 mtm -147.85 152.17 37.18 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.112 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -129.92 129.3 43.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.921 -1.112 . . . . 0.0 111.434 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.03 112.19 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.11 154.85 39.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.119 -0.988 . . . . 0.0 110.848 -178.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.77 168.45 17.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -56.08 160.18 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.073 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.71 150.14 33.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.77 -4.41 78.9 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 m -130.14 147.48 51.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.523 -0.986 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.53 150.2 50.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.502 -0.749 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.95 145.04 27.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.109 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -70.77 141.13 51.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 108.841 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.23 97.98 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.379 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.06 -45.03 96.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.294 . . . . 0.0 109.425 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mt -69.95 -24.1 63.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.102 179.261 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.5 tt -77.1 -55.43 5.45 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.956 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.97 -48.7 80.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.127 -0.983 . . . . 0.0 111.104 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 31' ' ' SER . 43.2 p-10 -64.19 -40.02 95.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.858 -1.151 . . . . 0.0 110.66 -178.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 75.5 m -60.9 -40.55 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.888 -1.133 . . . . 0.0 109.797 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 28' ' ' LEU . 96.8 mt -60.05 -48.27 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -61.63 -40.06 93.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.26 -20.03 65.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 0.0 110.245 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.552 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.74 1.05 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.663 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.5 61.66 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -80.0 154.68 28.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.264 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.12 136.94 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.12 106.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.051 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.497 ' HA3' ' CD2' ' A' ' 46' ' ' HIS . . . -94.66 172.83 31.71 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.661 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.54 -168.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 110.061 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 77.1 mtm 59.24 25.4 13.99 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.613 0.721 . . . . 0.0 109.844 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 50.64 36.35 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.641 -0.662 . . . . 0.0 111.823 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -140.09 167.52 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.004 -1.06 . . . . 0.0 108.594 177.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 111.083 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.497 ' CD2' ' HA3' ' A' ' 40' ' ' GLY . 37.7 m-70 -103.85 131.05 51.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.425 -0.797 . . . . 0.0 109.392 178.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.0 ttt180 -105.96 127.29 53.05 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.223 -0.923 . . . . 0.0 108.702 178.085 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 60.7 m-70 -97.37 171.71 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.0 110.173 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.28 -49.95 68.41 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -90.36 148.15 38.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.828 . . . . 0.0 109.014 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -70.27 -7.39 21.09 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.844 1.029 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.86 -0.27 55.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.116 -0.99 . . . . 0.0 110.283 -179.16 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.07 86.1 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -69.99 -41.26 74.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -1.145 . . . . 0.0 110.243 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.83 166.98 52.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.62 168.54 14.65 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.068 1.179 . . . . 0.0 111.393 179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.996 -1.065 . . . . 0.0 109.231 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.4 mp -101.66 -40.12 7.14 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.891 . . . . 0.0 109.563 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -150.12 163.14 38.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 109.316 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -134.1 178.71 6.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.881 0.848 . . . . 0.0 111.137 -177.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.0 tt -132.5 131.43 41.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.44 162.57 31.86 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.704 -0.623 . . . . 0.0 109.48 -179.352 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.633 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 84.1 m-20 -74.93 159.68 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 110.53 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.0 -23.52 63.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.593 -0.692 . . . . 0.0 110.119 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 65' ' ' VAL . 17.4 m -85.36 121.73 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.922 -1.111 . . . . 0.0 109.55 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -59.59 149.92 68.6 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.314 -0.866 . . . . 0.0 108.929 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -77.28 12.12 13.02 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.16 -0.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.19 85.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -87.14 170.58 11.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -1.088 . . . . 0.0 110.062 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.633 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -116.89 144.8 44.1 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' GLU . 78.1 m-20 -129.21 150.6 75.9 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -44.81 -12.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.697 0.931 . . . . 0.0 112.16 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -85.13 15.23 4.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 71' ' ' ASP . 7.8 ptp -81.79 -5.12 57.9 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.376 -179.14 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.9 mttm -88.11 -4.63 58.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.88 -1.137 . . . . 0.0 110.468 -179.073 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.0 m-20 -150.96 69.7 0.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.885 -1.134 . . . . 0.0 109.822 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -154.44 170.0 22.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.6 p -129.68 154.03 47.55 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.6 148.87 17.67 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.95 -1.094 . . . . 0.0 109.329 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.69 -51.17 9.45 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 120.416 0.744 . . . . 0.0 111.62 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.98 -149.52 7.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.03 163.07 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.608 -0.936 . . . . 0.0 110.068 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.6 m -115.04 126.54 54.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -109.88 130.02 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.98 155.15 40.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.785 -1.197 . . . . 0.0 111.556 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.6 ttm -119.51 131.18 55.52 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.5 mm-40 -90.38 112.33 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 88' ' ' VAL . 7.8 m -97.93 150.36 36.68 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.73 132.3 26.48 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.47 0.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 49.6 m -106.4 158.37 16.94 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.595 -0.691 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -73.01 153.07 41.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.61 -164.47 33.02 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -95.29 107.92 20.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -1.067 . . . . 0.0 108.918 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 136' ' ' ILE . 90.8 mt-10 -59.88 -30.26 68.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.667 -0.646 . . . . 0.0 110.529 -179.292 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.71 -39.99 76.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.274 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.88 -40.6 60.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.042 -1.036 . . . . 0.0 108.815 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -62.47 -35.83 80.56 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -59.6 -49.98 75.66 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -60.79 -40.08 91.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.96 -43.22 95.2 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.0 mtp -58.5 -41.17 84.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 0.0 109.1 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.15 -40.76 86.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.601 179.513 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.04 -40.13 88.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 0.0 109.526 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.6 p -72.53 -40.01 67.11 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 109.458 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.54 -53.51 57.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 110.102 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.62 -37.74 82.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.975 -1.078 . . . . 0.0 109.314 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -59.98 -47.48 85.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.048 179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.03 -49.95 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.401 -0.812 . . . . 0.0 109.208 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.16 -50.39 49.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.571 -0.705 . . . . 0.0 109.513 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.07 -39.99 87.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.327 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.64 -39.95 80.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 110.591 -178.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -100.2 -0.16 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.58 24.33 76.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.29 -173.53 49.21 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.76 134.38 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.631 -0.923 . . . . 0.0 108.956 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.601 HG12 ' SD ' ' A' ' 124' ' ' MET . 2.5 t -71.71 128.25 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 108.94 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.06 159.99 35.96 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.395 -0.816 . . . . 0.0 109.824 -179.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -85.95 -170.07 2.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.757 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.2 m-20 -60.12 -39.85 87.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.295 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.88 14.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 108.962 -179.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.4 mtt180 56.23 35.13 25.24 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.382 0.61 . . . . 0.0 109.371 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 122' ' ' ARG . 13.0 mtt-85 -109.7 153.33 24.42 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.619 -0.676 . . . . 0.0 109.315 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.2 mtm -50.27 124.37 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.601 ' SD ' HG12 ' A' ' 116' ' ' VAL . 52.3 mtp -60.03 140.0 57.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.866 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 p -131.65 150.83 77.39 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.34 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -43.64 -42.75 11.47 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.706 0.937 . . . . 0.0 112.411 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.01 -39.92 87.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.59 -39.61 88.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 109.528 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.9 -39.96 83.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 108.071 179.36 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.73 -40.06 96.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.01 -47.87 84.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 109.688 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -60.08 -42.58 94.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.862 -1.149 . . . . 0.0 108.585 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -60.79 -40.01 91.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.69 -38.93 86.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.631 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.0 -43.34 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.031 . . . . 0.0 108.608 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 94' ' ' GLU . 81.7 mt -59.94 -41.35 85.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 108.684 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 57.0 mtp180 -59.89 -39.97 87.16 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.443 -0.786 . . . . 0.0 109.431 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 80.8 mm-40 -60.01 -41.36 91.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 109.805 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.92 -32.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.845 -179.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -60.04 -40.28 88.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.953 -1.092 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -59.98 -30.96 69.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.266 179.878 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.57 94.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 109.953 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -96.84 -2.67 43.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.0 109.433 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -142.89 149.9 39.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.66 170.98 16.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.601 -1.312 . . . . 0.0 110.605 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.04 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.95 128.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.65 140.84 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.844 0.83 . . . . 0.0 110.63 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.411 ' ND2' HG23 ' A' ' 83' ' ' THR . 30.5 m120 -136.88 127.32 26.68 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.848 -1.158 . . . . 0.0 111.335 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.7 114.45 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.06 153.03 41.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.91 -165.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -69.89 155.71 40.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.065 -1.022 . . . . 0.0 109.178 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.89 140.51 55.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 109.64 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.76 6.12 73.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -129.76 143.1 50.65 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.607 -0.937 . . . . 0.0 108.856 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.2 mt-10 -123.07 150.94 42.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.409 -0.807 . . . . 0.0 109.324 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -87.5 142.44 27.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.222 -0.924 . . . . 0.0 109.864 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -67.9 140.32 56.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -0.923 . . . . 0.0 108.736 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.14 97.68 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.768 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.68 -46.58 87.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.961 -1.317 . . . . 0.0 109.783 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.02 -30.64 67.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.314 -0.866 . . . . 0.0 108.919 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.19 -56.8 4.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.627 -0.671 . . . . 0.0 109.352 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.04 -42.86 95.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.35 -40.98 92.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.503 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -64.82 -41.98 95.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.929 -1.107 . . . . 0.0 110.033 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.53 -46.67 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.328 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.56 -40.13 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 0.0 110.022 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.99 -17.77 64.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.56 5.43 24.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.911 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.33 72.14 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 121.05 -1.031 . . . . 0.0 110.697 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.68 150.36 30.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.355 . . . . 0.0 109.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.05 133.05 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 109.67 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.773 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.92 171.29 23.54 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.79 -163.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -1.116 . . . . 0.0 109.725 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 92.4 mmm 58.2 20.35 7.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.71 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m120 50.08 39.11 18.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.559 -0.713 . . . . 0.0 111.396 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.94 161.56 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.098 -1.001 . . . . 0.0 108.558 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 120.62 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.05 -1.031 . . . . 0.0 110.352 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 38.6 m80 -105.12 127.9 53.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.5 ttt180 -102.67 129.23 49.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.052 -1.03 . . . . 0.0 108.893 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 13.4 m-70 -93.27 168.77 10.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.422 -0.799 . . . . 0.0 109.052 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.3 tp -52.71 -52.59 55.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.6 m -93.58 149.99 38.09 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.22 -2.14 10.01 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.57 0.846 . . . . 0.0 111.713 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -95.94 0.03 51.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.02 14.07 82.12 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.8 p -68.41 -38.59 81.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.155 -1.203 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -90.44 171.43 36.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 27.6 Cg_endo -74.55 178.67 6.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 120.944 1.096 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.57 118.83 22.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.129 -0.982 . . . . 0.0 108.847 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.81 -26.55 14.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -159.25 160.61 35.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.067 -1.02 . . . . 0.0 108.927 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.1 m -134.32 -178.56 5.1 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.915 -1.115 . . . . 0.0 112.094 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -137.9 134.06 34.57 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.322 0.582 . . . . 0.0 109.476 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.636 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.15 162.22 32.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -75.32 160.81 29.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 109.849 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -69.93 -22.98 63.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 110.92 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 71.8 t -86.76 121.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.822 -1.174 . . . . 0.0 109.719 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -58.57 147.31 70.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.054 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -76.33 15.98 6.95 Favored 'Cis proline' 0 N--CA 1.492 1.435 0 C-N-CA 123.402 -1.499 . . . . 0.0 111.76 -0.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 70.05 18.66 74.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.2 p -90.76 171.47 9.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -114.6 151.94 32.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 77.8 m-20 -131.2 148.42 70.12 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -46.08 -13.96 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.562 0.842 . . . . 0.0 111.668 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.4 mt-10 -85.46 16.12 4.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 21.8 ptt? -81.94 -2.82 52.7 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 58.9 mttm -86.24 -0.76 56.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.029 -1.044 . . . . 0.0 108.773 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.5 m-20 -152.15 69.34 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.559 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -155.32 169.94 23.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.909 -1.119 . . . . 0.0 109.53 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.411 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 80.4 p -130.41 154.49 47.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.69 149.88 20.75 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.872 -1.142 . . . . 0.0 109.57 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.24 -36.43 99.02 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.508 0.805 . . . . 0.0 112.185 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.68 -157.78 19.94 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.159 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.0 160.3 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.594 -0.945 . . . . 0.0 109.116 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.411 HG23 ' ND2' ' A' ' 14' ' ' ASN . 54.5 m -116.62 124.36 49.6 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.549 0.69 . . . . 0.0 109.867 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.05 129.48 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.24 163.61 34.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 110.282 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -140.02 128.56 22.89 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -88.97 118.67 28.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 108.735 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.14 152.52 39.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.45 138.13 53.87 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.275 -1.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.7 m -105.46 160.94 14.76 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.799 0.809 . . . . 0.0 110.736 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.17 143.73 52.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.709 -0.62 . . . . 0.0 109.953 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.74 -152.96 24.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -93.72 110.15 21.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -1.115 . . . . 0.0 109.068 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -56.21 -31.05 63.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.678 -0.639 . . . . 0.0 109.713 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 -37.02 75.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.99 -38.98 76.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 108.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 58' ' ' LEU . 91.8 m-20 -60.16 -41.16 92.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CG ' ' NE2' ' A' ' 133' ' ' GLN . 70.7 t80 -59.79 -46.09 90.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -61.24 -46.59 89.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.11 -40.05 88.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.099 -1.001 . . . . 0.0 110.248 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.3 mtp -59.02 -49.14 79.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.0 110.124 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.478 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 96.8 mt -66.09 -40.04 90.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 109.782 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.4 mt-30 -60.02 -42.59 94.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 108.92 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 p -70.11 -39.9 75.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.454 -0.779 . . . . 0.0 109.19 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.41 -57.8 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 110.275 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 103' ' ' GLN . 18.5 pt20 -60.12 -39.69 87.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.999 -1.063 . . . . 0.0 109.764 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 13.6 m-70 -59.99 -48.3 82.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.913 -1.117 . . . . 0.0 108.636 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.14 -49.9 82.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.63 -50.13 66.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.504 -0.747 . . . . 0.0 109.327 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.81 -40.0 91.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 110.275 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.94 -40.18 75.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.1 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.12 1.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.163 -0.961 . . . . 0.0 109.609 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.45 23.07 77.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.87 -176.58 49.6 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.146 -1.208 . . . . 0.0 110.349 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.06 130.37 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.696 -0.884 . . . . 0.0 108.791 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 116' ' ' VAL . 2.6 t -71.54 130.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 108.953 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -130.34 159.61 36.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.369 -0.832 . . . . 0.0 109.411 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -88.34 -173.31 4.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.74 -38.51 85.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -76.4 14.6 0.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 121' ' ' ARG . 18.7 mtt-85 57.56 36.8 27.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 122' ' ' ARG . 52.4 mtt-85 -112.0 149.28 32.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.2 mtp -52.27 130.3 30.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.3 mmm -60.52 138.98 57.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 p -134.87 150.94 74.67 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.7 -46.49 10.33 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 120.813 1.008 . . . . 0.0 112.708 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.27 -41.34 93.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.0 -39.88 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.927 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.0 -40.02 79.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.199 -0.938 . . . . 0.0 108.476 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.12 -36.68 82.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.621 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.58 -46.57 86.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.005 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -60.01 -40.15 88.29 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 108.741 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.576 ' NE2' ' CG ' ' A' ' 98' ' ' PHE . 85.6 mm-40 -60.94 -40.05 91.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 0.0 109.009 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.31 -40.05 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.953 . . . . 0.0 108.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.86 -42.8 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.343 -0.848 . . . . 0.0 108.754 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.07 -40.49 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 32.2 mmt180 -61.33 -37.31 82.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.38 -0.825 . . . . 0.0 109.706 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.0 mt-10 -59.88 -40.2 87.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.18 -32.97 27.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 111.008 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.9 mttt -59.79 -41.85 92.08 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.877 -1.139 . . . . 0.0 110.903 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.2 -29.48 68.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.83 -1.169 . . . . 0.0 109.811 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.43 91.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -104.62 -1.07 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.814 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -154.76 131.37 10.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.06 -170.2 1.87 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.576 -1.327 . . . . 0.0 110.88 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.06 132.3 65.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -86.87 130.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -126.94 144.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.091 0.948 . . . . 0.0 110.964 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.2 mtt -145.12 151.28 38.23 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -131.24 130.13 42.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.142 . . . . 0.0 111.153 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.0 t -109.31 118.43 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 154.75 39.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.978 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.02 -165.8 0.13 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.67 155.49 35.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.934 -1.104 . . . . 0.0 108.826 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -58.73 139.45 56.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.102 -0.999 . . . . 0.0 109.589 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.22 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -128.49 143.3 50.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.575 -0.956 . . . . 0.0 108.936 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -120.39 140.46 51.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.437 -0.789 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.64 142.12 28.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 109.944 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.99 137.78 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.44 -0.787 . . . . 0.0 109.347 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.26 96.82 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.581 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.05 -46.32 89.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.772 -1.428 . . . . 0.0 109.512 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.41 -24.69 63.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -72.6 -56.54 5.18 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' MET . 36.0 mt -60.11 -45.06 94.23 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.955 -1.09 . . . . 0.0 110.301 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.03 -45.99 90.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 111.518 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.4 p -63.47 -43.17 98.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.88 -1.138 . . . . 0.0 110.192 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.15 -47.14 93.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 110.202 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.0 -40.07 94.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -68.13 -19.56 64.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.536 -0.728 . . . . 0.0 109.833 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.54 7.85 11.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 109.693 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.85 9.39 84.54 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -79.76 147.6 31.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.386 . . . . 0.0 109.266 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 88.9 mt -122.91 134.37 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.98 102.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.253 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.44 168.09 29.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.53 -162.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.195 -1.179 . . . . 0.0 109.186 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.7 mtt 59.92 20.15 9.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.81 -0.557 . . . . 0.0 110.609 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.6 m120 52.35 33.19 12.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.129 -0.982 . . . . 0.0 111.362 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 12.2 pt -139.61 155.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.008 -1.058 . . . . 0.0 108.483 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -88.02 120.19 29.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.883 -1.136 . . . . 0.0 110.019 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 52.7 m-70 -105.41 127.14 52.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.638 -0.664 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 47' ' ' ARG . 15.4 ttt-85 -101.82 128.87 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -93.84 175.74 6.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.44 -49.97 68.75 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.167 -0.958 . . . . 0.0 108.53 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 55.2 m -92.65 149.24 37.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -71.34 -2.19 10.84 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.695 0.93 . . . . 0.0 111.644 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.01 -2.78 52.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.933 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.68 85.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.8 p -69.95 -40.0 75.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -1.184 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.58 171.51 54.05 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.49 177.23 7.0 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.04 1.16 . . . . 0.0 111.306 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.58 122.25 26.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 108.925 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -101.06 -47.58 4.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 163.08 33.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.123 -0.986 . . . . 0.0 108.526 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.489 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.2 m -136.15 -177.01 4.51 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.125 -0.984 . . . . 0.0 111.842 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -136.79 130.37 31.81 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.47 0.652 . . . . 0.0 109.43 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.48 160.54 33.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 93.8 m-20 -75.06 157.89 34.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.317 -0.865 . . . . 0.0 110.674 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.6 mtp -69.94 -22.19 63.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 65' ' ' VAL . 10.3 p -87.04 120.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.88 151.3 64.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 110.07 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.38 15.7 7.25 Favored 'Cis proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.042 -1.232 . . . . 0.0 112.344 -1.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.94 18.61 80.17 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.9 p -87.88 175.61 7.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -1.158 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.563 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 40.4 m-85 -125.31 156.4 38.72 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 73' ' ' GLU . 39.4 m-20 -140.02 147.24 49.96 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 121.175 -0.953 . . . . 0.0 110.676 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -47.56 -11.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.36 0.807 . . . . 0.0 110.806 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 71' ' ' ASP . 44.5 mp0 -85.56 22.37 1.59 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 29' ' ' LEU . 41.1 mtm -73.57 -0.1 14.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.0 mttm -88.13 -1.45 58.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.005 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.2 m-20 -151.23 74.78 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.725 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -160.05 164.61 33.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.01 -1.056 . . . . 0.0 109.544 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.5 p -139.11 155.88 47.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.62 149.02 16.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.826 -1.172 . . . . 0.0 109.353 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.85 -36.42 95.43 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.412 0.741 . . . . 0.0 111.812 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.43 -157.1 15.06 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 61' ' ' LEU . 30.8 m -130.02 158.8 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.697 -0.884 . . . . 0.0 109.114 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.8 m -110.03 118.3 36.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 109.842 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 94.5 mt -100.56 130.04 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.98 168.97 20.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.898 -1.126 . . . . 0.0 111.021 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 ttp -141.28 135.24 30.41 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -88.32 108.62 19.42 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 88' ' ' VAL . 3.8 p -97.41 141.36 22.9 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.53 135.25 34.39 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.498 0.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.594 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.0 m -105.32 168.52 9.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.394 -0.816 . . . . 0.0 109.289 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -69.98 149.96 47.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.97 -157.63 32.37 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.71 117.84 31.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -1.079 . . . . 0.0 109.575 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 90' ' ' SER . 57.8 mm-40 -57.6 -28.38 63.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.3 mt -69.91 -38.14 76.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 109.247 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.86 -40.0 76.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.522 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.6 m-20 -61.39 -40.55 94.77 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.3 t80 -59.21 -48.38 81.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.27 -46.45 89.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 108.94 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.29 -40.1 95.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.98 -46.68 88.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.023 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' A' ' 98' ' ' PHE . 90.4 mt -65.54 -45.04 84.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.519 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 29.3 mm100 -60.03 -40.23 88.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.164 -0.96 . . . . 0.0 108.448 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 p -70.02 -40.52 75.14 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.67 7.62 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.456 -0.777 . . . . 0.0 109.561 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -61.02 -40.89 95.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -60.63 -50.38 73.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.054 -1.029 . . . . 0.0 108.912 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.9 -50.09 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.71 -49.0 63.34 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.95 -40.02 87.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 110.227 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.89 -40.01 75.91 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.148 -0.97 . . . . 0.0 110.958 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.34 0.79 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.06 -1.025 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.04 21.52 76.94 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.52 50.39 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.01 136.43 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.602 -0.94 . . . . 0.0 108.916 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.03 135.05 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 109.938 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -134.85 160.21 38.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.356 -0.84 . . . . 0.0 109.425 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -86.41 -174.85 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.38 -0.825 . . . . 0.0 109.115 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.5 m-20 -60.04 -36.02 76.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.357 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -77.25 12.76 1.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 109.103 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 40.8 mtm-85 55.91 39.54 30.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.741 -0.6 . . . . 0.0 109.853 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -117.69 153.22 33.72 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.6 mmm -50.46 130.03 23.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 75.4 mmm -60.08 139.81 57.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.518 -0.739 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -134.45 151.21 75.74 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -43.98 -46.84 10.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.873 1.049 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -60.08 -39.99 88.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.1 -39.97 82.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 110.287 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.43 -40.04 85.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.949 -1.094 . . . . 0.0 108.603 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 130' ' ' ARG . 35.1 ttt-85 -63.64 -39.59 94.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.591 -0.693 . . . . 0.0 109.431 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.62 -46.97 87.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -59.86 -41.55 91.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -62.6 -40.13 95.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.83 -41.0 94.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.08 -43.3 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 108.891 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.97 -47.46 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.538 -0.727 . . . . 0.0 109.361 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.3 mtt180 -61.06 -39.9 91.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.11 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.441 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 51.5 mt-10 -60.48 -40.06 89.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.213 -0.93 . . . . 0.0 110.971 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 88' ' ' VAL . 62.6 t -70.52 -34.04 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.062 -1.024 . . . . 0.0 110.794 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 144' ' ' ALA . 98.1 mttt -60.01 -44.45 94.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.538 -1.352 . . . . 0.0 110.571 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.17 -31.08 69.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.924 -1.11 . . . . 0.0 109.566 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.96 95.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 109.671 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -104.76 -3.86 23.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.764 . . . . 0.0 109.679 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -150.86 149.25 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -163.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 109.675 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.54 130.45 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mm -93.33 122.87 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.429 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.7 mt -119.18 151.34 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.26 1.029 . . . . 0.0 111.77 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.2 mtt -148.25 158.66 44.22 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -141.46 127.33 19.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.747 -1.221 . . . . 0.0 111.066 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.97 118.72 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 157.93 43.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.955 -1.091 . . . . 0.0 110.484 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -175.32 1.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.507 -0.745 . . . . 0.0 109.346 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -65.55 158.38 27.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -59.29 143.35 49.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.145 -0.972 . . . . 0.0 109.42 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.53 77.26 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -129.98 140.23 50.93 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.973 . . . . 0.0 109.355 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -127.69 148.6 50.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.494 -0.754 . . . . 0.0 109.21 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 112' ' ' VAL . 74.4 mt -87.64 142.73 27.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.927 . . . . 0.0 110.151 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.76 145.58 54.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.19 98.23 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.728 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -61.71 -46.8 88.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.318 . . . . 0.0 109.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.87 -28.81 65.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.9 tt -73.08 -58.75 3.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.358 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 74' ' ' MET . 97.5 mt -60.27 -44.28 95.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.36 -44.13 97.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 110.802 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 m -60.54 -40.2 90.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.813 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.96 -47.63 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.38 -40.11 95.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.263 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -66.63 -20.58 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.0 111.022 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.505 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -82.12 -9.47 59.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.731 -1.231 . . . . 0.0 110.506 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.524 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 110.0 7.06 27.56 Favored Glycine 0 N--CA 1.503 3.126 0 O-C-N 121.125 -0.984 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.689 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 35.7 m-85 -78.04 150.89 33.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.775 -1.427 . . . . 0.0 110.105 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.3 mt -126.39 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.84 110.63 1.6 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 110.191 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.09 171.89 23.93 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -63.78 -163.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 109.033 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.7 mtp 57.19 19.81 5.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.0 109.816 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 m120 50.71 39.06 20.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.69 -0.631 . . . . 0.0 111.485 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.05 167.02 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.013 -1.054 . . . . 0.0 108.176 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.07 121.47 35.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.976 -1.077 . . . . 0.0 111.035 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.53 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 50.8 m80 -110.2 130.27 55.57 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.625 -0.672 . . . . 0.0 109.207 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.689 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 37.6 ttm180 -103.8 132.87 49.65 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.78 -1.2 . . . . 0.0 108.643 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.55 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 84.1 m-70 -95.74 169.8 9.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 109.684 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.8 tp -55.98 -51.15 68.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 108.938 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -92.93 145.94 31.11 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.48 -2.29 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.715 0.943 . . . . 0.0 111.839 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.65 -2.56 51.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.86 86.61 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.024 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -70.01 -40.57 75.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.001 -1.293 . . . . 0.0 109.311 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.55 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -82.56 168.03 47.37 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.28 174.86 9.33 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.433 1.422 . . . . 0.0 112.019 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.12 126.3 30.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 108.854 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.9 mp -99.82 -39.92 7.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.106 -0.996 . . . . 0.0 109.532 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -149.39 165.45 32.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 108.617 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 45.2 m -133.32 -179.91 5.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.201 -0.937 . . . . 0.0 111.333 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.5 tt -136.95 134.58 36.87 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.659 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.14 163.6 29.55 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.732 -0.605 . . . . 0.0 109.74 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 89.5 m-20 -77.02 164.77 25.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.527 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.6 mmm -69.94 -28.0 65.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.2 p -89.94 121.53 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.102 -0.999 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -60.95 152.82 68.71 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.687 -0.633 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.93 5.02 19.43 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.377 -0.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.88 19.2 70.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.395 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.0 p -86.36 165.12 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -1.21 . . . . 0.0 109.671 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 82.5 m-85 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.627 -0.67 . . . . 0.0 109.638 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' A' ' 74' ' ' MET . 90.7 m-20 -120.83 151.19 54.32 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -50.59 -12.55 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 CA-C-N 119.553 0.876 . . . . 0.0 112.178 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -88.9 4.36 48.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.474 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 72.5 mmm -81.71 16.86 1.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 44.7 mmtm -88.23 -4.72 58.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.004 -1.06 . . . . 0.0 108.584 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 78.2 m-20 -148.57 79.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.26 171.02 20.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.0 109.218 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.7 p -135.34 150.3 49.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.375 -0.828 . . . . 0.0 109.043 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.27 150.86 23.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.34 -44.08 20.77 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 120.529 0.82 . . . . 0.0 111.861 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.97 -154.56 12.1 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -129.97 160.51 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.688 -0.889 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.2 m -112.81 127.96 56.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.677 0.751 . . . . 0.0 110.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -111.34 130.06 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.27 169.71 19.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.701 -1.249 . . . . 0.0 110.245 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.2 ttp -137.52 132.39 33.15 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.415 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.6 mt-30 -91.1 118.76 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.023 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.26 150.37 37.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.37 136.17 43.24 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 123.724 -1.365 . . . . 0.0 111.964 0.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 35.3 m -106.6 159.45 16.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.515 -0.74 . . . . 0.0 110.601 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -73.53 146.56 44.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 0.0 109.294 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.74 -160.9 29.18 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.93 111.55 23.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.173 . . . . 0.0 109.422 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.48 -25.0 22.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.364 -0.835 . . . . 0.0 108.777 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.51 -40.14 73.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.095 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -70.88 -40.0 72.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.503 HD21 HD23 ' A' ' 58' ' ' LEU . 8.3 m120 -60.62 -40.01 90.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.8 t80 -58.64 -43.54 89.78 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.614 -0.679 . . . . 0.0 109.283 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.48 -41.7 96.31 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.366 -0.833 . . . . 0.0 109.66 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.94 -41.07 95.54 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 109.097 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.3 mtp -58.54 -48.61 80.29 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.45 -0.781 . . . . 0.0 108.989 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 98' ' ' PHE . 96.2 mt -64.34 -47.66 78.5 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.482 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.52 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.0 mt-30 -60.5 -40.79 92.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 108.978 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.8 p -70.04 -40.82 74.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.02 -59.48 5.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.805 -0.559 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.97 -38.07 84.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 110.01 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 11.9 m-70 -60.06 -46.54 89.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.825 -1.172 . . . . 0.0 109.049 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.15 -48.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 108.592 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.27 -50.01 40.92 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.47 -39.92 89.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.676 -0.64 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.02 -40.82 74.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.166 -0.959 . . . . 0.0 111.453 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 23' ' ' LEU . 12.3 m -101.87 3.39 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.083 -1.011 . . . . 0.0 109.978 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.01 29.53 75.18 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.22 46.51 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.9 138.54 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.694 -0.886 . . . . 0.0 108.843 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.05 135.66 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.963 -1.086 . . . . 0.0 109.58 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.0 mt -133.51 155.24 49.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.309 -0.87 . . . . 0.0 109.6 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -84.23 -170.2 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.454 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.3 m-20 -61.94 -33.28 73.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 109.89 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -78.07 10.43 2.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.202 -0.936 . . . . 0.0 108.62 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.579 HH11 ' HG2' ' A' ' 121' ' ' ARG . 10.7 mtt-85 59.67 40.44 19.94 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.494 0.664 . . . . 0.0 109.292 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -124.64 153.8 41.71 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.4 mtp -50.86 126.46 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.1 mtp -60.04 140.07 57.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -127.66 150.38 72.9 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -40.75 -47.42 4.69 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.83 1.02 . . . . 0.0 112.604 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.05 -39.84 87.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.391 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -65.71 -42.13 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.153 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.02 -40.44 89.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 108.833 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -63.65 -38.66 91.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.457 -0.777 . . . . 0.0 109.399 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -60.05 -46.64 88.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -59.99 -40.07 87.91 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.553 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.64 -40.01 93.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.95 -40.84 97.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.85 -40.52 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.39 -45.09 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.691 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -62.48 -36.74 83.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.173 . . . . 0.0 110.124 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.426 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.02 -44.29 94.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.166 -0.959 . . . . 0.0 110.94 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 139' ' ' VAL . 16.6 m -74.8 -30.81 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.969 -1.082 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.69 -39.86 85.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.956 -1.09 . . . . 0.0 111.003 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.03 -29.72 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.559 -1.338 . . . . 0.0 109.002 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.72 95.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.714 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -101.03 -27.83 13.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.204 -0.935 . . . . 0.0 109.817 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.594 -179.783 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.9 mttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.9 145.99 28.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.33 169.09 21.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.74 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -115.8 130.35 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mm -92.16 129.07 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.3 mt -124.22 143.95 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.832 0.825 . . . . 0.0 110.461 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.0 mtt -142.96 149.46 38.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -132.26 128.59 38.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.977 -1.077 . . . . 0.0 111.187 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.97 119.73 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.16 157.93 43.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.56 -176.04 2.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -63.15 147.34 51.14 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.092 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 4.5 p80 -51.57 147.22 6.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.01 78.38 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -131.54 149.99 52.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.586 -0.95 . . . . 0.0 109.595 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -127.59 150.0 49.91 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.2 mt -84.26 141.97 30.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -0.975 . . . . 0.0 109.673 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -66.27 140.04 58.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.256 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.49 95.88 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.771 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.07 -47.72 83.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.967 -1.313 . . . . 0.0 110.246 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.71 -29.96 67.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 108.991 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -71.51 -59.74 2.6 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.9 -45.88 91.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -60.09 -42.25 94.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 109.998 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 t -64.08 -40.3 95.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 0.0 109.494 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.11 -45.33 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.089 -1.007 . . . . 0.0 109.221 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.68 -39.96 95.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.279 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -65.91 -21.95 66.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.17 7.89 10.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.358 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.11 15.46 78.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.048 -1.072 . . . . 0.0 110.894 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -81.63 150.08 28.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.896 -1.355 . . . . 0.0 109.504 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.9 mt -119.98 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.9 103.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -0.924 . . . . 0.0 109.595 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.0 170.78 34.94 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -163.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 59.4 22.97 11.46 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.431 0.634 . . . . 0.0 110.202 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 50.96 36.15 14.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.751 . . . . 0.0 111.153 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.96 161.33 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.127 -0.983 . . . . 0.0 109.297 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -90.88 134.2 34.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.51 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 39.8 m-70 -123.02 127.86 49.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.803 -0.561 . . . . 0.0 109.505 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.4 ttt180 -100.0 123.92 44.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 25.9 m-70 -93.36 170.09 9.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.742 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.95 -51.74 66.63 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.369 -0.832 . . . . 0.0 108.92 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -97.59 148.89 35.09 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.0 108.855 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.69 -4.22 11.76 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.546 0.831 . . . . 0.0 111.611 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.14 -1.6 57.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.68 14.17 82.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -68.61 -44.21 74.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -1.198 . . . . 0.0 109.332 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.17 162.35 44.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -69.61 -176.68 1.52 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.587 1.194 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.22 127.45 33.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 109.438 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.4 mp -99.16 -39.33 8.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.203 -0.936 . . . . 0.0 108.696 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -149.38 154.37 38.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 29.9 m -129.97 170.48 13.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.263 -0.898 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -126.36 134.52 51.05 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.574 0.702 . . . . 0.0 109.493 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.64 161.81 33.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.543 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.0 m-20 -73.91 160.82 30.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.008 -1.057 . . . . 0.0 110.189 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.8 mmm -69.23 -22.03 63.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.0 110.013 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.29 120.59 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.208 -0.932 . . . . 0.0 110.048 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -60.67 150.91 73.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.53 8.26 11.87 Favored 'Cis proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.317 -0.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.55 79.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.7 p -87.74 171.06 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.249 -1.147 . . . . 0.0 109.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 88.4 m-85 -120.73 161.53 21.28 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.288 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t70 -136.65 137.63 24.24 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -45.19 -12.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 120.12 1.079 . . . . 0.0 111.802 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.8 mt-10 -85.19 12.88 7.09 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.2 ptt? -80.89 9.87 5.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.295 0.569 . . . . 0.0 109.578 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -84.39 -6.72 59.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.41 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 74.1 m-20 -150.16 75.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -0.847 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -155.78 169.99 23.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 108.849 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -133.88 153.63 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.325 -0.859 . . . . 0.0 109.136 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 148.62 19.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 109.182 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -47.43 -53.64 6.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 120.524 0.816 . . . . 0.0 111.646 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.24 -154.0 8.04 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.49 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.685 -0.891 . . . . 0.0 109.03 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 m -112.0 120.13 40.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.824 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.8 mt -105.03 130.05 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.8 170.0 17.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 34.8 ttm -138.94 129.8 26.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -90.09 112.63 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.4 142.33 24.39 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 88' ' ' VAL . 8.9 Cg_endo -76.49 138.92 57.18 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 124.022 -1.241 . . . . 0.0 112.927 0.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -114.05 164.72 13.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.337 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -71.12 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.52 -165.71 39.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -94.9 117.77 30.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -1.115 . . . . 0.0 108.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -55.71 -29.48 59.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.432 -0.792 . . . . 0.0 109.621 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.43 -39.97 77.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.236 -0.915 . . . . 0.0 108.947 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -70.19 -39.99 74.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.917 -1.115 . . . . 0.0 108.557 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.604 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.9 m-20 -61.38 -40.07 92.97 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE2' HD11 ' A' ' 102' ' ' LEU . 84.7 t80 -58.2 -42.95 87.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.93 -44.84 95.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 108.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.53 -39.99 93.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.8 mmm -57.56 -50.05 74.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.5 mt -66.83 -44.27 81.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.975 . . . . 0.0 109.421 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.469 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -59.99 -40.52 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.948 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 p -70.18 -41.84 73.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.64 7.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.819 . . . . 0.0 110.146 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.8 m-70 -60.08 -50.03 75.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.082 . . . . 0.0 109.235 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.98 -50.02 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.176 -0.953 . . . . 0.0 109.561 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.05 -50.58 58.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 110.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.98 -39.97 75.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.956 . . . . 0.0 111.076 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 m -98.86 -0.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.044 . . . . 0.0 109.509 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.47 23.9 77.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.48 -170.7 47.41 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.4 t -134.5 139.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -1.027 . . . . 0.0 109.337 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.5 133.57 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.44 154.8 49.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 25.6 p-10 -84.86 -174.86 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.8 m-20 -59.93 -36.96 78.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 109.252 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.501 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.1 mt-30 -77.4 16.87 0.56 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.396 -0.815 . . . . 0.0 109.31 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.2 mtt180 60.07 20.81 10.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.967 -0.458 . . . . 0.0 111.0 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.542 ' NH2' ' NZ ' ' A' ' 128' ' ' LYS . 34.4 mtm-85 -106.18 147.63 28.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.209 -0.932 . . . . 0.0 108.518 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.96 137.14 21.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.161 -0.962 . . . . 0.0 110.542 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.9 mtt -59.93 144.22 49.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.623 -0.673 . . . . 0.0 110.327 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 5.6 p -132.94 152.23 79.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -42.09 -47.69 6.7 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 120.639 0.893 . . . . 0.0 112.074 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.401 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 27.7 mp0 -60.85 -43.22 98.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.542 ' NZ ' ' NH2' ' A' ' 122' ' ' ARG . 98.4 mttt -67.29 -39.97 86.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 110.218 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.93 -39.93 87.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.997 -1.064 . . . . 0.0 108.275 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -67.8 -38.59 83.5 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.684 -0.635 . . . . 0.0 109.909 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -59.75 -46.07 90.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.73 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -60.06 -41.08 91.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.044 . . . . 0.0 108.239 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.5 -39.99 95.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.558 -0.714 . . . . 0.0 109.125 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.04 -40.03 92.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.511 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -43.45 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 108.769 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.98 -42.08 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 137' ' ' ARG . 49.3 mtt-85 -62.23 -39.85 94.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 74.9 mm-40 -60.02 -39.97 87.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.107 -0.995 . . . . 0.0 109.35 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.19 -27.96 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 mmtt -60.04 -45.3 93.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.0 110.173 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.95 -31.06 70.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.309 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.63 96.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 46.4 p-10 -105.31 -3.3 22.93 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.29 -0.881 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.8 mttt . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.6 149.55 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.46 162.59 27.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 109.69 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.32 130.67 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 0.0 109.145 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mm -90.82 132.49 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.9 mt -129.93 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 122.279 1.038 . . . . 0.0 111.344 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.3 mtt -142.87 151.66 41.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -131.55 121.71 24.89 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.833 -1.167 . . . . 0.0 111.113 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.1 t -99.71 110.01 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.54 159.79 42.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.11 -166.3 0.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.11 159.96 32.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -58.38 145.14 39.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.45 10.26 82.22 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -130.06 147.52 51.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -1.043 . . . . 0.0 109.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.71 145.75 50.8 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 17' ' ' ALA . 58.7 mt -85.19 147.68 26.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.777 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.14 142.98 55.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.024 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.31 99.36 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.918 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.33 -43.74 98.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.374 . . . . 0.0 109.835 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.94 -28.51 65.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.1 tt -71.04 -59.58 2.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.16 -39.95 88.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.6 p -66.45 -39.82 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 109.968 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.87 -49.94 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -62.16 -40.0 94.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.956 -1.09 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.81 -22.88 66.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.99 7.72 12.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.029 -1.045 . . . . 0.0 110.266 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.58 75.98 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.138 -0.976 . . . . 0.0 111.118 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.78 150.01 26.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.323 . . . . 0.0 110.051 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.78 132.39 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.62 100.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.908 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.34 171.72 32.56 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.76 -161.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -1.156 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 98.0 mtp 60.0 20.55 9.65 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.51 0.671 . . . . 0.0 109.914 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 m120 51.93 33.56 11.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.567 -0.708 . . . . 0.0 111.565 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 pt -141.65 168.13 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.0 109.189 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.06 121.5 33.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.459 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 63.3 m-70 -106.51 130.03 54.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.784 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 7.2 ttt-85 -102.8 126.89 50.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.274 -0.892 . . . . 0.0 109.184 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 28.5 m-70 -97.35 170.92 8.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.0 -49.99 74.08 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -91.36 145.72 31.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 -2.72 9.4 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.668 0.912 . . . . 0.0 111.833 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.54 -3.68 52.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 109.85 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.0 9.78 86.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -70.9 -42.61 69.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.294 . . . . 0.0 110.229 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.01 164.99 54.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -68.4 175.12 7.28 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.997 1.131 . . . . 0.0 111.374 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.8 121.84 26.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.004 . . . . 0.0 109.323 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -97.68 -38.1 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.207 -0.933 . . . . 0.0 108.741 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.57 167.52 29.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 67.5 m -137.33 -179.08 5.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 111.173 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -136.51 131.65 34.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.538 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 160.29 34.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 109.543 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.59 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 94.0 m-20 -74.5 159.45 32.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.03 -21.32 63.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 110.177 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.15 121.24 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.056 -1.028 . . . . 0.0 109.901 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -60.69 150.66 74.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 109.189 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.34 12.21 20.22 Favored 'Cis proline' 0 N--CA 1.494 1.526 0 C-N-CA 123.584 -1.423 . . . . 0.0 111.723 -0.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 19.03 67.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.6 167.18 14.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.285 -1.127 . . . . 0.0 110.443 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 88.7 m-85 -122.39 141.87 51.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.573 -0.705 . . . . 0.0 109.484 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' GLU . 47.8 m-20 -128.79 150.0 73.76 Favored Pre-proline 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.68 -6.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.548 0.874 . . . . 0.0 111.778 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' ASP . 97.2 mt-10 -89.32 0.22 56.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.433 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 65.8 mmm -85.33 13.68 6.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.46 -0.775 . . . . 0.0 109.585 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -85.42 -8.6 58.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.164 . . . . 0.0 108.75 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -150.76 79.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -155.8 174.14 15.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.1 p -129.84 150.28 51.21 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.28 150.22 19.5 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.156 -0.965 . . . . 0.0 109.095 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -44.76 -43.61 14.69 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 120.415 0.743 . . . . 0.0 111.619 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -149.54 10.9 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 159.95 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.985 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -113.22 120.88 42.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 109.537 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.0 mt -103.03 130.5 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -145.85 170.6 16.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.936 -1.102 . . . . 0.0 110.496 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -138.45 130.68 28.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.35 123.91 33.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 9' ' ' ALA . 4.4 m -102.26 148.81 35.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.857 . . . . 0.0 109.016 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.42 141.93 72.76 Favored 'Cis proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.94 -1.275 . . . . 0.0 111.87 -1.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -107.0 155.72 19.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.971 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 92' ' ' GLY . 64.7 t80 -72.33 155.3 40.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 109.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CD2' ' A' ' 91' ' ' TYR . . . 80.75 -157.85 40.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -97.49 118.05 33.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -1.095 . . . . 0.0 109.076 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.38 -32.9 70.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.583 -0.698 . . . . 0.0 110.432 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.1 mt -69.9 -40.07 75.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.931 -1.106 . . . . 0.0 109.973 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -71.64 -40.02 70.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.923 -1.111 . . . . 0.0 108.361 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.428 ' ND2' HD23 ' A' ' 58' ' ' LEU . 18.6 m120 -61.9 -39.83 93.34 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.891 0.853 . . . . 0.0 108.811 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 64.8 t80 -59.51 -50.0 75.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -62.42 -39.94 94.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.01 -41.92 93.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.27 -46.06 89.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.375 -0.828 . . . . 0.0 109.473 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.17 -41.4 98.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.015 -1.053 . . . . 0.0 108.764 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.483 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.1 mt-30 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.349 -0.844 . . . . 0.0 108.803 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 p -71.76 -40.25 69.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.9 67.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.58 -35.64 80.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 109.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.2 m-70 -60.09 -45.84 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.074 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.27 -49.9 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 108.948 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.61 -49.7 55.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.51 -0.744 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.55 -39.98 89.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.18 -40.08 78.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.319 -0.863 . . . . 0.0 110.909 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 114' ' ' GLY . 10.3 m -103.14 0.02 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.99 22.93 77.29 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -85.66 -171.24 47.89 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.06 141.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.988 . . . . 0.0 109.561 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.76 130.04 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 108.985 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' ' SD ' ' A' ' 124' ' ' MET . 76.0 mt -132.0 159.97 37.2 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' N ' ' SD ' ' A' ' 124' ' ' MET . 35.7 p-10 -85.31 -172.59 4.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -59.97 -37.94 81.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.986 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -76.95 14.02 0.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 108.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.7 mtt180 55.91 32.81 20.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.732 -0.605 . . . . 0.0 109.526 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.54 156.58 19.34 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.9 mmm -50.92 133.97 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 117' ' ' LEU . 96.5 mmm -58.27 139.91 54.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.742 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 p -129.4 148.71 70.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -49.96 -43.76 40.2 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 119.43 0.832 . . . . 0.0 111.947 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.42 -40.1 89.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.76 -39.95 91.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.049 -1.032 . . . . 0.0 109.878 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.98 -40.05 87.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 108.675 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.63 -39.22 91.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.06 -46.37 88.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -59.98 -46.31 89.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.564 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 37.4 mm-40 -60.01 -39.98 87.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.396 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.95 -41.64 92.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.69 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.6 mt -63.36 -43.64 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.741 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.08 -44.96 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.803 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.474 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.1 mmt180 -60.03 -39.93 87.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 96.2 mt-10 -60.17 -38.63 83.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.529 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 88' ' ' VAL . 75.0 t -66.42 -39.73 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 110.537 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.8 mttt -59.88 -50.08 75.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.887 -1.133 . . . . 0.0 110.889 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 2.1 p-10 -62.38 -36.99 84.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.822 -1.174 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.42 99.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.305 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -102.27 -0.76 32.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.22 -0.925 . . . . 0.0 109.783 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 109.526 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -148.89 142.02 24.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.87 171.91 17.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 109.607 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.63 129.92 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.07 129.94 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.3 mt -128.72 146.12 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.083 0.944 . . . . 0.0 110.775 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -145.76 151.09 37.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.405 ' OD1' ' SD ' ' A' ' 64' ' ' MET . 67.3 m-80 -136.86 130.28 31.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.647 -1.283 . . . . 0.0 111.244 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.25 129.96 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.74 159.9 41.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 110.577 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.39 -172.47 1.46 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -65.96 155.99 34.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.839 -1.163 . . . . 0.0 108.298 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -55.53 133.1 50.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.128 . . . . 0.0 109.636 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.29 5.8 75.49 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.5 m -127.04 153.69 45.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.478 -1.013 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.98 153.67 45.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.533 -0.73 . . . . 0.0 109.083 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.87 138.37 32.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.989 . . . . 0.0 109.693 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -69.75 145.19 52.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.14 -42.97 98.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.1 -46.66 89.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -1.191 . . . . 0.0 109.906 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.73 -28.48 65.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.1 tt -71.7 -57.31 4.48 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.593 -0.692 . . . . 0.0 109.549 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.97 -46.12 90.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.045 . . . . 0.0 110.824 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -64.79 -41.36 95.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.002 -1.062 . . . . 0.0 111.067 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 m -63.03 -39.99 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.027 -1.046 . . . . 0.0 110.098 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.12 -49.82 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 110.695 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -63.26 -40.06 96.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.926 -1.109 . . . . 0.0 109.806 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -61.65 -23.62 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 110.761 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.616 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.32 -8.69 59.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.831 -1.168 . . . . 0.0 110.614 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 109.37 9.96 24.55 Favored Glycine 0 N--CA 1.503 3.105 0 O-C-N 121.01 -1.056 . . . . 0.0 110.845 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.768 ' N ' HH21 ' A' ' 47' ' ' ARG . 30.0 m-85 -79.89 148.95 31.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.683 -1.481 . . . . 0.0 109.972 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.6 133.56 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.24 105.69 0.53 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 110.265 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.59 171.38 30.48 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.45 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.125 -1.221 . . . . 0.0 110.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.9 mtt 59.96 22.68 11.77 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.406 0.622 . . . . 0.0 110.198 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.1 m120 52.57 36.21 19.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 111.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.08 161.6 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.995 -1.066 . . . . 0.0 108.572 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.08 120.94 33.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.064 -1.022 . . . . 0.0 110.677 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 54.3 m80 -106.79 131.5 53.83 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 37' ' ' PHE . 32.6 ttm180 -104.5 130.22 52.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.006 -1.059 . . . . 0.0 108.497 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -100.15 169.42 9.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.844 . . . . 0.0 109.979 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.1 tp -57.06 -50.0 74.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -89.91 148.32 39.41 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.49 -4.45 15.02 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.597 0.865 . . . . 0.0 111.83 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -94.96 -0.17 54.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.187 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 9.05 87.2 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -69.91 -40.4 75.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -1.187 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.49 166.01 52.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.63 175.03 7.63 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 120.916 1.078 . . . . 0.0 111.737 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.408 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.35 123.36 29.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.84 -37.14 9.18 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.09 161.93 41.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 108.672 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 49.2 m -134.44 -177.97 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.859 0.838 . . . . 0.0 110.844 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.4 tt -136.66 130.85 32.8 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.82 162.67 30.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.5 m120 -78.49 164.9 24.34 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.045 -1.034 . . . . 0.0 110.547 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 14' ' ' ASN . 89.8 mmm -70.03 -22.61 63.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 0.0 110.461 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 94.2 t -86.95 119.24 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.978 -1.076 . . . . 0.0 110.115 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.91 147.72 78.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.151 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.64 14.56 6.93 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.552 -1.437 . . . . 0.0 111.842 -0.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 72.13 17.75 77.47 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 p -87.29 175.92 7.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -1.229 . . . . 0.0 109.728 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 80.1 m-85 -119.59 147.9 43.95 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 0.0 109.52 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 27.0 m-20 -134.0 150.2 73.72 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -46.66 -8.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.641 0.894 . . . . 0.0 112.306 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.7 mt-10 -85.66 10.36 13.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.74 -1.29 53.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.766 -0.584 . . . . 0.0 109.87 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.7 mttp -84.3 -6.78 59.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.5 m-20 -150.1 78.01 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -162.31 171.39 17.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.842 -1.161 . . . . 0.0 109.814 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.8 p -131.86 156.99 45.1 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.04 18.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.024 -1.048 . . . . 0.0 109.141 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 -24.36 54.05 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 120.515 0.81 . . . . 0.0 111.89 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.4 -164.02 36.27 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.731 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.11 166.52 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.751 -0.852 . . . . 0.0 108.735 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -119.89 129.97 54.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.532 -0.73 . . . . 0.0 110.387 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.52 128.96 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.72 164.08 32.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.001 -1.062 . . . . 0.0 110.827 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.7 ttm -132.19 130.22 40.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.73 105.35 17.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 88' ' ' VAL . 15.3 m -97.38 148.72 34.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.82 134.43 35.74 Favored 'Cis proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.364 0.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -105.56 159.89 15.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.07 145.49 49.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.339 -0.851 . . . . 0.0 109.214 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.31 -161.55 23.29 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 89.6 m-20 -96.25 108.96 21.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.013 -1.286 . . . . 0.0 109.05 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.29 -31.34 65.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.46 -0.775 . . . . 0.0 110.065 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.05 -40.63 74.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.014 . . . . 0.0 110.338 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -77.09 -40.61 45.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.619 -1.3 . . . . 0.0 108.925 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 81.0 m-20 -60.05 -38.09 81.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -58.45 -40.96 84.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -63.68 -40.08 95.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.941 -1.099 . . . . 0.0 108.604 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.56 -39.96 89.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.93 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.8 mtp -58.13 -49.88 75.44 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.537 -0.727 . . . . 0.0 109.36 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 102' ' ' LEU . 89.0 mt -64.53 -45.53 86.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 109.294 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.5 mt-30 -60.25 -40.17 89.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 108.445 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' HH12 ' A' ' 47' ' ' ARG . 93.7 p -70.39 -44.0 68.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.57 44.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.517 -0.739 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.096 -1.002 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.6 m-70 -59.98 -43.66 94.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.0 108.506 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.24 -49.99 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.71 -49.41 68.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.09 -39.97 91.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.9 -40.0 75.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.895 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.17 2.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.018 -1.052 . . . . 0.0 109.532 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 67.13 25.36 73.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -162.67 38.52 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.417 -1.049 . . . . 0.0 110.487 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.59 154.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.646 -0.914 . . . . 0.0 109.203 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.2 t -94.93 129.82 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.426 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.1 mt -122.05 160.08 25.71 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.563 -0.711 . . . . 0.0 110.102 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.11 -171.29 3.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.7 m-20 -60.09 -40.04 88.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 109.697 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -76.23 17.76 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 119' ' ' ASP . 87.1 mtm180 56.2 35.02 25.01 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.468 0.651 . . . . 0.0 109.756 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -110.24 144.2 39.29 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.7 mtp -51.3 129.56 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 108.943 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.2 mtt -59.08 141.19 54.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 110.106 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 p -129.56 150.4 75.58 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -42.5 -45.17 8.26 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.469 0.78 . . . . 0.0 112.237 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -61.34 -40.01 92.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.188 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.054 -1.029 . . . . 0.0 110.544 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.92 -40.11 83.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.872 . . . . 0.0 108.765 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -65.95 -39.88 90.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.462 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.83 -43.57 94.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 109.839 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -60.14 -44.03 95.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.019 -1.051 . . . . 0.0 108.394 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.72 -40.07 96.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.58 -40.04 93.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.615 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.53 -40.95 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.145 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.67 -38.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 108.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 137' ' ' ARG . 27.2 mtt-85 -59.86 -38.91 83.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.045 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.6 -39.99 90.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.117 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.58 -28.77 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 111.025 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 144' ' ' ALA . 68.5 mttm -60.03 -45.24 93.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.663 -1.273 . . . . 0.0 110.179 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.07 -30.13 69.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.906 -1.121 . . . . 0.0 109.192 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.52 93.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.963 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -100.48 -25.62 14.13 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.354 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -147.5 130.85 16.6 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -162.3 -166.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.699 -1.251 . . . . 0.0 110.272 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.2 t -140.02 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 95.5 mt -120.0 147.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.281 1.039 . . . . 0.0 111.652 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.0 mtt -146.2 158.82 43.9 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' CG ' ' NH1' ' A' ' 121' ' ' ARG . 34.6 m120 -141.15 121.77 14.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.658 -1.277 . . . . 0.0 111.457 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.49 113.48 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.42 44.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.82 -169.91 0.51 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.88 157.34 37.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.03 -1.044 . . . . 0.0 109.1 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -60.06 140.13 57.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.709 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.81 2.08 63.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.1 m -127.19 149.7 49.86 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.577 -0.955 . . . . 0.0 109.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -131.18 145.07 51.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.553 -0.717 . . . . 0.0 109.218 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 112' ' ' VAL . 85.3 mt -87.6 146.78 25.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.02 146.42 51.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 108.948 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.45 97.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mm-40 -61.19 -44.1 97.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.338 . . . . 0.0 109.857 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 89.5 mt -69.95 -27.85 65.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.3 tt -76.07 -59.62 2.68 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.71 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -47.93 83.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.288 -0.883 . . . . 0.0 111.579 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.3 p-10 -61.27 -39.99 92.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.894 -1.129 . . . . 0.0 110.342 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 56.5 m -62.21 -40.25 95.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.871 -1.143 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.59 -45.92 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.225 -0.922 . . . . 0.0 109.805 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -60.7 -40.03 90.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.31 -19.87 65.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.911 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.56 8.7 9.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.945 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.89 81.76 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -81.51 151.78 27.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.297 . . . . 0.0 110.113 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.98 139.95 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.62 107.41 0.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 109.572 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.83 171.49 34.52 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.43 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.235 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 72.1 mtm 56.73 26.1 10.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 110.09 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.9 m120 50.03 39.44 19.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 111.293 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 pt -141.67 161.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.5 130.76 37.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.532 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.9 m-70 -117.79 127.97 54.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 47' ' ' ARG . 14.5 ttt-85 -99.99 127.08 46.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.158 -0.964 . . . . 0.0 108.545 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.7 m-70 -95.8 170.05 9.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.492 -0.755 . . . . 0.0 109.701 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -49.99 -53.93 23.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.089 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -90.82 149.23 39.98 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.305 -0.872 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.66 -5.18 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.814 1.009 . . . . 0.0 112.452 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -93.04 0.04 57.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.135 -0.978 . . . . 0.0 110.041 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.1 81.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.4 p -70.0 -40.0 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -1.173 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -85.8 173.52 47.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.404 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 24.0 Cg_endo -73.96 178.4 6.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.37 1.38 . . . . 0.0 111.658 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.64 123.08 27.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.884 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.6 mp -97.38 -47.05 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.157 -0.965 . . . . 0.0 109.03 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -138.08 160.11 40.25 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.532 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.9 m -127.66 178.2 6.29 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.196 0.998 . . . . 0.0 111.694 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.2 tt -138.6 130.07 27.44 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.599 0.714 . . . . 0.0 109.146 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.63 160.11 34.33 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.62 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.5 m-20 -73.73 161.79 29.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.991 -1.068 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mtp -69.66 -29.96 67.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 110.906 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 65' ' ' VAL . 13.2 p -86.35 131.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.804 -1.185 . . . . 0.0 110.126 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -59.97 150.04 71.17 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -76.91 5.93 18.49 Favored 'Cis proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.552 -0.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.82 83.08 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -88.55 169.97 11.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.101 -1.235 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.62 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 75.3 m-85 -120.05 143.49 48.07 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -119.82 149.99 49.66 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.439 -0.788 . . . . 0.0 108.889 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.3 -20.15 61.23 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 120.498 0.798 . . . . 0.0 112.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.95 -2.71 58.21 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -0.927 . . . . 0.0 109.121 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.594 ' CE ' ' ND2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -89.24 25.24 1.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.526 -0.734 . . . . 0.0 110.652 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 29.4 mmtm -80.96 0.88 33.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.885 -1.134 . . . . 0.0 109.351 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 91.6 m-20 -142.0 86.77 2.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.96 177.97 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 109.724 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 p -131.73 150.12 52.26 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.56 149.48 19.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 0.0 109.219 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -45.28 -41.44 17.12 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 120.366 0.711 . . . . 0.0 111.393 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.59 -150.79 10.28 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HB ' HD21 ' A' ' 61' ' ' LEU . 23.4 m -130.11 159.98 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.607 -0.937 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.42 HG23 ' ND2' ' A' ' 14' ' ' ASN . 45.4 m -114.72 124.88 52.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.87 129.94 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -146.65 149.45 33.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.919 -1.113 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.2 ttm -102.31 133.33 47.4 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.464 -0.772 . . . . 0.0 109.526 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.7 mt-30 -91.07 105.36 17.76 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 16.0 m -97.46 147.21 32.65 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.185 -0.947 . . . . 0.0 108.537 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -74.23 133.64 31.97 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.377 0.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.6 m -105.29 158.85 16.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -72.73 149.9 43.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.732 . . . . 0.0 109.94 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.1 -160.36 34.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.1 116.15 28.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -1.159 . . . . 0.0 108.952 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.55 -31.81 69.76 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 110.219 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.07 -41.47 74.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.155 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -74.29 -39.98 62.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.63 -39.81 89.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 133' ' ' GLN . 55.9 t80 -53.09 -40.06 63.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -59.99 -40.0 87.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.198 -0.939 . . . . 0.0 108.713 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.82 -39.97 93.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 109.177 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mtp -56.61 -50.01 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.156 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.32 -44.7 90.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.91 . . . . 0.0 109.608 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.525 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 84.3 mt-30 -60.02 -40.84 90.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 108.826 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 p -70.17 -40.04 74.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.418 -0.801 . . . . 0.0 109.711 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.85 52.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.162 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -62.09 -37.2 84.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 0.0 109.971 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 10.9 m-70 -60.12 -47.63 85.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.987 -1.071 . . . . 0.0 109.126 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.11 -49.95 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.78 -47.72 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.69 -40.32 91.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 110.096 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -71.14 -39.99 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 0.0 111.158 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.4 m -101.33 2.33 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.76 23.1 68.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.08 -173.24 45.54 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 134.83 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.606 -0.938 . . . . 0.0 109.136 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.416 HG12 ' SD ' ' A' ' 124' ' ' MET . 16.8 t -70.69 135.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.62 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 mt -132.4 156.19 47.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.459 -0.776 . . . . 0.0 109.732 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -87.89 -173.62 4.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.581 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 95.6 m-20 -60.03 -34.47 73.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.021 . . . . 0.0 108.996 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.34 14.98 0.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 108.961 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' NH1' ' CG ' ' A' ' 14' ' ' ASN . 20.2 mmt180 60.11 24.12 13.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.656 -0.652 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -110.96 150.85 28.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.44 -0.788 . . . . 0.0 109.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.9 mtm -50.52 129.39 22.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.081 -1.012 . . . . 0.0 109.597 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.416 ' SD ' HG12 ' A' ' 116' ' ' VAL . 57.0 mtp -59.93 139.7 57.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -125.6 151.01 69.86 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -40.34 -46.43 4.31 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 120.911 1.074 . . . . 0.0 112.532 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -60.14 -39.99 88.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.616 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.82 -39.73 83.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.188 -0.945 . . . . 0.0 110.341 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.65 -40.53 75.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.973 -1.079 . . . . 0.0 108.128 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 34.3 ttm-85 -65.29 -39.33 92.42 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.84 -46.85 87.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.68 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.581 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 62.0 m-85 -60.13 -42.7 95.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.053 -1.029 . . . . 0.0 108.258 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 98' ' ' PHE . 23.6 mm100 -62.97 -40.1 96.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 95.6 m-20 -61.65 -40.97 96.83 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.419 -0.801 . . . . 0.0 109.838 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -40.05 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.906 -1.121 . . . . 0.0 109.432 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.25 -39.23 81.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 99.1 mtt180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.886 -1.134 . . . . 0.0 111.303 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 15.2 mp0 -60.09 -39.09 84.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.794 -1.191 . . . . 0.0 110.164 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.07 -39.33 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.916 -1.115 . . . . 0.0 110.391 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.96 -50.08 75.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.779 -1.2 . . . . 0.0 110.929 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -60.91 -32.54 72.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.684 -1.26 . . . . 0.0 109.253 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.34 -23.78 67.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 108.826 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -98.74 -2.2 38.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.064 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.465 -179.835 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -99.79 139.16 35.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.07 -175.93 5.55 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.738 -1.226 . . . . 0.0 110.231 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.04 133.32 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.93 135.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.468 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.1 mt -130.73 143.16 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.992 0.901 . . . . 0.0 110.701 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.529 ' C ' HD22 ' A' ' 14' ' ' ASN . 58.5 mtm -149.31 152.09 35.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.529 HD22 ' C ' ' A' ' 13' ' ' MET . 5.7 m120 -129.13 130.36 46.34 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.099 -1.0 . . . . 0.0 111.013 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.97 113.8 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.09 153.32 38.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.175 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.24 -175.94 1.34 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -60.07 150.52 29.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 108.99 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -59.9 148.27 35.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.04 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.54 -5.57 77.27 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -128.98 142.1 51.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.941 . . . . 0.0 108.894 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -121.93 150.15 42.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.746 . . . . 0.0 109.305 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.27 142.46 29.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.343 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -67.69 141.03 56.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.0 108.795 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.1 96.47 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -62.59 -46.52 87.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.217 . . . . 0.0 109.573 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.1 -29.16 66.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 109.031 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -73.65 -58.92 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.07 -44.11 94.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.64 -40.7 95.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.501 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -64.82 -40.08 94.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.86 -50.26 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.353 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -63.97 -40.07 95.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.05 -20.39 66.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.416 -0.802 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.53 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.47 1.07 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 109.657 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.86 16.84 43.36 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 121.156 -0.965 . . . . 0.0 111.166 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -82.35 152.46 26.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.403 . . . . 0.0 110.242 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.86 134.81 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.12 104.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.067 -1.021 . . . . 0.0 109.996 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.63 171.31 31.77 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -65.56 -163.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.249 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.6 mmm 58.7 19.96 7.33 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.643 0.735 . . . . 0.0 109.688 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 51.76 38.19 22.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.526 -0.734 . . . . 0.0 111.898 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 pt -140.56 166.29 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.875 -1.14 . . . . 0.0 108.505 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -92.63 122.58 35.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.829 -1.169 . . . . 0.0 110.201 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.9 m80 -106.45 127.33 53.21 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.457 -0.777 . . . . 0.0 109.092 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 37.5 ttt180 -103.88 128.71 51.36 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.06 -1.025 . . . . 0.0 109.05 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 64.4 m-70 -98.66 171.41 8.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.33 -0.856 . . . . 0.0 109.733 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.9 -49.68 72.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.8 m -91.15 147.79 36.41 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 109.015 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.45 -7.97 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.747 0.964 . . . . 0.0 111.905 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -91.44 -0.25 57.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 109.974 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.79 12.01 84.9 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.197 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.2 p -70.59 -40.59 73.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.008 -1.289 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.3 167.83 51.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -69.67 170.42 16.51 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 120.934 1.089 . . . . 0.0 111.427 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -78.71 126.2 30.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 109.301 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.0 mp -99.39 -30.72 12.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 109.098 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CB ' ' SD ' ' A' ' 101' ' ' MET . 28.2 p90 -159.15 159.98 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 108.615 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 17.6 m -129.88 175.88 8.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 110.564 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -133.24 132.45 41.47 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.506 0.669 . . . . 0.0 109.604 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 162.39 28.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 89.2 m-20 -75.28 160.92 29.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.974 -1.078 . . . . 0.0 110.782 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.6 mmm -69.51 -35.27 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.716 -0.615 . . . . 0.0 111.047 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.57 136.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.879 -1.138 . . . . 0.0 110.303 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -58.98 151.94 52.93 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -78.48 4.08 27.88 Favored 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.232 -0.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.31 86.0 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.6 p -85.91 170.32 12.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -1.133 . . . . 0.0 109.633 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 91.3 m-85 -113.99 155.99 24.88 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' GLU . 32.9 m-20 -135.52 148.75 67.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -44.05 -14.37 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.64 0.893 . . . . 0.0 112.498 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mp0 -86.17 16.3 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.5 ptt? -83.78 -4.96 59.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.33 0.586 . . . . 0.0 110.005 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 97.1 mttt -83.34 -4.61 58.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.785 -1.197 . . . . 0.0 109.429 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.4 m-20 -150.03 78.31 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 109.326 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.61 170.48 20.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.984 -1.072 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -131.49 150.74 52.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.65 149.68 20.47 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 0.0 109.19 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.84 -47.15 22.17 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 120.554 0.836 . . . . 0.0 111.916 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.14 -150.38 7.61 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -130.02 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.823 . . . . 0.0 109.886 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.469 HG23 HD21 ' A' ' 14' ' ' ASN . 53.3 m -113.2 122.81 48.61 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.99 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -145.09 150.21 36.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.0 ttm -110.15 135.7 50.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.675 -0.641 . . . . 0.0 109.404 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -91.83 104.02 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 m -98.32 149.04 35.33 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -74.46 137.59 51.05 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.263 0.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 74.3 m -103.35 168.0 9.45 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 0.0 110.541 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 65.3 t80 -72.32 154.6 40.86 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.377 0.608 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 72.85 -146.87 39.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.13 114.87 26.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.298 -1.119 . . . . 0.0 109.057 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -57.77 -31.04 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.928 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.4 ' CD1' HH12 ' A' ' 137' ' ' ARG . 90.2 mt -70.06 -39.8 75.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.67 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.29 -36.0 74.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.895 -1.128 . . . . 0.0 108.251 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 97' ' ' ASN . 3.0 m120 -59.95 -40.03 87.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 78.2 t80 -59.91 -44.36 94.34 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -63.05 -40.13 96.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.258 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.77 -45.2 94.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.471 ' SD ' ' CB ' ' A' ' 59' ' ' PHE . 20.5 mtm -59.92 -43.57 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.884 -1.135 . . . . 0.0 109.787 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.9 mt -63.88 -40.2 95.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.454 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 88.7 mm-40 -60.08 -40.93 91.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.0 109.791 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.1 p -70.48 -40.05 73.87 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 109.429 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.3 70.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.3 -40.44 94.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.872 -1.143 . . . . 0.0 109.206 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 26.4 m-70 -60.17 -49.36 77.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.29 -49.85 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.253 -0.905 . . . . 0.0 108.724 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.2 -48.98 64.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.673 . . . . 0.0 109.441 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.14 -40.02 88.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.93 -40.07 75.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.4 m -99.98 -0.93 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.99 -1.069 . . . . 0.0 109.838 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.48 20.79 75.76 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -80.57 -178.35 52.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.2 t -130.37 139.8 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.592 -0.946 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.505 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.8 t -74.72 130.78 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.311 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.06 155.79 45.57 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.375 -0.828 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -84.73 -174.91 5.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.465 -0.772 . . . . 0.0 109.963 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.5 m-20 -60.07 -35.12 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -78.53 11.53 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 108.82 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 56.41 38.45 29.71 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -116.08 145.82 42.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.7 mtt -51.16 126.7 17.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 129' ' ' LEU . 45.7 mtt -61.26 151.28 32.19 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.845 0.831 . . . . 0.0 111.195 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.6 p -133.74 149.24 71.39 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -42.43 -50.12 5.84 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 CA-C-N 119.574 0.884 . . . . 0.0 112.628 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.29 -40.0 88.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -65.14 -40.87 94.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.155 . . . . 0.0 110.461 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 124' ' ' MET . 87.7 mt -59.84 -40.32 88.13 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 108.485 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 130' ' ' ARG . 19.9 ttt-85 -63.93 -38.54 91.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.686 -0.634 . . . . 0.0 109.664 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.42 -44.85 89.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.989 -1.07 . . . . 0.0 109.815 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.93 -40.13 87.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 108.969 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -59.87 -39.92 86.9 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -38.39 84.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.466 -0.771 . . . . 0.0 109.301 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 139' ' ' VAL . 6.7 mm -56.52 -46.42 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.01 -43.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 137' ' ' ARG . 30.8 mtt-85 -60.08 -40.05 88.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 95.9 mt-10 -62.92 -38.68 91.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 135' ' ' ILE . 92.2 t -69.44 -24.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 110.883 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.3 mttm -60.03 -40.03 87.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.793 -1.192 . . . . 0.0 109.748 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 2.3 p30 -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.88 -1.137 . . . . 0.0 109.206 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.09 99.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 47.1 p-10 -102.87 -0.11 31.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.351 -0.843 . . . . 0.0 109.607 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -146.18 136.15 23.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -161.82 166.36 26.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.56 -1.338 . . . . 0.0 110.492 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.98 129.32 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -91.38 123.06 43.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.62 148.86 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 122.469 1.128 . . . . 0.0 111.59 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mtt -145.71 154.25 41.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -137.09 122.8 19.88 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.735 -1.228 . . . . 0.0 111.076 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.05 116.75 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.04 153.18 39.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.939 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.09 -177.0 1.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -59.96 146.58 41.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 108.845 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.97 141.78 13.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 -3.88 74.29 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -117.74 152.63 34.88 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.591 -0.946 . . . . 0.0 109.5 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.78 147.69 50.81 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.472 -0.767 . . . . 0.0 109.149 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.66 143.65 27.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.225 -0.922 . . . . 0.0 109.831 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -70.58 141.36 51.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 108.875 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.95 98.24 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 97.2 mt-10 -61.41 -46.07 91.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.958 -1.319 . . . . 0.0 109.636 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.94 -27.08 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.97 -60.23 2.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.54 -0.725 . . . . 0.0 109.171 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.48 -39.99 89.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 26' ' ' GLU . 96.2 m-20 -61.11 -40.98 95.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.7 p -67.69 -40.2 84.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.129 -0.982 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.11 -48.18 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.334 -0.853 . . . . 0.0 109.534 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.56 -40.14 96.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 109.697 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.48 -20.39 63.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.564 -0.71 . . . . 0.0 110.552 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.85 2.76 32.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 110.296 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.95 15.05 65.91 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.845 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -80.05 153.9 28.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.849 -1.383 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.446 HD12 ' CD2' ' A' ' 48' ' ' HIS . 96.6 mt -124.7 136.75 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -62.75 106.32 0.78 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.678 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.78 171.52 28.93 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -62.59 -164.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -1.093 . . . . 0.0 109.344 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.0 mtt 57.76 21.26 7.23 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.573 0.702 . . . . 0.0 109.827 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.2 m120 50.02 39.39 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.594 -0.691 . . . . 0.0 111.723 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 pt -140.01 165.86 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.809 -1.182 . . . . 0.0 108.983 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -91.52 118.44 30.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 110.417 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.542 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 42.1 m80 -105.15 128.46 53.39 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.419 -0.801 . . . . 0.0 109.085 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -100.15 129.23 46.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.993 -1.067 . . . . 0.0 108.7 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.446 ' CD2' HD12 ' A' ' 38' ' ' ILE . 52.1 m-70 -97.38 170.14 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.99 -49.99 74.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.167 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 m -91.25 144.23 29.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.28 -0.887 . . . . 0.0 109.102 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -67.23 -5.47 13.87 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.574 0.849 . . . . 0.0 111.738 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.45 -0.53 54.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.93 . . . . 0.0 110.157 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' CA ' ' CD1' ' A' ' 38' ' ' ILE . . . 77.67 10.03 86.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -68.23 -39.99 82.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -1.104 . . . . 0.0 109.854 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.79 165.67 46.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.434 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.9 Cg_endo -67.38 175.98 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.194 1.262 . . . . 0.0 112.087 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.475 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.41 124.94 29.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -101.0 -46.81 4.97 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.274 -0.892 . . . . 0.0 109.764 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -143.84 167.4 22.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.004 -1.06 . . . . 0.0 108.501 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.542 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 1.9 m -137.51 -177.04 4.61 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.869 -1.144 . . . . 0.0 112.04 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.9 tt -139.97 132.09 28.01 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.514 0.673 . . . . 0.0 109.992 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.66 166.66 22.71 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.3 m-20 -77.69 170.19 17.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.842 -1.161 . . . . 0.0 110.472 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mtp -68.97 -29.57 67.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.498 -0.752 . . . . 0.0 111.818 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 65' ' ' VAL . 34.0 m -86.2 118.82 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.51 -1.369 . . . . 0.0 109.749 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -61.5 147.81 87.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.538 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.91 2.87 17.87 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.175 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 69.99 33.32 69.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.3 p -84.34 169.95 14.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.042 -1.269 . . . . 0.0 109.887 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 70.8 m-85 -119.7 150.73 39.88 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 73' ' ' GLU . 53.9 m-20 -139.16 150.26 64.02 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -42.89 -15.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.901 1.067 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.5 mt-10 -85.09 16.21 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.2 ptt? -83.53 -0.0 48.42 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.024 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -85.02 -4.39 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.66 -1.275 . . . . 0.0 109.694 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -147.83 77.42 1.42 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.53 169.71 24.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 109.498 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -135.51 156.94 48.08 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.62 19.35 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.083 . . . . 0.0 109.37 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.77 -30.67 77.22 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 120.418 0.745 . . . . 0.0 111.744 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.86 -160.85 27.57 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 HD11 ' A' ' 28' ' ' LEU . 33.1 m -130.09 159.94 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.488 -1.007 . . . . 0.0 109.47 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -115.45 119.66 36.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.0 109.745 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -104.75 129.93 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -147.08 170.05 17.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.92 -1.113 . . . . 0.0 110.491 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.0 ttp -133.19 130.96 39.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.729 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.56 123.16 35.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 9' ' ' ALA . 3.7 m -98.43 150.07 36.36 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.262 -0.899 . . . . 0.0 108.62 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -76.06 142.72 74.48 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.386 -0.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 m -109.99 157.81 18.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.513 -0.742 . . . . 0.0 109.73 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 64.2 t80 -75.88 154.61 35.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.16 -159.39 45.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -93.78 114.95 27.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -1.107 . . . . 0.0 108.848 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.09 -27.22 43.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.936 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 95' ' ' LEU . 95.4 mt -69.99 -38.22 75.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.546 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.05 -39.32 75.78 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' ND2' HD23 ' A' ' 58' ' ' LEU . 4.0 m120 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.87 -41.06 86.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.13 -43.05 99.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 108.673 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.0 -39.87 93.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.026 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.0 mmm -56.79 -49.99 73.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.036 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.6 mm-40 -60.28 -41.4 93.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.153 -0.967 . . . . 0.0 109.0 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.8 p -71.93 -39.94 69.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -56.04 26.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.911 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.48 -40.69 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.608 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.7 m-70 -60.06 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.422 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.06 -49.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 108.856 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.69 -51.69 53.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.624 -0.673 . . . . 0.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 110.814 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.36 -39.9 77.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.409 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.87 0.06 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.27 20.53 76.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.4 -178.35 51.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.95 131.55 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.538 -0.978 . . . . 0.0 108.939 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.8 130.68 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.949 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.7 mt -132.7 159.91 38.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 37.8 p-10 -86.59 -172.2 3.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.5 m-20 -60.06 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.0 . . . . 0.0 109.735 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -76.31 13.91 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 108.653 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.5 mtt180 59.87 34.6 21.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.135 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -110.03 151.27 27.38 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.7 mtp -52.96 129.99 32.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.089 . . . . 0.0 109.319 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 39.5 mtt -59.6 140.86 56.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.98 . . . . 0.0 109.932 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 15.6 p -133.63 151.1 76.58 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -43.57 -47.74 9.18 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.486 0.791 . . . . 0.0 111.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.99 -41.58 92.37 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 125' ' ' THR . 27.4 mmtp -69.99 -39.98 75.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.2 mt -60.0 -39.96 87.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 108.501 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -62.43 -39.9 94.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.46 -46.97 85.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.085 -1.009 . . . . 0.0 109.549 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -60.01 -45.43 92.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.943 -1.098 . . . . 0.0 108.587 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.02 -39.57 86.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -45.73 91.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.82 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.84 -1.162 . . . . 0.0 108.698 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.05 -45.25 95.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.066 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -61.97 -38.18 87.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.84 . . . . 0.0 109.603 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.4 mt-10 -59.97 -39.7 86.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.421 -0.799 . . . . 0.0 110.715 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 -33.63 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.428 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.4 mttm -59.91 -45.5 92.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.82 -1.175 . . . . 0.0 110.545 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.23 -33.31 72.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.665 -1.272 . . . . 0.0 109.681 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.34 -39.96 93.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 110.936 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 41.3 p-10 -98.54 3.01 48.05 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.061 -1.024 . . . . 0.0 109.592 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.389 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 7.7 mtpm? . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -146.51 146.97 30.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.17 -166.22 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.436 -1.415 . . . . 0.0 111.393 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -131.5 134.89 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -90.27 127.81 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -119.98 148.03 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.385 1.088 . . . . 0.0 111.684 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.528 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.9 mtt -145.36 159.05 43.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.39 119.71 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.835 -1.166 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -101.96 110.02 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.58 159.34 44.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.98 179.0 3.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.02 156.26 15.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.108 -0.995 . . . . 0.0 108.773 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -59.95 145.49 45.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.071 -1.018 . . . . 0.0 109.336 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 1.52 68.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.2 m -131.26 147.54 52.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.973 . . . . 0.0 109.276 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.94 145.31 51.42 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.378 -0.826 . . . . 0.0 109.433 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.61 145.81 26.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.718 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.04 146.83 50.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.46 97.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 62.0 mm-40 -61.87 -45.69 92.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.004 -1.292 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 84.4 mt -70.01 -29.14 66.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 108.627 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.606 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.1 -57.14 4.16 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.391 0.615 . . . . 0.0 110.022 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.0 -49.99 75.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 111.63 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.9 p-10 -62.13 -40.07 94.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.841 -1.162 . . . . 0.0 110.315 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.458 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -60.42 -43.17 97.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.94 -46.57 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.428 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.14 -41.13 99.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 110.054 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.79 -18.96 64.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.2 3.96 21.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 5.41 65.9 Favored Glycine 0 N--CA 1.497 2.759 0 O-C-N 120.821 -1.174 . . . . 0.0 111.041 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.46 149.61 33.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.708 -1.466 . . . . 0.0 109.185 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.14 139.71 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.99 116.18 3.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.774 -1.204 . . . . 0.0 108.755 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.99 172.12 34.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.36 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.767 -0.843 . . . . 0.0 110.431 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mmm 58.18 -99.71 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 42' ' ' MET . 56.6 m-80 -164.81 28.47 0.06 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.74 168.21 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.355 -0.84 . . . . 0.0 110.556 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.58 119.96 32.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.327 -0.858 . . . . 0.0 109.95 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.526 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 47.4 m80 -103.2 141.19 36.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.299 -0.876 . . . . 0.0 109.04 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 45.8 ttt180 -120.49 131.29 54.66 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.476 -0.765 . . . . 0.0 109.047 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.558 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.3 m-70 -94.69 174.55 7.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.2 tp -53.56 -49.97 66.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 108.469 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -92.26 146.03 31.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.84 -3.01 10.52 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 120.593 0.862 . . . . 0.0 111.985 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.75 1.35 57.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.209 -0.932 . . . . 0.0 109.831 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.6 10.01 75.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.83 -41.89 70.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.015 -1.285 . . . . 0.0 110.167 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.558 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.37 173.41 54.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.454 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.8 Cg_endo -73.75 173.0 14.68 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.085 1.19 . . . . 0.0 111.431 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.57 122.05 26.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.065 -1.022 . . . . 0.0 109.213 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -103.17 -33.76 9.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.372 -0.83 . . . . 0.0 109.844 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.08 169.12 24.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.056 . . . . 0.0 108.685 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 8.2 m -139.13 -176.46 4.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 0.0 111.232 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -137.32 132.91 34.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.387 0.613 . . . . 0.0 109.397 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.594 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.06 162.32 31.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.0 m-20 -76.26 169.02 19.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.885 -1.134 . . . . 0.0 109.682 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.3 mmm -69.47 -28.75 66.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 110.648 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.32 118.08 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.767 -1.208 . . . . 0.0 110.234 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -62.54 152.02 81.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.477 -0.765 . . . . 0.0 108.944 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -78.12 1.95 28.08 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.711 -1.37 . . . . 0.0 111.964 -0.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.0 38.35 19.48 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.93 157.63 19.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -1.195 . . . . 0.0 109.744 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -120.0 139.97 51.67 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.53 -0.731 . . . . 0.0 109.373 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.19 149.98 67.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.86 -13.37 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 120.651 0.901 . . . . 0.0 112.561 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.35 -10.1 57.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 92.9 mtp -89.04 22.07 2.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.87 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -85.31 -7.8 58.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 108.558 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 89.3 m-20 -144.7 83.57 1.71 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.64 174.35 15.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.256 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -128.64 148.14 50.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 109.152 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.74 150.58 20.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 108.926 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -45.77 -50.6 9.36 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 CA-C-N 119.299 0.785 . . . . 0.0 111.763 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.6 -150.17 8.34 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 HD21 ' A' ' 28' ' ' LEU . 33.0 m -130.01 160.07 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.488 -1.007 . . . . 0.0 110.067 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' ALA . 24.6 m -107.89 119.96 40.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.0 109.458 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.35 129.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -146.94 168.01 22.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 110.916 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.7 ttp -136.75 129.97 31.29 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -91.39 114.64 27.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.39 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.4 151.98 37.63 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -78.51 134.19 32.38 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.394 -0.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.3 m -108.53 162.04 14.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.489 -0.757 . . . . 0.0 109.856 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.06 146.72 50.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -0.802 . . . . 0.0 109.938 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.24 -159.52 27.53 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -97.31 112.65 24.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.99 -29.14 65.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.822 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.29 -39.97 78.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -71.15 -40.13 71.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.012 -1.055 . . . . 0.0 108.868 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.557 ' ND2' HD23 ' A' ' 58' ' ' LEU . 28.1 m120 -60.97 -39.9 91.38 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 109.098 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 87.1 t80 -59.24 -49.96 75.83 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.82 -40.05 96.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.6 -47.46 86.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 110.68 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.8 mtm -59.96 -39.97 87.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.893 -1.129 . . . . 0.0 109.319 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.47 -41.5 98.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 109.103 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.13 -41.2 92.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 109.002 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 p -72.18 -40.03 68.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 108.941 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.0 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.552 -0.718 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -62.13 -39.2 91.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.94 -1.1 . . . . 0.0 109.689 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 14.9 m-70 -59.97 -44.14 94.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.674 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.2 mt -60.01 -49.45 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.35 -50.16 51.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.589 -0.695 . . . . 0.0 109.607 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.99 -40.19 92.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.792 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -39.92 75.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.805 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 114' ' ' GLY . 6.0 m -97.76 -1.44 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.0 109.704 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.73 19.89 75.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -87.58 -174.68 48.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.8 t -131.12 138.14 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.517 -0.99 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 t -70.44 133.2 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.658 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.5 159.99 35.44 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.556 -0.715 . . . . 0.0 109.759 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -87.76 -171.62 3.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 109.419 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.5 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -76.88 15.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.049 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.3 mtt180 55.6 38.96 30.86 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.4 0.619 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 122' ' ' ARG . 29.7 mtt-85 -112.07 151.9 28.85 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -51.5 130.65 28.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.0 mmm -59.16 139.97 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -137.6 150.31 67.81 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -47.9 -44.06 28.2 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.844 1.029 . . . . 0.0 112.401 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -39.91 87.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -67.89 -40.03 83.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 110.123 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.1 -39.88 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -61.96 -40.14 94.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.556 -0.715 . . . . 0.0 109.078 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -59.94 -48.2 82.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.862 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.584 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 94.5 mm-40 -59.97 -40.12 87.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.72 -40.39 97.03 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.81 -45.16 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 108.859 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.09 -49.38 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -60.05 -39.98 87.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 54.2 mm-40 -60.26 -41.66 93.71 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 109.821 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' GLU . 54.6 t -71.36 -40.79 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 111.073 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 144' ' ' ALA . 26.4 mtpp -59.98 -48.06 83.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.963 -1.086 . . . . 0.0 111.266 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 4.2 p30 -60.08 -32.34 70.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.999 -1.063 . . . . 0.0 110.357 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -62.26 -39.95 94.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -104.04 -1.64 27.16 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.169 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.407 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -145.17 133.71 22.01 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -159.93 170.47 21.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.85 -1.156 . . . . 0.0 110.355 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.82 131.4 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.364 -0.835 . . . . 0.0 109.069 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.58 130.92 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.2 mt -125.46 146.02 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.184 0.993 . . . . 0.0 111.937 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.5 mtt -145.96 157.36 43.89 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.705 ' ND2' HG23 ' A' ' 83' ' ' THR . 35.0 m120 -141.28 129.94 22.8 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.628 -1.295 . . . . 0.0 111.169 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.29 116.45 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.03 38.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -170.69 0.85 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -68.02 158.09 33.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.99 -1.069 . . . . 0.0 108.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -59.96 145.58 45.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.382 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.23 82.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 m -118.0 148.47 42.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.512 -0.993 . . . . 0.0 108.801 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 63.6 mm-40 -129.31 143.06 50.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.5 mt -86.35 139.21 31.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 109.458 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.6 145.16 52.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.343 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.91 97.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.91 -41.55 98.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.095 -1.238 . . . . 0.0 109.7 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.03 -27.1 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.612 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.0 tt -71.31 -59.03 2.99 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.418 -0.801 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' SD ' ' A' ' 74' ' ' MET . 83.0 mt -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.989 -1.069 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.96 -42.85 94.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 109.958 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -69.97 -46.92 64.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 110.52 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.8 mt -60.06 -44.23 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 0.0 110.102 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.24 -43.12 98.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 109.724 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -68.72 -16.39 63.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.513 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.25 3.91 25.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.875 . . . . 0.0 110.056 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.0 9.91 83.66 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -80.22 154.39 27.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.283 . . . . 0.0 109.398 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.17 141.69 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -59.64 111.7 1.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.973 -1.079 . . . . 0.0 109.083 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -92.72 171.85 33.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.34 -169.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.567 -0.961 . . . . 0.0 109.171 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.1 mtm 56.19 29.42 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.809 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 m120 49.94 38.66 16.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.558 -0.714 . . . . 0.0 111.493 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 pt -140.22 159.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.877 -1.14 . . . . 0.0 109.182 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 45.2 m-85 -89.34 129.99 35.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.089 -1.007 . . . . 0.0 109.872 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.551 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.3 m-70 -118.44 127.87 54.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 59.2 ttt180 -100.02 124.98 45.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.0 108.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 19.8 m-70 -95.05 169.68 9.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.8 tp -55.54 -50.06 70.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.7 m -92.34 144.55 29.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 108.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.44 -3.14 10.41 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.518 0.863 . . . . 0.0 111.975 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.25 0.06 57.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.1 11.36 84.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 m -70.06 -45.43 67.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -1.197 . . . . 0.0 109.878 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.49 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.59 166.35 54.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.74 177.92 4.43 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.081 1.187 . . . . 0.0 111.456 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.49 124.6 30.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.96 . . . . 0.0 109.053 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.9 mp -100.73 -39.76 7.68 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.099 -1.0 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -148.19 159.86 43.53 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.551 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.5 m -130.21 -179.85 5.48 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.204 1.002 . . . . 0.0 112.342 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -139.94 129.95 24.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.75 160.97 35.29 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 17.0 m120 -75.32 159.09 31.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.098 -1.002 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -69.98 -25.22 63.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.64 -0.662 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.7 t -85.21 126.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.733 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -59.73 149.99 69.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.102 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.29 9.87 15.94 Favored 'Cis proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.727 -0.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 14.5 80.98 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -88.99 170.14 10.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 110.877 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 39.3 m-85 -119.27 158.78 25.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.6 m-20 -143.07 150.65 53.41 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.197 -0.94 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -48.98 -8.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.125 0 CA-C-N 119.171 0.74 . . . . 0.0 110.94 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.3 mt-10 -86.77 18.18 3.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.831 ' SD ' HD21 ' A' ' 29' ' ' LEU . 47.5 mtm -73.89 1.24 11.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.9 mmtp -88.75 -0.07 56.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 109.943 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 60.7 m-20 -154.8 77.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.012 -1.055 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -167.76 170.66 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.7 p -137.11 159.17 42.67 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.97 148.3 18.43 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.932 -1.105 . . . . 0.0 109.251 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 3.5 Cg_endo -57.8 -35.58 98.72 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.577 0.851 . . . . 0.0 112.0 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.23 -161.09 25.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.99 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.51 -0.994 . . . . 0.0 108.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.705 HG23 ' ND2' ' A' ' 14' ' ' ASN . 94.2 m -114.7 128.08 56.11 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.488 -0.758 . . . . 0.0 110.454 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.6 mt -111.56 129.19 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 24.9 p90 -149.09 159.96 43.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.877 -1.139 . . . . 0.0 110.976 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.6 ttm -113.64 130.55 56.37 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.1 mt-30 -91.94 115.18 27.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.2 m -98.58 150.4 36.68 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 120.978 -1.076 . . . . 0.0 109.379 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.24 134.72 36.92 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.902 -1.291 . . . . 0.0 111.561 -1.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.9 m -104.56 154.2 20.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.409 -0.807 . . . . 0.0 110.097 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -71.31 148.59 46.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 109.509 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.61 -164.61 39.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.63 114.39 26.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -1.179 . . . . 0.0 109.322 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -52.99 -18.56 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.04 -40.02 75.39 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -75.98 -41.45 51.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 108.962 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.582 ' OD1' HD23 ' A' ' 58' ' ' LEU . 92.7 m-20 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 102' ' ' LEU . 90.5 t80 -57.61 -41.27 80.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.34 -40.11 89.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.074 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.09 -40.11 94.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.3 mtp -59.47 -49.91 75.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.1 mt -60.99 -45.9 92.93 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.062 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.2 mt-30 -60.28 -40.46 90.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 p -73.15 -40.03 65.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.76 -54.01 51.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.447 -0.783 . . . . 0.0 109.907 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -63.23 -40.0 96.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 109.638 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 3.9 m-70 -60.15 -45.94 91.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.366 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.95 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.15 -49.96 59.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -0.824 . . . . 0.0 109.291 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.36 -40.05 89.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.39 -40.15 77.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 110.796 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 114' ' ' GLY . 9.9 m -98.41 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.01 20.02 74.3 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.44 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -84.28 -170.24 46.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 132.92 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.934 . . . . 0.0 109.098 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.47 132.88 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.513 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 mt -132.13 159.96 37.4 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.481 -0.762 . . . . 0.0 109.795 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -88.55 -169.34 2.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 121' ' ' ARG . 94.1 m-20 -59.97 -39.61 86.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.181 -0.95 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -76.44 16.61 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.244 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 119' ' ' ASP . 49.6 mtm-85 57.75 28.88 16.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.584 . . . . 0.0 109.953 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 122' ' ' ARG . 51.0 mtt-85 -110.32 155.66 21.8 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.514 -0.741 . . . . 0.0 109.441 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.1 mtm -53.76 132.23 40.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.3 mtt -60.0 140.75 56.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -129.78 150.29 75.42 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -43.58 -41.07 10.95 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 CA-C-N 119.354 0.805 . . . . 0.0 111.744 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.3 -40.01 88.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.946 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -69.37 -39.31 78.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 109.791 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.74 -40.49 79.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 108.781 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -65.88 -38.95 90.12 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.93 -47.79 84.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.943 . . . . 0.0 109.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -59.95 -42.77 94.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 108.486 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.72 -40.02 95.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.539 -0.726 . . . . 0.0 109.047 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -40.02 87.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.447 -0.783 . . . . 0.0 109.692 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -40.03 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.953 -1.092 . . . . 0.0 109.259 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.93 -42.95 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.946 -1.096 . . . . 0.0 109.391 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 0.8 OUTLIER -60.08 -37.14 79.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.198 -0.939 . . . . 0.0 109.751 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 88' ' ' VAL . 97.8 t -72.73 -33.88 45.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 144' ' ' ALA . 39.3 mmtm -59.63 -45.96 90.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 109.958 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -62.44 -36.44 82.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.647 -1.283 . . . . 0.0 108.807 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 110.197 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -97.81 0.36 46.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 108.803 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.497 -0.752 . . . . 0.0 109.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mttt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -148.46 145.02 27.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -164.66 160.1 19.62 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.328 -1.482 . . . . 0.0 110.743 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.53 129.92 59.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -88.43 129.95 38.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.8 mt -122.0 147.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.303 1.049 . . . . 0.0 111.49 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -145.79 154.14 41.7 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -133.21 120.91 21.76 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.898 -1.126 . . . . 0.0 111.088 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.01 112.48 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.93 158.67 43.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 110.124 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.7 -170.55 0.7 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.555 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -59.93 154.3 19.14 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 108.762 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -59.83 141.56 55.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.071 -1.018 . . . . 0.0 109.606 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.19 -8.59 79.26 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 m -112.2 151.93 28.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.473 -1.016 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.97 150.54 49.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.425 -0.797 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.31 145.82 27.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.903 . . . . 0.0 109.908 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.42 140.62 57.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 109.016 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.22 -40.48 97.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.56 -47.74 82.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.2 mt -68.2 -24.5 64.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -76.53 -58.28 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.89 -49.93 75.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.214 -0.928 . . . . 0.0 111.084 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.4 p-10 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 110.023 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 53.7 m -61.99 -40.66 96.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.971 -1.081 . . . . 0.0 109.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.29 -48.45 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 108.886 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -60.22 -40.01 88.64 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.91 -21.56 64.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 9.87 7.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.956 -1.09 . . . . 0.0 110.376 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.21 9.67 86.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -80.4 155.47 27.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.296 . . . . 0.0 109.583 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 140.65 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 108.24 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 171.82 33.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.27 -167.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -1.107 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.8 mmm 57.22 26.87 12.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.475 -0.766 . . . . 0.0 109.654 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 51.11 39.91 24.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.446 -0.784 . . . . 0.0 111.514 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.6 pt -141.65 160.88 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.014 -1.054 . . . . 0.0 109.402 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.38 136.56 32.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 18.6 m-70 -125.72 128.13 47.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 47' ' ' ARG . 30.0 ttt-85 -101.09 126.2 47.76 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.388 -0.82 . . . . 0.0 109.083 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.555 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 58.6 m-70 -96.51 170.08 9.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.729 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.3 tp -55.83 -49.83 72.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -92.04 149.06 38.12 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.295 -0.878 . . . . 0.0 109.333 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.16 -5.89 17.52 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 120.926 1.084 . . . . 0.0 112.234 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 49.8 p-10 -94.18 -0.04 55.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.074 -1.016 . . . . 0.0 110.299 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.4 85.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.433 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 27.0 m -70.03 -41.71 73.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.749 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.61 165.35 52.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.555 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.6 Cg_endo -69.14 174.25 9.24 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.03 1.153 . . . . 0.0 111.602 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.56 125.88 30.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 109.134 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.06 -39.63 8.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.18 158.59 44.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.499 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 29.0 m -129.68 179.46 5.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.244 1.021 . . . . 0.0 112.159 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.8 tt -139.51 132.94 30.15 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.1 167.17 22.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.7 m120 -74.9 160.23 30.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.002 -1.061 . . . . 0.0 109.773 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.88 -20.51 63.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.862 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -87.95 113.57 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.002 -1.061 . . . . 0.0 109.114 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -62.74 151.73 83.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.501 -0.749 . . . . 0.0 109.563 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -76.67 10.97 12.62 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.6 -1.416 . . . . 0.0 112.34 -0.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.39 30.82 57.95 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.374 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -85.85 163.83 17.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -1.19 . . . . 0.0 109.836 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.1 m-85 -120.82 143.13 49.03 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.3 m-20 -129.12 149.93 73.99 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.1 -9.07 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.138 0.728 . . . . 0.0 111.569 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.0 mt-10 -89.77 3.92 51.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.548 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.455 ' O ' HD11 ' A' ' 29' ' ' LEU . 67.6 mmm -88.1 16.46 6.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 62.6 mttp -85.34 -6.32 59.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.962 -1.086 . . . . 0.0 109.182 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 68.6 m-20 -151.91 79.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.75 171.69 19.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.1 p -128.64 151.75 49.14 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.95 149.04 19.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.07 -1.019 . . . . 0.0 109.308 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -43.58 -49.98 7.35 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.666 0.911 . . . . 0.0 111.896 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.09 -154.75 13.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.401 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.8 m -129.97 160.02 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.395 -1.062 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.5 m -109.08 120.93 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.719 -0.613 . . . . 0.0 110.146 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mt -103.71 130.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 31.8 p90 -147.17 169.98 18.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 111.215 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.8 ttm -128.26 130.07 47.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.414 ' O ' ' OG ' ' A' ' 90' ' ' SER . 92.0 mm-40 -91.51 115.62 28.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.7 m -98.8 149.92 36.2 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.18 -0.95 . . . . 0.0 109.093 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.61 137.02 46.73 Favored 'Cis proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.867 -1.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.1 m -107.74 154.15 21.92 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.487 -0.758 . . . . 0.0 109.397 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.11 145.49 51.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 110.043 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.51 -165.61 33.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -96.39 112.29 24.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.34 -1.094 . . . . 0.0 109.114 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' OE1' HG23 ' A' ' 136' ' ' ILE . 88.3 mt-10 -55.3 -25.53 34.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.946 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.81 -40.14 76.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 109.591 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.28 -41.63 66.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.785 -1.197 . . . . 0.0 108.065 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.411 ' ND2' HD23 ' A' ' 58' ' ' LEU . 94.9 m-20 -62.69 -39.79 95.09 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 102' ' ' LEU . 76.0 t80 -51.34 -40.65 59.55 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.5 -40.02 94.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.86 -40.04 96.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 0.0 109.287 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mtp -58.66 -50.03 75.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.079 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.9 mt -65.95 -47.32 75.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.353 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 77.1 mt-30 -59.95 -40.81 90.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 108.977 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.5 p -70.4 -40.16 74.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.14 -56.42 22.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.823 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -61.21 -37.82 84.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.462 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.9 m-70 -59.94 -50.13 74.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.06 -1.025 . . . . 0.0 108.746 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.8 mt -60.99 -49.01 86.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.73 -49.23 65.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -70.03 -40.15 75.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.72 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 108' ' ' ILE . 13.6 m -97.44 -0.03 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 0.0 109.873 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.03 26.01 74.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.77 -176.54 50.21 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -130.21 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.702 -0.881 . . . . 0.0 109.202 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.488 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -74.96 130.26 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.132 -0.98 . . . . 0.0 109.352 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -130.56 159.88 35.82 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 40.3 p-10 -85.7 -170.69 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 0.0 108.989 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -60.13 -39.49 86.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 78.5 mt-30 -76.78 16.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.328 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 58.46 29.37 18.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 110.395 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HE ' ' HB2' ' A' ' 120' ' ' GLN . 84.5 mtm180 -107.91 154.33 21.76 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.336 -0.852 . . . . 0.0 108.969 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.2 mtt -52.42 125.17 15.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 109.722 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' HG12 ' A' ' 116' ' ' VAL . 51.5 mtp -60.14 140.49 56.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.522 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.2 p -127.18 150.53 72.53 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -43.64 -43.23 11.44 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.185 0.745 . . . . 0.0 112.018 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.431 ' O ' ' CD ' ' A' ' 131' ' ' GLU . 27.3 mt-30 -60.08 -44.74 94.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.59 -39.76 94.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 109.772 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.64 -39.01 76.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -65.83 -39.99 91.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -59.43 -48.6 81.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.701 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -60.08 -45.99 91.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 108.548 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.0 -40.02 96.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.491 -0.756 . . . . 0.0 108.961 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.4 -42.11 98.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.2 -42.8 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.003 -1.06 . . . . 0.0 109.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 94' ' ' GLU . 82.2 mt -60.07 -41.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 31.2 mmt180 -60.05 -40.91 91.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 108.962 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -61.11 -37.46 82.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 0.0 108.98 178.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.93 -39.86 78.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 110.27 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.02 -48.6 81.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 111.379 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 2.8 p-10 -59.91 -32.86 71.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.558 -1.339 . . . . 0.0 109.221 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.12 82.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 110.148 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -98.6 -11.35 22.22 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 109.506 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -147.89 150.4 34.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.1 -175.1 3.84 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.562 -1.336 . . . . 0.0 110.811 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.98 136.3 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -93.59 124.64 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.9 mt -121.36 151.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.043 0.925 . . . . 0.0 111.091 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 84' ' ' ILE . 67.5 mtt -148.88 159.02 44.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -140.17 121.29 14.75 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.973 -1.08 . . . . 0.0 110.603 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.28 117.27 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.42 155.0 40.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.14 -174.21 1.49 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.447 -0.783 . . . . 0.0 108.901 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -64.26 149.03 48.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.073 -1.017 . . . . 0.0 108.763 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -55.81 149.85 13.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 109.756 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.57 -7.18 82.43 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -121.06 154.69 35.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.564 -0.962 . . . . 0.0 109.477 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -129.16 147.34 50.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.07 137.68 33.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 55.3 t-20 -67.95 142.05 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.05 -41.42 97.99 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.795 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.73 -47.24 86.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.309 . . . . 0.0 110.095 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.01 -30.26 67.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -70.4 -57.48 4.77 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.551 -0.718 . . . . 0.0 109.252 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 74' ' ' MET . 96.2 mt -59.99 -44.23 94.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.385 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' OD1' ' OE1' ' A' ' 34' ' ' GLN . 60.3 t-20 -60.45 -40.27 90.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 110.192 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 p -65.82 -39.82 91.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.87 -48.82 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -62.35 -39.97 94.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.902 -1.124 . . . . 0.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' OD1' ' A' ' 30' ' ' ASN . 27.5 mt-30 -67.84 -22.41 65.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.377 -0.827 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.98 6.09 14.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.953 -1.092 . . . . 0.0 109.997 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.83 76.19 Favored Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.947 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -78.6 150.35 32.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.76 -1.435 . . . . 0.0 109.726 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.34 139.57 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -60.69 105.34 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.03 172.14 29.19 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.51 -165.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -1.035 . . . . 0.0 109.598 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mmm 58.36 20.12 7.02 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.689 . . . . 0.0 109.81 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 49.99 39.63 19.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.086 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.2 pt -140.51 166.98 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -91.91 127.02 37.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.917 -1.114 . . . . 0.0 110.487 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.546 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 36.5 m-70 -116.07 128.82 56.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.528 -0.732 . . . . 0.0 109.75 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 17.6 ttt-85 -102.97 126.95 50.35 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 70.9 m-70 -94.76 171.22 8.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.963 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.54 -50.14 70.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.9 . . . . 0.0 108.739 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -93.34 143.73 27.16 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -66.97 -2.65 8.24 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 119.552 0.876 . . . . 0.0 111.952 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -94.25 0.19 55.5 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 0.0 110.109 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.92 86.61 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.452 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 91.3 p -70.1 -40.0 75.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.914 -1.345 . . . . 0.0 109.762 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.77 162.82 52.18 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 12.3 Cg_endo -67.26 176.93 4.2 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.994 1.129 . . . . 0.0 111.247 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.23 118.67 22.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.017 -1.052 . . . . 0.0 109.319 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.6 mp -96.72 -47.97 5.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -142.95 159.99 41.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.993 . . . . 0.0 109.395 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.546 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.0 m -136.55 159.92 40.33 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.82 0.819 . . . . 0.0 111.208 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -113.11 131.69 55.73 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.361 0.601 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.637 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.57 162.78 32.84 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.9 m-20 -77.69 153.55 32.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.884 -1.135 . . . . 0.0 109.886 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.05 -29.86 66.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.094 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.43 134.94 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.972 -1.08 . . . . 0.0 109.774 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -56.87 154.02 20.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -79.77 2.06 36.52 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 123.753 -1.353 . . . . 0.0 112.464 -0.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.85 -4.73 73.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.5 p -89.6 169.89 10.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -1.051 . . . . 0.0 110.078 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 79.6 m-85 -121.76 152.47 39.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.5 m-20 -135.17 149.74 70.91 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -49.04 -11.11 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 120.47 0.78 . . . . 0.0 111.792 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.4 mm-40 -89.95 4.46 50.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 73.9 mmm -87.92 20.24 3.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.0 110.155 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.0 mttp -88.23 -1.69 58.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 81.7 m-20 -146.73 81.55 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -160.33 172.49 17.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 p -130.67 151.58 50.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.31 150.02 21.48 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.263 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.48 -38.37 95.49 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 CA-C-N 119.092 0.712 . . . . 0.0 111.566 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.08 -156.47 15.17 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 24.4 m -131.51 160.08 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.768 -0.843 . . . . 0.0 109.066 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.5 m -114.14 120.26 39.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.473 -0.767 . . . . 0.0 110.432 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 13' ' ' MET . 97.5 mt -105.95 128.19 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -145.27 152.34 39.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.176 -0.953 . . . . 0.0 110.136 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttp -121.2 130.04 53.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -86.33 110.88 19.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 108.96 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 2.4 m -98.19 147.44 33.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.439 ' HG2' HD22 ' A' ' 143' ' ' ASN . 4.1 Cg_endo -75.8 131.49 24.43 Favored 'Cis proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.605 0.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m -100.36 166.73 10.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.736 0.779 . . . . 0.0 110.186 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.13 146.02 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.771 -0.581 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.4 -156.46 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -93.77 119.09 32.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -1.209 . . . . 0.0 108.537 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -57.44 -32.64 67.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.838 -0.539 . . . . 0.0 110.511 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.96 -40.11 75.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.85 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.11 -40.62 68.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.004 -1.06 . . . . 0.0 109.157 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.253 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.481 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.8 t80 -58.83 -45.03 90.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -61.11 -39.73 91.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.448 -0.783 . . . . 0.0 109.43 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.11 -43.78 95.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 109.678 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.15 -44.92 94.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.481 HD11 ' CE2' ' A' ' 98' ' ' PHE . 86.5 mt -61.49 -46.2 91.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.054 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.5 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 78.3 mt-30 -60.05 -43.93 95.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -70.42 -40.01 74.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.23 -55.58 33.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.041 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 103' ' ' GLN . 19.4 pt20 -60.28 -35.93 76.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.925 -1.11 . . . . 0.0 108.897 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 9.0 m-70 -60.08 -45.88 91.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.11 -0.994 . . . . 0.0 108.839 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -60.01 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.048 -1.032 . . . . 0.0 108.568 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.2 -48.99 61.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.487 0.66 . . . . 0.0 109.286 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.09 -40.01 88.1 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.926 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.9 -40.04 75.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 111.349 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.75 -0.39 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.075 -1.015 . . . . 0.0 109.566 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.83 25.96 74.89 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.06 -169.3 44.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.51 134.04 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -1.016 . . . . 0.0 109.238 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.14 130.89 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.054 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.0 mt -126.74 159.02 34.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 108.907 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -86.49 -171.51 3.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 109.069 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.532 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 97.2 m-20 -60.07 -35.01 74.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.323 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.84 16.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 45.1 mtm-85 58.16 26.28 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.641 . . . . 0.0 109.914 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 54.0 mtp180 -109.18 151.49 26.4 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.593 -0.692 . . . . 0.0 109.331 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -52.51 134.69 34.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.886 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.4 mmm -59.9 133.61 56.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.0 p -132.72 151.15 77.58 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -41.36 -45.99 5.78 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 120.926 1.084 . . . . 0.0 113.04 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -60.09 -39.97 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.95 -1.094 . . . . 0.0 109.409 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.36 -40.11 85.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.32 -39.97 84.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 108.828 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -62.58 -39.54 94.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.474 -0.766 . . . . 0.0 109.143 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.59 -48.59 81.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.123 -0.986 . . . . 0.0 109.75 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 65.3 m-85 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.041 -1.037 . . . . 0.0 109.398 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.87 87.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.316 -0.865 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.21 -44.42 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 108.702 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.07 -45.78 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.383 -0.823 . . . . 0.0 109.379 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 99.0 mtt180 -60.31 -37.41 80.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 110.161 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.6 mt-10 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.866 . . . . 0.0 110.29 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.6 t -73.35 -35.56 46.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 110.8 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 144' ' ' ALA . 49.4 mtpt -60.15 -46.61 89.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 111.464 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.7 p-10 -61.17 -29.15 69.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.606 -1.309 . . . . 0.0 110.125 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.07 99.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.439 HD22 ' HG2' ' A' ' 89' ' ' PRO . 98.6 m-20 -112.44 -11.55 13.63 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.382 -0.824 . . . . 0.0 110.192 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -150.02 133.56 16.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.63 8.36 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.67 -1.269 . . . . 0.0 110.477 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -125.03 132.29 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.94 134.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.1 mt -131.2 141.84 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.947 0.88 . . . . 0.0 111.196 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.43 148.01 29.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -128.01 130.54 48.5 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.054 -1.029 . . . . 0.0 110.901 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.73 117.94 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.01 159.82 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 110.383 -178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.12 -164.96 0.2 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.704 -0.622 . . . . 0.0 109.645 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -70.0 155.97 39.82 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -57.57 135.78 56.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 5.18 65.0 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -126.31 144.41 50.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -1.019 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -124.52 147.69 48.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.51 137.04 33.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.167 -0.958 . . . . 0.0 110.233 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.43 143.07 57.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 108.862 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.49 -41.85 97.34 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.084 -1.01 . . . . 0.0 111.061 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.98 -43.15 95.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.889 -1.359 . . . . 0.0 108.877 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 95.5 mt -69.95 -27.12 64.48 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.6 tt -76.57 -56.3 4.74 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 110.463 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.98 -49.0 79.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.03 -1.044 . . . . 0.0 111.312 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 31' ' ' SER . 42.8 p-10 -61.85 -39.15 90.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 110.866 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 93.4 p -62.62 -40.43 96.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.789 -1.194 . . . . 0.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.415 HG21 ' CG ' ' A' ' 45' ' ' TYR . 95.9 mt -60.29 -49.71 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.989 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -65.66 -39.93 91.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 109.817 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -63.72 -22.42 66.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.03 -1.24 52.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.0 . . . . 0.0 109.602 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.08 19.08 44.03 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.041 -1.037 . . . . 0.0 111.418 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -81.23 160.61 24.25 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.356 . . . . 0.0 110.281 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.22 137.01 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.96 102.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.061 . . . . 0.0 109.841 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 171.02 41.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.4 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.443 -1.034 . . . . 0.0 109.242 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 95.4 mtp 56.66 23.52 7.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.664 -0.647 . . . . 0.0 110.222 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.71 40.26 23.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 111.259 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.552 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.9 pt -139.84 163.82 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.024 -1.047 . . . . 0.0 109.179 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 32' ' ' ILE . 80.2 m-85 -90.51 131.77 36.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.043 -1.035 . . . . 0.0 110.167 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 17.5 m-70 -123.68 132.07 53.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.687 -0.633 . . . . 0.0 109.869 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 30.9 ttt180 -104.86 121.71 44.26 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 48.1 m-70 -95.4 171.0 8.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.393 -0.817 . . . . 0.0 109.562 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.63 -50.05 71.2 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.8 m -92.37 144.23 28.59 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.33 -6.0 17.3 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.7 0.933 . . . . 0.0 112.104 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -93.15 0.89 57.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.154 -0.967 . . . . 0.0 109.407 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.48 14.25 82.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 p -70.43 -40.45 73.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.081 -1.246 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.46 166.86 48.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.483 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 20.8 Cg_endo -70.86 -179.49 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.195 1.263 . . . . 0.0 111.751 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.25 121.69 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -95.96 -20.54 18.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.995 -1.066 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -169.63 158.15 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.937 . . . . 0.0 108.948 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.473 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.6 m -127.26 171.86 11.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.935 0.874 . . . . 0.0 111.822 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.2 tt -140.08 130.2 25.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.543 0.687 . . . . 0.0 109.189 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.17 163.89 28.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.522 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 12.4 m120 -74.11 158.03 34.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.062 . . . . 0.0 110.127 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.02 -23.8 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.62 -0.675 . . . . 0.0 110.537 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.5 p -87.17 129.88 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.978 -1.076 . . . . 0.0 109.775 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -60.45 149.86 75.83 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.481 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.31 4.72 26.34 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.546 -0.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.88 85.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -85.48 170.98 12.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -1.202 . . . . 0.0 109.473 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 82.7 m-85 -116.46 150.58 37.62 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 7.5 m-20 -139.06 152.31 69.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.89 -15.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.045 1.163 . . . . 0.0 112.65 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.1 mt-10 -85.24 13.33 6.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' ASP . 24.3 ptt? -82.7 -7.3 59.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.77 -0.581 . . . . 0.0 110.243 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.8 mttt -85.25 -4.03 59.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.08 -1.013 . . . . 0.0 110.222 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 71.1 m-20 -150.29 73.23 1.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.933 -1.104 . . . . 0.0 109.885 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -158.1 169.86 23.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 p -131.96 150.11 52.25 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.218 -0.926 . . . . 0.0 109.093 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.75 147.78 19.66 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.972 -1.08 . . . . 0.0 108.77 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.99 -33.53 5.52 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.62 0.88 . . . . 0.0 111.866 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.44 -146.42 9.8 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.481 -1.343 . . . . 0.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 28.1 m -130.03 159.11 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.602 -0.94 . . . . 0.0 109.655 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 m -114.23 121.12 42.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.592 -0.692 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -102.55 125.72 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -149.86 161.96 41.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.953 -1.092 . . . . 0.0 110.65 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 4.9 tpt -146.31 147.46 31.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.72 . . . . 0.0 109.238 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' N ' ' SD ' ' A' ' 86' ' ' MET . 92.9 mt-30 -94.07 121.88 36.01 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.44 151.59 37.74 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.89 172.5 56.33 Favored 'Cis proline' 0 N--CA 1.503 2.033 0 C-N-CA 124.057 -1.226 . . . . 0.0 113.055 0.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.562 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 15.9 m -130.32 167.11 19.03 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.841 0.829 . . . . 0.0 111.031 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -72.8 144.47 47.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.05 -151.01 34.64 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -97.31 123.22 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.359 -1.083 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' N ' ' A' ' 90' ' ' SER . 53.5 mm-40 -56.21 -30.05 61.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 0.0 109.532 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.95 -40.02 79.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.258 -0.901 . . . . 0.0 109.077 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -73.05 -40.37 65.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.928 -1.108 . . . . 0.0 108.093 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 58' ' ' LEU . 77.7 m-20 -64.65 -40.01 94.69 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.14 -46.02 91.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.739 -0.601 . . . . 0.0 109.97 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.5 -39.87 89.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.417 ' O ' ' OG ' ' A' ' 104' ' ' SER . 64.9 mtp -60.03 -49.65 76.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.161 -0.962 . . . . 0.0 108.793 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.98 -45.98 83.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.427 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.1 mt-30 -59.98 -39.93 87.37 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 101' ' ' MET . 16.4 p -69.91 -41.49 74.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.369 -0.832 . . . . 0.0 109.035 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.01 -57.71 11.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.415 -0.803 . . . . 0.0 110.085 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.61 -39.62 88.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.693 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.5 m-70 -59.82 -49.8 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 108.775 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.19 -48.87 61.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.98 -39.84 93.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 110.281 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.66 -40.11 84.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.22 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 114' ' ' GLY . 5.8 m -100.65 -0.68 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.267 -0.896 . . . . 0.0 109.903 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 20.89 74.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -82.44 -173.76 49.35 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.47 132.96 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -1.049 . . . . 0.0 109.851 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.17 131.96 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.7 158.23 39.16 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.615 0.721 . . . . 0.0 109.645 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -86.23 -174.31 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.517 -0.74 . . . . 0.0 109.564 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.9 m-20 -59.97 -36.09 76.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.011 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 120' ' ' GLN . 27.4 mp0 -78.73 16.32 0.88 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.4 mtm-85 56.19 39.52 30.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.521 -0.737 . . . . 0.0 110.582 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.84 155.59 33.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.463 -0.773 . . . . 0.0 109.202 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.5 mtm -54.14 132.75 43.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.373 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 79.4 mmm -60.35 140.04 57.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.257 -0.902 . . . . 0.0 110.193 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.7 p -130.81 150.56 76.85 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -48.43 -39.44 36.11 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 CA-C-N 119.36 0.807 . . . . 0.0 111.974 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.32 -40.77 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.439 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.84 -39.42 76.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.49 -0.756 . . . . 0.0 110.087 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.39 -40.08 77.46 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 130' ' ' ARG . 26.4 ttm-85 -62.91 -40.01 96.27 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.358 -0.839 . . . . 0.0 109.1 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.83 -47.9 83.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.958 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.07 -41.93 93.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.986 -1.071 . . . . 0.0 108.182 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.423 ' HA ' HD12 ' A' ' 136' ' ' ILE . 97.3 mt-30 -62.29 -38.25 88.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 96.0 m-20 -60.35 -40.78 91.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.329 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.8 -39.84 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.988 . . . . 0.0 108.994 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 133' ' ' GLN . 83.1 mt -60.06 -49.2 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.3 mtm180 -61.59 -39.58 91.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.019 -1.051 . . . . 0.0 110.396 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.9 mt-10 -60.23 -39.99 88.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.972 -1.08 . . . . 0.0 110.769 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.88 -36.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 144' ' ' ALA . 60.5 mttm -59.94 -45.5 92.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.97 -1.081 . . . . 0.0 111.702 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 1.1 p-10 -60.85 -34.27 74.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.713 -1.242 . . . . 0.0 110.036 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.65 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.769 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.76 -2.23 30.61 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.087 -1.008 . . . . 0.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 mttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.11 141.17 35.37 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -157.84 159.97 37.23 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.697 -1.252 . . . . 0.0 110.469 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.86 132.34 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.628 -0.67 . . . . 0.0 109.98 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.05 139.23 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 93.8 mt -127.85 143.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 122.203 1.002 . . . . 0.0 111.558 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -144.32 151.05 38.81 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -134.56 126.14 28.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.712 -1.242 . . . . 0.0 110.951 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.71 114.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.53 152.83 38.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.862 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.26 -164.49 0.11 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.391 -0.818 . . . . 0.0 109.274 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -62.55 153.03 33.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.99 140.78 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.05 -1.031 . . . . 0.0 109.14 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.12 -1.97 80.83 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.2 m -118.67 151.4 38.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.566 -0.961 . . . . 0.0 109.185 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -128.15 148.9 50.61 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.49 -0.756 . . . . 0.0 108.999 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.16 144.46 28.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.51 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.92 141.99 56.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.094 -1.004 . . . . 0.0 108.929 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' HD22 ' A' ' 24' ' ' ASN . . . -59.92 -42.33 98.19 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.576 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.27 -47.64 85.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.044 -1.268 . . . . 0.0 110.153 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.74 -28.26 66.65 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.9 tt -73.44 -59.8 2.54 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.115 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.07 -41.43 92.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 109.264 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.56 ' CG ' HE21 ' A' ' 34' ' ' GLN . 42.7 t30 -62.91 -43.3 99.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 110.02 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.1 p -65.55 -38.59 90.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.03 -46.21 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.998 -1.064 . . . . 0.0 109.358 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.5 -40.85 98.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.734 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.56 HE21 ' CG ' ' A' ' 30' ' ' ASN . 74.7 mt-30 -67.8 -22.3 65.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 110.036 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.06 8.09 9.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 82.28 12.64 80.37 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.36 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -81.19 153.74 27.05 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.741 -1.446 . . . . 0.0 109.856 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.4 mt -124.38 133.89 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -60.89 98.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.908 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.91 171.1 44.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.99 -163.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -1.219 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.3 mtt 58.46 20.0 7.04 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 49.95 39.95 19.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.671 -0.643 . . . . 0.0 111.248 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 pt -141.08 167.25 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.052 -1.03 . . . . 0.0 108.817 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -93.49 123.33 36.72 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.971 -1.08 . . . . 0.0 110.552 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.446 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 39.9 m80 -106.53 136.45 46.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.686 -0.634 . . . . 0.0 109.367 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HG2' HH11 ' A' ' 47' ' ' ARG . 0.0 OUTLIER -99.89 128.43 45.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 108.598 178.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.41 165.18 11.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.534 -0.729 . . . . 0.0 109.14 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 tp -59.73 -49.32 78.21 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.2 m -90.54 145.0 31.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.855 . . . . 0.0 109.142 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -67.2 -10.72 29.59 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 120.679 0.919 . . . . 0.0 111.712 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 44.8 t0 -92.91 -1.33 56.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 109.815 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.4 t -70.03 -40.06 75.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.942 -1.328 . . . . 0.0 109.391 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.61 160.99 45.93 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.46 170.97 10.09 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.397 1.099 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.509 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.34 129.94 35.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.277 -0.89 . . . . 0.0 109.638 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.3 mp -101.76 -39.58 7.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.188 -0.945 . . . . 0.0 109.679 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -150.0 162.88 39.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.09 -1.006 . . . . 0.0 108.692 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 14.1 m -129.61 173.06 10.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.961 0.886 . . . . 0.0 111.273 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.7 tt -131.79 129.96 41.2 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.37 162.94 29.82 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 93.8 m-20 -74.25 157.22 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 109.651 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -69.92 -28.21 65.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.747 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.68 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -60.06 152.25 62.09 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.95 1.9 48.71 Favored 'Cis proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.58 0.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.62 -0.11 79.74 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.9 p -87.81 169.55 11.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -1.111 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 94.0 m-85 -121.3 140.8 51.6 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 73' ' ' GLU . 75.9 m-20 -121.7 150.21 54.81 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -50.45 -9.17 0.17 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 119.267 0.774 . . . . 0.0 111.63 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.1 mm-40 -90.12 6.84 40.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.856 . . . . 0.0 109.498 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.439 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 68.9 mmm -86.39 21.84 1.99 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 26.7 mtpp -86.0 -6.9 58.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.901 -1.124 . . . . 0.0 109.07 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.2 m-20 -149.94 80.12 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.2 170.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.834 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.7 p -133.98 152.28 51.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.16 148.43 18.38 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.077 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -46.66 -44.17 22.0 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 CA-C-N 119.094 0.712 . . . . 0.0 111.232 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.16 -152.98 11.05 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.453 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -129.98 160.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.994 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.5 m -114.42 120.52 40.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.2 129.98 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -145.7 152.97 40.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.022 -1.048 . . . . 0.0 110.592 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.5 ttm -109.2 129.92 55.49 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.702 -0.624 . . . . 0.0 109.376 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 108.758 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 9' ' ' ALA . 2.1 m -98.16 151.14 37.38 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.207 -0.933 . . . . 0.0 108.569 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.91 138.19 53.8 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.043 -1.232 . . . . 0.0 112.57 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.9 m -113.24 149.41 33.83 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.488 0.661 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -70.95 149.2 46.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -0.772 . . . . 0.0 110.023 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.04 -164.16 32.2 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -98.38 114.66 27.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -1.145 . . . . 0.0 109.359 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.89 -27.95 63.76 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.0 -41.68 61.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 108.133 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.14 -34.55 77.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.13 -50.02 74.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.53 -39.97 89.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -61.17 -40.0 92.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.95 -45.02 93.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 108.997 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.24 -42.53 99.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.328 -0.858 . . . . 0.0 108.866 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.7 mm-40 -60.18 -40.13 88.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 109.135 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.3 p -70.48 -40.0 73.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.515 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.73 43.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 110.044 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.83 -37.68 85.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 5.7 m-70 -59.94 -49.36 77.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.074 -1.016 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 89.2 mt -60.06 -46.44 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.303 -0.873 . . . . 0.0 108.729 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.66 -46.81 63.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.443 -0.785 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.49 -40.08 90.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 110.547 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.89 -40.1 75.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -0.965 . . . . 0.0 110.931 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 114' ' ' GLY . 12.8 m -100.18 0.75 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.187 -0.946 . . . . 0.0 110.018 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.58 25.32 70.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -86.07 -173.04 49.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -129.9 132.76 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.691 -0.887 . . . . 0.0 109.285 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.52 134.68 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.302 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.9 mt -135.05 159.95 39.87 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -86.47 -169.2 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.506 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 96.8 m-20 -60.06 -38.95 84.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -75.4 12.42 0.98 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.28 37.58 28.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.803 -0.56 . . . . 0.0 109.764 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -117.11 158.72 23.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.713 -0.617 . . . . 0.0 109.747 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.1 mmm -51.17 120.67 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.297 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 mtp -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.195 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -130.18 152.12 79.58 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -43.96 -42.97 12.49 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 120.582 0.855 . . . . 0.0 111.976 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.88 -39.93 91.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.83 -40.02 83.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.854 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.1 mt -57.54 -40.04 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.95 -39.96 93.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.592 -0.692 . . . . 0.0 109.265 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.42 -47.25 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.125 -0.985 . . . . 0.0 109.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 55.7 m-85 -60.06 -41.98 93.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 108.983 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.36 -40.09 89.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.3 m-20 -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.63 -43.82 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.118 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 78.6 mt -60.18 -39.95 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.964 . . . . 0.0 109.798 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.0 -39.98 87.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.961 -1.087 . . . . 0.0 109.104 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.15 -30.72 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.0 mmtt -59.98 -45.0 94.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.023 -1.048 . . . . 0.0 110.446 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -59.92 -36.2 76.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.845 -1.16 . . . . 0.0 109.805 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.29 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -103.7 -0.56 29.29 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.328 -0.858 . . . . 0.0 110.353 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -150.56 135.45 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.01 177.99 10.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.208 -1.557 . . . . 0.0 112.011 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.54 138.88 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -91.28 126.37 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -125.78 145.05 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 121.961 0.886 . . . . 0.0 110.806 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.5 mtm -148.33 154.37 39.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' ' 83' ' ' THR . 15.1 m120 -132.15 131.84 42.64 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.963 -1.086 . . . . 0.0 111.383 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -109.17 118.81 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 156.79 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.21 175.63 5.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.473 -0.767 . . . . 0.0 109.059 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -56.08 160.14 3.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.228 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -60.07 141.72 55.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.389 -0.82 . . . . 0.0 109.832 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.28 2.02 74.47 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.1 m -125.52 148.52 48.86 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.422 -1.046 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.0 151.37 50.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.452 -0.78 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.17 139.54 30.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.323 -0.86 . . . . 0.0 110.331 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.63 141.42 56.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.813 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.23 96.43 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.39 -47.46 85.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.324 . . . . 0.0 109.56 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.34 -25.81 64.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 108.817 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.13 -55.61 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.566 -0.709 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.86 -49.03 79.29 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 0.0 110.315 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 39.9 t30 -60.07 -44.52 94.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 111.591 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.7 m -61.83 -42.92 99.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.866 -1.146 . . . . 0.0 110.369 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.79 -44.86 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.964 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.22 -40.0 95.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.71 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 50.9 mt-30 -69.48 -19.72 63.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.19 -0.944 . . . . 0.0 111.431 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.502 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -81.47 -9.89 59.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.626 -1.296 . . . . 0.0 110.83 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.551 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.72 8.75 22.17 Favored Glycine 0 N--CA 1.502 3.086 0 O-C-N 121.029 -1.044 . . . . 0.0 110.817 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.677 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 38.1 m-85 -81.59 144.6 31.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.827 -1.396 . . . . 0.0 110.094 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.47 132.23 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.07 106.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 110.131 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.6 171.9 29.54 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.78 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -1.109 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.2 mtt 58.12 20.09 6.67 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.687 0.756 . . . . 0.0 109.777 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 52.94 33.7 15.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 111.613 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.97 163.28 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -89.75 129.2 36.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.981 -1.075 . . . . 0.0 110.689 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.6 m80 -115.72 130.02 56.69 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.677 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 39.9 ttm180 -104.64 124.31 49.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 24.9 m-70 -92.89 170.01 10.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 0.0 109.562 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.8 tp -55.66 -49.3 73.3 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -89.17 148.42 40.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -71.2 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.739 0.96 . . . . 0.0 112.372 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.69 0.23 54.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.01 -1.056 . . . . 0.0 110.383 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.82 86.3 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -72.25 -44.62 62.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.155 -1.203 . . . . 0.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -70.49 168.15 49.15 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.32 175.65 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.18 1.253 . . . . 0.0 111.837 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.85 121.25 26.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.5 mp -98.06 -55.21 2.85 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.068 -1.02 . . . . 0.0 109.715 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -142.97 160.54 40.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.07 . . . . 0.0 108.702 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 19.7 m -129.36 -179.05 4.93 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.231 1.015 . . . . 0.0 111.35 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.1 tt -139.77 130.23 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.624 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.25 168.46 18.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.47 -0.769 . . . . 0.0 109.61 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.8 m120 -77.85 166.37 22.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.753 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 80.2 mmm -69.97 -22.2 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.89 -0.506 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 68' ' ' GLY . 14.3 t -87.66 118.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -62.27 149.31 87.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.206 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.47 10.73 15.5 Favored 'Cis proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.91 -1.287 . . . . 0.0 111.484 -1.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 79.04 29.12 52.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.7 p -86.03 169.04 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -1.108 . . . . 0.0 110.676 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.3 m-85 -126.06 156.38 40.06 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.1 p-10 -135.6 148.49 65.88 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.01 -16.82 6.76 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.503 0.858 . . . . 0.0 111.665 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -89.91 6.98 39.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.083 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.546 ' SD ' ' O ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.51 21.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.82 . . . . 0.0 109.808 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -86.05 -8.58 57.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.997 . . . . 0.0 109.911 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 83.7 m-20 -144.57 82.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.256 -0.903 . . . . 0.0 108.912 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.03 172.31 18.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 109.065 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.4 p -131.18 152.32 50.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.368 -0.833 . . . . 0.0 108.76 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.28 149.44 19.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -43.91 -49.73 8.02 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 120.495 0.796 . . . . 0.0 111.719 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.39 -152.26 8.7 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.99 160.89 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.6 -0.941 . . . . 0.0 109.573 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.45 HG23 ' ND2' ' A' ' 14' ' ' ASN . 52.8 m -112.15 128.03 56.1 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.558 -0.714 . . . . 0.0 110.103 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.98 130.0 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -149.64 167.08 27.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.565 -1.335 . . . . 0.0 110.879 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 ttp -132.94 130.8 40.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' OG ' ' A' ' 90' ' ' SER . 91.8 mt-30 -87.59 108.52 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 108.953 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.4 OUTLIER -97.54 144.05 27.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 88' ' ' VAL . 5.9 Cg_exo -74.04 134.91 37.73 Favored 'Cis proline' 0 N--CA 1.498 1.761 0 C-N-CA 124.341 -1.108 . . . . 0.0 113.371 0.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.3 m -110.41 159.91 17.06 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.54 0.686 . . . . 0.0 109.828 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -70.75 142.18 51.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.174 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.33 -159.71 26.41 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.59 123.55 39.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.16 -1.2 . . . . 0.0 109.562 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 39.5 mp0 -59.93 -36.61 77.41 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 110.402 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.69 -38.81 80.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.958 . . . . 0.0 109.955 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -69.97 -39.96 75.66 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.892 -1.13 . . . . 0.0 108.123 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -61.34 -39.99 92.6 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 102' ' ' LEU . 91.1 t80 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.85 -41.37 97.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.087 -1.008 . . . . 0.0 109.007 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.24 -39.98 94.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.897 . . . . 0.0 109.041 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.1 mtp -58.13 -48.36 80.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.429 -0.794 . . . . 0.0 109.312 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 98' ' ' PHE . 98.7 mt -63.66 -42.68 98.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.922 -1.111 . . . . 0.0 109.184 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -41.72 92.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.711 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -69.94 -39.98 75.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.39 58.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -62.2 -40.63 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.001 -1.062 . . . . 0.0 110.084 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -60.47 -47.45 86.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.174 . . . . 0.0 108.749 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.92 -50.02 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.03 -49.97 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.661 -0.649 . . . . 0.0 109.844 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.18 -40.19 89.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.282 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.9 -40.01 75.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.937 . . . . 0.0 111.151 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.3 m -100.69 -1.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.084 -1.01 . . . . 0.0 109.826 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 24.63 75.38 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.9 -176.42 51.14 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.46 133.03 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.636 -0.92 . . . . 0.0 108.905 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 t -70.24 130.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.013 -1.054 . . . . 0.0 109.096 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 14' ' ' ASN . 77.4 mt -129.23 155.99 44.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.587 -0.695 . . . . 0.0 109.286 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.515 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 30.4 p-10 -85.42 -172.64 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 109.481 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.1 m-20 -60.01 -38.71 83.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.65 16.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.377 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.0 mtm180 56.1 33.55 22.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -109.87 149.1 30.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 0.0 109.144 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 65.5 mtt -50.75 135.73 23.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.977 . . . . 0.0 109.265 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.67 137.15 57.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -134.47 150.35 73.56 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.02 -42.37 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 119.162 0.736 . . . . 0.0 111.879 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -60.6 -39.98 90.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 51.0 mmtt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.058 -1.026 . . . . 0.0 110.051 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.9 -43.15 94.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -69.3 -32.9 72.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.799 -1.188 . . . . 0.0 109.747 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -59.98 -45.31 93.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.005 -1.06 . . . . 0.0 108.876 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -60.78 -41.07 94.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.69 -39.96 93.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 0.0 109.085 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.54 -40.2 96.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.65 -42.06 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.03 -41.93 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.208 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.5 mtt180 -61.92 -37.65 85.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.7 mt-10 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.778 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.35 -32.16 30.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.9 mmmm -60.07 -45.92 91.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.075 -1.016 . . . . 0.0 110.17 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.79 -31.83 71.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.754 -1.216 . . . . 0.0 108.892 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.01 94.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 110.385 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 55.6 p30 -97.91 0.37 46.41 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 0.0 110.104 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.545 -179.88 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -145.0 151.86 39.24 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.29 160.34 32.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 109.932 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.16 129.99 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.27 117.16 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 84.2 mt -121.58 142.16 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 121.946 0.879 . . . . 0.0 111.191 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.0 mtm -146.1 150.18 35.45 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -129.71 128.67 42.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.972 -1.08 . . . . 0.0 111.291 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.45 116.4 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' VAL . . . -147.34 157.24 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 109.97 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.89 -174.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 109.063 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -61.02 156.65 17.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 108.88 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -60.02 140.12 57.01 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.51 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.18 70.23 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -121.11 147.3 45.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.551 -0.97 . . . . 0.0 109.699 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -125.87 145.5 50.22 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.42 149.18 25.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 110.564 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -70.84 145.27 50.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.129 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.56 -42.05 99.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.51 -43.75 98.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.301 . . . . 0.0 110.166 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.79 -27.02 64.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.0 tt -75.12 -57.86 3.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.541 -0.724 . . . . 0.0 109.912 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.32 -42.33 95.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.0 110.532 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -64.04 -40.06 95.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.2 m -65.19 -41.38 94.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 110.419 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.02 -46.88 93.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.009 -1.057 . . . . 0.0 109.4 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -65.38 -43.25 91.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 0.0 109.401 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -17.24 64.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.432 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.35 1.57 36.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.023 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.71 9.55 66.2 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 121.071 -1.018 . . . . 0.0 111.016 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -80.75 151.07 29.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.822 -1.399 . . . . 0.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.9 mt -120.0 130.67 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.88 101.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.995 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.05 171.22 38.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.3 -163.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.469 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.7 mtm 58.03 23.25 9.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.428 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.36 39.41 20.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 111.231 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.0 pt -142.0 164.84 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.026 -1.047 . . . . 0.0 109.429 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -91.89 136.28 33.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.072 -1.017 . . . . 0.0 109.886 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 43.8 m-70 -125.16 125.11 43.18 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.726 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.7 ttt180 -105.09 125.53 51.08 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.501 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 34.2 m-70 -94.73 173.99 7.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.442 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.64 -50.76 65.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.261 -0.899 . . . . 0.0 108.832 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -93.83 144.06 27.52 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 0.0 108.784 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.36 -4.42 11.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 120.57 0.847 . . . . 0.0 112.149 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -91.48 -0.94 57.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.383 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.28 86.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 t -69.95 -41.01 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -1.198 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.37 169.13 54.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.501 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.1 Cg_endo -69.55 173.47 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.2 1.266 . . . . 0.0 111.427 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 120.8 25.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.034 . . . . 0.0 108.649 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.591 HD23 ' ND2' ' A' ' 97' ' ' ASN . 9.7 mp -100.81 -35.08 9.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.234 -0.916 . . . . 0.0 109.75 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -153.47 165.45 35.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.924 -1.11 . . . . 0.0 108.762 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 5.4 m -138.48 161.97 35.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.037 -1.039 . . . . 0.0 111.229 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.6 tt -114.75 135.07 54.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.547 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.41 162.08 32.01 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.587 -0.696 . . . . 0.0 109.29 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.606 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 76.6 m-20 -78.64 166.85 22.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.015 -1.053 . . . . 0.0 110.053 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.4 mmm -69.92 -23.09 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.465 -0.772 . . . . 0.0 110.205 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -88.14 112.5 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 110.521 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -60.3 150.42 72.41 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -77.87 8.55 19.93 Favored 'Cis proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.114 -1.202 . . . . 0.0 111.982 -0.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.43 35.83 25.16 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.6 p -85.94 160.47 19.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.256 -1.143 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 32.7 m-85 -128.52 139.02 52.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 t70 -127.77 137.82 31.57 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -48.13 -4.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.591 1.247 . . . . 0.0 112.888 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -90.83 3.96 53.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.054 -1.028 . . . . 0.0 111.345 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.502 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 21.5 mtm -79.72 26.14 0.32 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.567 -1.333 . . . . 0.0 110.099 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.0 mmtp -81.91 2.39 30.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.581 -1.325 . . . . 0.0 109.261 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 70.1 m-20 -153.79 81.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 108.76 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -158.84 171.41 20.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.11 -0.994 . . . . 0.0 109.964 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.7 p -137.88 154.68 49.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.23 149.12 17.35 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 109.19 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -46.93 -45.22 21.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 120.786 0.991 . . . . 0.0 112.027 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.23 -152.84 10.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.94 159.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -1.05 . . . . 0.0 109.396 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ALA . 51.9 m -111.53 124.94 53.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.226 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.11 130.61 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.77 160.41 41.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 110.85 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.9 ttp -141.46 131.73 25.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.658 -0.651 . . . . 0.0 109.622 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.18 115.21 27.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.048 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.24 152.38 38.65 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.357 -0.839 . . . . 0.0 109.065 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.644 ' CG ' HD22 ' A' ' 143' ' ' ASN . 6.5 Cg_endo -77.63 136.77 44.29 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.655 -1.394 . . . . 0.0 112.149 -0.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.9 m -104.59 166.52 10.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.574 -0.704 . . . . 0.0 109.721 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -68.93 141.5 54.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.446 -0.784 . . . . 0.0 109.045 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.78 28.4 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -94.19 115.33 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.966 -1.314 . . . . 0.0 109.703 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 50.5 mp0 -58.05 -28.0 64.11 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.696 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.8 mt -69.73 -40.04 76.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.196 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -73.05 -40.51 65.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.901 -1.124 . . . . 0.0 108.948 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.591 ' ND2' HD23 ' A' ' 58' ' ' LEU . 26.9 m120 -61.86 -41.96 98.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 102' ' ' LEU . 73.8 t80 -59.86 -49.92 75.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.75 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.13 -39.96 94.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -43.39 95.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.0 mtp -57.78 -44.57 86.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 108.746 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.4 mt -62.0 -41.21 97.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 108.726 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.2 mt-30 -60.15 -41.54 92.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.086 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -70.28 -39.89 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 109.147 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.82 68.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 110.435 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -60.76 -37.83 83.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.87 -1.144 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 19.3 m-70 -60.06 -50.05 75.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.048 -1.033 . . . . 0.0 109.151 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.9 -50.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.539 -0.725 . . . . 0.0 109.652 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.46 -49.36 55.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.58 -39.78 89.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 110.338 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.11 -40.06 75.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.675 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.1 m -98.84 0.4 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.055 -1.028 . . . . 0.0 109.491 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.22 21.87 75.9 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -79.94 -176.8 49.96 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 16' ' ' ALA . 58.4 t -135.33 140.74 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.6 -0.941 . . . . 0.0 108.952 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.536 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -73.3 127.95 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.978 . . . . 0.0 109.945 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 mt -128.8 153.62 47.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.76 -178.04 6.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' NH1' ' A' ' 121' ' ' ARG . 97.9 m-20 -59.39 -28.89 67.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.049 -1.032 . . . . 0.0 109.082 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -82.13 12.36 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 108.972 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 119' ' ' ASP . 14.6 mmt-85 61.48 27.59 17.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.7 -0.625 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -107.88 147.8 30.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 0.0 109.328 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . 0.402 ' SD ' HG11 ' A' ' 115' ' ' VAL . 92.2 mmm -50.41 121.6 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.665 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.536 ' SD ' HG12 ' A' ' 116' ' ' VAL . 35.2 mtp -59.79 139.93 56.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.839 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -130.29 151.0 77.74 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -41.94 -41.64 6.54 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 120.503 0.802 . . . . 0.0 111.622 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.07 -42.19 94.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.445 -0.784 . . . . 0.0 109.235 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.49 -39.88 77.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.862 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.5 mt -56.61 -40.09 74.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.814 -1.179 . . . . 0.0 108.373 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -64.63 -38.23 90.29 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.017 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.98 -45.56 92.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.971 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.23 -41.96 94.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.862 -1.149 . . . . 0.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.62 -39.78 92.49 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 97.6 m-20 -60.06 -39.63 86.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.513 -0.742 . . . . 0.0 109.183 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.1 mt -59.93 -41.73 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 108.65 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.21 -39.87 81.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.36 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.528 ' HG2' HH11 ' A' ' 137' ' ' ARG . 16.3 mtt-85 -59.99 -40.14 88.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.576 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -60.39 -39.8 88.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.925 -1.109 . . . . 0.0 109.035 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.6 -32.03 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.6 mttt -60.0 -42.68 94.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.841 -1.162 . . . . 0.0 110.923 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.985 -1.072 . . . . 0.0 109.854 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.89 -59.13 3.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.924 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.644 HD22 ' CG ' ' A' ' 89' ' ' PRO . 80.9 m-20 -103.9 -14.57 15.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.296 -0.878 . . . . 0.0 110.478 -178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.4 148.11 29.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.47 175.97 8.6 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.67 -1.269 . . . . 0.0 110.359 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.08 131.44 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -91.25 125.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.12 144.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.896 0.855 . . . . 0.0 110.867 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.5 mtt -144.6 156.16 43.99 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.5 126.72 24.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.959 -1.088 . . . . 0.0 111.022 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.01 119.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.3 158.63 44.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.775 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.65 -164.49 0.09 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -69.26 159.42 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 108.815 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -60.07 140.79 56.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.09 80.39 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.8 m -110.04 152.4 25.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.391 -1.064 . . . . 0.0 109.216 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -130.25 149.03 52.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.8 140.36 29.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.02 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.82 143.42 54.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.12 96.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.03 -44.83 96.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -1.209 . . . . 0.0 109.545 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.02 -29.48 66.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -0.812 . . . . 0.0 108.931 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.3 tt -71.14 -57.3 4.64 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.6 -0.687 . . . . 0.0 109.456 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.99 -43.41 95.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.187 -0.946 . . . . 0.0 110.476 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.93 -40.02 94.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 110.056 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -65.51 -40.16 92.68 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.928 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -48.34 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -62.23 -43.32 99.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.982 . . . . 0.0 110.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.87 -20.01 66.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.5 5.62 17.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.35 85.14 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -81.22 154.37 26.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.038 -1.272 . . . . 0.0 109.619 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.9 mt -128.63 142.81 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -59.04 99.92 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.113 -0.992 . . . . 0.0 109.542 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.22 168.85 45.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -62.99 -163.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.496 -1.003 . . . . 0.0 108.923 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt 56.5 22.2 6.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -0.819 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.6 m120 51.89 40.09 27.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 111.146 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.08 170.03 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 109.327 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.22 135.08 34.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.978 -1.076 . . . . 0.0 109.836 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 6.2 m-70 -119.53 133.91 55.46 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.407 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 7.5 tpt180 -102.38 120.97 41.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.385 -0.822 . . . . 0.0 108.972 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 68.7 m-70 -98.26 170.06 9.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 109.723 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.26 -49.98 74.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 108.988 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.8 m -91.93 147.78 35.61 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.95 -6.18 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.671 0.914 . . . . 0.0 112.794 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -93.23 -0.89 56.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.917 -1.115 . . . . 0.0 110.158 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.43 12.09 84.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.466 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.9 p -70.2 -39.9 74.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.53 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.88 167.1 51.05 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.03 171.31 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.228 1.285 . . . . 0.0 112.113 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.35 122.82 28.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.209 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' OD1' ' A' ' 97' ' ' ASN . 8.4 mp -98.91 -36.87 9.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.228 -0.92 . . . . 0.0 109.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.8 162.31 40.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 108.589 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.529 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 4.4 m -131.06 175.99 8.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.081 -1.012 . . . . 0.0 111.859 -177.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.65 131.69 33.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.44 162.17 35.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.4 m120 -77.2 162.92 27.01 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.212 -0.93 . . . . 0.0 110.751 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mtt -69.96 -23.72 63.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.598 -0.689 . . . . 0.0 110.396 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -85.85 119.99 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.971 -1.081 . . . . 0.0 109.632 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -59.89 149.71 71.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.52 -0.738 . . . . 0.0 109.064 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -77.12 8.94 16.4 Favored 'Cis proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.758 -0.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 16.69 76.52 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.1 p -87.99 173.56 8.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.079 -1.247 . . . . 0.0 109.924 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.04 140.12 51.49 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLU . 5.6 m-20 -126.52 150.08 69.66 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -45.39 -12.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.6 0.867 . . . . 0.0 111.93 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -83.54 13.22 4.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.4 ptt? -83.82 -1.39 54.25 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.513 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 98.9 mttt -85.94 -3.78 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.798 -1.189 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.0 m-20 -150.45 75.75 1.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.686 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -159.06 168.98 25.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.118 -0.989 . . . . 0.0 109.414 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.8 p -136.53 155.56 49.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.44 150.43 20.7 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 109.449 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -47.22 -46.72 18.86 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 120.366 0.711 . . . . 0.0 111.24 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.38 -151.04 8.06 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.98 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.529 -0.983 . . . . 0.0 109.322 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.5 m -113.02 120.18 40.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 0.0 109.489 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.21 129.97 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -143.71 163.69 32.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.125 -0.984 . . . . 0.0 110.496 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.0 ttp -138.97 129.74 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.713 -0.617 . . . . 0.0 109.563 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -92.28 119.71 32.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 0.0 109.117 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -102.75 150.31 37.6 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.24 133.76 32.69 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.568 0.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.8 m -102.18 170.23 8.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.95 139.95 55.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.377 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.82 -154.38 24.65 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -99.58 122.02 42.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.299 -1.118 . . . . 0.0 109.652 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.6 mp0 -55.87 -28.61 57.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.5 -39.93 77.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.037 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -40.34 70.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.095 -1.003 . . . . 0.0 109.102 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.741 ' OD1' HD23 ' A' ' 58' ' ' LEU . 98.6 m-20 -60.59 -40.04 90.3 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 102' ' ' LEU . 86.2 t80 -57.02 -41.43 78.54 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.41 -42.03 99.14 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.137 -0.977 . . . . 0.0 108.733 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.01 -39.99 95.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 108.71 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mmm -57.23 -50.12 73.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.832 . . . . 0.0 109.497 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.545 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.8 mt -64.35 -47.75 78.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.24 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.529 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -60.0 -40.84 90.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.782 . . . . 0.0 109.217 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 p -71.96 -42.93 65.99 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.167 -0.958 . . . . 0.0 109.298 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.12 -54.53 44.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -62.78 -35.09 78.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.585 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.8 m-70 -60.05 -49.94 75.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 112' ' ' VAL . 81.5 mt -59.97 -49.91 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.889 -1.132 . . . . 0.0 108.011 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.95 -49.22 66.49 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.04 -40.01 91.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.558 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.94 77.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.8 m -96.12 0.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.975 -1.078 . . . . 0.0 108.873 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 21.67 76.91 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . -84.07 -169.68 45.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -131.97 138.11 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.602 -0.94 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG12 ' SD ' ' A' ' 124' ' ' MET . 19.8 t -73.69 138.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.284 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.28 160.0 37.5 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.436 -0.79 . . . . 0.0 109.649 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -84.13 -171.67 3.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.402 -0.811 . . . . 0.0 109.672 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.512 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 94.7 m-20 -60.01 -39.86 87.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.217 -0.927 . . . . 0.0 110.083 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.43 14.47 0.97 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -0.909 . . . . 0.0 109.396 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 57.4 37.63 28.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.745 -0.597 . . . . 0.0 109.744 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -112.13 151.48 29.42 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 19.5 mmt -50.2 126.37 14.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.957 -1.09 . . . . 0.0 109.284 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 116' ' ' VAL . 24.9 mtt -58.9 139.97 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.788 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -129.12 151.36 77.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -41.47 -45.0 6.1 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 120.762 0.975 . . . . 0.0 112.184 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -60.8 -39.9 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.768 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -63.74 -40.05 95.79 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.243 -0.91 . . . . 0.0 109.717 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.57 -40.05 86.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.706 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -66.26 -37.94 86.64 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.615 -0.678 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.13 -49.99 75.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.528 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.512 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 73.1 m-85 -59.97 -49.37 77.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 108.738 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.17 -38.05 82.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.08 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.1 -40.96 91.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.149 -0.969 . . . . 0.0 109.67 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.65 -40.06 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.639 -1.288 . . . . 0.0 108.467 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.97 -47.57 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.15 -39.89 87.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.863 . . . . 0.0 108.915 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 89.6 mt-10 -60.98 -41.1 95.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.85 -39.95 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -60.01 -44.92 94.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.349 -0.844 . . . . 0.0 111.592 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.6 p30 -59.97 -34.15 72.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.574 -1.329 . . . . 0.0 109.112 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.39 -35.92 82.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.027 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -97.31 -0.23 46.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.741 . . . . 0.0 109.382 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.39 144.11 27.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.17 9.83 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.584 -1.322 . . . . 0.0 110.148 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.81 130.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.17 122.67 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.2 mt -120.06 147.63 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.23 1.014 . . . . 0.0 111.372 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -143.81 147.37 34.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.43 120.96 25.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.5 117.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.54 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.452 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.53 -164.49 0.12 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.9 155.03 39.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.925 -1.109 . . . . 0.0 108.482 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -59.93 139.99 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.076 . . . . 0.0 109.349 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.57 3.5 66.6 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -124.42 149.43 46.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.501 -1.0 . . . . 0.0 109.248 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.73 145.81 50.46 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.21 146.34 27.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -68.67 143.62 54.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 109.156 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.55 -43.43 98.88 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.28 -45.67 92.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -1.214 . . . . 0.0 110.152 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.79 -29.83 67.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -71.32 -58.79 3.2 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.583 -0.698 . . . . 0.0 109.347 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.7 mt -60.09 -41.63 92.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.62 -39.89 94.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -64.26 -40.81 96.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.695 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.19 -44.64 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.333 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.34 -40.37 95.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.029 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' OE1' ' OE2' ' A' ' 111' ' ' GLU . 78.0 mt-30 -68.27 -20.04 64.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.279 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.71 7.29 15.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.196 -0.94 . . . . 0.0 110.292 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.63 83.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.988 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -80.63 152.53 28.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.434 . . . . 0.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.39 145.26 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.82 118.86 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.0 108.966 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -87.67 171.57 41.59 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.6 -162.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.569 -0.96 . . . . 0.0 109.711 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 89.8 mmm 54.78 -101.34 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' MET . 26.7 m120 -163.27 31.85 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 pt -134.69 163.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.494 -0.754 . . . . 0.0 110.115 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 66.8 m-85 -88.07 134.41 33.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.296 -0.878 . . . . 0.0 110.143 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.451 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 8.0 m-70 -118.34 129.79 55.64 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.55 HH21 HD22 ' A' ' 100' ' ' LEU . 15.9 ttt180 -106.11 125.42 50.97 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.568 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 49.4 m-70 -95.13 174.12 7.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.824 . . . . 0.0 110.222 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.33 -49.97 74.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.8 m -92.7 147.89 35.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.28 -0.887 . . . . 0.0 108.693 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.12 -5.95 17.07 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.68 0.92 . . . . 0.0 112.06 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -92.65 1.28 57.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.179 -0.95 . . . . 0.0 110.204 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.74 11.45 84.53 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -70.15 -40.07 74.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.241 . . . . 0.0 110.091 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.547 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.0 169.82 53.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.568 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.4 Cg_endo -72.78 -179.96 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.133 1.222 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.43 123.4 29.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 108.729 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.2 mp -101.02 -28.3 12.8 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -159.94 165.31 32.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.599 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.451 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 17.2 m -132.48 170.11 15.6 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.129 -0.982 . . . . 0.0 111.53 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.7 tt -132.63 130.96 40.88 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.625 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.14 169.68 17.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 91.7 m-20 -75.14 163.49 27.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 109.617 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -70.02 -21.68 63.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.44 -0.788 . . . . 0.0 110.464 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.17 114.85 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.109 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -60.13 149.75 73.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.417 -0.802 . . . . 0.0 109.422 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -76.49 6.8 16.3 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.858 -1.309 . . . . 0.0 111.374 -1.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.89 31.23 49.5 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 p -86.09 165.85 16.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.286 . . . . 0.0 109.944 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.548 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.24 148.65 43.42 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' MET . 1.8 p30 -133.96 151.4 76.7 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.34 -11.86 0.41 Allowed 'Trans proline' 0 N--CA 1.486 1.072 0 CA-C-N 119.429 0.832 . . . . 0.0 110.362 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 75.3 mm-40 -82.17 6.48 16.42 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 23.3 ptt? -79.61 1.65 25.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -85.02 -2.15 57.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.82 -1.175 . . . . 0.0 108.267 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -154.09 78.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -159.3 167.61 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.221 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.6 p -140.72 154.58 46.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.235 -0.916 . . . . 0.0 108.936 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.83 150.16 21.02 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.075 -1.015 . . . . 0.0 109.248 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -41.93 -36.87 3.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 120.724 0.95 . . . . 0.0 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.41 -150.63 12.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.97 159.97 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 109.58 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -113.17 125.9 54.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.675 . . . . 0.0 109.632 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.12 129.97 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -146.79 166.26 27.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.972 -1.08 . . . . 0.0 110.274 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 50.3 ttp -137.33 131.32 32.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 90' ' ' SER . 90.4 mm-40 -88.15 117.73 27.25 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -105.5 148.2 35.94 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 137.5 50.24 Favored 'Cis proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.695 -1.377 . . . . 0.0 112.262 -0.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 51.2 m -103.73 166.94 10.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.502 -0.749 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -72.19 146.22 47.51 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.587 -0.696 . . . . 0.0 109.352 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 -156.35 31.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.14 111.95 23.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -1.135 . . . . 0.0 109.019 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.8 mp0 -54.18 -26.46 28.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.467 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.9 mt -70.02 -39.95 75.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.0 108.68 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -71.61 -40.02 70.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.601 ' N ' HD22 ' A' ' 97' ' ' ASN . 1.7 m120 -59.99 -40.41 89.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 102' ' ' LEU . 89.8 t80 -59.91 -45.45 92.52 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.44 -40.59 97.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 HH21 ' A' ' 47' ' ' ARG . 92.6 mt -60.98 -40.04 91.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 108.842 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp -59.41 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 98' ' ' PHE . 99.5 mt -65.26 -43.46 91.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.176 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 77.8 mt-30 -60.1 -39.98 88.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 p -70.47 -40.06 73.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.413 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.13 -53.78 54.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 110.239 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -61.88 -41.09 97.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.876 -1.14 . . . . 0.0 109.244 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 28.0 m-70 -60.34 -50.01 75.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.14 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 112' ' ' VAL . 90.5 mt -60.8 -49.99 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.101 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.49 -49.47 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.503 -0.748 . . . . 0.0 109.135 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.07 -40.1 88.32 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.428 -0.795 . . . . 0.0 110.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.406 ' OE2' ' OE1' ' A' ' 34' ' ' GLN . 41.4 mt-10 -69.57 -39.92 77.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.975 -1.078 . . . . 0.0 110.721 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.6 m -99.65 -2.24 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.059 -1.026 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.06 23.76 76.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.07 -176.15 51.07 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.289 -1.124 . . . . 0.0 110.57 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.03 136.32 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.945 . . . . 0.0 109.692 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.64 133.13 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -133.15 161.81 33.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.802 . . . . 0.0 109.168 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -84.23 -170.57 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.915 . . . . 0.0 109.702 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 89.4 m-20 -60.09 -39.94 87.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.85 . . . . 0.0 110.046 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.547 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.6 mt-30 -80.33 14.18 2.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 59.68 34.52 22.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.983 -0.448 . . . . 0.0 111.702 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.547 HH12 ' CD ' ' A' ' 120' ' ' GLN . 50.9 mtm-85 -107.19 158.0 17.44 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.042 -1.036 . . . . 0.0 108.821 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.9 mtm -52.59 130.52 32.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.942 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mmm -59.94 141.57 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 110.066 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.0 p -132.25 150.04 74.88 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -47.3 -42.37 27.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.513 0.862 . . . . 0.0 112.082 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.09 -39.87 87.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.312 -0.868 . . . . 0.0 109.579 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -66.72 -40.02 88.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.94 -40.25 88.29 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.835 -1.166 . . . . 0.0 109.412 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.9 -37.66 86.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.349 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.87 -48.89 79.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.951 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.02 -45.36 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.986 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.8 -39.99 93.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.21 -40.02 88.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.28 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.07 -40.7 84.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.922 -1.112 . . . . 0.0 108.711 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.447 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.6 mmt180 -63.55 -36.15 82.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.18 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.02 -39.93 87.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.515 -0.741 . . . . 0.0 109.856 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.33 -35.15 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -59.77 -47.19 86.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 0.0 110.109 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -60.59 -31.96 71.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.871 -1.143 . . . . 0.0 109.3 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.99 92.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.589 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.79 0.26 44.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 108.904 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -144.36 142.59 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.73 -175.65 4.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.724 -1.235 . . . . 0.0 110.602 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -133.39 139.06 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mm -91.62 131.12 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.0 mt -121.11 147.29 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.989 0.9 . . . . 0.0 110.979 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.3 mtt -147.39 156.49 42.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -136.97 118.37 14.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.879 -1.138 . . . . 0.0 110.632 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.9 t -101.24 111.19 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.72 43.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.67 -164.11 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -68.39 161.47 27.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 108.624 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -61.93 140.04 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.047 -1.033 . . . . 0.0 109.895 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.35 2.13 85.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -116.94 146.33 43.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.446 -1.032 . . . . 0.0 109.054 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.7 144.98 50.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.92 147.94 26.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.43 138.25 55.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.44 97.07 Favored Glycine 0 N--CA 1.493 2.433 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.287 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.1 -45.49 94.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.284 . . . . 0.0 109.338 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.84 -27.02 64.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.1 tt -74.41 -59.61 2.65 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.558 -0.714 . . . . 0.0 109.593 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.99 -43.52 95.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.291 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.01 -41.85 97.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -64.3 -40.99 97.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.165 -0.96 . . . . 0.0 109.676 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.08 -48.22 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.89 -40.99 95.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 109.667 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.68 -19.79 63.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.489 -0.757 . . . . 0.0 110.468 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.86 6.16 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 0.0 110.136 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.34 78.37 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -1.2 . . . . 0.0 109.995 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.74 138.82 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.46 98.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.082 . . . . 0.0 109.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 171.46 53.9 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.14 -170.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.464 -1.021 . . . . 0.0 109.578 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 70.8 mtm 56.74 30.11 17.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.484 -0.76 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 48.78 40.05 15.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 111.642 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.24 162.33 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.03 -1.044 . . . . 0.0 109.541 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.1 121.55 32.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.614 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 7.2 m-70 -103.92 130.5 51.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.296 -0.878 . . . . 0.0 109.818 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 7.5 tpt180 -101.75 120.62 40.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 59.1 m-70 -98.19 169.43 9.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -0.896 . . . . 0.0 109.735 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.67 -49.48 76.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -90.65 138.82 26.41 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.335 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.56 -7.29 14.04 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 CA-C-N 119.69 0.925 . . . . 0.0 111.616 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -92.61 -0.17 57.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.85 86.58 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.19 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -68.63 -41.38 79.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.499 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.42 163.39 50.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 15.3 Cg_endo -67.77 171.38 12.25 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.002 1.134 . . . . 0.0 112.05 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.65 120.61 24.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 108.723 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.663 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -97.04 -31.28 12.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.181 -0.949 . . . . 0.0 108.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -156.84 164.52 37.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.614 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 1.7 m -135.72 -179.09 5.44 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.104 -0.997 . . . . 0.0 111.223 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.68 132.54 35.08 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.04 160.78 33.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.2 m-20 -73.66 159.27 33.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 109.266 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.02 -21.28 63.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.867 . . . . 0.0 110.573 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 65' ' ' VAL . 5.1 m -88.16 126.21 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.844 -1.16 . . . . 0.0 109.526 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -62.29 148.82 88.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 108.529 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.92 14.91 8.8 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.609 -1.413 . . . . 0.0 112.057 -0.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 71.26 20.42 78.11 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 p -88.01 167.97 13.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -1.138 . . . . 0.0 110.494 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 51.6 m-85 -120.28 143.46 48.32 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.683 -0.635 . . . . 0.0 109.476 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -126.87 136.66 29.13 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -49.1 -11.96 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 119.852 0.983 . . . . 0.0 113.17 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -87.46 -0.69 57.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.898 -1.126 . . . . 0.0 108.714 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 93.1 mtp -88.93 24.69 2.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.1 mttm -82.69 -3.96 57.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.841 -1.162 . . . . 0.0 109.282 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 84.0 m-20 -145.14 82.8 1.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.849 . . . . 0.0 108.734 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.42 176.43 11.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.7 p -130.24 153.44 48.6 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.57 150.42 19.42 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.801 -1.187 . . . . 0.0 110.506 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -46.4 -40.23 22.49 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 120.794 0.996 . . . . 0.0 111.912 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.89 -151.71 17.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.14 159.99 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.444 -1.033 . . . . 0.0 109.411 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.5 m -114.82 119.34 36.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.7 mt -102.6 134.48 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.44 163.21 35.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 110.025 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.5 ttp -137.74 129.55 28.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.713 . . . . 0.0 109.496 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.01 117.7 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 108.673 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.37 153.25 39.2 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.45 137.72 51.6 Favored 'Cis proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.789 -1.338 . . . . 0.0 112.132 0.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.0 m -106.15 165.71 11.04 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.55 -0.718 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -70.29 142.69 52.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 0.0 110.421 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.45 -152.97 22.36 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -97.37 116.97 30.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.328 -1.101 . . . . 0.0 108.951 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 32.5 mp0 -59.55 -34.11 72.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 110.165 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.09 -39.96 78.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.032 -1.042 . . . . 0.0 109.838 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -73.0 -39.5 66.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.791 -1.193 . . . . 0.0 108.368 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.1 -40.04 88.29 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 84.7 t80 -60.0 -46.48 89.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.08 -40.06 95.41 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.99 -44.28 94.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 90.9 mtp -57.47 -44.82 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 108.915 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.33 -43.71 98.18 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 108.765 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.534 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 91.7 mt-30 -59.87 -41.13 90.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.377 -0.827 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -71.31 -41.45 69.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.25 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.08 71.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.435 -0.79 . . . . 0.0 110.255 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -61.62 -37.02 82.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.794 -1.191 . . . . 0.0 109.157 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.0 m-70 -59.97 -47.6 85.17 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.07 -1.019 . . . . 0.0 109.128 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.9 mt -60.04 -49.94 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 108.927 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -54.13 -50.31 67.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.93 -40.19 88.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 110.052 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -70.05 -40.44 75.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 111.341 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 114' ' ' GLY . 10.2 m -99.35 -0.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.949 -1.094 . . . . 0.0 109.382 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.28 19.61 72.51 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -79.77 -172.34 43.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -127.83 133.61 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.483 -1.01 . . . . 0.0 109.221 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.95 131.52 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.702 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.61 159.52 36.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.454 -0.779 . . . . 0.0 109.448 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 42.9 p-10 -88.58 -170.26 2.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.4 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 109.881 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 93.8 mm-40 -76.13 14.61 0.69 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 108.645 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.2 mtm180 57.4 27.87 14.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.861 -0.525 . . . . 0.0 110.432 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.467 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 84.8 mtm180 -105.25 157.07 17.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.83 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 99.2 mtp -51.93 134.17 31.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.7 mmm -58.08 140.25 53.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -131.08 151.25 78.6 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.73 -42.96 62.04 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 120.524 0.816 . . . . 0.0 111.829 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.95 -39.95 87.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.493 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 27.5 mmtp -64.74 -40.0 94.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 110.166 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.19 -40.11 84.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 108.616 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.409 HH11 ' HG2' ' A' ' 130' ' ' ARG . 40.4 ttt-85 -64.11 -39.99 95.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.476 -0.765 . . . . 0.0 109.261 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -46.64 88.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 110.228 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -60.01 -38.59 83.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.134 -0.979 . . . . 0.0 109.628 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -59.92 -38.81 83.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 108.536 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.75 -37.32 81.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 108.739 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.02 -43.38 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.75 -39.98 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -60.23 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.526 -0.733 . . . . 0.0 109.581 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.03 -37.56 80.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.32 -28.62 20.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.638 -0.664 . . . . 0.0 111.568 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.576 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 33.1 mttm -60.11 -40.07 88.38 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 111.535 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 50.7 p-10 -59.97 -29.48 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.444 -1.41 . . . . 0.0 109.627 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.59 -40.54 92.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 111.089 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.617 ' H ' HD22 ' A' ' 143' ' ' ASN . 0.1 OUTLIER -100.51 -11.44 20.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.156 -0.965 . . . . 0.0 110.264 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.07 . . . . 0.0 109.382 179.362 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -147.41 134.76 20.68 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.6 -174.44 3.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.292 -1.505 . . . . 0.0 111.066 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.8 134.72 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.94 122.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -119.89 147.76 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 122.148 0.975 . . . . 0.0 111.407 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -146.68 156.37 43.13 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 83' ' ' THR . 73.8 m-20 -137.11 127.74 26.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.961 -1.087 . . . . 0.0 110.599 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.9 t -109.93 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.48 156.76 42.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.0 -177.23 1.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.66 159.93 17.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.265 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -60.1 141.16 56.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.135 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.1 71.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -127.79 147.27 50.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.955 . . . . 0.0 109.105 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -130.19 148.37 52.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.8 137.4 32.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.585 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -68.23 145.93 53.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.052 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.31 -42.6 98.86 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.208 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 77.2 mm-40 -61.04 -44.28 97.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.952 -1.322 . . . . 0.0 109.416 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.0 mt -69.58 -27.19 64.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 108.819 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.71 -58.28 3.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 110.027 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.2 -48.33 82.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 111.043 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 31' ' ' SER . 35.7 p-10 -62.73 -39.93 95.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.781 -1.199 . . . . 0.0 109.957 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -61.47 -45.75 92.94 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.023 -1.048 . . . . 0.0 109.21 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.05 -44.88 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.158 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.77 -40.05 91.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.25 -20.39 64.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 110.253 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.486 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.86 5.36 21.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.988 -1.07 . . . . 0.0 110.174 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.35 15.19 62.62 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 121.049 -1.032 . . . . 0.0 111.711 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -80.3 153.85 28.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.617 -1.52 . . . . 0.0 109.151 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.68 139.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -58.68 101.64 0.09 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.29 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.07 49.72 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.45 -167.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -1.064 . . . . 0.0 108.774 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.6 mtm 57.67 22.43 8.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.144 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 m120 51.93 40.12 27.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.754 -0.591 . . . . 0.0 111.598 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 pt -140.0 166.94 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.123 -0.986 . . . . 0.0 108.689 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.39 129.61 38.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 60' ' ' SER . 12.6 m-70 -119.57 126.45 51.26 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 55.0 ttt180 -100.45 127.12 46.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.095 -1.003 . . . . 0.0 109.299 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 23.5 m-70 -97.83 169.92 9.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.501 -0.75 . . . . 0.0 110.109 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.1 tp -56.94 -49.93 74.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -91.48 145.94 32.31 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 109.036 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.31 -6.61 17.86 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.57 0.847 . . . . 0.0 112.082 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -94.11 -1.78 53.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.023 -1.048 . . . . 0.0 110.274 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 10.3 85.78 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.3 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 m -69.95 -39.96 75.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.333 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.73 166.44 50.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -71.54 173.68 12.13 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.074 1.182 . . . . 0.0 111.732 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.93 125.06 29.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.4 -25.71 15.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 109.303 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -159.66 159.84 33.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 109.136 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 4.0 m -126.53 172.75 9.97 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.021 0.915 . . . . 0.0 111.427 -177.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -139.64 128.66 23.63 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.533 0.682 . . . . 0.0 109.298 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.62 163.21 32.67 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.476 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -77.53 156.07 31.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.885 -1.135 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' NH1' ' A' ' 121' ' ' ARG . 77.6 mtm -69.89 -19.75 63.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.256 -0.902 . . . . 0.0 110.076 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.7 p -87.06 123.65 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 109.502 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -60.03 149.97 71.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 109.672 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -78.32 4.46 26.66 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.823 -1.324 . . . . 0.0 112.239 -0.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.58 9.32 85.85 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p -89.2 170.14 10.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.134 -1.215 . . . . 0.0 109.711 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 96.9 m-85 -120.33 150.26 41.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.572 -0.705 . . . . 0.0 109.533 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' H ' ' CG ' ' A' ' 74' ' ' MET . 84.9 m-20 -128.81 151.48 77.34 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.98 -11.13 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 120.503 0.802 . . . . 0.0 111.628 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 77.1 mm-40 -90.94 5.52 48.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.635 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.55 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 70.8 mmm -85.56 14.1 6.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.9 mttm -85.99 -4.03 59.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.011 -1.055 . . . . 0.0 108.595 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 80.8 m-20 -148.27 80.74 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -159.67 171.11 20.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.9 p -126.01 149.35 48.89 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.418 -0.801 . . . . 0.0 109.045 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.0 149.91 20.42 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.048 -1.033 . . . . 0.0 109.21 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.83 -47.07 27.01 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 CA-C-N 119.16 0.736 . . . . 0.0 111.665 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.63 -152.5 7.94 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.484 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -133.16 160.05 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.865 . . . . 0.0 109.184 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ALA . 6.6 m -109.54 120.82 43.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.558 -0.714 . . . . 0.0 110.246 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.5 mt -108.99 127.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -147.68 170.53 17.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.505 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -142.24 129.99 21.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.6 -0.688 . . . . 0.0 109.158 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.602 ' N ' ' SD ' ' A' ' 86' ' ' MET . 96.4 mt-30 -93.5 121.73 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.32 153.7 38.32 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.091 -1.006 . . . . 0.0 108.714 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.12 147.62 87.83 Favored 'Cis proline' 0 N--CA 1.505 2.17 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.211 -0.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.451 ' OG ' ' SD ' ' A' ' 86' ' ' MET . 1.8 m -107.0 167.96 9.53 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.633 0.73 . . . . 0.0 110.7 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.64 149.33 42.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 110.167 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.5 -138.35 33.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -99.2 120.74 40.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -1.06 . . . . 0.0 109.777 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.21 -31.12 67.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.779 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.04 -39.66 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.915 . . . . 0.0 109.357 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -69.89 -40.06 75.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 108.173 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.508 ' N ' HD22 ' A' ' 97' ' ' ASN . 2.1 m120 -59.93 -40.06 87.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -59.61 -41.55 90.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.706 -0.621 . . . . 0.0 109.545 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.72 -42.0 96.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.63 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 109.753 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 97.5 mtp -57.62 -49.96 74.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.98 -43.66 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 109.191 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.6 mm-40 -60.03 -41.83 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.912 . . . . 0.0 109.006 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p -70.94 -40.42 72.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.782 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.39 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.291 -0.88 . . . . 0.0 110.014 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -62.01 -37.77 86.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 109.789 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.93 -49.18 78.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 0.0 109.296 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 94.8 mt -60.2 -49.89 82.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.88 -48.06 64.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.703 -0.623 . . . . 0.0 109.794 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.18 -40.37 89.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -69.92 -40.11 75.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 111.053 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 108' ' ' ILE . 11.1 m -100.91 2.32 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 109.935 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.51 24.45 72.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.31 -176.95 51.38 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.91 133.89 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.973 . . . . 0.0 109.089 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.61 132.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.237 -0.914 . . . . 0.0 109.425 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.7 mt -130.54 160.02 35.39 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.415 -0.803 . . . . 0.0 109.803 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -86.63 -170.25 2.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 109.163 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 96.3 m-20 -60.13 -39.87 87.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 109.739 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.68 18.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 121' ' ' ARG . 24.3 mtt-85 59.84 22.58 11.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.1 mtt180 -102.44 145.25 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.449 -0.782 . . . . 0.0 109.478 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.2 mtp -50.08 126.14 13.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.4 mtp -60.04 140.0 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.811 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 3.9 p -131.55 153.17 81.48 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.83 -44.87 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 120.848 1.032 . . . . 0.0 112.081 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.12 -41.2 92.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.222 -0.924 . . . . 0.0 109.166 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 125' ' ' THR . 98.9 mttt -70.06 -40.06 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 110.197 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.57 -40.1 82.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.387 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 130' ' ' ARG . 0.1 OUTLIER -63.14 -40.06 96.49 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.417 -0.802 . . . . 0.0 109.189 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.835 . . . . 0.0 109.662 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -60.02 -43.35 95.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 108.445 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -63.01 -40.09 96.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.353 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.06 -39.97 94.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.682 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.95 -44.72 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 108.709 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -41.3 85.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.804 . . . . 0.0 109.069 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 137' ' ' ARG . 51.3 mtt-85 -60.5 -39.96 89.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.224 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 73.9 mm-40 -62.4 -39.94 94.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 109.571 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -32.19 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 111.021 -177.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -59.98 -40.24 88.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.927 -1.108 . . . . 0.0 109.871 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.3 p30 -61.56 -30.61 70.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.0 108.717 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.65 -22.34 66.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -95.72 -1.81 49.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.812 . . . . 0.0 110.001 179.626 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -143.08 150.01 38.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.27 164.5 27.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.835 -1.166 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -120.0 131.4 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mm -90.62 133.38 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.456 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -129.26 143.32 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 122.092 0.949 . . . . 0.0 110.811 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -142.76 149.86 39.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -131.04 126.57 36.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.73 -1.231 . . . . 0.0 110.951 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.14 119.99 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.23 160.25 43.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.068 . . . . 0.0 110.025 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -168.38 0.35 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -61.54 157.82 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.815 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -59.97 139.97 57.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.55 74.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.8 m -129.31 144.27 51.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.474 -1.016 . . . . 0.0 109.309 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 42.3 mp0 -120.28 147.51 44.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.729 . . . . 0.0 109.311 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.17 143.99 30.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -68.99 144.51 54.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.136 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -42.16 98.3 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.1 -45.52 93.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -1.234 . . . . 0.0 109.773 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -69.97 -30.19 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 108.889 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.3 tt -72.15 -55.76 6.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.666 -0.647 . . . . 0.0 109.605 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 74' ' ' MET . 90.9 mt -60.01 -48.64 80.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.844 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -64.62 -40.08 94.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.235 -0.916 . . . . 0.0 111.683 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.1 p -64.81 -41.0 96.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 110.235 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.63 -44.07 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 109.824 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.47 -40.0 85.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.0 110.455 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.01 -19.66 64.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 111.024 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.558 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.57 -11.47 58.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.175 . . . . 0.0 110.87 -178.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.538 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.4 11.12 18.47 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.015 -1.053 . . . . 0.0 111.14 178.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.723 ' N ' HH21 ' A' ' 47' ' ' ARG . 36.3 m-85 -80.87 152.87 27.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.669 -1.489 . . . . 0.0 109.712 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.4 139.35 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.52 104.7 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -0.999 . . . . 0.0 110.055 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.2 171.58 34.08 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -67.12 -166.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -1.073 . . . . 0.0 109.315 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.7 mtm 57.42 25.58 11.53 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.603 0.716 . . . . 0.0 109.887 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 50.02 39.37 18.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.644 -0.66 . . . . 0.0 111.601 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.6 pt -140.85 167.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.021 -1.05 . . . . 0.0 109.005 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -92.42 136.77 32.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.037 -1.039 . . . . 0.0 110.333 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.497 ' CG ' ' OG ' ' A' ' 60' ' ' SER . 19.4 m-70 -126.3 126.82 44.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.723 HH21 ' N ' ' A' ' 37' ' ' PHE . 28.9 ttm180 -99.21 124.28 44.15 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 56.9 m-70 -95.6 171.84 8.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 109.717 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -56.89 -50.01 73.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.762 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -91.67 141.99 26.28 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 109.071 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.53 -10.23 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.555 0.877 . . . . 0.0 112.08 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -91.87 -0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 109.947 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.42 83.51 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.0 p -69.9 -40.05 75.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.83 -1.394 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.28 168.24 50.1 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 18.5 Cg_endo -70.91 174.88 9.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.286 1.324 . . . . 0.0 112.223 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.22 122.4 27.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.9 mp -97.97 -43.81 6.92 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' SD ' ' A' ' 101' ' ' MET . 20.9 p90 -144.91 160.01 42.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.934 -1.104 . . . . 0.0 109.51 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.497 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 9.0 m -132.74 165.51 24.37 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.031 0.92 . . . . 0.0 111.44 -177.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.3 tt -119.96 134.79 55.14 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.696 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.02 159.95 39.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.599 . . . . 0.0 109.413 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -76.45 160.71 29.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.432 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.7 mtp -70.03 -25.56 63.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 110.254 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -86.8 121.51 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.963 -1.086 . . . . 0.0 109.738 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -59.43 151.03 62.12 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -77.57 5.02 22.42 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.686 -1.381 . . . . 0.0 112.479 -0.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.43 55.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.8 p -91.26 169.55 10.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.223 -1.163 . . . . 0.0 110.69 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -124.1 140.68 52.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.691 -0.63 . . . . 0.0 109.376 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -130.37 150.76 77.11 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.0 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -50.72 -7.0 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.42 0.829 . . . . 0.0 112.001 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mt-10 -89.45 2.53 54.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.431 -0.793 . . . . 0.0 109.556 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.415 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.3 mmm -86.83 16.32 4.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.2 mttm -87.42 -3.16 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 108.805 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -149.68 77.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.06 169.41 24.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.994 -1.066 . . . . 0.0 109.251 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -130.04 150.19 51.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.68 150.21 21.31 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.08 -52.83 5.94 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 120.438 0.759 . . . . 0.0 111.726 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.25 -151.82 8.12 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.6 m -130.05 160.0 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.963 . . . . 0.0 109.545 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.4 m -112.07 123.78 51.01 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.115 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.87 132.02 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.08 164.43 33.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.828 -1.17 . . . . 0.0 110.89 -178.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.2 ttp -138.15 128.63 26.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -92.96 112.57 24.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 109.236 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.41 154.3 37.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -75.72 134.36 35.44 Favored 'Cis proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.679 0.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.7 m -107.39 160.2 15.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.529 0.68 . . . . 0.0 109.624 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -70.51 150.43 46.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.928 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -158.96 26.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.16 117.11 30.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -1.146 . . . . 0.0 109.292 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.03 -37.56 80.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.635 . . . . 0.0 110.851 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.81 -39.88 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.99 -39.98 75.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.047 -1.033 . . . . 0.0 108.894 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.436 ' OD1' HD23 ' A' ' 58' ' ' LEU . 78.0 m-20 -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 102' ' ' LEU . 79.1 t80 -60.01 -50.03 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.59 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.8 -41.52 97.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.4 tp -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 59' ' ' PHE . 23.4 mmm -56.11 -46.81 78.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.416 -0.803 . . . . 0.0 109.255 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.9 mt -63.85 -40.76 97.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.103 -0.998 . . . . 0.0 109.061 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.533 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 0.0 109.881 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.6 p -69.38 -41.0 77.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.02 -1.05 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.92 52.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 110.272 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -62.33 -34.93 77.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 15.0 m-70 -60.02 -46.54 89.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 108.767 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.1 -49.97 81.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.4 -0.813 . . . . 0.0 108.988 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.55 -47.7 63.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.541 -0.724 . . . . 0.0 109.97 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.73 -179.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.22 -40.01 74.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.047 -1.033 . . . . 0.0 111.165 -178.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.92 1.99 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.68 27.22 71.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.85 -172.0 45.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.19 139.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.608 -0.937 . . . . 0.0 108.881 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.484 HG12 ' SD ' ' A' ' 124' ' ' MET . 4.5 t -80.56 134.94 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 109.736 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.11 160.01 37.23 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 -179.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -87.25 -168.86 2.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 94.9 m-20 -60.01 -39.57 86.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 109.849 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.17 21.75 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 55.85 31.33 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.16 150.9 27.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.438 -0.789 . . . . 0.0 109.297 179.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mmm -52.08 125.66 16.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 109.152 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 116' ' ' VAL . 64.1 mtp -60.0 139.94 57.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.8 p -130.06 150.65 76.59 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -42.58 -43.49 8.47 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.849 1.032 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.418 ' HG2' HH21 ' A' ' 130' ' ' ARG . 96.5 mt-30 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.389 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.72 -39.97 80.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.4 mt -55.69 -42.29 74.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 0.0 108.937 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.418 HH21 ' HG2' ' A' ' 127' ' ' GLN . 85.4 mtm180 -65.71 -38.87 90.4 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -59.97 -44.61 94.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.993 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 53.1 m-85 -60.01 -42.18 93.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.52 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.78 -39.72 89.9 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 98.3 m-20 -60.03 -40.03 87.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.354 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.0 -41.13 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.048 -1.033 . . . . 0.0 108.833 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.11 -44.93 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 108.996 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 79.9 mtm180 -62.22 -35.25 78.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -0.969 . . . . 0.0 110.424 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 66.4 mm-40 -59.94 -38.86 83.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.736 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.1 t -73.31 -30.07 29.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 110.674 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.8 mttm -60.04 -41.1 91.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.759 -1.213 . . . . 0.0 110.987 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -59.94 -29.02 68.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.756 -1.215 . . . . 0.0 109.176 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.852 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 43.4 p-10 -104.57 -3.71 23.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.34 -0.85 . . . . 0.0 109.495 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.899 . . . . 0.0 109.524 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -102.24 143.68 31.72 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -160.96 179.54 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.49 -1.381 . . . . 0.0 110.633 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -125.65 130.0 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 mm -92.26 127.95 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.8 mt -120.21 147.47 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.33 1.062 . . . . 0.0 111.712 -177.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -145.8 159.03 43.78 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' HG23 ' A' ' 83' ' ' THR . 35.1 m120 -139.26 125.26 19.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.715 -1.241 . . . . 0.0 111.34 -179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.51 124.97 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -144.61 164.59 30.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.046 -1.034 . . . . 0.0 111.979 -177.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.71 -164.51 0.36 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -71.37 160.05 33.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -58.79 130.01 44.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.746 -1.221 . . . . 0.0 109.356 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.47 -2.23 84.68 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 m -110.92 155.55 22.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.365 -1.079 . . . . 0.0 109.757 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -129.98 150.09 51.42 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.27 140.48 29.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -65.62 141.16 58.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' PHE . . . -60.06 -39.99 96.49 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.107 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.51 -46.69 88.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 109.662 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -30.01 68.17 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -71.41 -58.78 3.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.03 -40.05 88.0 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.349 -0.844 . . . . 0.0 109.708 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -64.28 -40.73 96.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -65.73 -39.64 91.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.304 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.02 -48.4 88.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.074 -1.017 . . . . 0.0 109.859 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -63.37 -39.96 95.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.138 . . . . 0.0 109.704 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.358 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.02 8.3 10.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . 80.09 10.47 85.49 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.39 148.61 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.722 -1.458 . . . . 0.0 108.972 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.6 mt -122.14 134.52 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -58.3 102.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.108 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.74 170.6 38.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.28 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.322 -1.105 . . . . 0.0 109.006 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.1 mtt 58.09 21.38 7.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 51.79 40.06 26.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.797 . . . . 0.0 111.48 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.26 159.29 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.881 -1.137 . . . . 0.0 109.187 178.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -90.49 119.55 30.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.058 -1.026 . . . . 0.0 109.118 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 13.9 m-70 -104.12 134.94 46.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.481 -0.762 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' NH1' ' O ' ' A' ' 36' ' ' GLY . 21.6 tpt180 -100.03 115.62 30.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 72.5 m-70 -95.25 169.31 10.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.225 -0.922 . . . . 0.0 109.907 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.12 -49.96 75.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.855 . . . . 0.0 109.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -96.1 150.0 36.67 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -70.6 -7.1 20.52 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.869 1.046 . . . . 0.0 112.455 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.85 0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.046 -1.034 . . . . 0.0 110.095 -179.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.34 7.66 86.97 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.317 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.07 -40.05 75.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.249 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.72 160.42 50.49 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.468 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 12.9 Cg_endo -68.02 175.09 6.95 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.068 1.179 . . . . 0.0 112.218 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.544 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -84.19 127.06 33.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.37 -0.831 . . . . 0.0 109.209 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.2 mp -100.56 -35.38 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.135 -0.978 . . . . 0.0 108.8 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 2.5 p90 -151.01 166.53 30.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.521 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 2.1 m -134.73 179.44 6.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.08 -1.013 . . . . 0.0 111.525 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -139.95 131.65 27.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.611 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.94 159.74 35.72 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.526 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -76.93 161.53 28.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.05 -22.99 63.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 110.373 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 65' ' ' VAL . 26.8 m -88.89 119.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.757 -1.215 . . . . 0.0 109.879 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -61.24 151.37 76.34 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.38 8.89 17.51 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.486 -0.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.1 63.23 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.9 p -83.92 167.89 16.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -1.2 . . . . 0.0 109.344 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.4 m-85 -120.29 143.8 48.15 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.638 -0.664 . . . . 0.0 109.784 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLU . 20.5 t70 -126.41 134.32 25.88 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -49.5 -9.34 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 119.959 1.021 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -88.38 1.0 55.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.42 ' CE ' ' CZ ' ' A' ' 77' ' ' PHE . 90.6 mtp -86.99 22.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 109.996 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 94.9 mttt -83.65 -4.81 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.021 -1.049 . . . . 0.0 108.955 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.0 m-20 -148.12 83.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' ' CE ' ' A' ' 74' ' ' MET . 7.1 p90 -158.85 177.65 10.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.551 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.0 p -134.03 149.98 51.2 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.12 150.3 23.64 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.063 -1.023 . . . . 0.0 109.35 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.93 -26.06 30.12 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.46 0.773 . . . . 0.0 111.657 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.33 33.96 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.036 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 28' ' ' LEU . 34.3 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.886 . . . . 0.0 108.952 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.491 HG23 ' ND2' ' A' ' 14' ' ' ASN . 86.7 m -109.76 125.2 52.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.659 -0.651 . . . . 0.0 109.686 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.79 128.41 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -146.74 149.78 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.968 -1.082 . . . . 0.0 110.952 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.1 ttm -104.91 129.91 53.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.836 -0.54 . . . . 0.0 109.581 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -92.84 108.38 19.95 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.7 m -97.2 151.04 37.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 109.133 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.0 139.24 60.44 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.914 -1.286 . . . . 0.0 112.839 -0.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.2 m -105.22 159.51 15.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.627 -0.671 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -71.1 150.62 45.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.98 -152.38 38.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -98.96 121.09 40.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.414 -1.05 . . . . 0.0 109.29 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.94 -32.24 69.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.589 -0.694 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.03 -39.91 75.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.663 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.04 -42.2 73.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.953 -1.092 . . . . 0.0 108.088 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.684 ' OD1' HD23 ' A' ' 58' ' ' LEU . 89.8 m-20 -62.94 -39.88 95.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.14 -40.1 73.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.19 -40.03 94.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.16 -39.9 91.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.132 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.2 mtp -57.84 -50.33 73.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.84 -42.91 89.92 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.986 -1.071 . . . . 0.0 108.961 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.8 mt-30 -61.99 -39.99 94.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 108.796 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -73.14 -43.74 61.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.04 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 0.0 110.014 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -60.31 -39.82 88.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.052 -1.03 . . . . 0.0 109.358 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 4.1 m-70 -59.9 -43.37 94.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.985 . . . . 0.0 108.891 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.0 -50.11 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.26 -48.33 68.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.607 -0.683 . . . . 0.0 109.263 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.64 -40.13 90.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 109.899 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -40.0 75.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.36 -0.838 . . . . 0.0 111.346 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -101.03 -0.81 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.116 -0.99 . . . . 0.0 109.678 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.37 23.39 76.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . -91.33 -167.56 41.01 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.211 -1.17 . . . . 0.0 110.249 -179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 16' ' ' ALA . 3.6 m -130.0 159.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.596 -0.944 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.421 HG12 ' SD ' ' A' ' 124' ' ' MET . 11.4 t -96.93 129.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.234 -0.916 . . . . 0.0 108.712 179.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.1 mt -124.49 163.63 21.45 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.82 0.819 . . . . 0.0 110.639 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -86.27 -170.92 3.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.752 -0.593 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 85.4 m-20 -60.12 -39.99 88.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.872 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.99 15.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.068 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' ASP . 86.4 mtm180 57.25 37.16 28.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.837 -0.539 . . . . 0.0 109.769 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 122' ' ' ARG . 20.0 mtt-85 -112.23 151.97 28.97 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.9 mtp -50.92 122.1 6.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.929 -1.107 . . . . 0.0 109.133 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.421 ' SD ' HG12 ' A' ' 116' ' ' VAL . 61.4 mtp -59.96 140.01 57.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.264 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.5 p -122.25 152.17 60.19 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -43.49 -43.61 10.92 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 120.61 0.873 . . . . 0.0 112.017 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -60.11 -40.5 89.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.277 -0.89 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.7 -40.01 84.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.794 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.82 -39.95 78.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 108.409 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.49 -39.97 89.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.457 -0.777 . . . . 0.0 109.397 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.46 77.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.93 -46.05 90.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.956 -1.09 . . . . 0.0 108.779 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.98 -39.93 93.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.36 -0.838 . . . . 0.0 109.124 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 87.8 m-20 -61.72 -46.15 90.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.521 -0.737 . . . . 0.0 110.57 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.19 -37.59 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 108.997 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.05 -42.54 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.052 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 81.7 mtm180 -60.02 -38.69 83.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.853 -1.154 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 40.4 mm-40 -59.98 -39.96 87.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.46 -0.775 . . . . 0.0 109.867 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.5 -33.64 63.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.596 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 144' ' ' ALA . 87.8 mttt -59.95 -50.0 75.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.817 -1.177 . . . . 0.0 110.027 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -61.19 -37.57 83.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.982 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.93 95.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.447 -0.783 . . . . 0.0 110.17 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 50.5 p30 -98.85 -2.98 36.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.309 -0.869 . . . . 0.0 109.406 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -144.64 132.56 21.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.85 -172.14 3.17 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.015 -1.053 . . . . 0.0 110.536 -178.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.92 140.59 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.49 130.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.0 mt -118.45 144.13 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 122.245 1.021 . . . . 0.0 111.681 -177.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -142.0 150.02 40.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' ND2' HG23 ' A' ' 83' ' ' THR . 35.0 m120 -128.02 119.62 25.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.019 -1.051 . . . . 0.0 111.037 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.62 110.86 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 80' ' ' PRO . . . -148.99 160.79 42.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -165.25 0.25 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.56 142.42 55.42 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 108.826 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -51.47 137.15 24.59 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.039 -1.038 . . . . 0.0 109.237 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.27 1.22 66.93 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.1 m -121.02 149.95 41.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.516 -0.991 . . . . 0.0 108.697 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -125.41 146.87 49.42 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.764 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 148.62 25.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -68.93 142.48 54.71 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.42 96.99 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.31 -46.85 86.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 0.0 109.83 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.81 -30.17 67.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.197 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.607 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -71.15 -58.67 3.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.23 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -59.99 -46.02 90.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.659 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.81 -42.26 97.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.698 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 t -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.479 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.94 -47.0 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -63.83 -41.57 97.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.69 -21.89 66.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.6 11.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.47 75.73 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.15 -0.969 . . . . 0.0 111.338 178.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -81.65 147.51 29.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.661 -1.494 . . . . 0.0 109.584 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -120.03 132.33 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.74 101.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.72 170.82 37.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.34 -162.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -1.044 . . . . 0.0 109.265 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 91.0 mmm 59.78 20.61 9.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.683 -0.635 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 51.21 34.97 12.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 111.362 178.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.2 165.83 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.006 -1.058 . . . . 0.0 108.999 178.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -89.72 141.51 28.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.947 -1.096 . . . . 0.0 110.464 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.542 ' CD2' ' HG ' ' A' ' 60' ' ' SER . 29.0 m80 -130.19 130.07 44.22 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.511 ' HG2' HH11 ' A' ' 47' ' ' ARG . 4.0 ttt-85 -103.0 127.29 50.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 17.9 m-70 -91.45 169.84 10.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.664 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.69 -49.96 73.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -92.65 144.81 29.26 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.58 -6.37 16.45 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.798 0.999 . . . . 0.0 112.213 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -92.71 1.92 57.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.949 . . . . 0.0 110.031 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.14 10.67 85.27 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.4 p -70.14 -40.8 74.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -1.184 . . . . 0.0 110.0 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.48 164.0 50.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -66.68 179.74 2.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.473 1.136 . . . . 0.0 111.852 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.56 29.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -97.65 -70.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.355 -0.841 . . . . 0.0 109.691 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 1.7 p90 -114.41 160.0 19.66 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.97 -1.081 . . . . 0.0 109.909 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.542 ' HG ' ' CD2' ' A' ' 46' ' ' HIS . 15.1 m -121.88 161.47 22.73 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.573 0.701 . . . . 0.0 109.927 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -132.26 130.59 41.11 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.43 165.3 26.13 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.489 -0.757 . . . . 0.0 110.073 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 88.7 m-20 -75.05 156.92 35.62 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.4 mtt -69.88 -23.88 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.0 p -87.5 121.12 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.068 -179.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -58.06 151.78 43.79 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -80.43 -0.2 41.15 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.979 0.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.62 18.83 61.12 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.4 p -85.92 167.3 15.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.991 -1.299 . . . . 0.0 109.618 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.4 m-85 -124.33 141.85 51.75 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.519 -0.738 . . . . 0.0 109.808 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -129.8 151.09 77.57 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.58 -12.5 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 120.497 0.798 . . . . 0.0 112.409 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.91 -3.01 58.86 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.072 -1.017 . . . . 0.0 109.322 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.2 mtp -88.65 22.68 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.4 mttp -83.06 -4.84 58.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 94.0 m-20 -143.75 84.63 1.8 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.376 -0.828 . . . . 0.0 108.776 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.7 177.24 11.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 110.362 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.5 p -129.67 146.8 51.43 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.19 148.22 18.19 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 108.862 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.411 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 14.2 Cg_exo -45.16 -31.65 6.17 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 120.611 0.874 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.65 -147.71 16.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.49 159.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.457 -1.025 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.4 HG23 ' ND2' ' A' ' 14' ' ' ASN . 54.7 m -108.74 122.48 47.23 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -105.77 130.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.323 -0.861 . . . . 0.0 108.727 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.47 148.03 32.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.12 -0.988 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.9 tpp -104.02 130.28 51.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' O ' ' OG ' ' A' ' 90' ' ' SER . 95.0 mt-30 -90.54 108.6 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 88' ' ' VAL . 9.2 m -98.67 150.03 36.31 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.211 -0.93 . . . . 0.0 109.238 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.65 135.07 38.67 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.859 -1.309 . . . . 0.0 112.564 -0.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.5 m -108.05 162.58 13.91 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.632 0.73 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 59.6 t80 -73.78 158.14 35.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 110.041 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.548 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.72 -160.28 44.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -98.15 111.96 24.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.38 -1.07 . . . . 0.0 108.971 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.62 -30.33 68.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.768 . . . . 0.0 110.602 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.33 -40.06 77.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 109.363 -179.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.81 -40.35 63.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.743 -1.223 . . . . 0.0 108.242 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -61.2 -37.5 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.093 0.949 . . . . 0.0 108.606 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -56.33 -50.09 72.46 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.25 -39.19 92.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.12 -46.02 91.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.608 -0.683 . . . . 0.0 110.219 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.8 mtm -58.91 -42.67 90.21 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.667 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.61 -46.61 87.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.913 . . . . 0.0 108.937 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.4 mm-40 -60.17 -42.63 95.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 108.928 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -71.55 -41.07 69.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 109.375 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.56 -55.41 35.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.601 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -61.25 -35.7 77.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.148 -0.97 . . . . 0.0 109.103 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.89 -47.08 87.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 112' ' ' VAL . 82.2 mt -59.98 -49.95 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.9 -47.7 60.63 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.77 -39.96 93.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.43 -40.02 77.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.05 -1.031 . . . . 0.0 110.703 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.7 m -98.44 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 109.275 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.85 24.88 76.15 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.34 -169.83 46.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.8 138.0 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.128 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 t -77.57 132.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 109.475 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.17 160.33 35.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.415 -0.803 . . . . 0.0 110.022 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -84.58 -173.12 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.477 -0.764 . . . . 0.0 108.976 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.514 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 93.3 m-20 -60.02 -36.07 76.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.088 -1.007 . . . . 0.0 109.994 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -79.61 15.3 1.37 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.916 . . . . 0.0 110.219 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 19.8 mmm-85 58.19 30.84 19.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -106.43 151.93 24.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 81.0 mmm -51.72 133.37 31.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.026 -1.046 . . . . 0.0 109.45 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.2 mmm -56.08 138.66 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.096 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.3 p -136.81 151.28 72.12 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.426 -0.797 . . . . 0.0 109.034 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -44.58 -45.72 12.85 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 120.449 0.766 . . . . 0.0 111.73 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.08 -40.01 88.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -68.48 -39.92 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.02 -40.13 88.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.995 -1.065 . . . . 0.0 109.011 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -65.28 -39.67 92.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.445 -0.785 . . . . 0.0 109.405 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.75 -47.6 85.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.195 -0.941 . . . . 0.0 110.348 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.514 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 71.3 m-85 -60.07 -46.59 89.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.928 -1.107 . . . . 0.0 108.526 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.2 -40.35 93.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.194 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.416 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.7 m-20 -62.35 -40.09 95.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.32 -40.68 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.052 -1.03 . . . . 0.0 108.596 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.56 -40.03 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.504 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 137' ' ' ARG . 7.4 mmt-85 -60.04 -39.96 87.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.066 -1.021 . . . . 0.0 110.554 -179.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.99 -40.07 92.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.725 -1.235 . . . . 0.0 109.524 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.15 -29.74 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' ALA . 47.4 mmtt -60.07 -39.47 86.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.835 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 2.2 p30 -60.07 -30.01 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.659 -1.276 . . . . 0.0 108.566 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.888 . . . . 0.0 109.218 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -101.22 -13.38 18.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.372 -0.83 . . . . 0.0 110.409 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.891 -1.13 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.32 147.11 31.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.61 -177.64 6.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.322 -1.486 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.99 131.46 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 mm -92.87 125.31 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 90.8 mt -123.66 143.71 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-O 122.166 0.984 . . . . 0.0 111.248 -177.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.402 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.4 mtt -142.88 138.18 30.07 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -120.85 127.46 51.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.992 -1.068 . . . . 0.0 111.251 -178.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.38 114.67 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.71 152.27 38.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.288 -0.882 . . . . 0.0 109.647 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.91 -166.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.64 152.89 44.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.161 -0.962 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.06 141.23 56.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.609 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.09 1.91 64.7 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.4 m -129.01 150.01 50.6 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.438 -1.036 . . . . 0.0 109.137 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.11 148.16 49.44 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.45 146.67 26.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.749 HD22 ' H ' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -71.0 142.15 50.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 109.115 179.065 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.9 99.83 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.871 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.749 ' H ' HD22 ' A' ' 24' ' ' ASN . 99.0 mt-10 -61.62 -44.65 96.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.964 -1.315 . . . . 0.0 109.669 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.87 -26.58 64.26 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -74.71 -59.88 2.53 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.652 -0.655 . . . . 0.0 109.76 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.86 -40.9 94.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 110.581 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.09 94.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 109.911 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 t -66.05 -41.05 91.33 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.16 -0.962 . . . . 0.0 109.806 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.13 -46.28 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 110.027 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.59 -40.2 96.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.974 -1.079 . . . . 0.0 109.395 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.56 -19.61 64.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.601 -0.687 . . . . 0.0 109.975 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.53 8.18 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.915 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.5 10.68 85.0 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.584 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -80.8 151.55 28.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.993 -1.299 . . . . 0.0 109.735 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.06 148.11 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.13 112.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.06 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.65 30.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.2 -170.18 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.596 -0.943 . . . . 0.0 108.626 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mtp 55.27 24.95 6.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.861 . . . . 0.0 109.726 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.04 42.1 24.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.745 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.7 pt -138.31 167.02 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.099 -1.0 . . . . 0.0 108.303 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -93.34 120.42 33.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.821 -1.174 . . . . 0.0 110.427 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.429 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 16.4 m170 -108.53 128.11 54.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.421 -0.8 . . . . 0.0 109.611 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 47' ' ' ARG . 9.3 ttt-85 -100.08 123.77 44.7 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.214 -0.928 . . . . 0.0 108.775 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 26.0 m-70 -92.46 171.59 8.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.57 -50.01 66.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 109.031 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -93.07 147.29 33.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 0.0 109.158 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -69.15 -4.2 13.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.65 0.9 . . . . 0.0 112.092 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -93.67 -1.07 55.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 0.0 109.746 -179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 13.42 83.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -68.93 -43.22 75.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -1.201 . . . . 0.0 109.533 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.435 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.33 171.62 54.26 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.415 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.2 Cg_endo -71.67 176.36 8.28 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.018 1.145 . . . . 0.0 111.463 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.406 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.16 126.63 32.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 108.906 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.4 mp -101.16 -35.88 9.15 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.078 -1.014 . . . . 0.0 109.74 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -146.68 160.78 41.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.029 -1.044 . . . . 0.0 109.006 178.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 63.2 m -129.99 160.29 34.08 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.002 0.906 . . . . 0.0 111.437 -177.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -120.97 129.48 53.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.537 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -139.6 161.73 36.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.521 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 81.9 m-20 -77.66 159.93 28.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 48.7 mtm -67.83 -18.84 64.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.7 p -88.16 121.28 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.818 -1.176 . . . . 0.0 109.844 -179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -61.11 147.76 85.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.35 -0.843 . . . . 0.0 109.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.6 -0.53 19.46 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.763 -1.349 . . . . 0.0 111.741 -0.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.99 17.43 74.68 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 p -88.79 169.05 11.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.196 -1.179 . . . . 0.0 110.601 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.4 m-85 -119.91 143.8 47.77 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.27 150.01 72.91 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.349 -0.844 . . . . 0.0 109.146 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.23 -19.32 2.62 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.689 0.926 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -89.94 -4.36 57.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.95 -1.093 . . . . 0.0 109.131 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 85.6 mtp -93.51 23.51 4.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 110.372 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -85.49 -8.99 58.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.911 -1.118 . . . . 0.0 108.476 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -136.96 87.27 2.27 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 7.7 p90 -157.96 179.65 8.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.387 -0.821 . . . . 0.0 109.522 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.5 p -128.76 149.96 50.49 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.73 149.17 19.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.051 -1.03 . . . . 0.0 109.221 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.95 -40.64 80.14 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.669 0.913 . . . . 0.0 111.907 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.39 -156.54 17.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -130.38 159.96 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.617 -0.931 . . . . 0.0 109.506 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 m -114.21 120.68 41.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.526 -0.733 . . . . 0.0 109.476 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.64 128.49 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -149.28 159.92 43.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.699 -1.251 . . . . 0.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 44.2 ttm -120.25 129.95 54.28 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.31 102.08 14.5 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' CG1' ' OE1' ' A' ' 94' ' ' GLU . 15.9 m -96.04 148.31 34.34 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.308 -0.87 . . . . 0.0 108.894 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HG3' HD21 ' A' ' 143' ' ' ASN . 10.3 Cg_endo -73.67 130.24 19.96 Favored 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.796 -1.335 . . . . 0.0 112.957 0.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 m -105.42 161.36 14.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.64 -0.662 . . . . 0.0 109.644 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.04 150.02 47.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.694 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -164.65 31.29 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 96.0 m-20 -96.09 116.74 29.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.198 -1.178 . . . . 0.0 108.921 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE1' ' CG1' ' A' ' 88' ' ' VAL . 41.9 mt-10 -59.95 -34.86 73.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.649 . . . . 0.0 110.799 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.06 -39.99 75.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.535 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.22 -42.21 55.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.717 -1.239 . . . . 0.0 108.701 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 31.3 m120 -61.53 -39.89 92.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 73.0 t80 -52.44 -40.01 61.72 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.607 -0.683 . . . . 0.0 109.207 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -60.96 -40.01 91.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.112 -0.992 . . . . 0.0 109.1 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.37 -40.08 89.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 109.177 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.6 mtp -57.09 -50.33 73.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.17 -45.28 81.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.15 -39.99 88.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 108.822 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 p -70.14 -41.07 74.37 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.199 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.6 -55.62 31.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.319 -0.863 . . . . 0.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -60.73 -39.95 90.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 109.704 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 8.1 m-70 -59.83 -46.32 89.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.76 -47.45 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 108.977 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.86 -47.01 64.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.92 -40.67 94.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.851 . . . . 0.0 110.949 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.03 -40.08 75.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.708 -178.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 114' ' ' GLY . 6.3 m -99.59 0.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.224 -0.923 . . . . 0.0 109.877 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.31 21.76 74.28 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.62 -176.8 51.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.49 132.02 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.604 -0.939 . . . . 0.0 109.272 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.96 131.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.188 -0.945 . . . . 0.0 108.898 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.6 mt -131.49 158.62 40.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.411 -0.806 . . . . 0.0 109.377 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.03 -170.77 3.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.253 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 92.0 m-20 -60.06 -36.37 77.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.834 . . . . 0.0 109.623 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.59 14.91 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.6 mtt180 56.35 38.64 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 109.765 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.18 152.2 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.2 mtp -50.72 129.24 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.07 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.95 139.81 57.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -120.66 151.33 54.13 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -43.02 -43.92 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 120.8 1.0 . . . . 0.0 112.603 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.06 -40.0 87.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.31 -39.83 92.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 110.124 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.03 -40.05 83.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.954 -1.091 . . . . 0.0 108.543 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -65.07 -39.5 93.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.597 -0.689 . . . . 0.0 109.86 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.12 -47.65 85.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.304 -0.873 . . . . 0.0 110.565 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -59.98 -43.86 94.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 0.0 109.322 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 136' ' ' ILE . 78.3 mt-30 -60.38 -39.94 89.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.704 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 95.8 m-20 -60.58 -40.17 90.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.13 -39.94 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 108.904 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 133' ' ' GLN . 96.5 mt -59.9 -44.63 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.2 mtm180 -60.1 -38.0 81.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.46 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.4 mt-10 -60.09 -37.33 79.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 0.0 109.52 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.88 -38.17 74.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.369 -0.832 . . . . 0.0 110.38 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -60.06 -46.56 89.16 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.077 -1.015 . . . . 0.0 111.558 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -60.08 -35.06 74.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.697 -1.252 . . . . 0.0 109.588 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.49 -19.51 65.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.781 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.436 HD21 ' HG3' ' A' ' 89' ' ' PRO . 12.1 m120 -99.52 -8.7 24.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 109.832 -179.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 0.0 109.524 179.894 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -152.21 140.58 20.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.75 164.56 26.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.426 -1.421 . . . . 0.0 110.734 -178.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.99 129.47 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.31 122.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -122.29 144.27 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 122.039 0.923 . . . . 0.0 110.835 -177.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.8 mtt -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -130.81 119.5 22.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.978 -1.076 . . . . 0.0 110.392 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.27 112.89 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.79 44.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.65 -164.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.175 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -67.25 155.03 39.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.962 . . . . 0.0 108.716 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -59.56 140.01 56.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.33 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -6.19 77.11 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 m -115.26 148.44 39.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.448 -1.031 . . . . 0.0 109.042 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -126.8 146.49 50.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.461 -0.774 . . . . 0.0 109.606 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.34 141.91 28.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -69.95 146.12 51.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.243 -0.911 . . . . 0.0 108.876 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.0 98.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.0 -45.73 93.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.061 -1.258 . . . . 0.0 109.755 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.1 mt -69.85 -24.48 63.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.537 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -79.8 -57.49 3.63 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 110.46 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.94 -45.21 93.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 0.0 111.585 -178.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 31' ' ' SER . 39.4 p-10 -61.62 -39.8 92.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.0 110.28 -178.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.532 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 9.3 p -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 0.0 110.316 -179.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.04 -50.04 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 0.0 110.335 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.72 -39.96 95.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 0.0 110.127 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.26 -20.09 66.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.59 1.02 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.94 -1.1 . . . . 0.0 110.022 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 13.58 56.87 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.011 -1.056 . . . . 0.0 110.921 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.93 150.81 28.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.973 -1.31 . . . . 0.0 109.692 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.62 138.84 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.58 106.75 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.687 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.83 171.51 26.19 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.41 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 109.481 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 56.9 19.98 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.502 -0.749 . . . . 0.0 110.014 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.4 m120 49.86 40.04 19.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 111.379 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.16 167.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.973 -1.079 . . . . 0.0 108.574 178.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -93.18 120.91 33.99 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.787 -1.196 . . . . 0.0 110.68 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.53 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 47.1 m-70 -109.18 124.58 51.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.523 ' NH1' HD21 ' A' ' 100' ' ' LEU . 13.9 ttt-85 -100.02 127.25 46.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.257 -0.902 . . . . 0.0 108.661 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 18.5 m-70 -95.67 171.55 8.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.37 -0.831 . . . . 0.0 110.399 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.97 -50.08 71.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 108.848 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.2 m -94.09 146.91 32.48 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 179.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.2 -6.37 18.16 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 CA-C-N 119.436 0.834 . . . . 0.0 112.368 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -92.54 -2.24 56.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 109.773 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.05 86.02 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -67.64 -40.43 84.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.011 -1.288 . . . . 0.0 109.189 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.507 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.54 162.66 49.4 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.89 179.25 2.84 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 118.448 1.124 . . . . 0.0 111.716 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.69 119.83 23.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.156 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 58' ' ' LEU . 10.3 mp -96.56 -47.52 5.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CG ' ' SD ' ' A' ' 101' ' ' MET . 40.2 p90 -145.33 159.16 43.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.904 -1.122 . . . . 0.0 109.01 178.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.2 m -132.02 169.74 15.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.856 0.836 . . . . 0.0 111.526 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.667 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.6 tt -123.48 133.0 54.09 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.512 0.672 . . . . 0.0 109.211 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.568 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.77 159.08 42.76 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.3 m-20 -76.27 152.48 36.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 0.0 108.732 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.7 mtm -70.02 -20.26 63.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.996 -1.065 . . . . 0.0 109.663 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.0 p -88.66 131.94 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 109.555 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -59.5 150.95 63.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.068 -1.02 . . . . 0.0 108.485 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -80.25 5.3 36.31 Favored 'Cis proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.243 -0.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.69 3.51 90.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.3 p -92.4 174.89 7.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.268 -1.137 . . . . 0.0 110.818 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.5 m-85 -126.24 146.76 49.86 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLU . 51.3 m-20 -129.99 149.82 74.22 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -49.13 -7.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.567 0.881 . . . . 0.0 111.85 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.0 mt-10 -90.0 3.26 53.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.475 ' O ' HD11 ' A' ' 29' ' ' LEU . 65.1 mmm -86.16 21.0 2.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -0.852 . . . . 0.0 109.866 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -85.93 -5.82 59.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 108.882 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -149.85 80.0 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.424 -0.797 . . . . 0.0 109.159 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -157.45 170.54 22.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.195 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.0 p -129.4 150.25 50.84 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.03 149.27 20.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.024 -1.047 . . . . 0.0 109.213 -179.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -48.05 -45.11 26.26 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.509 0.806 . . . . 0.0 111.639 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.16 -149.11 7.83 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.45 162.13 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.539 -0.977 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' ALA . 5.6 m -114.87 116.6 28.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.53 126.79 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -146.5 160.23 42.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.003 -1.061 . . . . 0.0 111.221 -178.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.0 ttm -124.15 131.08 53.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -90.15 120.0 30.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 108.545 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.5 m -98.38 150.02 36.31 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.26 -0.9 . . . . 0.0 109.375 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.69 137.05 48.0 Favored 'Cis proline' 0 N--CA 1.498 1.784 0 C-N-CA 124.084 -1.215 . . . . 0.0 111.94 -2.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.3 m -105.26 150.31 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.394 -0.816 . . . . 0.0 110.047 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.7 152.06 41.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.587 -0.696 . . . . 0.0 109.83 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -163.02 31.94 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 95.8 m-20 -95.25 113.06 24.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.144 -1.209 . . . . 0.0 109.254 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 57.1 mp0 -58.99 -29.5 67.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.0 -42.9 72.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.99 -42.28 60.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.053 -1.03 . . . . 0.0 108.613 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 80.9 m-20 -62.2 -40.63 96.73 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.601 -0.687 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.498 -0.751 . . . . 0.0 109.02 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.5 -39.79 94.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.523 HD21 ' NH1' ' A' ' 47' ' ' ARG . 7.1 tt -60.01 -42.41 94.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.743 -0.598 . . . . 0.0 109.541 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' CG ' ' A' ' 59' ' ' PHE . 21.7 mtm -59.92 -41.64 92.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.82 -1.175 . . . . 0.0 108.576 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.26 -43.14 98.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 108.676 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.2 mt-30 -60.07 -41.32 92.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.098 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 p -70.95 -40.03 72.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.57 -53.83 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 -179.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.102 . . . . 0.0 109.127 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.3 m-70 -60.02 -49.57 77.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.077 -1.014 . . . . 0.0 108.608 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.1 -50.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.87 -51.09 42.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.667 -0.646 . . . . 0.0 109.828 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.04 -40.07 88.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 110.617 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.09 -39.92 78.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 -178.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.73 0.34 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 20.25 76.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.78 -173.04 46.61 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.33 139.29 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.504 -0.998 . . . . 0.0 108.872 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 t -76.62 129.96 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.081 -1.012 . . . . 0.0 108.824 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' C ' ' SD ' ' A' ' 124' ' ' MET . 52.5 mt -131.4 159.85 36.8 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -0.767 . . . . 0.0 109.72 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' ' SD ' ' A' ' 124' ' ' MET . 43.6 p-10 -84.78 -173.97 5.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 109.173 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.7 m-20 -60.04 -36.45 77.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.472 ' CB ' ' NH1' ' A' ' 122' ' ' ARG . 96.5 mm-40 -77.17 13.24 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.7 mtm180 55.42 33.78 21.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.87 -0.518 . . . . 0.0 110.422 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 120' ' ' GLN . 25.1 mtm-85 -109.67 156.67 19.96 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.5 mtm -51.9 133.24 32.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 118' ' ' ASP . 97.6 mmm -60.68 139.95 57.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.627 ' N ' ' NZ ' ' A' ' 128' ' ' LYS . 74.6 p -130.43 149.87 74.63 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -48.63 -43.9 32.42 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 119.38 0.814 . . . . 0.0 111.963 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -60.3 -42.99 96.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.627 ' NZ ' ' N ' ' A' ' 125' ' ' THR . 9.8 mtmp? -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.105 . . . . 0.0 110.288 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.44 -39.99 81.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.738 -1.226 . . . . 0.0 108.409 179.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.08 -36.87 85.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.391 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.07 -49.44 77.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -60.05 -43.75 95.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.45 -39.83 94.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.0 -40.99 91.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.268 -0.895 . . . . 0.0 109.294 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.93 -41.03 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.885 -1.134 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.03 -46.28 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 137' ' ' ARG . 1.6 mmt-85 -60.27 -40.02 88.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.098 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.5 mt-10 -60.93 -38.84 87.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.52 0.676 . . . . 0.0 109.63 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 88' ' ' VAL . 71.7 t -68.81 -39.61 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 110.673 -179.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' ALA . 56.6 mttm -58.23 -46.9 85.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.927 -1.108 . . . . 0.0 110.572 -178.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.11 -33.02 71.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.704 -1.248 . . . . 0.0 108.622 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.26 93.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.56 -0.713 . . . . 0.0 110.289 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -99.96 -18.58 17.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -146.4 141.78 27.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -165.8 166.82 17.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 109.799 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.3 129.97 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mm -92.57 131.83 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.0 mt -131.13 142.09 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 122.165 0.983 . . . . 0.0 110.971 -178.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.85 135.06 32.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -116.24 122.68 45.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.048 -1.033 . . . . 0.0 111.342 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.46 111.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.27 155.69 40.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.111 -0.993 . . . . 0.0 110.55 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.48 -164.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.559 -0.713 . . . . 0.0 109.096 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -74.51 157.44 35.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.096 -1.003 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.24 143.56 52.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.73 0.24 72.55 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.7 m -130.01 141.78 50.7 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.587 -0.949 . . . . 0.0 109.341 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.72 149.11 44.52 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.451 -0.78 . . . . 0.0 108.936 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.4 145.34 26.9 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 62.6 t-20 -68.07 138.82 56.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.527 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.8 -40.42 98.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.351 . . . . 0.0 109.489 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -29.73 67.81 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -70.37 -57.93 4.29 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 74' ' ' MET . 83.7 mt -60.2 -40.89 91.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.0 109.926 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -64.0 -40.37 96.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.4 t -65.77 -39.06 90.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 111.105 -179.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.82 -42.24 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.197 . . . . 0.0 109.972 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -64.88 -39.94 94.34 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.153 -0.967 . . . . 0.0 108.549 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -64.71 -20.62 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.492 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.62 2.01 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.779 . . . . 0.0 110.114 -178.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.68 13.49 82.35 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.425 179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -79.99 153.17 29.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.049 -1.266 . . . . 0.0 110.059 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 83.0 mt -120.21 133.84 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 110.182 -178.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.95 169.07 27.93 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -59.95 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -1.115 . . . . 0.0 109.189 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.9 mtt 58.89 19.86 7.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.5 m120 51.32 37.62 19.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.222 -0.924 . . . . 0.0 111.336 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.58 164.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.945 -1.097 . . . . 0.0 108.717 178.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -91.72 123.14 34.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.115 -0.991 . . . . 0.0 110.47 -178.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 44.8 m-70 -114.67 131.3 56.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.609 -0.682 . . . . 0.0 109.654 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 17.4 ttp180 -107.32 126.76 52.86 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.9 m-70 -92.75 171.47 8.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.378 -0.826 . . . . 0.0 110.676 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.41 -49.98 72.93 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.2 m -90.49 148.05 37.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.239 -0.913 . . . . 0.0 108.948 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.97 -12.0 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 120.748 0.966 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 56.3 p-10 -90.24 0.78 57.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 0.0 109.901 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.15 10.67 85.87 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 53.5 m -66.88 -40.06 87.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.848 -1.383 . . . . 0.0 109.726 -179.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.521 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.98 166.21 51.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 19.4 Cg_endo -71.16 175.78 8.75 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.493 1.462 . . . . 0.0 112.125 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.29 124.04 27.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.037 . . . . 0.0 109.25 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 86' ' ' MET . 10.2 mp -102.94 -57.25 2.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.405 -0.809 . . . . 0.0 110.026 -179.216 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -130.5 159.49 36.96 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.77 -1.207 . . . . 0.0 108.518 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.8 m -137.3 162.26 34.01 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.017 -1.052 . . . . 0.0 111.731 -177.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 62' ' ' ALA . 8.1 tt -113.58 136.16 53.12 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.663 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.36 160.53 38.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -75.92 161.5 28.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.095 -1.003 . . . . 0.0 109.904 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.1 mtp -69.83 -19.41 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 110.492 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.9 p -89.49 117.44 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.741 -1.224 . . . . 0.0 109.747 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -62.04 148.86 87.71 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -75.43 9.29 10.7 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.828 -1.322 . . . . 0.0 112.234 0.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 73.86 21.76 78.88 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.926 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.2 p -86.08 171.85 11.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.1 -1.235 . . . . 0.0 109.789 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 84.0 m-85 -121.43 144.81 48.47 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.562 -0.711 . . . . 0.0 109.943 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.9 m-20 -129.98 150.44 75.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.59 -8.79 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 120.512 0.808 . . . . 0.0 112.123 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 48.7 mt-10 -89.94 2.61 54.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.448 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.6 mmm -86.23 17.28 3.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -87.41 -7.84 57.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 108.939 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.1 m-20 -150.3 79.99 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -156.25 172.44 18.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.2 p -129.81 150.97 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.177 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.12 148.15 18.18 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.912 . . . . 0.0 109.341 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -45.34 -43.1 17.35 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 120.594 0.863 . . . . 0.0 111.547 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.9 10.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.6 m -129.98 160.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.325 -1.103 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' ALA . 97.9 m -116.47 129.99 56.51 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.617 0.722 . . . . 0.0 110.517 -179.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.9 131.96 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 22.3 p90 -147.03 170.65 16.68 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.916 -1.115 . . . . 0.0 111.172 -178.068 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 4.9 tpp -139.61 122.63 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.3 mt-30 -88.94 114.98 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 0.0 108.66 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.4 m -101.43 152.08 37.93 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.411 -0.805 . . . . 0.0 109.103 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.27 140.51 61.11 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 C-N-CA 123.7 -1.375 . . . . 0.0 112.214 -0.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 20.4 m -119.47 154.38 33.85 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.471 -0.768 . . . . 0.0 109.788 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -71.04 152.61 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.323 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.47 -163.53 26.3 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 92.7 m-20 -95.82 110.41 22.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.276 -1.132 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -59.89 -32.53 70.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.565 -0.709 . . . . 0.0 110.228 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.75 -40.08 76.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.961 -1.087 . . . . 0.0 109.875 -178.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -72.06 -40.26 68.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.636 -1.29 . . . . 0.0 108.627 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 35.7 m120 -60.49 -40.07 90.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.3 t80 -58.18 -43.12 87.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.83 -41.23 95.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.98 -40.18 94.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 108.872 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.92 -49.06 79.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.008 179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.6 mt -66.27 -41.47 89.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.96 . . . . 0.0 110.046 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.536 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 32.5 mt-30 -59.95 -41.83 92.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.966 -1.084 . . . . 0.0 108.873 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -71.13 -40.28 71.5 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.433 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.28 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.069 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.71 -42.21 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 20.0 m-70 -60.1 -46.73 88.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.894 179.387 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.04 -50.0 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.353 -0.842 . . . . 0.0 109.076 179.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.73 -49.57 62.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.77 -40.22 91.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 110.578 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.41 -39.87 77.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.931 -1.105 . . . . 0.0 110.568 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 m -98.78 -0.0 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.95 -1.094 . . . . 0.0 109.741 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.17 22.88 77.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.03 -170.17 46.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.29 137.12 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.578 -0.954 . . . . 0.0 108.93 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -72.01 133.19 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 0.0 108.953 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.01 159.32 39.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 36.7 p-10 -87.47 -172.0 3.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.078 179.315 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 121' ' ' ARG . 73.6 m-20 -60.02 -39.84 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.809 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.465 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 79.0 mt-30 -76.38 17.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.34 -0.85 . . . . 0.0 109.388 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 121' ' ' ARG . 22.3 mtt-85 58.24 25.49 12.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.688 -0.633 . . . . 0.0 110.185 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 85.7 mtm180 -105.12 151.87 23.48 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.325 -0.86 . . . . 0.0 109.267 179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 98.2 mtp -51.93 136.55 28.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.2 mmm -58.81 139.95 55.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.588 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.1 p -132.2 150.65 76.62 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -41.45 -49.92 4.85 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.804 1.003 . . . . 0.0 112.878 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 110.039 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -66.56 -39.94 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.928 -1.108 . . . . 0.0 110.329 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.82 -40.15 87.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 0.0 108.044 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.22 -38.79 85.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.16 -48.94 79.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.876 -1.14 . . . . 0.0 109.721 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -59.94 -46.32 89.79 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.4 ' NE2' ' CE2' ' A' ' 98' ' ' PHE . 98.1 mt-30 -61.89 -39.48 92.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.607 -0.683 . . . . 0.0 109.187 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.24 -40.97 96.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.47 -41.78 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.875 -1.141 . . . . 0.0 109.133 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.21 -46.25 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 59.6 mtp180 -60.21 -40.16 89.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.703 . . . . 0.0 109.83 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.85 -40.45 88.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.04 -1.038 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.67 -38.05 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' ALA . 24.6 mtpp -59.83 -42.87 94.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.718 -1.239 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.08 -34.07 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.432 -1.417 . . . . 0.0 109.072 179.685 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.68 92.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.159 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.14 0.44 45.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.48 -0.763 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.153 -0.967 . . . . 0.0 109.313 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -149.65 145.2 26.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.79 -172.66 3.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.886 -1.134 . . . . 0.0 110.394 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.08 133.47 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mm -88.46 132.71 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.458 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 91.0 mt -131.42 140.63 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 122.346 1.07 . . . . 0.0 111.514 -177.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.9 mtm -147.21 138.39 23.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -118.82 132.56 56.13 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.196 -0.94 . . . . 0.0 111.908 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.56 118.94 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.23 38.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.62 -173.24 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 108.672 178.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -68.76 160.06 31.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.989 -1.07 . . . . 0.0 109.255 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -59.46 142.5 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.95 -6.22 79.16 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -121.9 148.9 44.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.2 mp0 -130.71 149.36 52.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 109.091 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.3 mt -84.91 136.23 33.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.25 146.32 53.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.156 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.87 98.56 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.79 -47.14 87.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.248 . . . . 0.0 109.581 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.07 -32.68 73.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -73.99 -56.93 4.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.638 -0.664 . . . . 0.0 109.842 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.97 -46.91 87.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -61.8 -40.78 96.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.23 -0.919 . . . . 0.0 110.586 -179.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 t -63.89 -40.04 95.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 110.139 -179.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -40.96 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 108.993 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.53 -40.27 95.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.352 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -68.81 -18.09 64.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.459 -0.776 . . . . 0.0 109.804 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -80.76 5.41 15.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.09 11.94 83.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -80.17 156.7 26.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.245 . . . . 0.0 110.031 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.84 137.19 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -62.13 105.89 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.955 -1.091 . . . . 0.0 109.77 -179.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.69 172.6 31.46 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.31 -164.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -1.03 . . . . 0.0 109.85 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 68.2 mtt 58.84 20.06 7.62 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.828 0.823 . . . . 0.0 109.092 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 53.14 40.06 30.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.727 -0.608 . . . . 0.0 111.691 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.13 169.7 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.8 -1.188 . . . . 0.0 109.052 178.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -94.53 115.51 27.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.0 110.629 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 52.2 m80 -101.06 127.93 47.36 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.356 -0.84 . . . . 0.0 109.437 178.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 61.9 ttt180 -106.05 127.55 53.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.099 -1.001 . . . . 0.0 108.514 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 48' ' ' HIS . 15.2 m-70 -97.44 177.1 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 109.648 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -56.51 -49.66 74.06 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 108.833 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -90.28 149.16 40.71 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.362 -0.836 . . . . 0.0 109.224 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.96 -12.22 33.83 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 120.967 1.112 . . . . 0.0 112.95 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -93.03 0.01 57.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.894 -1.129 . . . . 0.0 110.34 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 13.41 82.23 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.705 179.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -69.86 -39.99 76.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.835 -1.391 . . . . 0.0 109.523 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.64 170.57 54.23 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -68.76 169.22 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.355 1.37 . . . . 0.0 111.891 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.94 121.71 26.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.918 . . . . 0.0 109.089 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.7 mp -101.34 -37.36 8.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.273 -0.892 . . . . 0.0 109.533 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -151.38 159.86 44.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.418 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.0 m -133.69 -179.56 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.841 0.829 . . . . 0.0 110.723 -177.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.695 HD23 ' C ' ' A' ' 61' ' ' LEU . 5.9 tt -134.02 134.08 42.02 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.77 160.0 36.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.733 -0.605 . . . . 0.0 109.74 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 70' ' ' PHE . 9.0 m120 -73.36 160.74 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.99 -1.069 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mmm -68.88 -29.84 68.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 110.673 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.0 m -86.79 121.78 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.398 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -59.59 152.58 55.7 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -79.14 3.94 31.36 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.799 -1.334 . . . . 0.0 112.86 0.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.41 21.61 61.98 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.9 p -85.3 160.45 19.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.112 -1.228 . . . . 0.0 109.883 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 63' ' ' ASN . 28.3 m-85 -125.13 139.95 53.31 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.624 -0.672 . . . . 0.0 109.426 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.429 ' N ' ' SD ' ' A' ' 74' ' ' MET . 41.9 m-20 -120.25 149.51 49.63 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.04 -14.49 41.87 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 119.345 0.802 . . . . 0.0 111.936 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.71 -0.0 57.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.279 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 71' ' ' ASP . 10.9 ptm -84.59 25.75 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.336 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 56.5 mtpt -79.08 2.44 20.66 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.546 -1.346 . . . . 0.0 109.282 -179.07 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 90.8 m-20 -142.76 84.25 1.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -161.29 174.13 14.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.977 -1.077 . . . . 0.0 109.977 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -130.09 152.54 49.43 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.72 149.03 18.51 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.14 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -49.33 -49.51 15.33 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-N 119.058 0.699 . . . . 0.0 111.732 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.93 18.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG11 HD21 ' A' ' 28' ' ' LEU . 33.4 m -129.99 159.91 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.492 -1.005 . . . . 0.0 110.132 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.6 m -108.82 122.43 47.17 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.356 0.598 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.2 mt -104.07 129.72 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -148.73 157.28 43.34 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.803 -1.186 . . . . 0.0 111.655 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.4 ttm -121.62 134.58 55.0 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' OG ' ' A' ' 90' ' ' SER . 98.4 mm-40 -90.64 104.01 16.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 88' ' ' VAL . 10.6 m -97.75 149.18 35.45 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.192 -0.943 . . . . 0.0 109.471 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.65 131.81 25.46 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.636 -1.402 . . . . 0.0 112.205 -0.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 60.8 m -103.82 166.68 10.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.75 148.54 47.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.641 -0.662 . . . . 0.0 109.398 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.75 -160.02 33.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.45 113.27 24.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.105 . . . . 0.0 109.443 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.99 -33.01 71.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.619 -0.675 . . . . 0.0 109.916 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.01 -41.49 74.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 110.597 -178.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.32 -42.1 62.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.834 -1.167 . . . . 0.0 108.681 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -62.6 -33.84 75.8 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.07 -48.69 80.67 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -59.96 -39.97 87.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.77 -40.16 91.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.7 mtp -59.89 -42.81 94.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 108.763 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.39 -40.04 96.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.28 -0.887 . . . . 0.0 109.211 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 27.7 mt-30 -60.15 -40.04 88.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 p -71.62 -40.06 70.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.92 71.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.98 -40.06 96.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.246 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.4 m-70 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.997 . . . . 0.0 108.961 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.91 -49.22 84.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.4 -49.61 66.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.831 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.88 -39.97 75.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.256 -0.903 . . . . 0.0 111.046 -178.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 114' ' ' GLY . 4.4 m -102.0 -1.02 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.04 -1.037 . . . . 0.0 110.388 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.09 20.76 73.21 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -82.93 -172.58 48.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.36 139.23 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.588 -0.948 . . . . 0.0 109.077 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 t -77.18 133.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.155 -0.966 . . . . 0.0 108.894 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.0 mt -130.08 156.87 43.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.359 -0.838 . . . . 0.0 109.213 -179.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -86.29 -173.36 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 0.0 109.358 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 87.5 m-20 -60.08 -38.26 82.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.92 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -77.59 15.29 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 56.37 39.58 30.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.702 . . . . 0.0 109.776 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 122' ' ' ARG . 43.4 mtt-85 -116.23 151.16 36.32 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.682 . . . . 0.0 109.292 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.3 mtt -50.56 134.79 23.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.8 mmm -58.39 138.63 56.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.396 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -140.0 152.85 68.67 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -48.0 -43.56 29.95 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 CA-C-N 119.018 0.685 . . . . 0.0 111.391 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.18 -40.81 91.27 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -69.92 -41.04 75.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.052 . . . . 0.0 108.974 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.166 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -62.53 -40.03 95.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.95 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.77 . . . . 0.0 110.277 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' O ' ' A' ' 12' ' ' ILE . 65.0 m-85 -60.04 -42.56 94.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.065 . . . . 0.0 108.692 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -62.56 -39.96 95.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 92.8 m-20 -62.01 -43.07 99.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 0.0 110.236 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.37 -40.64 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.828 -1.17 . . . . 0.0 109.673 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.21 -43.45 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 85.5 mtm180 -60.04 -40.18 88.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.043 . . . . 0.0 110.385 -179.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -61.51 -39.9 92.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.005 -1.059 . . . . 0.0 110.172 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.09 -26.19 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 111.987 -178.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -59.86 -39.65 85.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.581 -1.324 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 57.0 p-10 -59.99 -30.03 68.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.697 -1.252 . . . . 0.0 109.54 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.595 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -63.54 -37.43 87.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -96.99 -13.27 22.43 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.237 -0.915 . . . . 0.0 109.481 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.707 179.869 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.79 104.37 3.32 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' H ' ' CG2' ' A' ' 139' ' ' VAL . . . -99.34 175.23 5.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 110.443 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.42 130.16 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mm -95.8 123.83 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.17 144.21 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 121.777 0.799 . . . . 0.0 109.979 -178.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.6 mtt -143.81 151.32 39.78 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.487 HD21 HG23 ' A' ' 83' ' ' THR . 34.2 m120 -133.52 125.06 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.87 117.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 159.43 44.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.117 -0.989 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.64 174.05 8.12 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -59.34 151.96 22.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 108.567 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -53.21 148.51 8.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.178 -0.951 . . . . 0.0 108.936 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.13 -1.3 79.92 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -130.04 148.47 51.9 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.426 -1.044 . . . . 0.0 109.026 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 55.8 mm-40 -127.53 148.7 50.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.426 -0.796 . . . . 0.0 108.942 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 17' ' ' ALA . 51.5 mt -87.92 139.02 30.94 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.117 -0.989 . . . . 0.0 110.007 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -70.85 145.57 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.78 -40.85 98.73 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.44 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -48.49 81.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.94 -1.33 . . . . 0.0 109.715 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.45 -27.43 65.24 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -75.0 -59.31 2.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.589 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 74' ' ' MET . 92.5 mt -59.71 -45.44 92.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 14.1 t-20 -61.29 -40.4 93.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.0 t -64.45 -39.74 94.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -49.16 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.973 -1.079 . . . . 0.0 110.051 -178.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.13 -40.26 97.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.995 -1.066 . . . . 0.0 109.296 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 34.9 mt-30 -68.1 -16.5 64.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 110.117 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -84.79 -0.63 54.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.994 -1.066 . . . . 0.0 109.96 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.33 13.2 57.63 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.907 -1.12 . . . . 0.0 110.49 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -82.94 149.92 26.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -1.226 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.9 mt -120.4 133.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.04 104.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 -178.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.86 171.34 32.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.72 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -1.169 . . . . 0.0 109.27 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.0 mmm 57.9 20.28 6.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.461 -0.775 . . . . 0.0 109.851 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 50.61 39.45 21.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 111.59 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.2 pt -140.04 160.69 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -91.03 118.57 30.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.005 -1.059 . . . . 0.0 110.409 -179.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.445 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 29.4 m-70 -103.49 127.08 50.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 58.5 ttt180 -102.22 124.27 47.52 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.56 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 57.9 m-70 -94.06 171.14 9.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.64 -47.94 78.62 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -91.45 147.1 34.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.758 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.85 -8.85 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.622 0.881 . . . . 0.0 111.941 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -94.67 -0.33 54.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.08 -1.013 . . . . 0.0 110.742 -179.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.76 86.43 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.9 p -70.22 -40.13 74.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.048 -1.266 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.35 162.8 51.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.56 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.3 Cg_endo -66.53 176.25 4.35 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.067 1.178 . . . . 0.0 112.103 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.57 118.95 23.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 108.771 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.5 mp -97.6 -42.08 7.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.79 159.54 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.988 -1.07 . . . . 0.0 108.549 178.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.4 m -132.32 175.21 9.47 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.326 -0.858 . . . . 0.0 111.078 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.665 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -128.37 131.78 48.55 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.597 0.713 . . . . 0.0 109.138 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.542 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.31 160.21 33.73 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.611 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 84.2 m-20 -74.6 158.24 34.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.92 -1.112 . . . . 0.0 110.334 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -70.11 -27.57 64.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.633 -0.667 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.69 135.51 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.951 -1.093 . . . . 0.0 109.592 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -62.88 149.81 89.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.525 -0.734 . . . . 0.0 110.114 -179.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.13 5.35 24.78 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.962 -0.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.16 4.97 80.83 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -88.81 170.48 10.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.611 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.6 m-85 -118.61 140.09 50.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.574 -0.703 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 74' ' ' MET . 58.2 m-20 -124.33 150.02 62.83 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.79 -10.99 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.441 0.836 . . . . 0.0 112.551 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' ASP . 31.0 mp0 -88.9 2.37 53.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.001 . . . . 0.0 109.344 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.523 ' O ' HD11 ' A' ' 29' ' ' LEU . 63.5 mmm -86.51 18.42 3.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.605 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.7 mttm -85.92 -4.66 59.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.082 -1.011 . . . . 0.0 108.941 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.9 m-20 -149.92 80.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 108.914 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.66 173.11 17.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 109.898 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.4 p -130.24 149.85 51.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.57 149.41 20.11 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.016 -1.053 . . . . 0.0 109.286 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.533 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 18.1 Cg_exo -44.71 -53.59 4.93 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.312 0.675 . . . . 0.0 111.39 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.09 -147.34 5.48 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.97 160.0 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.84 -0.8 . . . . 0.0 109.51 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.487 HG23 HD21 ' A' ' 14' ' ' ASN . 88.2 m -113.42 118.59 34.96 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.9 mt -105.04 129.1 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.77 165.53 27.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.256 -179.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.0 ttp -140.08 127.78 21.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -90.33 117.58 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.998 . . . . 0.0 108.573 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 88' ' ' VAL . 5.5 m -98.7 150.72 36.98 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 108.704 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -74.87 139.08 59.7 Favored 'Cis proline' 0 N--CA 1.496 1.645 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.639 -0.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.6 m -104.86 167.12 9.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -70.24 141.93 52.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.02 -155.74 27.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -95.34 119.39 33.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 108.724 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.7 mp0 -57.54 -31.55 66.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.534 -0.729 . . . . 0.0 110.442 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.51 -40.4 77.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.394 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.48 -40.18 70.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.24 -40.02 94.77 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -59.89 -50.11 75.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 108.699 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -60.01 -40.11 88.14 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 tp -60.52 -41.49 94.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -59.61 -45.4 92.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.116 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.12 -42.9 95.77 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.045 -1.034 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.03 -40.84 90.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.265 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -70.33 -40.12 74.35 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.339 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.96 -55.54 32.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.537 -0.727 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.37 -37.25 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.008 -179.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -60.07 -44.6 94.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.042 -1.036 . . . . 0.0 108.963 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.39 -49.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.27 -47.69 65.7 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.33 -40.02 89.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.149 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.8 -40.38 79.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.1 -1.0 . . . . 0.0 110.938 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.7 1.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.083 -1.011 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.44 25.58 72.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.68 -167.84 43.92 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.2 t -137.43 140.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.412 -1.052 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.437 HG12 ' SD ' ' A' ' 124' ' ' MET . 10.7 t -71.66 130.65 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.163 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -127.01 157.51 39.37 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.0 109.297 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -84.62 -173.41 4.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.312 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.9 m-20 -60.65 -38.65 85.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.268 -0.895 . . . . 0.0 108.69 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.63 17.74 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.49 -0.756 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.15 32.44 20.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.606 -0.684 . . . . 0.0 110.709 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -111.7 147.65 35.12 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.4 mtt -52.14 125.55 16.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.609 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.437 ' SD ' HG12 ' A' ' 116' ' ' VAL . 58.2 mtp -60.88 136.24 58.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.904 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 30.7 p -122.93 149.99 57.94 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -41.19 -44.07 5.35 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 120.662 0.908 . . . . 0.0 112.185 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.67 -39.89 90.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.291 -0.881 . . . . 0.0 109.056 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 125' ' ' THR . 68.6 mttm -67.89 -39.61 83.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.42 -40.18 74.3 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 130' ' ' ARG . 48.6 mtt-85 -63.37 -39.48 94.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -59.96 -44.19 94.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.121 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -62.58 -40.11 95.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 108.676 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -60.91 -39.03 87.78 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.297 -0.877 . . . . 0.0 108.841 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.58 -39.99 93.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.33 -40.89 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.007 -1.058 . . . . 0.0 108.852 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.29 -41.97 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.1 mtt180 -61.82 -28.87 69.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.916 -0.49 . . . . 0.0 110.725 -179.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 97.3 mt-10 -60.12 -40.1 88.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.831 -1.168 . . . . 0.0 109.645 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.462 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 64.1 t -71.97 -34.03 49.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.466 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 144' ' ' ALA . 62.9 mttm -59.88 -43.15 94.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.929 -1.107 . . . . 0.0 110.902 -179.025 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.89 -26.62 68.27 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.172 179.736 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.51 -59.7 3.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -112.21 -28.01 8.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.488 -0.757 . . . . 0.0 110.133 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.329 -0.857 . . . . 0.0 109.809 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.83 142.71 30.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.7 -174.27 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.566 -1.334 . . . . 0.0 110.5 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.8 t -131.46 136.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.2 mm -91.27 129.43 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.486 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 81.4 mt -131.64 142.72 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.056 0.931 . . . . 0.0 110.912 -177.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.8 mtm -147.85 152.17 37.18 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -129.92 129.3 43.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.921 -1.112 . . . . 0.0 111.434 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.03 112.19 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.11 154.85 39.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.119 -0.988 . . . . 0.0 110.848 -178.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.77 168.45 17.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -56.08 160.18 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.073 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.71 150.14 33.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.77 -4.41 78.9 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 m -130.14 147.48 51.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.523 -0.986 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.53 150.2 50.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.502 -0.749 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.95 145.04 27.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.109 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -70.77 141.13 51.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 108.841 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.23 97.98 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.379 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.06 -45.03 96.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.294 . . . . 0.0 109.425 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mt -69.95 -24.1 63.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.102 179.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.5 tt -77.1 -55.43 5.45 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.956 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.97 -48.7 80.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.127 -0.983 . . . . 0.0 111.104 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 31' ' ' SER . 43.2 p-10 -64.19 -40.02 95.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.858 -1.151 . . . . 0.0 110.66 -178.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 75.5 m -60.9 -40.55 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.888 -1.133 . . . . 0.0 109.797 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 28' ' ' LEU . 96.8 mt -60.05 -48.27 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -61.63 -40.06 93.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.26 -20.03 65.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 0.0 110.245 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.552 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.74 1.05 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.663 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.5 61.66 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -80.0 154.68 28.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.264 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.12 136.94 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.12 106.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.051 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.66 172.83 31.71 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.54 -168.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 110.061 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 77.1 mtm 59.24 25.4 13.99 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.613 0.721 . . . . 0.0 109.844 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 50.64 36.35 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.641 -0.662 . . . . 0.0 111.823 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -140.09 167.52 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.004 -1.06 . . . . 0.0 108.594 177.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 111.083 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 56.4 m80 -103.85 131.05 51.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.425 -0.797 . . . . 0.0 109.392 178.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.0 ttt180 -105.96 127.29 53.05 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.223 -0.923 . . . . 0.0 108.702 178.085 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 60.7 m-70 -97.37 171.71 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.0 110.173 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.28 -49.95 68.41 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -90.36 148.15 38.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.828 . . . . 0.0 109.014 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -70.27 -7.39 21.09 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.844 1.029 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.86 -0.27 55.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.116 -0.99 . . . . 0.0 110.283 -179.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.07 86.1 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -69.99 -41.26 74.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -1.145 . . . . 0.0 110.243 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.83 166.98 52.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.62 168.54 14.65 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.068 1.179 . . . . 0.0 111.393 179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.996 -1.065 . . . . 0.0 109.231 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.4 mp -101.66 -40.12 7.14 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.891 . . . . 0.0 109.563 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -150.12 163.14 38.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 109.316 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 74.8 m -134.1 178.71 6.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.881 0.848 . . . . 0.0 111.137 -177.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.0 tt -132.5 131.43 41.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.44 162.57 31.86 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.704 -0.623 . . . . 0.0 109.48 -179.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.48 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 11.6 m120 -74.93 159.68 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 110.53 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.0 -23.52 63.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.593 -0.692 . . . . 0.0 110.119 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 65' ' ' VAL . 17.4 m -85.36 121.73 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.922 -1.111 . . . . 0.0 109.55 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -59.59 149.92 68.6 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.314 -0.866 . . . . 0.0 108.929 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -77.28 12.12 13.02 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.16 -0.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.19 85.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -87.14 170.58 11.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -1.088 . . . . 0.0 110.062 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -116.89 144.8 44.1 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' GLU . 78.1 m-20 -129.21 150.6 75.9 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -44.81 -12.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.697 0.931 . . . . 0.0 112.16 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -85.13 15.23 4.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 71' ' ' ASP . 7.8 ptp -81.79 -5.12 57.9 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.376 -179.14 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.9 mttm -88.11 -4.63 58.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.88 -1.137 . . . . 0.0 110.468 -179.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.0 m-20 -150.96 69.7 0.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.885 -1.134 . . . . 0.0 109.822 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -154.44 170.0 22.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.6 p -129.68 154.03 47.55 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.6 148.87 17.67 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.95 -1.094 . . . . 0.0 109.329 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.69 -51.17 9.45 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 120.416 0.744 . . . . 0.0 111.62 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.98 -149.52 7.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.03 163.07 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.608 -0.936 . . . . 0.0 110.068 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.6 m -115.04 126.54 54.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -109.88 130.02 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.98 155.15 40.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.785 -1.197 . . . . 0.0 111.556 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.6 ttm -119.51 131.18 55.52 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.5 mm-40 -90.38 112.33 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 88' ' ' VAL . 7.8 m -97.93 150.36 36.68 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.73 132.3 26.48 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.47 0.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 49.6 m -106.4 158.37 16.94 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.595 -0.691 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -73.01 153.07 41.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.61 -164.47 33.02 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 71.5 m-20 -95.29 107.92 20.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -1.067 . . . . 0.0 108.918 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 136' ' ' ILE . 90.8 mt-10 -59.88 -30.26 68.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.667 -0.646 . . . . 0.0 110.529 -179.292 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.71 -39.99 76.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.274 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.88 -40.6 60.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.042 -1.036 . . . . 0.0 108.815 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 72.3 m-80 -62.47 -35.83 80.56 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -59.6 -49.98 75.66 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -60.79 -40.08 91.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.96 -43.22 95.2 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.0 mtp -58.5 -41.17 84.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 0.0 109.1 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.15 -40.76 86.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.601 179.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.8 mt-30 -60.04 -40.13 88.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 0.0 109.526 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.6 p -72.53 -40.01 67.11 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 109.458 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.54 -53.51 57.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 110.102 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.62 -37.74 82.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.975 -1.078 . . . . 0.0 109.314 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 12.5 m-70 -59.98 -47.48 85.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.048 179.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.03 -49.95 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.401 -0.812 . . . . 0.0 109.208 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.16 -50.39 49.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.571 -0.705 . . . . 0.0 109.513 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.07 -39.99 87.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.327 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.64 -39.95 80.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 110.591 -178.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -100.2 -0.16 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.58 24.33 76.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.29 -173.53 49.21 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.76 134.38 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.631 -0.923 . . . . 0.0 108.956 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.601 HG12 ' SD ' ' A' ' 124' ' ' MET . 2.5 t -71.71 128.25 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 108.94 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.06 159.99 35.96 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.395 -0.816 . . . . 0.0 109.824 -179.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -85.95 -170.07 2.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.757 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.2 m-20 -60.12 -39.85 87.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.295 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.88 14.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 108.962 -179.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.4 mtt180 56.23 35.13 25.24 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.382 0.61 . . . . 0.0 109.371 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 122' ' ' ARG . 13.0 mtt-85 -109.7 153.33 24.42 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.619 -0.676 . . . . 0.0 109.315 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.2 mtm -50.27 124.37 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.601 ' SD ' HG12 ' A' ' 116' ' ' VAL . 52.3 mtp -60.03 140.0 57.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.866 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 p -131.65 150.83 77.39 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -43.64 -42.75 11.47 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.706 0.937 . . . . 0.0 112.411 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.01 -39.92 87.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.59 -39.61 88.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 109.528 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.9 -39.96 83.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 108.071 179.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.73 -40.06 96.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.01 -47.87 84.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 109.688 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -60.08 -42.58 94.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.862 -1.149 . . . . 0.0 108.585 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -60.79 -40.01 91.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.69 -38.93 86.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.631 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.0 -43.34 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.031 . . . . 0.0 108.608 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 94' ' ' GLU . 81.7 mt -59.94 -41.35 85.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 108.684 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 57.0 mtp180 -59.89 -39.97 87.16 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.443 -0.786 . . . . 0.0 109.431 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.443 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 80.8 mm-40 -60.01 -41.36 91.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 109.805 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.92 -32.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.845 -179.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -60.04 -40.28 88.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.953 -1.092 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -59.98 -30.96 69.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.266 179.878 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.57 94.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 109.953 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -96.84 -2.67 43.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.0 109.433 179.817 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.45 ' O ' HD11 ' A' ' 135' ' ' ILE . 81.9 m-20 -90.47 6.43 43.46 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.918 -1.114 . . . . 0.0 109.699 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.89 72.85 79.25 Favored Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 6' ' ' ARG . 11.5 Cg_exo -58.18 129.37 32.63 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.047 1.165 . . . . 0.0 112.583 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -78.77 32.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.1 -1.0 . . . . 0.0 108.563 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 4' ' ' PRO . 97.7 mtt180 -75.38 156.66 35.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.645 -0.659 . . . . 0.0 110.791 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -83.78 -6.88 59.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -142.89 149.9 39.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -163.66 170.98 16.32 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.601 -1.312 . . . . 0.0 110.605 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.5 t -123.04 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.4 mm -91.95 128.24 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.9 mt -128.65 140.84 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.844 0.83 . . . . 0.0 110.63 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.411 ' ND2' HG23 ' A' ' 83' ' ' THR . 30.5 m120 -136.88 127.32 26.68 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.848 -1.158 . . . . 0.0 111.335 -178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.7 114.45 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.06 153.03 41.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.078 -1.014 . . . . 0.0 110.258 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.91 -165.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -69.89 155.71 40.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.065 -1.022 . . . . 0.0 109.178 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.89 140.51 55.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.973 . . . . 0.0 109.64 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.76 6.12 73.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.1 m -129.76 143.1 50.65 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.607 -0.937 . . . . 0.0 108.856 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.411 ' OE1' ' OG1' ' A' ' 78' ' ' THR . 99.2 mt-10 -123.07 150.94 42.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.409 -0.807 . . . . 0.0 109.324 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.3 mt -87.5 142.44 27.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.222 -0.924 . . . . 0.0 109.864 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -67.9 140.32 56.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -0.923 . . . . 0.0 108.736 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.14 97.68 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.768 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.68 -46.58 87.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.961 -1.317 . . . . 0.0 109.783 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.02 -30.64 67.99 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.314 -0.866 . . . . 0.0 108.919 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.19 -56.8 4.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.627 -0.671 . . . . 0.0 109.352 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.04 -42.86 95.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.35 -40.98 92.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.503 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.5 p -64.82 -41.98 95.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.929 -1.107 . . . . 0.0 110.033 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.53 -46.67 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 110.328 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.56 -40.13 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.214 -0.929 . . . . 0.0 110.022 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -65.99 -17.77 64.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.56 5.43 24.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.123 -0.986 . . . . 0.0 109.911 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.33 72.14 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 121.05 -1.031 . . . . 0.0 110.697 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -79.68 150.36 30.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.897 -1.355 . . . . 0.0 109.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.05 133.05 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -62.25 109.67 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.773 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.92 171.29 23.54 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.79 -163.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.303 -1.116 . . . . 0.0 109.725 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 92.4 mmm 58.2 20.35 7.01 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.71 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m120 50.08 39.11 18.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.559 -0.713 . . . . 0.0 111.396 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.94 161.56 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.098 -1.001 . . . . 0.0 108.558 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.9 120.62 31.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.05 -1.031 . . . . 0.0 110.352 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 38.6 m80 -105.12 127.9 53.11 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.5 ttt180 -102.67 129.23 49.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.052 -1.03 . . . . 0.0 108.893 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 13.4 m-70 -93.27 168.77 10.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.422 -0.799 . . . . 0.0 109.052 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 56.3 tp -52.71 -52.59 55.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 108.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.6 m -93.58 149.99 38.09 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.22 -2.14 10.01 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.57 0.846 . . . . 0.0 111.713 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -95.94 0.03 51.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.818 . . . . 0.0 110.465 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.02 14.07 82.12 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.8 p -68.41 -38.59 81.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.155 -1.203 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -90.44 171.43 36.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 27.6 Cg_endo -74.55 178.67 6.78 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 120.944 1.096 . . . . 0.0 111.696 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.57 118.83 22.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.129 -0.982 . . . . 0.0 108.847 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.81 -26.55 14.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -159.25 160.61 35.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.067 -1.02 . . . . 0.0 108.927 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.1 m -134.32 -178.56 5.1 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.915 -1.115 . . . . 0.0 112.094 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -137.9 134.06 34.57 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.322 0.582 . . . . 0.0 109.476 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.636 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.15 162.22 32.72 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.632 -0.668 . . . . 0.0 109.346 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.578 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 86.8 m-20 -75.32 160.81 29.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 0.0 109.849 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.1 mtp -69.93 -22.98 63.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 110.92 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 71.8 t -86.76 121.46 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.822 -1.174 . . . . 0.0 109.719 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -58.57 147.31 70.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.054 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -76.33 15.98 6.95 Favored 'Cis proline' 0 N--CA 1.492 1.435 0 C-N-CA 123.402 -1.499 . . . . 0.0 111.76 -0.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 70.05 18.66 74.84 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 82.2 p -90.76 171.47 9.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -114.6 151.94 32.64 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 77.8 m-20 -131.2 148.42 70.12 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -46.08 -13.96 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 120.562 0.842 . . . . 0.0 111.668 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.4 mt-10 -85.46 16.12 4.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 71' ' ' ASP . 21.8 ptt? -81.94 -2.82 52.7 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 58.9 mttm -86.24 -0.76 56.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.029 -1.044 . . . . 0.0 108.773 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.5 m-20 -152.15 69.34 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.559 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -155.32 169.94 23.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.909 -1.119 . . . . 0.0 109.53 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.411 ' OG1' ' OE1' ' A' ' 22' ' ' GLU . 80.4 p -130.41 154.49 47.66 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.69 149.88 20.75 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.872 -1.142 . . . . 0.0 109.57 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -57.24 -36.43 99.02 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.508 0.805 . . . . 0.0 112.185 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.68 -157.78 19.94 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.159 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.0 160.3 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.594 -0.945 . . . . 0.0 109.116 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.411 HG23 ' ND2' ' A' ' 14' ' ' ASN . 54.5 m -116.62 124.36 49.6 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.549 0.69 . . . . 0.0 109.867 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -108.05 129.48 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.24 163.61 34.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 110.282 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -140.02 128.56 22.89 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -88.97 118.67 28.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 108.735 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -104.14 152.52 39.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -73.45 138.13 53.87 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 C-N-CA 124.016 -1.243 . . . . 0.0 112.275 -1.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.7 m -105.46 160.94 14.76 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.799 0.809 . . . . 0.0 110.736 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.17 143.73 52.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.709 -0.62 . . . . 0.0 109.953 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.74 -152.96 24.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -93.72 110.15 21.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.305 -1.115 . . . . 0.0 109.068 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -56.21 -31.05 63.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.678 -0.639 . . . . 0.0 109.713 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 -37.02 75.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.99 -38.98 76.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 108.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 58' ' ' LEU . 91.8 m-20 -60.16 -41.16 92.21 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.576 ' CG ' ' NE2' ' A' ' 133' ' ' GLN . 70.7 t80 -59.79 -46.09 90.28 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -61.24 -46.59 89.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 109.762 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.11 -40.05 88.34 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.099 -1.001 . . . . 0.0 110.248 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 84.3 mtp -59.02 -49.14 79.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.0 110.124 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.478 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 96.8 mt -66.09 -40.04 90.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.895 -1.128 . . . . 0.0 109.782 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.4 mt-30 -60.02 -42.59 94.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.116 -0.99 . . . . 0.0 108.92 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 p -70.11 -39.9 75.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.454 -0.779 . . . . 0.0 109.19 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.41 -57.8 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 110.275 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.402 HE21 ' HA ' ' A' ' 103' ' ' GLN . 18.5 pt20 -60.12 -39.69 87.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.999 -1.063 . . . . 0.0 109.764 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 13.6 m-70 -59.99 -48.3 82.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.913 -1.117 . . . . 0.0 108.636 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.9 mt -60.14 -49.9 82.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.63 -50.13 66.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.504 -0.747 . . . . 0.0 109.327 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.81 -40.0 91.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 110.275 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.94 -40.18 75.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.211 -0.931 . . . . 0.0 111.1 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.12 1.2 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.163 -0.961 . . . . 0.0 109.609 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.45 23.07 77.82 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.87 -176.58 49.6 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 121.146 -1.208 . . . . 0.0 110.349 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.06 130.37 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.696 -0.884 . . . . 0.0 108.791 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 116' ' ' VAL . 2.6 t -71.54 130.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.139 -0.975 . . . . 0.0 108.953 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -130.34 159.61 36.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.369 -0.832 . . . . 0.0 109.411 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -88.34 -173.31 4.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.74 -38.51 85.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -76.4 14.6 0.73 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 121' ' ' ARG . 18.7 mtt-85 57.56 36.8 27.24 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 122' ' ' ARG . 52.4 mtt-85 -112.0 149.28 32.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.2 mtp -52.27 130.3 30.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.3 mmm -60.52 138.98 57.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.972 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 p -134.87 150.94 74.67 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.7 -46.49 10.33 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 120.813 1.008 . . . . 0.0 112.708 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.27 -41.34 93.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.228 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.0 -39.88 95.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.927 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.0 -40.02 79.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.199 -0.938 . . . . 0.0 108.476 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -67.12 -36.68 82.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.621 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.58 -46.57 86.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.005 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -60.01 -40.15 88.29 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.179 -0.951 . . . . 0.0 108.741 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.576 ' NE2' ' CG ' ' A' ' 98' ' ' PHE . 85.6 mm-40 -60.94 -40.05 91.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 0.0 109.009 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.31 -40.05 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.953 . . . . 0.0 108.987 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 2' ' ' ASP . 89.7 mt -61.86 -42.8 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.343 -0.848 . . . . 0.0 108.754 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.07 -40.49 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 32.2 mmt180 -61.33 -37.31 82.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.38 -0.825 . . . . 0.0 109.706 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 94.0 mt-10 -59.88 -40.2 87.91 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.18 -32.97 27.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 111.008 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.9 mttt -59.79 -41.85 92.08 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.877 -1.139 . . . . 0.0 110.903 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.2 -29.48 68.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.83 -1.169 . . . . 0.0 109.811 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.21 -45.43 91.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.079 -1.013 . . . . 0.0 110.261 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -104.62 -1.07 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.814 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.467 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG3' ' H ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 1' ' ' MET . 94.8 m-20 -87.07 -9.73 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.915 -1.116 . . . . 0.0 108.849 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -91.07 149.94 40.84 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 52.3 Cg_exo -35.71 158.24 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 121.4 1.4 . . . . 0.0 113.271 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.18 29.89 0.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.567 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -78.28 92.34 4.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.085 . . . . 0.0 109.357 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -85.98 -16.15 39.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -154.76 131.37 10.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.06 -170.2 1.87 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.576 -1.327 . . . . 0.0 110.88 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.06 132.3 65.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -86.87 130.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -126.94 144.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 122.091 0.948 . . . . 0.0 110.964 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.2 mtt -145.12 151.28 38.23 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -131.24 130.13 42.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.142 . . . . 0.0 111.153 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.0 t -109.31 118.43 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 154.75 39.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.978 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.02 -165.8 0.13 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -65.67 155.49 35.81 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.934 -1.104 . . . . 0.0 108.826 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -58.73 139.45 56.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.102 -0.999 . . . . 0.0 109.589 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.22 62.43 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -128.49 143.3 50.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.575 -0.956 . . . . 0.0 108.936 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -120.39 140.46 51.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.437 -0.789 . . . . 0.0 109.923 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.64 142.12 28.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.885 . . . . 0.0 109.944 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -68.99 137.78 54.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.44 -0.787 . . . . 0.0 109.347 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -40.26 96.82 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.581 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -60.05 -46.32 89.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.772 -1.428 . . . . 0.0 109.512 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.41 -24.69 63.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 tt -72.6 -56.54 5.18 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' MET . 36.0 mt -60.11 -45.06 94.23 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.955 -1.09 . . . . 0.0 110.301 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.03 -45.99 90.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -0.821 . . . . 0.0 111.518 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 88.4 p -63.47 -43.17 98.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.88 -1.138 . . . . 0.0 110.192 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.15 -47.14 93.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 110.202 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.0 -40.07 94.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.138 -0.976 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -68.13 -19.56 64.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.536 -0.728 . . . . 0.0 109.833 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.54 7.85 11.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.178 -0.951 . . . . 0.0 109.693 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.85 9.39 84.54 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -79.76 147.6 31.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.386 . . . . 0.0 109.266 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 88.9 mt -122.91 134.37 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.98 102.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.326 -0.859 . . . . 0.0 110.253 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.44 168.09 29.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.53 -162.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.195 -1.179 . . . . 0.0 109.186 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.7 mtt 59.92 20.15 9.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.81 -0.557 . . . . 0.0 110.609 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.6 m120 52.35 33.19 12.36 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.129 -0.982 . . . . 0.0 111.362 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 12.2 pt -139.61 155.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.008 -1.058 . . . . 0.0 108.483 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -88.02 120.19 29.13 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.883 -1.136 . . . . 0.0 110.019 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 52.7 m-70 -105.41 127.14 52.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.638 -0.664 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 47' ' ' ARG . 15.4 ttt-85 -101.82 128.87 47.98 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -93.84 175.74 6.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.44 -49.97 68.75 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.167 -0.958 . . . . 0.0 108.53 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 55.2 m -92.65 149.24 37.68 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -71.34 -2.19 10.84 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.695 0.93 . . . . 0.0 111.644 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.01 -2.78 52.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.102 -0.999 . . . . 0.0 109.933 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.62 11.68 85.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.8 p -69.95 -40.0 75.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -1.184 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.58 171.51 54.05 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.49 177.23 7.0 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.04 1.16 . . . . 0.0 111.306 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.58 122.25 26.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.0 108.925 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -101.06 -47.58 4.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.169 -0.957 . . . . 0.0 109.439 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -141.63 163.08 33.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.123 -0.986 . . . . 0.0 108.526 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.489 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.2 m -136.15 -177.01 4.51 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.125 -0.984 . . . . 0.0 111.842 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.3 tt -136.79 130.37 31.81 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.47 0.652 . . . . 0.0 109.43 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.63 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.48 160.54 33.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 93.8 m-20 -75.06 157.89 34.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.317 -0.865 . . . . 0.0 110.674 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.6 mtp -69.94 -22.19 63.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.549 -0.719 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 65' ' ' VAL . 10.3 p -87.04 120.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.88 151.3 64.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.0 110.07 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.38 15.7 7.25 Favored 'Cis proline' 0 N--CA 1.501 1.95 0 C-N-CA 124.042 -1.232 . . . . 0.0 112.344 -1.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.94 18.61 80.17 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 36.9 p -87.88 175.61 7.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.231 -1.158 . . . . 0.0 110.31 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.563 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 40.4 m-85 -125.31 156.4 38.72 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 73' ' ' GLU . 39.4 m-20 -140.02 147.24 49.96 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 121.175 -0.953 . . . . 0.0 110.676 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -47.56 -11.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 CA-C-N 119.36 0.807 . . . . 0.0 110.806 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 71' ' ' ASP . 44.5 mp0 -85.56 22.37 1.59 Allowed 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.73 ' HB3' HD11 ' A' ' 29' ' ' LEU . 41.1 mtm -73.57 -0.1 14.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.0 mttm -88.13 -1.45 58.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.005 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 69.2 m-20 -151.23 74.78 1.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.725 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -160.05 164.61 33.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.01 -1.056 . . . . 0.0 109.544 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.5 p -139.11 155.88 47.57 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.62 149.02 16.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.826 -1.172 . . . . 0.0 109.353 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -55.85 -36.42 95.43 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.412 0.741 . . . . 0.0 111.812 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.43 -157.1 15.06 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 61' ' ' LEU . 30.8 m -130.02 158.8 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.697 -0.884 . . . . 0.0 109.114 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.8 m -110.03 118.3 36.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.616 -0.678 . . . . 0.0 109.842 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 94.5 mt -100.56 130.04 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -147.98 168.97 20.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.898 -1.126 . . . . 0.0 111.021 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 ttp -141.28 135.24 30.41 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -88.32 108.62 19.42 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 88' ' ' VAL . 3.8 p -97.41 141.36 22.9 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -79.53 135.25 34.39 Favored 'Cis proline' 0 N--CA 1.498 1.736 0 C-N-CA 124.147 -1.189 . . . . 0.0 112.498 0.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.594 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.0 m -105.32 168.52 9.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.394 -0.816 . . . . 0.0 109.289 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -69.98 149.96 47.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.97 -157.63 32.37 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -96.71 117.84 31.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.366 -1.079 . . . . 0.0 109.575 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 90' ' ' SER . 57.8 mm-40 -57.6 -28.38 63.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.3 mt -69.91 -38.14 76.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.746 . . . . 0.0 109.247 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.86 -40.0 76.02 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.522 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.6 m-20 -61.39 -40.55 94.77 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.3 t80 -59.21 -48.38 81.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.27 -46.45 89.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -0.838 . . . . 0.0 108.94 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -62.29 -40.1 95.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.98 -46.68 88.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.023 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' A' ' 98' ' ' PHE . 90.4 mt -65.54 -45.04 84.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.519 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 29.3 mm100 -60.03 -40.23 88.64 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.164 -0.96 . . . . 0.0 108.448 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.2 p -70.02 -40.52 75.14 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.321 -0.862 . . . . 0.0 109.364 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.67 7.62 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.456 -0.777 . . . . 0.0 109.561 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -61.02 -40.89 95.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.145 -0.972 . . . . 0.0 109.661 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -60.63 -50.38 73.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.054 -1.029 . . . . 0.0 108.912 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -59.9 -50.09 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.71 -49.0 63.34 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -59.95 -40.02 87.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.0 110.227 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.89 -40.01 75.91 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.148 -0.97 . . . . 0.0 110.958 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.34 0.79 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.06 -1.025 . . . . 0.0 109.623 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.04 21.52 76.94 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.52 50.39 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.01 136.43 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.602 -0.94 . . . . 0.0 108.916 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.0 t -74.03 135.05 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.101 -1.0 . . . . 0.0 109.938 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -134.85 160.21 38.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.356 -0.84 . . . . 0.0 109.425 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -86.41 -174.85 5.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.38 -0.825 . . . . 0.0 109.115 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.5 m-20 -60.04 -36.02 76.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.357 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -77.25 12.76 1.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 0.0 109.103 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 40.8 mtm-85 55.91 39.54 30.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.741 -0.6 . . . . 0.0 109.853 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -117.69 153.22 33.72 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.6 mmm -50.46 130.03 23.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 75.4 mmm -60.08 139.81 57.25 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.518 -0.739 . . . . 0.0 109.476 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 p -134.45 151.21 75.74 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -43.98 -46.84 10.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.873 1.049 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -60.08 -39.99 88.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 0.0 110.225 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.1 -39.97 82.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 110.287 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.43 -40.04 85.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.949 -1.094 . . . . 0.0 108.603 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 130' ' ' ARG . 35.1 ttt-85 -63.64 -39.59 94.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.591 -0.693 . . . . 0.0 109.431 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -59.62 -46.97 87.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.586 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -59.86 -41.55 91.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -62.6 -40.13 95.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.83 -41.0 94.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.308 -0.87 . . . . 0.0 109.845 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.08 -43.3 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.899 -1.126 . . . . 0.0 108.891 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.97 -47.46 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.538 -0.727 . . . . 0.0 109.361 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.3 mtt180 -61.06 -39.9 91.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.11 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 51.5 mt-10 -60.48 -40.06 89.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.213 -0.93 . . . . 0.0 110.971 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 88' ' ' VAL . 62.6 t -70.52 -34.04 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.062 -1.024 . . . . 0.0 110.794 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 144' ' ' ALA . 98.1 mttt -60.01 -44.45 94.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.538 -1.352 . . . . 0.0 110.571 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.17 -31.08 69.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.924 -1.11 . . . . 0.0 109.566 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.96 95.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 109.671 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -104.76 -3.86 23.06 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.764 . . . . 0.0 109.679 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.573 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.368 0.604 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -89.9 10.05 25.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 0.0 109.572 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -129.73 79.99 72.43 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.514 -0.741 . . . . 0.0 109.448 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -72.94 10.02 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.027 1.152 . . . . 0.0 111.473 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -88.15 5.43 41.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -75.73 143.93 41.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.705 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -85.83 -17.42 35.74 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -150.86 149.25 29.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.7 -163.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.978 -1.076 . . . . 0.0 109.675 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.54 130.45 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mm -93.33 122.87 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.429 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.7 mt -119.18 151.34 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 122.26 1.029 . . . . 0.0 111.77 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.2 mtt -148.25 158.66 44.22 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -141.46 127.33 19.3 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.747 -1.221 . . . . 0.0 111.066 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.97 118.72 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 157.93 43.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.955 -1.091 . . . . 0.0 110.484 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -175.32 1.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.507 -0.745 . . . . 0.0 109.346 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -65.55 158.38 27.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -59.29 143.35 49.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.145 -0.972 . . . . 0.0 109.42 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.53 77.26 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -129.98 140.23 50.93 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.973 . . . . 0.0 109.355 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -127.69 148.6 50.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.494 -0.754 . . . . 0.0 109.21 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 112' ' ' VAL . 74.4 mt -87.64 142.73 27.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.927 . . . . 0.0 110.151 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.76 145.58 54.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.19 98.23 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.728 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -61.71 -46.8 88.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.96 -1.318 . . . . 0.0 109.488 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.87 -28.81 65.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.322 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.9 tt -73.08 -58.75 3.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.358 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 74' ' ' MET . 97.5 mt -60.27 -44.28 95.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.36 -44.13 97.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.248 -0.907 . . . . 0.0 110.802 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 m -60.54 -40.2 90.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.813 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.96 -47.63 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.38 -40.11 95.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.263 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -66.63 -20.58 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.0 111.022 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.505 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -82.12 -9.47 59.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.731 -1.231 . . . . 0.0 110.506 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.524 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 110.0 7.06 27.56 Favored Glycine 0 N--CA 1.503 3.126 0 O-C-N 121.125 -0.984 . . . . 0.0 110.835 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.689 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 35.7 m-85 -78.04 150.89 33.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.775 -1.427 . . . . 0.0 110.105 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.3 mt -126.39 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.84 110.63 1.6 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 110.191 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.09 171.89 23.93 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -63.78 -163.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 109.033 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.7 mtp 57.19 19.81 5.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.0 109.816 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 m120 50.71 39.06 20.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.69 -0.631 . . . . 0.0 111.485 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.05 167.02 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.013 -1.054 . . . . 0.0 108.176 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -94.07 121.47 35.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.976 -1.077 . . . . 0.0 111.035 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 50.8 m80 -110.2 130.27 55.57 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.625 -0.672 . . . . 0.0 109.207 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.689 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 37.6 ttm180 -103.8 132.87 49.65 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.78 -1.2 . . . . 0.0 108.643 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.55 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 84.1 m-70 -95.74 169.8 9.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.217 -0.927 . . . . 0.0 109.684 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.8 tp -55.98 -51.15 68.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 108.938 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.9 m -92.93 145.94 31.11 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -67.48 -2.29 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.715 0.943 . . . . 0.0 111.839 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.65 -2.56 51.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.86 86.61 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.024 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -70.01 -40.57 75.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.001 -1.293 . . . . 0.0 109.311 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.55 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -82.56 168.03 47.37 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.28 174.86 9.33 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.433 1.422 . . . . 0.0 112.019 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.12 126.3 30.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.286 -0.884 . . . . 0.0 108.854 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.9 mp -99.82 -39.92 7.97 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.106 -0.996 . . . . 0.0 109.532 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -149.39 165.45 32.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.1 -1.0 . . . . 0.0 108.617 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 45.2 m -133.32 -179.91 5.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.201 -0.937 . . . . 0.0 111.333 -176.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.5 tt -136.95 134.58 36.87 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.659 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.14 163.6 29.55 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.732 -0.605 . . . . 0.0 109.74 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.514 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 89.5 m-20 -77.02 164.77 25.43 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 109.527 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 72.6 mmm -69.94 -28.0 65.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.2 p -89.94 121.53 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.102 -0.999 . . . . 0.0 110.493 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -60.95 152.82 68.71 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.687 -0.633 . . . . 0.0 109.653 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.93 5.02 19.43 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.736 -1.36 . . . . 0.0 112.377 -0.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.88 19.2 70.87 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.395 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.0 p -86.36 165.12 16.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -1.21 . . . . 0.0 109.671 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 82.5 m-85 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.627 -0.67 . . . . 0.0 109.638 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' A' ' 74' ' ' MET . 90.7 m-20 -120.83 151.19 54.32 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -50.59 -12.55 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 CA-C-N 119.553 0.876 . . . . 0.0 112.178 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -88.9 4.36 48.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.474 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 72.5 mmm -81.71 16.86 1.63 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 44.7 mmtm -88.23 -4.72 58.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.004 -1.06 . . . . 0.0 108.584 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 78.2 m-20 -148.57 79.55 1.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -158.26 171.02 20.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -0.983 . . . . 0.0 109.218 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.7 p -135.34 150.3 49.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.375 -0.828 . . . . 0.0 109.043 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.27 150.86 23.04 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 0.0 109.197 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -46.34 -44.08 20.77 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 C-N-CA 120.529 0.82 . . . . 0.0 111.861 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.97 -154.56 12.1 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.416 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -129.97 160.51 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.688 -0.889 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 62' ' ' ALA . 53.2 m -112.81 127.96 56.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.677 0.751 . . . . 0.0 110.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -111.34 130.06 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -148.27 169.71 19.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.701 -1.249 . . . . 0.0 110.245 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.2 ttp -137.52 132.39 33.15 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.415 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.6 mt-30 -91.1 118.76 30.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 0.0 109.023 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -103.26 150.37 37.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -76.37 136.17 43.24 Favored 'Cis proline' 0 N--CA 1.498 1.79 0 C-N-CA 123.724 -1.365 . . . . 0.0 111.964 0.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 35.3 m -106.6 159.45 16.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.515 -0.74 . . . . 0.0 110.601 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -73.53 146.56 44.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 0.0 109.294 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.74 -160.9 29.18 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.93 111.55 23.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.207 -1.173 . . . . 0.0 109.422 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -54.48 -25.0 22.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.364 -0.835 . . . . 0.0 108.777 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.51 -40.14 73.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.095 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -70.88 -40.0 72.51 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.503 HD21 HD23 ' A' ' 58' ' ' LEU . 8.3 m120 -60.62 -40.01 90.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.8 t80 -58.64 -43.54 89.78 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.614 -0.679 . . . . 0.0 109.283 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -64.48 -41.7 96.31 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.366 -0.833 . . . . 0.0 109.66 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.94 -41.07 95.54 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.168 -0.958 . . . . 0.0 109.097 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 83.3 mtp -58.54 -48.61 80.29 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.45 -0.781 . . . . 0.0 108.989 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 98' ' ' PHE . 96.2 mt -64.34 -47.66 78.5 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.482 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.52 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.0 mt-30 -60.5 -40.79 92.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 108.978 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.8 p -70.04 -40.82 74.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.02 -59.48 5.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.805 -0.559 . . . . 0.0 109.767 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.97 -38.07 84.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.376 -0.827 . . . . 0.0 110.01 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 11.9 m-70 -60.06 -46.54 89.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.825 -1.172 . . . . 0.0 109.049 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.15 -48.79 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 108.592 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.27 -50.01 40.92 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.47 -39.92 89.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.676 -0.64 . . . . 0.0 110.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.02 -40.82 74.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.166 -0.959 . . . . 0.0 111.453 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 23' ' ' LEU . 12.3 m -101.87 3.39 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.083 -1.011 . . . . 0.0 109.978 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.01 29.53 75.18 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.22 46.51 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.9 138.54 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.694 -0.886 . . . . 0.0 108.843 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.05 135.66 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.963 -1.086 . . . . 0.0 109.58 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 24.0 mt -133.51 155.24 49.95 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.309 -0.87 . . . . 0.0 109.6 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -84.23 -170.2 2.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.454 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.3 m-20 -61.94 -33.28 73.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 109.89 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -78.07 10.43 2.92 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.202 -0.936 . . . . 0.0 108.62 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.579 HH11 ' HG2' ' A' ' 121' ' ' ARG . 10.7 mtt-85 59.67 40.44 19.94 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.494 0.664 . . . . 0.0 109.292 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -124.64 153.8 41.71 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.4 mtp -50.86 126.46 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 42.1 mtp -60.04 140.07 57.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.7 p -127.66 150.38 72.9 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -40.75 -47.42 4.69 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.83 1.02 . . . . 0.0 112.604 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.05 -39.84 87.36 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.391 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -65.71 -42.13 91.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.153 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.02 -40.44 89.3 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.245 -0.91 . . . . 0.0 108.833 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -63.65 -38.66 91.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.457 -0.777 . . . . 0.0 109.399 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -60.05 -46.64 88.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -59.99 -40.07 87.91 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.134 -1.026 . . . . 0.0 108.553 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.64 -40.01 93.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.428 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -63.95 -40.84 97.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.85 -40.52 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.39 -45.09 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.691 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -62.48 -36.74 83.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.823 -1.173 . . . . 0.0 110.124 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.426 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.02 -44.29 94.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.166 -0.959 . . . . 0.0 110.94 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 139' ' ' VAL . 16.6 m -74.8 -30.81 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.969 -1.082 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -59.69 -39.86 85.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.956 -1.09 . . . . 0.0 111.003 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.03 -29.72 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.559 -1.338 . . . . 0.0 109.002 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.72 95.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.714 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -101.03 -27.83 13.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.204 -0.935 . . . . 0.0 109.817 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.594 -179.783 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' OD1' ' OE2' ' A' ' 131' ' ' GLU . 96.4 m-20 -86.05 -11.03 53.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 109.111 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -130.07 71.46 82.2 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 6' ' ' ARG . 1.2 Cg_endo -61.79 140.49 85.96 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 120.613 0.876 . . . . 0.0 112.315 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -80.0 31.04 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 4' ' ' PRO . 14.0 mmm180 -75.06 127.28 32.86 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 109.999 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -85.65 -23.93 27.27 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.9 145.99 28.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.33 169.09 21.17 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.881 -1.137 . . . . 0.0 109.74 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -115.8 130.35 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mm -92.16 129.07 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.3 mt -124.22 143.95 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.832 0.825 . . . . 0.0 110.461 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.0 mtt -142.96 149.46 38.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -132.26 128.59 38.16 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.977 -1.077 . . . . 0.0 111.187 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -109.97 119.73 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.16 157.93 43.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.978 . . . . 0.0 110.363 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.56 -176.04 2.2 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -63.15 147.34 51.14 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.087 -1.008 . . . . 0.0 109.092 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' O ' ' ND1' ' A' ' 19' ' ' HIS . 4.5 p80 -51.57 147.22 6.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.01 78.38 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -131.54 149.99 52.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.586 -0.95 . . . . 0.0 109.595 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -127.59 150.0 49.91 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.2 mt -84.26 141.97 30.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.139 -0.975 . . . . 0.0 109.673 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -66.27 140.04 58.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.256 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.49 95.88 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.771 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.07 -47.72 83.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.967 -1.313 . . . . 0.0 110.246 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.71 -29.96 67.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 108.991 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -71.51 -59.74 2.6 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.4 mt -59.9 -45.88 91.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -60.09 -42.25 94.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 109.998 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.8 t -64.08 -40.3 95.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 0.0 109.494 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.11 -45.33 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.089 -1.007 . . . . 0.0 109.221 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -62.68 -39.96 95.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.279 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -65.91 -21.95 66.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 109.735 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.17 7.89 10.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.22 -0.925 . . . . 0.0 110.358 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.11 15.46 78.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.048 -1.072 . . . . 0.0 110.894 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -81.63 150.08 28.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.896 -1.355 . . . . 0.0 109.504 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.9 mt -119.98 131.22 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.9 103.14 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -0.924 . . . . 0.0 109.595 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.0 170.78 34.94 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.31 -163.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -1.161 . . . . 0.0 109.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 59.4 22.97 11.46 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.431 0.634 . . . . 0.0 110.202 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 50.96 36.15 14.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.499 -0.751 . . . . 0.0 111.153 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.96 161.33 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.127 -0.983 . . . . 0.0 109.297 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -90.88 134.2 34.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 110.317 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.51 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 39.8 m-70 -123.02 127.86 49.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.803 -0.561 . . . . 0.0 109.505 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.4 ttt180 -100.0 123.92 44.77 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 25.9 m-70 -93.36 170.09 9.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.742 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.95 -51.74 66.63 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.369 -0.832 . . . . 0.0 108.92 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -97.59 148.89 35.09 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.368 -0.833 . . . . 0.0 108.855 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.69 -4.22 11.76 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.546 0.831 . . . . 0.0 111.611 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -92.14 -1.6 57.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.37 -0.831 . . . . 0.0 109.803 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.68 14.17 82.33 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -68.61 -44.21 74.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.164 -1.198 . . . . 0.0 109.332 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.17 162.35 44.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -69.61 -176.68 1.52 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 118.587 1.194 . . . . 0.0 111.24 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.22 127.45 33.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 109.438 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.4 mp -99.16 -39.33 8.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.203 -0.936 . . . . 0.0 108.696 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -149.38 154.37 38.82 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 29.9 m -129.97 170.48 13.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.263 -0.898 . . . . 0.0 111.156 -177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -126.36 134.52 51.05 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.574 0.702 . . . . 0.0 109.493 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.64 161.81 33.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.543 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.0 m-20 -73.91 160.82 30.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.008 -1.057 . . . . 0.0 110.189 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.8 mmm -69.23 -22.03 63.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.0 110.013 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.6 t -89.29 120.59 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.208 -0.932 . . . . 0.0 110.048 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -60.67 150.91 73.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.53 8.26 11.87 Favored 'Cis proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.317 -0.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.6 16.55 79.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.7 p -87.74 171.06 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.249 -1.147 . . . . 0.0 109.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.543 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 88.4 m-85 -120.73 161.53 21.28 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.56 -0.712 . . . . 0.0 109.288 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 8.8 t70 -136.65 137.63 24.24 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -45.19 -12.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 120.12 1.079 . . . . 0.0 111.802 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.8 mt-10 -85.19 12.88 7.09 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.2 ptt? -80.89 9.87 5.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.295 0.569 . . . . 0.0 109.578 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -84.39 -6.72 59.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.41 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 74.1 m-20 -150.16 75.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.345 -0.847 . . . . 0.0 109.372 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -155.78 169.99 23.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 0.0 108.849 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.1 p -133.88 153.63 51.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.325 -0.859 . . . . 0.0 109.136 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.6 148.62 19.02 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.165 -0.959 . . . . 0.0 109.182 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -47.43 -53.64 6.17 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 C-N-CA 120.524 0.816 . . . . 0.0 111.646 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.24 -154.0 8.04 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.49 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.685 -0.891 . . . . 0.0 109.03 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 m -112.0 120.13 40.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.666 -0.646 . . . . 0.0 109.824 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.8 mt -105.03 130.05 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.8 170.0 17.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.0 110.997 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 34.8 ttm -138.94 129.8 26.35 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -90.09 112.63 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.4 142.33 24.39 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 88' ' ' VAL . 8.9 Cg_endo -76.49 138.92 57.18 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 124.022 -1.241 . . . . 0.0 112.927 0.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -114.05 164.72 13.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.337 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -71.12 151.41 44.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.52 -165.71 39.11 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -94.9 117.77 30.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -1.115 . . . . 0.0 108.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -55.71 -29.48 59.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.432 -0.792 . . . . 0.0 109.621 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.43 -39.97 77.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.236 -0.915 . . . . 0.0 108.947 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -70.19 -39.99 74.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.917 -1.115 . . . . 0.0 108.557 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.604 ' OD1' HD23 ' A' ' 58' ' ' LEU . 96.9 m-20 -61.38 -40.07 92.97 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.509 ' CE2' HD11 ' A' ' 102' ' ' LEU . 84.7 t80 -58.2 -42.95 87.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.93 -44.84 95.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 108.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.53 -39.99 93.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.246 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 39.8 mmm -57.56 -50.05 74.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.5 mt -66.83 -44.27 81.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.141 -0.975 . . . . 0.0 109.421 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.469 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -59.99 -40.52 89.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.948 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 p -70.18 -41.84 73.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.415 -0.803 . . . . 0.0 109.284 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.64 7.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.389 -0.819 . . . . 0.0 110.146 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.304 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.8 m-70 -60.08 -50.03 75.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.97 -1.082 . . . . 0.0 109.235 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.98 -50.02 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.176 -0.953 . . . . 0.0 109.561 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.05 -50.58 58.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 110.298 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.98 -39.97 75.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.956 . . . . 0.0 111.076 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 m -98.86 -0.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.03 -1.044 . . . . 0.0 109.509 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.47 23.9 77.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.48 -170.7 47.41 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.4 t -134.5 139.0 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -1.027 . . . . 0.0 109.337 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.5 133.57 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.178 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.44 154.8 49.5 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 25.6 p-10 -84.86 -174.86 5.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.8 m-20 -59.93 -36.96 78.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 109.252 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.501 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.1 mt-30 -77.4 16.87 0.56 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.396 -0.815 . . . . 0.0 109.31 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.2 mtt180 60.07 20.81 10.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.967 -0.458 . . . . 0.0 111.0 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.542 ' NH2' ' NZ ' ' A' ' 128' ' ' LYS . 34.4 mtm-85 -106.18 147.63 28.81 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.209 -0.932 . . . . 0.0 108.518 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 86.7 mtp -50.96 137.14 21.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.161 -0.962 . . . . 0.0 110.542 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 31.9 mtt -59.93 144.22 49.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.623 -0.673 . . . . 0.0 110.327 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 5.6 p -132.94 152.23 79.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -42.09 -47.69 6.7 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 120.639 0.893 . . . . 0.0 112.074 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.401 ' CD ' ' H ' ' A' ' 127' ' ' GLN . 27.7 mp0 -60.85 -43.22 98.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.542 ' NZ ' ' NH2' ' A' ' 122' ' ' ARG . 98.4 mttt -67.29 -39.97 86.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 110.218 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.93 -39.93 87.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.997 -1.064 . . . . 0.0 108.275 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -67.8 -38.59 83.5 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.684 -0.635 . . . . 0.0 109.909 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' OE2' ' OD1' ' A' ' 2' ' ' ASP . 58.9 mm-40 -59.75 -46.07 90.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.032 -1.043 . . . . 0.0 109.73 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -60.06 -41.08 91.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.044 . . . . 0.0 108.239 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.5 -39.99 95.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.558 -0.714 . . . . 0.0 109.125 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.04 -40.03 92.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.511 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -43.45 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.174 -0.954 . . . . 0.0 108.769 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.98 -42.08 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 137' ' ' ARG . 49.3 mtt-85 -62.23 -39.85 94.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.705 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.44 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 74.9 mm-40 -60.02 -39.97 87.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.107 -0.995 . . . . 0.0 109.35 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.19 -27.96 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 mmtt -60.04 -45.3 93.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.0 110.173 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.95 -31.06 70.62 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.309 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.63 96.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -0.868 . . . . 0.0 110.221 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 46.4 p-10 -105.31 -3.3 22.93 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.29 -0.881 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.66 42.24 1.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 109.601 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 5' ' ' LYS . 4.4 mtmm -130.02 78.03 75.53 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.495 -0.753 . . . . 0.0 109.513 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -65.7 37.6 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.161 1.24 . . . . 0.0 111.747 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 3' ' ' LYS . 88.0 mttt -70.86 -26.45 63.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.404 ' HG3' ' NH1' ' A' ' 6' ' ' ARG . 49.9 mtm-85 -83.71 119.31 24.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -86.42 -19.25 29.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.6 149.55 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.46 162.59 27.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 0.0 109.69 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -109.32 130.67 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 0.0 109.145 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mm -90.82 132.49 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.464 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.9 mt -129.93 141.67 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 CA-C-O 122.279 1.038 . . . . 0.0 111.344 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.3 mtt -142.87 151.66 41.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -131.55 121.71 24.89 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.833 -1.167 . . . . 0.0 111.113 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.1 t -99.71 110.01 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.54 159.79 42.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.11 -166.3 0.23 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -70.11 159.96 32.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.061 -1.024 . . . . 0.0 109.27 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -58.38 145.14 39.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.45 10.26 82.22 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -130.06 147.52 51.81 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.428 -1.043 . . . . 0.0 109.311 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -127.71 145.75 50.8 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 17' ' ' ALA . 58.7 mt -85.19 147.68 26.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.777 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.14 142.98 55.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.024 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.31 99.36 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.918 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.33 -43.74 98.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.374 . . . . 0.0 109.835 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.94 -28.51 65.64 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.1 tt -71.04 -59.58 2.7 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.16 -39.95 88.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -0.911 . . . . 0.0 109.661 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.6 p -66.45 -39.82 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 109.968 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.8 mt -59.87 -49.94 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.078 -1.014 . . . . 0.0 109.827 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -62.16 -40.0 94.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.956 -1.09 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.81 -22.88 66.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.339 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.99 7.72 12.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.029 -1.045 . . . . 0.0 110.266 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.2 12.58 75.98 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.138 -0.976 . . . . 0.0 111.118 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.78 150.01 26.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.951 -1.323 . . . . 0.0 110.051 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.78 132.39 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -60.62 100.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.908 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.34 171.72 32.56 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -60.76 -161.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.235 -1.156 . . . . 0.0 109.902 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 98.0 mtp 60.0 20.55 9.65 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.51 0.671 . . . . 0.0 109.914 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 m120 51.93 33.56 11.91 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.567 -0.708 . . . . 0.0 111.565 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 pt -141.65 168.13 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.0 109.189 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.06 121.5 33.68 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.032 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.459 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 63.3 m-70 -106.51 130.03 54.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.784 . . . . 0.0 109.21 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 7.2 ttt-85 -102.8 126.89 50.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.274 -0.892 . . . . 0.0 109.184 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 28.5 m-70 -97.35 170.92 8.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.466 -0.771 . . . . 0.0 109.941 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.0 -49.99 74.08 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -91.36 145.72 31.99 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.334 -0.854 . . . . 0.0 109.042 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 -2.72 9.4 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.668 0.912 . . . . 0.0 111.833 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.54 -3.68 52.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.168 -0.958 . . . . 0.0 109.85 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.0 9.78 86.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -70.9 -42.61 69.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.001 -1.294 . . . . 0.0 110.229 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.01 164.99 54.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -68.4 175.12 7.28 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 120.997 1.131 . . . . 0.0 111.374 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.8 121.84 26.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.093 -1.004 . . . . 0.0 109.323 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -97.68 -38.1 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.207 -0.933 . . . . 0.0 108.741 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.57 167.52 29.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 67.5 m -137.33 -179.08 5.52 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.984 -1.072 . . . . 0.0 111.173 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.629 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -136.51 131.65 34.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.538 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 160.29 34.18 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 109.543 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.59 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 94.0 m-20 -74.5 159.45 32.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.559 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.03 -21.32 63.2 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.505 -0.747 . . . . 0.0 110.177 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.5 t -88.15 121.24 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.056 -1.028 . . . . 0.0 109.901 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -60.69 150.66 74.9 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 109.189 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.34 12.21 20.22 Favored 'Cis proline' 0 N--CA 1.494 1.526 0 C-N-CA 123.584 -1.423 . . . . 0.0 111.723 -0.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 19.03 67.88 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.6 167.18 14.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.285 -1.127 . . . . 0.0 110.443 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 88.7 m-85 -122.39 141.87 51.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.573 -0.705 . . . . 0.0 109.484 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 73' ' ' GLU . 47.8 m-20 -128.79 150.0 73.76 Favored Pre-proline 0 N--CA 1.501 2.118 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.68 -6.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.548 0.874 . . . . 0.0 111.778 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 71' ' ' ASP . 97.2 mt-10 -89.32 0.22 56.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.433 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 65.8 mmm -85.33 13.68 6.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.46 -0.775 . . . . 0.0 109.585 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -85.42 -8.6 58.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.164 . . . . 0.0 108.75 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -150.76 79.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -155.8 174.14 15.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.197 -0.939 . . . . 0.0 109.95 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.1 p -129.84 150.28 51.21 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.28 150.22 19.5 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.156 -0.965 . . . . 0.0 109.095 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -44.76 -43.61 14.69 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 120.415 0.743 . . . . 0.0 111.619 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.03 -149.54 10.9 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 159.95 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.526 -0.985 . . . . 0.0 109.604 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -113.22 120.88 42.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 109.537 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 56.0 mt -103.03 130.5 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -145.85 170.6 16.23 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.936 -1.102 . . . . 0.0 110.496 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.0 ttp -138.45 130.68 28.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.619 -0.675 . . . . 0.0 109.746 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.35 123.91 33.95 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.898 . . . . 0.0 109.351 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 9' ' ' ALA . 4.4 m -102.26 148.81 35.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.857 . . . . 0.0 109.016 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.42 141.93 72.76 Favored 'Cis proline' 0 N--CA 1.497 1.692 0 C-N-CA 123.94 -1.275 . . . . 0.0 111.87 -1.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -107.0 155.72 19.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.412 -0.805 . . . . 0.0 109.971 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 92' ' ' GLY . 64.7 t80 -72.33 155.3 40.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 109.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CD2' ' A' ' 91' ' ' TYR . . . 80.75 -157.85 40.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -97.49 118.05 33.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.339 -1.095 . . . . 0.0 109.076 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.38 -32.9 70.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.583 -0.698 . . . . 0.0 110.432 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.1 mt -69.9 -40.07 75.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.931 -1.106 . . . . 0.0 109.973 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -71.64 -40.02 70.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.923 -1.111 . . . . 0.0 108.361 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.428 ' ND2' HD23 ' A' ' 58' ' ' LEU . 18.6 m120 -61.9 -39.83 93.34 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.891 0.853 . . . . 0.0 108.811 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 64.8 t80 -59.51 -50.0 75.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.464 -0.772 . . . . 0.0 109.77 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -62.42 -39.94 94.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.01 -41.92 93.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.27 -46.06 89.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.375 -0.828 . . . . 0.0 109.473 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.17 -41.4 98.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.015 -1.053 . . . . 0.0 108.764 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.483 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.1 mt-30 -60.0 -40.04 87.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.349 -0.844 . . . . 0.0 108.803 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 p -71.76 -40.25 69.44 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.404 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.9 67.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.859 . . . . 0.0 110.207 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.58 -35.64 80.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 109.56 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.2 m-70 -60.09 -45.84 91.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.074 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.27 -49.9 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 108.948 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.61 -49.7 55.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.51 -0.744 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -60.55 -39.98 89.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -69.18 -40.08 78.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.319 -0.863 . . . . 0.0 110.909 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 114' ' ' GLY . 10.3 m -103.14 0.02 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.99 22.93 77.29 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.746 -1.741 . . . . 0.0 108.746 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -85.66 -171.24 47.89 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -135.06 141.76 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.988 . . . . 0.0 109.561 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.76 130.04 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 0.0 108.985 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' C ' ' SD ' ' A' ' 124' ' ' MET . 76.0 mt -132.0 159.97 37.2 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' N ' ' SD ' ' A' ' 124' ' ' MET . 35.7 p-10 -85.31 -172.59 4.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -59.97 -37.94 81.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.986 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -76.95 14.02 0.94 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 108.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.7 mtt180 55.91 32.81 20.45 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.732 -0.605 . . . . 0.0 109.526 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.54 156.58 19.34 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.9 mmm -50.92 133.97 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.435 ' SD ' ' C ' ' A' ' 117' ' ' LEU . 96.5 mmm -58.27 139.91 54.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.742 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 p -129.4 148.71 70.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -49.96 -43.76 40.2 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 119.43 0.832 . . . . 0.0 111.947 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -60.42 -40.1 89.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -65.76 -39.95 91.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.049 -1.032 . . . . 0.0 109.878 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.98 -40.05 87.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 108.675 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.63 -39.22 91.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.566 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.06 -46.37 88.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -59.98 -46.31 89.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.954 -1.091 . . . . 0.0 108.971 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.564 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 37.4 mm-40 -60.01 -39.98 87.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.396 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.95 -41.64 92.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.69 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.6 mt -63.36 -43.64 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.941 -1.1 . . . . 0.0 108.741 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.08 -44.96 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 108.803 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.474 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.1 mmt180 -60.03 -39.93 87.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 96.2 mt-10 -60.17 -38.63 83.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.529 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 88' ' ' VAL . 75.0 t -66.42 -39.73 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 110.537 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.8 mttt -59.88 -50.08 75.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.887 -1.133 . . . . 0.0 110.889 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 2.1 p-10 -62.38 -36.99 84.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.822 -1.174 . . . . 0.0 109.574 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.42 99.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.305 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -102.27 -0.76 32.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.22 -0.925 . . . . 0.0 109.783 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 109.526 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -90.8 7.89 37.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.549 -0.719 . . . . 0.0 109.332 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -77.81 131.11 71.29 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.15 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -50.21 118.06 3.65 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 CA-C-N 119.992 1.033 . . . . 0.0 112.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.89 33.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.652 0.739 . . . . 0.0 109.327 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -69.97 150.53 46.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.489 -0.757 . . . . 0.0 110.249 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -81.15 -9.31 59.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -148.89 142.02 24.95 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.87 171.91 17.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.089 -1.007 . . . . 0.0 109.607 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.63 129.92 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.07 129.94 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.3 mt -128.72 146.12 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 122.083 0.944 . . . . 0.0 110.775 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.1 mtt -145.76 151.09 37.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.405 ' OD1' ' SD ' ' A' ' 64' ' ' MET . 67.3 m-80 -136.86 130.28 31.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.647 -1.283 . . . . 0.0 111.244 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -104.25 129.96 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.74 159.9 41.21 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 110.577 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.39 -172.47 1.46 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -65.96 155.99 34.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.839 -1.163 . . . . 0.0 108.298 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -55.53 133.1 50.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.128 . . . . 0.0 109.636 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.29 5.8 75.49 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.5 m -127.04 153.69 45.62 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.478 -1.013 . . . . 0.0 109.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.98 153.67 45.58 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.533 -0.73 . . . . 0.0 109.083 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.87 138.37 32.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.117 -0.989 . . . . 0.0 109.693 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -69.75 145.19 52.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.14 -42.97 98.78 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -61.1 -46.66 89.7 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -1.191 . . . . 0.0 109.906 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.73 -28.48 65.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.1 tt -71.7 -57.31 4.48 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.593 -0.692 . . . . 0.0 109.549 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.97 -46.12 90.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.045 . . . . 0.0 110.824 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -64.79 -41.36 95.88 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.002 -1.062 . . . . 0.0 111.067 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.2 m -63.03 -39.99 96.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.027 -1.046 . . . . 0.0 110.098 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.5 mt -60.12 -49.82 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.915 . . . . 0.0 110.695 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -63.26 -40.06 96.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.926 -1.109 . . . . 0.0 109.806 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -61.65 -23.62 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.445 -0.784 . . . . 0.0 110.761 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.616 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.32 -8.69 59.64 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.831 -1.168 . . . . 0.0 110.614 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' C ' ' NE ' ' A' ' 47' ' ' ARG . . . 109.37 9.96 24.55 Favored Glycine 0 N--CA 1.503 3.105 0 O-C-N 121.01 -1.056 . . . . 0.0 110.845 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.768 ' N ' HH21 ' A' ' 47' ' ' ARG . 30.0 m-85 -79.89 148.95 31.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.683 -1.481 . . . . 0.0 109.972 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.6 133.56 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.24 105.69 0.53 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 110.265 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.59 171.38 30.48 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.45 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.125 -1.221 . . . . 0.0 110.093 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.9 mtt 59.96 22.68 11.77 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.406 0.622 . . . . 0.0 110.198 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.1 m120 52.57 36.21 19.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 0.0 111.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 pt -140.08 161.6 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.995 -1.066 . . . . 0.0 108.572 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -93.08 120.94 33.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.064 -1.022 . . . . 0.0 110.677 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 54.3 m80 -106.79 131.5 53.83 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.768 HH21 ' N ' ' A' ' 37' ' ' PHE . 32.6 ttm180 -104.5 130.22 52.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.006 -1.059 . . . . 0.0 108.497 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -100.15 169.42 9.17 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.844 . . . . 0.0 109.979 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.1 tp -57.06 -50.0 74.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.833 . . . . 0.0 108.876 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.1 m -89.91 148.32 39.41 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.49 -4.45 15.02 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.597 0.865 . . . . 0.0 111.83 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -94.96 -0.17 54.12 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.378 -0.826 . . . . 0.0 110.187 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.94 9.05 87.2 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.6 m -69.91 -40.4 75.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -1.187 . . . . 0.0 109.902 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.49 166.01 52.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.63 175.03 7.63 Favored 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 120.916 1.078 . . . . 0.0 111.737 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.408 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.35 123.36 29.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.283 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.84 -37.14 9.18 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.09 161.93 41.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.151 -0.968 . . . . 0.0 108.672 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 49.2 m -134.44 -177.97 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.859 0.838 . . . . 0.0 110.844 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.579 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.4 tt -136.66 130.85 32.8 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.579 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.82 162.67 30.92 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.545 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.5 m120 -78.49 164.9 24.34 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.045 -1.034 . . . . 0.0 110.547 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 14' ' ' ASN . 89.8 mmm -70.03 -22.61 63.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 0.0 110.461 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 68' ' ' GLY . 94.2 t -86.95 119.24 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.978 -1.076 . . . . 0.0 110.115 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.91 147.72 78.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.151 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -75.64 14.56 6.93 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.552 -1.437 . . . . 0.0 111.842 -0.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 72.13 17.75 77.47 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.9 p -87.29 175.92 7.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -1.229 . . . . 0.0 109.728 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 80.1 m-85 -119.59 147.9 43.95 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 0.0 109.52 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 73' ' ' GLU . 27.0 m-20 -134.0 150.2 73.72 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -46.66 -8.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.641 0.894 . . . . 0.0 112.306 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.7 mt-10 -85.66 10.36 13.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -83.74 -1.29 53.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.766 -0.584 . . . . 0.0 109.87 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.7 mttp -84.3 -6.78 59.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 0.0 109.733 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.5 m-20 -150.1 78.01 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.369 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -162.31 171.39 17.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.842 -1.161 . . . . 0.0 109.814 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.8 p -131.86 156.99 45.1 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.04 18.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.024 -1.048 . . . . 0.0 109.141 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -56.66 -24.36 54.05 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 120.515 0.81 . . . . 0.0 111.89 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.4 -164.02 36.27 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.731 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.11 166.52 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.751 -0.852 . . . . 0.0 108.735 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 62' ' ' ALA . 94.2 m -119.89 129.97 54.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.532 -0.73 . . . . 0.0 110.387 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.52 128.96 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -145.72 164.08 32.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.001 -1.062 . . . . 0.0 110.827 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.7 ttm -132.19 130.22 40.76 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -88.73 105.35 17.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 88' ' ' VAL . 15.3 m -97.38 148.72 34.83 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.82 134.43 35.74 Favored 'Cis proline' 0 N--CA 1.497 1.705 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.364 0.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -105.56 159.89 15.6 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -71.07 145.49 49.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.339 -0.851 . . . . 0.0 109.214 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.31 -161.55 23.29 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 89.6 m-20 -96.25 108.96 21.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.013 -1.286 . . . . 0.0 109.05 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.29 -31.34 65.52 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.46 -0.775 . . . . 0.0 110.065 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.05 -40.63 74.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.014 . . . . 0.0 110.338 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -77.09 -40.61 45.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.619 -1.3 . . . . 0.0 108.925 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 81.0 m-20 -60.05 -38.09 81.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -58.45 -40.96 84.04 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -63.68 -40.08 95.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.941 -1.099 . . . . 0.0 108.604 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.56 -39.96 89.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.93 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.8 mtp -58.13 -49.88 75.44 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.537 -0.727 . . . . 0.0 109.36 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 102' ' ' LEU . 89.0 mt -64.53 -45.53 86.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 109.294 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.542 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.5 mt-30 -60.25 -40.17 89.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 108.445 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.489 ' CB ' HH12 ' A' ' 47' ' ' ARG . 93.7 p -70.39 -44.0 68.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.89 -54.57 44.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.517 -0.739 . . . . 0.0 110.197 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.096 -1.002 . . . . 0.0 109.989 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.6 m-70 -59.98 -43.66 94.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.0 108.506 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.24 -49.99 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.71 -49.41 68.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.65 -0.656 . . . . 0.0 109.284 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.09 -39.97 91.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -69.9 -40.0 75.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.036 -1.04 . . . . 0.0 110.895 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 m -101.17 2.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.018 -1.052 . . . . 0.0 109.532 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 67.13 25.36 73.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -162.67 38.52 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 121.417 -1.049 . . . . 0.0 110.487 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.59 154.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.646 -0.914 . . . . 0.0 109.203 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.2 t -94.93 129.82 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.185 -0.947 . . . . 0.0 109.426 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.1 mt -122.05 160.08 25.71 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.563 -0.711 . . . . 0.0 110.102 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.11 -171.29 3.5 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.7 m-20 -60.09 -40.04 88.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.087 -1.008 . . . . 0.0 109.697 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -76.23 17.76 0.34 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 119' ' ' ASP . 87.1 mtm180 56.2 35.02 25.01 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.468 0.651 . . . . 0.0 109.756 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -110.24 144.2 39.29 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.7 mtp -51.3 129.56 25.02 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 108.943 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.2 mtt -59.08 141.19 54.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -0.902 . . . . 0.0 110.106 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.1 p -129.56 150.4 75.58 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -42.5 -45.17 8.26 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 120.469 0.78 . . . . 0.0 112.237 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -61.34 -40.01 92.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.188 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.054 -1.029 . . . . 0.0 110.544 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.92 -40.11 83.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.872 . . . . 0.0 108.765 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -65.95 -39.88 90.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.672 -0.643 . . . . 0.0 110.462 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.83 -43.57 94.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 109.839 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -60.14 -44.03 95.24 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.019 -1.051 . . . . 0.0 108.394 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.72 -40.07 96.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.218 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.47 ' OD2' ' NZ ' ' A' ' 3' ' ' LYS . 96.1 m-20 -61.58 -40.04 93.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.615 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.53 -40.95 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.204 -0.935 . . . . 0.0 109.145 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 77.2 mt -61.67 -38.32 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 108.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.477 ' HG2' HH11 ' A' ' 137' ' ' ARG . 27.2 mtt-85 -59.86 -38.91 83.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.045 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 69.1 mm-40 -60.6 -39.99 90.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.117 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.58 -28.77 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 111.025 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 144' ' ' ALA . 68.5 mttm -60.03 -45.24 93.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.663 -1.273 . . . . 0.0 110.179 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -60.07 -30.13 69.01 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.906 -1.121 . . . . 0.0 109.192 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.71 -39.52 93.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.963 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -100.48 -25.62 14.13 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.354 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -88.79 -9.17 52.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 109.457 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -80.0 150.0 71.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.036 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.53 111.37 0.52 Allowed 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 120.572 0.848 . . . . 0.0 111.637 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.04 7.94 8.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.281 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' HG2' HH11 ' A' ' 6' ' ' ARG . 0.1 OUTLIER -78.68 118.39 20.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.092 -1.005 . . . . 0.0 110.723 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.56 -11.15 52.36 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -147.5 130.85 16.6 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -162.3 -166.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.699 -1.251 . . . . 0.0 110.272 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.2 t -140.02 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.14 130.28 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.421 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 95.5 mt -120.0 147.61 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.281 1.039 . . . . 0.0 111.652 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.0 mtt -146.2 158.82 43.9 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' CG ' ' NH1' ' A' ' 121' ' ' ARG . 34.6 m120 -141.15 121.77 14.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.658 -1.277 . . . . 0.0 111.457 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.49 113.48 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.42 44.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.103 . . . . 0.0 110.452 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.82 -169.91 0.51 Allowed 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -69.88 157.34 37.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.03 -1.044 . . . . 0.0 109.1 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -60.06 140.13 57.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.709 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.81 2.08 63.1 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.1 m -127.19 149.7 49.86 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.577 -0.955 . . . . 0.0 109.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -131.18 145.07 51.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.553 -0.717 . . . . 0.0 109.218 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 112' ' ' VAL . 85.3 mt -87.6 146.78 25.59 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.18 -0.95 . . . . 0.0 110.038 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.02 146.42 51.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 108.948 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.29 -44.45 97.49 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.17 -1.015 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mm-40 -61.19 -44.1 97.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.925 -1.338 . . . . 0.0 109.857 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 89.5 mt -69.95 -27.85 65.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.3 tt -76.07 -59.62 2.68 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.71 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -47.93 83.83 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.288 -0.883 . . . . 0.0 111.579 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.3 p-10 -61.27 -39.99 92.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.894 -1.129 . . . . 0.0 110.342 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 56.5 m -62.21 -40.25 95.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.871 -1.143 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.59 -45.92 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.225 -0.922 . . . . 0.0 109.805 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -60.7 -40.03 90.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.298 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -66.31 -19.87 65.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.911 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.56 8.7 9.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.143 -0.973 . . . . 0.0 109.945 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.97 9.89 81.76 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -81.51 151.78 27.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.297 . . . . 0.0 110.113 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.2 mt -126.98 139.95 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.62 107.41 0.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 109.572 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.83 171.49 34.52 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.43 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.235 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 72.1 mtm 56.73 26.1 10.97 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 110.09 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.9 m120 50.03 39.44 19.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 111.293 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 pt -141.67 161.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.5 130.76 37.28 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.532 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.9 m-70 -117.79 127.97 54.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 47' ' ' ARG . 14.5 ttt-85 -99.99 127.08 46.24 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.158 -0.964 . . . . 0.0 108.545 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.7 m-70 -95.8 170.05 9.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.492 -0.755 . . . . 0.0 109.701 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -49.99 -53.93 23.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.089 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -90.82 149.23 39.98 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.305 -0.872 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.66 -5.18 16.19 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.814 1.009 . . . . 0.0 112.452 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -93.04 0.04 57.25 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.135 -0.978 . . . . 0.0 110.041 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.88 16.1 81.06 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.4 p -70.0 -40.0 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -1.173 . . . . 0.0 109.669 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -85.8 173.52 47.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.404 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 24.0 Cg_endo -73.96 178.4 6.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.37 1.38 . . . . 0.0 111.658 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.64 123.08 27.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.135 -0.978 . . . . 0.0 109.884 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.6 mp -97.38 -47.05 5.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.157 -0.965 . . . . 0.0 109.03 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -138.08 160.11 40.25 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.532 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.9 m -127.66 178.2 6.29 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.196 0.998 . . . . 0.0 111.694 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.2 tt -138.6 130.07 27.44 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.599 0.714 . . . . 0.0 109.146 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.634 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.63 160.11 34.33 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.62 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.5 m-20 -73.73 161.79 29.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.991 -1.068 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mtp -69.66 -29.96 67.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.459 -0.776 . . . . 0.0 110.906 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 65' ' ' VAL . 13.2 p -86.35 131.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.804 -1.185 . . . . 0.0 110.126 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -59.97 150.04 71.17 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -76.91 5.93 18.49 Favored 'Cis proline' 0 N--CA 1.494 1.503 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.552 -0.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.82 83.08 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -88.55 169.97 11.27 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.101 -1.235 . . . . 0.0 110.487 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.62 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 75.3 m-85 -120.05 143.49 48.07 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -119.82 149.99 49.66 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.439 -0.788 . . . . 0.0 108.889 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.3 -20.15 61.23 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 120.498 0.798 . . . . 0.0 112.142 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -89.95 -2.71 58.21 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.216 -0.927 . . . . 0.0 109.121 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.594 ' CE ' ' ND2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -89.24 25.24 1.94 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.526 -0.734 . . . . 0.0 110.652 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 29.4 mmtm -80.96 0.88 33.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.885 -1.134 . . . . 0.0 109.351 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 91.6 m-20 -142.0 86.77 2.0 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -159.96 177.97 10.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 109.724 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.2 p -131.73 150.12 52.26 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.56 149.48 19.26 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 0.0 109.219 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -45.28 -41.44 17.12 Favored 'Trans proline' 0 N--CA 1.486 1.056 0 C-N-CA 120.366 0.711 . . . . 0.0 111.393 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.59 -150.79 10.28 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' HB ' HD21 ' A' ' 61' ' ' LEU . 23.4 m -130.11 159.98 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.607 -0.937 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.42 HG23 ' ND2' ' A' ' 14' ' ' ASN . 45.4 m -114.72 124.88 52.92 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.87 129.94 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -146.65 149.45 33.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.919 -1.113 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.2 ttm -102.31 133.33 47.4 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.464 -0.772 . . . . 0.0 109.526 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.7 mt-30 -91.07 105.36 17.76 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 16.0 m -97.46 147.21 32.65 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.185 -0.947 . . . . 0.0 108.537 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -74.23 133.64 31.97 Favored 'Cis proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.667 -1.389 . . . . 0.0 112.377 0.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.6 m -105.29 158.85 16.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -72.73 149.9 43.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.53 -0.732 . . . . 0.0 109.94 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.1 -160.36 34.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -96.1 116.15 28.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -1.159 . . . . 0.0 108.952 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.55 -31.81 69.76 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.694 -0.629 . . . . 0.0 110.219 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.07 -41.47 74.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.155 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -74.29 -39.98 62.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.63 -39.81 89.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 133' ' ' GLN . 55.9 t80 -53.09 -40.06 63.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -59.99 -40.0 87.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.198 -0.939 . . . . 0.0 108.713 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.82 -39.97 93.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.0 109.177 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.3 mtp -56.61 -50.01 73.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.313 -0.867 . . . . 0.0 109.156 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.32 -44.7 90.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.91 . . . . 0.0 109.608 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 84.3 mt-30 -60.02 -40.84 90.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 108.826 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 p -70.17 -40.04 74.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.418 -0.801 . . . . 0.0 109.711 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.85 52.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.387 -0.821 . . . . 0.0 110.162 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -62.09 -37.2 84.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 0.0 109.971 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 10.9 m-70 -60.12 -47.63 85.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.987 -1.071 . . . . 0.0 109.126 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.7 mt -60.11 -49.95 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.901 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.78 -47.72 67.33 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.69 -40.32 91.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.364 -0.835 . . . . 0.0 110.096 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -71.14 -39.99 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 0.0 111.158 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.4 m -101.33 2.33 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 109.521 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.76 23.1 68.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.08 -173.24 45.54 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.95 134.83 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.606 -0.938 . . . . 0.0 109.136 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.416 HG12 ' SD ' ' A' ' 124' ' ' MET . 16.8 t -70.69 135.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.62 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 37.9 mt -132.4 156.19 47.11 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.459 -0.776 . . . . 0.0 109.732 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -87.89 -173.62 4.36 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.581 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 95.6 m-20 -60.03 -34.47 73.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.066 -1.021 . . . . 0.0 108.996 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.34 14.98 0.65 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 108.961 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' NH1' ' CG ' ' A' ' 14' ' ' ASN . 20.2 mmt180 60.11 24.12 13.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.656 -0.652 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -110.96 150.85 28.66 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.44 -0.788 . . . . 0.0 109.321 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.9 mtm -50.52 129.39 22.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.081 -1.012 . . . . 0.0 109.597 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.416 ' SD ' HG12 ' A' ' 116' ' ' VAL . 57.0 mtp -59.93 139.7 57.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.778 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.3 p -125.6 151.01 69.86 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -40.34 -46.43 4.31 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 120.911 1.074 . . . . 0.0 112.532 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -60.14 -39.99 88.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.282 -0.886 . . . . 0.0 109.616 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -67.82 -39.73 83.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.188 -0.945 . . . . 0.0 110.341 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.1 mt -56.65 -40.53 75.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.973 -1.079 . . . . 0.0 108.128 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 130' ' ' ARG . 34.3 ttm-85 -65.29 -39.33 92.42 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.458 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.84 -46.85 87.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.949 . . . . 0.0 109.68 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.581 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 62.0 m-85 -60.13 -42.7 95.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.053 -1.029 . . . . 0.0 108.258 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 98' ' ' PHE . 23.6 mm100 -62.97 -40.1 96.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 95.6 m-20 -61.65 -40.97 96.83 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.419 -0.801 . . . . 0.0 109.838 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.77 -40.05 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.906 -1.121 . . . . 0.0 109.432 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.5 mt -61.25 -39.23 81.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.44 ' O ' ' OD2' ' A' ' 141' ' ' ASP . 99.1 mtt180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.886 -1.134 . . . . 0.0 111.303 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 15.2 mp0 -60.09 -39.09 84.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.794 -1.191 . . . . 0.0 110.164 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.07 -39.33 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.916 -1.115 . . . . 0.0 110.391 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -59.96 -50.08 75.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.779 -1.2 . . . . 0.0 110.929 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' OD2' ' O ' ' A' ' 137' ' ' ARG . 0.4 OUTLIER -60.91 -32.54 72.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.684 -1.26 . . . . 0.0 109.253 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.34 -23.78 67.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 108.826 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -98.74 -2.2 38.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.438 -0.789 . . . . 0.0 109.064 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.362 -0.836 . . . . 0.0 109.465 -179.835 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -86.59 -33.19 20.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' N ' ' OE2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -134.57 74.43 65.6 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -70.97 19.39 0.23 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.048 1.165 . . . . 0.0 111.834 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 3' ' ' LYS . 9.0 mtpm? -74.14 -37.91 63.91 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.72 -0.612 . . . . 0.0 109.626 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.43 120.91 26.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.712 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -81.85 -69.85 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -99.79 139.16 35.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.07 -175.93 5.55 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.738 -1.226 . . . . 0.0 110.231 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.04 133.32 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.93 135.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.468 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.1 mt -130.73 143.16 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.992 0.901 . . . . 0.0 110.701 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.529 ' C ' HD22 ' A' ' 14' ' ' ASN . 58.5 mtm -149.31 152.09 35.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.529 HD22 ' C ' ' A' ' 13' ' ' MET . 5.7 m120 -129.13 130.36 46.34 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.099 -1.0 . . . . 0.0 111.013 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.0 t -106.97 113.8 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.09 153.32 38.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.175 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.24 -175.94 1.34 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -60.07 150.52 29.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.059 -1.026 . . . . 0.0 108.99 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -59.9 148.27 35.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.04 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.54 -5.57 77.27 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -128.98 142.1 51.04 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.601 -0.941 . . . . 0.0 108.894 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -121.93 150.15 42.42 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.746 . . . . 0.0 109.305 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.27 142.46 29.37 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.343 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -67.69 141.03 56.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.0 108.795 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.95 -40.1 96.47 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -62.59 -46.52 87.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.13 -1.217 . . . . 0.0 109.573 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.1 -29.16 66.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.402 -0.811 . . . . 0.0 109.031 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -73.65 -58.92 2.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.07 -44.11 94.99 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.196 -0.94 . . . . 0.0 110.695 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.64 -40.7 95.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.501 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.0 m -64.82 -40.08 94.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.86 -50.26 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 0.0 110.353 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -63.97 -40.07 95.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.05 -20.39 66.46 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.416 -0.802 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.53 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.47 1.07 43.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 109.657 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.86 16.84 43.36 Favored Glycine 0 N--CA 1.499 2.898 0 O-C-N 121.156 -0.965 . . . . 0.0 111.166 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -82.35 152.46 26.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.403 . . . . 0.0 110.242 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.86 134.81 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.12 104.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.067 -1.021 . . . . 0.0 109.996 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.63 171.31 31.77 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -65.56 -163.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.077 -1.249 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.6 mmm 58.7 19.96 7.33 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.643 0.735 . . . . 0.0 109.688 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 51.76 38.19 22.38 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.526 -0.734 . . . . 0.0 111.898 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 pt -140.56 166.29 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.875 -1.14 . . . . 0.0 108.505 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -92.63 122.58 35.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.829 -1.169 . . . . 0.0 110.201 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.9 m80 -106.45 127.33 53.21 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.457 -0.777 . . . . 0.0 109.092 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 37.5 ttt180 -103.88 128.71 51.36 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.06 -1.025 . . . . 0.0 109.05 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.512 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 64.4 m-70 -98.66 171.41 8.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.33 -0.856 . . . . 0.0 109.733 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.9 -49.68 72.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.8 m -91.15 147.79 36.41 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.383 -0.823 . . . . 0.0 109.015 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.45 -7.97 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.747 0.964 . . . . 0.0 111.905 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -91.44 -0.25 57.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.189 -0.944 . . . . 0.0 109.974 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.79 12.01 84.9 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.197 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.2 p -70.59 -40.59 73.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.008 -1.289 . . . . 0.0 110.008 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.3 167.83 51.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -69.67 170.42 16.51 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 120.934 1.089 . . . . 0.0 111.427 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -78.71 126.2 30.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.116 -0.99 . . . . 0.0 109.301 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.0 mp -99.39 -30.72 12.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 109.098 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CB ' ' SD ' ' A' ' 101' ' ' MET . 28.2 p90 -159.15 159.98 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.94 . . . . 0.0 108.615 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 17.6 m -129.88 175.88 8.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 110.564 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.68 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.4 tt -133.24 132.45 41.47 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.506 0.669 . . . . 0.0 109.604 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.629 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -130.1 162.39 28.9 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 89.2 m-20 -75.28 160.92 29.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.974 -1.078 . . . . 0.0 110.782 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 74.6 mmm -69.51 -35.27 75.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.716 -0.615 . . . . 0.0 111.047 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 p -86.57 136.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.879 -1.138 . . . . 0.0 110.303 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -58.98 151.94 52.93 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -78.48 4.08 27.88 Favored 'Cis proline' 0 N--CA 1.497 1.718 0 C-N-CA 123.61 -1.413 . . . . 0.0 112.232 -0.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.66 -2.31 86.0 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.6 p -85.91 170.32 12.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -1.133 . . . . 0.0 109.633 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 91.3 m-85 -113.99 155.99 24.88 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' GLU . 32.9 m-20 -135.52 148.75 67.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -44.05 -14.37 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.64 0.893 . . . . 0.0 112.498 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mp0 -86.17 16.3 4.45 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 71' ' ' ASP . 25.5 ptt? -83.78 -4.96 59.07 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.33 0.586 . . . . 0.0 110.005 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 97.1 mttt -83.34 -4.61 58.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.785 -1.197 . . . . 0.0 109.429 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.4 m-20 -150.03 78.31 1.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 109.326 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.61 170.48 20.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.984 -1.072 . . . . 0.0 109.462 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -131.49 150.74 52.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.65 149.68 20.47 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 0.0 109.19 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -48.84 -47.15 22.17 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 120.554 0.836 . . . . 0.0 111.916 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.14 -150.38 7.61 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.259 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -130.02 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.8 -0.823 . . . . 0.0 109.886 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.469 HG23 HD21 ' A' ' 14' ' ' ASN . 53.3 m -113.2 122.81 48.61 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 84.6 mt -109.99 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -145.09 150.21 36.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.096 -1.002 . . . . 0.0 110.504 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.0 ttm -110.15 135.7 50.52 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.675 -0.641 . . . . 0.0 109.404 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -91.83 104.02 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 m -98.32 149.04 35.33 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 0.0 109.138 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -74.46 137.59 51.05 Favored 'Cis proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.263 0.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 74.3 m -103.35 168.0 9.45 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.428 -0.795 . . . . 0.0 110.541 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 65.3 t80 -72.32 154.6 40.86 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.377 0.608 . . . . 0.0 110.295 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 72.85 -146.87 39.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.13 114.87 26.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.298 -1.119 . . . . 0.0 109.057 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -57.77 -31.04 66.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.928 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' CD1' HH12 ' A' ' 137' ' ' ARG . 90.2 mt -70.06 -39.8 75.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 0.0 109.67 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -70.29 -36.0 74.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.895 -1.128 . . . . 0.0 108.251 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 97' ' ' ASN . 3.0 m120 -59.95 -40.03 87.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 78.2 t80 -59.91 -44.36 94.34 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -63.05 -40.13 96.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.258 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -61.77 -45.2 94.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.471 ' SD ' ' CB ' ' A' ' 59' ' ' PHE . 20.5 mtm -59.92 -43.57 94.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.884 -1.135 . . . . 0.0 109.787 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 92.9 mt -63.88 -40.2 95.97 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.454 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 88.7 mm-40 -60.08 -40.93 91.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.0 109.791 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.1 p -70.48 -40.05 73.87 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 109.429 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.3 70.44 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.388 -0.82 . . . . 0.0 110.355 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -61.3 -40.44 94.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.872 -1.143 . . . . 0.0 109.206 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 26.4 m-70 -60.17 -49.36 77.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.29 -49.85 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.253 -0.905 . . . . 0.0 108.724 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.2 -48.98 64.78 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.673 . . . . 0.0 109.441 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -60.14 -40.02 88.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.809 . . . . 0.0 110.288 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.93 -40.07 75.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.4 m -99.98 -0.93 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.99 -1.069 . . . . 0.0 109.838 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.48 20.79 75.76 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -80.57 -178.35 52.01 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.2 t -130.37 139.8 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.592 -0.946 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.505 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.8 t -74.72 130.78 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.311 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.8 mt -130.06 155.79 45.57 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.375 -0.828 . . . . 0.0 109.995 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -84.73 -174.91 5.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.465 -0.772 . . . . 0.0 109.963 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.5 m-20 -60.07 -35.12 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -78.53 11.53 2.45 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 108.82 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 56.41 38.45 29.71 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -116.08 145.82 42.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.7 mtt -51.16 126.7 17.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 129' ' ' LEU . 45.7 mtt -61.26 151.28 32.19 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.845 0.831 . . . . 0.0 111.195 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.6 p -133.74 149.24 71.39 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -42.43 -50.12 5.84 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 CA-C-N 119.574 0.884 . . . . 0.0 112.628 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -60.29 -40.0 88.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.123 -0.986 . . . . 0.0 110.576 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -65.14 -40.87 94.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.155 . . . . 0.0 110.461 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 124' ' ' MET . 87.7 mt -59.84 -40.32 88.13 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 108.485 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' A' ' 130' ' ' ARG . 19.9 ttt-85 -63.93 -38.54 91.45 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.686 -0.634 . . . . 0.0 109.664 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -58.42 -44.85 89.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.989 -1.07 . . . . 0.0 109.815 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.93 -40.13 87.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 108.969 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -59.87 -39.92 86.9 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.47 -38.39 84.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.466 -0.771 . . . . 0.0 109.301 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 139' ' ' VAL . 6.7 mm -56.52 -46.42 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.01 -43.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.503 ' HG2' HH11 ' A' ' 137' ' ' ARG . 30.8 mtt-85 -60.08 -40.05 88.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.304 -0.873 . . . . 0.0 109.164 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 3' ' ' LYS . 95.9 mt-10 -62.92 -38.68 91.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.542 -0.724 . . . . 0.0 109.457 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 135' ' ' ILE . 92.2 t -69.44 -24.13 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 110.883 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.3 mttm -60.03 -40.03 87.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.793 -1.192 . . . . 0.0 109.748 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 2.3 p30 -64.87 -26.65 68.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.88 -1.137 . . . . 0.0 109.206 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.09 99.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 47.1 p-10 -102.87 -0.11 31.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.351 -0.843 . . . . 0.0 109.607 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.392 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.296 0.57 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.17 -1.78 57.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 108.563 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -79.93 123.71 83.53 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.47 129.96 15.47 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 CA-C-N 120.016 1.041 . . . . 0.0 112.511 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -82.49 -9.93 59.22 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -92.36 102.36 14.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 111.425 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -93.29 -20.34 20.49 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -146.18 136.15 23.51 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -161.82 166.36 26.51 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.56 -1.338 . . . . 0.0 110.492 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.7 t -109.98 129.32 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -91.38 123.06 43.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.43 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.62 148.86 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 122.469 1.128 . . . . 0.0 111.59 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mtt -145.71 154.25 41.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -137.09 122.8 19.88 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.735 -1.228 . . . . 0.0 111.076 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.5 t -106.05 116.75 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.04 153.18 39.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 109.939 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.09 -177.0 1.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -59.96 146.58 41.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 108.845 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.97 141.78 13.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 -3.88 74.29 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -117.74 152.63 34.88 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.591 -0.946 . . . . 0.0 109.5 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.78 147.69 50.81 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.472 -0.767 . . . . 0.0 109.149 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.66 143.65 27.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.225 -0.922 . . . . 0.0 109.831 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -70.58 141.36 51.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 108.875 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.95 98.24 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' O ' ' ND2' ' A' ' 30' ' ' ASN . 97.2 mt-10 -61.41 -46.07 91.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.958 -1.319 . . . . 0.0 109.636 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.94 -27.08 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -72.97 -60.23 2.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.54 -0.725 . . . . 0.0 109.171 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.48 -39.99 89.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 26' ' ' GLU . 96.2 m-20 -61.11 -40.98 95.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.7 p -67.69 -40.2 84.39 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.129 -0.982 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.11 -48.18 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.334 -0.853 . . . . 0.0 109.534 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -63.56 -40.14 96.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.854 . . . . 0.0 109.697 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.48 -20.39 63.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.564 -0.71 . . . . 0.0 110.552 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.85 2.76 32.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 110.296 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.95 15.05 65.91 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.845 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -80.05 153.9 28.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.849 -1.383 . . . . 0.0 109.191 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.446 HD12 ' CD2' ' A' ' 48' ' ' HIS . 96.6 mt -124.7 136.75 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -62.75 106.32 0.78 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.678 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.78 171.52 28.93 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -62.59 -164.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -1.093 . . . . 0.0 109.344 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.0 mtt 57.76 21.26 7.23 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.573 0.702 . . . . 0.0 109.827 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.2 m120 50.02 39.39 18.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.594 -0.691 . . . . 0.0 111.723 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.5 pt -140.01 165.86 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.809 -1.182 . . . . 0.0 108.983 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -91.52 118.44 30.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 110.417 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.542 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 42.1 m80 -105.15 128.46 53.39 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.419 -0.801 . . . . 0.0 109.085 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -100.15 129.23 46.15 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.993 -1.067 . . . . 0.0 108.7 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.446 ' CD2' HD12 ' A' ' 38' ' ' ILE . 52.1 m-70 -97.38 170.14 9.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 55.5 tp -56.99 -49.99 74.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.167 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.3 m -91.25 144.23 29.51 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.28 -0.887 . . . . 0.0 109.102 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -67.23 -5.47 13.87 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.574 0.849 . . . . 0.0 111.738 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.45 -0.53 54.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.213 -0.93 . . . . 0.0 110.157 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' CA ' ' CD1' ' A' ' 38' ' ' ILE . . . 77.67 10.03 86.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -68.23 -39.99 82.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -1.104 . . . . 0.0 109.854 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.79 165.67 46.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.434 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 10.9 Cg_endo -67.38 175.98 5.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.194 1.262 . . . . 0.0 112.087 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.475 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.41 124.94 29.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 109.353 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.1 mp -101.0 -46.81 4.97 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.274 -0.892 . . . . 0.0 109.764 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -143.84 167.4 22.4 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.004 -1.06 . . . . 0.0 108.501 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.542 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 1.9 m -137.51 -177.04 4.61 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.869 -1.144 . . . . 0.0 112.04 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.9 tt -139.97 132.09 28.01 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.514 0.673 . . . . 0.0 109.992 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.66 166.66 22.71 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.3 m-20 -77.69 170.19 17.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.842 -1.161 . . . . 0.0 110.472 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.2 mtp -68.97 -29.57 67.81 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.498 -0.752 . . . . 0.0 111.818 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 65' ' ' VAL . 34.0 m -86.2 118.82 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.51 -1.369 . . . . 0.0 109.749 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -61.5 147.81 87.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.538 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.91 2.87 17.87 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.175 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 69.99 33.32 69.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.3 p -84.34 169.95 14.13 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.042 -1.269 . . . . 0.0 109.887 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.496 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 70.8 m-85 -119.7 150.73 39.88 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 73' ' ' GLU . 53.9 m-20 -139.16 150.26 64.02 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -42.89 -15.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 120.901 1.067 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.5 mt-10 -85.09 16.21 3.64 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.493 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.2 ptt? -83.53 -0.0 48.42 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.024 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 64.3 mttp -85.02 -4.39 59.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.66 -1.275 . . . . 0.0 109.694 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -147.83 77.42 1.42 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.693 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -157.53 169.71 24.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 109.498 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 73.5 p -135.51 156.94 48.08 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.62 19.35 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.083 . . . . 0.0 109.37 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -55.77 -30.67 77.22 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 120.418 0.745 . . . . 0.0 111.744 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.86 -160.85 27.57 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 HD11 ' A' ' 28' ' ' LEU . 33.1 m -130.09 159.94 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.488 -1.007 . . . . 0.0 109.47 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -115.45 119.66 36.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.0 109.745 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -104.75 129.93 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -147.08 170.05 17.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.92 -1.113 . . . . 0.0 110.491 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.0 ttp -133.19 130.96 39.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.533 -0.729 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.56 123.16 35.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.165 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 9' ' ' ALA . 3.7 m -98.43 150.07 36.36 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.262 -0.899 . . . . 0.0 108.62 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -76.06 142.72 74.48 Favored 'Cis proline' 0 N--CA 1.498 1.763 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.386 -0.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 m -109.99 157.81 18.9 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.513 -0.742 . . . . 0.0 109.73 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 64.2 t80 -75.88 154.61 35.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.195 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.16 -159.39 45.15 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -93.78 114.95 27.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.318 -1.107 . . . . 0.0 108.848 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.09 -27.22 43.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.936 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 95' ' ' LEU . 95.4 mt -69.99 -38.22 75.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.546 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.05 -39.32 75.78 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' ND2' HD23 ' A' ' 58' ' ' LEU . 4.0 m120 -60.03 -40.0 87.83 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.87 -41.06 86.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.13 -43.05 99.46 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 108.673 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.0 -39.87 93.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.026 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.0 mmm -56.79 -49.99 73.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.036 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.265 -0.897 . . . . 0.0 109.592 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 94.6 mm-40 -60.28 -41.4 93.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.153 -0.967 . . . . 0.0 109.0 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.8 p -71.93 -39.94 69.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.385 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -56.04 26.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.911 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.48 -40.69 97.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.065 -1.022 . . . . 0.0 109.608 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.7 m-70 -60.06 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.422 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.1 mt -61.06 -49.89 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 108.856 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.69 -51.69 53.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.624 -0.673 . . . . 0.0 109.939 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.498 -0.751 . . . . 0.0 110.814 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.36 -39.9 77.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.409 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -97.87 0.06 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.175 -0.953 . . . . 0.0 109.857 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.27 20.53 76.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.4 -178.35 51.88 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.95 131.55 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.538 -0.978 . . . . 0.0 108.939 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.8 130.68 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 109.949 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.7 mt -132.7 159.91 38.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 37.8 p-10 -86.59 -172.2 3.91 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 121' ' ' ARG . 91.5 m-20 -60.06 -39.87 87.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.0 . . . . 0.0 109.735 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -76.31 13.91 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 108.653 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 119' ' ' ASP . 97.5 mtt180 59.87 34.6 21.76 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.208 0.528 . . . . 0.0 110.135 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -110.03 151.27 27.38 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.7 mtp -52.96 129.99 32.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.957 -1.089 . . . . 0.0 109.319 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 39.5 mtt -59.6 140.86 56.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.133 -0.98 . . . . 0.0 109.932 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 15.6 p -133.63 151.1 76.58 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -43.57 -47.74 9.18 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.486 0.791 . . . . 0.0 111.892 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.99 -41.58 92.37 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 125' ' ' THR . 27.4 mmtp -69.99 -39.98 75.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 99.2 mt -60.0 -39.96 87.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.993 -1.067 . . . . 0.0 108.501 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -62.43 -39.9 94.83 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.46 -46.97 85.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.085 -1.009 . . . . 0.0 109.549 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -60.01 -45.43 92.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.943 -1.098 . . . . 0.0 108.587 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.02 -39.57 86.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -45.73 91.81 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 109.82 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.84 -1.162 . . . . 0.0 108.698 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.05 -45.25 95.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.066 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -61.97 -38.18 87.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.355 -0.84 . . . . 0.0 109.603 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.4 mt-10 -59.97 -39.7 86.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.421 -0.799 . . . . 0.0 110.715 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 -33.63 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 110.428 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 68.4 mttm -59.91 -45.5 92.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.82 -1.175 . . . . 0.0 110.545 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.23 -33.31 72.08 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.665 -1.272 . . . . 0.0 109.681 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.34 -39.96 93.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 110.936 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 41.3 p-10 -98.54 3.01 48.05 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.061 -1.024 . . . . 0.0 109.592 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.148 -0.97 . . . . 0.0 109.389 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.9 1.92 55.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.917 . . . . 0.0 109.652 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 5' ' ' LYS . 1.6 mptp? -77.54 119.18 76.42 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.153 -0.967 . . . . 0.0 108.771 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.39 19.0 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.277 1.135 . . . . 0.0 112.455 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 3' ' ' LYS . 99.4 mttt -88.49 15.77 7.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HG3' HH11 ' A' ' 6' ' ' ARG . 11.4 mmm-85 -78.81 135.1 36.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.922 . . . . 0.0 111.907 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 7.7 mtpm? -85.23 -28.33 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.8 OUTLIER -146.51 146.97 30.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.17 -166.22 0.69 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.436 -1.415 . . . . 0.0 111.393 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -131.5 134.89 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.9 mm -90.27 127.81 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -119.98 148.03 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 122.385 1.088 . . . . 0.0 111.684 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.528 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.9 mtt -145.36 159.05 43.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -138.39 119.71 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.835 -1.166 . . . . 0.0 110.394 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -101.96 110.02 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.58 159.34 44.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.98 179.0 3.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.02 156.26 15.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.108 -0.995 . . . . 0.0 108.773 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -59.95 145.49 45.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.071 -1.018 . . . . 0.0 109.336 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 1.52 68.49 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.2 m -131.26 147.54 52.6 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.973 . . . . 0.0 109.276 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.94 145.31 51.42 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.378 -0.826 . . . . 0.0 109.433 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.3 mt -86.61 145.81 26.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.718 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.04 146.83 50.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.241 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.46 97.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 62.0 mm-40 -61.87 -45.69 92.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.004 -1.292 . . . . 0.0 110.102 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 84.4 mt -70.01 -29.14 66.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 108.627 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.1 -57.14 4.16 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.391 0.615 . . . . 0.0 110.022 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.0 -49.99 75.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 111.63 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.9 p-10 -62.13 -40.07 94.68 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.841 -1.162 . . . . 0.0 110.315 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.458 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -60.42 -43.17 97.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.96 -1.088 . . . . 0.0 109.519 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.94 -46.57 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.1 -1.0 . . . . 0.0 109.428 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.14 -41.13 99.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 110.054 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -68.79 -18.96 64.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 109.819 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.544 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.2 3.96 21.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 5.41 65.9 Favored Glycine 0 N--CA 1.497 2.759 0 O-C-N 120.821 -1.174 . . . . 0.0 111.041 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.46 149.61 33.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.708 -1.466 . . . . 0.0 109.185 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.14 139.71 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.99 116.18 3.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.774 -1.204 . . . . 0.0 108.755 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.99 172.12 34.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -65.36 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.767 -0.843 . . . . 0.0 110.431 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.416 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mmm 58.18 -99.71 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.416 ' CG ' ' O ' ' A' ' 42' ' ' MET . 56.6 m-80 -164.81 28.47 0.06 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.74 168.21 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.355 -0.84 . . . . 0.0 110.556 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.58 119.96 32.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.327 -0.858 . . . . 0.0 109.95 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.526 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 47.4 m80 -103.2 141.19 36.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.299 -0.876 . . . . 0.0 109.04 178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 45.8 ttt180 -120.49 131.29 54.66 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.476 -0.765 . . . . 0.0 109.047 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.558 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.3 m-70 -94.69 174.55 7.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.2 tp -53.56 -49.97 66.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 108.469 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -92.26 146.03 31.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.84 -3.01 10.52 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 120.593 0.862 . . . . 0.0 111.985 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.75 1.35 57.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.209 -0.932 . . . . 0.0 109.831 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.6 10.01 75.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.83 -41.89 70.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.015 -1.285 . . . . 0.0 110.167 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.558 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.37 173.41 54.97 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.454 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.8 Cg_endo -73.75 173.0 14.68 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.085 1.19 . . . . 0.0 111.431 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.57 122.05 26.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.065 -1.022 . . . . 0.0 109.213 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -103.17 -33.76 9.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.372 -0.83 . . . . 0.0 109.844 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.08 169.12 24.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.011 -1.056 . . . . 0.0 108.685 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 8.2 m -139.13 -176.46 4.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.079 -1.013 . . . . 0.0 111.232 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -137.32 132.91 34.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.387 0.613 . . . . 0.0 109.397 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.594 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.06 162.32 31.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 87.0 m-20 -76.26 169.02 19.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.885 -1.134 . . . . 0.0 109.682 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.3 mmm -69.47 -28.75 66.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 110.648 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.32 118.08 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.767 -1.208 . . . . 0.0 110.234 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -62.54 152.02 81.86 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.477 -0.765 . . . . 0.0 108.944 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -78.12 1.95 28.08 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.711 -1.37 . . . . 0.0 111.964 -0.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.0 38.35 19.48 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -86.93 157.63 19.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -1.195 . . . . 0.0 109.744 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.2 m-85 -120.0 139.97 51.67 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.53 -0.731 . . . . 0.0 109.373 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.19 149.98 67.71 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.422 -0.799 . . . . 0.0 108.903 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -49.86 -13.37 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 120.651 0.901 . . . . 0.0 112.561 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.35 -10.1 57.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 92.9 mtp -89.04 22.07 2.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.87 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.1 mttm -85.31 -7.8 58.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 108.558 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 89.3 m-20 -144.7 83.57 1.71 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -158.64 174.35 15.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.256 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -128.64 148.14 50.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 109.152 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.74 150.58 20.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.0 108.926 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -45.77 -50.6 9.36 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 CA-C-N 119.299 0.785 . . . . 0.0 111.763 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.6 -150.17 8.34 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.503 HG11 HD21 ' A' ' 28' ' ' LEU . 33.0 m -130.01 160.07 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.488 -1.007 . . . . 0.0 110.067 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 62' ' ' ALA . 24.6 m -107.89 119.96 40.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.0 109.458 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.9 mt -105.35 129.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -146.94 168.01 22.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.091 . . . . 0.0 110.916 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 35.7 ttp -136.75 129.97 31.29 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -91.39 114.64 27.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.39 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.4 151.98 37.63 Favored Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -78.51 134.19 32.38 Favored 'Cis proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.394 -0.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.3 m -108.53 162.04 14.5 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.489 -0.757 . . . . 0.0 109.856 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.06 146.72 50.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.416 -0.802 . . . . 0.0 109.938 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.24 -159.52 27.53 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -97.31 112.65 24.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.99 -29.14 65.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.822 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.29 -39.97 78.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -71.15 -40.13 71.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.012 -1.055 . . . . 0.0 108.868 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.557 ' ND2' HD23 ' A' ' 58' ' ' LEU . 28.1 m120 -60.97 -39.9 91.38 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 109.098 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.584 ' CD2' ' NE2' ' A' ' 133' ' ' GLN . 87.1 t80 -59.24 -49.96 75.83 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.82 -40.05 96.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.6 -47.46 86.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 110.68 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.8 mtm -59.96 -39.97 87.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.893 -1.129 . . . . 0.0 109.319 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.47 -41.5 98.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 109.103 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.13 -41.2 92.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.243 -0.911 . . . . 0.0 109.002 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.7 p -72.18 -40.03 68.22 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 108.941 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.0 -53.62 56.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.552 -0.718 . . . . 0.0 110.231 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -62.13 -39.2 91.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.94 -1.1 . . . . 0.0 109.689 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 14.9 m-70 -59.97 -44.14 94.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.006 -1.059 . . . . 0.0 108.674 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.2 mt -60.01 -49.45 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.35 -50.16 51.97 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.589 -0.695 . . . . 0.0 109.607 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -60.99 -40.19 92.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.792 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.06 -39.92 75.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.805 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 114' ' ' GLY . 6.0 m -97.76 -1.44 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.057 -1.027 . . . . 0.0 109.704 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.73 19.89 75.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -87.58 -174.68 48.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.8 t -131.12 138.14 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.517 -0.99 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 t -70.44 133.2 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.658 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.5 159.99 35.44 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.556 -0.715 . . . . 0.0 109.759 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -87.76 -171.62 3.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.374 -0.829 . . . . 0.0 109.419 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.5 m-20 -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.873 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -76.88 15.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.049 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.3 mtt180 55.6 38.96 30.86 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.4 0.619 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 122' ' ' ARG . 29.7 mtt-85 -112.07 151.9 28.85 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -51.5 130.65 28.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.215 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.0 mmm -59.16 139.97 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 p -137.6 150.31 67.81 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -47.9 -44.06 28.2 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.844 1.029 . . . . 0.0 112.401 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -39.91 87.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -67.89 -40.03 83.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.053 -1.029 . . . . 0.0 110.123 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.1 -39.88 75.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -61.96 -40.14 94.54 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.556 -0.715 . . . . 0.0 109.078 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -59.94 -48.2 82.69 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.862 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.185 -0.947 . . . . 0.0 109.118 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.584 ' NE2' ' CD2' ' A' ' 98' ' ' PHE . 94.5 mm-40 -59.97 -40.12 87.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.72 -40.39 97.03 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.81 -45.16 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 108.859 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.09 -49.38 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 110.431 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -60.05 -39.98 87.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 54.2 mm-40 -60.26 -41.66 93.71 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.064 -1.022 . . . . 0.0 109.821 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' GLU . 54.6 t -71.36 -40.79 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 111.073 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 144' ' ' ALA . 26.4 mtpp -59.98 -48.06 83.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.963 -1.086 . . . . 0.0 111.266 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 4.2 p30 -60.08 -32.34 70.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.999 -1.063 . . . . 0.0 110.357 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.532 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -62.26 -39.95 94.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.0 . . . . 0.0 109.681 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -104.04 -1.64 27.16 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.47 -0.769 . . . . 0.0 109.169 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 109.407 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mtp . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -90.97 7.12 41.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.335 -0.853 . . . . 0.0 109.096 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -127.31 80.24 72.0 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.532 -0.73 . . . . 0.0 109.24 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 16.4 Cg_exo -56.91 -145.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.511 1.474 . . . . 0.0 113.549 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -76.34 36.46 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.226 0.536 . . . . 0.0 110.159 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 46.3 mtt-85 -60.15 146.78 42.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 109.614 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -83.64 -9.84 58.61 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -145.17 133.71 22.01 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -159.93 170.47 21.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.85 -1.156 . . . . 0.0 110.355 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.82 131.4 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.364 -0.835 . . . . 0.0 109.069 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.58 130.92 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 88.2 mt -125.46 146.02 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.184 0.993 . . . . 0.0 111.937 -177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.5 mtt -145.96 157.36 43.89 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.705 ' ND2' HG23 ' A' ' 83' ' ' THR . 35.0 m120 -141.28 129.94 22.8 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.628 -1.295 . . . . 0.0 111.169 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.29 116.45 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.03 38.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -170.69 0.85 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -68.02 158.09 33.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.99 -1.069 . . . . 0.0 108.947 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -59.96 145.58 45.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.382 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.02 -3.23 82.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 m -118.0 148.47 42.2 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.512 -0.993 . . . . 0.0 108.801 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 63.6 mm-40 -129.31 143.06 50.7 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.0 109.34 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.5 mt -86.35 139.21 31.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 109.458 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.6 145.16 52.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.343 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.91 97.79 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.91 -41.55 98.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.095 -1.238 . . . . 0.0 109.7 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -70.03 -27.1 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.612 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.0 tt -71.31 -59.03 2.99 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.418 -0.801 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' SD ' ' A' ' 74' ' ' MET . 83.0 mt -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.989 -1.069 . . . . 0.0 109.706 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.96 -42.85 94.98 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 109.958 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.6 t -69.97 -46.92 64.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.166 -0.959 . . . . 0.0 110.52 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.8 mt -60.06 -44.23 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 0.0 110.102 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.24 -43.12 98.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.871 -1.143 . . . . 0.0 109.724 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -68.72 -16.39 63.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.665 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.513 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.25 3.91 25.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.299 -0.875 . . . . 0.0 110.056 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.0 9.91 83.66 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -80.22 154.39 27.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.283 . . . . 0.0 109.398 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.17 141.69 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -59.64 111.7 1.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.973 -1.079 . . . . 0.0 109.083 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -92.72 171.85 33.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.34 -169.84 0.23 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.567 -0.961 . . . . 0.0 109.171 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.1 mtm 56.19 29.42 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.406 -0.809 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 m120 49.94 38.66 16.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.558 -0.714 . . . . 0.0 111.493 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 pt -140.22 159.58 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.877 -1.14 . . . . 0.0 109.182 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 45.2 m-85 -89.34 129.99 35.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.089 -1.007 . . . . 0.0 109.872 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.551 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 12.3 m-70 -118.44 127.87 54.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 59.2 ttt180 -100.02 124.98 45.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.217 -0.927 . . . . 0.0 108.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 19.8 m-70 -95.05 169.68 9.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.8 tp -55.54 -50.06 70.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.7 m -92.34 144.55 29.1 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.417 -0.802 . . . . 0.0 108.955 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.44 -3.14 10.41 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.518 0.863 . . . . 0.0 111.975 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -92.25 0.06 57.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 109.59 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.1 11.36 84.06 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 m -70.06 -45.43 67.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -1.197 . . . . 0.0 109.878 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.49 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -73.59 166.35 54.66 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -68.74 177.92 4.43 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.081 1.187 . . . . 0.0 111.456 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.49 124.6 30.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.165 -0.96 . . . . 0.0 109.053 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.9 mp -100.73 -39.76 7.68 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.099 -1.0 . . . . 0.0 109.441 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -148.19 159.86 43.53 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.551 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 2.5 m -130.21 -179.85 5.48 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.204 1.002 . . . . 0.0 112.342 -176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -139.94 129.95 24.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.75 160.97 35.29 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.559 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 17.0 m120 -75.32 159.09 31.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.098 -1.002 . . . . 0.0 110.416 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -69.98 -25.22 63.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.64 -0.662 . . . . 0.0 109.797 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.7 t -85.21 126.27 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.733 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -59.73 149.99 69.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.102 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -77.29 9.87 15.94 Favored 'Cis proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.687 -1.38 . . . . 0.0 111.727 -0.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 14.5 80.98 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -88.99 170.14 10.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 110.877 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 39.3 m-85 -119.27 158.78 25.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.6 m-20 -143.07 150.65 53.41 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.197 -0.94 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -48.98 -8.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.487 1.125 0 CA-C-N 119.171 0.74 . . . . 0.0 110.94 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.3 mt-10 -86.77 18.18 3.58 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.831 ' SD ' HD21 ' A' ' 29' ' ' LEU . 47.5 mtm -73.89 1.24 11.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.9 mmtp -88.75 -0.07 56.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 109.943 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 60.7 m-20 -154.8 77.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.012 -1.055 . . . . 0.0 110.087 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -167.76 170.66 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.7 p -137.11 159.17 42.67 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.97 148.3 18.43 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.932 -1.105 . . . . 0.0 109.251 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 3.5 Cg_endo -57.8 -35.58 98.72 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.577 0.851 . . . . 0.0 112.0 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.23 -161.09 25.18 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.99 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.51 -0.994 . . . . 0.0 108.73 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.705 HG23 ' ND2' ' A' ' 14' ' ' ASN . 94.2 m -114.7 128.08 56.11 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.488 -0.758 . . . . 0.0 110.454 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.6 mt -111.56 129.19 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 24.9 p90 -149.09 159.96 43.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.877 -1.139 . . . . 0.0 110.976 -179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.6 ttm -113.64 130.55 56.37 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.439 ' O ' ' OG ' ' A' ' 90' ' ' SER . 78.1 mt-30 -91.94 115.18 27.84 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.2 m -98.58 150.4 36.68 Favored Pre-proline 0 N--CA 1.502 2.162 0 O-C-N 120.978 -1.076 . . . . 0.0 109.379 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.24 134.72 36.92 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.902 -1.291 . . . . 0.0 111.561 -1.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.9 m -104.56 154.2 20.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.409 -0.807 . . . . 0.0 110.097 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -71.31 148.59 46.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.696 -0.628 . . . . 0.0 109.509 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.61 -164.61 39.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.63 114.39 26.83 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.196 -1.179 . . . . 0.0 109.322 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -52.99 -18.56 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.04 -40.02 75.39 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -75.98 -41.45 51.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.116 -0.99 . . . . 0.0 108.962 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.582 ' OD1' HD23 ' A' ' 58' ' ' LEU . 92.7 m-20 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.575 ' CE2' HD11 ' A' ' 102' ' ' LEU . 90.5 t80 -57.61 -41.27 80.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -66.34 -40.11 89.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.074 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.09 -40.11 94.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.124 -0.985 . . . . 0.0 109.524 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.3 mtp -59.47 -49.91 75.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.336 -0.852 . . . . 0.0 109.64 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.1 mt -60.99 -45.9 92.93 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.062 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.2 mt-30 -60.28 -40.46 90.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.863 . . . . 0.0 109.552 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.3 p -73.15 -40.03 65.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.143 -0.973 . . . . 0.0 109.299 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.76 -54.01 51.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.447 -0.783 . . . . 0.0 109.907 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -63.23 -40.0 96.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 109.638 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 3.9 m-70 -60.15 -45.94 91.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.104 -0.997 . . . . 0.0 109.366 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.95 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.15 -49.96 59.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.381 -0.824 . . . . 0.0 109.291 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -60.36 -40.05 89.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.505 -0.747 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.39 -40.15 77.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 110.796 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 114' ' ' GLY . 9.9 m -98.41 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.01 20.02 74.3 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.44 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -84.28 -170.24 46.53 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.28 132.92 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.613 -0.934 . . . . 0.0 109.098 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.47 132.88 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.144 -0.973 . . . . 0.0 109.513 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 62.5 mt -132.13 159.96 37.4 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.481 -0.762 . . . . 0.0 109.795 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -88.55 -169.34 2.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 121' ' ' ARG . 94.1 m-20 -59.97 -39.61 86.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.181 -0.95 . . . . 0.0 109.822 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -76.44 16.61 0.46 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.244 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 119' ' ' ASP . 49.6 mtm-85 57.75 28.88 16.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.584 . . . . 0.0 109.953 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 122' ' ' ARG . 51.0 mtt-85 -110.32 155.66 21.8 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.514 -0.741 . . . . 0.0 109.441 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.1 mtm -53.76 132.23 40.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.449 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.3 mtt -60.0 140.75 56.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 p -129.78 150.29 75.42 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -43.58 -41.07 10.95 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 CA-C-N 119.354 0.805 . . . . 0.0 111.744 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.3 -40.01 88.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.946 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -69.37 -39.31 78.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.159 -0.963 . . . . 0.0 109.791 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.74 -40.49 79.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 108.781 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -65.88 -38.95 90.12 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.93 -47.79 84.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.19 -0.943 . . . . 0.0 109.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -59.95 -42.77 94.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.208 -0.932 . . . . 0.0 108.486 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.72 -40.02 95.89 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.539 -0.726 . . . . 0.0 109.047 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.93 -40.02 87.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.447 -0.783 . . . . 0.0 109.692 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.51 -40.03 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.953 -1.092 . . . . 0.0 109.259 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.0 mt -59.93 -42.95 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.946 -1.096 . . . . 0.0 109.391 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 0.8 OUTLIER -60.08 -37.14 79.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.03 -1.044 . . . . 0.0 109.346 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 97.3 mt-10 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.198 -0.939 . . . . 0.0 109.751 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.561 HG21 HG21 ' A' ' 88' ' ' VAL . 97.8 t -72.73 -33.88 45.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 144' ' ' ALA . 39.3 mmtm -59.63 -45.96 90.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 109.958 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -62.44 -36.44 82.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.647 -1.283 . . . . 0.0 108.807 179.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.64 -40.0 92.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.462 -0.774 . . . . 0.0 110.197 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -97.81 0.36 46.65 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.357 -0.84 . . . . 0.0 108.803 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.497 -0.752 . . . . 0.0 109.754 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' NE ' ' A' ' 6' ' ' ARG . 95.7 mmm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.235 0.541 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.9 -4.69 54.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.181 -0.95 . . . . 0.0 109.873 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 5' ' ' LYS . 8.3 mptt -80.55 149.77 68.86 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.0 109.127 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.69 9.7 0.33 Allowed 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 120.481 0.787 . . . . 0.0 111.489 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 3' ' ' LYS . 44.2 mtmt -81.29 27.37 0.42 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 1' ' ' MET . 94.2 mtt180 -79.85 100.82 8.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.286 -0.884 . . . . 0.0 111.635 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.8 -16.78 29.47 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -148.46 145.02 27.78 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -164.66 160.1 19.62 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.328 -1.482 . . . . 0.0 110.743 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -106.53 129.92 59.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.7 mm -88.43 129.95 38.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.8 mt -122.0 147.67 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.303 1.049 . . . . 0.0 111.49 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -145.79 154.14 41.7 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -133.21 120.91 21.76 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.898 -1.126 . . . . 0.0 111.088 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.01 112.48 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.93 158.67 43.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.0 110.124 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.7 -170.55 0.7 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.555 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -59.93 154.3 19.14 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 108.762 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -59.83 141.56 55.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.071 -1.018 . . . . 0.0 109.606 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.19 -8.59 79.26 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 m -112.2 151.93 28.98 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.473 -1.016 . . . . 0.0 109.409 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -127.97 150.54 49.86 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.425 -0.797 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.31 145.82 27.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.903 . . . . 0.0 109.908 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.42 140.62 57.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.37 -0.831 . . . . 0.0 109.016 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.22 -40.48 97.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.56 -47.74 82.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -1.212 . . . . 0.0 110.063 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.2 mt -68.2 -24.5 64.95 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.2 tt -76.53 -58.28 3.37 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.588 -0.695 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.89 -49.93 75.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.214 -0.928 . . . . 0.0 111.084 -178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 31' ' ' SER . 37.4 p-10 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.946 -1.096 . . . . 0.0 110.023 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.551 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 53.7 m -61.99 -40.66 96.38 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.971 -1.081 . . . . 0.0 109.628 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.29 -48.45 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.104 -0.998 . . . . 0.0 108.886 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -60.22 -40.01 88.64 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.91 -21.56 64.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 110.658 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.0 9.87 7.59 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.956 -1.09 . . . . 0.0 110.376 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.21 9.67 86.33 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -80.4 155.47 27.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.296 . . . . 0.0 109.583 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 140.65 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.6 108.24 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.85 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 171.82 33.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.27 -167.7 0.13 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.319 -1.107 . . . . 0.0 109.347 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.8 mmm 57.22 26.87 12.76 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.475 -0.766 . . . . 0.0 109.654 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 51.11 39.91 24.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.446 -0.784 . . . . 0.0 111.514 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.523 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.6 pt -141.65 160.88 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.014 -1.054 . . . . 0.0 109.402 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -88.38 136.56 32.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.34 -0.85 . . . . 0.0 109.881 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 18.6 m-70 -125.72 128.13 47.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.0 109.587 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 47' ' ' ARG . 30.0 ttt-85 -101.09 126.2 47.76 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.388 -0.82 . . . . 0.0 109.083 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.555 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 58.6 m-70 -96.51 170.08 9.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 109.729 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.3 tp -55.83 -49.83 72.19 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -92.04 149.06 38.12 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.295 -0.878 . . . . 0.0 109.333 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.16 -5.89 17.52 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 120.926 1.084 . . . . 0.0 112.234 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 49.8 p-10 -94.18 -0.04 55.46 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.074 -1.016 . . . . 0.0 110.299 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.4 85.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.433 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 27.0 m -70.03 -41.71 73.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.749 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.61 165.35 52.66 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.555 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 18.6 Cg_endo -69.14 174.25 9.24 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.03 1.153 . . . . 0.0 111.602 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.56 125.88 30.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 109.134 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -99.06 -39.63 8.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.18 158.59 44.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.172 -0.955 . . . . 0.0 108.513 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.499 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 29.0 m -129.68 179.46 5.81 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.244 1.021 . . . . 0.0 112.159 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.8 tt -139.51 132.94 30.15 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.1 167.17 22.06 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 16.7 m120 -74.9 160.23 30.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.002 -1.061 . . . . 0.0 109.773 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.88 -20.51 63.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.862 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -87.95 113.57 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.002 -1.061 . . . . 0.0 109.114 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -62.74 151.73 83.8 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.501 -0.749 . . . . 0.0 109.563 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -76.67 10.97 12.62 Favored 'Cis proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.6 -1.416 . . . . 0.0 112.34 -0.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.39 30.82 57.95 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.374 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.9 p -85.85 163.83 17.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -1.19 . . . . 0.0 109.836 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.1 m-85 -120.82 143.13 49.03 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.3 m-20 -129.12 149.93 73.99 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.1 -9.07 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 CA-C-N 119.138 0.728 . . . . 0.0 111.569 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.0 mt-10 -89.77 3.92 51.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.0 109.548 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.455 ' O ' HD11 ' A' ' 29' ' ' LEU . 67.6 mmm -88.1 16.46 6.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 62.6 mttp -85.34 -6.32 59.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.962 -1.086 . . . . 0.0 109.182 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 68.6 m-20 -151.91 79.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.75 171.69 19.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.1 p -128.64 151.75 49.14 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.95 149.04 19.12 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.07 -1.019 . . . . 0.0 109.308 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -43.58 -49.98 7.35 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.666 0.911 . . . . 0.0 111.896 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.09 -154.75 13.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.401 ' HB ' HD21 ' A' ' 61' ' ' LEU . 33.8 m -129.97 160.02 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.395 -1.062 . . . . 0.0 109.82 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.5 m -109.08 120.93 44.01 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.719 -0.613 . . . . 0.0 110.146 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.1 mt -103.71 130.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 31.8 p90 -147.17 169.98 18.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 111.215 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 43.8 ttm -128.26 130.07 47.34 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.414 ' O ' ' OG ' ' A' ' 90' ' ' SER . 92.0 mm-40 -91.51 115.62 28.19 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.7 m -98.8 149.92 36.2 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.18 -0.95 . . . . 0.0 109.093 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.61 137.02 46.73 Favored 'Cis proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.948 -1.272 . . . . 0.0 111.867 -1.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.1 m -107.74 154.15 21.92 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.487 -0.758 . . . . 0.0 109.397 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.11 145.49 51.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 110.043 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.51 -165.61 33.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -96.39 112.29 24.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.34 -1.094 . . . . 0.0 109.114 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' OE1' HG23 ' A' ' 136' ' ' ILE . 88.3 mt-10 -55.3 -25.53 34.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.915 . . . . 0.0 109.946 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.3 mt -69.81 -40.14 76.09 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.982 -1.074 . . . . 0.0 109.591 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.28 -41.63 66.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.785 -1.197 . . . . 0.0 108.065 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.411 ' ND2' HD23 ' A' ' 58' ' ' LEU . 94.9 m-20 -62.69 -39.79 95.09 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 102' ' ' LEU . 76.0 t80 -51.34 -40.65 59.55 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.5 -40.02 94.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.86 -40.04 96.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.188 -0.945 . . . . 0.0 109.287 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.5 mtp -58.66 -50.03 75.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.079 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.9 mt -65.95 -47.32 75.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 109.353 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.489 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 77.1 mt-30 -59.95 -40.81 90.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.126 -0.984 . . . . 0.0 108.977 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.5 p -70.4 -40.16 74.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.14 -56.42 22.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.612 -0.68 . . . . 0.0 109.823 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -61.21 -37.82 84.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.462 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 2.9 m-70 -59.94 -50.13 74.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.06 -1.025 . . . . 0.0 108.746 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 112' ' ' VAL . 83.8 mt -60.99 -49.01 86.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.73 -49.23 65.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.06 -39.92 87.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.58 -0.7 . . . . 0.0 110.354 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -70.03 -40.15 75.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.72 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 108' ' ' ILE . 13.6 m -97.44 -0.03 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.057 -1.027 . . . . 0.0 109.873 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.03 26.01 74.86 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.77 -176.54 50.21 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -130.21 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.702 -0.881 . . . . 0.0 109.202 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.488 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -74.96 130.26 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.132 -0.98 . . . . 0.0 109.352 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -130.56 159.88 35.82 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 40.3 p-10 -85.7 -170.69 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.102 -0.999 . . . . 0.0 108.989 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 95.6 m-20 -60.13 -39.49 86.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 78.5 mt-30 -76.78 16.65 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.328 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' ASP . 99.2 mtt180 58.46 29.37 18.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.798 -0.564 . . . . 0.0 110.395 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HE ' ' HB2' ' A' ' 120' ' ' GLN . 84.5 mtm180 -107.91 154.33 21.76 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.336 -0.852 . . . . 0.0 108.969 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.2 mtt -52.42 125.17 15.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -0.998 . . . . 0.0 109.722 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' HG12 ' A' ' 116' ' ' VAL . 51.5 mtp -60.14 140.49 56.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.38 -0.825 . . . . 0.0 109.522 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.2 p -127.18 150.53 72.53 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -43.64 -43.23 11.44 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 CA-C-N 119.185 0.745 . . . . 0.0 112.018 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.431 ' O ' ' CD ' ' A' ' 131' ' ' GLU . 27.3 mt-30 -60.08 -44.74 94.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.59 -39.76 94.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.988 -1.07 . . . . 0.0 109.772 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.64 -39.01 76.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -65.83 -39.99 91.34 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -59.43 -48.6 81.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.701 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -60.08 -45.99 91.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 108.548 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.0 -40.02 96.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.491 -0.756 . . . . 0.0 108.961 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.4 -42.11 98.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.2 -42.8 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.003 -1.06 . . . . 0.0 109.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 94' ' ' GLU . 82.2 mt -60.07 -41.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 31.2 mmt180 -60.05 -40.91 91.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.031 . . . . 0.0 108.962 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -61.11 -37.46 82.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -0.784 . . . . 0.0 108.98 178.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.93 -39.86 78.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.406 -0.809 . . . . 0.0 110.27 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.02 -48.6 81.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.916 -1.115 . . . . 0.0 111.379 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 2.8 p-10 -59.91 -32.86 71.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.558 -1.339 . . . . 0.0 109.221 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.12 82.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 0.0 110.148 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -98.6 -11.35 22.22 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 109.506 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -90.44 23.53 2.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 0.0 109.338 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -129.01 77.67 77.56 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 121.435 -0.791 . . . . 0.0 109.58 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 44.8 Cg_endo -82.46 46.91 2.31 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 121.352 1.368 . . . . 0.0 111.928 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -77.44 18.66 0.4 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.609 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.408 ' H ' ' C ' ' A' ' 4' ' ' PRO . 42.9 mtt-85 -78.25 153.37 31.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.377 -0.827 . . . . 0.0 110.942 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -85.42 -5.26 59.31 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -147.89 150.4 34.04 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.1 -175.1 3.84 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.562 -1.336 . . . . 0.0 110.811 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.98 136.3 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mm -93.59 124.64 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.9 mt -121.36 151.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-O 122.043 0.925 . . . . 0.0 111.091 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.422 ' N ' ' O ' ' A' ' 84' ' ' ILE . 67.5 mtt -148.88 159.02 44.56 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -140.17 121.29 14.75 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.973 -1.08 . . . . 0.0 110.603 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.28 117.27 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.42 155.0 40.66 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.14 -174.21 1.49 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.447 -0.783 . . . . 0.0 108.901 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -64.26 149.03 48.87 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.073 -1.017 . . . . 0.0 108.763 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -55.81 149.85 13.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 109.756 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.57 -7.18 82.43 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -121.06 154.69 35.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.564 -0.962 . . . . 0.0 109.477 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -129.16 147.34 50.99 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.07 137.68 33.45 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.121 -0.987 . . . . 0.0 109.626 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 55.3 t-20 -67.95 142.05 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.05 -41.42 97.99 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.795 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.73 -47.24 86.13 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.309 . . . . 0.0 110.095 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.1 mt -70.01 -30.26 67.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.9 tt -70.4 -57.48 4.77 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.551 -0.718 . . . . 0.0 109.252 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 74' ' ' MET . 96.2 mt -59.99 -44.23 94.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 110.385 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' OD1' ' OE1' ' A' ' 34' ' ' GLN . 60.3 t-20 -60.45 -40.27 90.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 110.192 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.1 p -65.82 -39.82 91.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 110.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.87 -48.82 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -62.35 -39.97 94.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.902 -1.124 . . . . 0.0 109.421 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' OD1' ' A' ' 30' ' ' ASN . 27.5 mt-30 -67.84 -22.41 65.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.377 -0.827 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.98 6.09 14.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.953 -1.092 . . . . 0.0 109.997 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.67 6.83 76.19 Favored Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.947 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -78.6 150.35 32.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.76 -1.435 . . . . 0.0 109.726 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.34 139.57 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -60.69 105.34 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.03 172.14 29.19 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.51 -165.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -1.035 . . . . 0.0 109.598 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mmm 58.36 20.12 7.02 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.689 . . . . 0.0 109.81 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.9 m120 49.99 39.63 19.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.086 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 8.2 pt -140.51 166.98 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -91.91 127.02 37.21 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.917 -1.114 . . . . 0.0 110.487 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.546 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 36.5 m-70 -116.07 128.82 56.0 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.528 -0.732 . . . . 0.0 109.75 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 47' ' ' ARG . 17.6 ttt-85 -102.97 126.95 50.35 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 70.9 m-70 -94.76 171.22 8.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.963 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.4 tp -55.54 -50.14 70.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.259 -0.9 . . . . 0.0 108.739 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -93.34 143.73 27.16 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -66.97 -2.65 8.24 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 CA-C-N 119.552 0.876 . . . . 0.0 111.952 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -94.25 0.19 55.5 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 0.0 110.109 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.25 9.92 86.61 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.452 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 91.3 p -70.1 -40.0 75.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.914 -1.345 . . . . 0.0 109.762 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.77 162.82 52.18 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.447 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 12.3 Cg_endo -67.26 176.93 4.2 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.994 1.129 . . . . 0.0 111.247 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.23 118.67 22.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.017 -1.052 . . . . 0.0 109.319 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.6 mp -96.72 -47.97 5.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -142.95 159.99 41.19 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.112 -0.993 . . . . 0.0 109.395 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.546 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.0 m -136.55 159.92 40.33 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.82 0.819 . . . . 0.0 111.208 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -113.11 131.69 55.73 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.361 0.601 . . . . 0.0 109.392 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.637 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.57 162.78 32.84 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 92.9 m-20 -77.69 153.55 32.96 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.884 -1.135 . . . . 0.0 109.886 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.05 -29.86 66.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.258 -0.901 . . . . 0.0 110.094 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.43 134.94 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.972 -1.08 . . . . 0.0 109.774 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -56.87 154.02 20.41 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -79.77 2.06 36.52 Favored 'Cis proline' 0 N--CA 1.497 1.719 0 C-N-CA 123.753 -1.353 . . . . 0.0 112.464 -0.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.85 -4.73 73.51 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.5 p -89.6 169.89 10.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.413 -1.051 . . . . 0.0 110.078 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.519 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 79.6 m-85 -121.76 152.47 39.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.5 m-20 -135.17 149.74 70.91 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -49.04 -11.11 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 120.47 0.78 . . . . 0.0 111.792 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.4 mm-40 -89.95 4.46 50.0 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.434 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 73.9 mmm -87.92 20.24 3.19 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.0 110.155 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.0 mttp -88.23 -1.69 58.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 81.7 m-20 -146.73 81.55 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -160.33 172.49 17.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 p -130.67 151.58 50.96 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.31 150.02 21.48 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.929 -1.107 . . . . 0.0 109.263 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -56.48 -38.37 95.49 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 CA-C-N 119.092 0.712 . . . . 0.0 111.566 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.08 -156.47 15.17 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 24.4 m -131.51 160.08 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.768 -0.843 . . . . 0.0 109.066 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.5 m -114.14 120.26 39.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.473 -0.767 . . . . 0.0 110.432 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' A' ' 13' ' ' MET . 97.5 mt -105.95 128.19 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -145.27 152.34 39.79 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.176 -0.953 . . . . 0.0 110.136 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttp -121.2 130.04 53.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -86.33 110.88 19.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 108.96 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 88' ' ' VAL . 2.4 m -98.19 147.44 33.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.439 ' HG2' HD22 ' A' ' 143' ' ' ASN . 4.1 Cg_endo -75.8 131.49 24.43 Favored 'Cis proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.605 0.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.5 m -100.36 166.73 10.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.736 0.779 . . . . 0.0 110.186 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -70.13 146.02 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.771 -0.581 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.4 -156.46 30.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -93.77 119.09 32.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -1.209 . . . . 0.0 108.537 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -57.44 -32.64 67.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.838 -0.539 . . . . 0.0 110.511 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.96 -40.11 75.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.85 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.11 -40.62 68.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.004 -1.06 . . . . 0.0 109.157 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -60.34 -40.53 91.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.253 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.481 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.8 t80 -58.83 -45.03 90.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -61.11 -39.73 91.09 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.448 -0.783 . . . . 0.0 109.43 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.11 -43.78 95.36 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 109.678 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 30.3 mtm -60.15 -44.92 94.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 109.126 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.481 HD11 ' CE2' ' A' ' 98' ' ' PHE . 86.5 mt -61.49 -46.2 91.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.054 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 78.3 mt-30 -60.05 -43.93 95.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -70.42 -40.01 74.1 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.23 -55.58 33.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.041 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 103' ' ' GLN . 19.4 pt20 -60.28 -35.93 76.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.925 -1.11 . . . . 0.0 108.897 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 9.0 m-70 -60.08 -45.88 91.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.11 -0.994 . . . . 0.0 108.839 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 94.6 mt -60.01 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.048 -1.032 . . . . 0.0 108.568 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.2 -48.99 61.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 121.487 0.66 . . . . 0.0 109.286 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.09 -40.01 88.1 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.374 -0.829 . . . . 0.0 109.926 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.9 -40.04 75.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 111.349 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.75 -0.39 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.075 -1.015 . . . . 0.0 109.566 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.83 25.96 74.89 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.06 -169.3 44.46 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.3 t -134.51 134.04 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -1.016 . . . . 0.0 109.238 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.14 130.89 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.054 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 45.0 mt -126.74 159.02 34.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.437 -0.789 . . . . 0.0 108.907 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 29.8 p-10 -86.49 -171.51 3.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.957 . . . . 0.0 109.069 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.532 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 97.2 m-20 -60.07 -35.01 74.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.323 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -77.84 16.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 45.1 mtm-85 58.16 26.28 13.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.641 . . . . 0.0 109.914 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 54.0 mtp180 -109.18 151.49 26.4 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.593 -0.692 . . . . 0.0 109.331 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -52.51 134.69 34.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.905 . . . . 0.0 109.886 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 73.4 mmm -59.9 133.61 56.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.0 p -132.72 151.15 77.58 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -41.36 -45.99 5.78 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 C-N-CA 120.926 1.084 . . . . 0.0 113.04 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -60.09 -39.97 87.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.95 -1.094 . . . . 0.0 109.409 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.36 -40.11 85.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.32 -39.97 84.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 108.828 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -62.58 -39.54 94.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.474 -0.766 . . . . 0.0 109.143 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.59 -48.59 81.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.123 -0.986 . . . . 0.0 109.75 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 65.3 m-85 -60.28 -41.42 93.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.041 -1.037 . . . . 0.0 109.398 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.87 87.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.316 -0.865 . . . . 0.0 109.398 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.21 -44.42 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 0.0 108.702 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.07 -45.78 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.383 -0.823 . . . . 0.0 109.379 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.467 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 99.0 mtt180 -60.31 -37.41 80.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.87 . . . . 0.0 110.161 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.6 mt-10 -59.94 -40.06 87.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.315 -0.866 . . . . 0.0 110.29 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.6 t -73.35 -35.56 46.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 110.8 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 144' ' ' ALA . 49.4 mtpt -60.15 -46.61 89.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 111.464 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.7 p-10 -61.17 -29.15 69.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.606 -1.309 . . . . 0.0 110.125 -179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -42.07 99.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 110.675 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.439 HD22 ' HG2' ' A' ' 89' ' ' PRO . 98.6 m-20 -112.44 -11.55 13.63 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.382 -0.824 . . . . 0.0 110.192 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' N ' HH12 ' A' ' 6' ' ' ARG . 73.6 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.78 2.77 36.48 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 109.12 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -72.97 130.17 85.43 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.75 18.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 CA-C-N 119.854 0.984 . . . . 0.0 112.226 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 3' ' ' LYS . 68.3 mttm -85.37 -9.8 57.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.616 -0.677 . . . . 0.0 109.613 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.507 HH12 ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -82.33 98.74 8.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 110.293 -179.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -88.57 -17.07 30.96 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -150.02 133.56 16.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.63 8.36 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.67 -1.269 . . . . 0.0 110.477 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.8 t -125.03 132.29 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.7 mm -87.94 134.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.449 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.1 mt -131.2 141.84 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.947 0.88 . . . . 0.0 111.196 -177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.43 148.01 29.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -128.01 130.54 48.5 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.054 -1.029 . . . . 0.0 110.901 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.73 117.94 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.01 159.82 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 110.383 -178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.12 -164.96 0.2 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.704 -0.622 . . . . 0.0 109.645 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -70.0 155.97 39.82 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -57.57 135.78 56.7 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.33 -0.856 . . . . 0.0 109.621 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 5.18 65.0 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -126.31 144.41 50.82 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -1.019 . . . . 0.0 109.433 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -124.52 147.69 48.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.51 137.04 33.16 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.167 -0.958 . . . . 0.0 110.233 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -66.43 143.07 57.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 108.862 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.49 -41.85 97.34 Favored Glycine 0 N--CA 1.496 2.635 0 O-C-N 121.084 -1.01 . . . . 0.0 111.061 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.98 -43.15 95.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.889 -1.359 . . . . 0.0 108.877 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.435 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 95.5 mt -69.95 -27.12 64.48 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.6 tt -76.57 -56.3 4.74 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.509 -0.744 . . . . 0.0 110.463 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.98 -49.0 79.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.03 -1.044 . . . . 0.0 111.312 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 31' ' ' SER . 42.8 p-10 -61.85 -39.15 90.85 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.967 -1.083 . . . . 0.0 110.866 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 93.4 p -62.62 -40.43 96.95 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.789 -1.194 . . . . 0.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.415 HG21 ' CG ' ' A' ' 45' ' ' TYR . 95.9 mt -60.29 -49.71 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.288 -0.883 . . . . 0.0 109.989 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -65.66 -39.93 91.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 109.817 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -63.72 -22.42 66.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.03 -1.24 52.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.099 -1.0 . . . . 0.0 109.602 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.08 19.08 44.03 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.041 -1.037 . . . . 0.0 111.418 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -81.23 160.61 24.25 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.895 -1.356 . . . . 0.0 110.281 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 94.8 mt -128.22 137.01 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.96 102.67 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.061 . . . . 0.0 109.841 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 171.02 41.92 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.4 -164.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.443 -1.034 . . . . 0.0 109.242 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 95.4 mtp 56.66 23.52 7.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.664 -0.647 . . . . 0.0 110.222 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.71 40.26 23.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.241 -0.912 . . . . 0.0 111.259 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.552 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.9 pt -139.84 163.82 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.024 -1.047 . . . . 0.0 109.179 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 32' ' ' ILE . 80.2 m-85 -90.51 131.77 36.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.043 -1.035 . . . . 0.0 110.167 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 17.5 m-70 -123.68 132.07 53.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.687 -0.633 . . . . 0.0 109.869 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 30.9 ttt180 -104.86 121.71 44.26 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 48.1 m-70 -95.4 171.0 8.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.393 -0.817 . . . . 0.0 109.562 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 66.0 tp -55.63 -50.05 71.2 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.8 m -92.37 144.23 28.59 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.33 -6.0 17.3 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.7 0.933 . . . . 0.0 112.104 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -93.15 0.89 57.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.154 -0.967 . . . . 0.0 109.407 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.48 14.25 82.61 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 p -70.43 -40.45 73.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.081 -1.246 . . . . 0.0 109.237 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.46 166.86 48.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.483 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 20.8 Cg_endo -70.86 -179.49 3.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.195 1.263 . . . . 0.0 111.751 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.25 121.69 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.592 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.0 mp -95.96 -20.54 18.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.995 -1.066 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -169.63 158.15 7.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.2 -0.937 . . . . 0.0 108.948 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.473 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 15.6 m -127.26 171.86 11.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.935 0.874 . . . . 0.0 111.822 -176.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.2 tt -140.08 130.2 25.0 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.543 0.687 . . . . 0.0 109.189 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.536 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.17 163.89 28.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.522 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 12.4 m120 -74.11 158.03 34.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.0 -1.062 . . . . 0.0 110.127 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.02 -23.8 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.62 -0.675 . . . . 0.0 110.537 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.5 p -87.17 129.88 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.978 -1.076 . . . . 0.0 109.775 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -60.45 149.86 75.83 Favored Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.509 -0.744 . . . . 0.0 109.481 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.31 4.72 26.34 Favored 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.546 -0.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.46 4.88 85.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.2 p -85.48 170.98 12.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.157 -1.202 . . . . 0.0 109.473 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 82.7 m-85 -116.46 150.58 37.62 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 7.5 m-20 -139.06 152.31 69.72 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -40.89 -15.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.045 1.163 . . . . 0.0 112.65 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.1 mt-10 -85.24 13.33 6.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 71' ' ' ASP . 24.3 ptt? -82.7 -7.3 59.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.77 -0.581 . . . . 0.0 110.243 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 99.8 mttt -85.25 -4.03 59.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.08 -1.013 . . . . 0.0 110.222 -178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 71.1 m-20 -150.29 73.23 1.14 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.933 -1.104 . . . . 0.0 109.885 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -158.1 169.86 23.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 p -131.96 150.11 52.25 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.218 -0.926 . . . . 0.0 109.093 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.75 147.78 19.66 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.972 -1.08 . . . . 0.0 108.77 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -43.99 -33.53 5.52 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 120.62 0.88 . . . . 0.0 111.866 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 170.44 -146.42 9.8 Favored Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.481 -1.343 . . . . 0.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 61' ' ' LEU . 28.1 m -130.03 159.11 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.602 -0.94 . . . . 0.0 109.655 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.8 m -114.23 121.12 42.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.592 -0.692 . . . . 0.0 109.439 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -102.55 125.72 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -149.86 161.96 41.25 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.953 -1.092 . . . . 0.0 110.65 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.539 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 4.9 tpt -146.31 147.46 31.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.547 -0.72 . . . . 0.0 109.238 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' N ' ' SD ' ' A' ' 86' ' ' MET . 92.9 mt-30 -94.07 121.88 36.01 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 m -97.44 151.59 37.74 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -71.89 172.5 56.33 Favored 'Cis proline' 0 N--CA 1.503 2.033 0 C-N-CA 124.057 -1.226 . . . . 0.0 113.055 0.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.562 ' N ' ' OE2' ' A' ' 94' ' ' GLU . 15.9 m -130.32 167.11 19.03 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.841 0.829 . . . . 0.0 111.031 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -72.8 144.47 47.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.05 -151.01 34.64 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -97.31 123.22 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.359 -1.083 . . . . 0.0 109.675 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' N ' ' A' ' 90' ' ' SER . 53.5 mm-40 -56.21 -30.05 61.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 0.0 109.532 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.6 mt -68.95 -40.02 79.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.258 -0.901 . . . . 0.0 109.077 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -73.05 -40.37 65.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.928 -1.108 . . . . 0.0 108.093 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.495 ' OD1' HD23 ' A' ' 58' ' ' LEU . 77.7 m-20 -64.65 -40.01 94.69 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.14 -46.02 91.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.739 -0.601 . . . . 0.0 109.97 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.5 -39.87 89.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.42 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.02 -39.88 87.38 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.417 ' O ' ' OG ' ' A' ' 104' ' ' SER . 64.9 mtp -60.03 -49.65 76.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.161 -0.962 . . . . 0.0 108.793 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.98 -45.98 83.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.427 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.1 mt-30 -59.98 -39.93 87.37 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 101' ' ' MET . 16.4 p -69.91 -41.49 74.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.369 -0.832 . . . . 0.0 109.035 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.01 -57.71 11.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.415 -0.803 . . . . 0.0 110.085 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -60.61 -39.62 88.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.693 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.427 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.5 m-70 -59.82 -49.8 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.085 -1.009 . . . . 0.0 108.775 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -48.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.19 -48.87 61.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -61.98 -39.84 93.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.725 . . . . 0.0 110.281 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.66 -40.11 84.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.22 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 114' ' ' GLY . 5.8 m -100.65 -0.68 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.267 -0.896 . . . . 0.0 109.903 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 20.89 74.51 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.458 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -82.44 -173.76 49.35 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.47 132.96 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -1.049 . . . . 0.0 109.851 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.17 131.96 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.623 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.3 mt -128.7 158.23 39.16 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.615 0.721 . . . . 0.0 109.645 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -86.23 -174.31 4.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.517 -0.74 . . . . 0.0 109.564 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.9 m-20 -59.97 -36.09 76.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.011 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' CD ' ' N ' ' A' ' 120' ' ' GLN . 27.4 mp0 -78.73 16.32 0.88 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.274 -0.891 . . . . 0.0 109.662 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.4 mtm-85 56.19 39.52 30.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.521 -0.737 . . . . 0.0 110.582 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.84 155.59 33.76 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.463 -0.773 . . . . 0.0 109.202 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.5 mtm -54.14 132.75 43.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.373 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 79.4 mmm -60.35 140.04 57.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.257 -0.902 . . . . 0.0 110.193 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.7 p -130.81 150.56 76.85 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -48.43 -39.44 36.11 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 CA-C-N 119.36 0.807 . . . . 0.0 111.974 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -60.32 -40.77 91.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.439 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.84 -39.42 76.42 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.49 -0.756 . . . . 0.0 110.087 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.39 -40.08 77.46 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 130' ' ' ARG . 26.4 ttm-85 -62.91 -40.01 96.27 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.358 -0.839 . . . . 0.0 109.1 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.83 -47.9 83.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.958 . . . . 0.0 109.76 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.07 -41.93 93.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.986 -1.071 . . . . 0.0 108.182 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.423 ' HA ' HD12 ' A' ' 136' ' ' ILE . 97.3 mt-30 -62.29 -38.25 88.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 96.0 m-20 -60.35 -40.78 91.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.329 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.8 -39.84 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.988 . . . . 0.0 108.994 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 133' ' ' GLN . 83.1 mt -60.06 -49.2 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.573 -0.704 . . . . 0.0 109.419 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.3 mtm180 -61.59 -39.58 91.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.019 -1.051 . . . . 0.0 110.396 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 94.9 mt-10 -60.23 -39.99 88.6 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.972 -1.08 . . . . 0.0 110.769 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.88 -36.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.167 -0.958 . . . . 0.0 110.437 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 144' ' ' ALA . 60.5 mttm -59.94 -45.5 92.41 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.97 -1.081 . . . . 0.0 111.702 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 1.1 p-10 -60.85 -34.27 74.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.713 -1.242 . . . . 0.0 110.036 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.65 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.769 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.76 -2.23 30.61 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.245 -0.909 . . . . 0.0 110.245 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.087 -1.008 . . . . 0.0 109.337 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mtp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.131 0.491 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -86.19 -10.26 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.3 76.96 75.09 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 6' ' ' ARG . 9.2 Cg_endo -73.95 135.87 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.807 1.005 . . . . 0.0 111.339 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.18 29.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.082 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 4' ' ' PRO . 98.7 mtt180 -76.39 149.44 36.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.543 -0.723 . . . . 0.0 110.274 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -82.9 -53.81 5.57 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.11 141.17 35.37 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.613 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -157.84 159.97 37.23 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.697 -1.252 . . . . 0.0 110.469 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.86 132.34 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.628 -0.67 . . . . 0.0 109.98 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.05 139.23 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 93.8 mt -127.85 143.93 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 122.203 1.002 . . . . 0.0 111.558 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.7 mtt -144.32 151.05 38.81 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -134.56 126.14 28.69 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.712 -1.242 . . . . 0.0 110.951 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.8 t -107.71 114.95 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.53 152.83 38.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.214 -0.929 . . . . 0.0 109.862 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.26 -164.49 0.11 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.391 -0.818 . . . . 0.0 109.274 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -62.55 153.03 33.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.99 140.78 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.05 -1.031 . . . . 0.0 109.14 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.12 -1.97 80.83 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.2 m -118.67 151.4 38.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.566 -0.961 . . . . 0.0 109.185 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -128.15 148.9 50.61 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.49 -0.756 . . . . 0.0 108.999 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.7 mt -85.16 144.46 28.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.842 . . . . 0.0 109.477 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.51 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.92 141.99 56.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.094 -1.004 . . . . 0.0 108.929 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' HD22 ' A' ' 24' ' ' ASN . . . -59.92 -42.33 98.19 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.576 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.27 -47.64 85.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.044 -1.268 . . . . 0.0 110.153 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.74 -28.26 66.65 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.447 -0.783 . . . . 0.0 108.947 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.9 tt -73.44 -59.8 2.54 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.115 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.07 -41.43 92.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 109.264 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.56 ' CG ' HE21 ' A' ' 34' ' ' GLN . 42.7 t30 -62.91 -43.3 99.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 110.02 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.1 p -65.55 -38.59 90.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.03 -46.21 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.998 -1.064 . . . . 0.0 109.358 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -63.5 -40.85 98.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 109.734 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.56 HE21 ' CG ' ' A' ' 30' ' ' ASN . 74.7 mt-30 -67.8 -22.3 65.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.436 -0.79 . . . . 0.0 110.036 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.06 8.09 9.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 82.28 12.64 80.37 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.36 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -81.19 153.74 27.05 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.741 -1.446 . . . . 0.0 109.856 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 87.4 mt -124.38 133.89 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -60.89 98.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.908 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.91 171.1 44.39 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.99 -163.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -1.219 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.3 mtt 58.46 20.0 7.04 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 49.95 39.95 19.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.671 -0.643 . . . . 0.0 111.248 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 pt -141.08 167.25 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.052 -1.03 . . . . 0.0 108.817 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -93.49 123.33 36.72 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.971 -1.08 . . . . 0.0 110.552 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.446 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 39.9 m80 -106.53 136.45 46.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.686 -0.634 . . . . 0.0 109.367 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HG2' HH11 ' A' ' 47' ' ' ARG . 0.0 OUTLIER -99.89 128.43 45.98 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.2 -0.938 . . . . 0.0 108.598 178.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.41 165.18 11.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.534 -0.729 . . . . 0.0 109.14 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 tp -59.73 -49.32 78.21 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.2 m -90.54 145.0 31.48 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.331 -0.855 . . . . 0.0 109.142 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -67.2 -10.72 29.59 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 120.679 0.919 . . . . 0.0 111.712 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 44.8 t0 -92.91 -1.33 56.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.266 -0.896 . . . . 0.0 109.815 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.4 t -70.03 -40.06 75.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.942 -1.328 . . . . 0.0 109.391 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.61 160.99 45.93 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.46 170.97 10.09 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.397 1.099 . . . . 0.0 112.056 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.34 129.94 35.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.277 -0.89 . . . . 0.0 109.638 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.3 mp -101.76 -39.58 7.35 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.188 -0.945 . . . . 0.0 109.679 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -150.0 162.88 39.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.09 -1.006 . . . . 0.0 108.692 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 14.1 m -129.61 173.06 10.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.961 0.886 . . . . 0.0 111.273 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.7 tt -131.79 129.96 41.2 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.57 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.37 162.94 29.82 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.535 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 93.8 m-20 -74.25 157.22 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 109.651 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -69.92 -28.21 65.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.747 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -86.68 134.11 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.931 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -60.06 152.25 62.09 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -81.95 1.9 48.71 Favored 'Cis proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.881 -1.3 . . . . 0.0 112.58 0.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.62 -0.11 79.74 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.9 p -87.81 169.55 11.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -1.111 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 94.0 m-85 -121.3 140.8 51.6 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 73' ' ' GLU . 75.9 m-20 -121.7 150.21 54.81 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -50.45 -9.17 0.17 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 119.267 0.774 . . . . 0.0 111.63 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 71' ' ' ASP . 80.1 mm-40 -90.12 6.84 40.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.856 . . . . 0.0 109.498 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.439 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 68.9 mmm -86.39 21.84 1.99 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 26.7 mtpp -86.0 -6.9 58.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.901 -1.124 . . . . 0.0 109.07 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 75.2 m-20 -149.94 80.12 1.37 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.2 170.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.175 -0.953 . . . . 0.0 109.834 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.7 p -133.98 152.28 51.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.16 148.43 18.38 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.077 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -46.66 -44.17 22.0 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 CA-C-N 119.094 0.712 . . . . 0.0 111.232 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.16 -152.98 11.05 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.453 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.8 m -129.98 160.02 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.994 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.5 m -114.42 120.52 40.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.2 129.98 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -145.7 152.97 40.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.022 -1.048 . . . . 0.0 110.592 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.5 ttm -109.2 129.92 55.49 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.702 -0.624 . . . . 0.0 109.376 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 108.758 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 9' ' ' ALA . 2.1 m -98.16 151.14 37.38 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.207 -0.933 . . . . 0.0 108.569 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.91 138.19 53.8 Favored 'Cis proline' 0 N--CA 1.498 1.768 0 C-N-CA 124.043 -1.232 . . . . 0.0 112.57 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.9 m -113.24 149.41 33.83 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.488 0.661 . . . . 0.0 109.58 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -70.95 149.2 46.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.464 -0.772 . . . . 0.0 110.023 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.04 -164.16 32.2 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -98.38 114.66 27.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -1.145 . . . . 0.0 109.359 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.89 -27.95 63.76 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.0 -41.68 61.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 108.133 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.14 -34.55 77.86 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.13 -50.02 74.96 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.53 -39.97 89.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -61.17 -40.0 92.24 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.95 -45.02 93.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 108.997 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.24 -42.53 99.22 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.328 -0.858 . . . . 0.0 108.866 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.498 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.7 mm-40 -60.18 -40.13 88.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.437 -0.79 . . . . 0.0 109.135 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.3 p -70.48 -40.0 73.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 109.515 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.73 43.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.369 -0.832 . . . . 0.0 110.044 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.83 -37.68 85.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 5.7 m-70 -59.94 -49.36 77.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.074 -1.016 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 112' ' ' VAL . 89.2 mt -60.06 -46.44 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.303 -0.873 . . . . 0.0 108.729 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.66 -46.81 63.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.443 -0.785 . . . . 0.0 109.519 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.49 -40.08 90.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.889 . . . . 0.0 110.547 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -69.89 -40.1 75.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.156 -0.965 . . . . 0.0 110.931 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 114' ' ' GLY . 12.8 m -100.18 0.75 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.187 -0.946 . . . . 0.0 110.018 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.58 25.32 70.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -86.07 -173.04 49.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 68.0 t -129.9 132.76 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.691 -0.887 . . . . 0.0 109.285 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -70.52 134.68 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 109.302 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.9 mt -135.05 159.95 39.87 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.276 -0.89 . . . . 0.0 110.081 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -86.47 -169.2 2.53 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.408 -0.807 . . . . 0.0 109.717 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 96.8 m-20 -60.06 -38.95 84.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -75.4 12.42 0.98 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.28 37.58 28.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.803 -0.56 . . . . 0.0 109.764 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -117.11 158.72 23.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.713 -0.617 . . . . 0.0 109.747 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.1 mmm -51.17 120.67 5.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.181 -0.949 . . . . 0.0 109.297 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 47.9 mtp -60.02 139.97 57.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.195 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -130.18 152.12 79.58 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -43.96 -42.97 12.49 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 120.582 0.855 . . . . 0.0 111.976 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.88 -39.93 91.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.83 -40.02 83.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.854 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.1 mt -57.54 -40.04 77.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.95 -39.96 93.92 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.592 -0.692 . . . . 0.0 109.265 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.42 -47.25 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.125 -0.985 . . . . 0.0 109.009 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 55.7 m-85 -60.06 -41.98 93.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 108.983 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.36 -40.09 89.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.3 m-20 -60.79 -40.02 91.06 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.63 -43.82 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.018 -1.051 . . . . 0.0 109.118 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 78.6 mt -60.18 -39.95 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -0.964 . . . . 0.0 109.798 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -60.0 -39.98 87.63 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.961 -1.087 . . . . 0.0 109.104 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.15 -30.72 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 144' ' ' ALA . 59.0 mmtt -59.98 -45.0 94.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.023 -1.048 . . . . 0.0 110.446 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -59.92 -36.2 76.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.845 -1.16 . . . . 0.0 109.805 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.11 94.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.0 110.29 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -103.7 -0.56 29.29 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.328 -0.858 . . . . 0.0 110.353 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.498 ' O ' ' NH2' ' A' ' 6' ' ' ARG . 92.3 mmm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.325 0.584 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -90.24 5.93 45.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 108.806 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' O ' ' NH1' ' A' ' 6' ' ' ARG . 23.2 mmtp -92.76 112.34 55.34 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.506 -0.746 . . . . 0.0 109.4 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' CB ' ' OE2' ' A' ' 138' ' ' GLU . 18.7 Cg_endo -73.18 23.68 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.144 0 CA-C-N 120.236 1.12 . . . . 0.0 111.705 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 3' ' ' LYS . 53.5 mtpt -87.18 -0.36 56.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 110.276 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 3' ' ' LYS . 59.7 mtm-85 -79.11 130.67 35.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.995 . . . . 0.0 111.356 -178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -89.22 -9.73 49.66 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -150.56 135.45 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.01 177.99 10.17 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.208 -1.557 . . . . 0.0 112.011 -177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.54 138.88 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -91.28 126.37 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -125.78 145.05 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-O 121.961 0.886 . . . . 0.0 110.806 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.5 mtm -148.33 154.37 39.89 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' ' 83' ' ' THR . 15.1 m120 -132.15 131.84 42.64 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.963 -1.086 . . . . 0.0 111.383 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 73.5 t -109.17 118.81 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.01 156.79 42.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.197 -0.94 . . . . 0.0 110.317 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.21 175.63 5.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.473 -0.767 . . . . 0.0 109.059 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -56.08 160.14 3.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.228 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -60.07 141.72 55.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.389 -0.82 . . . . 0.0 109.832 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.28 2.02 74.47 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.1 m -125.52 148.52 48.86 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.422 -1.046 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.0 151.37 50.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.452 -0.78 . . . . 0.0 109.136 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.4 mt -88.17 139.54 30.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.323 -0.86 . . . . 0.0 110.331 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.63 141.42 56.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.326 -0.859 . . . . 0.0 108.813 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.23 96.43 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.39 -47.46 85.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.949 -1.324 . . . . 0.0 109.56 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.34 -25.81 64.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.401 -0.812 . . . . 0.0 108.817 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -74.13 -55.61 5.88 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.566 -0.709 . . . . 0.0 109.869 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.86 -49.03 79.29 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 0.0 110.315 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 39.9 t30 -60.07 -44.52 94.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 111.591 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.7 m -61.83 -42.92 99.63 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.866 -1.146 . . . . 0.0 110.369 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 66.0 mt -60.79 -44.86 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.964 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -64.22 -40.0 95.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.71 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 50.9 mt-30 -69.48 -19.72 63.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.19 -0.944 . . . . 0.0 111.431 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' C ' ' NH2' ' A' ' 47' ' ' ARG . . . -81.47 -9.89 59.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.626 -1.296 . . . . 0.0 110.83 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.72 8.75 22.17 Favored Glycine 0 N--CA 1.502 3.086 0 O-C-N 121.029 -1.044 . . . . 0.0 110.817 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.677 ' CD2' ' NH2' ' A' ' 47' ' ' ARG . 38.1 m-85 -81.59 144.6 31.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.827 -1.396 . . . . 0.0 110.094 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.47 132.23 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.07 106.76 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 110.131 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.6 171.9 29.54 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -65.78 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -1.109 . . . . 0.0 109.261 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.2 mtt 58.12 20.09 6.67 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.687 0.756 . . . . 0.0 109.777 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 52.94 33.7 15.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.54 -0.725 . . . . 0.0 111.613 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.97 163.28 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -89.75 129.2 36.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.981 -1.075 . . . . 0.0 110.689 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 48.6 m80 -115.72 130.02 56.69 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.677 ' NH2' ' CD2' ' A' ' 37' ' ' PHE . 39.9 ttm180 -104.64 124.31 49.12 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.523 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 24.9 m-70 -92.89 170.01 10.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.819 . . . . 0.0 109.562 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.8 tp -55.66 -49.3 73.3 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -89.17 148.42 40.79 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -71.2 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.739 0.96 . . . . 0.0 112.372 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.69 0.23 54.88 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.01 -1.056 . . . . 0.0 110.383 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.82 86.3 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.1 p -72.25 -44.62 62.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.155 -1.203 . . . . 0.0 110.364 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -70.49 168.15 49.15 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -67.32 175.65 5.63 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.18 1.253 . . . . 0.0 111.837 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.85 121.25 26.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.5 mp -98.06 -55.21 2.85 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.068 -1.02 . . . . 0.0 109.715 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -142.97 160.54 40.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.07 . . . . 0.0 108.702 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 19.7 m -129.36 -179.05 4.93 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.231 1.015 . . . . 0.0 111.35 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.1 tt -139.77 130.23 25.55 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.624 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -133.25 168.46 18.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.47 -0.769 . . . . 0.0 109.61 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.8 m120 -77.85 166.37 22.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 0.0 110.753 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 80.2 mmm -69.97 -22.2 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.89 -0.506 . . . . 0.0 110.09 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 68' ' ' GLY . 14.3 t -87.66 118.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -0.953 . . . . 0.0 109.822 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -62.27 149.31 87.6 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.206 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.47 10.73 15.5 Favored 'Cis proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.91 -1.287 . . . . 0.0 111.484 -1.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 79.04 29.12 52.41 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.7 p -86.03 169.04 13.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -1.108 . . . . 0.0 110.676 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.55 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.3 m-85 -126.06 156.38 40.06 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.1 p-10 -135.6 148.49 65.88 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.01 -16.82 6.76 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.503 0.858 . . . . 0.0 111.665 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -89.91 6.98 39.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.083 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.546 ' SD ' ' O ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -84.51 21.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.82 . . . . 0.0 109.808 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -86.05 -8.58 57.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.997 . . . . 0.0 109.911 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 83.7 m-20 -144.57 82.93 1.7 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.256 -0.903 . . . . 0.0 108.912 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -158.03 172.31 18.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.501 -0.749 . . . . 0.0 109.065 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 57.4 p -131.18 152.32 50.57 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.368 -0.833 . . . . 0.0 108.76 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.28 149.44 19.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -43.91 -49.73 8.02 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 120.495 0.796 . . . . 0.0 111.719 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.39 -152.26 8.7 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.99 160.89 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.6 -0.941 . . . . 0.0 109.573 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.45 HG23 ' ND2' ' A' ' 14' ' ' ASN . 52.8 m -112.15 128.03 56.1 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.558 -0.714 . . . . 0.0 110.103 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.98 130.0 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -149.64 167.08 27.39 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.565 -1.335 . . . . 0.0 110.879 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.7 ttp -132.94 130.8 40.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' O ' ' OG ' ' A' ' 90' ' ' SER . 91.8 mt-30 -87.59 108.52 19.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 108.953 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 89' ' ' PRO . 0.4 OUTLIER -97.54 144.05 27.27 Favored Pre-proline 0 N--CA 1.494 1.769 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 88' ' ' VAL . 5.9 Cg_exo -74.04 134.91 37.73 Favored 'Cis proline' 0 N--CA 1.498 1.761 0 C-N-CA 124.341 -1.108 . . . . 0.0 113.371 0.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 66.3 m -110.41 159.91 17.06 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.54 0.686 . . . . 0.0 109.828 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -70.75 142.18 51.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.174 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.33 -159.71 26.41 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -95.59 123.55 39.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.16 -1.2 . . . . 0.0 109.562 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 39.5 mp0 -59.93 -36.61 77.41 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.805 -0.559 . . . . 0.0 110.402 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.69 -38.81 80.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.958 . . . . 0.0 109.955 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -69.97 -39.96 75.66 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.892 -1.13 . . . . 0.0 108.123 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -61.34 -39.99 92.6 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 102' ' ' LEU . 91.1 t80 -60.0 -40.9 90.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -61.85 -41.37 97.74 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.087 -1.008 . . . . 0.0 109.007 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.24 -39.98 94.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.897 . . . . 0.0 109.041 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 82.1 mtp -58.13 -48.36 80.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.429 -0.794 . . . . 0.0 109.312 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 98' ' ' PHE . 98.7 mt -63.66 -42.68 98.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.922 -1.111 . . . . 0.0 109.184 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.01 -41.72 92.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 109.711 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -69.94 -39.98 75.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.55 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.39 58.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -62.2 -40.63 96.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.001 -1.062 . . . . 0.0 110.084 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -60.47 -47.45 86.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.174 . . . . 0.0 108.749 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.92 -50.02 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.03 -49.97 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.661 -0.649 . . . . 0.0 109.844 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.18 -40.19 89.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.282 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.9 -40.01 75.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.937 . . . . 0.0 111.151 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 114' ' ' GLY . 7.3 m -100.69 -1.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.084 -1.01 . . . . 0.0 109.826 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.69 24.63 75.38 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.9 -176.42 51.14 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.46 133.03 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.636 -0.92 . . . . 0.0 108.905 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 t -70.24 130.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.013 -1.054 . . . . 0.0 109.096 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 14' ' ' ASN . 77.4 mt -129.23 155.99 44.68 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.587 -0.695 . . . . 0.0 109.286 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 30.4 p-10 -85.42 -172.64 4.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 109.481 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 97.1 m-20 -60.01 -38.71 83.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.65 16.07 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.377 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.0 mtm180 56.1 33.55 22.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -109.87 149.1 30.36 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 0.0 109.144 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 65.5 mtt -50.75 135.73 23.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.136 -0.977 . . . . 0.0 109.265 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.7 mmm -58.67 137.15 57.73 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.379 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -134.47 150.35 73.56 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -44.02 -42.37 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 119.162 0.736 . . . . 0.0 111.879 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -60.6 -39.98 90.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 110.104 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.515 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 51.0 mmtt -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.058 -1.026 . . . . 0.0 110.051 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.9 -43.15 94.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -69.3 -32.9 72.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.799 -1.188 . . . . 0.0 109.747 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -59.98 -45.31 93.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.005 -1.06 . . . . 0.0 108.876 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -60.78 -41.07 94.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -61.69 -39.96 93.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.472 -0.767 . . . . 0.0 109.085 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -63.54 -40.2 96.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 92.5 mt -61.65 -42.06 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.994 . . . . 0.0 108.88 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.03 -41.93 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.208 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.5 mtt180 -61.92 -37.65 85.46 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.445 -0.784 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.486 ' OE2' ' CB ' ' A' ' 4' ' ' PRO . 94.7 mt-10 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 110.778 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.35 -32.16 30.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.9 mmmm -60.07 -45.92 91.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.075 -1.016 . . . . 0.0 110.17 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.79 -31.83 71.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.754 -1.216 . . . . 0.0 108.892 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.4 -40.01 94.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 110.385 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 55.6 p30 -97.91 0.37 46.41 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 0.0 110.104 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.545 -179.88 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 tpp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.368 0.604 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -90.12 30.87 1.04 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -130.02 75.79 78.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 6' ' ' ARG . 2.5 Cg_endo -65.85 122.05 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 120.858 1.039 . . . . 0.0 111.816 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -78.95 32.43 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 4' ' ' PRO . 98.9 mtt180 -72.13 153.13 41.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.54 -0.725 . . . . 0.0 109.338 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -80.45 -9.94 59.75 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -145.0 151.86 39.24 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.29 160.34 32.41 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 109.932 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.16 129.99 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.0 mm -92.27 117.16 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 84.2 mt -121.58 142.16 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-O 121.946 0.879 . . . . 0.0 111.191 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.0 mtm -146.1 150.18 35.45 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -129.71 128.67 42.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.972 -1.08 . . . . 0.0 111.291 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.45 116.4 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 115' ' ' VAL . . . -147.34 157.24 43.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 109.97 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.89 -174.24 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.39 -0.819 . . . . 0.0 109.063 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -61.02 156.65 17.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 108.88 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -60.02 140.12 57.01 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.51 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.18 70.23 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.5 m -121.11 147.3 45.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.551 -0.97 . . . . 0.0 109.699 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -125.87 145.5 50.22 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.4 mt -86.42 149.18 25.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 110.564 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -70.84 145.27 50.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.129 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.56 -42.05 99.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.51 -43.75 98.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.301 . . . . 0.0 110.166 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.3 mt -69.79 -27.02 64.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.0 tt -75.12 -57.86 3.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.541 -0.724 . . . . 0.0 109.912 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.32 -42.33 95.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.0 110.532 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -64.04 -40.06 95.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 110.221 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.2 m -65.19 -41.38 94.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 110.419 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.02 -46.88 93.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.009 -1.057 . . . . 0.0 109.4 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -65.38 -43.25 91.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 0.0 109.401 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -68.04 -17.24 64.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.35 1.57 36.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.023 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.71 9.55 66.2 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 121.071 -1.018 . . . . 0.0 111.016 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -80.75 151.07 29.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.822 -1.399 . . . . 0.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.9 mt -120.0 130.67 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.88 101.36 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 109.995 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.05 171.22 38.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -65.3 -163.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -1.166 . . . . 0.0 109.469 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.7 mtm 58.03 23.25 9.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.428 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.36 39.41 20.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 111.231 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.0 pt -142.0 164.84 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.026 -1.047 . . . . 0.0 109.429 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -91.89 136.28 33.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.072 -1.017 . . . . 0.0 109.886 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 43.8 m-70 -125.16 125.11 43.18 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.726 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 49.7 ttt180 -105.09 125.53 51.08 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.501 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 34.2 m-70 -94.73 173.99 7.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.489 -0.757 . . . . 0.0 109.442 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.64 -50.76 65.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.261 -0.899 . . . . 0.0 108.832 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -93.83 144.06 27.52 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.196 -0.94 . . . . 0.0 108.784 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.36 -4.42 11.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 120.57 0.847 . . . . 0.0 112.149 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -91.48 -0.94 57.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 0.0 109.383 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.28 86.34 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.3 t -69.95 -41.01 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -1.198 . . . . 0.0 109.792 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.37 169.13 54.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.501 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.1 Cg_endo -69.55 173.47 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.2 1.266 . . . . 0.0 111.427 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.74 120.8 25.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.045 -1.034 . . . . 0.0 108.649 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.591 HD23 ' ND2' ' A' ' 97' ' ' ASN . 9.7 mp -100.81 -35.08 9.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.234 -0.916 . . . . 0.0 109.75 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -153.47 165.45 35.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.924 -1.11 . . . . 0.0 108.762 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 5.4 m -138.48 161.97 35.68 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.037 -1.039 . . . . 0.0 111.229 -177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.6 tt -114.75 135.07 54.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.547 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -132.41 162.08 32.01 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.587 -0.696 . . . . 0.0 109.29 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.606 ' ND2' ' CZ ' ' A' ' 70' ' ' PHE . 76.6 m-20 -78.64 166.85 22.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.015 -1.053 . . . . 0.0 110.053 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 82.4 mmm -69.92 -23.09 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.465 -0.772 . . . . 0.0 110.205 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.2 t -88.14 112.5 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 110.521 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -60.3 150.42 72.41 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -77.87 8.55 19.93 Favored 'Cis proline' 0 N--CA 1.497 1.696 0 C-N-CA 124.114 -1.202 . . . . 0.0 111.982 -0.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.43 35.83 25.16 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.6 p -85.94 160.47 19.37 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.256 -1.143 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CZ ' ' ND2' ' A' ' 63' ' ' ASN . 32.7 m-85 -128.52 139.02 52.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 t70 -127.77 137.82 31.57 Favored Pre-proline 0 N--CA 1.505 2.284 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -48.13 -4.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.591 1.247 . . . . 0.0 112.888 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -90.83 3.96 53.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.054 -1.028 . . . . 0.0 111.345 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.502 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 21.5 mtm -79.72 26.14 0.32 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.567 -1.333 . . . . 0.0 110.099 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 32.0 mmtp -81.91 2.39 30.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.581 -1.325 . . . . 0.0 109.261 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 70.1 m-20 -153.79 81.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.322 -0.861 . . . . 0.0 108.76 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -158.84 171.41 20.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.11 -0.994 . . . . 0.0 109.964 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.7 p -137.88 154.68 49.44 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.23 149.12 17.35 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 109.19 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -46.93 -45.22 21.3 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 120.786 0.991 . . . . 0.0 112.027 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.23 -152.84 10.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.94 159.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.415 -1.05 . . . . 0.0 109.396 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ALA . 51.9 m -111.53 124.94 53.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.538 -0.726 . . . . 0.0 110.226 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.11 130.61 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -144.77 160.41 41.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.847 -1.158 . . . . 0.0 110.85 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.9 ttp -141.46 131.73 25.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.658 -0.651 . . . . 0.0 109.622 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -90.18 115.21 27.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.048 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 m -103.24 152.38 38.65 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.357 -0.839 . . . . 0.0 109.065 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.644 ' CG ' HD22 ' A' ' 143' ' ' ASN . 6.5 Cg_endo -77.63 136.77 44.29 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.655 -1.394 . . . . 0.0 112.149 -0.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.9 m -104.59 166.52 10.34 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.574 -0.704 . . . . 0.0 109.721 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -68.93 141.5 54.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.446 -0.784 . . . . 0.0 109.045 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.78 28.4 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -94.19 115.33 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.966 -1.314 . . . . 0.0 109.703 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 50.5 mp0 -58.05 -28.0 64.11 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.696 . . . . 0.0 109.52 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 98.8 mt -69.73 -40.04 76.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -0.945 . . . . 0.0 109.196 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -73.05 -40.51 65.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.901 -1.124 . . . . 0.0 108.948 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.591 ' ND2' HD23 ' A' ' 58' ' ' LEU . 26.9 m120 -61.86 -41.96 98.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 102' ' ' LEU . 73.8 t80 -59.86 -49.92 75.81 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.75 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -62.13 -39.96 94.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -43.39 95.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.0 mtp -57.78 -44.57 86.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 108.746 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.4 mt -62.0 -41.21 97.81 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 108.726 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 28.2 mt-30 -60.15 -41.54 92.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.086 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.1 p -70.28 -39.89 74.63 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 109.147 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -51.82 68.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.541 -0.725 . . . . 0.0 110.435 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -60.76 -37.83 83.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.87 -1.144 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 19.3 m-70 -60.06 -50.05 75.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.048 -1.033 . . . . 0.0 109.151 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.9 -50.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.539 -0.725 . . . . 0.0 109.652 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.46 -49.36 55.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.58 -39.78 89.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.46 -0.775 . . . . 0.0 110.338 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.11 -40.06 75.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 110.675 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.1 m -98.84 0.4 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.055 -1.028 . . . . 0.0 109.491 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.22 21.87 75.9 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -79.94 -176.8 49.96 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 16' ' ' ALA . 58.4 t -135.33 140.74 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.6 -0.941 . . . . 0.0 108.952 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.536 HG12 ' SD ' ' A' ' 124' ' ' MET . 5.7 t -73.3 127.95 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.136 -0.978 . . . . 0.0 109.945 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 mt -128.8 153.62 47.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.76 -178.04 6.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.461 ' O ' ' NH1' ' A' ' 121' ' ' ARG . 97.9 m-20 -59.39 -28.89 67.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.049 -1.032 . . . . 0.0 109.082 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -82.13 12.36 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.348 -0.845 . . . . 0.0 108.972 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.461 ' NH1' ' O ' ' A' ' 119' ' ' ASP . 14.6 mmt-85 61.48 27.59 17.1 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.7 -0.625 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -107.88 147.8 30.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.396 -0.815 . . . . 0.0 109.328 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . 0.402 ' SD ' HG11 ' A' ' 115' ' ' VAL . 92.2 mmm -50.41 121.6 5.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.665 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.536 ' SD ' HG12 ' A' ' 116' ' ' VAL . 35.2 mtp -59.79 139.93 56.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.839 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 21.8 p -130.29 151.0 77.74 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -41.94 -41.64 6.54 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 120.503 0.802 . . . . 0.0 111.622 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.07 -42.19 94.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.445 -0.784 . . . . 0.0 109.235 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -69.49 -39.88 77.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.862 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 74.5 mt -56.61 -40.09 74.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.814 -1.179 . . . . 0.0 108.373 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -64.63 -38.23 90.29 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.017 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -59.98 -45.56 92.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.971 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.23 -41.96 94.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.862 -1.149 . . . . 0.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -61.62 -39.78 92.49 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 97.6 m-20 -60.06 -39.63 86.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.513 -0.742 . . . . 0.0 109.183 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 95.1 mt -59.93 -41.73 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.103 -0.998 . . . . 0.0 108.65 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.21 -39.87 81.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.549 -0.719 . . . . 0.0 109.36 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.528 ' HG2' HH11 ' A' ' 137' ' ' ARG . 16.3 mtt-85 -59.99 -40.14 88.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.95 . . . . 0.0 110.576 -178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.429 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -60.39 -39.8 88.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.925 -1.109 . . . . 0.0 109.035 179.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.6 -32.03 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 0.0 110.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.6 mttt -60.0 -42.68 94.81 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.841 -1.162 . . . . 0.0 110.923 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.6 OUTLIER -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.985 -1.072 . . . . 0.0 109.854 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.89 -59.13 3.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.924 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.644 HD22 ' CG ' ' A' ' 89' ' ' PRO . 80.9 m-20 -103.9 -14.57 15.95 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.296 -0.878 . . . . 0.0 110.478 -178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -90.46 28.32 1.5 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.942 . . . . 0.0 109.609 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -119.94 82.92 29.17 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.429 -0.794 . . . . 0.0 109.475 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.41 14.66 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 120.575 0.85 . . . . 0.0 112.053 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 3' ' ' LYS . 64.1 mttp -85.79 -4.23 59.11 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.634 -0.666 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 6' ' ' ARG . 35.7 mtt-85 -82.42 115.8 21.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.952 -1.093 . . . . 0.0 110.052 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -85.66 -10.42 55.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -149.4 148.11 29.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.47 175.97 8.6 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.67 -1.269 . . . . 0.0 110.359 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.08 131.44 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -91.25 125.91 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 92.7 mt -116.12 144.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.896 0.855 . . . . 0.0 110.867 -177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.5 mtt -144.6 156.16 43.99 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -137.5 126.72 24.61 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.959 -1.088 . . . . 0.0 111.022 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.01 119.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.3 158.63 44.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.775 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.65 -164.49 0.09 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -69.26 159.42 33.11 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 108.815 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -60.07 140.79 56.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.284 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.09 80.39 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.8 m -110.04 152.4 25.98 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.391 -1.064 . . . . 0.0 109.216 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -130.25 149.03 52.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.513 -0.742 . . . . 0.0 109.593 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.8 140.36 29.87 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.321 -0.862 . . . . 0.0 110.02 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -68.82 143.42 54.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.07 -40.12 96.65 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.03 -44.83 96.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -1.209 . . . . 0.0 109.545 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.02 -29.48 66.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.401 -0.812 . . . . 0.0 108.931 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.641 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.3 tt -71.14 -57.3 4.64 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.6 -0.687 . . . . 0.0 109.456 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.99 -43.41 95.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.187 -0.946 . . . . 0.0 110.476 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -61.93 -40.02 94.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 110.056 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.4 p -65.51 -40.16 92.68 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 109.928 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -48.34 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -62.23 -43.32 99.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.128 -0.982 . . . . 0.0 110.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -65.87 -20.01 66.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.5 5.62 17.27 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 110.04 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.93 10.35 85.14 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -81.22 154.37 26.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.038 -1.272 . . . . 0.0 109.619 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.9 mt -128.63 142.81 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -59.04 99.92 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.113 -0.992 . . . . 0.0 109.542 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.22 168.85 45.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -62.99 -163.59 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.496 -1.003 . . . . 0.0 108.923 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt 56.5 22.2 6.34 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.389 -0.819 . . . . 0.0 109.93 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.6 m120 51.89 40.09 27.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 111.146 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.1 pt -143.08 170.03 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 109.327 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -93.22 135.08 34.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.978 -1.076 . . . . 0.0 109.836 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 6.2 m-70 -119.53 133.91 55.46 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.407 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 7.5 tpt180 -102.38 120.97 41.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.385 -0.822 . . . . 0.0 108.972 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 68.7 m-70 -98.26 170.06 9.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.306 -0.871 . . . . 0.0 109.723 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.26 -49.98 74.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 108.988 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.8 m -91.93 147.78 35.61 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.95 -6.18 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.671 0.914 . . . . 0.0 112.794 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -93.23 -0.89 56.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.917 -1.115 . . . . 0.0 110.158 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.43 12.09 84.17 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.466 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.9 p -70.2 -39.9 74.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.53 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.486 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.88 167.1 51.05 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.03 171.31 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.228 1.285 . . . . 0.0 112.113 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.35 122.82 28.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 109.209 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' OD1' ' A' ' 97' ' ' ASN . 8.4 mp -98.91 -36.87 9.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.228 -0.92 . . . . 0.0 109.28 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.8 162.31 40.05 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 108.589 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.529 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 4.4 m -131.06 175.99 8.63 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.081 -1.012 . . . . 0.0 111.859 -177.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.65 131.69 33.99 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.44 162.17 35.13 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 15.4 m120 -77.2 162.92 27.01 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.212 -0.93 . . . . 0.0 110.751 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 29.4 mtt -69.96 -23.72 63.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.598 -0.689 . . . . 0.0 110.396 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.4 t -85.85 119.99 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.971 -1.081 . . . . 0.0 109.632 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -59.89 149.71 71.97 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.52 -0.738 . . . . 0.0 109.064 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -77.12 8.94 16.4 Favored 'Cis proline' 0 N--CA 1.494 1.536 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.758 -0.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 16.69 76.52 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.1 p -87.99 173.56 8.82 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.079 -1.247 . . . . 0.0 109.924 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.04 140.12 51.49 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLU . 5.6 m-20 -126.52 150.08 69.66 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.458 -0.776 . . . . 0.0 108.94 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -45.39 -12.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.6 0.867 . . . . 0.0 111.93 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -83.54 13.22 4.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 71' ' ' ASP . 26.4 ptt? -83.82 -1.39 54.25 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.513 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 98.9 mttt -85.94 -3.78 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.798 -1.189 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.0 m-20 -150.45 75.75 1.24 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.686 179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -159.06 168.98 25.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.118 -0.989 . . . . 0.0 109.414 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.8 p -136.53 155.56 49.79 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.44 150.43 20.7 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 109.449 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -47.22 -46.72 18.86 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 120.366 0.711 . . . . 0.0 111.24 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.38 -151.04 8.06 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.98 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.529 -0.983 . . . . 0.0 109.322 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.5 m -113.02 120.18 40.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 0.0 109.489 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.21 129.97 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -143.71 163.69 32.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.125 -0.984 . . . . 0.0 110.496 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 59.0 ttp -138.97 129.74 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.713 -0.617 . . . . 0.0 109.563 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -92.28 119.71 32.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 0.0 109.117 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -102.75 150.31 37.6 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.24 133.76 32.69 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.568 0.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.8 m -102.18 170.23 8.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.505 -0.747 . . . . 0.0 109.502 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -68.95 139.95 55.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.377 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.82 -154.38 24.65 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -99.58 122.02 42.02 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.299 -1.118 . . . . 0.0 109.652 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.6 mp0 -55.87 -28.61 57.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.5 -39.93 77.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 109.037 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -71.52 -40.34 70.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.095 -1.003 . . . . 0.0 109.102 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.741 ' OD1' HD23 ' A' ' 58' ' ' LEU . 98.6 m-20 -60.59 -40.04 90.3 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 102' ' ' LEU . 86.2 t80 -57.02 -41.43 78.54 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.41 -42.03 99.14 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.137 -0.977 . . . . 0.0 108.733 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 82.8 mt -64.01 -39.99 95.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.326 -0.859 . . . . 0.0 108.71 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 70.3 mmm -57.23 -50.12 73.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.368 -0.832 . . . . 0.0 109.497 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.545 HD11 ' CE2' ' A' ' 98' ' ' PHE . 94.8 mt -64.35 -47.75 78.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.284 -0.885 . . . . 0.0 109.24 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.529 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -60.0 -40.84 90.59 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.782 . . . . 0.0 109.217 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 p -71.96 -42.93 65.99 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.167 -0.958 . . . . 0.0 109.298 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.12 -54.53 44.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.394 -0.816 . . . . 0.0 109.931 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -62.78 -35.09 78.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.585 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.8 m-70 -60.05 -49.94 75.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 112' ' ' VAL . 81.5 mt -59.97 -49.91 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.889 -1.132 . . . . 0.0 108.011 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.95 -49.22 66.49 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.04 -40.01 91.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.583 -0.698 . . . . 0.0 110.558 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.58 -39.94 77.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.8 m -96.12 0.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.975 -1.078 . . . . 0.0 108.873 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 21.67 76.91 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . -84.07 -169.68 45.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -131.97 138.11 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.602 -0.94 . . . . 0.0 109.631 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG12 ' SD ' ' A' ' 124' ' ' MET . 19.8 t -73.69 138.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.284 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 mt -132.28 160.0 37.5 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.436 -0.79 . . . . 0.0 109.649 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -84.13 -171.67 3.74 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.402 -0.811 . . . . 0.0 109.672 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.512 ' H ' ' HH ' ' A' ' 132' ' ' TYR . 94.7 m-20 -60.01 -39.86 87.29 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.217 -0.927 . . . . 0.0 110.083 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.43 14.47 0.97 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -0.909 . . . . 0.0 109.396 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 57.4 37.63 28.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.745 -0.597 . . . . 0.0 109.744 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -112.13 151.48 29.42 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 19.5 mmt -50.2 126.37 14.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.957 -1.09 . . . . 0.0 109.284 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 116' ' ' VAL . 24.9 mtt -58.9 139.97 55.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.788 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -129.12 151.36 77.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -41.47 -45.0 6.1 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 120.762 0.975 . . . . 0.0 112.184 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -60.8 -39.9 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 0.0 109.768 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -63.74 -40.05 95.79 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.243 -0.91 . . . . 0.0 109.717 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -59.57 -40.05 86.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.706 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -66.26 -37.94 86.64 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.615 -0.678 . . . . 0.0 109.55 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.13 -49.99 75.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.528 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.512 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 73.1 m-85 -59.97 -49.37 77.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 108.738 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.17 -38.05 82.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.08 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.1 -40.96 91.46 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.149 -0.969 . . . . 0.0 109.67 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.65 -40.06 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.639 -1.288 . . . . 0.0 108.467 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.97 -47.57 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.431 -0.793 . . . . 0.0 109.031 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.15 -39.89 87.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.863 . . . . 0.0 108.915 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 89.6 mt-10 -60.98 -41.1 95.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.31 -0.869 . . . . 0.0 109.688 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.85 -39.95 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 0.0 110.164 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -60.01 -44.92 94.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.349 -0.844 . . . . 0.0 111.592 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.6 p30 -59.97 -34.15 72.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.574 -1.329 . . . . 0.0 109.112 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.39 -35.92 82.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.027 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -97.31 -0.23 46.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.741 . . . . 0.0 109.382 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 78.5 mtm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.314 0.578 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.9 -0.1 57.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -80.64 143.53 54.88 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.115 -0.991 . . . . 0.0 109.71 -179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.43 23.46 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.505 0.859 . . . . 0.0 111.915 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 3' ' ' LYS . 64.2 mttp -81.82 -22.63 36.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.785 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' A' ' 1' ' ' MET . 60.1 mtt-85 -86.19 119.62 26.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.032 -1.042 . . . . 0.0 110.261 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -88.21 -10.19 50.58 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.39 144.11 27.26 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.17 9.83 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.584 -1.322 . . . . 0.0 110.148 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.81 130.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.3 mm -93.17 122.67 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.2 mt -120.06 147.63 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.23 1.014 . . . . 0.0 111.372 -177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.7 mtt -143.81 147.37 34.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.43 120.96 25.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.053 -1.03 . . . . 0.0 110.821 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.5 117.64 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.54 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.452 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.53 -164.49 0.12 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -66.9 155.03 39.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.925 -1.109 . . . . 0.0 108.482 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -59.93 139.99 57.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.979 -1.076 . . . . 0.0 109.349 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.57 3.5 66.6 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.2 m -124.42 149.43 46.75 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.501 -1.0 . . . . 0.0 109.248 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.73 145.81 50.46 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.538 -0.726 . . . . 0.0 109.493 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.21 146.34 27.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -68.67 143.62 54.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 109.156 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.55 -43.43 98.88 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.28 -45.67 92.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.135 -1.214 . . . . 0.0 110.152 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.79 -29.83 67.23 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -71.32 -58.79 3.2 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.583 -0.698 . . . . 0.0 109.347 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.7 mt -60.09 -41.63 92.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.163 -0.961 . . . . 0.0 110.011 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.62 -39.89 94.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.157 -0.964 . . . . 0.0 109.727 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.8 p -64.26 -40.81 96.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.695 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.19 -44.64 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.04 -1.038 . . . . 0.0 109.333 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.34 -40.37 95.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 110.029 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' OE1' ' OE2' ' A' ' 111' ' ' GLU . 78.0 mt-30 -68.27 -20.04 64.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.279 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.71 7.29 15.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.196 -0.94 . . . . 0.0 110.292 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.68 11.63 83.78 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.988 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -80.63 152.53 28.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.763 -1.434 . . . . 0.0 109.598 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -121.39 145.26 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -59.82 118.86 6.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.0 108.966 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 45' ' ' TYR . . . -87.67 171.57 41.59 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -67.6 -162.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.569 -0.96 . . . . 0.0 109.711 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.419 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 89.8 mmm 54.78 -101.34 0.12 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' MET . 26.7 m120 -163.27 31.85 0.09 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.0 pt -134.69 163.92 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.494 -0.754 . . . . 0.0 110.115 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 66.8 m-85 -88.07 134.41 33.76 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.296 -0.878 . . . . 0.0 110.143 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.451 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 8.0 m-70 -118.34 129.79 55.64 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.55 HH21 HD22 ' A' ' 100' ' ' LEU . 15.9 ttt180 -106.11 125.42 50.97 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.568 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 49.4 m-70 -95.13 174.12 7.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.824 . . . . 0.0 110.222 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.33 -49.97 74.43 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.359 -0.838 . . . . 0.0 109.41 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.8 m -92.7 147.89 35.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.28 -0.887 . . . . 0.0 108.693 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.12 -5.95 17.07 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.68 0.92 . . . . 0.0 112.06 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -92.65 1.28 57.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.179 -0.95 . . . . 0.0 110.204 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.74 11.45 84.53 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -70.15 -40.07 74.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.241 . . . . 0.0 110.091 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.547 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.0 169.82 53.33 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.568 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 24.4 Cg_endo -72.78 -179.96 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.133 1.222 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.43 123.4 29.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -0.957 . . . . 0.0 108.729 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.2 mp -101.02 -28.3 12.8 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.145 -0.972 . . . . 0.0 109.517 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -159.94 165.31 32.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.599 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.451 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 17.2 m -132.48 170.11 15.6 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.129 -0.982 . . . . 0.0 111.53 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.7 tt -132.63 130.96 40.88 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.625 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -137.14 169.68 17.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.417 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 91.7 m-20 -75.14 163.49 27.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.032 -1.043 . . . . 0.0 109.617 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -70.02 -21.68 63.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.44 -0.788 . . . . 0.0 110.464 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.7 t -87.17 114.85 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.926 -1.109 . . . . 0.0 109.457 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -60.13 149.75 73.72 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.417 -0.802 . . . . 0.0 109.422 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -76.49 6.8 16.3 Favored 'Cis proline' 0 N--CA 1.495 1.601 0 C-N-CA 123.858 -1.309 . . . . 0.0 111.374 -1.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.89 31.23 49.5 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.5 p -86.09 165.85 16.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.013 -1.286 . . . . 0.0 109.944 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.548 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.0 m-85 -120.24 148.65 43.42 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 74' ' ' MET . 1.8 p30 -133.96 151.4 76.7 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.432 -0.792 . . . . 0.0 108.924 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.34 -11.86 0.41 Allowed 'Trans proline' 0 N--CA 1.486 1.072 0 CA-C-N 119.429 0.832 . . . . 0.0 110.362 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 75.3 mm-40 -82.17 6.48 16.42 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' ASP . 23.3 ptt? -79.61 1.65 25.35 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -85.02 -2.15 57.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.82 -1.175 . . . . 0.0 108.267 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -154.09 78.62 1.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -159.3 167.61 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.254 -0.904 . . . . 0.0 109.221 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.6 p -140.72 154.58 46.39 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.235 -0.916 . . . . 0.0 108.936 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.83 150.16 21.02 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.075 -1.015 . . . . 0.0 109.248 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -41.93 -36.87 3.93 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 120.724 0.95 . . . . 0.0 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.41 -150.63 12.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.97 159.97 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.418 -1.048 . . . . 0.0 109.58 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -113.17 125.9 54.85 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.619 -0.675 . . . . 0.0 109.632 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.12 129.97 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -146.79 166.26 27.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.972 -1.08 . . . . 0.0 110.274 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 50.3 ttp -137.33 131.32 32.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.735 -0.603 . . . . 0.0 109.584 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' OG ' ' A' ' 90' ' ' SER . 90.4 mm-40 -88.15 117.73 27.25 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 m -105.5 148.2 35.94 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -73.66 137.5 50.24 Favored 'Cis proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.695 -1.377 . . . . 0.0 112.262 -0.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 51.2 m -103.73 166.94 10.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.502 -0.749 . . . . 0.0 110.34 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -72.19 146.22 47.51 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.587 -0.696 . . . . 0.0 109.352 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 -156.35 31.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.14 111.95 23.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -1.135 . . . . 0.0 109.019 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.8 mp0 -54.18 -26.46 28.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.467 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.9 mt -70.02 -39.95 75.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.0 108.68 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -71.61 -40.02 70.07 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.601 ' N ' HD22 ' A' ' 97' ' ' ASN . 1.7 m120 -59.99 -40.41 89.09 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 102' ' ' LEU . 89.8 t80 -59.91 -45.45 92.52 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -63.44 -40.59 97.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.55 HD22 HH21 ' A' ' 47' ' ' ARG . 92.6 mt -60.98 -40.04 91.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.962 . . . . 0.0 108.842 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 85.5 mtp -59.41 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.728 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 98' ' ' PHE . 99.5 mt -65.26 -43.46 91.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.176 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 77.8 mt-30 -60.1 -39.98 88.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 p -70.47 -40.06 73.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.413 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.13 -53.78 54.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 110.239 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -61.88 -41.09 97.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.876 -1.14 . . . . 0.0 109.244 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 28.0 m-70 -60.34 -50.01 75.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.14 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 112' ' ' VAL . 90.5 mt -60.8 -49.99 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.101 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.49 -49.47 67.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.503 -0.748 . . . . 0.0 109.135 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.07 -40.1 88.32 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.428 -0.795 . . . . 0.0 110.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' OE2' ' OE1' ' A' ' 34' ' ' GLN . 41.4 mt-10 -69.57 -39.92 77.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.975 -1.078 . . . . 0.0 110.721 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.6 m -99.65 -2.24 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.059 -1.026 . . . . 0.0 109.628 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.06 23.76 76.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.07 -176.15 51.07 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 121.289 -1.124 . . . . 0.0 110.57 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.03 136.32 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.593 -0.945 . . . . 0.0 109.692 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.64 133.13 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.6 mt -133.15 161.81 33.43 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.416 -0.802 . . . . 0.0 109.168 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -84.23 -170.57 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.915 . . . . 0.0 109.702 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 89.4 m-20 -60.09 -39.94 87.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.85 . . . . 0.0 110.046 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.547 ' CD ' HH12 ' A' ' 122' ' ' ARG . 96.6 mt-30 -80.33 14.18 2.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.776 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 59.68 34.52 22.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.983 -0.448 . . . . 0.0 111.702 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.547 HH12 ' CD ' ' A' ' 120' ' ' GLN . 50.9 mtm-85 -107.19 158.0 17.44 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.042 -1.036 . . . . 0.0 108.821 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 72.9 mtm -52.59 130.52 32.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.942 . . . . 0.0 109.843 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mmm -59.94 141.57 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 110.066 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.0 p -132.25 150.04 74.88 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -47.3 -42.37 27.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 CA-C-N 119.513 0.862 . . . . 0.0 112.082 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -60.09 -39.87 87.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.312 -0.868 . . . . 0.0 109.579 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -66.72 -40.02 88.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.084 -1.01 . . . . 0.0 110.522 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.94 -40.25 88.29 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.835 -1.166 . . . . 0.0 109.412 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.9 -37.66 86.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.349 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.87 -48.89 79.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.951 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.02 -45.36 93.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.058 -1.026 . . . . 0.0 108.986 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.8 -39.99 93.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.21 -40.02 88.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.28 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.07 -40.7 84.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.922 -1.112 . . . . 0.0 108.711 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.447 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 30.6 mmt180 -63.55 -36.15 82.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.18 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.02 -39.93 87.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.515 -0.741 . . . . 0.0 109.856 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.33 -35.15 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -59.77 -47.19 86.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.902 -1.124 . . . . 0.0 110.109 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -60.59 -31.96 71.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.871 -1.143 . . . . 0.0 109.3 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.99 92.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.404 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.589 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.79 0.26 44.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 108.904 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.426 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.322 0.582 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -90.07 -0.02 57.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.98 78.3 75.14 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.53 -0.731 . . . . 0.0 109.693 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 7.1 Cg_exo -62.9 121.39 9.26 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.653 1.569 . . . . 0.0 113.175 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -80.92 33.0 0.32 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -69.89 156.36 39.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.482 -0.761 . . . . 0.0 110.802 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -82.08 -8.65 59.67 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -144.36 142.59 30.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.73 -175.65 4.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.724 -1.235 . . . . 0.0 110.602 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.5 t -133.39 139.06 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.7 mm -91.62 131.12 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.44 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 87.0 mt -121.11 147.29 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 121.989 0.9 . . . . 0.0 110.979 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.3 mtt -147.39 156.49 42.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -136.97 118.37 14.7 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.879 -1.138 . . . . 0.0 110.632 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.9 t -101.24 111.19 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.72 43.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 0.0 110.281 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.67 -164.11 0.08 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -68.39 161.47 27.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 108.624 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -61.93 140.04 58.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.047 -1.033 . . . . 0.0 109.895 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.35 2.13 85.54 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.5 m -116.94 146.33 43.05 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.446 -1.032 . . . . 0.0 109.054 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.7 144.98 50.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 109.392 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.2 mt -85.92 147.94 26.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.396 -0.815 . . . . 0.0 110.296 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.43 138.25 55.14 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.06 -40.44 97.07 Favored Glycine 0 N--CA 1.493 2.433 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.287 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.1 -45.49 94.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.018 -1.284 . . . . 0.0 109.338 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.84 -27.02 64.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.1 tt -74.41 -59.61 2.65 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.558 -0.714 . . . . 0.0 109.593 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.99 -43.52 95.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.119 -0.988 . . . . 0.0 110.291 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.01 -41.85 97.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 109.812 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.1 t -64.3 -40.99 97.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.165 -0.96 . . . . 0.0 109.676 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.08 -48.22 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.167 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.89 -40.99 95.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.866 . . . . 0.0 109.667 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -69.68 -19.79 63.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.489 -0.757 . . . . 0.0 110.468 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.86 6.16 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 0.0 110.136 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.34 78.37 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -81.86 150.58 27.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -1.2 . . . . 0.0 109.995 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 91.0 mt -123.74 138.82 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.46 98.4 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.968 -1.082 . . . . 0.0 109.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 171.46 53.9 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.14 -170.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.464 -1.021 . . . . 0.0 109.578 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 70.8 mtm 56.74 30.11 17.07 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.484 -0.76 . . . . 0.0 109.885 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 48.78 40.05 15.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.558 -0.714 . . . . 0.0 111.642 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.24 162.33 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.03 -1.044 . . . . 0.0 109.541 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.1 121.55 32.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.052 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.614 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 7.2 m-70 -103.92 130.5 51.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.296 -0.878 . . . . 0.0 109.818 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 7.5 tpt180 -101.75 120.62 40.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 59.1 m-70 -98.19 169.43 9.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.266 -0.896 . . . . 0.0 109.735 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.67 -49.48 76.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -90.65 138.82 26.41 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.55 -0.719 . . . . 0.0 109.335 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.56 -7.29 14.04 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 CA-C-N 119.69 0.925 . . . . 0.0 111.616 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -92.61 -0.17 57.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.85 86.58 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.19 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -68.63 -41.38 79.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.928 -1.337 . . . . 0.0 109.499 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.42 163.39 50.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 15.3 Cg_endo -67.77 171.38 12.25 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.002 1.134 . . . . 0.0 112.05 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -79.65 120.61 24.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 108.723 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.663 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.1 mp -97.04 -31.28 12.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.181 -0.949 . . . . 0.0 108.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -156.84 164.52 37.98 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.614 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 1.7 m -135.72 -179.09 5.44 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.104 -0.997 . . . . 0.0 111.223 -177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -136.68 132.54 35.08 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.573 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.04 160.78 33.61 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 69.2 m-20 -73.66 159.27 33.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.17 -0.956 . . . . 0.0 109.266 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.02 -21.28 63.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.867 . . . . 0.0 110.573 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 65' ' ' VAL . 5.1 m -88.16 126.21 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.844 -1.16 . . . . 0.0 109.526 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -62.29 148.82 88.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 108.529 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.92 14.91 8.8 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.609 -1.413 . . . . 0.0 112.057 -0.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 71.26 20.42 78.11 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 p -88.01 167.97 13.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -1.138 . . . . 0.0 110.494 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 51.6 m-85 -120.28 143.46 48.32 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.683 -0.635 . . . . 0.0 109.476 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -126.87 136.66 29.13 Favored Pre-proline 0 N--CA 1.502 2.151 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -49.1 -11.96 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 119.852 0.983 . . . . 0.0 113.17 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -87.46 -0.69 57.17 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.898 -1.126 . . . . 0.0 108.714 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 93.1 mtp -88.93 24.69 2.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.708 -0.62 . . . . 0.0 110.503 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.1 mttm -82.69 -3.96 57.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.841 -1.162 . . . . 0.0 109.282 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 84.0 m-20 -145.14 82.8 1.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.342 -0.849 . . . . 0.0 108.734 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.42 176.43 11.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.51 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.7 p -130.24 153.44 48.6 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.57 150.42 19.42 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 120.801 -1.187 . . . . 0.0 110.506 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -46.4 -40.23 22.49 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 120.794 0.996 . . . . 0.0 111.912 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.89 -151.71 17.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.14 159.99 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.444 -1.033 . . . . 0.0 109.411 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.5 m -114.82 119.34 36.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.7 mt -102.6 134.48 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -145.44 163.21 35.35 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 110.025 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 28.5 ttp -137.74 129.55 28.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.56 -0.713 . . . . 0.0 109.496 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -90.01 117.7 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 108.673 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.37 153.25 39.2 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.45 137.72 51.6 Favored 'Cis proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.789 -1.338 . . . . 0.0 112.132 0.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.0 m -106.15 165.71 11.04 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.55 -0.718 . . . . 0.0 110.422 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -70.29 142.69 52.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.592 -0.693 . . . . 0.0 110.421 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.45 -152.97 22.36 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -97.37 116.97 30.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.328 -1.101 . . . . 0.0 108.951 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 32.5 mp0 -59.55 -34.11 72.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 110.165 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.09 -39.96 78.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.032 -1.042 . . . . 0.0 109.838 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -73.0 -39.5 66.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.791 -1.193 . . . . 0.0 108.368 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.1 -40.04 88.29 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 84.7 t80 -60.0 -46.48 89.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.08 -40.06 95.41 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.99 -44.28 94.63 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 90.9 mtp -57.47 -44.82 85.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 108.915 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.33 -43.71 98.18 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.355 -0.841 . . . . 0.0 108.765 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.534 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 91.7 mt-30 -59.87 -41.13 90.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.377 -0.827 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -71.31 -41.45 69.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.25 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.08 71.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.435 -0.79 . . . . 0.0 110.255 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -61.62 -37.02 82.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.794 -1.191 . . . . 0.0 109.157 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.0 m-70 -59.97 -47.6 85.17 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.07 -1.019 . . . . 0.0 109.128 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 96.9 mt -60.04 -49.94 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 108.927 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -54.13 -50.31 67.2 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.209 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.93 -40.19 88.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 110.052 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -70.05 -40.44 75.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.177 -0.952 . . . . 0.0 111.341 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 114' ' ' GLY . 10.2 m -99.35 -0.65 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.949 -1.094 . . . . 0.0 109.382 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.28 19.61 72.51 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' H ' HG23 ' A' ' 112' ' ' VAL . . . -79.77 -172.34 43.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -127.83 133.61 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.483 -1.01 . . . . 0.0 109.221 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.95 131.52 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 108.702 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.61 159.52 36.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.454 -0.779 . . . . 0.0 109.448 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 42.9 p-10 -88.58 -170.26 2.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 121' ' ' ARG . 92.4 m-20 -60.16 -39.92 88.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.173 -0.954 . . . . 0.0 109.881 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 93.8 mm-40 -76.13 14.61 0.69 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 108.645 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 119' ' ' ASP . 88.2 mtm180 57.4 27.87 14.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.861 -0.525 . . . . 0.0 110.432 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.467 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 84.8 mtm180 -105.25 157.07 17.56 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.83 . . . . 0.0 109.126 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 99.2 mtp -51.93 134.17 31.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.7 mmm -58.08 140.25 53.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.3 p -131.08 151.25 78.6 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.73 -42.96 62.04 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 120.524 0.816 . . . . 0.0 111.829 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.95 -39.95 87.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.372 -0.83 . . . . 0.0 109.756 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.493 ' NZ ' ' OD2' ' A' ' 118' ' ' ASP . 27.5 mmtp -64.74 -40.0 94.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.149 -0.969 . . . . 0.0 110.166 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -59.19 -40.11 84.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 108.616 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.409 HH11 ' HG2' ' A' ' 130' ' ' ARG . 40.4 ttt-85 -64.11 -39.99 95.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.476 -0.765 . . . . 0.0 109.261 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -46.64 88.84 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -0.89 . . . . 0.0 110.228 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -60.01 -38.59 83.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.134 -0.979 . . . . 0.0 109.628 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -59.92 -38.81 83.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 108.536 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -60.75 -37.32 81.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 108.739 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.02 -43.38 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.342 -0.849 . . . . 0.0 108.757 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.75 -39.98 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -60.23 -39.58 87.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.526 -0.733 . . . . 0.0 109.581 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.472 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 95.3 mt-10 -60.03 -37.56 80.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -75.32 -28.62 20.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.638 -0.664 . . . . 0.0 111.568 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.576 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 33.1 mttm -60.11 -40.07 88.38 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.696 -1.252 . . . . 0.0 111.535 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 50.7 p-10 -59.97 -29.48 68.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.444 -1.41 . . . . 0.0 109.627 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.59 -40.54 92.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 111.089 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.617 ' H ' HD22 ' A' ' 143' ' ' ASN . 0.1 OUTLIER -100.51 -11.44 20.14 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.156 -0.965 . . . . 0.0 110.264 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 120.987 -1.07 . . . . 0.0 109.382 179.362 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -92.32 26.63 2.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 82.03 58.82 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.484 -0.76 . . . . 0.0 108.955 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.04 18.2 0.38 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.158 1.239 . . . . 0.0 112.762 -178.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -86.98 1.03 54.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.437 -0.789 . . . . 0.0 109.72 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 6' ' ' ARG . 54.2 mtt-85 -82.05 133.12 35.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.238 -0.914 . . . . 0.0 112.22 -178.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -90.11 -8.38 51.48 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -147.41 134.76 20.68 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.6 -174.44 3.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.292 -1.505 . . . . 0.0 111.066 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.8 134.72 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.94 122.88 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -119.89 147.76 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 122.148 0.975 . . . . 0.0 111.407 -177.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.6 mtt -146.68 156.37 43.13 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.439 ' OD1' HG23 ' A' ' 83' ' ' THR . 73.8 m-20 -137.11 127.74 26.96 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.961 -1.087 . . . . 0.0 110.599 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.9 t -109.93 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.48 156.76 42.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.0 -177.23 1.96 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -63.66 159.93 17.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 109.265 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -60.1 141.16 56.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.856 . . . . 0.0 109.135 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 1.1 71.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.6 m -127.79 147.27 50.42 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.576 -0.955 . . . . 0.0 109.105 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -130.19 148.37 52.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.8 137.4 32.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.585 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -68.23 145.93 53.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.052 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.31 -42.6 98.86 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.208 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 77.2 mm-40 -61.04 -44.28 97.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.952 -1.322 . . . . 0.0 109.416 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 96.0 mt -69.58 -27.19 64.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 108.819 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -76.71 -58.28 3.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.567 -0.708 . . . . 0.0 110.027 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.2 -48.33 82.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.283 -0.886 . . . . 0.0 111.043 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 31' ' ' SER . 35.7 p-10 -62.73 -39.93 95.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.781 -1.199 . . . . 0.0 109.957 -179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 42.4 t -61.47 -45.75 92.94 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.023 -1.048 . . . . 0.0 109.21 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.05 -44.88 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 0.0 109.158 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -65.77 -40.05 91.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 110.34 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -68.25 -20.39 64.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 110.253 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.86 5.36 21.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.988 -1.07 . . . . 0.0 110.174 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.35 15.19 62.62 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 121.049 -1.032 . . . . 0.0 111.711 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -80.3 153.85 28.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.617 -1.52 . . . . 0.0 109.151 179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.68 139.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -58.68 101.64 0.09 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 0.0 109.29 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.3 171.07 49.72 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -69.45 -167.22 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -1.064 . . . . 0.0 108.774 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.6 mtm 57.67 22.43 8.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.144 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.8 m120 51.93 40.12 27.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.754 -0.591 . . . . 0.0 111.598 178.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 pt -140.0 166.94 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.123 -0.986 . . . . 0.0 108.689 178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.39 129.61 38.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.99 -1.069 . . . . 0.0 110.739 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.525 ' CE1' ' OG ' ' A' ' 60' ' ' SER . 12.6 m-70 -119.57 126.45 51.26 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 55.0 ttt180 -100.45 127.12 46.89 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.095 -1.003 . . . . 0.0 109.299 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 23.5 m-70 -97.83 169.92 9.33 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.501 -0.75 . . . . 0.0 110.109 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.1 tp -56.94 -49.93 74.16 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -91.48 145.94 32.31 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.354 -0.841 . . . . 0.0 109.036 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.31 -6.61 17.86 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.57 0.847 . . . . 0.0 112.082 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -94.11 -1.78 53.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.023 -1.048 . . . . 0.0 110.274 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 10.3 85.78 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.3 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 m -69.95 -39.96 75.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.333 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -79.73 166.44 50.62 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -71.54 173.68 12.13 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.074 1.182 . . . . 0.0 111.732 179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -80.93 125.06 29.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.63 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.8 mp -97.4 -25.71 15.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.135 -0.978 . . . . 0.0 109.303 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -159.66 159.84 33.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.195 -0.941 . . . . 0.0 109.136 178.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 46' ' ' HIS . 4.0 m -126.53 172.75 9.97 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.021 0.915 . . . . 0.0 111.427 -177.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -139.64 128.66 23.63 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.533 0.682 . . . . 0.0 109.298 -179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -138.62 163.21 32.67 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.476 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -77.53 156.07 31.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.885 -1.135 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.408 ' SD ' ' NH1' ' A' ' 121' ' ' ARG . 77.6 mtm -69.89 -19.75 63.41 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.256 -0.902 . . . . 0.0 110.076 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.7 p -87.06 123.65 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.986 -1.071 . . . . 0.0 109.502 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -60.03 149.97 71.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 109.672 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -78.32 4.46 26.66 Favored 'Cis proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.823 -1.324 . . . . 0.0 112.239 -0.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.58 9.32 85.85 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 37.0 p -89.2 170.14 10.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.134 -1.215 . . . . 0.0 109.711 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 96.9 m-85 -120.33 150.26 41.02 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.572 -0.705 . . . . 0.0 109.533 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' H ' ' CG ' ' A' ' 74' ' ' MET . 84.9 m-20 -128.81 151.48 77.34 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -49.98 -11.13 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 120.503 0.802 . . . . 0.0 111.628 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 71' ' ' ASP . 77.1 mm-40 -90.94 5.52 48.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.635 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.55 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 70.8 mmm -85.56 14.1 6.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 63.9 mttm -85.99 -4.03 59.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.011 -1.055 . . . . 0.0 108.595 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 80.8 m-20 -148.27 80.74 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.522 -0.737 . . . . 0.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -159.67 171.11 20.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.9 p -126.01 149.35 48.89 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.418 -0.801 . . . . 0.0 109.045 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.0 149.91 20.42 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.048 -1.033 . . . . 0.0 109.21 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.83 -47.07 27.01 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 CA-C-N 119.16 0.736 . . . . 0.0 111.665 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.63 -152.5 7.94 Favored Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.484 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.7 m -133.16 160.05 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.865 . . . . 0.0 109.184 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 62' ' ' ALA . 6.6 m -109.54 120.82 43.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.558 -0.714 . . . . 0.0 110.246 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.5 mt -108.99 127.89 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -147.68 170.53 17.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.505 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -142.24 129.99 21.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.6 -0.688 . . . . 0.0 109.158 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.602 ' N ' ' SD ' ' A' ' 86' ' ' MET . 96.4 mt-30 -93.5 121.73 35.2 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.32 153.7 38.32 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.091 -1.006 . . . . 0.0 108.714 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -71.12 147.62 87.83 Favored 'Cis proline' 0 N--CA 1.505 2.17 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.211 -0.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.451 ' OG ' ' SD ' ' A' ' 86' ' ' MET . 1.8 m -107.0 167.96 9.53 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.633 0.73 . . . . 0.0 110.7 -178.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.64 149.33 42.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 110.167 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.5 -138.35 33.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -99.2 120.74 40.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.398 -1.06 . . . . 0.0 109.777 -179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.21 -31.12 67.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.779 . . . . 0.0 109.515 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.04 -39.66 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.915 . . . . 0.0 109.357 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -69.89 -40.06 75.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.977 -1.077 . . . . 0.0 108.173 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.508 ' N ' HD22 ' A' ' 97' ' ' ASN . 2.1 m120 -59.93 -40.06 87.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -59.61 -41.55 90.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.706 -0.621 . . . . 0.0 109.545 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.72 -42.0 96.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.63 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.041 -1.037 . . . . 0.0 109.753 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 97.5 mtp -57.62 -49.96 74.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.98 -43.66 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 109.191 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 96.6 mm-40 -60.03 -41.83 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.912 . . . . 0.0 109.006 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p -70.94 -40.42 72.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.782 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.39 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.291 -0.88 . . . . 0.0 110.014 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -62.01 -37.77 86.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 109.789 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.93 -49.18 78.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 0.0 109.296 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 112' ' ' VAL . 94.8 mt -60.2 -49.89 82.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.88 -48.06 64.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.703 -0.623 . . . . 0.0 109.794 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -60.18 -40.37 89.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -69.92 -40.11 75.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 111.053 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 108' ' ' ILE . 11.1 m -100.91 2.32 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.145 -0.972 . . . . 0.0 109.935 -179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.51 24.45 72.42 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.31 -176.95 51.38 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.91 133.89 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.546 -0.973 . . . . 0.0 109.089 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.61 132.84 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.237 -0.914 . . . . 0.0 109.425 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 41.7 mt -130.54 160.02 35.39 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.415 -0.803 . . . . 0.0 109.803 -179.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 27.9 p-10 -86.63 -170.25 2.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.336 -0.853 . . . . 0.0 109.163 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 96.3 m-20 -60.13 -39.87 87.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 109.739 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.68 18.86 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.73 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 121' ' ' ARG . 24.3 mtt-85 59.84 22.58 11.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.569 -0.707 . . . . 0.0 109.454 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.436 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 99.1 mtt180 -102.44 145.25 29.83 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.449 -0.782 . . . . 0.0 109.478 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 97.2 mtp -50.08 126.14 13.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.116 -0.99 . . . . 0.0 109.359 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 57.4 mtp -60.04 140.0 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 109.811 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 3.9 p -131.55 153.17 81.48 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.83 -44.87 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 C-N-CA 120.848 1.032 . . . . 0.0 112.081 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.12 -41.2 92.13 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.222 -0.924 . . . . 0.0 109.166 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 125' ' ' THR . 98.9 mttt -70.06 -40.06 75.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 110.197 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.57 -40.1 82.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.387 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' A' ' 130' ' ' ARG . 0.1 OUTLIER -63.14 -40.06 96.49 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.417 -0.802 . . . . 0.0 109.189 179.489 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.05 -49.37 78.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.835 . . . . 0.0 109.662 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -60.02 -43.35 95.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 108.445 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -63.01 -40.09 96.72 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.549 -0.72 . . . . 0.0 109.353 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.06 -39.97 94.17 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.682 -179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.95 -44.72 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 108.709 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.07 -41.3 85.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.804 . . . . 0.0 109.069 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 137' ' ' ARG . 51.3 mtt-85 -60.5 -39.96 89.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 0.0 109.224 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 141' ' ' ASP . 73.9 mm-40 -62.4 -39.94 94.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 109.571 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -32.19 36.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.342 -0.849 . . . . 0.0 111.021 -177.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -59.98 -40.24 88.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.927 -1.108 . . . . 0.0 109.871 -178.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 3.3 p30 -61.56 -30.61 70.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.0 108.717 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -65.65 -22.34 66.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -95.72 -1.81 49.17 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.812 . . . . 0.0 110.001 179.626 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.32 -8.6 58.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.18 -0.95 . . . . 0.0 109.665 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.57 70.83 76.02 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.416 -0.803 . . . . 0.0 108.965 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 6' ' ' ARG . 32.6 Cg_endo -77.44 112.89 3.44 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.227 1.285 . . . . 0.0 112.161 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.08 29.55 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 4' ' ' PRO . 50.9 mtt-85 -78.5 150.97 32.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.735 . . . . 0.0 110.462 -179.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.58 -6.83 59.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -143.08 150.01 38.94 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.27 164.5 27.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.835 -1.166 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.2 t -120.0 131.4 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mm -90.62 133.38 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.456 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.7 mt -129.26 143.32 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 122.092 0.949 . . . . 0.0 110.811 -178.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -142.76 149.86 39.27 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -131.04 126.57 36.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.73 -1.231 . . . . 0.0 110.951 -178.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.14 119.99 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.23 160.25 43.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.068 . . . . 0.0 110.025 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -168.38 0.35 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.474 -0.766 . . . . 0.0 109.357 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -61.54 157.82 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.177 -0.952 . . . . 0.0 108.815 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -59.97 139.97 57.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.55 74.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.8 m -129.31 144.27 51.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.474 -1.016 . . . . 0.0 109.309 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 42.3 mp0 -120.28 147.51 44.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.533 -0.729 . . . . 0.0 109.311 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.7 mt -83.17 143.99 30.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.333 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -68.99 144.51 54.1 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.314 -0.866 . . . . 0.0 109.136 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.05 -42.16 98.3 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.1 -45.52 93.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -1.234 . . . . 0.0 109.773 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.5 mt -69.97 -30.19 67.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 108.889 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 28' ' ' LEU . 8.3 tt -72.15 -55.76 6.73 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.666 -0.647 . . . . 0.0 109.605 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 74' ' ' MET . 90.9 mt -60.01 -48.64 80.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.844 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -64.62 -40.08 94.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.235 -0.916 . . . . 0.0 111.683 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.1 p -64.81 -41.0 96.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 110.235 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.63 -44.07 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 109.824 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -67.47 -40.0 85.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.0 110.455 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.01 -19.66 64.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 0.0 111.024 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.558 ' CB ' HH22 ' A' ' 47' ' ' ARG . . . -82.57 -11.47 58.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.175 . . . . 0.0 110.87 -178.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.538 ' C ' ' HE ' ' A' ' 47' ' ' ARG . . . 111.4 11.12 18.47 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.015 -1.053 . . . . 0.0 111.14 178.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.723 ' N ' HH21 ' A' ' 47' ' ' ARG . 36.3 m-85 -80.87 152.87 27.93 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.669 -1.489 . . . . 0.0 109.712 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.4 139.35 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -61.52 104.7 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -0.999 . . . . 0.0 110.055 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.2 171.58 34.08 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -67.12 -166.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -1.073 . . . . 0.0 109.315 179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 76.7 mtm 57.42 25.58 11.53 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.603 0.716 . . . . 0.0 109.887 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 50.02 39.37 18.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.644 -0.66 . . . . 0.0 111.601 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.6 pt -140.85 167.61 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.021 -1.05 . . . . 0.0 109.005 178.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -92.42 136.77 32.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.037 -1.039 . . . . 0.0 110.333 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.497 ' CG ' ' OG ' ' A' ' 60' ' ' SER . 19.4 m-70 -126.3 126.82 44.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.625 -0.672 . . . . 0.0 109.726 179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.723 HH21 ' N ' ' A' ' 37' ' ' PHE . 28.9 ttm180 -99.21 124.28 44.15 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 56.9 m-70 -95.6 171.84 8.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 109.717 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 53.5 tp -56.89 -50.01 73.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.244 -0.91 . . . . 0.0 108.762 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -91.67 141.99 26.28 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.321 -0.862 . . . . 0.0 109.071 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.53 -10.23 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 119.555 0.877 . . . . 0.0 112.08 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -91.87 -0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.082 -1.011 . . . . 0.0 109.947 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.84 12.42 83.51 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.779 -1.2 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.0 p -69.9 -40.05 75.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.83 -1.394 . . . . 0.0 109.439 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -81.28 168.24 50.1 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 18.5 Cg_endo -70.91 174.88 9.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.286 1.324 . . . . 0.0 112.223 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -82.22 122.4 27.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.9 mp -97.97 -43.81 6.92 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' CD2' ' SD ' ' A' ' 101' ' ' MET . 20.9 p90 -144.91 160.01 42.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.934 -1.104 . . . . 0.0 109.51 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.497 ' OG ' ' CG ' ' A' ' 46' ' ' HIS . 9.0 m -132.74 165.51 24.37 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.031 0.92 . . . . 0.0 111.44 -177.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 62' ' ' ALA . 7.3 tt -119.96 134.79 55.14 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.696 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.02 159.95 39.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.742 -0.599 . . . . 0.0 109.413 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.523 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -76.45 160.71 29.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.432 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 87.7 mtp -70.03 -25.56 63.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.707 -0.621 . . . . 0.0 110.254 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -86.8 121.51 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.963 -1.086 . . . . 0.0 109.738 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -59.43 151.03 62.12 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -77.57 5.02 22.42 Favored 'Cis proline' 0 N--CA 1.496 1.64 0 C-N-CA 123.686 -1.381 . . . . 0.0 112.479 -0.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.74 22.43 55.77 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.8 p -91.26 169.55 10.72 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.223 -1.163 . . . . 0.0 110.69 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -124.1 140.68 52.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.691 -0.63 . . . . 0.0 109.376 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -130.37 150.76 77.11 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.0 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -50.72 -7.0 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.42 0.829 . . . . 0.0 112.001 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' ASP . 49.3 mt-10 -89.45 2.53 54.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.431 -0.793 . . . . 0.0 109.556 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.415 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.3 mmm -86.83 16.32 4.96 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 66.2 mttm -87.42 -3.16 59.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.127 -0.983 . . . . 0.0 108.805 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.1 m-20 -149.68 77.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.606 -0.684 . . . . 0.0 109.161 179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.06 169.41 24.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.994 -1.066 . . . . 0.0 109.251 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -130.04 150.19 51.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.68 150.21 21.31 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 -179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -45.08 -52.83 5.94 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 C-N-CA 120.438 0.759 . . . . 0.0 111.726 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.25 -151.82 8.12 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' HB ' HD21 ' A' ' 61' ' ' LEU . 27.6 m -130.05 160.0 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.963 . . . . 0.0 109.545 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.4 m -112.07 123.78 51.01 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.615 -0.678 . . . . 0.0 110.115 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -104.87 132.02 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -147.08 164.43 33.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.828 -1.17 . . . . 0.0 110.89 -178.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 48.2 ttp -138.15 128.63 26.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.639 . . . . 0.0 109.302 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -92.96 112.57 24.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -0.97 . . . . 0.0 109.236 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.41 154.3 37.35 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -75.72 134.36 35.44 Favored 'Cis proline' 0 N--CA 1.495 1.59 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.679 0.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.7 m -107.39 160.2 15.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.529 0.68 . . . . 0.0 109.624 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -70.51 150.43 46.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.928 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -158.96 26.77 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.16 117.11 30.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.251 -1.146 . . . . 0.0 109.292 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.03 -37.56 80.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.635 . . . . 0.0 110.851 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.81 -39.88 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 109.933 -178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -69.99 -39.98 75.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.047 -1.033 . . . . 0.0 108.894 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.436 ' OD1' HD23 ' A' ' 58' ' ' LEU . 78.0 m-20 -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 108.929 179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' A' ' 102' ' ' LEU . 79.1 t80 -60.01 -50.03 75.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.641 -0.662 . . . . 0.0 109.59 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.8 -41.52 97.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.4 tp -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.467 ' SD ' ' CD2' ' A' ' 59' ' ' PHE . 23.4 mmm -56.11 -46.81 78.98 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.416 -0.803 . . . . 0.0 109.255 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 98' ' ' PHE . 88.9 mt -63.85 -40.76 97.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.103 -0.998 . . . . 0.0 109.061 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.533 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 26.7 mt-30 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.785 . . . . 0.0 109.881 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.6 p -69.38 -41.0 77.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.02 -1.05 . . . . 0.0 109.362 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.92 52.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 110.272 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -62.33 -34.93 77.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 15.0 m-70 -60.02 -46.54 89.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 108.767 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.1 -49.97 81.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.4 -0.813 . . . . 0.0 108.988 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.55 -47.7 63.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.541 -0.724 . . . . 0.0 109.97 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.77 -40.77 93.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 110.73 -179.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.22 -40.01 74.79 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.047 -1.033 . . . . 0.0 111.165 -178.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.92 1.99 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.196 -0.94 . . . . 0.0 109.719 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 64.68 27.22 71.67 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.85 -172.0 45.27 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.19 139.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.608 -0.937 . . . . 0.0 108.881 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.484 HG12 ' SD ' ' A' ' 124' ' ' MET . 4.5 t -80.56 134.94 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.096 -1.002 . . . . 0.0 109.736 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.11 160.01 37.23 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.521 -0.737 . . . . 0.0 109.314 -179.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -87.25 -168.86 2.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.233 -0.917 . . . . 0.0 109.436 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 94.9 m-20 -60.01 -39.57 86.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.197 -0.939 . . . . 0.0 109.849 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -80.17 21.75 0.57 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 55.85 31.33 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 110.039 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -109.16 150.9 27.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.438 -0.789 . . . . 0.0 109.297 179.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mmm -52.08 125.66 16.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 109.152 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.484 ' SD ' HG12 ' A' ' 116' ' ' VAL . 64.1 mtp -60.0 139.94 57.1 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.8 p -130.06 150.65 76.59 Favored Pre-proline 0 N--CA 1.5 2.026 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -42.58 -43.49 8.47 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 120.849 1.032 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.418 ' HG2' HH21 ' A' ' 130' ' ' ARG . 96.5 mt-30 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.389 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -68.72 -39.97 80.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.4 mt -55.69 -42.29 74.96 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 0.0 108.937 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.418 HH21 ' HG2' ' A' ' 127' ' ' GLN . 85.4 mtm180 -65.71 -38.87 90.4 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -59.97 -44.61 94.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.993 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' HH ' ' H ' ' A' ' 119' ' ' ASP . 53.1 m-85 -60.01 -42.18 93.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.054 . . . . 0.0 108.52 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.78 -39.72 89.9 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.46 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 98.3 m-20 -60.03 -40.03 87.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.826 . . . . 0.0 109.354 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.0 -41.13 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.048 -1.033 . . . . 0.0 108.833 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.11 -44.93 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.36 -0.837 . . . . 0.0 108.996 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 79.9 mtm180 -62.22 -35.25 78.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.149 -0.969 . . . . 0.0 110.424 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 66.4 mm-40 -59.94 -38.86 83.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.052 . . . . 0.0 108.736 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.1 t -73.31 -30.07 29.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 110.674 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 144' ' ' ALA . 65.8 mttm -60.04 -41.1 91.55 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.759 -1.213 . . . . 0.0 110.987 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -59.94 -29.02 68.11 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.756 -1.215 . . . . 0.0 109.176 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.05 93.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.852 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 43.4 p-10 -104.57 -3.71 23.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.34 -0.85 . . . . 0.0 109.495 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.899 . . . . 0.0 109.524 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -86.83 -8.96 56.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 0.0 110.141 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 70.01 69.25 Favored Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.206 -0.934 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -76.23 -160.87 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.562 1.508 . . . . 0.0 111.421 178.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -81.88 -10.76 59.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.01 . . . . 0.0 109.888 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 6' ' ' ARG . 47.4 mtm-85 -83.48 91.03 7.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.967 -1.083 . . . . 0.0 110.208 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.31 -70.0 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -102.24 143.68 31.72 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 177.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -160.96 179.54 8.38 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.49 -1.381 . . . . 0.0 110.633 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -125.65 130.0 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 mm -92.26 127.95 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 96.8 mt -120.21 147.47 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 122.33 1.062 . . . . 0.0 111.712 -177.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.3 mtt -145.8 159.03 43.78 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' HG23 ' A' ' 83' ' ' THR . 35.1 m120 -139.26 125.26 19.86 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.715 -1.241 . . . . 0.0 111.34 -179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.51 124.97 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -144.61 164.59 30.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.046 -1.034 . . . . 0.0 111.979 -177.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.71 -164.51 0.36 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -71.37 160.05 33.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -58.79 130.01 44.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.746 -1.221 . . . . 0.0 109.356 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.47 -2.23 84.68 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 m -110.92 155.55 22.49 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.365 -1.079 . . . . 0.0 109.757 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -129.98 150.09 51.42 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.27 140.48 29.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.209 -0.932 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -65.62 141.16 58.5 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' PHE . . . -60.06 -39.99 96.49 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.107 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.51 -46.69 88.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 109.662 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -30.01 68.17 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -71.41 -58.78 3.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.03 -40.05 88.0 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.349 -0.844 . . . . 0.0 109.708 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -64.28 -40.73 96.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.3 p -65.73 -39.64 91.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.304 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.02 -48.4 88.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.074 -1.017 . . . . 0.0 109.859 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -63.37 -39.96 95.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.138 . . . . 0.0 109.704 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -62.5 -23.1 66.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.358 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.02 8.3 10.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . 80.09 10.47 85.49 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -79.39 148.61 31.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.722 -1.458 . . . . 0.0 108.972 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.6 mt -122.14 134.52 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -58.3 102.12 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.0 109.108 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.74 170.6 38.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -66.28 -163.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.322 -1.105 . . . . 0.0 109.006 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.1 mtt 58.09 21.38 7.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 51.79 40.06 26.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.797 . . . . 0.0 111.48 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.26 159.29 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.881 -1.137 . . . . 0.0 109.187 178.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -90.49 119.55 30.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.058 -1.026 . . . . 0.0 109.118 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.521 ' CE1' ' HG ' ' A' ' 60' ' ' SER . 13.9 m-70 -104.12 134.94 46.53 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.481 -0.762 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' NH1' ' O ' ' A' ' 36' ' ' GLY . 21.6 tpt180 -100.03 115.62 30.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 72.5 m-70 -95.25 169.31 10.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.225 -0.922 . . . . 0.0 109.907 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 67.3 tp -59.12 -49.96 75.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.855 . . . . 0.0 109.323 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.1 m -96.1 150.0 36.67 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.318 -0.864 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -70.6 -7.1 20.52 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 120.869 1.046 . . . . 0.0 112.455 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -91.85 0.01 57.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.046 -1.034 . . . . 0.0 110.095 -179.195 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.34 7.66 86.97 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.317 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -70.07 -40.05 75.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.249 . . . . 0.0 109.394 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -76.72 160.42 50.49 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.468 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 12.9 Cg_endo -68.02 175.09 6.95 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.068 1.179 . . . . 0.0 112.218 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.544 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -84.19 127.06 33.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.37 -0.831 . . . . 0.0 109.209 179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.2 mp -100.56 -35.38 9.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.135 -0.978 . . . . 0.0 108.8 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 2.5 p90 -151.01 166.53 30.41 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.521 ' HG ' ' CE1' ' A' ' 46' ' ' HIS . 2.1 m -134.73 179.44 6.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.08 -1.013 . . . . 0.0 111.525 -177.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -139.95 131.65 27.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.611 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.94 159.74 35.72 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.526 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.0 m120 -76.93 161.53 28.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.05 -22.99 63.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 110.373 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 65' ' ' VAL . 26.8 m -88.89 119.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.757 -1.215 . . . . 0.0 109.879 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -61.24 151.37 76.34 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -77.38 8.89 17.51 Favored 'Cis proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.782 -1.341 . . . . 0.0 112.486 -0.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.1 63.23 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.9 p -83.92 167.89 16.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.16 -1.2 . . . . 0.0 109.344 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 71.4 m-85 -120.29 143.8 48.15 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.638 -0.664 . . . . 0.0 109.784 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLU . 20.5 t70 -126.41 134.32 25.88 Favored Pre-proline 0 N--CA 1.497 1.925 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -49.5 -9.34 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 119.959 1.021 . . . . 0.0 111.993 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ASP . 98.9 mt-10 -88.38 1.0 55.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.42 ' CE ' ' CZ ' ' A' ' 77' ' ' PHE . 90.6 mtp -86.99 22.82 1.92 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 0.0 109.996 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 94.9 mttt -83.65 -4.81 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.021 -1.049 . . . . 0.0 108.955 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 79.0 m-20 -148.12 83.47 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CZ ' ' CE ' ' A' ' 74' ' ' MET . 7.1 p90 -158.85 177.65 10.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.551 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 74.0 p -134.03 149.98 51.2 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.12 150.3 23.64 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.063 -1.023 . . . . 0.0 109.35 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.93 -26.06 30.12 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 C-N-CA 120.46 0.773 . . . . 0.0 111.657 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.37 -161.33 33.96 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.036 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG11 HD21 ' A' ' 28' ' ' LEU . 34.3 m -130.0 160.06 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.886 . . . . 0.0 108.952 179.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.491 HG23 ' ND2' ' A' ' 14' ' ' ASN . 86.7 m -109.76 125.2 52.45 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.659 -0.651 . . . . 0.0 109.686 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.9 mt -105.79 128.41 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -146.74 149.78 34.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.968 -1.082 . . . . 0.0 110.952 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.1 ttm -104.91 129.91 53.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.836 -0.54 . . . . 0.0 109.581 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -92.84 108.38 19.95 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.7 m -97.2 151.04 37.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 109.133 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.0 139.24 60.44 Favored 'Cis proline' 0 N--CA 1.499 1.829 0 C-N-CA 123.914 -1.286 . . . . 0.0 112.839 -0.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.2 m -105.22 159.51 15.82 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.627 -0.671 . . . . 0.0 109.63 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -71.1 150.62 45.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.454 -0.779 . . . . 0.0 109.823 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.98 -152.38 38.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -98.96 121.09 40.46 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.414 -1.05 . . . . 0.0 109.29 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.94 -32.24 69.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.589 -0.694 . . . . 0.0 109.818 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.03 -39.91 75.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 109.663 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.04 -42.2 73.23 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.953 -1.092 . . . . 0.0 108.088 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.684 ' OD1' HD23 ' A' ' 58' ' ' LEU . 89.8 m-20 -62.94 -39.88 95.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.14 -40.1 73.31 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.19 -40.03 94.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.16 -39.9 91.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.848 . . . . 0.0 109.132 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 95.2 mtp -57.84 -50.33 73.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.738 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.84 -42.91 89.92 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.986 -1.071 . . . . 0.0 108.961 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 96.8 mt-30 -61.99 -39.99 94.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 108.796 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 25.9 p -73.14 -43.74 61.12 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.05 -53.04 62.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.856 . . . . 0.0 110.014 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -60.31 -39.82 88.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.052 -1.03 . . . . 0.0 109.358 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.42 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 4.1 m-70 -59.9 -43.37 94.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.985 . . . . 0.0 108.891 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.0 -50.11 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.26 -48.33 68.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.607 -0.683 . . . . 0.0 109.263 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.64 -40.13 90.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 109.899 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -40.0 75.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.36 -0.838 . . . . 0.0 111.346 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -101.03 -0.81 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.116 -0.99 . . . . 0.0 109.678 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.37 23.39 76.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . -91.33 -167.56 41.01 Favored Glycine 0 N--CA 1.496 2.65 0 O-C-N 121.211 -1.17 . . . . 0.0 110.249 -179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 16' ' ' ALA . 3.6 m -130.0 159.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.596 -0.944 . . . . 0.0 109.372 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.421 HG12 ' SD ' ' A' ' 124' ' ' MET . 11.4 t -96.93 129.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.234 -0.916 . . . . 0.0 108.712 179.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.1 mt -124.49 163.63 21.45 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.82 0.819 . . . . 0.0 110.639 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -86.27 -170.92 3.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.752 -0.593 . . . . 0.0 109.756 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 85.4 m-20 -60.12 -39.99 88.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -0.858 . . . . 0.0 109.872 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -76.99 15.01 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.068 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 119' ' ' ASP . 86.4 mtm180 57.25 37.16 28.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.837 -0.539 . . . . 0.0 109.769 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 122' ' ' ARG . 20.0 mtt-85 -112.23 151.97 28.97 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.9 mtp -50.92 122.1 6.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.929 -1.107 . . . . 0.0 109.133 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.421 ' SD ' HG12 ' A' ' 116' ' ' VAL . 61.4 mtp -59.96 140.01 57.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 109.264 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.5 p -122.25 152.17 60.19 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -43.49 -43.61 10.92 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 120.61 0.873 . . . . 0.0 112.017 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -60.11 -40.5 89.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.277 -0.89 . . . . 0.0 109.65 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -67.7 -40.01 84.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 109.794 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.9 mt -57.82 -39.95 78.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 108.409 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -66.49 -39.97 89.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.457 -0.777 . . . . 0.0 109.397 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -49.46 77.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.93 -46.05 90.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.956 -1.09 . . . . 0.0 108.779 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.98 -39.93 93.86 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.36 -0.838 . . . . 0.0 109.124 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 87.8 m-20 -61.72 -46.15 90.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.521 -0.737 . . . . 0.0 110.57 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.19 -37.59 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.121 -0.987 . . . . 0.0 108.997 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.05 -42.54 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.052 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.428 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 81.7 mtm180 -60.02 -38.69 83.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.853 -1.154 . . . . 0.0 109.008 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.416 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 40.4 mm-40 -59.98 -39.96 87.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.46 -0.775 . . . . 0.0 109.867 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.5 -33.64 63.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 110.596 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 144' ' ' ALA . 87.8 mttt -59.95 -50.0 75.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.817 -1.177 . . . . 0.0 110.027 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -61.19 -37.57 83.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.844 -1.16 . . . . 0.0 108.982 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.93 95.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.447 -0.783 . . . . 0.0 110.17 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 140' ' ' LYS . 50.5 p30 -98.85 -2.98 36.45 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.309 -0.869 . . . . 0.0 109.406 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.82 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.34 -0.36 57.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.946 . . . . 0.0 109.138 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 75.9 72.48 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.478 -0.764 . . . . 0.0 109.549 179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.22 83.63 2.17 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.382 1.388 . . . . 0.0 112.122 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -80.54 30.01 0.3 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.272 -0.892 . . . . 0.0 109.589 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.521 ' N ' ' CD ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -78.47 171.5 15.02 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.465 -0.772 . . . . 0.0 109.749 -179.1 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -79.26 -3.76 47.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.984 -1.072 . . . . 0.0 108.345 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -144.64 132.56 21.37 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.85 -172.14 3.17 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.015 -1.053 . . . . 0.0 110.536 -178.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.92 140.59 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.49 130.1 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 97.0 mt -118.45 144.13 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 122.245 1.021 . . . . 0.0 111.681 -177.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.9 mtt -142.0 150.02 40.79 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' ND2' HG23 ' A' ' 83' ' ' THR . 35.0 m120 -128.02 119.62 25.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.019 -1.051 . . . . 0.0 111.037 -178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.62 110.86 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 80' ' ' PRO . . . -148.99 160.79 42.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.687 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -165.25 0.25 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -60.56 142.42 55.42 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 108.826 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -51.47 137.15 24.59 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.039 -1.038 . . . . 0.0 109.237 -179.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.27 1.22 66.93 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.1 m -121.02 149.95 41.9 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.516 -0.991 . . . . 0.0 108.697 179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -125.41 146.87 49.42 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.365 -0.834 . . . . 0.0 109.764 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.51 148.62 25.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -68.93 142.48 54.71 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.42 96.99 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.31 -46.85 86.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 0.0 109.83 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.81 -30.17 67.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 109.197 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.607 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.5 tt -71.15 -58.67 3.33 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.596 -0.69 . . . . 0.0 109.23 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.9 mt -59.99 -46.02 90.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 110.659 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -60.81 -42.26 97.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.314 -0.866 . . . . 0.0 110.698 -178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 t -64.77 -39.92 94.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.092 -1.005 . . . . 0.0 110.479 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.94 -47.0 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.907 -1.121 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -63.83 -41.57 97.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.69 -21.89 66.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.38 6.6 11.7 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.47 75.73 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.15 -0.969 . . . . 0.0 111.338 178.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -81.65 147.51 29.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.661 -1.494 . . . . 0.0 109.584 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 98.2 mt -120.03 132.33 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.74 101.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.099 -1.001 . . . . 0.0 109.493 -179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.72 170.82 37.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.34 -162.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -1.044 . . . . 0.0 109.265 179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 91.0 mmm 59.78 20.61 9.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.683 -0.635 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 51.21 34.97 12.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 111.362 178.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.2 165.83 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.006 -1.058 . . . . 0.0 108.999 178.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -89.72 141.51 28.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.947 -1.096 . . . . 0.0 110.464 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.542 ' CD2' ' HG ' ' A' ' 60' ' ' SER . 29.0 m80 -130.19 130.07 44.22 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.511 ' HG2' HH11 ' A' ' 47' ' ' ARG . 4.0 ttt-85 -103.0 127.29 50.3 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 17.9 m-70 -91.45 169.84 10.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.32 -0.862 . . . . 0.0 109.664 -178.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.69 -49.96 73.57 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.6 m -92.65 144.81 29.26 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.58 -6.37 16.45 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 120.798 0.999 . . . . 0.0 112.213 179.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -92.71 1.92 57.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.949 . . . . 0.0 110.031 -179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.14 10.67 85.27 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.4 p -70.14 -40.8 74.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -1.184 . . . . 0.0 110.0 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.477 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.48 164.0 50.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -66.68 179.74 2.01 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 CA-C-N 118.473 1.136 . . . . 0.0 111.852 179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.41 124.56 29.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.6 mp -97.65 -70.61 0.71 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.355 -0.841 . . . . 0.0 109.691 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 1.7 p90 -114.41 160.0 19.66 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.97 -1.081 . . . . 0.0 109.909 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.542 ' HG ' ' CD2' ' A' ' 46' ' ' HIS . 15.1 m -121.88 161.47 22.73 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.573 0.701 . . . . 0.0 109.927 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.5 tt -132.26 130.59 41.11 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.587 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.43 165.3 26.13 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.489 -0.757 . . . . 0.0 110.073 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.461 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 88.7 m-20 -75.05 156.92 35.62 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 66.4 mtt -69.88 -23.88 63.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -178.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.0 p -87.5 121.12 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.065 -1.022 . . . . 0.0 110.068 -179.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -58.06 151.78 43.79 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -80.43 -0.2 41.15 Favored 'Cis proline' 0 N--CA 1.499 1.822 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.979 0.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.62 18.83 61.12 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.22 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.4 p -85.92 167.3 15.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.991 -1.299 . . . . 0.0 109.618 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.4 m-85 -124.33 141.85 51.75 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.519 -0.738 . . . . 0.0 109.808 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -129.8 151.09 77.57 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.58 -12.5 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 120.497 0.798 . . . . 0.0 112.409 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.91 -3.01 58.86 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.072 -1.017 . . . . 0.0 109.322 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.2 mtp -88.65 22.68 2.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 57.4 mttp -83.06 -4.84 58.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 109.808 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 94.0 m-20 -143.75 84.63 1.8 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.376 -0.828 . . . . 0.0 108.776 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.7 177.24 11.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 110.362 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.5 p -129.67 146.8 51.43 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.19 148.22 18.19 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.101 -0.999 . . . . 0.0 108.862 179.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.411 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 14.2 Cg_exo -45.16 -31.65 6.17 Favored 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 120.611 0.874 . . . . 0.0 111.768 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.65 -147.71 16.55 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -135.49 159.93 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.457 -1.025 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.4 HG23 ' ND2' ' A' ' 14' ' ' ASN . 54.7 m -108.74 122.48 47.23 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.5 mt -105.77 130.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 121.323 -0.861 . . . . 0.0 108.727 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.47 148.03 32.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.12 -0.988 . . . . 0.0 111.042 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.9 tpp -104.02 130.28 51.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' O ' ' OG ' ' A' ' 90' ' ' SER . 95.0 mt-30 -90.54 108.6 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 88' ' ' VAL . 9.2 m -98.67 150.03 36.31 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.211 -0.93 . . . . 0.0 109.238 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.65 135.07 38.67 Favored 'Cis proline' 0 N--CA 1.497 1.722 0 C-N-CA 123.859 -1.309 . . . . 0.0 112.564 -0.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 53.5 m -108.05 162.58 13.91 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.632 0.73 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 59.6 t80 -73.78 158.14 35.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.535 -0.728 . . . . 0.0 110.041 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.548 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 79.72 -160.28 44.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -98.15 111.96 24.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.38 -1.07 . . . . 0.0 108.971 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.62 -30.33 68.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.768 . . . . 0.0 110.602 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.33 -40.06 77.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 109.363 -179.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.81 -40.35 63.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.743 -1.223 . . . . 0.0 108.242 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -61.2 -37.5 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.093 0.949 . . . . 0.0 108.606 179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -56.33 -50.09 72.46 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -62.25 -39.19 92.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.12 -46.02 91.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.608 -0.683 . . . . 0.0 110.219 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.8 mtm -58.91 -42.67 90.21 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.667 -179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.61 -46.61 87.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.913 . . . . 0.0 108.937 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.532 ' O ' ' CG ' ' A' ' 107' ' ' HIS . 95.4 mm-40 -60.17 -42.63 95.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.426 -0.797 . . . . 0.0 108.928 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.6 p -71.55 -41.07 69.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.136 -0.978 . . . . 0.0 109.375 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.56 -55.41 35.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.601 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -61.25 -35.7 77.98 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.148 -0.97 . . . . 0.0 109.103 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 103' ' ' GLN . 6.2 m-70 -59.89 -47.08 87.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 112' ' ' VAL . 82.2 mt -59.98 -49.95 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.9 -47.7 60.63 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -61.77 -39.96 93.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.8 . . . . 0.0 110.528 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.43 -40.02 77.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.05 -1.031 . . . . 0.0 110.703 -178.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 114' ' ' GLY . 13.7 m -98.44 -0.75 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.155 -0.965 . . . . 0.0 109.275 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.85 24.88 76.15 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -84.34 -169.83 46.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.8 138.0 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.378 -1.072 . . . . 0.0 109.128 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.5 t -77.57 132.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 109.475 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.17 160.33 35.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.415 -0.803 . . . . 0.0 110.022 -178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -84.58 -173.12 4.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.477 -0.764 . . . . 0.0 108.976 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.514 ' N ' ' OH ' ' A' ' 132' ' ' TYR . 93.3 m-20 -60.02 -36.07 76.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.088 -1.007 . . . . 0.0 109.994 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -79.61 15.3 1.37 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.235 -0.916 . . . . 0.0 110.219 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 121' ' ' ARG . 19.8 mmm-85 58.19 30.84 19.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 -179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -106.43 151.93 24.28 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 81.0 mmm -51.72 133.37 31.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.026 -1.046 . . . . 0.0 109.45 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.2 mmm -56.08 138.66 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.096 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.3 p -136.81 151.28 72.12 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.426 -0.797 . . . . 0.0 109.034 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -44.58 -45.72 12.85 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 120.449 0.766 . . . . 0.0 111.73 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.08 -40.01 88.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.343 -0.848 . . . . 0.0 109.452 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -68.48 -39.92 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 61.9 mt -60.02 -40.13 88.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.995 -1.065 . . . . 0.0 109.011 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -65.28 -39.67 92.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.445 -0.785 . . . . 0.0 109.405 179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -59.75 -47.6 85.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.195 -0.941 . . . . 0.0 110.348 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.514 ' OH ' ' N ' ' A' ' 119' ' ' ASP . 71.3 m-85 -60.07 -46.59 89.06 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.928 -1.107 . . . . 0.0 108.526 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.2 -40.35 93.61 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.194 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.416 ' O ' ' OE2' ' A' ' 138' ' ' GLU . 96.7 m-20 -62.35 -40.09 95.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.32 -40.68 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.052 -1.03 . . . . 0.0 108.596 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 80.4 mt -60.56 -40.03 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.504 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 137' ' ' ARG . 7.4 mmt-85 -60.04 -39.96 87.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.066 -1.021 . . . . 0.0 110.554 -179.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -60.99 -40.07 92.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.725 -1.235 . . . . 0.0 109.524 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.15 -29.74 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.586 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' ALA . 47.4 mmtt -60.07 -39.47 86.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.378 -0.826 . . . . 0.0 110.835 -179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 2.2 p30 -60.07 -30.01 68.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.659 -1.276 . . . . 0.0 108.566 -179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -64.95 -36.62 84.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.28 -0.888 . . . . 0.0 109.218 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -101.22 -13.38 18.13 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.372 -0.83 . . . . 0.0 110.409 -179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.891 -1.13 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.553 ' N ' ' HE ' ' A' ' 6' ' ' ARG . 96.0 mmm . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.317 0.579 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -90.61 17.92 6.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 109.931 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -97.73 109.96 53.15 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' CB ' ' OE2' ' A' ' 138' ' ' GLU . 19.0 Cg_endo -74.34 13.97 0.82 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 CA-C-N 119.981 1.029 . . . . 0.0 112.663 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -88.28 0.04 56.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.466 -0.771 . . . . 0.0 109.005 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.553 ' HE ' ' N ' ' A' ' 1' ' ' MET . 57.9 mtt-85 -80.71 135.02 35.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.566 -0.709 . . . . 0.0 111.586 -178.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -89.88 -12.43 39.0 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.32 147.11 31.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.61 -177.64 6.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.322 -1.486 . . . . 0.0 111.066 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.99 131.46 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 mm -92.87 125.31 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 90.8 mt -123.66 143.71 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-O 122.166 0.984 . . . . 0.0 111.248 -177.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.402 ' CE ' ' CE1' ' A' ' 98' ' ' PHE . 66.4 mtt -142.88 138.18 30.07 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -120.85 127.46 51.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.992 -1.068 . . . . 0.0 111.251 -178.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.0 t -106.38 114.67 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.71 152.27 38.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.288 -0.882 . . . . 0.0 109.647 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.91 -166.76 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.64 152.89 44.47 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.161 -0.962 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -60.06 141.23 56.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.609 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.09 1.91 64.7 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.4 m -129.01 150.01 50.6 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.438 -1.036 . . . . 0.0 109.137 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -126.11 148.16 49.44 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -86.45 146.67 26.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.306 -0.871 . . . . 0.0 109.906 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.749 HD22 ' H ' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -71.0 142.15 50.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 109.115 179.065 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.9 99.83 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.187 -1.006 . . . . 0.0 110.871 -179.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.749 ' H ' HD22 ' A' ' 24' ' ' ASN . 99.0 mt-10 -61.62 -44.65 96.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.964 -1.315 . . . . 0.0 109.669 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.87 -26.58 64.26 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -74.71 -59.88 2.53 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.652 -0.655 . . . . 0.0 109.76 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.86 -40.9 94.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.856 . . . . 0.0 110.581 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.09 94.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.076 -1.015 . . . . 0.0 109.911 -179.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 t -66.05 -41.05 91.33 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.16 -0.962 . . . . 0.0 109.806 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.13 -46.28 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 110.027 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.59 -40.2 96.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.974 -1.079 . . . . 0.0 109.395 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.56 -19.61 64.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.601 -0.687 . . . . 0.0 109.975 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.53 8.18 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 0.0 109.915 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.5 10.68 85.0 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.057 -1.068 . . . . 0.0 110.584 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -80.8 151.55 28.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.993 -1.299 . . . . 0.0 109.735 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.1 mt -123.06 148.11 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.13 112.14 1.99 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.06 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.65 30.92 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.2 -170.18 0.08 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.596 -0.943 . . . . 0.0 108.626 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 93.5 mtp 55.27 24.95 6.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.861 . . . . 0.0 109.726 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.04 42.1 24.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.745 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.429 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 11.7 pt -138.31 167.02 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.099 -1.0 . . . . 0.0 108.303 178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -93.34 120.42 33.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.821 -1.174 . . . . 0.0 110.427 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.429 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 16.4 m170 -108.53 128.11 54.52 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.421 -0.8 . . . . 0.0 109.611 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 47' ' ' ARG . 9.3 ttt-85 -100.08 123.77 44.7 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.214 -0.928 . . . . 0.0 108.775 178.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 26.0 m-70 -92.46 171.59 8.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.055 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.8 tp -53.57 -50.01 66.49 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.28 -0.888 . . . . 0.0 109.031 -179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.0 m -93.07 147.29 33.56 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 0.0 109.158 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -69.15 -4.2 13.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.65 0.9 . . . . 0.0 112.092 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -93.67 -1.07 55.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 0.0 109.746 -179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 13.42 83.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -68.93 -43.22 75.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -1.201 . . . . 0.0 109.533 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.435 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -80.33 171.62 54.26 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 19.2 Cg_endo -71.67 176.36 8.28 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.018 1.145 . . . . 0.0 111.463 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.406 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.16 126.63 32.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 108.906 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.4 mp -101.16 -35.88 9.15 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.078 -1.014 . . . . 0.0 109.74 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -146.68 160.78 41.78 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.029 -1.044 . . . . 0.0 109.006 178.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 63.2 m -129.99 160.29 34.08 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.002 0.906 . . . . 0.0 111.437 -177.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.5 tt -120.97 129.48 53.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.537 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -139.6 161.73 36.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.521 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 81.9 m-20 -77.66 159.93 28.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.139 . . . . 0.0 109.546 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 48.7 mtm -67.83 -18.84 64.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.7 p -88.16 121.28 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.818 -1.176 . . . . 0.0 109.844 -179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -61.11 147.76 85.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.35 -0.843 . . . . 0.0 109.206 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.6 -0.53 19.46 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.763 -1.349 . . . . 0.0 111.741 -0.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.99 17.43 74.68 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 50.1 p -88.79 169.05 11.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.196 -1.179 . . . . 0.0 110.601 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.521 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.4 m-85 -119.91 143.8 47.77 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.27 150.01 72.91 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.349 -0.844 . . . . 0.0 109.146 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.23 -19.32 2.62 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.689 0.926 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -89.94 -4.36 57.53 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.95 -1.093 . . . . 0.0 109.131 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 85.6 mtp -93.51 23.51 4.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.641 -0.662 . . . . 0.0 110.372 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -85.49 -8.99 58.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.911 -1.118 . . . . 0.0 108.476 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -136.96 87.27 2.27 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 7.7 p90 -157.96 179.65 8.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.387 -0.821 . . . . 0.0 109.522 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.5 p -128.76 149.96 50.49 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.73 149.17 19.54 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.051 -1.03 . . . . 0.0 109.221 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -53.95 -40.64 80.14 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.669 0.913 . . . . 0.0 111.907 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.39 -156.54 17.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -130.38 159.96 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.617 -0.931 . . . . 0.0 109.506 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 m -114.21 120.68 41.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.526 -0.733 . . . . 0.0 109.476 179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.64 128.49 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -149.28 159.92 43.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.699 -1.251 . . . . 0.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 44.2 ttm -120.25 129.95 54.28 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -88.31 102.08 14.5 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' CG1' ' OE1' ' A' ' 94' ' ' GLU . 15.9 m -96.04 148.31 34.34 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.308 -0.87 . . . . 0.0 108.894 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HG3' HD21 ' A' ' 143' ' ' ASN . 10.3 Cg_endo -73.67 130.24 19.96 Favored 'Cis proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.796 -1.335 . . . . 0.0 112.957 0.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 m -105.42 161.36 14.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.64 -0.662 . . . . 0.0 109.644 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.04 150.02 47.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.694 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -164.65 31.29 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 96.0 m-20 -96.09 116.74 29.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.198 -1.178 . . . . 0.0 108.921 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE1' ' CG1' ' A' ' 88' ' ' VAL . 41.9 mt-10 -59.95 -34.86 73.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.649 . . . . 0.0 110.799 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.06 -39.99 75.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.535 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.22 -42.21 55.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.717 -1.239 . . . . 0.0 108.701 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 31.3 m120 -61.53 -39.89 92.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.402 ' CE1' ' CE ' ' A' ' 13' ' ' MET . 73.0 t80 -52.44 -40.01 61.72 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.607 -0.683 . . . . 0.0 109.207 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -60.96 -40.01 91.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.112 -0.992 . . . . 0.0 109.1 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 94.7 mt -60.37 -40.08 89.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.109 -0.994 . . . . 0.0 109.177 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.6 mtp -57.09 -50.33 73.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.17 -45.28 81.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.524 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.6 mt-30 -60.15 -39.99 88.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.099 -1.001 . . . . 0.0 108.822 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.0 p -70.14 -41.07 74.37 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.178 -0.951 . . . . 0.0 109.199 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.6 -55.62 31.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.319 -0.863 . . . . 0.0 110.276 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -60.73 -39.95 90.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.073 -1.017 . . . . 0.0 109.704 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 8.1 m-70 -59.83 -46.32 89.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.079 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.76 -47.45 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.206 -0.934 . . . . 0.0 108.977 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.86 -47.01 64.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.463 -0.773 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -60.92 -40.67 94.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.851 . . . . 0.0 110.949 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.03 -40.08 75.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.708 -178.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 114' ' ' GLY . 6.3 m -99.59 0.05 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.224 -0.923 . . . . 0.0 109.877 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.31 21.76 74.28 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.445 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -81.62 -176.8 51.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.49 132.02 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.604 -0.939 . . . . 0.0 109.272 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.96 131.04 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.188 -0.945 . . . . 0.0 108.898 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 42.6 mt -131.49 158.62 40.39 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.411 -0.806 . . . . 0.0 109.377 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -84.03 -170.77 3.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.394 -0.816 . . . . 0.0 109.253 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 92.0 m-20 -60.06 -36.37 77.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.834 . . . . 0.0 109.623 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.59 14.91 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 108.999 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.6 mtt180 56.35 38.64 29.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 109.765 -179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -122.18 152.2 40.21 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.2 mtp -50.72 129.24 22.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.943 -1.098 . . . . 0.0 109.07 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 61.4 mtp -59.95 139.81 57.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.847 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -120.66 151.33 54.13 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -43.02 -43.92 9.47 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 120.8 1.0 . . . . 0.0 112.603 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.06 -40.0 87.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -65.31 -39.83 92.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.123 -0.986 . . . . 0.0 110.124 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.03 -40.05 83.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.954 -1.091 . . . . 0.0 108.543 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -65.07 -39.5 93.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.597 -0.689 . . . . 0.0 109.86 179.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.12 -47.65 85.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.304 -0.873 . . . . 0.0 110.565 -178.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -59.98 -43.86 94.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.01 -1.056 . . . . 0.0 109.322 -179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HA ' HD12 ' A' ' 136' ' ' ILE . 78.3 mt-30 -60.38 -39.94 89.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.942 . . . . 0.0 109.704 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 95.8 m-20 -60.58 -40.17 90.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.13 -39.94 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 108.904 179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 133' ' ' GLN . 96.5 mt -59.9 -44.63 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 82.2 mtm180 -60.1 -38.0 81.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.783 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE2' ' CB ' ' A' ' 4' ' ' PRO . 95.4 mt-10 -60.09 -37.33 79.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.394 -0.816 . . . . 0.0 109.52 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 64.5 t -69.88 -38.17 74.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.369 -0.832 . . . . 0.0 110.38 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -60.06 -46.56 89.16 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.077 -1.015 . . . . 0.0 111.558 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.1 p-10 -60.08 -35.06 74.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.697 -1.252 . . . . 0.0 109.588 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.49 -19.51 65.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.781 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.436 HD21 ' HG3' ' A' ' 89' ' ' PRO . 12.1 m120 -99.52 -8.7 24.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 109.832 -179.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 0.0 109.524 179.894 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.65 -16.09 27.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.176 -0.953 . . . . 0.0 110.026 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -134.02 77.16 62.74 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.81 1.61 5.59 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.786 0.991 . . . . 0.0 111.822 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -87.01 -0.83 57.26 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -81.75 103.72 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.879 . . . . 0.0 110.615 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -87.7 -11.54 48.0 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -152.21 140.58 20.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -162.75 164.56 26.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.426 -1.421 . . . . 0.0 110.734 -178.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.99 129.47 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.3 mm -90.31 122.94 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.5 mt -122.29 144.27 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 122.039 0.923 . . . . 0.0 110.835 -177.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.8 mtt -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -130.81 119.5 22.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.978 -1.076 . . . . 0.0 110.392 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.27 112.89 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.79 44.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.189 -0.944 . . . . 0.0 110.361 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.65 -164.4 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.514 -0.741 . . . . 0.0 109.175 179.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -67.25 155.03 39.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.16 -0.962 . . . . 0.0 108.716 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -59.56 140.01 56.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.33 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -6.19 77.11 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 m -115.26 148.44 39.15 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.448 -1.031 . . . . 0.0 109.042 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -126.8 146.49 50.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.461 -0.774 . . . . 0.0 109.606 -179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 88.1 mt -86.34 141.91 28.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.317 -0.864 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -69.95 146.12 51.39 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.243 -0.911 . . . . 0.0 108.876 179.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.0 98.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.0 -45.73 93.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.061 -1.258 . . . . 0.0 109.755 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 92.1 mt -69.85 -24.48 63.44 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.537 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.0 tt -79.8 -57.49 3.63 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.593 -0.692 . . . . 0.0 110.46 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 74' ' ' MET . 95.7 mt -59.94 -45.21 93.34 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 0.0 111.585 -178.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 31' ' ' SER . 39.4 p-10 -61.62 -39.8 92.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.815 -1.178 . . . . 0.0 110.28 -178.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.532 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 9.3 p -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 0.0 110.316 -179.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.04 -50.04 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 0.0 110.335 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.72 -39.96 95.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 0.0 110.127 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.26 -20.09 66.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 0.0 110.477 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.59 1.02 44.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.94 -1.1 . . . . 0.0 110.022 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 13.58 56.87 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.011 -1.056 . . . . 0.0 110.921 178.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -80.93 150.81 28.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.973 -1.31 . . . . 0.0 109.692 179.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.62 138.84 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.58 106.75 0.82 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.094 -1.004 . . . . 0.0 109.687 -179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.83 171.51 26.19 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.41 -164.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -1.178 . . . . 0.0 109.481 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.3 mtm 56.9 19.98 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.502 -0.749 . . . . 0.0 110.014 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.4 m120 49.86 40.04 19.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.512 -0.742 . . . . 0.0 111.379 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.16 167.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 120.973 -1.079 . . . . 0.0 108.574 178.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -93.18 120.91 33.99 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.787 -1.196 . . . . 0.0 110.68 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.53 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 47.1 m-70 -109.18 124.58 51.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.662 -0.649 . . . . 0.0 109.531 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.523 ' NH1' HD21 ' A' ' 100' ' ' LEU . 13.9 ttt-85 -100.02 127.25 46.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.257 -0.902 . . . . 0.0 108.661 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 18.5 m-70 -95.67 171.55 8.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.37 -0.831 . . . . 0.0 110.399 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.7 tp -55.97 -50.08 71.81 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.37 -0.832 . . . . 0.0 108.848 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.2 m -94.09 146.91 32.48 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 179.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -69.2 -6.37 18.16 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 CA-C-N 119.436 0.834 . . . . 0.0 112.368 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -92.54 -2.24 56.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 109.773 -179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.99 10.05 86.02 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -67.64 -40.43 84.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.011 -1.288 . . . . 0.0 109.189 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.507 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.54 162.66 49.4 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.89 179.25 2.84 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 118.448 1.124 . . . . 0.0 111.716 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.69 119.83 23.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.071 -1.018 . . . . 0.0 109.156 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 58' ' ' LEU . 10.3 mp -96.56 -47.52 5.9 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 -179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CG ' ' SD ' ' A' ' 101' ' ' MET . 40.2 p90 -145.33 159.16 43.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.904 -1.122 . . . . 0.0 109.01 178.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 74.2 m -132.02 169.74 15.91 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.856 0.836 . . . . 0.0 111.526 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.667 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.6 tt -123.48 133.0 54.09 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.512 0.672 . . . . 0.0 109.211 179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.568 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -135.77 159.08 42.76 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 94.3 m-20 -76.27 152.48 36.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.974 -1.079 . . . . 0.0 108.732 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.7 mtm -70.02 -20.26 63.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.996 -1.065 . . . . 0.0 109.663 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.0 p -88.66 131.94 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 109.555 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -59.5 150.95 63.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.068 -1.02 . . . . 0.0 108.485 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -80.25 5.3 36.31 Favored 'Cis proline' 0 N--CA 1.494 1.541 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.243 -0.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.69 3.51 90.48 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.3 p -92.4 174.89 7.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.268 -1.137 . . . . 0.0 110.818 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 97.5 m-85 -126.24 146.76 49.86 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLU . 51.3 m-20 -129.99 149.82 74.22 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.334 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -49.13 -7.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 CA-C-N 119.567 0.881 . . . . 0.0 111.85 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ASP . 99.0 mt-10 -90.0 3.26 53.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.475 ' O ' HD11 ' A' ' 29' ' ' LEU . 65.1 mmm -86.16 21.0 2.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.336 -0.852 . . . . 0.0 109.866 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -85.93 -5.82 59.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 108.882 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -149.85 80.0 1.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.424 -0.797 . . . . 0.0 109.159 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -157.45 170.54 22.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.195 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.0 p -129.4 150.25 50.84 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.03 149.27 20.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.024 -1.047 . . . . 0.0 109.213 -179.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -48.05 -45.11 26.26 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 120.509 0.806 . . . . 0.0 111.639 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.16 -149.11 7.83 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.45 162.13 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.539 -0.977 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 62' ' ' ALA . 5.6 m -114.87 116.6 28.82 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -102.53 126.79 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -146.5 160.23 42.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.003 -1.061 . . . . 0.0 111.221 -178.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.0 ttm -124.15 131.08 53.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -90.15 120.0 30.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 108.545 179.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 9' ' ' ALA . 1.5 m -98.38 150.02 36.31 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.26 -0.9 . . . . 0.0 109.375 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.69 137.05 48.0 Favored 'Cis proline' 0 N--CA 1.498 1.784 0 C-N-CA 124.084 -1.215 . . . . 0.0 111.94 -2.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.3 m -105.26 150.31 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.394 -0.816 . . . . 0.0 110.047 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.7 152.06 41.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.587 -0.696 . . . . 0.0 109.83 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.74 -163.02 31.94 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 95.8 m-20 -95.25 113.06 24.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.144 -1.209 . . . . 0.0 109.254 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 57.1 mp0 -58.99 -29.5 67.26 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.0 -42.9 72.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -73.99 -42.28 60.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.053 -1.03 . . . . 0.0 108.613 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 80.9 m-20 -62.2 -40.63 96.73 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.601 -0.687 . . . . 0.0 109.196 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -60.08 -49.95 75.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.498 -0.751 . . . . 0.0 109.02 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -62.5 -39.79 94.63 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.523 HD21 ' NH1' ' A' ' 47' ' ' ARG . 7.1 tt -60.01 -42.41 94.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.743 -0.598 . . . . 0.0 109.541 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.412 ' SD ' ' CG ' ' A' ' 59' ' ' PHE . 21.7 mtm -59.92 -41.64 92.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.82 -1.175 . . . . 0.0 108.576 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.26 -43.14 98.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 108.676 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 90.2 mt-30 -60.07 -41.32 92.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.799 . . . . 0.0 109.098 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 p -70.95 -40.03 72.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.316 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.57 -53.83 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.34 -0.85 . . . . 0.0 110.213 -179.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -60.21 -37.01 78.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.936 -1.102 . . . . 0.0 109.127 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 7.3 m-70 -60.02 -49.57 77.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.077 -1.014 . . . . 0.0 108.608 179.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.1 -50.02 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -49.87 -51.09 42.95 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.667 -0.646 . . . . 0.0 109.828 -179.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.04 -40.07 88.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.437 -0.789 . . . . 0.0 110.617 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -69.09 -39.92 78.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 0.0 110.604 -178.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.73 0.34 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.98 20.25 76.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.78 -173.04 46.61 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.33 139.29 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.504 -0.998 . . . . 0.0 108.872 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 t -76.62 129.96 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.081 -1.012 . . . . 0.0 108.824 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' C ' ' SD ' ' A' ' 124' ' ' MET . 52.5 mt -131.4 159.85 36.8 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -0.767 . . . . 0.0 109.72 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.481 ' N ' ' SD ' ' A' ' 124' ' ' MET . 43.6 p-10 -84.78 -173.97 5.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 109.173 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 121' ' ' ARG . 96.7 m-20 -60.04 -36.45 77.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.472 ' CB ' ' NH1' ' A' ' 122' ' ' ARG . 96.5 mm-40 -77.17 13.24 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' ASP . 85.7 mtm180 55.42 33.78 21.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.87 -0.518 . . . . 0.0 110.422 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' NH1' ' CB ' ' A' ' 120' ' ' GLN . 25.1 mtm-85 -109.67 156.67 19.96 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 74.5 mtm -51.9 133.24 32.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 118' ' ' ASP . 97.6 mmm -60.68 139.95 57.67 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.627 ' N ' ' NZ ' ' A' ' 128' ' ' LYS . 74.6 p -130.43 149.87 74.63 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -48.63 -43.9 32.42 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 CA-C-N 119.38 0.814 . . . . 0.0 111.963 179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -60.3 -42.99 96.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.627 ' NZ ' ' N ' ' A' ' 125' ' ' THR . 9.8 mtmp? -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.932 -1.105 . . . . 0.0 110.288 -179.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.44 -39.99 81.36 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.738 -1.226 . . . . 0.0 108.409 179.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.08 -36.87 85.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.391 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.07 -49.44 77.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -60.05 -43.75 95.15 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.45 -39.83 94.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.0 -40.99 91.13 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.268 -0.895 . . . . 0.0 109.294 -179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.6 mt -61.93 -41.03 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.885 -1.134 . . . . 0.0 108.198 179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 68.8 mt -60.03 -46.28 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 137' ' ' ARG . 1.6 mmt-85 -60.27 -40.02 88.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.098 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 92.5 mt-10 -60.93 -38.84 87.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.52 0.676 . . . . 0.0 109.63 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 88' ' ' VAL . 71.7 t -68.81 -39.61 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 110.673 -179.007 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 144' ' ' ALA . 56.6 mttm -58.23 -46.9 85.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.927 -1.108 . . . . 0.0 110.572 -178.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 1.2 p-10 -60.11 -33.02 71.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.704 -1.248 . . . . 0.0 108.622 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.26 93.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.56 -0.713 . . . . 0.0 110.289 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -99.96 -18.58 17.0 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.31 -0.869 . . . . 0.0 110.424 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.407 0.622 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -87.29 6.72 31.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.4 81.45 10.98 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -45.01 118.27 1.9 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.961 1.107 . . . . 0.0 113.105 -178.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -80.06 32.77 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -69.98 150.27 46.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.424 -0.798 . . . . 0.0 110.709 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -82.94 -9.34 59.34 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -146.4 141.78 27.52 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 179.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -165.8 166.82 17.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.926 -1.109 . . . . 0.0 109.799 -179.411 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.1 t -117.3 129.97 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mm -92.57 131.83 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 86.0 mt -131.13 142.09 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 122.165 0.983 . . . . 0.0 110.971 -178.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -139.85 135.06 32.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 178.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -116.24 122.68 45.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.048 -1.033 . . . . 0.0 111.342 -177.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -101.46 111.24 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.27 155.69 40.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.111 -0.993 . . . . 0.0 110.55 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.48 -164.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.559 -0.713 . . . . 0.0 109.096 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -74.51 157.44 35.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.096 -1.003 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.24 143.56 52.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.73 0.24 72.55 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.7 m -130.01 141.78 50.7 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.587 -0.949 . . . . 0.0 109.341 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -122.72 149.11 44.52 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.451 -0.78 . . . . 0.0 108.936 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.4 145.34 26.9 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 62.6 t-20 -68.07 138.82 56.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.34 -0.85 . . . . 0.0 109.527 179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -60.8 -40.42 98.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.23 -44.52 97.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.904 -1.351 . . . . 0.0 109.489 -179.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -29.73 67.81 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.9 tt -70.37 -57.93 4.29 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 74' ' ' MET . 83.7 mt -60.2 -40.89 91.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.0 109.926 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -64.0 -40.37 96.2 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.4 t -65.77 -39.06 90.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 111.105 -179.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.82 -42.24 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.197 . . . . 0.0 109.972 -178.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -64.88 -39.94 94.34 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.153 -0.967 . . . . 0.0 108.549 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -64.71 -20.62 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.53 -0.731 . . . . 0.0 109.681 179.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.492 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -81.62 2.01 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.779 . . . . 0.0 110.114 -178.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.68 13.49 82.35 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 120.019 -1.086 . . . . 0.0 110.425 179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -79.99 153.17 29.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.049 -1.266 . . . . 0.0 110.059 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 83.0 mt -120.21 133.84 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.66 106.69 0.7 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.944 -1.098 . . . . 0.0 110.182 -178.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.95 169.07 27.93 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -59.95 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.304 -1.115 . . . . 0.0 109.189 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.9 mtt 58.89 19.86 7.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.695 -0.628 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.5 m120 51.32 37.62 19.34 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.222 -0.924 . . . . 0.0 111.336 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.518 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 7.2 pt -140.58 164.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.945 -1.097 . . . . 0.0 108.717 178.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -91.72 123.14 34.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.115 -0.991 . . . . 0.0 110.47 -178.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.523 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 44.8 m-70 -114.67 131.3 56.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.609 -0.682 . . . . 0.0 109.654 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 17.4 ttp180 -107.32 126.76 52.86 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 44.9 m-70 -92.75 171.47 8.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.378 -0.826 . . . . 0.0 110.676 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.41 -49.98 72.93 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.2 m -90.49 148.05 37.92 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.239 -0.913 . . . . 0.0 108.948 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.97 -12.0 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 120.748 0.966 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD2' ' OG ' ' A' ' 54' ' ' SER . 56.3 p-10 -90.24 0.78 57.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.193 -0.942 . . . . 0.0 109.901 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.15 10.67 85.87 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' OD2' ' A' ' 52' ' ' ASP . 53.5 m -66.88 -40.06 87.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.848 -1.383 . . . . 0.0 109.726 -179.51 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.98 166.21 51.62 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' ND1' ' A' ' 48' ' ' HIS . 19.4 Cg_endo -71.16 175.78 8.75 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.493 1.462 . . . . 0.0 112.125 179.481 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.29 124.04 27.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.037 . . . . 0.0 109.25 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' O ' ' SD ' ' A' ' 86' ' ' MET . 10.2 mp -102.94 -57.25 2.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.405 -0.809 . . . . 0.0 110.026 -179.216 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -130.5 159.49 36.96 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 120.77 -1.207 . . . . 0.0 108.518 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.523 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 69.8 m -137.3 162.26 34.01 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.017 -1.052 . . . . 0.0 111.731 -177.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 62' ' ' ALA . 8.1 tt -113.58 136.16 53.12 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.663 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -136.36 160.53 38.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 70' ' ' PHE . 17.4 m120 -75.92 161.5 28.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.095 -1.003 . . . . 0.0 109.904 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.1 mtp -69.83 -19.41 63.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.476 -0.765 . . . . 0.0 110.492 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 65' ' ' VAL . 7.9 p -89.49 117.44 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.741 -1.224 . . . . 0.0 109.747 179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -62.04 148.86 87.71 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.268 -0.895 . . . . 0.0 109.317 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -75.43 9.29 10.7 Favored 'Cis proline' 0 N--CA 1.496 1.654 0 C-N-CA 123.828 -1.322 . . . . 0.0 112.234 0.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' VAL . . . 73.86 21.76 78.88 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.957 -1.116 . . . . 0.0 110.926 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.2 p -86.08 171.85 11.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.1 -1.235 . . . . 0.0 109.789 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 63' ' ' ASN . 84.0 m-85 -121.43 144.81 48.47 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.562 -0.711 . . . . 0.0 109.943 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.9 m-20 -129.98 150.44 75.95 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -49.59 -8.79 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 120.512 0.808 . . . . 0.0 112.123 179.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 71' ' ' ASP . 48.7 mt-10 -89.94 2.61 54.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.448 ' O ' HD11 ' A' ' 29' ' ' LEU . 66.6 mmm -86.23 17.28 3.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 0.0 110.272 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.2 mttm -87.41 -7.84 57.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.957 -1.089 . . . . 0.0 108.939 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.1 m-20 -150.3 79.99 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -156.25 172.44 18.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.538 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.2 p -129.81 150.97 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.177 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.12 148.15 18.18 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.912 . . . . 0.0 109.341 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -45.34 -43.1 17.35 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 120.594 0.863 . . . . 0.0 111.547 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.9 10.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.6 m -129.98 160.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.325 -1.103 . . . . 0.0 109.476 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.41 ' N ' ' O ' ' A' ' 62' ' ' ALA . 97.9 m -116.47 129.99 56.51 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.617 0.722 . . . . 0.0 110.517 -179.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.9 131.96 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 22.3 p90 -147.03 170.65 16.68 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.916 -1.115 . . . . 0.0 111.172 -178.068 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 58' ' ' LEU . 4.9 tpp -139.61 122.63 16.75 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.431 ' O ' ' OG ' ' A' ' 90' ' ' SER . 27.3 mt-30 -88.94 114.98 26.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 0.0 108.66 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 9' ' ' ALA . 3.4 m -101.43 152.08 37.93 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.411 -0.805 . . . . 0.0 109.103 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.27 140.51 61.11 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 C-N-CA 123.7 -1.375 . . . . 0.0 112.214 -0.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 20.4 m -119.47 154.38 33.85 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.471 -0.768 . . . . 0.0 109.788 -179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -71.04 152.61 43.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.439 -0.788 . . . . 0.0 110.323 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.47 -163.53 26.3 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 97' ' ' ASN . 92.7 m-20 -95.82 110.41 22.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.276 -1.132 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -59.89 -32.53 70.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.565 -0.709 . . . . 0.0 110.228 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.75 -40.08 76.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.961 -1.087 . . . . 0.0 109.875 -178.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -72.06 -40.26 68.43 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.636 -1.29 . . . . 0.0 108.627 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 35.7 m120 -60.49 -40.07 90.02 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 102' ' ' LEU . 63.3 t80 -58.18 -43.12 87.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 178.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.83 -41.23 95.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.913 178.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.98 -40.18 94.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 108.872 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.92 -49.06 79.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.208 -0.932 . . . . 0.0 109.008 179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 98' ' ' PHE . 85.6 mt -66.27 -41.47 89.81 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.96 . . . . 0.0 110.046 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.536 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 32.5 mt-30 -59.95 -41.83 92.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.966 -1.084 . . . . 0.0 108.873 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -71.13 -40.28 71.5 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.078 -1.014 . . . . 0.0 109.433 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.28 48.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.154 -0.966 . . . . 0.0 110.069 -179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.71 -42.21 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 20.0 m-70 -60.1 -46.73 88.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.015 -1.053 . . . . 0.0 108.894 179.387 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -60.04 -50.0 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.353 -0.842 . . . . 0.0 109.076 179.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.73 -49.57 62.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.77 -40.22 91.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.503 -0.748 . . . . 0.0 110.578 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.41 -39.87 77.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.931 -1.105 . . . . 0.0 110.568 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 m -98.78 -0.0 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.95 -1.094 . . . . 0.0 109.741 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 70.17 22.88 77.49 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.03 -170.17 46.54 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.29 137.12 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.578 -0.954 . . . . 0.0 108.93 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -72.01 133.19 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 0.0 108.953 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.0 mt -132.01 159.32 39.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 -179.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 122' ' ' ARG . 36.7 p-10 -87.47 -172.0 3.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.428 -0.795 . . . . 0.0 109.078 179.315 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 121' ' ' ARG . 73.6 m-20 -60.02 -39.84 87.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.809 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.465 ' HB2' ' HE ' ' A' ' 122' ' ' ARG . 79.0 mt-30 -76.38 17.08 0.4 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.34 -0.85 . . . . 0.0 109.388 -179.357 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 121' ' ' ARG . 22.3 mtt-85 58.24 25.49 12.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.688 -0.633 . . . . 0.0 110.185 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 85.7 mtm180 -105.12 151.87 23.48 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.325 -0.86 . . . . 0.0 109.267 179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 98.2 mtp -51.93 136.55 28.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 98.2 mmm -58.81 139.95 55.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.588 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.1 p -132.2 150.65 76.62 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -41.45 -49.92 4.85 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 120.804 1.003 . . . . 0.0 112.878 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.969 -1.082 . . . . 0.0 110.039 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -66.56 -39.94 88.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.928 -1.108 . . . . 0.0 110.329 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.82 -40.15 87.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 0.0 108.044 179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -67.22 -38.79 85.86 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.86 -0.525 . . . . 0.0 109.864 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.16 -48.94 79.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.876 -1.14 . . . . 0.0 109.721 -179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -59.94 -46.32 89.79 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.4 ' NE2' ' CE2' ' A' ' 98' ' ' PHE . 98.1 mt-30 -61.89 -39.48 92.09 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.607 -0.683 . . . . 0.0 109.187 179.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.24 -40.97 96.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 110.226 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.47 -41.78 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.875 -1.141 . . . . 0.0 109.133 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.21 -46.25 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.465 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 59.6 mtp180 -60.21 -40.16 89.14 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.703 . . . . 0.0 109.83 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -59.85 -40.45 88.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.04 -1.038 . . . . 0.0 109.503 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.2 t -71.67 -38.05 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.457 -0.777 . . . . 0.0 110.973 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 144' ' ' ALA . 24.6 mtpp -59.83 -42.87 94.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.718 -1.239 . . . . 0.0 110.574 -178.127 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.08 -34.07 74.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.432 -1.417 . . . . 0.0 109.072 179.685 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.68 92.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.159 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.14 0.44 45.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.48 -0.763 . . . . 0.0 109.511 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.153 -0.967 . . . . 0.0 109.313 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mtp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.202 0.525 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -89.0 1.65 55.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -75.3 125.17 89.25 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.041 -1.037 . . . . 0.0 108.649 179.858 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.49 25.2 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 CA-C-N 120.111 1.075 . . . . 0.0 112.486 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 -11.06 55.21 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.69 124.4 32.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.922 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -87.22 -10.06 53.51 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -149.65 145.2 26.61 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.79 -172.66 3.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.886 -1.134 . . . . 0.0 110.394 -178.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.08 133.47 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 mm -88.46 132.71 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 179.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.458 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 91.0 mt -131.42 140.63 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 CA-C-O 122.346 1.07 . . . . 0.0 111.514 -177.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.9 mtm -147.21 138.39 23.86 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -118.82 132.56 56.13 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.196 -0.94 . . . . 0.0 111.908 -177.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.56 118.94 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.23 38.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.753 -179.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.62 -173.24 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 108.672 178.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -68.76 160.06 31.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.989 -1.07 . . . . 0.0 109.255 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -59.46 142.5 52.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.95 -6.22 79.16 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -121.9 148.9 44.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 22' ' ' GLU . 57.2 mp0 -130.71 149.36 52.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 109.091 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.3 mt -84.91 136.23 33.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.389 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -68.25 146.32 53.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.156 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.87 98.56 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.79 -47.14 87.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.078 -1.248 . . . . 0.0 109.581 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.07 -32.68 73.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -73.99 -56.93 4.34 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.638 -0.664 . . . . 0.0 109.842 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.97 -46.91 87.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -61.8 -40.78 96.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.23 -0.919 . . . . 0.0 110.586 -179.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 t -63.89 -40.04 95.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.007 -1.058 . . . . 0.0 110.139 -179.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -40.96 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 108.993 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.53 -40.27 95.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.352 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -68.81 -18.09 64.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.459 -0.776 . . . . 0.0 109.804 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -80.76 5.41 15.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 -178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.09 11.94 83.85 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -80.17 156.7 26.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.245 . . . . 0.0 110.031 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.84 137.19 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -62.13 105.89 0.65 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.955 -1.091 . . . . 0.0 109.77 -179.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.69 172.6 31.46 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.31 -164.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.449 -1.03 . . . . 0.0 109.85 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 68.2 mtt 58.84 20.06 7.62 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.828 0.823 . . . . 0.0 109.092 -179.475 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 53.14 40.06 30.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.727 -0.608 . . . . 0.0 111.691 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.13 169.7 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.8 -1.188 . . . . 0.0 109.052 178.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -94.53 115.51 27.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.0 110.629 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 52.2 m80 -101.06 127.93 47.36 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.356 -0.84 . . . . 0.0 109.437 178.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 61.9 ttt180 -106.05 127.55 53.25 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.099 -1.001 . . . . 0.0 108.514 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 48' ' ' HIS . 15.2 m-70 -97.44 177.1 5.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 109.648 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.4 tp -56.51 -49.66 74.06 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 108.833 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.5 m -90.28 149.16 40.71 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.362 -0.836 . . . . 0.0 109.224 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.96 -12.22 33.83 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 120.967 1.112 . . . . 0.0 112.95 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -93.03 0.01 57.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.894 -1.129 . . . . 0.0 110.34 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.92 13.41 82.23 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.705 179.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.3 p -69.86 -39.99 76.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.835 -1.391 . . . . 0.0 109.523 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.64 170.57 54.23 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -68.76 169.22 18.08 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.355 1.37 . . . . 0.0 111.891 179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.94 121.71 26.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.918 . . . . 0.0 109.089 179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.7 mp -101.34 -37.36 8.52 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.273 -0.892 . . . . 0.0 109.533 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -151.38 159.86 44.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.418 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 2.0 m -133.69 -179.56 5.61 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.841 0.829 . . . . 0.0 110.723 -177.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.695 HD23 ' C ' ' A' ' 61' ' ' LEU . 5.9 tt -134.02 134.08 42.02 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.566 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -131.77 160.0 36.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.733 -0.605 . . . . 0.0 109.74 -179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.49 ' CG ' ' CZ ' ' A' ' 70' ' ' PHE . 9.0 m120 -73.36 160.74 31.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.99 -1.069 . . . . 0.0 109.412 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mmm -68.88 -29.84 68.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.517 -0.739 . . . . 0.0 110.673 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.0 m -86.79 121.78 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.956 -1.09 . . . . 0.0 110.398 -178.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -59.59 152.58 55.7 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -79.14 3.94 31.36 Favored 'Cis proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.799 -1.334 . . . . 0.0 112.86 0.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.41 21.61 61.98 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.9 p -85.3 160.45 19.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.112 -1.228 . . . . 0.0 109.883 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.49 ' CZ ' ' CG ' ' A' ' 63' ' ' ASN . 28.3 m-85 -125.13 139.95 53.31 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.624 -0.672 . . . . 0.0 109.426 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.429 ' N ' ' SD ' ' A' ' 74' ' ' MET . 41.9 m-20 -120.25 149.51 49.63 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.04 -14.49 41.87 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 CA-C-N 119.345 0.802 . . . . 0.0 111.936 179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -90.71 -0.0 57.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.279 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 71' ' ' ASP . 10.9 ptm -84.59 25.75 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.135 -0.978 . . . . 0.0 110.336 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 56.5 mtpt -79.08 2.44 20.66 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.546 -1.346 . . . . 0.0 109.282 -179.07 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 90.8 m-20 -142.76 84.25 1.84 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -161.29 174.13 14.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.977 -1.077 . . . . 0.0 109.977 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -130.09 152.54 49.43 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.72 149.03 18.51 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.962 -1.086 . . . . 0.0 109.14 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -49.33 -49.51 15.33 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 CA-C-N 119.058 0.699 . . . . 0.0 111.732 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.93 18.05 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG11 HD21 ' A' ' 28' ' ' LEU . 33.4 m -129.99 159.91 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.492 -1.005 . . . . 0.0 110.132 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.6 m -108.82 122.43 47.17 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.356 0.598 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.2 mt -104.07 129.72 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -148.73 157.28 43.34 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.803 -1.186 . . . . 0.0 111.655 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.4 ttm -121.62 134.58 55.0 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' OG ' ' A' ' 90' ' ' SER . 98.4 mm-40 -90.64 104.01 16.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 88' ' ' VAL . 10.6 m -97.75 149.18 35.45 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.192 -0.943 . . . . 0.0 109.471 -179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.65 131.81 25.46 Favored 'Cis proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.636 -1.402 . . . . 0.0 112.205 -0.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 60.8 m -103.82 166.68 10.26 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.465 -0.772 . . . . 0.0 110.217 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -70.75 148.54 47.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.641 -0.662 . . . . 0.0 109.398 179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.75 -160.02 33.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -96.45 113.27 24.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.105 . . . . 0.0 109.443 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.99 -33.01 71.39 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.619 -0.675 . . . . 0.0 109.916 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.01 -41.49 74.26 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 110.597 -178.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -73.32 -42.1 62.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.834 -1.167 . . . . 0.0 108.681 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -62.6 -33.84 75.8 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -59.07 -48.69 80.67 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -59.96 -39.97 87.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.77 -40.16 91.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.538 -0.726 . . . . 0.0 109.075 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.7 mtp -59.89 -42.81 94.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 108.763 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.39 -40.04 96.16 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.28 -0.887 . . . . 0.0 109.211 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 27.7 mt-30 -60.15 -40.04 88.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 109.486 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.5 p -71.62 -40.06 70.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.925 . . . . 0.0 109.526 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.43 -50.92 71.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 109.682 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -62.98 -40.06 96.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.01 -1.056 . . . . 0.0 109.246 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 17.4 m-70 -60.04 -48.13 82.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.104 -0.997 . . . . 0.0 108.961 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 83.3 mt -59.91 -49.22 84.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -53.4 -49.61 66.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.412 -0.805 . . . . 0.0 109.831 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -69.88 -39.97 75.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.256 -0.903 . . . . 0.0 111.046 -178.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 114' ' ' GLY . 4.4 m -102.0 -1.02 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.04 -1.037 . . . . 0.0 110.388 -179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 68.09 20.76 73.21 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 112' ' ' VAL . . . -82.93 -172.58 48.72 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.36 139.23 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.588 -0.948 . . . . 0.0 109.077 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.7 t -77.18 133.03 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.155 -0.966 . . . . 0.0 108.894 179.628 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.0 mt -130.08 156.87 43.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.359 -0.838 . . . . 0.0 109.213 -179.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -86.29 -173.36 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.868 . . . . 0.0 109.358 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 87.5 m-20 -60.08 -38.26 82.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.92 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -77.59 15.29 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.368 -179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 56.37 39.58 30.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.702 . . . . 0.0 109.776 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.443 HH11 ' HG2' ' A' ' 122' ' ' ARG . 43.4 mtt-85 -116.23 151.16 36.32 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.61 -0.682 . . . . 0.0 109.292 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 64.3 mtt -50.56 134.79 23.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.8 mmm -58.39 138.63 56.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.396 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -140.0 152.85 68.67 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -48.0 -43.56 29.95 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 CA-C-N 119.018 0.685 . . . . 0.0 111.391 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.18 -40.81 91.27 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -69.92 -41.04 75.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.016 -1.052 . . . . 0.0 108.974 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.0 mt -60.0 -40.1 88.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 0.0 109.166 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -62.53 -40.03 95.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.362 -0.836 . . . . 0.0 108.977 179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.95 -49.49 77.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.77 . . . . 0.0 110.277 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' O ' ' A' ' 12' ' ' ILE . 65.0 m-85 -60.04 -42.56 94.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.995 -1.065 . . . . 0.0 108.692 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -62.56 -39.96 95.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 137' ' ' ARG . 92.8 m-20 -62.01 -43.07 99.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.719 . . . . 0.0 110.236 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 89.2 mt -64.37 -40.64 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.828 -1.17 . . . . 0.0 109.673 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.21 -43.45 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 134' ' ' ASP . 85.5 mtm180 -60.04 -40.18 88.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.032 -1.043 . . . . 0.0 110.385 -179.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -61.51 -39.9 92.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.005 -1.059 . . . . 0.0 110.172 179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.09 -26.19 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.109 -0.994 . . . . 0.0 111.987 -178.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -59.86 -39.65 85.94 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.581 -1.324 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 142' ' ' ALA . 57.0 p-10 -59.99 -30.03 68.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.697 -1.252 . . . . 0.0 109.54 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.595 ' N ' ' OD1' ' A' ' 141' ' ' ASP . . . -63.54 -37.43 87.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -96.99 -13.27 22.43 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.237 -0.915 . . . . 0.0 109.481 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.373 -0.83 . . . . 0.0 109.707 179.869 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.26 15.11 11.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.451 -0.781 . . . . 0.0 109.857 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -129.99 77.77 76.03 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.422 -0.799 . . . . 0.0 109.6 -179.079 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' OE1' ' A' ' 138' ' ' GLU . 3.8 Cg_exo -64.76 138.5 58.63 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.796 0.997 . . . . 0.0 111.878 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -79.79 33.32 0.26 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 110.288 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.8 mtt-85 -69.7 148.81 48.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.129 -0.982 . . . . 0.0 109.949 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -80.51 -7.36 59.17 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.79 104.37 3.32 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 177.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' H ' ' CG2' ' A' ' 139' ' ' VAL . . . -99.34 175.23 5.94 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 110.443 -178.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.42 130.16 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 mm -95.8 123.83 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 85.2 mt -122.17 144.21 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-O 121.777 0.799 . . . . 0.0 109.979 -178.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ILE . 68.6 mtt -143.81 151.32 39.78 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.487 HD21 HG23 ' A' ' 83' ' ' THR . 34.2 m120 -133.52 125.06 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.967 -1.083 . . . . 0.0 110.59 -179.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.87 117.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.21 159.43 44.26 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.117 -0.989 . . . . 0.0 110.301 -178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -72.64 174.05 8.12 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.613 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -59.34 151.96 22.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 108.567 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -53.21 148.51 8.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.178 -0.951 . . . . 0.0 108.936 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.13 -1.3 79.92 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.9 m -130.04 148.47 51.9 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.426 -1.044 . . . . 0.0 109.026 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 80' ' ' PRO . 55.8 mm-40 -127.53 148.7 50.33 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.426 -0.796 . . . . 0.0 108.942 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 17' ' ' ALA . 51.5 mt -87.92 139.02 30.94 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.117 -0.989 . . . . 0.0 110.007 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -70.85 145.57 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -0.967 . . . . 0.0 109.429 179.388 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.78 -40.85 98.73 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.052 -1.071 . . . . 0.0 110.44 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -48.49 81.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.94 -1.33 . . . . 0.0 109.715 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.45 -27.43 65.24 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 28' ' ' LEU . 5.8 tt -75.0 -59.31 2.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.589 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 74' ' ' MET . 92.5 mt -59.71 -45.44 92.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.478 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 14.1 t-20 -61.29 -40.4 93.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 110.587 -179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.0 t -64.45 -39.74 94.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -49.16 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.973 -1.079 . . . . 0.0 110.051 -178.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.13 -40.26 97.07 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.995 -1.066 . . . . 0.0 109.296 -179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.478 ' NE2' ' OD1' ' A' ' 30' ' ' ASN . 34.9 mt-30 -68.1 -16.5 64.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 110.117 179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.519 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -84.79 -0.63 54.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.994 -1.066 . . . . 0.0 109.96 -179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.33 13.2 57.63 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.907 -1.12 . . . . 0.0 110.49 179.132 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -82.94 149.92 26.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.116 -1.226 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 85.9 mt -120.4 133.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -59.04 104.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 -178.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.86 171.34 32.88 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.72 -163.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -1.169 . . . . 0.0 109.27 179.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.0 mmm 57.9 20.28 6.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.461 -0.775 . . . . 0.0 109.851 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 50.61 39.45 21.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 0.0 111.59 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.445 ' CD1' ' NE2' ' A' ' 46' ' ' HIS . 6.2 pt -140.04 160.69 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -91.03 118.57 30.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.005 -1.059 . . . . 0.0 110.409 -179.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' NE2' ' CD1' ' A' ' 44' ' ' ILE . 29.4 m-70 -103.49 127.08 50.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.8 179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 58.5 ttt180 -102.22 124.27 47.52 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.56 ' HD1' ' C ' ' A' ' 56' ' ' PRO . 57.9 m-70 -94.06 171.14 9.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -178.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 49.0 tp -56.64 -47.94 78.62 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -91.45 147.1 34.62 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.758 . . . . 0.0 109.528 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -68.85 -8.85 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.622 0.881 . . . . 0.0 111.941 178.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -94.67 -0.33 54.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.08 -1.013 . . . . 0.0 110.742 -179.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.79 9.76 86.43 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.9 p -70.22 -40.13 74.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.048 -1.266 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -77.35 162.8 51.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.56 ' C ' ' HD1' ' A' ' 48' ' ' HIS . 11.3 Cg_endo -66.53 176.25 4.35 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.067 1.178 . . . . 0.0 112.103 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -81.57 118.95 23.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 108.771 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.5 mp -97.6 -42.08 7.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 109.631 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -150.79 159.54 44.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.988 -1.07 . . . . 0.0 108.549 178.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.4 m -132.32 175.21 9.47 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.326 -0.858 . . . . 0.0 111.078 -178.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.665 HD23 ' C ' ' A' ' 61' ' ' LEU . 7.2 tt -128.37 131.78 48.55 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.597 0.713 . . . . 0.0 109.138 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.542 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.31 160.21 33.73 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.611 ' ND2' ' CE1' ' A' ' 70' ' ' PHE . 84.2 m-20 -74.6 158.24 34.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.92 -1.112 . . . . 0.0 110.334 -179.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.3 mtp -70.11 -27.57 64.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.633 -0.667 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.69 135.51 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.951 -1.093 . . . . 0.0 109.592 -179.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -62.88 149.81 89.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.525 -0.734 . . . . 0.0 110.114 -179.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.13 5.35 24.78 Favored 'Cis proline' 0 N--CA 1.496 1.674 0 C-N-CA 123.614 -1.411 . . . . 0.0 111.962 -0.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.16 4.97 80.83 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.4 p -88.81 170.48 10.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 -179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.611 ' CE1' ' ND2' ' A' ' 63' ' ' ASN . 87.6 m-85 -118.61 140.09 50.45 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.574 -0.703 . . . . 0.0 109.519 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 74' ' ' MET . 58.2 m-20 -124.33 150.02 62.83 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -49.79 -10.99 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.441 0.836 . . . . 0.0 112.551 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' ASP . 31.0 mp0 -88.9 2.37 53.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.099 -1.001 . . . . 0.0 109.344 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.523 ' O ' HD11 ' A' ' 29' ' ' LEU . 63.5 mmm -86.51 18.42 3.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.605 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 68.7 mttm -85.92 -4.66 59.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.082 -1.011 . . . . 0.0 108.941 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 73.9 m-20 -149.92 80.14 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 108.914 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.66 173.11 17.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.183 -0.948 . . . . 0.0 109.898 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.4 p -130.24 149.85 51.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.57 149.41 20.11 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.016 -1.053 . . . . 0.0 109.286 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.533 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 18.1 Cg_exo -44.71 -53.59 4.93 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 120.312 0.675 . . . . 0.0 111.39 179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.09 -147.34 5.48 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.97 160.0 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.84 -0.8 . . . . 0.0 109.51 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.487 HG23 HD21 ' A' ' 14' ' ' ASN . 88.2 m -113.42 118.59 34.96 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' MET . 96.9 mt -105.04 129.1 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.77 165.53 27.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.0 110.256 -179.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.0 ttp -140.08 127.78 21.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -90.33 117.58 29.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.998 . . . . 0.0 108.573 179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 88' ' ' VAL . 5.5 m -98.7 150.72 36.98 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 108.704 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -74.87 139.08 59.7 Favored 'Cis proline' 0 N--CA 1.496 1.645 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.639 -0.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.6 m -104.86 167.12 9.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -70.24 141.93 52.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.946 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.02 -155.74 27.84 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -95.34 119.39 33.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -1.089 . . . . 0.0 108.724 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 56.7 mp0 -57.54 -31.55 66.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.534 -0.729 . . . . 0.0 110.442 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.51 -40.4 77.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.394 -179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.48 -40.18 70.42 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.24 -40.02 94.77 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -59.89 -50.11 75.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 108.699 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -60.01 -40.11 88.14 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 tp -60.52 -41.49 94.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.609 -0.682 . . . . 0.0 109.491 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 86.5 mtp -59.61 -45.4 92.05 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 110.116 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.12 -42.9 95.77 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.045 -1.034 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -60.03 -40.84 90.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.143 -0.973 . . . . 0.0 109.265 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -70.33 -40.12 74.35 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.339 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.96 -55.54 32.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.537 -0.727 . . . . 0.0 110.063 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.37 -37.25 82.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 110.008 -179.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -60.07 -44.6 94.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.042 -1.036 . . . . 0.0 108.963 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 84.5 mt -60.39 -49.53 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -52.27 -47.69 65.7 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.33 -40.02 89.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.149 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.8 -40.38 79.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.1 -1.0 . . . . 0.0 110.938 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 m -101.7 1.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.083 -1.011 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 66.44 25.58 72.63 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.68 -167.84 43.92 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.2 t -137.43 140.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.412 -1.052 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG12 ' SD ' ' A' ' 124' ' ' MET . 10.7 t -71.66 130.65 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.163 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -127.01 157.51 39.37 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.0 109.297 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -84.62 -173.41 4.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.312 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 121' ' ' ARG . 97.9 m-20 -60.65 -38.65 85.55 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.268 -0.895 . . . . 0.0 108.69 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.63 17.74 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.49 -0.756 . . . . 0.0 109.653 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.9 mtt180 56.15 32.44 20.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.606 -0.684 . . . . 0.0 110.709 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -111.7 147.65 35.12 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 67.4 mtt -52.14 125.55 16.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.95 -1.094 . . . . 0.0 109.609 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.437 ' SD ' HG12 ' A' ' 116' ' ' VAL . 58.2 mtp -60.88 136.24 58.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 109.904 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 30.7 p -122.93 149.99 57.94 Favored Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -41.19 -44.07 5.35 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 120.662 0.908 . . . . 0.0 112.185 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.67 -39.89 90.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.291 -0.881 . . . . 0.0 109.056 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 125' ' ' THR . 68.6 mttm -67.89 -39.61 83.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.268 -0.895 . . . . 0.0 110.175 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.42 -40.18 74.3 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 130' ' ' ARG . 48.6 mtt-85 -63.37 -39.48 94.64 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.617 -0.677 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -59.96 -44.19 94.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 109.121 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -62.58 -40.11 95.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 108.676 179.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -60.91 -39.03 87.78 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.297 -0.877 . . . . 0.0 108.841 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.58 -39.99 93.14 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.33 -40.89 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.007 -1.058 . . . . 0.0 108.852 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.29 -41.97 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 98.1 mtt180 -61.82 -28.87 69.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.916 -0.49 . . . . 0.0 110.725 -179.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 4' ' ' PRO . 97.3 mt-10 -60.12 -40.1 88.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.831 -1.168 . . . . 0.0 109.645 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.462 ' CG2' ' H ' ' A' ' 9' ' ' ALA . 64.1 t -71.97 -34.03 49.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.466 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 144' ' ' ALA . 62.9 mttm -59.88 -43.15 94.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.929 -1.107 . . . . 0.0 110.902 -179.025 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.8 OUTLIER -61.89 -26.62 68.27 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.172 179.736 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.51 -59.7 3.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -112.21 -28.01 8.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.488 -0.757 . . . . 0.0 110.133 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.329 -0.857 . . . . 0.0 109.809 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -86.96 -7.57 58.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.75 69.99 79.2 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.333 -0.855 . . . . 0.0 109.763 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 6' ' ' ARG . 9.6 Cg_endo -71.05 99.4 0.88 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.943 1.096 . . . . 0.0 111.834 178.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -79.28 31.97 0.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.221 -0.924 . . . . 0.0 108.581 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 4' ' ' PRO . 92.0 mtt180 -73.54 158.55 34.64 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.478 0.656 . . . . 0.0 110.415 -179.064 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -83.32 -7.64 59.55 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.83 142.71 30.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.7 -174.27 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.566 -1.334 . . . . 0.0 110.5 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.8 t -131.46 136.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.2 mm -91.27 129.43 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.486 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 81.4 mt -131.64 142.72 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 122.056 0.931 . . . . 0.0 110.912 -177.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.8 mtm -147.85 152.17 37.18 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -129.92 129.3 43.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.921 -1.112 . . . . 0.0 111.434 -178.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.03 112.19 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.11 154.85 39.83 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.119 -0.988 . . . . 0.0 110.848 -178.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.77 168.45 17.78 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -56.08 160.18 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.073 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -60.71 150.14 33.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -0.929 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.77 -4.41 78.9 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 m -130.14 147.48 51.88 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.523 -0.986 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.53 150.2 50.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.502 -0.749 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.95 145.04 27.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.29 -0.881 . . . . 0.0 110.109 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -70.77 141.13 51.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 108.841 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.23 97.98 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.379 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.06 -45.03 96.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.0 -1.294 . . . . 0.0 109.425 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 81.6 mt -69.95 -24.1 63.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.102 179.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 28' ' ' LEU . 4.5 tt -77.1 -55.43 5.45 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.5 -0.75 . . . . 0.0 109.956 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.97 -48.7 80.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.127 -0.983 . . . . 0.0 111.104 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 31' ' ' SER . 43.2 p-10 -64.19 -40.02 95.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.858 -1.151 . . . . 0.0 110.66 -178.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 75.5 m -60.9 -40.55 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.888 -1.133 . . . . 0.0 109.797 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.416 HD11 ' CD2' ' A' ' 28' ' ' LEU . 96.8 mt -60.05 -48.27 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -61.63 -40.06 93.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.849 . . . . 0.0 109.685 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -67.26 -20.03 65.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 0.0 110.245 -179.266 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.552 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -82.74 1.05 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 109.663 -179.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.65 10.5 61.66 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -80.0 154.68 28.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.052 -1.264 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 96.7 mt -126.12 136.94 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.12 106.38 0.51 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.983 -1.073 . . . . 0.0 110.051 -178.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.66 172.83 31.71 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.54 -168.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 110.061 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 77.1 mtm 59.24 25.4 13.99 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.613 0.721 . . . . 0.0 109.844 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.4 m120 50.64 36.35 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.641 -0.662 . . . . 0.0 111.823 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -140.09 167.52 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.004 -1.06 . . . . 0.0 108.594 177.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.901 -1.124 . . . . 0.0 111.083 -178.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 56.4 m80 -103.85 131.05 51.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.425 -0.797 . . . . 0.0 109.392 178.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 54.0 ttt180 -105.96 127.29 53.05 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.223 -0.923 . . . . 0.0 108.702 178.085 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 60.7 m-70 -97.37 171.71 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.0 110.173 -179.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.28 -49.95 68.41 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -90.36 148.15 38.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.374 -0.828 . . . . 0.0 109.014 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -70.27 -7.39 21.09 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.844 1.029 . . . . 0.0 112.355 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.86 -0.27 55.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.116 -0.99 . . . . 0.0 110.283 -179.16 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.78 10.07 86.1 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -69.99 -41.26 74.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -1.145 . . . . 0.0 110.243 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -78.83 166.98 52.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -65.62 168.54 14.65 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.068 1.179 . . . . 0.0 111.393 179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.996 -1.065 . . . . 0.0 109.231 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.4 mp -101.66 -40.12 7.14 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.275 -0.891 . . . . 0.0 109.563 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -150.12 163.14 38.98 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 109.316 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 46' ' ' HIS . 74.8 m -134.1 178.71 6.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.881 0.848 . . . . 0.0 111.137 -177.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 61' ' ' LEU . 8.0 tt -132.5 131.43 41.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.56 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -134.44 162.57 31.86 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.704 -0.623 . . . . 0.0 109.48 -179.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.48 ' OD1' ' CE2' ' A' ' 70' ' ' PHE . 11.6 m120 -74.93 159.68 31.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 110.53 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.2 mtp -70.0 -23.52 63.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.593 -0.692 . . . . 0.0 110.119 -179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 65' ' ' VAL . 17.4 m -85.36 121.73 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.922 -1.111 . . . . 0.0 109.55 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -59.59 149.92 68.6 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.314 -0.866 . . . . 0.0 108.929 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -77.28 12.12 13.02 Favored 'Cis proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.16 -0.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.5 11.19 85.1 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.2 p -87.14 170.58 11.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.351 -1.088 . . . . 0.0 110.062 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.48 ' CE2' ' OD1' ' A' ' 63' ' ' ASN . 87.2 m-85 -116.89 144.8 44.1 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 73' ' ' GLU . 78.1 m-20 -129.21 150.6 75.9 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -44.81 -12.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.697 0.931 . . . . 0.0 112.16 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 71' ' ' ASP . 97.4 mt-10 -85.13 15.23 4.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 71' ' ' ASP . 7.8 ptp -81.79 -5.12 57.9 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.376 -179.14 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 67.9 mttm -88.11 -4.63 58.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.88 -1.137 . . . . 0.0 110.468 -179.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.0 m-20 -150.96 69.7 0.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.885 -1.134 . . . . 0.0 109.822 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -154.44 170.0 22.43 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 75.6 p -129.68 154.03 47.55 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.6 148.87 17.67 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.95 -1.094 . . . . 0.0 109.329 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -46.69 -51.17 9.45 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 120.416 0.744 . . . . 0.0 111.62 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.98 -149.52 7.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.03 163.07 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.608 -0.936 . . . . 0.0 110.068 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.6 m -115.04 126.54 54.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.8 mt -109.88 130.02 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.98 155.15 40.4 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.785 -1.197 . . . . 0.0 111.556 -178.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 42.6 ttm -119.51 131.18 55.52 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 90' ' ' SER . 93.5 mm-40 -90.38 112.33 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 88' ' ' VAL . 7.8 m -97.93 150.36 36.68 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.73 132.3 26.48 Favored 'Cis proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.47 0.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 87' ' ' GLN . 49.6 m -106.4 158.37 16.94 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.595 -0.691 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -73.01 153.07 41.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 0.0 109.884 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.61 -164.47 33.02 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.5 ' O ' ' ND2' ' A' ' 97' ' ' ASN . 71.5 m-20 -95.29 107.92 20.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -1.067 . . . . 0.0 108.918 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 136' ' ' ILE . 90.8 mt-10 -59.88 -30.26 68.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.667 -0.646 . . . . 0.0 110.529 -179.292 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.71 -39.99 76.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.274 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -74.88 -40.6 60.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.042 -1.036 . . . . 0.0 108.815 179.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 93' ' ' ASP . 72.3 m-80 -62.47 -35.83 80.56 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -59.6 -49.98 75.66 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -60.79 -40.08 91.27 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.96 -43.22 95.2 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.0 mtp -58.5 -41.17 84.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.26 -0.9 . . . . 0.0 109.1 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.15 -40.76 86.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.601 179.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.524 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 97.8 mt-30 -60.04 -40.13 88.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 0.0 109.526 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.6 p -72.53 -40.01 67.11 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.175 -0.953 . . . . 0.0 109.458 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.54 -53.51 57.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.442 -0.786 . . . . 0.0 110.102 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.62 -37.74 82.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.975 -1.078 . . . . 0.0 109.314 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 12.5 m-70 -59.98 -47.48 85.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.097 -1.002 . . . . 0.0 109.048 179.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 92.7 mt -60.03 -49.95 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.401 -0.812 . . . . 0.0 109.208 179.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -50.16 -50.39 49.12 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.571 -0.705 . . . . 0.0 109.513 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.07 -39.99 87.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.327 179.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.64 -39.95 80.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 110.591 -178.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -100.2 -0.16 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 69.58 24.33 76.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.29 -173.53 49.21 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.4 t -130.76 134.38 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.631 -0.923 . . . . 0.0 108.956 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.601 HG12 ' SD ' ' A' ' 124' ' ' MET . 2.5 t -71.71 128.25 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 108.94 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.3 mt -131.06 159.99 35.96 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.395 -0.816 . . . . 0.0 109.824 -179.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -85.95 -170.07 2.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.757 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 98.2 m-20 -60.12 -39.85 87.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.352 -0.843 . . . . 0.0 110.295 -179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.88 14.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 108.962 -179.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 119' ' ' ASP . 98.4 mtt180 56.23 35.13 25.24 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.382 0.61 . . . . 0.0 109.371 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 122' ' ' ARG . 13.0 mtt-85 -109.7 153.33 24.42 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.619 -0.676 . . . . 0.0 109.315 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.2 mtm -50.27 124.37 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.289 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.601 ' SD ' HG12 ' A' ' 116' ' ' VAL . 52.3 mtp -60.03 140.0 57.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.866 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 p -131.65 150.83 77.39 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -43.64 -42.75 11.47 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 120.706 0.937 . . . . 0.0 112.411 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.01 -39.92 87.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -66.59 -39.61 88.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.158 -0.964 . . . . 0.0 109.528 -179.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.9 -39.96 83.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.097 . . . . 0.0 108.071 179.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.73 -40.06 96.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -60.01 -47.87 84.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 109.688 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -60.08 -42.58 94.88 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.862 -1.149 . . . . 0.0 108.585 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -60.79 -40.01 91.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.69 -38.93 86.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.631 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.0 -43.34 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.031 . . . . 0.0 108.608 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 94' ' ' GLU . 81.7 mt -59.94 -41.35 85.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.266 -0.896 . . . . 0.0 108.684 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.454 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 57.0 mtp180 -59.89 -39.97 87.16 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.443 -0.786 . . . . 0.0 109.431 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 80.8 mm-40 -60.01 -41.36 91.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -0.916 . . . . 0.0 109.805 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.3 t -77.92 -32.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 110.845 -179.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -60.04 -40.28 88.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.953 -1.092 . . . . 0.0 110.532 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 137' ' ' ARG . 0.6 OUTLIER -59.98 -30.96 69.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.266 179.878 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.57 94.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.358 -0.839 . . . . 0.0 109.953 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -96.84 -2.67 43.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.222 -0.924 . . . . 0.0 109.9 -179.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.0 109.433 179.817 . . . . . . . . 0 0 . 1 stop_ save_